AU2005278901A1 - Method for analyzing genes of industrial yeasts - Google Patents

Description

WO 2006/024951 PCT/IB2005/002908 DESCRIPTION METHOD FOR ANALYZING GENES OF INDUSTRIAL YEASTS 5 Technical Field The present invention relates to a method analyzing genes of an industrial yeast used for the production of an alcoholic beverage such as beer or sake, a fuel alcohol, etc. and particularly for genes of brewing yeast used for 10 the production of an alcoholic beverage. More particularly, it relates to a method where, in the production of an alcoholic beverage, DNA sequence information of brewing yeast is compiled in a database so that the gene which involves in increase in productivity 15 and/or improvement in flavor such as stabilization, reinforcement, etc. of the flavor is selected; a method for breeding yeast suitable for the brewing in which expression of a gene is controlled, such as yeast in which the selected gene is disrupted or'yeast in which the gene is 20 overexpressed; and a method for the production of an alcoholic beverage using the bred yeast. Background Art Development of techniques for production of fuel 25 alcohols, alcoholic beverages such as beer or sake, etc. has been carried out using industrial yeast. Especially in the production of an alcoholic beverage using brewing yeast, there has been a brisk development in the techniques

I

WO 2006/024951 PCT/IB2005/002908 for increasing productivity and improving flavor such as stabilization or enhancement of flavor of an alcoholic beverage. The most consumed alcoholic beverage in the world is 5 beer and the amount of beer produced in the world in 2001 was about 140,000,000 kL. Type of beer is roughly classified into three depending upon types of yeast and fermentation methods. The three types are, naturally fermented beer where fermentation is carried out utilizing 10 yeast and microorganisms inhabiting in breweries; ale-type beer where fermentation is carried out using a top fermenting yeast belonging to Saccharomyces cerevisiae (hereinafter, abbreviated as S. cerevisiae) at the temperature of 20 to 25 0 C and the following aging period is 15 shortened; and lager-type beer where fermentation is carried out using a bottom fermenting yeast belonging to Saccharomyces pastorianus at the temperature of 6 to 15 0 C and then subjected to a low-temperature aging. At present, not less than 90% of the beer produced in the world is a 20 lager-type beer and, therefore, the bottom fermenting yeast that is used for brewing of the lager-type beer has been most widely used in beer brewing. In the so-called fermentation production where production is carried out using a microorganism including 25 the above-mentioned brewing yeast, it is important that the fermentation process is optimized and that the useful strain is selected and bred, in order to increase productivity and improve quality of the product. 2 WO 2006/024951 PCT/IB2005/002908 In the case of optimization of beer brewing, a method where an amount of yeast metabolites such as alcohol (e.g. ethanol), ester, organic acid, etc. are monitored, and then temperature, quantity of airflow, content of raw material, 5 etc. are controlled, has been conducted. In such a case, material uptake and excretion by yeast cells and metabolism in the cells are handled as a black box and only very superficial control is carried out. In addition, for the purpose of giving, for example, high flavor to an alcoholic 10 beverage, a process controling method to suppress the amount of oxygen supply during beer brewing or the like has been tried. In such a method, however, growth rate of the yeast itself is reduced due to insufficient oxygen, and adverse effects such as retardation of fermentation and/or 15 deterioration of beer quality may arise. Accordingly, there has been a limit on the improvement in productivity and quality of beer by means of optimization of fermentation processes. On the other hand, with regard to a method of breeding 20 useful industrial yeast such as useful beer yeast, a technique for selecting a desirable strain has widely been used rather than actual breeding. Beer brewing per se has been performed since well before the discovery of microorganisms by Pasteur. In the beer brewing, a method 25 of selecting a more suitable strain of beer yeast from many strains of yeast used in the beer brewery has been traditionally carried out while there have been few cases where beer yeast with good traits is positively bred. 3 WO 2006/024951 PCT/IB2005/002908 As an example of a positive breeding method, there is a method where artificial mutagenesis by chemicals or radioactive rays is used. However, brewing yeast, particularly a bottom fermenting yeast which is widely used 5 in beer brewing, is in many cases a polyploid. In that case, it is not possible to produce a desired mutant unless mutation takes place in all of the alleles to be mutated. Accordingly, although it is possible to induce a desirable mutation in the case of a haploid laboratory yeast, it is 10 substantially impossible in the case of beer yeast which is a polyploid. In recent years, a breeding where mutation or cross breeding is carried out by using spores isolated from bottom fermenting yeast (c.f., for example, Non-Patent 15 Document 1) has been tried. However, the bottom fermenting yeast is a polyploid, and has complicated chromosome structure. Therefore, isolation of spores having a proliferation ability is difficult, and moreover, it is almost impossible to obtain a strain with good traits from 20 them. On the other hand, it has recently become possible that desired genes are introduced and expressed in the brewing yeast using a genetic engineering technique, whereby it has become possible to breed yeast with the 25 desired character by using the results of functional analysis of genes and the genes which have been functionally analyzed. However, as compared with the baker's yeast (S. cerevisiae; c.f., for example, Non-Patent 4 WO 2006/024951 PCT/IB2005/002908 Document 2) of which the whole genome sequence is already clarified, the genome sequence of the bottom fermenting yeast has not been clarified and there have been only a very few findings about the bottomfermenting yeast specific 5 gene involved in brewing character specific to bottom fermenting yeast and about the function of the said gene during beer brewing. In recent years, transcriptome analysis has been conducted using DNA array where DNA fragments or nucleotide 10 oligomers, each of which has a partial sequence of structural genes or internal regions of the chromosomes are fixed on solid support. For example, Olesen, et al. conducted a comprehensive genetic expression analysis of bottom fermenting yeast during the-brewing using 15 GeneFilters (manufactured by Research Genetics Co.)(c.f., for example, Non-Patent Document 3). However, since the genome sequence of bottom fermenting yeast has not been clarified yet, it is ambiguous that which gene is monitored for its expression precisely. Thus, the information about 20 bottom fermenting yeast is quite insufficient to apply to metabolic analysis, and to breeding of useful yeast, and to control of beer brewing process. At present, the whole genome sequences of more than 100 species of microorganisms have been determined (c.f., 25 for example, Non-Patent Document 6) including S. cerevisiae, Escherichia coli (c.f., for example, Non-Patent Document 4) and Mycobacterium tuberculosis (c.f., for example, Non-Patent Document 5). On the basis of the 5 WO 2006/024951 PCT/IB2005/002908 determined DNA sequences, genes of these microorganisms are identified and function of an enormous number of genes have been predicted without conducting genetic, biochemical or molecular biological experiments. However, industrial 5 yeast such as brewing yeast which has high ploidy and a complicated chromosome structure, and thus an assembly (an operation for connecting the DNA sequences) is presumed to be difficult. Therefore, the genome sequence of bottom fermenting yeast which contains two different types of 10 genome (c.f., for example, Non-Patent Document 7) has not been reported yet. In the production of specific alcohols or alcoholic beverages, there is a technique to increase concentration of sulfite in the product for the control of flavor. 15 Sulfite is known as a compound which has anti-oxidative activity, and has been widely used as an antioxidant in the fields of food, beverage and pharmaceuticals, and also in an alcoholic beverage. For example, in the case of wine that requires a long aging period, sulfite plays an 20 important role for the preservation of its quality. It is also known that, in beer brewing, the quality preservation period becomes long in accordance with the increase in concentration of sulfite contained in the product. Thus, when the amount of sulfite in the product is increased, it 25 is possible to prepare a product that has excellent flavor stability and a long quality preservation period. The simplest way to increase the amount of sulfite in the product is addition of sulfite. In Japan, so far as 6 WO 2006/024951 PCT/IB2005/002908 wine is concerned, it is permitted by the Ministry of Health, Labor and Welfare to add sulfite to an extent of not more than 350 ppm in terms of residual sulfite concentration. In that case, however, since sulfite is 5 categorized as ,food additives, it is not desirable to add sulfite to beer when a negative image of consumers to food additives is taken into consideration. However, the yeast used in brewing produces hydrogen sulfide by the reduction of sulfate in the medium in order 10 to synthesize sulfur-containing metabolites such as sulfur containing amino acids. Sulfite is an intermediate metabolite of this pathway. If sulfite is efficiently excreted outside of the cells during fermentation period, it is possible to increase the amount of sulfite both in 15 the wort and in the product. There are two methods for increasing sulfite concentration in the wort during fermentation. One is to control a fermentation process and another is to breed brewing yeast. As for the control of fermentation process, 20 the amount of sulfite produced during fermentation is inversely proportional to the concentration of dissolved oxygen and, therefore, there has been an attempt of a method where the concentration of dissolved oxygen is reduced so that the amount of sulfite is increased and at 25 the same time the oxidation of sulfite is suppressed. However, in that method, growth rate of yeast is reduced due to the lack of oxygen, which has negative effects such 7 WO 2006/024951 PCT/IB2005/002908 as retardation of fermentation and deterioration of quality. Therefore that method is not practical. On the other hand, as mentioned above, a genetic engineering technique has been developed for breeding 5 brewing yeast. For example, there are some reports focused on sulfur metabolism of yeast. Sulfite (SO 2 ) is an intermediate product of sulfur-containing amino acid and vitamin synthesis and is produced via a pathway of sulfate ion (SO42) -+ APS (adenyl sulfate) -- PAPS (phosphoadenylyl 10 sulfate) -- sulfite ion (SO 3 ) where the sulfate ion is incorporated from outside of the cells. There is an attempt in which copy numbers of MET 3 gene participating in the reaction of sulfate ion (SO42) -> APS (adenylyl sulfate) and of MET 14 gene participating in the reaction 15 of APS (adenylyl sulfate) -+ PAPS (phosphoadenylyl sulfate) are increased to improve the ability of the yeast for the production of sulfite (c.f., for example, Non-Patent Document 8). There is another example of an attempt where reduction of sulfite ion (S0 3 2 ) is inhibited by the 20 disruption of MET 10 gene whereby amount of sulfite produced by the yeast is increased (c.f., for example, Non Patent Document 9). According to such attempts, the amount of sulfite produced by an MET 10 gene disruptant is increased to an extent of not less than ten-fold of the 25 parental strain , but on the other hand, some retardation in fermentation and increase in the amounts of acetaldehyde and 1-propanol in the beer are noted, which has become a problem for the practical use. 8 WO 2006/024951 PCT/IB2005/002908 Accordingly, although development of breeding methods for industrial yeast such as brewing yeast using genetic engineering have been in progress, it is the current status that, due to insufficient genomic information of brewing 5 yeast, selection of the brewing yeast specific gene involved in a brewing character of brewing yeast, analysis of function of protein encoded by the gene and utilization of those findings for breeding have not been sufficiently carried out. 10 Thus, a method for breeding yeast which shows the desired character without deterioration of fermentation speed and product quality has not been established yet and there has been a big demand for the development of such a method not only in the brewing industry but also in the 15 industries where the yeast is used. (Non-Patent Document 1) C. Gjermansen: "Construction of a hybrid brewing strain of Saccharomyces carlsbergensis by mating of meiotic segregants", Carlsberg Res. Commun., volume 46, pages 1 to 11 (1981). 20 (Non-Patent Document 2) A. Goffeau, et al.: "The Yeast Genome Directory", Nature, volume 387, pages 5 to 105 (1997). (Non-Patent Document 3) K. Olesen, et al.: "The dynamics of the Saccharomyces carlsbergensis brewing yeast 25 transcriptome during a production-scale lager beer fermentation", FEMS Yeast Research, volume 2, pages 563 to 573 (2000). 9 WO 2006/024951 PCT/IB2005/002908 (Non-Patent Document 4) F. R. Blattner, et al.: "The Complete Genome Sequence of Escherichia coli K-12", Science, volume 277, pages 1453-1462 (1997). (Non-Patent Document 5) S. T. Cole, et al.; 5 "Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence", Nature, volume 393, pages 537-544 (1998). (Non-Patent Document 6) The National Center for Biotechnology Information, 10 http://www.ncbi.nlm.nih.gov/PMGifs/Genomes/micr.html. (Non-Patent Document 7) Y. Tamai et al.:"Co-existence of two types of chromosome in the fermenting yeast, Sacchaomyces cerevisiae", Yeast, volume 10, pages 923-933 (1998). 15 (Non-Patent Document 8) C. Korch, et al.: Proc. Eur. Brew. Conv. Congress, Lisbon, pages 201-208 (1991). (Non-Patent Document 9) J. Hansen, et al.: "Inactivation of MET 10 in brewer's yeast specifically increases SO 2 formation during beer production", Nature 20 Biotech., volume 14, pages 1587-1591 (1996). (Non-Patent Document 10) T. Sijen, et al.: "Transcriptional and posttranscriptional gene silencing are mechanistically related", Curr. Biol., volume 11, pages 436-440 (2001). 25 (Non-Patent Document 11) N. Goto, et al.: "SSUl-R, a sulphite resistance gene of wine yeast, is an allele of SSU 1 with a different upstream sequence", J. Ferment. Bioeng., volume 86, pages 427-433 (1998). 10 WO 2006/024951 PCT/IB2005/002908 (Non-Patent Document 12) D. Avram, et al.: "SSU 1 encodes a plasma membrane protein with a central role in a network of proteins conferring sulfite tolerance in Saccharomyces cerevisiae", J. Bacteriol., volume 179, pages 5 5971-5974 (1997). (Non-Patent Document 13) H. Park, et al.; "SSU 1 mediates sulphite efflux in Saccharomyces cerevisiae", Yeast, volume 16, pages 881-888 (2000). 10 Disclosure of the Invention An object of the present invention is to provide a method of analyzing and selecting genes relating to the desired brewing characters, which is achieved in such a manner that a database compiling the genome sequence 15 (hereinafter, may be abbreviated as genomic DB) of industrial yeast, particularly brewing yeast used for an alcoholic beverage such as beer, is prepared; gene that the brewing yeast possesses is selected from the database; functional analysis of the gene may be carried out by 20 disruption or overexpression. Another object of the present invention is to provide a DNA array which is useful for an analyzing method of genes of an industrial yeast. Further object is to provide a breeding method of the yeast showing the brewing character which the said gene is 25 relating to and also a method of producing an alcohol or an alcoholic beverage where productivity and quality are improved using the said yeast. Still another object is to 11 WO 2006/024951 PCT/IB2005/002908 provide genes mentioned above and peptides encoded by the said genes. It has been known that brewing yeast widely used for industrial purpose is a polyploid and especially, bottom 5 fermenting yeast is an allopolyploid which is composed of at least two kinds of genomes. One of the genomes is thought to be a genome derived from S. cerevisiae of which the whole genome sequence has been clarified, while the source of another genome(s) has not been clarified yet. 10 The present inventors have analyzed the genome sequence of the bottom fermenting yeast in order to find unidentified genes displaying essential functions for excellent brewing. The amino acid sequences of the bottom fermenting yeast were then compared with those registered 15 in the genomic DB for S. cerevisiae, and functions of proteins encoded by genes of the brewing yeast were estimated. As a result, it has been clarified that the genes of the bottom fermenting yeast are roughly classified into Sc type genes showing nearly 100% amino acid identity 20 to those of S. cerevisiae and non-Sc type genes showing around 70 to 97% amino acid identify (this corresponds to around 60 to 94% identity in nucleotide level). Moreover, it has been clarified that the bottom fermenting yeast has a complicated chromosome structure consists of Sc-type 25 chromosomes, non-Sc-type chromosomes and Sc/non-Sc-type chimera chromosomes. Structure of the whole chromosomes of the bottom fermenting yeast is shown in Fig. 1. On the basis of genomic information clarified by the present 12 WO 2006/024951 PCT/IB2005/002908 invention, the present inventors have found such an unexpectedly complicated structure of chromosomes, and developed a screening method for the genes of bottom fermenting yeast. 5 To be more specific, the inventors have achieved a method for analyzing gene of an industrial yeast comprising (a) analyzing nucleotide sequence of the genome of the industrial yeast, particularly bottom fermenting yeast which is one of the brewing yeasts,; and 10 (c-1) selecting a gene of the industrial yeast encoding an amino acid sequence having 70 to 97% identity to an amino acid sequence encoded by the gene of Saccharomyces cerevisiae, or (c-2) selecting a gene of the industrial yeast 15 consisting of a nucleotide sequence having 60 to 94% identity to the nucleotide sequence of the gene of Saccharomyces cerevisiae. Preferably, the method of the present invention comprises, 20 (b)- comparing the genome sequence with the genome sequence of Saccharomyces cerevisiae after the step (a) and before the step (c-1) or (c-2). Preferably, the analyzing method of the present invention comprises, (d) carrying out functional analysis 25 of the selected gene, after the step (c-1) or (c-2), whereby the brewing character given to the yeast by the genes are identified. The present inventors have repeatedly carried out intensive investigations on the 13 WO 2006/024951 PCT/IB2005/002908 basis of those findings and accomplished the present invention. Thus, the present invention includes the following embodiments: 5 1. A method for analyzing gene of an industrial yeast comprising (a) analyzing nucleotide sequence of the genome sequence of the industrial yeast; and (c-1) selecting a gene of the industrial yeast encoding 10 an amino acid sequence having 70 to 97% identity to an amino acid sequence encoded by the gene of Saccharomyces cerevisiae, or (c-2) selecting a gene of the industrial yeast consisting of a nucleotide sequence having 60 to 94% 15 identity to the nucleotide sequence of the gene of Saccharomyces cerevisiae. 2. The analyzing method according to Embodiment 1, comprising, (b) comparing the genome sequence of the industrial 20 yeast with that pf the genome sequence of Saccharomyces cerevisiae after the step (a) and before the step (c-1) or (c-2). 3. The analyzing method according to Embodiment 1 or 2, comprising 25 (d) carrying out functional analysis of the selected gene after the step (c-1) or (c-2). 4. The analyzing method according to Embodiment 3, which comprises screening genes involved in increase of 14 WO 2006/024951 PCT/IB2005/002908 productivity and/or improvement in flavor in the production of an alcohol or an alcoholic beverage by the functional analysis of the step (d). 5. The analyzing method according to Embodiment 3 or 5 4, wherein the functional analysis is performed by disruption of a gene or overexpression of a gene. 6. The analyzing method according to any of Embodiments 1-5, wherein the industrial yeast is a brewing yeast. 10 7. The analyzing method according to Embodiment 6, wherein the brewing yeast is a beer yeast. 8. The analyzing method according to Embodiment 7, wherein the beer yeast is a bottom fermenting yeast. 9. A gene of the industrial yeast encoding an amino 15 acid sequence having 70 to 97% identity to an amino acid sequence encoded by the gene of Saccharomyces cerevisiae, or consisting of a nucleotide sequence having 60 to 94% identity to the nucleotide sequence of the gene of Saccharomyces cerevisiae, which is obtained by the 20 analyzing method according to any one of Embodiments 1-8. 10. A gene library comprising one or more of genes of the industrial yeast each of which encodes an amino acid sequence having 70 to 97% identity to an amino acid sequence encoded by the gene of Saccharomyces cerevisiae, 25 or consists of a nucleotide sequence having 60 to 94% identity to the nucleotide sequence of the gene of Saccharomyces cerevisiae, which is obtained by the analyzing method according to any one of Embodiments 1-8. 15 WO 2006/024951 PCT/IB2005/002908 11. The gene library according to Embodiment 10, wherein the gene of the industrial yeast is comprised in, consists of or has any nucleotide sequence selected from SEQ ID NOs:33 to 6236, SEQ ID NOs:166154 to 166181, SEQ ID 5 NOs:166490 to 167042 and SEQ ID NOs:173125 to 174603. 12. A DNA array comprising one or more of DNAs, wherein each DNA is selected from at least one group of (1) to (4): (1) DNA consisting of a nucleotide sequence of an open 10 reading frame of the genome sequence of an industrial yeast which encodes an amino acid sequence having 70 to 97% identity to an amino acid sequence encoded by the gene of Saccharomyces cerevisiae, or a nucleotide sequence complementary to the above nucleotide sequence, or a 15 nucleotide sequence of continuous 10 or more nucleotides selected from the above nucleotide sequences; (2) DNA consisting of a nucleotide sequence of the genome sequence of an industrial yeast other than from open reading frames which consists of a nucleotide sequence 20 having 60 to 94% identity to the nucleotide sequence of the gene of Saccharomyces cerevisiae, or a nucleotide sequence complementary to the above nucleotide sequence, or a nucleotide sequence of continuous 10 or more nucleotides selected from the above nucleotide sequences; 25 (3) DNA having a nucleotide sequence of any of SEQ ID NOs:166490 to 167042, or DNA having a nucleotide sequence of any of SEQ ID NOs:167043 to 173124;and 16 WO 2006/024951 PCT/IB2005/002908 (4) DNA having a nucleotide sequence of any of SEQ ID NOs:173125 to 174603, or DNA having a nucleotide sequence of any of SEQ ID NOs:174604 to 190810. 13. The DNA array according to Embodiment 12 5 comprising DNAs wherein at least one DNA is selected from every group of (1) to (4). 14. The DNA array according to Embodiment 12 or 13, wherein the DNAs of (1) is comprised in, consists of or has any nucleotide sequence selected from SEQ ID NOs:33 to 10 6236, SEQ ID NOs:166154 to 166181, SEQ ID NOs:6237 to 75336 and SEQ ID NOs:166182 to 166489. 15. The DNA array according to any one of Embodiments 12-14, which further comprises, in addition to at least one group of DNAs selected from (1) to (4), DNAs of the 15 following (5) and/or (6),: (5) DNA consisting of a nucleotide sequence of an open reading frame of the genome sequence of an industrial yeast which encodes an amino acid sequence having identity of more than 97% to an amino acid sequence encoded by the gene 20 of Saccharomyces cerevisiae, or a nucleotide sequence complementary to the above nucleotide sequence, or a nucleotide sequence of continuous 10 or more nucleotides selected from the above nucleotide sequences; and (6) DNA consisting of a nucleotide sequence of the 25 genome sequence of an industrial yeast other than from open reading frames which consists of a nucleotide sequence having identity of more than 94% to the nucleotide sequence of the gene of Saccharomyces cerevisiae, or a nucleotide 17 WO 2006/024951 PCT/IB2005/002908 sequence complementary to the above nucleotide sequence, or a nucleotide sequence of continuous 10 or more nucleotides selected from the above nucleotide sequences, and optionally comprises DNAs of the following (5') and/or 5 (6'): (5') DNA consisting of a nucleotide sequence which contains mismatch of 1 or more base(s) to the DNA of (5), or a nucleotide sequence complementary to the above nucleotide sequence; and 10 (6') DNA consisting of a nucleotide sequence which contains mismatch of 1 or more base(s) to the DNA of (6), or a nucleotide sequence complementary to the above nucleotide sequence. 16. The DNA array according to Embodiment 15, wherein 15 the DNAs of (5) has a nucleotide sequence of any one of SEQ ID NOs:75337 to 82784, or SEQ ID NOs:82785 to 166153. 17. The DNA array according to any one of Embodiments 12-16, which comprises, in addition to at least one group of DNAs selected from (1) to (4), DNAs selected from at 20 least one of (7) to (10): (7) DNA consisting of a nucleotide sequence which contains mismatch of 1 or more base(s) to the DNA of (1), or a nucleotide sequence complementary to the above nucleotide sequence; 25 (8) DNA consisting of a nucleotide sequence which contains mismatch of 1 or more base(s) to the DNA of (2), or a nucleotide sequence complementary to the above nucleotide sequence; 18 WO 2006/024951 PCT/IB2005/002908 (9) DNA consisting of a nucleotide sequence which contains mismatch of 1 or more base(s) to the DNA of (3), or a nucleotide sequence complementary to the above nucleotide sequence; and 5 (10) DNA consisting of a nucleotide sequence which contains mismatch of 1 or more base(s) to the DNA of (4), or a nucleotide sequence complementary to the above nucleotide sequence. 18. The DNA array according to Embodiment 17, which 10 comprises, in addition to at least one group of DNAs selected from (1) to (4), DNAs selected from at least one of (7-1) to (10-1): (7-1) DNA consisting of a nucleotide sequence which contains mismatch of 1 base to the DNA of (1), or a 15 nucleotide sequence complementary to the above nucleotide sequence; (8-1) DNA consisting of a nucleotide sequence which contains mismatch of 1 base to the DNA of (2), or a nucleotide sequence complementary to the above nucleotide 20 sequence; (9-1) DNA consisting of a nucleotide sequence which contains mismatch of 1 base to the DNA of (3), or a nucleotide sequence complementary to the above nucleotide sequence; and 25 (10-1) DNA consisting of a nucleotide sequence which contains mismatch of 1 base to the DNA of (4), or a nucleotide sequence complementary to the above nucleotide sequence. 19 WO 2006/024951 PCT/IB2005/002908 19. The DNA array according to any one of Embodiments 12-18, which comprises at least one group of DNAs selected from (1) to (4), at least one group of DNAs selected from (7) to (10), DNAs of (5) and/or (6) and DNAs of (5') and/or 5 (6'). 20. The DNA array according to any one of Embodiments 12-19, wherein the DNAs are oligonucleotides consisting of 10-30 nucleotides. 21. Use of the DNA array according to any one of 10 Embodiments 12-20 as an analyzing method of genes of an industrial yeast. 22. A method for classifying an industrial yeast comprising (a) hybridizing genomic DNA prepared from the industrial 15 yeast to the DNA array of any one of Embodiments 15-20 and (b) calculating hybridization ratio to any of (1) to (4), and hybridization ratio to (5) and/or (6). 23. The method for classification according to 20 Embodiment 22, wherein the DNA array of Embodiment 19 is used, and percentage of genes which hybridize to DNAs of (1) and/or (2), but not to DNAs of (7) and/or (8) is determined as hybridization ratio to any of (1) to (4), and 25 percentage of genes which hybridize to DNAs of (5) and/or (6), but not to DNAs of (5') and/or (6') is determined as hybridization ratio to any of (5) and/or (6). 20 WO 2006/024951 PCT/IB2005/002908 24. A method for detecting nucleotide polymorphism in genome of an industrial yeast comprising (a) hybridizing genomic DNA prepared from the industrial yeast to the DNA array of any one of Embodiments 17-20; and 5 (b) selecting a gene wherein hybridization intensity to the DNAs of any of (7) to (10) is higher than hybridization intensity to the DNAs of any of (1) to (4). 25. A method for screening a useful strain of industrial yeast, comprising 10 (a) hybridizing genomic DNA prepared from the industrial yeast strain to the DNA array of any one of Embodiments 12 20; and (b) determining the industrial yeast strain as useful when the strain contain 1 or more genes wherein 15 hybridization intensity thereof is 1.5 times higher, or 2/3 or less compared to an average hybridization intensity to the DNAs of any of (1) to (4). 26. A method for screening a gene of an industrial yeast, comprising 20 (a) hybridizing genomic DNA prepared from the industrial yeast strain to the DNA array of any one of Embodiments 12 20; and (b) selecting a gene wherein hybridization intensity thereof is 1.5 times higher, or 2/3 or less compared to an 25 average hybridization intensity to the DNAs of any of (1) to (4). 27. A method for screening a gene of an industrial yeast, comprising 21 WO 2006/024951 PCT/IB2005/002908 (a-1) hybridizing genomic DNA, cDNA or cRNA prepared from the industrial yeast to the DNA array of any one of Embodiments 12-20; (a-2) independently from the step (a-1), hybridizing 5 genomic DNA, cDNA or cRNA prepared from another industrial yeast of any one of Embodiments 12-20; and (b) selecting a gene wherein hybridization intensity thereof to the DNAs of any of (1) to (4) in the step (a-1) is significantly different from hybridization intensity 10 thereof in the step (a-2). 28. A method for screening a gene of an industrial yeast, comprising (a-1) hybridizing cDNA or cRNA prepared from the industrial yeast to the DNA array of any one of Embodiments 15 12-20; (a-2) independently from the step (a-1), hybridizing cDNA or cRNA prepared from the industrial yeast to the DNA array of any one of Embodiments 12-20, wherein the industrial yeast of (a-2) has been cultured in a different condition 20 from the culture condition for the industrial yeast of (a 1); and (b) selecting a gene wherein hybridization intensity thereof to the DNAs of any of (1) to (4) at the step (a-1) is significantly different from hybridization intensity 25 thereof at the step (a-2). 29. A gene obtained by the screening method of any one of Embodiments 26-28. 22 WO 2006/024951 PCT/IB2005/002908 30. The gene according to Embodiment 9 or 29 characterized in that concentration of sulfite in a culture medium of an industrial yeast increases when the gene is expressed in the yeast. 5 31. A nucleic acid encoding a polypeptide of any one of the following i) and ii): i) a polypeptide having the amino acid sequence represented by SEQ ID NO:3, and ii) a polypeptide having an amino acid sequence wherein 10 one or more amino acid residue(s) is deleted from, substituted for and/or added to the amino acid sequence represented by SEQ ID NO:3, and having an activity to increase concentration of sulfite in a culture medium of an industrial yeast when the gene is expressed in the yeast. 15 32. The nucleic acid according to Embodiment 31, which is selected from the following a) and b): (a) a nucleic acid having the nucleotide sequence represented by SEQ ID NO:1; and (b) a nucleic acid having a nucleotide sequence which 20 hybridizes to the nucleotide sequence complementary to the nucleotide sequence represented by SEQ ID NO:1 under a stringent condition, and encodes a polypeptide having an activity to increase concentration of sulfite in a culture medium of an industrial yeast when the gene is expressed in 25 the yeast. 33. A recombinant vector containing the gene of Embodiment 9 or Embodiments 29-30, or the nucleic acid of Embodiment 31-32. 23 WO 2006/024951 PCT/IB2005/002908 34. A transformant comprising the recombinant vector of Embodiment 33. 35. The transformant according to Embodiment 34, which is a yeast of genus Saccharomyces. 5 36. A polypeptide of any one of the following i) and ii): i) a polypeptide having the amino acid sequence represented by SEQ ID NO:3; and ii) a polypaptide having an amino acid sequence wherein 10 one or more amino acid residue(s) is deleted from, substituted for and/or added to the amino acid sequence represented by SEQ ID N:3, and having an activity to increase concentration of sulfite in a culture medium of an industrial yeast when the gene is expressed in the yeast. 15 37. The polypeptide according to Embodiment 36, which is encoded by a nucleic acid selected from the following a) and b): (a) a nucleic acid having the nucleotide sequence represented by SEQ ID NO:1; and 20 (b) a nucleic acid having a nucleotide sequence which hybridizes to the nucleotide sequence complementary to the nucleotide sequence represented by SEQ ID No.1 under a stringent condition, and encodes a polypeptide having an activity to increase concentration of sulfite in a culture 25 medium of an industrial yeast when the gene is expressed in the yeast. 38. A method for producing an alcohol or an alcoholic beverage, using the transformant of Embodiment 34 or 35. 24 WO 2006/024951 PCT/IB2005/002908 39. A breeding method of yeast which is suitable for \the production of an alcohol or an alcoholic beverage, characterized in that, expression of the gene of Embodiment 9 or Embodiments 29-30, or the nucleic acid of Embodiments 5 31-32 is controlled. 40. The breeding method according to Embodiment 39, wherein the yeast belongs to the genus Saccharomyces. 41. Yeast obtained by the breeding method of Embodiment 39 or 40. 10 42. A method for producing an alcohol or an alcoholic beverage using the yeast mentioned in Embodiment 41. 43. An alcohol or an alcoholic beverage which is produced by the producing method of Embodiment 42. 44. A method for analyzing gene of an industrial 15 yeast comprising (c-1) selecting a gene of the industrial yeast encoding an amino acid sequence having 70 to 97% identity to an amino acid sequence encoded by the gene of Saccharomyces cerevisiae, or 20 (c-2) selecting a gene of the industrial yeast consisting of a nucleotide sequence having 60 to 94% identity to the nucleotide sequence of the gene of Saccharomyces cerevisiae. 25 Brief Description of the Drawing Fig. 1 shows total chromosome structures of bottom fermenting yeast. A white bar represents an Sc type chromosome while a black bar represents a non-Sc type 25 WO 2006/024951 PCT/IB2005/002908 chromosome. An ellipse represents a centromere. Roman numerals show chromosome numbers for the corresponding S. cerevisiae. In a drawing which shows a non-Sc chromosome, a part marked out in black shows that ligation takes place 5 at the region. For example, in nonScII-nonScIV, it is shown that nonScII and nonScIV are ligated at the part marked out in black (300 kb). Fig. 2 shows a distribution of identify of the DNA sequence at both ends of 3648 cosmids prepared from the 10 genomic DNA of strain 34/70 with the genome sequence of S. cerevisiae. The X-axis shows the identity to S. cerevisiae and, for example, 84% on the X-axis shows an identity of more than 82% and not more than 84%. The Y-axis shows the numbers of cosmid end sequences showing the identity. 15 Fig. 3 shows a mapping example of cosmid and shotgun clones to genome sequence of S. cerevisiae. (1) and (2) show genes existing on Watson strand and Crick strand on the chromosome XVI of S. cerevisiae, respectively. (3)and (4) show Sc type and non-Sc type DNA fragments inserted in 20 cosmid clones, respectively. (5) and (6) show Sc type and non-Sc type DNA fragments inserted in shotgun clones, respectively. Fig. 4 shows a mapping example of contigs to the genome sequence of S. cerevisiae. (A) is a schematic 25 depiction of Chromosome XVI of S. cerevisiae. (B) is a drawing where the parts of 857 to 886 kb of the Chromosome XVI of S. cerevisiae is enlarged. Y-axis indicates % identity of contigs with S. cerevisiae genome sequence. X 26 WO 2006/024951 PCT/IB2005/002908 axis indicates position of contigs against S.cerevisiae genome sequence. Contigs (solid lines) are connected with the forward-reverse links (dot lines) from the shotgun and cosmid reads, respectively. 5 Fig. 5 shows the result of DNA array-based comparative genomic hybridization. The genomic DNA of strain 34/70 was hybridized to a DNA array (Affymetrix Gene Chip Yeast Genome S98 Array) and the signal of each ORF (open reading frame) was normalized to that of the haploid strain S288C 10 and shown as Signal Log Ratio (2n). Signal Log Ratios were lined following gene order in Chromosome XVI. The non-Sc type genes do not hybridize to this Sc type array, therefore, the points (indicated by arrows) where the Signal Log Ratios show vigorous changes were considered to 15 be translocation sites. Fig. 6 shows the structure of the Chromosome XVI of strain 34/70 deduced from DNA array and PCR analysis. Fig. 7 shows the fermentation profiles of SSUl disruptants and parental strain (BH96). a) shows yeast 20 growth(OD 600), b) shows the change of apparent extract (w/w %) and c) shows sulfite concentration(ppm). Fig. 8 shows the fermentation profiles of SSUl overexpressed strains and parental strain (BH225). a) shows yeast growth(OD 600), b) shows the change of apparent 25 extract (w/w %) and c) shows sulfite concentration(ppm). Fig. 9 shows the change of sulfite concentration during fermentation using MET14 overexpressed strains and parental strains (KNO09F and FOY227). 27 WO 2006/024951 PCT/IB2005/002908 Fig. 10 shows DNA sequences of ScSSU1 and non-ScSSUl. Fig. 11 shows DNA sequences of ScMET14 and non ScMET14. Fig. 12 shows the fermentation profiles of strain 5 34/70. a) shows yeast growth(OD 600) and b) shows the change of apparent extract (w/w %). Embodiments for Carrying Out the Invention I. A method for analyzing gene of an industrial yeast 10 The present invention provides a method for analyzing gene of an industrial yeast. The present method comprises (c-1) selecting a gene of the industrial yeast encoding an amino acid sequence having 70 to 97% identity to an amino acid sequence encoded by the gene of Saccharomyces 15 cerevisiae, or (c-2) selecting a gene of the industrial yeast consisting of a nucleotide sequence having 60 to 94% identity to the nucleotide sequence of the gene of Saccharomyces cerevisiae. 20 In a preferred ambodiment, the method of the present invention omprises, (a) analyzing nucleotide sequence of the genome sequence of the industrial yeast, before the step (c-1) or (c-2).In a preferred embodiment, the method of the present invention comprises, (b) comparing the 25 genome sequence with the genome sequence of Saccharomyces cerevisiae, after the step (a), if any, and before the step (c-1) or (c-2). 28 WO 2006/024951 PCT/IB2005/002908 In a preferred embodiment, the analyzing method of the present invention further comprises the step of d) carrying out functional analysis of the selected gene, after the step (c-1) or (c-2). 5 With regard to the industrial yeast in the present invention, brewing yeast for beer, wine, sake, etc. and yeasts used for the production of fuel alcohols are exemplified. To be more specific, yeast of genus Saccharomyces, etc. may be listed, and in the present 10 invention beer yeasts such as Saccharomyces pastorianus Weihenstephan 34/70, NCYC456, NBRC 1951, NBRC 1952, NBRC 1953, NBRC 1954, etc. may be used. It is also possible to use whisky yeasts such as S. cerevisiae NCYC 90, etc., wine yeasts such as Kyokai wine yeast No. 1, No. 3, No. 4, etc., 15 sake yeasts such as Kyokai sake yeast No. 7, No. 9, etc. and the like. Preferably, the industrial yeast of the present invention is a brewing yeast, more preferably, a beer yeast. Most preferably, the industrial yeast of the 20 present invention is a bottom fermenting yeast. The bottom fermenting yeast means a yeast used for the lager beer production. Some strains of beer yeasts, such as Saccharomyces pastorianus Weihenstephan 34/70, NCYC456 or the like are classified as bottom fermenting yeasts. The 25 strain used in the following Examples is one of the bottom fermenting yeasts commonly used for the lager beer production. The most of the bottom fermenting yeasts seem to have almost the same genome with that of strain 34/70. 29 WO 2006/024951 PCT/IB2005/002908 It is also possible to breed yeast having an excellent brewing character when the gene obtained by the method of the present invention is used for carrying out an expression control in such a way that the gene is 5 overexpressed in the yeast, and/or the gene is disrupted. Accordingly, the gene which is obtained by the method of the present invention, peptide which is encoded by the gene, a breeding method of an industrial yeast using the gene, yeast which is obtained by the breeding method, and a 10 method for the production of an alcohol or an alcoholic beverage using the yeast are also within a scope of the present invention. (A) Analysis of nucleotide sequence of the genome sequence of industrial yeast 15 If the genome sequence of a target industrial yeast is not determined, "anayzing" at the step (a) can maen determining the genome sequence of industrial yeast. In the present specification, the "genome sequence" means the whole genome sequence or a part of the genome sequence. 20 If the genome sequence of a target industrial yeast is determined, "anayzing" in step (a) can mean obtaining information regarding the genome sequence of a target industrial yeast from an appropriate source, for example, from a publicly available database. 25 Determination of the genome sequence of an industrial yeast can be achieved by any conventional methods. For example, it includes the steps of (a) genomic DNA is prepared from yeast, (b) shotgun library and (c) cosmid 30 WO 2006/024951 PCT/IB2005/002908 library are prepared from those genomic DNA, (d) DNA fragments to be used for determination of DNA sequence are prepared from those library clones, (e) DNA sequence of the library DNA fragments is determined by a sequence reaction 5 and (f) the sequences of those DNA fragments are assembled to reconstruct the genome sequence. Both or either one of (b) shotgun library and (c) cosmid library may be prepared for this purpose. There is no particular limitation for the methods used 10 for (a) to (f) and the method may be conducted according to the known means, while preferred method for each of them is mentioned below. (a) Preparation such as extraction, purification, etc. of the genomic DNA is preferably carried out in accordance 15 with the known methods, for example, in "Yeast, a practical approach (IRL Press, 6.2.1, p. 228)" and "Seibutukagakujikkennhou, No. 39, Experiments in Yeast Molecular Genetics (edited by Yasuharu Oshima, Gakkai Shuppan Center, pages 84 to 85, 1996)". The specific 20 examples of the preferred method for the preparation of DNA are mentioned below. Yeast cells for the preparation of genomic DNA are cultured by a common method. With regard to a medium, any of natural and synthetic media may be used so far as the 25 medium contains carbon source, nitrogen source, inorganic salt, etc. which are able to be metabolized by the yeast, whereby cultivation of the microorganism can be efficiently carried out. For example, YPD medium (2% (w/w) glucose, 1% 31 WO 2006/024951 PCT/IB2005/002908 (w/w) yeast extract and 2% (w/w) polypeptone) may be used. With regard to a method of incubation, incubation by shaking at about 25 to 35 0 C through the night is recommended. 5 After the cultivation, cells are recovered from the culture medium by centrifugation. The resulting cell pellet is washed with a washing solution. Example of the washing solution is buffer A (50 mM sodium phosphate, 25 mM EDTA and 1% (v/v) P-mercaptoethanol; pH 7.5), etc. 10 Preparation of the genomic DNA from the washed cells may be carried out according to a common preparation method of genomic DNA where cell walls are lysed using Zymolyase and SDS; protein, etc. are removed using a phenol and phenol/chloroform solution; and genomic DNA is precipitated 15 using ethanol or the like. To be more specific, the following method may be exemplified. Cultivated cells are washed and resuspended in buffer A, then about 5 to 10 mg of Zymolyase 100T (Seikagaku Kogyo) are added and the mixture is gently shaken at about 20 25 to 40 0 C for about 30 minutes to 2 hours. After the shaking, buffer containing SDS such as buffer B (0.2 M Tris-HCl, 80 mM EDTA and 1% SDS; pH 9.5) is added thereto and the mixture is allowed to stand at about 60 to 70 0 C for about 30 minutes to lyse the cells. After that, the cell 25 lysate is cooled on ice, mixed with 5 M potassium acetate and allowed to stand on ice for about 60 minutes further. The resulting solution is centrifuged (for example, at 5,000 g for 10 minutes at 15 0 C) to take supernatant. The 32 WO 2006/024951 PCT/IB2005/002908 same volume of ethanol is added to the supernatant to precipitate DNA and the mixture is immediately centrifuged (for example, at 5,000 g for 10 minutes at 15'C) to obtain DNA. The resulting precipitate is washed with 70% (v/v) 5 ethanol, subjected to natural drying and dissolved in a solution such as TE buffer (10 mM Tris-HCl and 1 mM EDTA; pH 8.0) to give a crude genomic DNA solution. Cesium chloride and bisbenzimide are added to and dissolved in the crude genomic DNA solution, the mixed solution is subjected 10 to an ultracentrifugal separation (for example, at 100,000 g for 17 hours at 25 0 C), irradiation with UV light is conducted so that the DNA bands are visualized and the lower band is recovered. Bisbenzimide is removed by extracting the recovered DNA solution with isopropanol 15 which is saturated with cesium chloride solution, then 4 fold by volume of 0.3 M sodium acetate are added to the recovered aqueous layer followed by mixing and the DNA is precipitated by ethanol and recovered by centrifugation. The recovered DNA is treated with RNase and extracted with 20 phenol/chloroform and DNA is purified from the recovered aqueous layer by precipitation with ethanol again. The precipitate recovered by centrifugation is washed with 70% (v/v) ethanol, subjected to natural drying and dissolved in a TE buffer to prepare the genomic DNA solution. 25 (b) Preparation of a shotgun library As to a method for the preparation of a genomic DNA library using the genomic DNA of yeast prepared in the above (a), a method mentioned in "Molecular Cloning, A 33 WO 2006/024951 PCT/IB2005/002908 Laboratory Manual, Third Edition (2001)" (hereinafter, abbreviated as "Molecular Cloning, Third Edition") may be used and, with regard to a method for the preparation of a shotgun library which is particularly suitable for the 5 determination of the genome sequence, the following method may be exemplified. A TE buffer is added to the genomic DNA prepared in (a) and the genomic DNA is fragmented using Hydroshear (manufactured by GeneMachines) or the like. Terminal of 10 the genome fragment is blunted using a DNA Blunting Kit (manufactured by Takara Shuzo) or the like, and fractionated by means of an agarose gel electrophoresis. Then, genome fragments of about 1.5 to 2.5 kb are excised from the gel and a buffer for the elution of DNA such as an 15 MG-elution buffer (0.5 mol/L ammonium acetate, 10 mmol/L magnesium acetate, 1 mmol/L EDTA and 0.1% SDS) or the like is added to the gel followed by shaking at about 25 to 40 0 C through the night to elute DNA. The DNA eluate is treated with phenol/chloroform and precipitated with ethanol to 20 give a genomic library insert. All of the above-mentioned insert and an appropriate vector such as pUC 18 SmaI/BAP (manufactured by Amersham Biosciences) are subjected to ligation using T4 ligase (manufactured by Takara Shuzo) at about 10 to 20 0 C for about 20 to 50 hours. The ligation 25 reaction product is precipitated with ethanol and the resulting recombinant vector DNA is dissolved in an appropriate amount of TE buffer. By means of electroporation or the like, the recombinant vector DNA is 34 WO 2006/024951 PCT/IB2005/002908 transformed to Escherichia coli such as an Electro Cell DH5a strain (manufactured by Takara Shuzo). It is recommended that the electroporation is carried out under the condition mentioned in the attached experimental 5 manual. The transformants into which recombinant vector containing the genomic DNA fragments is inserted are selected on an appropriate selective medium. For example, when pUC 18 SmaI/BAP is used as a vector, the transformants 10 form white colonies on an LB plate medium (an LB medium (10 g/L of bactotryptone, 5 g/L of yeast extract and 10 g/L of sodium chloride; pH 7.0) which contains 1.6% of agar) containing about 0.01 to 0.1 mg/mL of ampicillin, about 0.1 mg/mL of X-gal and about 1 mmol/L of isopropyl-$-D 15 thiogalactopyranoside (IPTG) upon incubation through the night at about 30 to 37 0 C and, therefore, the selection is easy. The transformants are cultured in LB medium containing about 0.1 mg/mL of ampicillin through the night at about 30 to 37 0 C using a 384-well titer plate, a 50% 20 aqueous solution of glycerol in the same volume as the LB is added thereto and the mixture is stirred to give a glycerol stock. Usually, the glycerol stock can be preserved at about -80 0 C. (c) Preparation of a cosmid library 25 The genomic DNA prepared in (a) is subjected to a partial digestion using an appropriate restriction enzyme such as Sau3AI (manufactured by Takara Shuzo). It is possible to insert the DNA fragment digested by Sau3AI into 35 WO 2006/024951 PCT/IB2005/002908 a BamHI site of a cosmid vector such as Super CosI vector (manufactured by Stratagene). The treatment with the restriction enzyme and the ligation may be carried out according to the protocol attached thereto. The ligated 5 product obtained by such a method is subjected to a packaging using, for example, Gigapack III Gold (manufactured by Stratagene), and according to the manual for the experimental procedure attached thereto, it is introduced into Escherichia coli such as an XL1-Blue MR 10 strain (manufactured by Stratagene). That is spread on an LB plate medium containing ampicillin and incubated through the night at about 30 to 37 0 C to get transformants. The resultant transformants are cultured in LB medium containing about 0.1 mg/mL of ampicillin through the night 15 at about 30 to 37 0 C using a 96-well titer plate, a 50% aqueous solution of glycerol in the same volume as the LB is added thereto and the mixture is stirred to give a glycerol stock. Usually, the glycerol stock can be preserved at about -80 0 C. 20 (d) Preparation of DNA fragment for determination of DNA sequence The genome sequence of industrial yeast can be determined mainly using the -genome shotgun method. The DNA fragment of which DNA sequence is determined can be 25 prepared by a PCR using the shotgun library prepared in the above (b). To be specific, clone of the genome shotgun library is inoculated using a replicator (manufactured by Gene Solution) to a 384-well titer plate where about 50pl 36 WO 2006/024951 PCT/IB2005/002908 each of an ampicillin-containing LB medium is placed to each well and cultured without shaking through the night at about 30 to 37 0 C. The culture is transferred using a replicator (manufactured by Gene Solution) or the like to a 5 384-well reaction plate (manufactured by AB Gene) where about 10pl each of a reaction solution for PCR (TaKaRa Ex Taq manufactured by Takara Shuzo) is placed, and PCR is carried out according to a protocol by Makino, et al. (DNA Research, volume 5, pages 1 to 9 (1998)) or the like using 10 a GeneAmp PCR System 9700 (manufactured by Applied Biosystems) or the like, whereupon amplification of the inserted fragment is carried out. Excessive primer and nucleotide are removed using a kit for the purification of PCR products (manufactured by 15 Amersham Bioscience), etc. and a sequence reaction is carried out using the sample as a template. Determination of the genome sequence can also be performed by preparing and using a cosmid library. Cosmid DNA from the cosmid library of (c) can be prepared by the 20 following method. That is, clone derived from cosmid library is inoculated to each well of a 96-well plate where about 1.0 mL each of an ampicillin-containing appropriate medium such as a 2 x YT medium (1.6% bactotryptone, 1% yeast extract and 0.5% sodium chloride; pH 7.0) is placed 25 and cultured with shaking through the night at about 30 to 37 0 C. Cosmid DNA from the said culture can be prepared using KURABO PI-1100 AUTOMATIC DNA ISOLATION SYSTEM (manufactured by KURABO) according to a manual of KURABO or 37 WO 2006/024951 PCT/IB2005/002908 the like, and they can be used as templates for sequencing reaction. (e) Sequencing reaction A Sequencing reaction can be carried out using a 5 commercially available sequence kit, etc. Preferred examples of the present invention are shown below. A sequence reaction mixture can be prepared as follows. The PCR product or cosmid DNA prepared in the above (d) is mixed with about 2 pl of DYEnamic ET 10 Terminator Sequencing Kit (manufactured by Amersham Bioscience) and appropriate primers to give about 8Rl of reaction mixture. An M13 forward (M13-21) primer and an M13 reverse (M13RV) primer (manufactured by Takara Bio), etc. are used for the sequence reaction of a PCR product derived 15 from shotgun DNA, while a forward primer such as SS-cos F.1 (SEQ ID NO: 7) and a reverse primer such as SS-cos R.1 (SEQ ID NO: 8), etc. are used for cosmid DNA. Amounts of the primer and the DNA fragment are about 1 to 4 pmole and about 50 to 200 ng, respectively. 20 A dye terminator sequence reaction of about 50 to 70 cycles can be carried out using the reaction solution and GeneAmp PCR System 9700 (manufactured by Applied Biosciences). When a commercially available kit such as DYEnamic ET Terminator Sequencing Kit is used, a cycle 25 parameter follows a manual attached thereto. Purification of the sample is carried out according to the manual of Millipore using MultiScreen HV plate (manufactured by Millipore), etc. The purified reaction product -is 38 WO 2006/024951 PCT/IB2005/002908 precipitated with ethanol and the resulting precipitate is dried and stored in a dark place of about 4 0 C. The dried product is analyzed using commercially available sequencer and analyzer such as MegaBACE.1000 Sequencing System 5 (manufactured by Amersham Bioscience) and ABI PRISM 3700 DNA Analyzer (manufactured by Applied Biosystems), etc. according to the manuals attached thereto. (f) Reconstruction of genome sequence by means of assembly (A process whereby the order of multiple sequenced 10 DNA fragments is determined) Reconstruction of genomic DNA may be carried out from sequence information of DNA fragments obtained in the above (e). All operations of the reconstruction of genomic DNA sequence can be carried out on an UNIX* platform. Base 15 call can be conducted by a software such as phred (The University of Washington) or the like, masking of vector sequence can be carried out by a software such as Cross Match (The University of Washington) or the like and assembly can be carried out by a software such as Phrap 20 (The University of Washington) or the like. Contig obtained as a result of assembly can be analyzed using a graphical editor such as consed, a graphical editor (The University of Washington) or the like. A series of works from base call to assembly can be carried out en bloc 25 utilizing phredPhrap, a script attached to the consed. (B) Comparison of the genome sequence of the industrial yeast with that of S. cerevisiae 39 WO 2006/024951 PCT/IB2005/002908 Optionally, comparison of the genome sequence obtained in (A) with that of S. cerevisiae can be carried out by any known means for comparing two sequences. It may include (g) Preparation of a comparative database compiling the 5 comparison data of each of DNA sequences of both ends of cosmid and shotgun clone and contig with S. cerevisiae genome sequence, and mapping of them on S. cerevisiae genome sequence. Widely used industrial yeast such as bottom fermenting 10 yeast (S. pastorianus) has been regarded as a natural hybrid of S. cerevisiae and its closely related species (such as S. bayanus) "Int. J. Syst. Bacteriol. volume 35, pages 508-511 (1985)". In this view, DNA sequences of the both ends of cosmid clone prepared in (e) are subjected to 15 a homology searching against S. cerevisiae genome sequence by a homology searching algorithm, whereupon the homologous region and the identity of each DNA sequence to S. cerevisiae genome sequence can be determined, thus database can be prepared. 20 The S. cerevisiae genome sequences are accessible from public available data bank, such as, Saccharomyces Genome Database (SGD: http://genome www.stanford.edu/Saccharomyces/).The percent identity of two amino acid or two nucleic acid sequences can be 25 determined by visual inspection and mathematical calculation, or more preferably, the comparison is done by comparing sequence information using a computer program. An exemplary, preferred computer program is the Genetics 40 WO 2006/024951 PCT/IB2005/002908 Computer Group (GCG; Madison, WI) Wisconsin package version 10.0 program, 'GAP' (Devereux et al., 1984, Nucl. Acids Res. 12: 387). The preferred default parameters for the 'GAP' program includes: (1) The GCG implementation of a 5 unary comparison matrix (containing a value of 1 for identities and 0 for non-identities) for nucleotides, and the weighted amino acid comparison matrix of Gribskov and Burgess, Nucl. Acids Res. 14:6745, 1986, as described by Schwartz and Dayhoff, eds., Atlas of Polypeptide Sequence 10 and Structure, National Biomedical Research Foundation, pp. 353-358, 1979; or other comparable comparison matrices; (2) a penalty of 30 for each gap and an additional penalty of 1 for each symbol in each gap for amino acid sequences, or penalty of 50 for each gap and an additional penalty of 15 3 for each symbol in each gap for nucleotide sequences; (3) no penalty for end gaps; and (4) no maximum penalty for long gaps. Other programs used by those skilled in the art of sequence comparison can also be used, such as, for example, the BLASTN program version 2.0.9, available for 20 use via the National Library of Medicine website nchi.nlm.nih.gov/gorf/wblast2.cgi, or the WU-BLAST 2.0 algorithm. Standard default parameter settings for WU BLAST 2.0 are described at the following Internet site: sapiens.wustl.edu/blast/blast/#Features. In addition, the 25 BLAST algorithm uses the BLOSUM62 amino acid scoring matix, and optional parameters that can be used are as follows: (A) inclusion of a filter to mask segments of the query sequence that have low compositional complexity (as 41 WO 2006/024951 PCT/IB2005/002908 determined by the SEG program of Wootton and Federhen (Computers and Chemistry, 1993); also see Wootton and Federhen, 1996, Analysis of compositionally biased regions in sequence databases, Methods Enzymol. 266: 554-71) or 5 segments consisting of short-periodicity internal repeats (as determined by the XNU program of Claverie and States (Computers and Chemistry, 1993)), and (B) a statistical significance threshold for reporting matches against database sequences, or E-score (the expected probability of 10 matches being found merely by chance, according to the stochastic model of Karlin and Altschul (1990); if the statistical significance ascribed to a match is greater than this E-score threshold, the match will not be reported.); preferred E-score threshold values are 0.5, or 15 in order of increasing preference, 0.25, 0.1, 0.05, 0.01, 0.001, 0.0001, le-5, le-10, le-15, le-20, le-25, le-30, le 40, le-50, le-75, or le-100. An example of identity percentages distribution graph of cosmid DNA sequence corresponding to S. cerevisiae 20 genomic DNA sequence is shown in Fig. 2. The DNA sequence of cosmid is roughly classified into a DNA sequence group showing more than 94% identity to S. cerevisiae genome sequence and a DNA sequence group showing around 84% identity thereto. Accordingly, a DNA sequence having 25 identity of more than 94% to the nucleotide sequence of the gene of Saccharomyces cerevisiae is named an Sc-type DNA sequence derived from S. cerevisiae. While a DNA sequence having 94% or less identity, more preferably,60 to 94% 42 WO 2006/024951 PCT/IB2005/002908 identity, most preferably around 84% identity to the nucleotide sequence of the gene of Saccharomyces cerevisiae is named a non-Sc-type DNA sequence derived from a closely related species of S. cerevisiae. A gene with the Sc type 5 DNA sequence or the non-Sc type DNA sequence is named Sc type gene or non-Sc type gene, respectively. Similarly, a comparative database of the DNA sequence of both ends of shotgun clone prepared in (e) with genomic DNA sequence of S. cerevisiae is prepared. On the basis of 10 the information obtained from the prepared comparative database, a mapping of cosmid clone and shotgun clone on S. cerevisiae genome sequence is carried out (refer, for example, to Fig. 3). A comparative database of the DNA sequence of the contig prepared in (f) with S. cerevisiae 15 genome sequence is also prepared and mapping is carried out. Although the mapping technique is nearly the same as that mentioned above, when contigs linked by paired forward-reverse DNA sequence from the same cosmid and shotgun clone, those contigs are linked (refer, for 20 example, to Fig. 4). (C) (C-1) Selection of a gene of the industrial yeast encoding an amino acid sequence having 70 to 97% identity 25 to an amino acid sequence encoded by the gene of Saccharomyces cerevisiae, and (C-2) selection of a gene of the industrial yeast consisting of a nucleotide sequence having 60 to 94% 43 WO 2006/024951 PCT/IB2005/002908 identity to the nucleotide sequence of the gene of Saccharomyces cerevisiae. A stage for the selection of the gene of bottom fermenting yeast encoding an amino acid sequence having 70 5 to 97% identity to an amino acid sequence encoded by the gene of S. cerevisiae may include (h) a process of identification of ORF (open reading frame) and assignment of function. (h) Identification of ORF and assignment of its 10 function Identification of ORF in the DNA sequence assembled in (f) is carried out. Preferred examples are specifically mentioned below. With regard to a certain length of DNA sequence (such as not less than 150 base) embraced by 15 initiation codon and termination codon, there can be carried out identification of ORF existing in a DNA sequence assembled in (f) using a program, such as ORF finder (http://www.ncbi.nih.gov/gorf/gorf.html) or the like for the identification of ORF for six kinds of reading 20 frames including complementary sequence. Assignment of function of protein encoded by the identified ORF can be carried out using a homology searching such as BLAST (http://www.ncbi.nlm.nih.gov/BLAST/) or the like to an 25 amino acid sequence of ORF of S. cerevisiae that has been registered and published in the Saccharomyces Genome Database (SGD: http://genome www.stanford.edu/Saccharomyces/). If necessary, it is 44 WO 2006/024951 PCT/IB2005/002908 possible to analyze the chromosomal structure of an industrial yeast by DNA array-based comparative genomic hybridization and PCR. In the Example 8 in the present specification, the choromosome structure of the S. 5 pastorianus strain 34/70 was analyzed by using a DNA array containing the DNA probes of known S. cerevisiae nucleotide sequences. Yeast genomic DNA is prepared using a Quiagen Genomic Tip 100/G (#10243) and Qiagen Genomic DNA Buffer Set 10 (#19060) according to the manual attached to the kit. The DNA (e.g., 10 Rg) is digested with DNase I (manufactured by Invitrogen) according to a method of Winzeler, et al. (Science, volume 281, pages 1194-1197 (1998)), biotinylated using a terminal transferase (manufactured by Roche) and 15 hybridized to a DNA array (Affymetrix Gene Chip Yeast Genome S98 Array). The DNA array contains the DNA probes of known S.- cerevisiae nucleotide sequences. Hybridization and detection of the signal intensity of the DNA array are carried out using a Gene Chip Analysis Basic System and 20 analysis soft ware (Microarray Suite 5.0) manufactured by Affymetrix. The signal of each probe hybridized with the DNA of brewing yeast is normalized to that of the haploid laboratory yeast strain 5288C using an analysis soft ware 25 (Microarray Suite 5.0) and shown as signal log ratio (2n). Signal log ratios were lined following genes order in each chromosome using a spreadsheet program (Microsoft Excel 2000) and the signal log ratios are shown in bar graphs 45 WO 2006/024951 PCT/IB2005/002908 (refer, for example, to Fig. 5). The non-Sc type genes do not hybridize to the S. cerevisiae array, therefore, the Sc type gene dosage affects the signal log ratio and the points where the signal log ratios show vigorous changes 5 are considered to be translocation sites between Sc type and non-Sc type chromosome. The chimera chromosome structure can be confirmed by PCR, wherein a genomic DNA derived from brewing yeast is used as a template and Sc type and non-Sc type shotgun 10 sequences are used as primers. PCR may be carried out using a Takara PCR Thermal Cycler SP according to the attached manual using a Takara LA Taq and a buffer attached thereto. As a result of the PCR, it is confirmed by 0.8% 15 agarose gel electrophoresis, for example, that a certain length of DNA fragment is amplified from the brewing yeast. When a genomic DNA of S. cerevisiae which is a laboratory strain is used as a template for the PCR, no amplification of DNA fragment is detected. If DNA sequences of the both 20 ends of the DNA fragment amplified from the brewing yeast are further confirmed, it is consistent with the genome sequences determined by a shotgun method and it can be confirmed that, within such region, translocation between Sc type and non-Sc type chromosome takes place, whereupon a 25 chimera chromosome is formed. Alternatively, a gene of the industrial yeast consisting of a nucleotide sequence having 60 to 94% identity to the nucleotide sequence of the gene of 46 WO 2006/024951 PCT/IB2005/002908 Saccharomyces cerevisiae can be selected. Identity of 60 to 94% in nucleotide sequence level corresponds approximately 70 to 97% in amino acid sequence level. Some nucleotide sequences in non-Sc type chromosome other than 5 open reading frames may have identity of less than 60% to the corresponding nucleotide sequences of Sc type chromosome. (D) Functional analysis of the selected genes 10 Further, selected genes may optionally be subjected to functional analysis. For example, functional analysis of gene may include (i) selection of the gene, (i') cloning of the gene, (j) functional analysis of the gene by disruption or (k) functional analysis of the gene by 15 overexpression. (i) Selecting of the gene There is no particular limitation for the methods used for the selection of gene(s) for functional analysis. While preferred methods are, for example, a method using 20 the assignment of the function obtained in the above (h) and a method using a DNA array as described below. One of the purposes of the present invention is to identify genes from industrial yeasts involved in increase of productivity and/or improvement in flavor in the 25 production of an alcohol or an alcoholic beverage. The whole genome sequence of Saccharomyces cerevisiae has been identified, and function of each gene of Saccharomyces cerevisiae has already been identified. As mentioned above 47 WO 2006/024951 PCT/IB2005/002908 for the step (h), functions of proteins encoded by the non Sc type genes can be assigned by a homology searching. Non-Sc type genes which are expected from the assignment to have an useful activity, e.g., involved in increase of 5 productivity and/or improvement in flavor in the production of an alcohol or an alcohol9fgggerage, are selected as target genes for functional analysis.

For example, the SSU1 gene and the MET14 gene are known to have the sulfite transporting activity, and the 10 adenylsulfate kinase activity, respectively. Both genes are known to play an important role for stabilizing flavor of beer. Other genes from the Sc gene analysis which are known to play some role in a step of producing beer are listed in Table 2 in the following Example 7. These genes, 15 however, do not exert sufficient activity enough for producing tasty beer. Therefore, without any limitation, for the purpose of identifying genes from industrial yeasts involved in increse of productivity and/or improvement in flavor in the production of an alcohol or an alcoholic 20 beverage, non-Sc genes corresponding to these Sc type genes can be selected. Alternatively, the method using DNA array is, for example, gene expression analysis to identify genes, which show a characteristic expression profile under some 25 conditions, or comparative genomic hybridization to identify genes, which have different copy numbers or different DNA sequences, by detecting deference of signal intensities of probes. 48 WO 2006/024951 PCT/IB2005/002908 (i') cloning of the gene Genes selected in the above (i) can be obtained from the bottom fermenting yeast according to a common method mentioned, for example, in Molecular Cloning, Third 5 Edition. That is, oligonucleotides having sequences adjacent to the gene are synthesized and a common PCR cloning method is carried out using a genomic DNA prepared from a bottom fermenting yeast as a template, whereupon the selected gene can be isolated and obtained. With regard to 10 DNA sequences obtained as such, for example, SEQ ID NO: 1 may be listed. When the gene is named, for example, a gene(1), the gene (1) or primer for amplifying the gene (1) by a PCR method may be also synthesized using a polynucleotide 15 synthesizer on the basis of the above-mentioned sequence information. In addition, gene (1) means not only a DNA fragment having the same DNA sequence as gene (1) but also a DNA fragment hybridizing to the above gene under stringent 20 condition as is defined in the present specification. The DNA fragment which hybridizes under stringent condition means a DNA fragment which is obtained by a colony hybridization method, a plaque hybridization method, a southern blot hybridization method or the like, using the 25 DNA fragment containing the sequence of the gene (1) identified in the above as a probe. The term "under stringent condition" means that two nucleic acid fragments can hybridize under a moderately 49 WO 2006/024951 PCT/IB2005/002908 stringent condition or a highly stringent condition. An artisan can easily choose an appropriate moderately or highly stringent condition. The basic parameters affecting the choice of 5 hybridization conditions and guidance for devising suitable conditions are set forth by Sambrook,, Fritsch, and Maniatis (2001, Molecular Cloning: A Laboratory Manual, third edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., chapters 6 and 7; and Current 10 Protocols in Molecular Biology, 1995, Ausubel et al., eds., John Wiley & Sons, Inc., sections 2.10 and 6.3-6.4), and can be readily determined by those having ordinary skill in the art based on, for example, the length and/or base composition of the DNA. 15 One way of achieving moderately stringent conditions involves the use of a prewashing solution containing 5 x SSC, 0.5% SDS, 1.0 mM EDTA (pH 8.0), hybridization buffer of about 50% formamide, 6 x SSC, and a hybridization temperature of about40-55 0 C (or other similar hybridization 20 solutions, such as one containing about 50% formamide, with a hybridization temperature of about 42 0 C), and washing conditions of about 60 0 C, in 0.5 x SSC, 0.1% SDS. Preferably, a moderately stringent condition may include hybridization at about 50 0 C and 2 X SSC. 25 Highly stringent conditions can also be appropriately selected based on factors like length of DNAs to be hybridized. Generally, such conditions include hybridization and/or washing at higher temperature and/or 50 WO 2006/024951 PCT/IB2005/002908 lower salt concentration (such as hybridization at about 65 0 C, 6 X SCC-0.2 X SSC, preferably, 6 X SCC, more preferably 2 X SSC, most preferably, 0.2 X SSC), compared to the moderately stringent condition. For example, highly 5 stringent conditions may include hybridization as defined above, and washing at approximately 68 0 C, 0.2 x SSC, 0.1% SDS. SSPE (1xSSPE is 0.15M NaCl, 10 mM NaH.sub.2 PO.sub.4, and 1.25 mM EDTA, pH 7.4) can be substituted for SSC (1xSSC is 0.15M NaCl and 15 mM sodium citrate) in the 10 hybridization and wash buffers; washes are performed for 15 minutes after hybridization is complete. It should be understood that the wash temperature and wash salt concentration can be adjusted as necessary to achieve a desired degree of stringency by applying the 15 basic principles that govern hybridization reactions and duplex stability, as known to those skilled in the art and described further below (see, e.g., Sambrook et al., 2001). When hybridizing a nucleic acid to a target nucleic acid of unknown sequence, the hybrid length is assumed to be that 20 of the hybridizing nucleic acid. When nucleic acids of known sequence are hybridized, the hybrid length can be determined by aligning the sequences of the nucleic acids and identifying the region or regions of optimal sequence complementarity. 25 The hybridization temperature for hybrids anticipated to be less than 50 base pairs in length should be 5 to 25 0 C, preferably 5 to 10 0 C less than the melting temperature (Tm) of the hybrid, where Tm is determined according to the 51 WO 2006/024951 PCT/IB2005/002908 following equations. For hybrids less than 18 base pairs in length, Tm (*C) = 2(number of A + T bases) + 4(number of G + C bases). For hybrids above 18 base pairs in length, Tm

(

0 C) = 81.5 + 16.6(logio [Na*]) + 0.41(% G + C) - 0.63(% 5 formamide - (500/N), where N is the number of bases in the hybrid, and [Na*] is the concentration of sodium ions in the hybridization buffer ([Na*] for 1xSSC = 0.165M). Preferably, each such hybridizing nucleic acid has a length that is at least 15 nucleotides (or more preferably at 10 least 18 nucleotides, or at least 20 nucleotides, or at least 25 nucleotides, or at least 30 nucleotides, or at least 40 nucleotides, or most preferably at least 50 nucleotides), or at least 25% (more preferably at least 50%, or at least 60%, or at least 70%, and most preferably 15 at least 80%) of the length of the nucleic acid of the present invention to which it hybridizes, and has at least 60% sequence identity (more preferably at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97.5%, or at least 99%, and most 20 preferably at least 99.5%) with the nucleic acid of the present invention to which it hybridizes, where sequence identity is determined by comparing the sequences of the hybridizing nucleic acids when aligned so as to maximize overlap and identity while minimizing sequence gaps as 25 described in more detail above. The hybridization may be carried out according to a method mentioned in "Molecular Cloning, Third Edition", "Current Protocols in Molecular Biology, John Wiley & Sons 52 WO 2006/024951 PCT/IB2005/002908 (1987-1997) (hereinafter, abbreviated as Current Protocols in Molecular Biology), "DNA Cloning 1: Core Techniques, A Practical Approach, Second Edition, Oxford University (1995)", and the like. 5 To be more specific, shotgun clone containing full length of the above-mentioned gene (1) can be retrieved using the comparative database obtained in (g) and, on the basis of homology and positional information, etc. When there is no clone containing full-length of the gene in the 10 shotgun library, a DNA fragment encoding the full length of the gene is prepared by a PCR method. For example, a DNA fragment containing the above-mentioned gene is obtained using synthetic DNA primer pair represented by SEQ ID NO: 13 and SEQ ID NO: 14, etc. Similarly, PCR is carried out 15 using a primer pair designed on the basis of the published information of SGD and using genomic DNA of S. cerevisiae or bottom fermenting yeast as a template, whereupon the full length of the Sc type gene corresponding to the non-Sc type gene is prepared. For example, using synthetic 20 oligonucleotides of SEQ ID NO: 15 and NO: 16 as the primer pair, the DNA fragment containing the Sc type gene can be obtained. Sc or non-Sc type DNA fragment prepared as mentioned above is inserted into, for example, pCR 2.1-TOPO vector 25 attached to a TA cloning kit (Invitrogen) using a TA cloning kit or the like, whereupon a recombinant vector TOPO/Sc gene and TOPO/non-Sc gene containing the DNA fragment having the Sc and the non-Sc type gene, 53 WO 2006/024951 PCT/IB2005/002908 respectively, are able to be prepared. DNA sequences of the Sc and non-Sc type DNA fragments can be comfirmed by Sanger's method "F. Sanger, Science, volume 214, page 1215, 1981". 5 (j) Functional analysis of the gene by disruption Functional analysis of the selected non-Sc gene may be performed by disruption of the gene, for example. Functional analysis by disruption of the gene can be done by any known conventional methods. In the present 10 specification, "method for disruption of a gene" includes any methods which stop, block, inhibit or suppress at least part of function of the gene, including deletion of the gene, blocking of the gene by antisense nucleic acid, RNAi method or the like. As an example, we will explain 15 disruption of the non-Sc SSU1 gene, which has been identified by the present invention. According to a method of the document "Goldstein, et al., Yeast, volume 15, page 1541, (1999)", it is possible to prepare a DNA fragment for gene disruption by PCR where 20 a plasmid containing a drug-resistance gene (such as pFA 6a (G418r), pAG 25 (nat1)) is used as a template. As a primer pair for the PCR, non-ScSSUlfor (SEQ ID NO: 17)/non ScSSU1_rv (SEQ ID NO: 18) or the like may be used for the non-ScSSU1 disruption. While for the Sc SSU1 disruprion, 25 ScSSUl_for (SEQ ID NO: 19)/ScSSU1_rv (SEQ ID NO: 20) or the like may be used. For the non-Sc type gene disruption, it is also possible to use a plasmid such as pPGAPAUR (AUR1-C) 54 WO 2006/024951 PCT/IB2005/002908 and a primer pair such as non-ScSSUlfor + pGAPAUR (SEQ ID NO: 21)/non-ScSSU1_rv + AURI-C (SEQ ID NO: 22). An industrial yeast is transformed with the DNA fragment for the gene disruption prepared by the above 5 mentioned method. The transformation may follow a method mentioned in the Japanese Patent Laid-Open Gazette No. 07/303,475, for example. Further, the concentration of the drug for the selection of transformants may be appropriately determined by investigating the sensitivity 10 of the yeast used as a host. With regard to the transformant prepared here, it is comfirmed whether each of the drug-resistance genes is introduced and the said gene is disrupted correctly using a Southern analysis. To be specific, the genomic DNA 15 extracted from the parental strain and the transformant are firstly digested by an appropriate restriction enzyme to distinguish Sc and non-Sc type gene (for example, at 37 0 C for 18 hours), then fractionated with 1.5% agarose gel electrophoresis and transferred to a membrane. After that, 20 they are hybridized to a probe specific to an Sc-type or a non-Sc type gene for example at 55 0 C for 18 hours according to a protocol of Alkphos Direct Labelling Reagents (Amersham) and a signal is detected by CDP-Star. The function of the gene obtained in (i') can be 25 studied by fermentation test using a parental strain and non-Sc SSU1 disruptants prepared in the above (j) and comparison of their fermentation character. Fermentation 55 WO 2006/024951 PCT/IB2005/002908 test can be carried out, for example, using wort under the following condition. Original extract: about 10 to 15% Fermentation scale: 1 to 3 liters 5 Dissolved oxygen concentration: about 8 to 10 ppm Fermentation temperature: about 15 0 C Pitching rate: about 4 to 6 g of wet yeast cells/ L Wort is periodically sampled and monitored in the cell growth (OD 600), apparent extract, the concentration of the 10 substance relating to the function of the gene obtained in (i'), etc. then, analyzed. For example, when the function of the gene obtained in (i') involved in discharge of sulfite, the sulfite concentration in the wort during the fermentation is 15 analyzed. Quantitative analysis of sulfite is carried out in such a manner that sulfite is captured in a hydrogen peroxide solution by means of distillation under an acidic condition and subjected to titration with an alkali (Revised Method for BCOJ Beer Analysis by the Brewing 20 Society of Japan). As candidates for useful genes involved in increase of productivity and/or improvement in flavor in the production of an alcohol or an alcoholic beverage, we may select genes wherein cell growth, apparent extract, and/or the 25 concentration of the substance relating with the function of the gene were substantially changed by disruption of the gene. Especially, the change in the concentration of the 56 WO 2006/024951 PCT/IB2005/002908 substance participating in the function of the gene is important and should be monitored. The "substance relating with the function of the gene" includes, without any limitation, sulfite, ethanol, ester 5 and fusel alcohol or the like. Substances, which are considered to have a negative effect on production of tasty beer, can also be a target of analysis, including diacetyl and phenolic compounds or the like. (k) Functional analysis of the gene by overexpression 10 Alternatively, functional analysis of a gene can be achieved by overexpression of the gene. A DNA fragment containing the full-length of the non Sc type gene is excised by an appropriate restriction enzyme from the plasmid TOPO/non-Sc gene prepared in (i'). 15 The DNA fragment is inserted into a cloning site of a vector for gene expression such as pNI-NUT to construct a vector (pYI-non-Sc type gene) for overexpression of the non-Sc type gene. The vector pNI-NUT contains URA3 as a homologous recombination site and nourseothricin-resistance 20 gene (natl) and ampicillin-resistance gene (Ampr) as selective markers. On the other hand, a vector for overexpression of the Sc type gene (pNI-Sc type gene) has a structure where the above-mentioned pYI-non-Sc type gene is substituted by the corresponding Sc type gene. For 25 overexpression of the Sc or non-Sc type gene introduced here, it is preferred to be driven by promoter and terminator of constitutively expressing gene, for example, glyceraldehyde-3-phosphate dehydrogenase gene (TDH3). 57 WO 2006/024951 PCT/IB2005/002908 An industrial yeast is transformed using the overexpression vector, which is prepared by the above mentioned method. The transformation is carried out by the method mentioned in the Japanese Patent Laid-Open Gazette 5 No. 07/303,475 and transformants are selected on an appropriate selective medium. Confirmation of the overexpression may be carried out by RT-PCR method, etc. Extraction of the total RNA may be carried out using an RNeasy Mini Kit (Qiagen) or the like, according to the 10 manual of "for total RNA isolation from yeast" attached to the kit. Regarding the SSul gene, for example, it is possible to use ScSSUlfor331 (SEQ ID NO: 23)/ScSSUl_982rv (SEQ ID NO: 24) and nonSc-SSU1_for329 (SEQ ID NO: 25)/nonSc-SSU1_981rv (SEQ ID NO: 26) as specific 15 primerpairs for the amplification of Sc and non-ScSSU1 gene, respectively. To amplify a constitutively expressed gene, for example PDA1, as an internal standard, PDA1_for1 (SEQ ID NO: 27)/PDA1_730rv (SEQ ID NO: 28) etc. may be used as a 20 specific primer pair. PCR product is fractionated with 1.2% agarose gel electrophoresis and detected with ethidium bromide staining. The overexpression of the said gene in the transformant is confirmed by comparison of quantity of the PCR products. 25 The functional analysis of the gene obtained in (i') can be carried out by a fermentation test using the parental strain and the overexpressed strain prepared in 58 WO 2006/024951 PCT/IB2005/002908 the above (k). Fermentation test may be carried out under the condition mentioned in (j). According to the same method mentioned in (j), the wort is periodically sampled and monitored the cell growth 5 (OD600), apparent extract and the concentration of the substance relating with the function of the gene obtained in (i'). As candidates for useful genes involved with increase in productivity and/or improvement in flavor in the 10 production of an alcohol or an alcoholic beverage, we may select genes wherein cell growth, apparent extract, and/or the concentration of the substance relating with the function of the gene were substantially changed by overexpression of the gene. Especially, the change in the 15 concentration of the substance relating with the function of the gene is important and should be monitored. (E) Genes and the gene library The present invention also provides genes obtained by 20 the analyzing method of the present invention. The genes of the present invention include both nucleotides of ORF encoding proteins, as well as nucleotides from non-coding regions. Nucleotides from non-coding regions may include regulatory regions, such as promoter, enhancer, silencer, 25 terminator or the like, which are important for regulation of expression of a gene. Specifically, one embodiment of the present invention is a gene of the industrial yeast encoding an amino acid 59 WO 2006/024951 PCT/IB2005/002908 sequence having 70 to 97% identity to an amino acid sequence encoded by the gene of Saccharomyces cerevisiae, or consisting of a nucleotide sequence having 60 to 94% identity to the nucleotide sequence of the gene of 5 Saccharomyces cerevisiae, which is obtained by the present analyzing method. The present invention also provides a gene library comprising one or more of genes of the industrial yeast as described above. 10 Preferably, the gene of the industrial yeast is comprised in, consists of or has any nucleotide sequence selected from SEQ ID NOs:33 to 6236, SEQ ID Nos:166154 to 166181, SEQ ID Nos:166490 to 167042 and SEQ ID Nos:173125 to 174603. 15 SEQ ID NOs: 33-6236 represent 6204 DNA sequences of non-Sc type ORFs, which can be preferably used as probes of the microarry. SEQ ID NOs: 166154-166181 represent 28 DNA sequences of mitochondrial ORFs from 34/70 strain, which can be 20 preferably used as probes of the microarry. SEQ ID NOs: 166490-167042 represent 553 DNA sequences which have not been identified as the above non-Sc ORFs but have significant similarity to the proteins of S. cerevisiae using NCBI-BlastX homology searching. 25 SEQ ID NOs: 173125-174603 represent 1479 DNA sequences ORFs which have not been identified as the above, but have significant similarity to the proteins of S. cerevisiae using NCBI-BlastP homology searching. 60 WO 2006/024951 PCT/IB2005/002908 The genes of the present invention also include variants of the natural genes, which may include some modification in one or more nucleotide sequence(s) and/or amino acid sequence(s). The genes of the present invention 5 will be described in detail in the section IV of the present specification. The "gene" and the "gene library" of the present invention can encompass not only genes in the form of chemical substance(s), but also in a form of nucleic acid 10 sequence information recorded in a computer-readable record medium or storage. Therefore, accessing and/or utilizing the nucleic acid seuqnece information of the "gene" and the "gene library" of the present invention are also included in the scope of the present invention. 15 The "computer-readable record medium or storage" includes any record medium or storage which is readable and accesible via a computer. This may include, without any limitation, a magnetic record medium such as floppy diskette, hard diskette, and magnetic tape; an optical 20 record medium such as CD-ROM, CD-R, CD-RW, DVD-ROM, DVD-RAM and DVD-RW; an electronic record medium such as RAM and ROM; as well as a hybrid of the above categories (e.g, a megnetic/optical record medium, such as MO). 25 II. DNA array Embodiments of the present DNA array The present invention also provides a DNA array which is useful for an analyzing method of genes. "Genes" which 61 WO 2006/024951 PCT/IB2005/002908 can be analyzed by using the DNA array of the present invention may include genomic DNA, cDNA or cRNA or the like of an industrial yeast. The present DNA array can also be applied to the ChIP (Chromatin Immuno-Precipitation)-chip 5 method for analyzing binding between DNA and a protein. The DNA array of the present invention comprises probe(s) of DNA(s) based on the nucleotide sequences of non-Sc genes which have been identified by the present invention. In the present specification, DNA 10 oligonucleotide or cDNA which is fixed on a DNA array is sometimes called "probe". Preferably, the DNA array of the present invention comprises one or more of DNAs, wherein each DNA is selected from at least one group of (1) to (4): 15 (1) DNA consisting of a nucleotide sequence of an open reading frame of the genome sequence of an industrial yeast which encodes an amino acid sequence having 70 to 97% identity to an amino acid sequence encoded by the gene of Saccharomyces cerevisiae, or a nucleotide sequence 20 complementary to the above nucleotide sequence, or a nucleotide sequence of continuous 10 or more nucleotides selected from the above nucleotide sequences; (2) DNA consisting of a nucleotide sequence of the genome sequence of an industrial yeast other than from open 25 reading frames which consists of a nucleotide sequence having 60 to 94% identity to the nucleotide sequence of the gene of Saccharomyces cerevisiae, or a nucleotide sequence complementary to the above nucleotide sequence, or a 62 WO 2006/024951 PCT/IB2005/002908 nucleotide sequence of continuous 10 or more nucleotides selected from the above nucleotide sequences; (3) DNA having a nucleotide sequence of any of SEQ ID Nos.166490 to 167042, or DNA having a nucleotide sequence 5 of any of SEQ ID Nos.167043 to 173124;and (4) DNA having a nucleotide sequence of any of SEQ ID Nos.173125 to 174603, or DNA having a nucleotide sequence of any of SEQ ID Nos.174604 to 190810. In a preferred embodiment of the present invention, the DNA array 10 comprises DNAs wherein at least one DNA is selected from every group of (1) to (4). In a preferred embodiments of the present invention, wherein the DNAs of (1) is comprised in, consists of or has any nucleotide sequence selected from SEQ ID NOs:33 to 6236 15 and SEQ ID NOs:166154 to 166181, and SEQ ID Nos:6237 to 75336 and SEQ ID Nos:166182 to 166489. SEQ ID NOs:33 to 6236 correspond to ORF encoding non SC proteins of the present invention. These sequences can be fixed to the DNA array as cDNA probes. SEQ ID NOs:6237 20 to 75336 are short nucleotide sequences of about 25 continuous nucleotides selected from each of SEQ ID NOs:1 to 6236. SEQ ID Nos: 166182-166489 represent sequences of oligonucleotides based on DNA sequences of SEQ ID NOs: 166154 to 166181. 25 The ORF sequences from yeast in the present specification may include intron. Such intron sequences can be easily recognized for an artisan. The term "comprised in", therefore, means that the nucleotide 63 WO 2006/024951 PCT/IB2005/002908 sequences of the DNA probes on the DNA array can include only exon sequences (without intron) which can be easily selected by referring to the ORF sequences disclosed in the present specification. 5 The term "have (has)" or "having" means that the nucleotide sequence of the present invention may include additional sequence which does not substantially affect the function of the DNA of the present invention. For example, DNAs encoding ORF may contain an additional signal or tag 10 sequence which can facilitate secretion and/or purification of the protein encoded by the ORF. Alternatively, oligonucleotides may contain additional one or several nucleotide sequences at its terminal which does not affect hybridization specificity of the oligonucleotides. 15 SEQ ID Nos. 167043-173124 represent sequences of oligonucleotides based on DNA sequences of SEQ ID NOs: 166490-167042. SEQ ID Nos. 174604-190810 represent sequences of oligonucleotides based on DNA sequences of SEQ ID NOs: 173125-174603. These sequence can be fixed to the 20 DNA array as oligonucleotide probes. Another embodiment of the DNA array of the present invention is that of further comprising, in addition to at least one group of DNAs selected from (1) to (4), DNAs of the following (5) and/or (6): 25 (5) DNA consisting of a nucleotide sequence of an open reading frame of the genome sequence of an industrial yeast which encodes an amino acid sequence having identity of more than 97% to an amino acid sequence encoded by the gene 64 WO 2006/024951 PCT/IB2005/002908 of Saccharomyces cerevisiae, or a nucleotide sequence complementary to the above nucleotide sequence, or a nucleotide sequence of continuous 10 or more nucleotides selected from the above nucleotide sequences; and 5 (6) DNA consisting of a nucleotide sequence of the genome sequence of an industrial yeast other than from open reading frames which consists of a nucleotide sequence having identity of more than 94% to the nucleotide sequence of the gene of Saccharomyces cerevisiae, or a nucleotide 10 sequence complementary to the above nucleotide sequence, or a nucleotide sequence of continuous 10 or more nucleotides selected from the above nucleotide sequences. DNAs of (5) correspond to ORF of Sc genes, and DNAs of (6) correspond to non-coding regions of Sc genes, 15 respectively. The DNA array comprising DNAs of (5) and/or (6) in addition to DNAs of any of (1) to (4), is useful for a method of classifying an industrial yeast, for example. In a preferred embodiment, the DNAs of (5) has a nucleotide sequence of any one of SEQ ID NOs: 75337 to 20 82784, or SEQ ID NOs: 82785 to 166153. SEQ ID NOs: 75337 to 82784 correspond to ORF encoding non-SC proteins of the present invention. SEQ ID NOs: 82785 to 166153 are short nucleotide sequences of about 25 continuous nucleotides selected from each of SEQ ID NOs:33 to 6236. 25 In a preferred embodiment, the DNA array comprises DNAs selected from the group of (1) and/or (2), together with DNAs selected from the group of (5) and/or (6). Hybridization intensity of a sample to a DNA probe of (1) 65 WO 2006/024951 PCT/IB2005/002908 is compared to the corresponding DNA probe of (5). Similarly, hybridization intensity of a sample to a DNA probe of (2) is compared to the corresponding DNA probe of (6). 5 Optionally, the present DNA array of this embodiment may further comprise DNAs of the following (5') and/or (6'): (5') DNA consisting of a nucleotide sequence which contains mismatch of 1 or more base(s) to the DNA of (5), 10 or a nucleotide sequence complementary to the above nucleotide sequence; and (6') DNA consisting of a nucleotide sequence which contains mismatch of 1 or more base(s) to the DNA of (6), or a nucleotide sequence complementary to the above 15 nucleotide sequence. As described above, DNAs of (5) correspond to ORF of Sc genes, and DNAs of (6) correspond to non-coding regions of Sc genes, respectively. DNAs of (5') and (6') contain mismatch of one or more base(s), preferably one base to (5) 20 and (6), respectively. In general, a sample of DNAs shows a different hybridization intensity to a probe having mismatch of one or more base(s) in the DNA array hybridization assay. In a preferred embodiment, if a sample DNA hybridizes to a DNA probe of (5) (or (6)) and 25 does not hybridize to the corresponding DNA probe of (5') (or (6')), it can be concluded that the sample DNA is positive as regards the DNA probe of (5) (or (6)) of Sc type gene. On the contrary, if a sample DNA hybridizes to 66 WO 2006/024951 PCT/IB2005/002908 a DNA probe of (5) (or (6)) but also hybridizes to the corresponding DNA probe of (5') (or (6')), it can be concluded that the sample DNA is negative or pseudopositive as regards the DNA probe of (5) (or (6)) of Sc type gene. 5 Accordingly, DNAs of (5') and/or (6') may be optionally used as DNA probes of the present DNA array for determining and confirming hybridization specificity of a sample to the DNAs of (5) and/or (6). 10 Still another aspect of the DNA array of the present invention is that of further comprising, in addition to at least one group of DNAs selected from (1) to (4), DNAs selected from at least one group of (7) to (10): (7) DNA consisting of a nucleotide sequence which 15 contains mismatch of 1 or more base(s) to the DNA of (1), or a nucleotide sequence complementary to the above nucleotide sequence; (8) DNA consisting of a nucleotide sequence which contains mismatch of 1 or more base(s) to the DNA of (2), 20 or a nucleotide sequence complementary to the above nucleotide sequence; (9) DNA consisting of a nucleotide sequence which contains mismatch of 1 or more base(s) to the DNA of (3), or a nucleotide sequence complementary to the above 25 nucleotide sequence; and (10) DNA consisting of a nucleotide sequence which contains mismatch of 1 or more base(s) to the DNA of (4), 67 WO 2006/024951 PCT/IB2005/002908 or a nucleotide sequence complementary to the above nucleotide sequence. In general, a sample of DNAs shows a different hybridization intensity to a probe having mismatch of one 5 or more base(s) in the DNA array hybridization assay. This type of DNA array, therefore, is useful for detecting a nucleotide polymorphism in genome of an industrial yeast. It can also be useful for the method to screen a useful strain of industrial yeast or useful genes themselves. 10 In a preferred embodiment, the DNAs of (7) to (10) includes mismatch of only one base. That is, the DNAs of (7) and (10) are the following DNAs of (7-1) to (10-1), respectively. (7-1) DNA consisting of a nucleotide sequence which 15 contains mismatch of 1 base to the DNA of (1), or a nucleotide sequence complementary to the above nucleotide sequence; (8-1) DNA consisting of a nucleotide sequence which contains mismatch of 1 base to the DNA of (2), or a 20 nucleotide sequence complementary to the above nucleotide sequence; (9-1) DNA consisting of a nucleotide sequence which contains mismatch of 1 base to the DNA of (3), or a nucleotide sequence complementary to the above nucleotide 25 sequence; and (10-1) DNA consisting of a nucleotide sequence which contains mismatch of 1 base to the DNA of (4), or a 68 WO 2006/024951 PCT/IB2005/002908 nucleotide sequence complementary to the above nucleotide sequence. Preferably, mismatch of one base is at the center or near the center of each DNA. 5 One of the most preferred embodiments of the present DNA array comprises at least one group of DNAs selected from (1) to (4) (preferably (1) and/or (2)), at least one group of DNAs selected from (7) to (10) (preferably (7) and/or (8)), DNAs of (5) and/or (6) and DNAs of (5') and/or 10 (6'). The DNA array of this embodiment is especially useful for the present method to classify an industrial yeast, as well as a method to analyze the chromosomal structure of an industrial yeast by DNA array-based comparative genomic hybridization as discussed in the 15 present specification below. Preferably, at least one group of DNAs selected from (7) to (10), and DNAs of (5') and/or (6') has a mismatch of only one base. Probes which are attached to the DNA arrays of the present invention can be cDNA probes or oligonucleotids. 20 There is no limitation to the length of cDNA probes, but preferably, no longer than 1,000 bases. Oligonucleotide probes range form about 5 to about 50 nucleotides, preferably, 10-30 nucleotides. Production of a DNA array of this invention 25 A DNA array of the present invention can be produced based on the DNA sequence information of the ORFs and/or non-coding regions (intergenic DNA sequence between two ORFs) obtained in the above (f). Examples include a DNA 69 WO 2006/024951 PCT/IB2005/002908 array comprising a solid support to which at least one of a polynucleotide comprising the DNA sequence obtained in the above items (f). DNA arrays of the present invention include substrates 5 known in the art, such as a DNA microarray, a DNA chip, polynucleotide array and a DNA macroarray, or the like, and comprises a solid support and plural polynucleotides of fragments thereof which are adhered to the surface of the solid support. As the polynucleotides or oligonucleotides 10 adhered to the solid support, the polynucleotides or oligonucleotides of the present invention obtained in the above (f) and (h) can be used. The analysis described below can be efficiently performed by adhering the polynucleotides or 15 oligonucleotides to the solid support at a high density, though a high fixation density is not always necessary. Apparatus for achieving a high density, such as an arrayer robot or the like, is commercially available from Takara Shuzo (GMS417 Arrayer), and the commercially available 20 product can be used. Also, the oligonucleotide of the present invention can be synthesized directly on the solid support by the photolithography method or the like (Nat. Genet. 21, 20-24 (1999)). In this method, a linker having a protective group which can be removed by light irradiation 25 is first adhered to a solid support, such as slide glass or the like. Then, it is irradiated with light through a mask (a photolithograph mask) permeating light exclusively at a definite part of the adhesion part. Next, an 70 WO 2006/024951 PCT/IB2005/002908 oligonucleotide having a protective group which can be removed by light irradiation is added to the part. Thus, a ligation reaction with the nucleotide arises exclusively at the irradiated part. 5 By repeating this procedure, oligonucleotides each having a desired sequence and different from each other can be synthesized in respective parts. Usually, the oligonucleotides to be synthesized have a length of 10 to 30 nucleotides. 10 Alternatively, cDNA probes which can be prepared by any known conventional methods based on the nucleotide sequences of mRNA obtained from the industrial yeast can be used. A cDNA probe is fixed to the DNA array after it has been prepared. Examples of general methods for preparing 15 and fixing the cDNA probes to the DNA array are explained in "Science volume 270, pages 467-470 (1995)", for example. There is no particular limitation for the methods used for the production of DNA array and the method may be conducted according to the known means, while preferred 20 method for each of them is mentioned below. (1) Production of a DNA array (1)-1 Solid support Any materials of which the polynucleotids or fragments can be adhere to the surface can be used as the 25 solid supports using the invention DNA array. There is no particular limitation for the material and shape used for the solid support, while preferred materials are some 71 WO 2006/024951 PCT/IB2005/002908 resinoids, such as polycarbonate, plastics or the like, as a material and a plate-like and film-like as a solid. (l)-2 Selection of an oligonucleotide The example of oligonucleotides to be fixed on the 5 plate of a DNA array of this invention are as follows. Based on the DNA sequences of ORFs obtained in the above (h) and/or intergenic DNA sequences deduced from the above (h), unique and perfect complementary probes (PM Probe; Perfect Match Probe) against genome sequence of brewing 10 yeast can be designed using a certain method of probe production, such as GeneChip@ (Affymetrix) technology or the like. The oligonucleotide probes range form about 5 to about 100 nucleotides, preferabaly about 5 to about 80 15 nucleotides, preferably about 5 to about 60 nucleotides, more preferably about 5 to about 50 nucleotides, more preferably from about 5 to about 45 nucleotides, still more preferably from about 10 to about 40 nucleotides and most preferably from about 10 to 30 nucletides in length. 20 Particularly preferred arrays contain probes ranging from about 20 to about 25 oligonucleotides in length. The array may comprise more than 10, preferably more than 50, more preferably more than 100, and most preferably more than 25 1000 oligonucleotide probes specific to the each target gene (Where the array refers to the DNA array to be fixed the oligonucleitide probes using a certain method of probe production, such as GeneChip@ (Affymetrix) technology or 72 WO 2006/024951 PCT/IB2005/002908 the like). In a preferred embodiment, the array comprises at least 10 different oligonucleotide probes for each gene. In another preferred embodiment, the array 20 or fewer oligonucleotides complementary each gene. 5 Widely used industrial yeast such as bottom fermenting yeast (S. pastorianus) has been regarded as a natural hybrid of S. cerevisiae and its closely related species (such as S. bayanus) as described above. So the bottom fermenting yeast has at least two different genes whose DNA 10 sequences are similar to each other. Thereby, it is desirable to remove probes that hybridize to transcription products of more than one gene. One can then remove any probes that are similar to any other genes, and make a probe set for that genes using a certain method of probe 15 production, such as GeneChip@ (Affymetrix) technology or the like) The array may further comprise mismatch control probes. Where such mismatch control probes are present, the quantifying step may comprise calculating the 20 difference in hybridization signal intensity between each of the oligonucleotide probes and its corresponding mismatch control probe. The quantifying may further comprise calculating the average difference in hybridization signal intensity between each of the 25 oligonucleotide probes and its corresponding mismatch control probe. The term mismatch probe refer to the probe whose sequence is deliberately selected not to be perfectly complementary to a particular target sequences. For each 73 WO 2006/024951 PCT/IB2005/002908 mismatch (MM) control in a high-density array, there typically exists a corresponding perfect match (PM) probe that is perfectly complementary to the same particular target sequence. The mismatch may comprise one or more 5 bases, preferably one base. While the mismatch(es) may be located anywhere in the mismatch probe, terminal mismatche is less desirable as a terminal mismatch is less likely to prevent hybridization of the target sequences. In a particularly preferred 10 embodiment, the mismatch is located at or near the center of the probe so that the mismatch is most likely to destabilize the duplex with the target sequence under the optimal hybridization conditions. Preferably, the mismatch is adenine (A) to thymine (T) and vice versa, or guanine 15 (G) to cytosine (c) and vice versa. Numbers of nucleotides of these oligonucleotides are not limited, but 10 to 30 nucleotides are preferable. 8-51 probes for each locus can be designed focusing on 3' prime side of each locus as the use of probes sets for each locus 20 provided redundancy in the detection and analysis of the data, can reduce the potentially confounding effects of occasional cross-hybridization, and can make it so all probes do not have to hybridize identity in order to obtain quantitative information. To further increase the 25 sensitivity and specificity of detection, each PM probe can be designed with a closely related mismatch probe (MM probe) that is identical to PM probe with the exception of a mismatched base, i.e. base 13. The preferable length of 74 WO 2006/024951 PCT/IB2005/002908 oligonucleotide which is used in this invention is 25 base, but no particular limitation for the length of oligonucleotide. Preferably, the mismatch is adenine (A) to thymine (T) and vice versa, or guanine (G) to cytosine 5 (c) and vice versa. (l)-3 Adhering oligonucleotides to solid support There is no particular limitation for the methods used for adhering oligonucleotides to solid support, and the method may be conducted according to the known means, while 10 preferred method is mentioned below. For example, all of designed PM and MM probes as above ((l)-2) can be adhered to the surface of solid support to produce a DNA array using a certain method, such as GeneChip@ technology or the like. 15 There is no particular limitation for the methods used for DNA maicroarray analysis, while preferred methods for each of them is mentioned below, i.e., the example of gene expression analysis to identify genes, which show a characteristic expression profile under some conditions, 20 classification of industrial yeast, detection of nucleotide polymorphism and selection of genes for functional analysis are mentioned below. III. Analyzing methods using the DNA array 25 The arrays of the invention can be used for various methods to analyze genomic DNA, cDNA or cRNA of an industrial yeast. The analyzing methods include, for example, 1) a method for determining expression of each 75 WO 2006/024951 PCT/IB2005/002908 gene of non-Sc type, 2) a method for classifying an industrial yeast, 3) a method for detecting nucleotide polymorphism in genome of an industrial yeast, 4) a method for screening a useful strain of industrial yeasts, and 5) 5 a method for screening a gene of an industrial yeast. (m) Gene expression analysis Gene expression analysis of an industrial yeast can be carried out using the DNA array of the present invention produced according to the method described in (1). It is 10 possible to identify the highly inducible or reducible gene(s) according to changes of not only medium but also environment using the DNA array. It is also possible to identify the specific gene(s) for lager brewing yeast in brewing using the DNA array. But it is not limited for 15 these examples. Gene expression analysis includes culturing of a industrial yeast, preparation of mRNA, synthesis of labeled cRNA(or cDNA), hybridization, and data analysis. There is no particular limitation for the methods of Gene 20 expression, while preferred methods for each of them is mentioned below. (m)-1 Culturing a industrial yeast in a various condition Industrial yeast can be cultivated under various 25 conditions for any purpose. For example, the cultivation for identification of genes which respond to the change of composition of culture medium can be carried out as mentioned below. Industrial yeast can be grown overnight in 76 WO 2006/024951 PCT/IB2005/002908 a Zinc replete medium, such as LZMM medium + 40 pM zinc sulfate at 30 0 C with shaking. LZMM medium contains 0.17 % yeast nitrogen base w/o amino acids (manufactured by DIFCO), 0.5 % ammonium sulfate, 20 mM sodium citrate (pH 5 4.2), 125 pM MnCl2, 10 pM FeCl2, 2 % maltose, 10 mM EDTA (pH 8.0), or the like. Cells are harvested and washed three times with sterile distilled water. An adequate amount of cells, an optical density (OD600) of 0.25, or the like, are inoculated to 1) zinc depleted medium (LZMM medium) or the 10 like, 2) zinc replete medium (LZMM+ 40 VM zinc sulfate) or the like, 3) oxidative stress medium (LZMM+ 40 VM zinc sulfate + 2mM H 2 0 2 ) or the like, 4) carbon starvation medium (deleting maltose from above LZMM+ 40 pM zinc sulfate) or the like. Cells are grown at 30 0 C for 6 hours and harvested 15 for RNA preparation.Cells withdrawn from fermentation tube under beer fermenting condition can be used for the following experiments. (m)-2 Preparation of mRNA Preparations of total RNA from each cell can be 20 carried out using an RNeasy@ Mini Kit (manufactured by QIAGEN) or the like according to a manual. Preparations of Poly (A)+ mRNA from each total RNA are carried out using an Oligotex Direct mRNA kit (manufactured by QIAGEN) or the like according to a manual. There is no particular 25 limitation for the methods used for preparation of mRNA and the method may be conducted according to the known means. (m)-3 Synthesis of Labeled cRNA 77 WO 2006/024951 PCT/IB2005/002908 Synthesis of Labeled cRNA can be carried out using a BioArray HighYield RNA Transcript Labeling Kit (manufactured by Affymetrix) or the like according to a manual. Biotin can be used for labeling. There is no 5 particular limitation for the methods to synthesize Labeled cRNA and the method may be conducted according to the known means. (m)-4 Hybridization 5 pig of Biotin-Labeled cRNA, 1.71 of 3 nM Control 10 Oligonucleotide B2 (manufactured by Affymetrix), 5 pl of 20X Eukaryotic Hybridization Controls (manufactured by Affymetrix), 1 Rl of 10 mg/ml Herring Sperm DNA (manufactured by Affymetrix), 1 ptl of 50 mg/ml Acetylated BSA (manufactured by Affymetrix), 50 pl of 2X Hybridization 15 buffer (manufactured by Affymetrix), and water (manufactured by Affymetrix) to give final volume of 100 Rl are mixed and hybridized to the DNA array according to a Technical Manual of Affymetrix. After 16 hours of hybridization, hybridization cocktail are removed and the 20 DNA array is washed using the a GeneChip® Fludics Station (manufactured by Affymetrix) or the like, and stained with a Streptavidin Phycoerythrin (300 1 of 2X MES Stain Buffer (manufactured by Affymetrix), 24 pl of 50 mg/ml acetylated BSA (manufactured by Affymetrix), 6 pl of lmg/ml 25 StreptAvidin-Phycoerythrin (manufactured by Affymetrix), 270 pl of DI Water (manufactured by Affymetrix)) according to a Technical Manual of Affymetrix. There is no particular 78 WO 2006/024951 PCT/IB2005/002908 limitation for the methods to hybridize, and the method may be conducted according to the known means. (m)-5 Data analysis Data analysis of the DNA array can be carried out 5 using a commercially available software (for example, GCOS (GeneChip Operating Software manufactured by Affymetrix; GeneSpring manufactured by Silicon Genetics; ImaGene manufactured by Takara Shuzo; Array Gauge manufactured by Fuji Photo Film; ImageQuant manufactured by Amersham 10 Pharmacia Biotech, or the like) according to a Technical Manual. Genes which show characteristic expression profiles can be identified and selected for functional analysis. Furthermore, the identified gene can be used as a gene marker to figure out a condition of the yeast cells. A 15 fluctuation in the expression level of a specific gene can be monitored using a nucleic acid molecule obtained in the time course of culture as the nucleic acid molecule derived from brewing yeast. The culture conditions can be optimized by analyzing the fluctuation. The expression 20 profile of the brewing yeast at the total gene level (namely, which genes among a great number of genes encoded by the genome have been expressed and the expression ratio thereof) can be determined using a nucleic acid molecule having the sequences of many genes determined from the 25 genome sequence of the yeast. Thus, the expression level of the genes determined by the genome sequence can be analyzed and, in its turn, the biological conditions of the 79 WO 2006/024951 PCT/IB2005/002908 yeast can be recognized as the expression pattern at the full gene level. As a result of gene expression analysis, a group of genes which shows distinctive expression under a certain 5 condition can be identified as target genes for further functional analysis. "A certain condition" may include, without any limitation, changes in environment, such as, temperature, pH, or osmotic pressure, as well as changes in components of medium. As a screening method for 10 identifying genes showing distinctive expression under the certain condition, for example, a gene wherein significant changes in expression of the gene are recognized according to changes in environment, can be selected. "Significant changes" mean preferably, 1.5 times higher, or 2/3 or less, 15 more preferably, 2 times higher, or 1/2 or less, even more preferably 3 times higher, or 1/3 or less, but not limited thereto. There is no particular limitation for the methods used 20 for analysis of data and the method may be conducted according to the known means. Comparative hybridization analysis The DNA array of the present invention can also be used for comparative hybridization analysis using genomic 25 DNA, cDNA or cRNA as a sample for hybridization. (n) Classification of industrial yeast An embodiments of the present invention includes a method for classifying an industrial yeast comprising 80 WO 2006/024951 PCT/IB2005/002908 (a) hybridizing genomic DNA prepared from the industrial yeast to the DNA array of the present invention; and (b) calculating hybridization ratio to any of (1) to (4), and hybridization ratio to (5) and/or (6). 5 For the purpose of this embodiment, the DNA array comprises, in addition to the DNAs of any of (1) to (4), DNAs of the (5) and/or (6) is preferably used (Embodiment 15 or 16). Preferably, hybridization intensity to the DNAs of (1) 10 and to the DNAs of (5) is compared. Alternatively, hybridization intensity to the DNAs of (2) and to the DNAs of (6) is compared. The present DNA array may optionally comprise DNAs of the (5') and/or (6') and/or (7) and/or (8)having one or 15 more mismatch(es) to the DNA of (5) and/or (6) and/or (1) and/or (2),respectively. DNAs of (5') and/or (6') and/or (7) and/or (8) may be optionally used as DNA probes of the present DNA array for determining and confirming hybridization specificity of a sample to the DNAs of (5) 20 and/or (6) and/or (1) and/or (2) ,respectively. Specifically, in one of preferred embodiments of the present invention, the DNA array comprises at least one group of DNAs selected from (1) to (4) (preferably (1) and/or (2)), at least one group of DNAs selected from (7) 25 to (10) (preferably (7) and/or (8)), DNAs of (5) and/or (6) and DNAs of (5') and/or (6'). In the method using the above DNA array, percentage of genes which hybridize to DNAs of (1) and/or (2), but not to DNAs of (7) and/or (8) 81 WO 2006/024951 PCT/IB2005/002908 is determined as hybridization ratio to any of (1) to (4), and percentage of genes which hybridize to DNAs of (5) and/or (6), but not to DNAs of (5') and/or (6') is determined as hybridization ratio to any of (5) and/or (6). 5 It is possible to classify industrial yeast using a DNA array mentioned above. Preparation of yeast genomic DNA and hybridization to a DNA array may be carried out as described before. Detection of the signal intensity of array is carried out using a Gene Chip Analysis Basic 10 System and analysis soft ware (GCOS; GeneChip Operating Software 1.0) manufactured by Affymetrix. The percentage of probes, to which the DNA of an industrial yeast hybridizes, is calculated. The identity between the strain from which the DNA probes of the DNA array are derived 15 (e.g.34/70) and the tested strain is estimated from the calculation result. Industrial yeast strains can be classified on the basis of the identity. A strain of industrial yeasts which shows hybridization percentage to the non-Sc genes and the 20 Sc-genes on the DNA array similar to that of another strain can be classified as a close strain of the another strain. (o) Detection of nucleotide polymorphism An embodiment of the present invention includes a method for detecting nucleotide polymorphism in genome of 25 an industrial yeast comprising (a) hybridizing genomic DNA prepared from the industrial yeast to the DNA array of the present invention; and 82 WO 2006/024951 PCT/IB2005/002908 (b) selecting a gene wherein hybridization intensity to the DNAs of any of (7) to (10) is higher than hybridization intensity to the DNAs of any of (1) to (4). For the purpose of this embodiment, the DNA array 5 comprises, in addition to the DNAs of any of (1) to (4), DNAs of any of (7) to (10) is preferably used (Embodiments 17-19). It is possible to detect nucleotide polymorphism of a industrial yeast by comparative genomic hybridization with 10 the DNA array mentioned above. For this embodiment, the probes on the array are preferably oligonuclotide probes. As an illustrative example, the sets of oligonucleotides for each probe consist of Perfect Match oligonucleotide (PM) which is identical to the sequence of 15 strain 34/70 and MisMatch oligonucleotide (MM) which contains a single base mismatch, e.g., in the central position of the oligonucleotide. It is possible to detect nucleotide polymorphism from the gene whose signal intensity in MM is higher (for example, more than 5-fold) 20 than that in PM. Genes comprising one or more mismatche(es) can be preferable candidates of target genes for further functional analysis. (p) Selection of useful yeast strains and genes 25 An embodiment of the present invention includes a method for screening a useful strain of industrial yeast, comprising 83 WO 2006/024951 PCT/IB2005/002908 (a) hybridizing genomic DNA prepared from the industrial yeast strain to the DNA array of the present invention; and (b) determining the industrial yeast strain as useful when the strain contain 1 or more genes, preferably, 2 or 5 more genes, wherein hybridization intensity thereof is 1.5 times higher or less than 2/3 compared to an average hybridization intensity to the DNA of any of (1) to (4). A gene of genomic DNA which shows hybridization intensity significantly different from other genes may be 10 selected as a candidate of useful gene for further functional analysis. Therefore, strains of industrial yeasts comprising 1 or more such genes, preferably 2 or more such genes can be selected as candidate of useful strains. Preferably, hybridization intensity of such gene 15 is significantly different from that of other genes, more preferably, thereof is 1.5 times higher or less than 2/3 compared to an average hybridization intensity to the DNA of (1) and/or (2). More preferably, the difference in hibridization intensity is 2 times higher, or 1/2 or less, 20 even more preferably 3 times higher, or 1/3 or less, but not limited thereto. Further embodiment of the present invention is a method for screening a gene of an industrial yeast, comprising 25 (a) hybridizing genomic DNA prepared from the industrial yeast strain to the DNA array of the present invention; and (b) selecting a gene wherein hybridization intensity thereof is 1.5 times higher or less than 2/3 compared to an 84 WO 2006/024951 PCT/IB2005/002908 average hybridization intensity to the DNA of any of (1) to (4). Another embodiment of the present invention is a method for screening a gene of an industrial yeast, 5 comprising (a-1) hybridizing genomic DNA, cDNA or cRNA prepared from the industrial yeast to the DNA array of the present invention; (a-2) independently from the step (a-1), hybridizing 10 genomic DNA, cDNA or cRNA prepared from the industrial yeast of the strain used for preparing the DNA array to the DNA array of the present invention; and (b) selecting a gene wherein hybridization intensity thereof to the DNA any of (1) to (4) in the step (a-1) is 15 significantly different from hybridization intensity thereof in the step (a-2). The above screening method enable to select genes of which hybridization intensity to the DNA array are different between strains. From the results of comparative 20 genomic hybridization analysis, a gene which has probe sets showing low signal intensities may be lost or have different sequence from that of the strain used for probes of the array (e.g., 34/70). In contrast, a gene which has probe sets showing high signal intensities may be high in 25 copy number. For example, as for a gene, which show hybridization intensity of 2 times higher in the step (a-1) than that of the strain used for preparing the DNA array in 85 WO 2006/024951 PCT/IB2005/002908 the step (a-2), the strain of (a-1) is likely to have two or more copies of the gene. Another embodiment of the present invention is a method for screening a gene of an industrial yeast, 5 comprising (a-1) hybridizing cDNA or cRNA prepared from the industrial yeast to the DNA array of the present invention; (a-2) independently from the step (a-1), hybridizing cDNA or cRNA prepared from another industrial yeast to the DNA 10 array of any one of Embodiments 10-19, wherein the industrial yeast of (a-2) has been cultured in a different condition from the culture condition for the industrial yeast of (a-1); and (b) selecting a gene wherein hybridization intensity 15 thereof to the DNA of any of (1) to (4) in the step (a-1) is significantly different from hybridization intensity thereof in the step (a-2). The above screening method enable to select genes wherein expression of the genes may be changed due to 20 difference in culture condition. The "industrial yeast cultured in a different condition" includes yeasts cultured in different medium or temperature, or sequential samples during the process of producing an alcohol or an alcoholic beverage, for example. 25 Genes obtained by the various screening methods of the present invention may be subjected for further functional analysis, because differences in hybridization intensity may contribute to the difference of fermentation character 86 WO 2006/024951 PCT/IB2005/002908 between strains. The genes which have nucleotide polymorphism detected by the method mentioned above can be also selected for functional analysis. As another alternative, the DNA array of the present 5 invention may be used to analyze the chromosomal structure of an industrial yeast by DNA array-based comparative genomic hybridization. Following description is an example of the chromosome structure analysis using the DNA array. Yeast genomic DNA is prepared using a Quiagen Genomic 10 Tip 100/G (#10243) and Qiagen Genomic DNA Buffer Set (#19060) according to the manual attached to the kit. The DNA (10 Rg) is digested with DNase I (manufactured by Invitrogen) according to a method of Winzeler, et al. (Science, volume 281, pages 1194-1197 (1998)), biotinylated 15 using a terminal transferase (manufactured by Roche) and hybridized to a DNA array (Affymetrix Gene Chip Yeast Genome S98 Array). The DNA array of the present invention may include DNAs of any one of (1) to (4) and (7) to (10) from Non-Sc type genes as well as (5) -and/or (6) and/or 20 (5') and/or (6')of the Sc type. Hybridization and detection of the signal intensity of DNA array are carried out using a Gene Chip Analysis Basic System and analysis soft ware (GCOS; GeneChip Operating Software 1.0) manufactured by Affymetrix. 25 The signals of probes hybridized with the DNA of brewing yeast were lined following genes order in each chromosome using a spreadsheet program (Microsoft Excel 2000) and the signals are shown in bar graphs. The Sc type 87 WO 2006/024951 PCT/IB2005/002908 genes do not hybridize to the non-Sc type DNA probes (i.e., DNAs of (1) to (4)). Contrary, the non-Sc type genes do not hybridize to the Sc type DNA probes (i.e., DNAs of (5) and/or (6)). Therefore, the gene dosage of Sc type DNA 5 and/or non-Sc type DNA affect the signal and the points where the signals show vigorous changes and which are considered to be translocation sites between Sc type and non-Sc type chromosome. In a preferred embodiment, hybridization to DNAs of any of (1) to (4) can be 10 determined by hybridization to DNAs of (1) and/or (2), but not to DNAs of (7) and/or (8), and hybridization to DNAs of any of (5) and/or (6) can be determined by hybridization to DNAs of (5) and/or (6), but not to DNAs of (5') and/or (6'). 15 IV. Genes and Polypeptides The present invention further provides a non-Sc gene obtained by the analyzing method and the screening method of the present invention. Preferably, genes of the present 20 invention involved in increase in productivity and/or improvement in flavor in the production of an alcohol or an alcoholic beverage. For example, genes of the present invention is, preferably, characterized in that concentration of sulfite in a culture medium of an 25 industrial yeast increases when the gene is expressed in the yeast. The present invention also provides polypeptides or proteins encoded by the genes. The polypeptides of the 88 WO 2006/024951 PCT/IB2005/002908 present invention may be obtained by any known conventional methods including expression of the gene by genetic engineering, or via polypeptide synthesizing technique. The genes of the present invention may include both 5 ORF and non-coding regions (non-ORF regions). "Gene" includes DNA, cDNA, mRNA, cRNA, without any limitation. The gene of the present invention can be prepared by any known conventional methods, for example, by screening a cDNA library, or via polynucleotide synthesizing 10 techniques. In the present specification, the term "nucleic acid" is used interchangeably with "gene". In the following explanation, "DNA" will be explained as an example of gene. With regard to the DNA which can be obtained by the 15 method of the present invention, a DNA containing the DNA sequence of the non-Sc type gene obtained in the above and a DNA which hybridizes to the said DNA under stringent condition and a protein having the substantially the same biological activity may be listed. 20 The DNA obtained by the method of the present invention includes single-stranded and double-stranded DNAs although they are non-limitative. A DNA which hybridizes to the DNA containing a DNA sequence of the non-Sc type gene obtained in the above under stringent condition 25 includes a degenerated mutant of codon for the protein encoded by the said gene, for example. A degenerated mutant means a polynucleotide fragment encoding the same amino acid sequence by degeneration of codon, although in 89 WO 2006/024951 PCT/IB2005/002908 terms of a DNA sequence, it is different from a DNA sequence of the non-Sc type selected by the present invention. As an example, the gene of the present invention 5 includes a nucleic acid encoding a polypeptide of any one of the following i) and ii): i) a polypeptide having the amino acid sequence represented by SEQ ID NO:3; and ii) a polypeptide having an amino acid sequence wherein 10 one or more amino acid residue(s) is deleted from, substituted for and/or added to the amino acid sequence represented by SEQ ID NO:3, and having an activity to increase concentration of sulfite in a culture medium of an industrial yeast when the gene is expressed in the yeast. 15 More preferably, the nucleic-acid according to the present invention is selected from the following a) and b): (a) a nucleic acid having the nucleotide sequence represented by SEQ ID NO:1; and 20 (b) a nucleic acid having a nucleotide sequence which hybridizes to the nucleotide sequence complementary to the nucleotide sequence represented by SEQ ID NO:1 under a stringent condition, and encodes a polypeptide having an activity to increase concentration of sulfite in a culture 25 medium of an industrial yeast when the gene is expressed in the yeast. Specific example thereof is a DNA with a sequence as shown by SEQ ID NO:1, a DNA which hybridizes to the said 90 WO 2006/024951 PCT/IB2005/002908 DNA under stringent condition, etc. The DNA which hybridizes under stringent condition means a DNA which is prepared by a colony hybridization method, a plaque hybridization method, a southern blot hybridization method 5 or the like using a DNA fragment with the sequence of the non-Sc type identified hereinabove as a probe. An appropriate stringent condition can be selected as described above. Hybridization may be carried out according to a method 10 mentioned in "Molecular Cloning, Third Edition", "Current Protocols in Molecular Biology", "DNA Cloning 1: Core Techniques, A Practical Approach, Second Edition, Oxford University (1995)", etc. Specific examples of the hybridizable DNA is a DNA 15 which shows at least not less than 60% identity, preferably a DNA which shows not less than 80% identity and, more preferably, a DNA which shows not less than 95% identity to a DNA sequence as shown in SEQ ID NO:1 when calculation is conducted using a parameter of the default setting (initial 20 setting) by a software for homology searching such as FASTA, BLAST, Smith-Waterman "Meth. Enzym., volume 164, page 765 (1988)", etc. An example of the DNA obtained by the screening method of the present invention is a DNA encoding a polypeptide 25 comprising an amino acid sequence shown by SEQ ID NO:3 , or a DNA which hybridizes to the said DNA under stringent condition. 91 WO 2006/024951 PCT/IB2005/002908 An example of the polypeptide which is encoded by the DNA obtained by the screening method of the present invention is a polypeptide encoded by the DNA containing the DNA sequence of ORF obtained in the above and a 5 polypeptide encoded by the DNA which is hybridized to the said DNA under stringent condition or a polypeptide comprising an amino acid sequence shown by SEQ ID NO:3 Further, a polypeptide having an amino acid sequence wherein one or more amino acid residue(s) is deleted from, 10 substituted for and/or added to the amino acid sequence of the said polypeptide, and has substantially same biological activity as the activity of the said polypeptide is also included in the present invention. The expression reading "substantially same activity as the activity of the said 15 polypeptide" means the same activity as the activity which is represented by enzymatic activity or the function inherent to the polypeptide before the deletion, substitution or addition. The said polypeptide can be prepared by a site-specific mutation introduction which is 20 mentioned in "Molecular Cloning, Third Edition", "Current Protocols in Molecular Biology", "Nuc. Acids. Res., volume 10, page 6487 (1982)", "Proc. Natl. Acad. Sic. USA, volume 79, page 6409 (1982)", "Gene, volume 34, page 315 (1985)", "Nuc. Acids. Res., volume 13, page 4431 (1985)", "Proc. 25 Natl. Acad. Sci. USA, volume 82, page 488 (1985)", etc. For example, it is able to be prepared by introducing a site-specific mutation into a DNA encoding a polypeptide comprising an amino acid sequence shown in SEQ ID NO:3 or 92 WO 2006/024951 PCT/IB2005/002908 4. Although there is no particular limitation for the number of the amino acid residue(s) which is/are deleted and/or substituted and/or added, the number is within such an extent that is able to be deleted and/or substituted 5 and/or added by known methods such as the above-mentioned site-specific mutation method and is one to several tens, preferably 1 to 20, more preferably 1 to 10 and, still more preferably, 1 to 5. A polypeptide having an amino acid sequence wherein 10 one or more amino acid residue(s) is deleted from, substituted for and/or added to the amino acid of the polypeptide of the present invention means that there is/are one or more deletion(s) and/or substitution(s) and/or addition(s) of one or more amino acid residue(s) at 15 any one or more site(s) of the amino acid sequence in the same sequence. Those deletion(s) and/or substitution(s) and/or addition(s) may take place at the same time and the substituted or added amino acid residue may be either naturally occurring type or a non-naturally occurring type. 20 Examples of the amino acid residue of a natural type are L alanine, L-asparagine, L-aspartic acid, L-glutamine, L glutamic acid, glycine, L-histidine, L-isoleucine, L leucine, L-lysine, L-methionine, L-phenylalanine, L proline, L-serine, L-threonine, L-tryptophan, L-tyrosine, 25 L-valine and L-cysteine, etc. Examples of the amino acid residue which is able to be substituted each other will be shown below. Amino acid 93 WO 2006/024951 PCT/IB2005/002908 residues in the same group may be substituted each other (conservative substitution). Group A: leucine, isoleucine, norleucine, valine, norvaline, alanine, 2-aminobutanoic acid, methionine, 0 5 methylserine, tert-butylglycine, tert-butylalanine and cyclohexylalanine. Group B: aspartic acid, glutamic acid, isoaspartic acid, isoglutamic acid, 2-aminoadipic acid and 2 aminosuberic acid. 10 Group C: asparagine and glutamine. Group D: lysine, arginine, ornithine, 2,4 diaminobutanoic acid and 2,3-diaminopropionic acid. Group E: proline, 3-hydroxyproline and 4 hydroxyproline. 15 Group F: serine, threonine and homoserine. Group G: phenyl alanine and tyrosine. For the purpose that the resulting mutated polypeptide has the substantially same activity as the activity of the polypeptide before the mutation, it is preferred that the 20 amino acid sequence of mutated one is at least 60% or more, usually 80% or more or, particularly, 95% or more of identity to the amino acid sequence of the polypeptide before the mutation when calculation is carried out using a parameter of the default setting (initial setting) by a 25 software for the analysis such as BLAST and FASTA. Identity between two amino acid sequence can be determined as discussed above. 94 WO 2006/024951 PCT/IB2005/002908 It is also possible to produce the polypeptide of the present invention by a chemical synthetic method such as Fmoc method (fluorenylmethyloxycarbonyl method), tBoc method (tert-butyloxycarbonyl method), etc. It is further 5 possible to synthesize chemically by using a peptide synthesizers manufactured by Advanced ChemTech, Perkin Elmer, Pharmacia, Protein Technology Instrument, Synthecell-Vega, PerSeptive, Shimadzu, etc. When the method of the present invention is used, it 10 is possible to determine the genome sequence of industrial yeast, to identify the useful genes of industrial yeast and to assign the functions of the said genes. There are many cases where the genes in industrial yeast are industrially useful and, when the genes are classified on the basis of 15 the assigned functions, character of the yeast is clarified and precious information for breeding of industrial yeast is able to be obtained. For example, when the industrial yeast is a brewing yeast, then a gene involved in increase in productivity and improvement in flavor in the production 20 of alcoholic beverage is identified and, in case the gene is disadvantageous for the increase of productivity or for the improvement of flavor, the gene expression is suppressed by a gene disruption or an antisense method or an RNAi method (c.f., for example, Non-Patent Document 10), 25 whereupon yeast which shows an excellent brewing character can be bred. In case the gene is advantageous for the increase of productivity, improvement of flavor, etc., then for example the gene is overexpressed in the yeast, 95 WO 2006/024951 PCT/IB2005/002908 whereupon brewing yeast which shows an excellent brewing character, which is industrially useful, can be bred. An example where the gene obtained by the method of the present invention is used to breed useful yeast is 5 shown as follows. As already mentioned above, when the sulfite concentration in a product is increased, it is possible to make a product with excellent flavor stability. Therefore, if the gene obtained by the screening method of the present 10 invention contributes to production and efflux of sulfite, it is now possible that a transformant is cultivated and expressed the said gene to make a product with excellent flavor stability as a result of the increase in the concentration of sulfite in the product. 15 It has been known that a bottom fermenting yeast reduces sulfate ion (S0 4 2 ) taken from outside of the cell to sulfite ion (SO 3 2 ). However, sulfite inhibits the activity of glyceroaldehyde-3-phosphate dehydrogenase and reduces the concentration of intracellular ATP, therefore, 20 yeast has a function of discharging sulfite so that excessive sulfite should not be accumulated in the cell. SSUl is a gene, which has been isolated and shown complement the sulfite-sensitive mutation (c.f., for example, Non-Patent Document 11). SSU1 gene product 25 comprises 485 amino acid residues, and the structural analysis suggests that it is a transporter with 9 to 10 membrane-spanning domains (c.f., for example, Non-Patent Document 12). Further, as a result of experiment using a 96 WO 2006/024951 PCT/IB2005/002908 SSU1 overexpressed strain, it has been already proved that the SSU1 gene product effects the discharge of sulfite (c.f., for example, Non-Patent Document 13). Bottom fermenting yeast usually has a high production 5 ability of sulfite, while top fermenting yeast rarely produces it. By using a screening method of the present invention, it is possible to select non-ScSSU1 gene which is specific to bottom fermenting yeast in addition to ScSSU1 gene which exists in both top and bottom fermenting 10 yeast. Breeding method of yeast, wherein the non-ScSSU1 gene 4 is intensified, is specifically mentioned in the Examples. 15 V. Recombinant vectors, transformants and other embodiments The present invention further includes the following embodiments: A recombinant vector containing the gene of the 20 present invention. A transformant comprising the recombinant vector. The transformant is preferably, a yeast of genus Saccharomyces. A method for producing an alcohol or an alcoholic 25 beverage, using the transformant of the present invention. Preferably, the present method may comprise culturing the transformant of the present invention in a sugar-containing medium. Preferably, the sugar containing medium is 97 WO 2006/024951 PCT/IB2005/002908 selected from a group consisting of wort, grape juice, rice juice and glucose and/or maltose syrup. A breeding method of yeast which is suitable for the production of an alcohol or an alcoholic beverage, 5 characterized in that, expression of the gene or the nucleic acid of the present invention is controlled. Preferably, the yeast belongs to the genus Saccharomyces. Yeast obtained by the breeding method of the present invention. 10 A method for producing an alcohol or an alcoholic beverage using the yeast of the present invention. An alcohol or an alcoholic beverage which is produced by the producing method of the present invention. With regard to yeast used as a host in the 15 introduction of the gene selected by the screening method of the present invention, there is no particular limitation so far as it is yeast which is usable for brewing, and any yeast which is widely used as a brewing yeast at present such as beer yeast including NCYC456, NBRC 1951, NBRC 1952, 20 NBRC 1953 and NBRC 1954. Further, whisky yeasts (such as S. cerevisiae NCYC 90), wine yeasts (such as wine yeast Kyokai No. 1, No. 3, No. 4, etc.) and sake yeasts (such as sake yeast Kyokai No. 7, No. 9, etc.) may be also used. With regard to a vector used for the introduction of 25 gene into the above-mentioned host, there is no particular limitation so far as it is a vector which can express gene in the yeast, and a multicopy plasmid (YEp type), a single copy plasmid (YCp type) and a chromosomal DNA-integrating 98 WO 2006/024951 PCT/IB2005/002908 plasmid (YIp type) may be utilized. An example of a YEp vector is YEp 51 (J. R. Broach, et al., Experimental Manipulation of Gene Expression, Academic Press, New York, 83, 1983), etc.; an example of a YCp vector is YCp 50 (M. 5 D. Rose, et al., Gene, volume 60, page 237, 1987), etc.; and an example of a YIp vector is YIp 5 (K. Struhl, et al., Proc. Natl. Acad. Sci. USA, volume 76, page 1035, 1979), etc. Those plasmids are put into the market and are easily available. 10 The above-mentioned vector may have other sequence for controlling expression of a gene in yeast such as, promoter, operator, enhancer, silencer, ribosome binding sequence, terminator, etc. With regard to a promoter and a terminator for a constitutive expression of a gene, but any 15 combination may be used as long as it functions in a brewing yeast and is independent from sulfite concentration in the product. As to a promoter for example, it is possible to use a promoter for glyceraldehyde-3-phosphate dehydrogenase (TDH3) gene, a promoter for phosphoglycerate 20 kinase (PGK1) gene, etc. Those promoters have been known, and PGK1 gene, for example, is mentioned in detail in publicly known documents such as M. F. Tuite, et al., EMBO J., volume 1, page 603 (1982) and easily available. It is not necessary that the above-mentioned other 25 sequences which regulate the expression of the introduced gene are particularly provided from vector so far as the DNA obtained by the screening method of the present invention includes them. When such other sequences are not 99 WO 2006/024951 PCT/IB2005/002908 contained in the said DNA, it is preferred that other sequences are prepared separately and ligated to the said DNA. Alternatively, even in the case of higher expression level or specific regulation of expression is required, 5 other sequences appropriate for such a purpose are ligated to the said DNA. A method for the transformation of the above vector to a host may follow known procedures. For example, the following methods may be used; an electroporation method 10 "Meth. Enzym., volume 194, page 182 (1991)", a spheroplast method "Proc. Natl. Acad. Sci. USA, volume 75, page 1929 (1978)", a lithium acetate method "J. Bacteriology, volume 153, page 163 (1983)", a method mentioned in "Proc. Natl. Acad. Sci. USA, volume 75, page 1929 (1978)", etc. 15 To be more specific, a host is cultivated in a standard yeast nutrient medium (such as YEPD medium "Genetic Engineering, vol. 1, Plenum Press, New York, 117 (1979)", etc.) so that the absorbance at 600 nm becomes 1 to 6. Cells are collected by centrifugation, washed and 20 subjected to a pre-treatment with an alkali metal ion or, preferably, lithium ion in a concentration of about 1M to 2M. After the cells are incubated at about 30 0 C for about 60 minutes, they are incubated together with DNA to be introduced (about 1 to 20 Rg) at about 30 0 C for about 60 25 minutes. Polyethyleneglycol or, preferably, polyethyleneglycol of about 4,000 daltons is added as the final concentration will be about 20% to 50%. After the incubation is carried out at about 30 0 C for about 30 100 WO 2006/024951 PCT/IB2005/002908 minutes, the cells are subjected to a heating treatment at about 42 0 C for about 5 minutes. Preferably, the cell suspension is washed with a standard yeast nutrient medium and placed in a predetermined amount of a fresh standard 5 yeast nutrient medium, then incubated at about 30 0 C for about 1 hour. After the incubation, it is spread on an appropriate selective medium plate. Besides the above, as for a general cloning technique, "Molecular Cloning, Third Edition", "Methods in Yeast 10 Genetics, A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY)", etc. were referred to. With regard to a selective marker used for the transformation, it is not possible to utilize an 15 auxotrophic marker in the case of brewing yeast and, therefore, G 418-resistance gene (G 418r), copper resistance gene (CUP 1) "M. Karin, et al., Proc. Natl. Acad. Sci. USA, volume 81, page 337, (1984)", serulenin resistance gene (fas2m, PDR 4) "Atsushi Inogoshi, et al., 20 Seikagaku, volume 64, page 660, (1992)", "M. Hussain, et al., Gene, volume 101, page 149, (1991)", etc. are applicable. The brewing yeast bred according to the present invention is not different from a parental strain in terms 25 of growth and fermentation ability. Accordingly, materials, facilities for the production, production control, etc. may be entirely the same as those in the conventional methods, which is an important aspect of the 101 WO 2006/024951 PCT/IB2005/002908 present invention. However, it goes without saying that, conditions such as fermentation period may be changed on a case-by-case, if desired. For example, when a brewing yeast in which discharging ability of sulfite is 5 intensified and an alcoholic beverage is produced using such yeast, only the content of sulfite in the product changes, and there is no difference from the case where a parental strain is used, in terms of growth and fermentation ability of the yeast. Accordingly, materials, 10 facilities for the production, production control, etc. may be entirely the same as those in the conventional methods, and there is no increase in the cost of production of an alcoholic beverage in which sulfite content increases and of which flavor is improved. 15 Examples Details of the present invention are mentioned with the following Examples although the present invention is not limited to the following Examples. 20 (Example 1) Preparation of chromosomal DNA of Saccharomyces pastorianus Weihenstephan 34/70 (hereinafter, abbreviated as strain 34/70) Preparation of chromosomal DNA was carried out by a method mentioned in "Yeast, a practical approach (IRL 25 Press) 6.2.1 (pages 228-229)", which was partially modified. Cells were inoculated and grown in 200 mL of YPD medium (2% glucose, 1% yeast extract and 2% polypeptone) at 30 0 C until absorbance of the culture at 660 nm became 4. 102 WO 2006/024951 PCT/IB2005/002908 Cells were collected by centrifugation, washed with buffer A (50 mM sodium phosphate, 25 mM EDTA and 1% (v/v) mercaptoethanol; pH 7.5) and resuspended in 25 mL of buffer A. 7 mg of Zymolyase 100T (Seikagaku Kogyo) was added 5 thereto and the mixture was mildly shaken at 37 0 C for 60 minutes. To this was added 25 mL of buffer B (0.2M Tris HC1, 80 mM EDTA and 1% SDS; pH 9.5), then the mixture was allowed to stand at 65 0 C for 30 minutes, cooled on ice, mixed with 12 mL of 5M potassium acetate and allowed to 10 stand on ice for further 60 minutes. The resulting solution was centrifuged at 5,000 g for 10 minutes at 15 0 C. To the recovered supernatant was added the same volume of ethanol to precipitate DNA, and the mixture was immediately centrifuged at 5,000 g for 10 minutes at 15 0 C to collect 15 the precipitate. The resulting precipitate was washed with 70% (v/v) ethanol, subjected to natural drying and dissolved in 5 mL of TE buffer (10 mM Tris-HCl and 1 mM of EDTA; pH 8.0) to give a crude DNA solution. Cesium chloride (4.06 g) and 840 pg of bisbenzimide (Hoechst 20 33258) were added and dissolved in 3.5 mL of the crude DNA solution, the mixture was subjected to centrifugal separation at 100,000 g for 17 hours at 25 0 C and exposed to UV light to make DNA bands visible, whereupon the band of the lower layer was recovered. The recovered DNA solution 25 was extracted with isopropanol which was saturated with a cesium chloride solution to remove bisbenzimide (Hoechst 33258). To the recovered aqueous layer was added 4-fold by volume of 0.3 M sodium acetate followed by mixing. Then, 103 WO 2006/024951 PCT/IB2005/002908 3-fold by volume of ethanol was added thereto to precipitate the DNA, which was recovered by centrifugation. The recovered DNA was dissolved in TE buffer containing 75 [tg/mL of RNase, kept at 37 0 C for 5 minutes, and extracted 5 with phenol/chloroform for three times and the aqueous layer was further subjected to precipitation with ethanol. The precipitate recovered by centrifugation was washed with 70% (v/v) ethanol, subjected to natural drying and dissolved in TE buffer to prepare a chromosomal DNA 10 solution. (Example 2) Preparation of a shotgun library The concentration of a genome solution of strain 34/70 prepared in Example 1 was adjusted to 1 mg/mL using a TE 15 buffer. 0.1 mL thereof was treated with a Hydroshear (manufactured by GeneMachines; speed: 6; cycle: 20) to fragmentize the genomic DNA. End of the genomic fragment was blunted using a DNA Blunting Kit (manufactured by Takara Shuzo), fractionated by 0.8% agarose gel 20 electrophoresis. Genomic fragments of 1.5 to 2.5 kb were excised from the gel, and DNA was eluted. The DNA eluate was treated with phenol/chloroform and precipitated with ethanol to give a genome library insert. All the above insert and 0.5 pg of pUC 18 SmaI/BAP (manufactured by 25 Amersham Biosciences) were subjected to ligation at 15 0 C for 15 hours using T4 ligase (manufactured by Takara Shuzo). 104 WO 2006/024951 PCT/IB2005/002908 The product of ligation reaction was precipitated with ethanol and dissolved in 10 pL of a TE buffer. A ligation solution (1 RL) was inserted into 40 FL of Escherichia coli Electro Cell DH5a (manufactured by Takara Shuzo) by means 5 of electroporation under the condition mentioned in- the attached experimental manual. The resulting product is spread on an LB plate medium containing 1.6% of agar (the LB medium (1% bactotryptone, 0.5% yeast extract and 1% sodium chloride; pH 7.0)) containing 0.1 mg/mL of 10 ampicillin, 0.1 mg/mL of X-gal and 1 mmol/L of isopropyl-p D-thiogalactopyranoside (IPTG), and incubated through the night at 37 0 C. The transformant obtained from colonies formed on the said plate medium was subjected to cultivation without 15 shaking through the night at 37 0 C in a 384-well titer plate to which 50 pL of an LB medium containing 0.1 mg/mL of ampicillin was added. Then 50 pL of a 50% aqueous solution of glycerol was added thereto followed by stirring, and the mixture was used as a glycerol stock. 20 (Example 3) Preparation of a cosmid library About 0.1 mg of the genomic DNA obtained in Example 1 was partially digested with Sau3AI (manufactured by Takara Shuzo). Insertion of the fragment into a BamHI site of 25 Super Cos I vector (manufactured by Stratagene) was carried out according to a manual. A ligated product prepared by this method was subjected to packaging using Gigapack III Gold (manufactured by Stratagene) and introduced into 105 WO 2006/024951 PCT/IB2005/002908 Escherichia coli XL1-Blue MR strain (manufactured by Stratagene) according to a manual. It was spread on an LB plate medium containing 0.1 mg/mL of ampicillin and incubated through the night at 37 0 C. The resulting 5 transformants were cultured through the night at 37 0 C in an LB medium (each well: 50 pL) containing 0.1 mg/mL of ampicillin using a 96-well titer plate, and then 50 pL of 50% glycerol solution was added thereto followed by stirring and the mixture was used as a glycerol stock. 10 (Example 4) Determination of DNA sequence (4-1) Preparation of DNA fragment The genome sequence of strain 34/70 was determined mainly using the genome shotgun method. A DNA fragment of 15 which DNA sequence is to be determined by that method was prepared by a PCR method from the shotgun library prepared in the above Example 2. To be specific, clone derived from the genome shotgun library was inoculated using a replicator (manufactured by Gene Solution) to a 384-well 20 titer plate where 50 pL of an LB medium containing 0.1 mg/mL of ampicillin was placed to each well and cultivated without shaking through the night at 37 0 C. The culture liquid was transferred to a 384-well reaction plate (manufactured by AB Gene) containing 10 RL of reaction 25 mixture for PCR (TaKaRa Ex Taq manufactured by Takara Shuzo) using a replicator (manufactured by Gene Solution) and PCR was carried out according to a protocol by Makino, et al. "DNA Research, volume 5, pages 1 to 9 (1998)" using 106 WO 2006/024951 PCT/IB2005/002908 a GeneAmP PCR System 9700 (manufactured by Applied Biosystems) to amplify the inserted fragment. After that, excessive primers and nucleotides were removed by a PCR product purification kit (manufactured by Amersham 5 Bioscience) and a sequence reaction was carried out using that sample as a template. A DNA fragment from the cosmid library of the above Example 3 was prepared according to the following method. That is, clone derived from the cosmid library was 10 inoculated to each well of a 96-well plate to which 1.0 mL each of a 2 x YT medium (1.6% bactotryptone, 0.1% yeast extract and 0.5% sodium chloride; pH 7.0) containing 50pg/mL of ampicillin was placed and subjected to shake culture at 30 0 C through the night. A cosmid DNA was 15 prepared from the said culture using KURABO PI-1100 AUTOMATIC DNA ISOLATION SYSTEM (manufactured by KURABO) according to a manual of KURABO, and was used as a template for a sequence reaction. (4-2) Sequence reaction 20 A sequence reaction mixture-was prepared as follows. The PCR product or cosmid DNA prepared in the above (4-1) is mixed with about 2 R1 of DYEnamic ET Terminator Sequencing Kit (manufactured by Amersham Bioscience) and appropriate primers to give about 8Rl of reaction mixture. 25 An M13 forward (M13-21) primer and an M13 reverse (M13RV) primer (manufactured by Takara Bio), are used for the sequence reaction of a PCR product derived from shotgun DNA, while a forward primer SS-cos F.1 (SEQ ID NO: 7) and a 107 WO 2006/024951 PCT/IB2005/002908 reverse primer SS-cos R.1 (SEQ ID NO: 8) are used for cosmid DNA. Amounts of the primers and the DNA fragment were 3.2 pmol and 50 to 200 ng, respectively. The said reaction solution was subjected to dye terminator sequence 5 reaction of 60 cycles using a GeneAmp PCR System 9700. Cycle parameter followed a manual attached to the DYEnamic ET Terminator Sequencing Kit. Purification of the sample was carried out using a Multi Screen HV Plate (manufactured by Millipore) according to a manual of Millipore. The 10 purified reactant was stored in a dark place of 4 0 C. The purified reactant was analyzed using a Mega BACE 1000 Sequencing System (manufactured by Amersham Bioscience) and ABI PRISM 3700 DNA Analyser (manufactured by Applied Biosystems) according to manuals attached thereto. The 15 data on 332,592 sequences obtained by the Mega BACE 1000 Sequencing System and on 13,461 sequences obtained by the 3700 DNA Analyser were transferred to a server Enterprise 6500 (manufactured by Sun Microsystems) and preserved. The data on 346,053 sequences corresponded to about 7-fold of 20 the genome size. A list of the primers for the PCR used in the Example is shown in Table 3. (Example 5) Assembly (A process whereby the order of 25 multiple sequenced DNA fragments is determined) All works for reconstruction of genomic DNA sequence from the sequence information for DNA fragment of the 346,053 sequences obtained in the above Example 4 were 108 WO 2006/024951 PCT/IB2005/002908 carried out on a UNIX@ platform. Base call was carried out by phred (The University of Washington), masking of vector sequence was carried out using Cross Match (The University of Washington) and assembly was carried out using Phrap 5 (The University of Washington). Contig obtained as a result of the assembly was analyzed using a graphical editor consed (The University of Washington). A series of works from base call to assembly was carried out all together utilizing a script phredPhrap attached to the 10 consed. (Example 6) Preparation of a comparative database with the genome sequence of S. cerevisiae S. pastorianus is believed to be a natural hybrid of 15 S. cerevisiae with its closely-related species "Int. J. Syst. Bacteriol., volume 35, pages 508 to 511 (1985)". Therefore, a DNA sequence (comprising 10,044 bases) of both ends of the cosmid DNA clone obtained in (4-2) was subjected to a homology searching by a homology searching 20 algorithm to S. cerevisiae genome sequence, whereupon for each DNA sequence alignment of homologous region on S. cerevisiae genome sequence and the identity thereof were determined to prepare a database. An identity distribution chart for cosmid DNA sequence with the corresponding 25 genomic DNA sequence of S. cerevisiae is shown in Fig. 2. The DNA sequence of cosmid was roughly classified into a DNA sequence group showing not less than 94% identity to the genomic DNA sequence of S. cerevisiae and a DNA 109 WO 2006/024951 PCT/IB2005/002908 sequence group showing around 84% identity thereto. The DNA sequence group showing not less than 94% identity is named a DNA sequence of an Sc type derived from S. cerevisiae and the DNA sequence group showing around 84% 5 identity is named a DNA sequence of a non-Sc type derived from genome of closely related species. Similarly, a comparative database (Table 1) was prepared for the DNA sequence of both ends of shotgun clone obtained in (4-1) with the genomic DNA sequence of S. cerevisiae. Table 1 10 shows an example of the comparative database of DNA sequence of both ends of 3,648-cosmid clone with the genomic DNA sequence of S. cerevisiae. There are shown the homologous region and the identity of forward sequence and reverse sequence of cosmid subjected to the DNA sequence 15 determination on each genomic DNA sequence of S. cerevisiae. 110 WO 2006/024951 PCT/1B2005/002908 (Table 1) W) - ) - M M OD m- omo 0 C'-i LO LO 0 .,- ) s CEDC" CEO C)O -tO 'CO CC) n 0

-

&j L C) ' C)1 0 _D air- (d o 'ODaC , C) : - ~ oC -m c 0 tLo o o co~~-C 65- m F AI ' u ' '0 C)coC C' * COCOCOFfCOC C)t D o o oc o oc -0Q ____ _Y _P c) Y)l 4 Cl) (IO ()cl C;)Co W MM 0 M111 0 WO 2006/024951 PCT/IB2005/002908 On the basis of the information obtained by the prepared comparative database, mapping of cosmid clone and shotgun clone on S. cerevisiae genome sequence was carried out (Fig. 3). In addition, a comparative database (Table 5 1) of contig DNA sequence obtained in Example 5 with S. cerevisiae genome sequence was prepared, then mapping was carried out. Although the means for the mapping was almost the same as the above-mentioned method, if forward and reverse sequences of cosmid and shotgun clones were present 10 in different contigs, these contigs were connected by forward-reverse link (Fig. 4). (Example 7) Identification and assignment of function of ORF 15 Identification of ORF (open reading frame) in the DNA sequence assembled in Example 5 was carried out. The examples are specifically shown below. Identification of ORF existing in the DNA sequence assembled in Example 5 was carried out using a available program using ORF finder 20 (http://www.ncbi.nih.gov/gorf/gorf.html). The identification of ORF was done for six kinds of reading frames in the sequence with the length of not less than 150 bases from initiation codon to termination codon including its complementary sequence. Assignment of function of the 25 extracted ORF was carried out by homology searching of amino acid sequence of ORF of S. cerevisiae that has been registered at the SGD and published. Table 2 is a table showing examples of the name of ORF in S. cerevisiae 112 WO 2006/024951 PCT/IB2005/002908 corresponding to the result to assignment of function of ORF existing in the non-Sc genome. From the left side of the table, there are shown name of the ORF existing in the brewing yeast, ORF length in polynucleotide, ORF length in 5 polypeptide, name of the ORF in S. cerevisiae determined by homology searching, identity, coincided length and functions of the gene. 113 WO 2006/024951 PCT/1B2005/002908 (Table 2) - - - - (D (D) 0 0 )P -o Z >3-~ 0 V ~> oE m- o -oo u < 0La)L0 0 LLJ:5 LO o c UDCJ coJ LOC 0 '' cz) r- m r r-~ r M 0 QD CO~ C) CO ~- CO Z t 0 Q£ -0 < LL1C4 WO 2006/024951 PCT/IB2005/002908 (Example 8) Analysis of chromosome structure by DNA array-based comparative genomic hybridization and PCR Preparation of genomic DNA from yeast was carried out using Qiagen Genomic Tip 100/G (#10243: manufactured by 5 Qiagen) and Qiagen Genomic DNA Buffer Set (#19060: manufactured by Qiagen) according to the manuals attached to the kits. The DNA (10 Rg) was digested with DNase I (manufactured by Invitrogen) according to a method of Winzeler, et al. "Science, volume 281, pages 1194 to 1197 10 (1998)", biotinylated by a terminal transferase (manufactured by Roche) and hybridized to a DNA array (Affymetrix Gene Chip Yeast Genome S98 Array: produced by Affymetrix). Hybridization and detection of signal intensity of array were carried out using a Gene Chip 15 Analysis Basic System manufactured by Affymetrix. The signal of each probe hybridized with the DNA of strain 34/70 is normalized to that of the haploid laboratory yeast strain 5288C using an analysis soft ware (Microarray Suite 5.0: manufactured by Affymetrix) and 20 shown as signal log ratio (2n). Signal log ratios were lined following gene order in each chromosome using a spreadsheet program (Microsoft Excel 2000) and the signal log ratios are shown in bar graphs as shown in Fig. 5. The non-Sc type genes do not hybridize to the S. cerevisiae 25 array, therefore, the Sc type gene dosage affects the signal log ratio and the points where the signal log ratios show vigorous changes and which are considered to be 115 WO 2006/024951 PCT/IB2005/002908 translocation sites between Sc type and non-Sc type chromosome. On the basis of genome sequence of strain 34/70 determined by a shotgun method, the chimera chromosome 5 structure was confirmed by PCR where two pairs of primers having DNA sequences in which one side is Sc type while the other side is a non-Sc type (XVI-1(L)cer-95894 (SEQ ID NO: 9)/XVI-1(R)nonSc-106302rv (SEQ ID NO: 10) and XVI-2(L)cer 859737 (SEQ ID NO: 11)/XVI-2(R)nonSc-864595rv (SEQ ID NO: 10 12)) were designed and the genomic DNA derived from strain 34/70 was used as a template. Two examples of translocation of chromosome XVI are shown as follows. The PCR was carried out using Takara LA Taqm and a buffer attached thereto in accordance with the attached 15 manual by a Takara PCR Thermal Cycler SP. As a result of the PCR, it was confirmed by a 0.8% agarose gel electrophoresis that, a DNA fragment in the predicted length was amplified from strain 34/70, while when genomic DNA of the experimental strain S. cerevisiae 20 X2180-1A was used as a template for the PCR, amplification of the DNA fragment was not detected. Furthermore, when DNA sequence of both ends of the DNA fragment amplified from strain 34/70 was confirmed, it was consistent with the genome sequence determined by a shotgun method and it was 25 confirmed that, within such a region, translocation between Sc type and non-Sc type chromosome took place. From the above result, it is estimated that at least two kinds of chromosomes were present in the chromosomeXVI 116 WO 2006/024951 PCT/IB2005/002908 as shown in Fig. 6. According to the same techniques, ligation between Sc chromosome and non-Sc chromosome (or inverse thereof) or, in other words, the region where the existence of chimera chromosome structure was suggested was 5 confirmed. Such chimera chromosome structure of the Sc chromosome and non-Sc chromosome was confirmed at least 13 places in the total chromosomes of strain 34/70 (Fig. 1). As a result of genome analysis, it was found that chromosome structure of bottom fermenting yeast was very 10 complicated and there were at least 37 kinds of chromosomes in strain 34/70. (Example 9) Cloning of SSU1 genes of strain 34/70 The shotgun clone containing non-ScSSU1 gene was 15 retrieved using a comparative database obtained in Example 6. There was SSS103_G08 which comprises about 2.4 kb of fragment containing full-length of non-ScSSUl ORF, where identity of forward and reverse sequence of shotgun clone to those of S. cerevisiae were 62.9% and 82.9%, 20 respectively. SSS103-GO8 was selected from a library of genomic DNA, then full length of non-ScSSU1 was prepared by PCR. Synthetic DNAs of SacI-non-Sc-SSUlfor1 (SEQ ID NO: 13) and BglII-non-Sc-SSU1_rv1460 (SEQ ID NO: 14) were used as 25 primers. As a result of such a combination, base numbers 1 to 1460 of nonScSSU1 was amplified to give a SacI-Bg1II fragment of about 1.5 kb. 117 WO 2006/024951 PCT/IB2005/002908 With regard to an ScSSUl gene, full length of gene was obtained by PCR using a primer pair designed on the basis of the information of SGD using a genomic DNA of strain 34/70 as a template. Synthetic DNAs of SacI-ScSSUl_forl 5 (SEQ ID NO: 15) and BglII-ScSSUl_rvl406 (SEQ ID NO: 16) were used as primers. As a result of such a combination, base numbers 1 to 1406 of ScSSUl gene was amplified to give a SacI-BglII fragment of about 1.4 kb. ScSSU1 and non-ScSSUl genes obtained as above were 10 inserted using TA cloning kit (Invitrogen) into pCR 2.1 TOPO vector attached to the kit, and they were named TOPO/ScSSUl and TOPO/non-ScSSU1, respectively. Sequences of the resulting ScSSU1 and non-ScSSU1 genes were confirmed by a method of Sanger "F. Sanger, Science, volume 214, page 15 1215, 1981" (Fig. 10). (Example 10) Disruption of each SSUl gene According to a method mentioned in the document "Goldstein, et al., Yeast, volume 15, page 1541 (1999)", 20 DNA fragment for gene disruption was prepared by PCR using a plasmid containing a drug-resistance marker (pFA6a (G418r), pAG 25 (natl)) as a template. As primers for the PCR, non-Sc-SSU1_for (SEQ ID NO: 17)/non-Sc-SSUlrv (SEQ ID NO: 18) were used for disruption of non-ScSSUl gene, while 25 for disruption of ScSSUl gene, ScSSUlfor (SEQ ID NO: 19)/ScSSU1_rv (SEQ ID NO: 20) were used. For disruption of non-ScSSUl gene, a plasmid pPGAPAUR (AUR1-C) and primers non-Sc-SSUlfor + pGAPAUR (SEQ ID NO: 21)/non-Sc-SSU1_rv + 118 WO 2006/024951 PCT/IB2005/002908 AURI-C (SEQ ID NO: 22) were further used. As such, two and three kinds of DNA fragments were prepared for ScSSU1 and non-ScSSU1 gene disruption, respectively. The bottom fermenting yeast BH 96 was transformed 5 using the DNA fragments for gene disruption prepared with above method. The transformation was carried out by a method mentioned in the Japanese Patent Laid-Open Gazette No. H07/303,475 and concentrations of the drugs were 300 mg/L for geneticin, 50 mg/L for nourseothricin and 1 mg/L 10 for aureobasidin A. With regard to the transformants prepared, gene disruption was confirmed by Southern analysis. Firstly, the genomic DNA extracted from parental strain and disruptant was subjected to restriction enzyme treatment 15 (at 37 0 C or 18 hours) using NcoI for the confirmation of ScSSU1 gene disruption and HindIII for the confirmation of non-ScSSU1 gene disruption, and then fractionated by 1.5% agarose gel electrophoresis and transferred to a membrane. After that, hybridization was carried out (at 55 0 C for 18 20 hours) with a probe specific to the ScSSU1 or non-ScSSU1 following a protocol of the Alkphos Direct Labelling Reagents (Amersham) and signals were detected by CDP-Star. Each of the strains where gene disruption was confirmed was named as follows. 25 Sc-1 (ScSSUl/Scssul::G418r) Sc-2 (Scssul::G418r/ScsSul: :natl) non-Sc-i (non-ScSSUl/non-ScSSU1/non-Scssul::G418r) non-Sc-2 (non-ScSSUl/non-Scssul::G418r/non-Scssul::natl) 119 WO 2006/024951 PCT/IB2005/002908 non-Sc-3 (non-Scssul::G418r/non-Scssul::natl/non-Scssul::AUR1-C) (Example 11) Quantitative analysis of sulfite 5 production in a fermentation test Fermentation test using parental strain and disruptant Sc-1 to non-Sc-3 prepared in Example 10 was carried out under the following condition. Original extract: 12.75% 10 Fermentation scale: 2 liters Dissolved oxygen concentration: about 9 ppm Fermentation temperature: 15 0 C Pitching rate: 10 g of wet yeast cells/2 L of wort Wort is periodically sampled and monitored the cell 15 growth (OD 600) (Fig. 7-(a)), apparent extract (Fig. 7-(b)) and sulfite concentration (Fig. 7-(c)). Quantitative analysis of sulfite in wort was carried out in such a method that it was captured in a hydrogen peroxide solution by means of distillation in an acidic condition and 20 subjected to titration with an alkali (Revised Method for BCOJ Beer Analysis by the Brewing Society of Japan). As a result, sulfite production in the wort by ScSSU1 disruptant was nearly same as that by parental strain, while it significantly decreased by non-ScSSU1 disruptant. 25 It was suggested that non-ScSSU1 gene which is specific to bottom fermenting yeast greatly contributes to sulfite production in wort. 120 WO 2006/024951 PCT/IB2005/002908 At the same time, growth rate and extract-consuming rate were significantly decreased in the non-ScSSU1 disruptant, and it supported that excessive sulfite in cells caused inhibition of cell growth. 5 (Example 12) Overexpression of each SSU1 gene From the plasmid TOPO/non-ScSSU1 mentioned in Example 9, a fragment of about 1.5 kb including the full length of non-ScSSU1 ORF was excised by a treatment with a 10 restriction enzyme (SacI-BglII). Then this fragment was inserted into a plasmid pNI-NUT which was similarly treated with a restriction enzyme (SacI-BglII) to construct a non ScSSU1 overexpression vector pYI-non-ScSSUl. The vector pNI-NUT contains URA3 as a homologous recombination site 15 and nourseothricin-resistance gene (natl) and ampicillin resistance gene (Ampr) as selective markers. On the other hand, the ScSSU1 overexpression vector pNI-ScSSU1 has a structure wherein the non-ScSSU1 gene of the above mentioned pYI-non-ScSSU1 has been substituted with the, 20 SSU1-R of about 2 kb derived from S. cerevisiae "J. Ferment. Bioeng., volume 86, page.427 (1998)". For overexpression of each SSU1 gene, promoter and terminator of glyceraldehyde-3-phosphate dehydrogenase gene (TDH3) were used. 25 Bottom fermenting yeast BH225 was transformed with a overexpression vector prepared in the above-mentioned method. Transformation was carried out by a method mentioned in the Japanese Patent Laid-Open Gazette No. 121 WO 2006/024951 PCT/IB2005/002908 H07/303,475 and selected on YPD plate medium containing 50 mg/L of nourseothricin. Confirmation of the overexpression was carried out by RT-PCR. Extraction of total RNA was carried out using an 5 RNeasy Mini Kit (Qiagen), according manual of "for total RNA isolation from yeast" attached the kit. ScSSUlfor331 (SEQ ID NO: 23)/ScSSU1_982rv (SEQ ID NO: 24) were used as ScSSUl-specific primers; non-ScSSUlfor329 (SEQ ID NO: 25)/non-ScSSU1_981rv (SEQ ID NO: 26) were used as non 10 ScSSUl-specific primers; and PDA1_forl (SEQ ID NO: 27)/PDAl_730rv (SEQ ID NO: 28) were used as specific primers for constitutively expressed gene PDA1 used as an internal standard. PCR product was fractionated by 1.2% agarose gel electrophoresis, stained with an ethidium 15 bromide solution and signal value of each SSU1 gene of transformant was normalized with a signal value of PDA 1 and compared with that of the parental strain. The overexpressed strains confirmed as such were named as ScSSUl overexpressed strain and non-ScSSU1 overexpressed 20 strain. (Example 13) Quantitative analysis of sulfite production in a fermentation test Fermentation test using parental strain and each of 25 SSU1 overexpressed strain obtained in the Example 12 was carried out under the following condition. Original extract: 12.83% Fermentation scale: 2 liters 122 WO 2006/024951 PCT/IB2005/002908 Dissolved oxygen concentration: about 9 ppm Fermentation temperature: 12 0 C Pitching rate: 10 g of wet yeast cells/2 L of wort As same as in Example 11, wort is periodically sampled 5 and monitored the cell growth (OD 600) (Fig. 8-(a)), apparent extract (Fig. 8-(b)) and sulfite concentration (Fig. 8-(c)). With regard to the sulfite production, it was only somewhat higher in Sc SSU1 overexpressed strain (19 ppm at the end of the fermentation) as compared with 10 that of the parental strain (12 ppm at the same stage), while non-Sc SSU1 over expressed strain showed a significant increase (45 ppm at the same stage). At the same time, there was no difference in the growth rate and in the extract-consuming rate between the parental strain 15 and the overexpressed strains. From the above result, by overexpression of the gene encoding the sulfite-discharging pump specific to the bottom fermenting yeast shown in the present invention, it is possible to increase sulfite concentration in beer 20 without changing the fermentation process and the fermentation period. As a result, it is now possible to produce an alcoholic beverage with excellent flavor stability and a longer quality preservation period. 25 (Example 14) Cloning of MET14 gene of strain 34/70 DNA sequence of non-Sc MET14 gene was retrieved from the comparative database obtained in Example 6. A shotgun clone SSS 134_021 containing about 1.9 kb (full-length) of 123 WO 2006/024951 PCT/IB2005/002908 non-Sc MET14 gene was obtained; its forward and reverse DNA sequence identity to S. cerevisiae were 79.0% and 56.0%, respectively. The shotgun clone 134_021 was selected from shotgun 5 library and a full length of non-Sc MET14 gene was obtained by PCR. As a primer pair, synthetic DNAs of SacI-nonSc MET14_for-21 (SEQ ID NO: 29) and BamHI-nonSc-MET14_rv618 (SEQ ID NO: 30) as shown in Table 3 were used. As a result of using such a pair of primers, a non-Sc MET14 gene (about 10 0.6 kb) embraced by SacI and BamHI restriction sites was obtained. 124 WO 2006/024951 PCT/IB2005/002908 (Table 3) SEQ ID No. Sequence Name 5-Base Sequence-3 5 M13-for agtcacgacg ttgta 6 M13 rv caggaaacag ctatgac 7 SS-cosF.1 aggcgtatca cgaggccctt tc 8 SS-cosR.1 cttategatg ataagcggtc aaacatgag 9 1XVI-M()cer-95894 cgcaagctcc gtacgttcaa cattcttatg aacggc 10 XVI-1(R)nonSc-106302rv g atcatcgt cgtgatcctt ctttggcaaa tgcagg 11 XVI-2(L)cer-859737 gegggtaitt tgatggtaaa tctacaagcc ctcggc 12 XVI-2(R)nonSc-864595rv _cccagacaca gtecagta tcatcctcgc agaac 13 SacI-nonScSSUl fort gagctcatgg tcgctagttg gatgct 14 BgIIl-nonScSSU rv1460 agatctcagc ttcagcccaa tccatt 15 SacI-ScSSU1 fort -gagcicaigg ttgccaattg ggtact 16 lBgII-ScSSUI rv1406 agatetetcc tacatgaaat gcttgc atggtcgcta gttggatgct cactgccaca agggattta 17 nonScSSUl for accctttcat atcgaatatt ctgtacagct gtttgtcalg gttatggggg teggtatttc ccttgacagt cttgacgtgc tgttaaatat gtactatcga tagccgagtt tgattcctcc 18 nonScSSUl_rv acacttlcga acagtcttct ccgtcccttc ctctgataaa tgctgttgaa aggagaattg cgcacttaac ttcgcatctg atggttgcca attgggtact tgctcttacg aggeagtg 19 ScSSU1_for acccettcat gtttatgatg gtcatgggtg tggcatttc itcgaatatt ctatatagct ccttgacagt cttgacgtgc ttatgetaaa cgcgtaaaat ctagagccga gttgattet 20 ScSSUIrv tecacgcttt caatgctgtt atacggagaa actgtcgtct tttccgtacc tgactctgaa cgcacttaac ttcgcatctg atggtegeta gttggatgct cactgccaca agggatttca 21 nonScSSUl_for+pGAPAUR accctttcat gttgtcatg gttatggggg tcggtatttc ategaatatt ctgtacagct ccggagctta ccagttctca tgttaaatat gtactatcga tagccgagtt tgattcctcc 22 nonScSSUl_rv+AURI-C acactttcga tgctgttgaa aggagaattg acagtcttct ccgtcccttc ctctgataaa tcgacttag aggatccaga 23 ScSSU1 for331 tcgaaagega acacgacgaa 24 ScSSUl 982rv egacagaaat cacggtgaaa a 25 nonScSSUl 329 tgtcacaaaa atttaccacg ac 26 nonScSSUl 981rv aagggaaatt accgtaaaga ag 27 PDAI forl atgtttgtcg cacctgtatc t 28 PDA1 730rv gattagaggc accatcac 29 SacI-nonSc-MET14 for-21 ctcgagctct cgtgaaattc attgaaacaa atg 30 BamHI-nonSc-MET14 rv618 ggatcecttat aagatttata gatgcttccg 31 SacI-ScMET14 for ctcgagctca gaaaagttgg aattatttct cca 32 IBaigI-ScMET14 rv ggatccaatg tacagtaatc ggtcaaatga With regard to Sc MET14 gene, a full length of the structural gene was obtained by PCR using a primer pair 5 designed on the basis of the information of SGD and using genomic DNA of strain 34/70 as a template. Synthetic DNAs of SacI-ScMETl4-for (SEQ ID NO: 31) and BamHI-ScMET14_rv 125 WO 2006/024951 PCT/IB2005/002908 (SEQ ID NO: 32) were used as primers. As a result of using such a pair of primers, Sc MET14 gene (about 0.6 kb) embraced by SacI and BamHI restriction sites was obtained. The Sc MET14 and non-Sc MET14 genes obtained as above 5 were inserted using a TA cloning kit (manufactured by Invitrogen) into pCR 2.1-TOPO vector attached to the kit, and they were named TOPO/ScMET14 and TOPO/nonSc-MET14, respectively. DNA sequences of the resulting Sc MET14 and non-Sc 10 MET14 genes were checked by a method of Sanger "Science, volume 214, page 1205 (1981)" (Fig. 11). (Example 15) Overexpression of each MET14 gene in Sc SSU1 overexpressed strain 15 A fragment of about 0.6 kb containing Sc MET14 or non Sc MET14 mentioned in Example 14 was inserted into a multi cloning site of a expression vector pUP3GLP (Japanese Patent Laid-Open Gazette No. 2000/316,559) to construct overexpression vectors pUP3Sc MET14 and pUP3nonSc-MET14 in 20 which each MET14 gene was expressed under control of glyceraldehyde-3-phosphate dehydrogenase promoter and terminator. On the other hand, top fermenting yeast, strain KNO09F, was transformed with an Sc SSU1 overexpression vector pNI-SSU1 mentioned in Example 12 to 25 prepare strain FOY227 which is an Sc SSU1 overexpressed strain. The strain F0Y227 was transformed with the above pUP3ScMET14 and pUP3nonSc-MET14 to prepare strain FOY306 126 WO 2006/024951 PCT/IB2005/002908 and strain FOY 307 in which Sc MET14 and non-Sc MET14, together with Sc SSU1, are overexpressed, respectively. (Example 16) Quantitative analysis of sulfite 5 production in a fermentation test Fermentation tests were carried out under the following condition using strains prepared in Example 15; strain F0Y227 which is Sc SSU1 overexpressed strain, strain FOY306 which is Sc MET14 overexpressed strain in strain 10 FOY227, strain FOY307 which is a non-Sc MET14 overexpressed strain in strain FOY227and the parental strain KNO09 F. Original extract: 12.84% Fermentation scale: 1.5 liters Dissolved oxygen concentration: about 9 ppm 15 Fermentation temperature: 25 0 C at all times Pitching rate: 7.5 g of wet yeast cells/1.5 L of wort In the same way as Example 11, wort is periodically sampled and monitored the cell growth (OD 600), apparent extract and sulfite concentration. With regard to the yeast 20 growth and the consumed amount of extract, there was no difference among the strains. However, with regard to the sulfite production, it was only somewhat higher in Sc SSU1 overexpressed strain FOY227 (3.4 ppm at the end of the fermentation),and Sc MET14 and Sc SSUl overexpressed strain 25 F0Y306 (6.4 ppm at the same stage) as compared with that of the parental strain KNO09F(0.32 ppm at the same stage), while non-Sc MET14 and Sc SSU1 overexpressed strain FOY307 127 WO 2006/024951 PCT/IB2005/002908 showed a significant increase (16.6 ppm at the same stage) as shown in Fig. 9. From the above results, it was found that overexpression of the gene encoding the adenylyl sulfate 5 kinase specific to the bottom fermenting yeast shown in the present invention was effective to increase sulfite concentration in beer without changing the fermentation process and the fermentation period. As a result, it is now possible to produce an alcoholic beverage with excellent 10 flavor stability and a longer quality preservation period. (Example 17) Production of the bottom fermenting yeast DNA array DNA array of bottom fermenting yeast was produced 15 based on the DNA sequence information of the ORFs obtained in the above (h) and intergenic DNA sequences located between ORFs deduced from the whole genome sequence of strain 34/70. 20 Production of the DNA array Based on the DNA sequence information from following three groups, PM probe (Perfect Match Probe; 25 base long) which is unique against the whole genome sequence of the bottom fermenting yeast was designed using GeneChip® 25 (Affymetrix) technology; (1) 15712 regions from the whole genome sequence information of strain 34/70, (2) 403 S. cerevisiae ORFs represented from SEQ ID NOS: 190811 to 191213 from SGD which are not identified as Sc type ORFs in 128 WO 2006/024951 PCT/IB2005/002908 strain 34/70,=(3) 64 DNA sequences of genes represented from SEQ ID NOS: 195588 to 195651 used as internal standard. In order to obtain quantitative and reproducible 5 information, 8 to 11 probes for each region of (1)and(2), and 20 to 51 probes for each region of (3) were designed. To further increase the sensitivity and specificity of the detection, mismatch probe (MM probe) that has sequences identical to PM probe with the exception of one mismatched 10 base, which substitutes the complementary base (adenine (A) to thymine (T) and vice versa, or guanine (G) to cytosine (C) and vice versa) at the central position (i.e. base 13), was also designed. All of designed PM and MM probes were synthesized and 15 packed (manufactured by Affymetrix) to produce the DNA array using GeneChip@ technology. Group (1) consists of: A) 6204 DNA sequences of non-Sc type ORFs represented 20 from SEQ ID NOS: 33 to 6236; B) 7448 DNA sequences of Sc type ORFs represented from SEQ ID NOS: 75337 to 82784; C) 28 DNA sequences of mitochondrial ORFs from 34/70 strain represented from SEQ ID NOS: 166154 to 166181; 25 D) 553 DNA sequences represented from SEQ ID NOS: 166490 to 167042, which have not been identified as the above ORFs but have significant similarity (E value <=10e 129 WO 2006/024951 PCT/IB2005/002908 7) to the proteins of S. cerevisiae using NCBI-BlastX homology searching, E) 1479 DNA sequences represented from SEQ ID NOS: 173125 to 174603, which have not been identified as the 5 above A) or B) but have significant similarity (E-value <=10e~ 7 ) to the proteins of S. cerevisiae using NCBI-BlastP homology searching. E-value is an expected value for a possibility that a query sequence is found in a data base by chance. For 10 example, E-value 10 means that 10 sequences can be found accidentally. The smaller the E-value is, the lesser is the chance of finding the sequence by chance, and thus meaning that similarity between the found sequence in data base and the query sequence is significant. 15 The E-value as the result of homology searching such as NCBI-BLAST can be significant when it is less than 10~7, preferably less than 1010, more preferably less than 10-20 The function can be assigned as having the least value with the DNA sequences of the ORFs as the result of the homology 20 searching. Group (2) consists of: YBL108C-A, YBRO74W, YFL061W, YIL165C, YGR291C, YJR052W, YDR2.23W, YALO25C, YARO73W, YFL057C, YLL015W, YJR105W, YLR299C-A, YNR073C, YDL246C, YHLO49C, YAR010C, 25 YKL096W, YBLO26W, YMR230W, YALO37C-A, YALO37C-B, YAL037W, YAL063C-A, YAL064C-A, YAL064W, YAL065C, YAL068W-A, YAL069W, YAR009C, YARO20C, YARO42W, YAR047C, YAR053W, YAR060C, YAR061W, YAR062W, YBLO27W, YBLO40C, YBL068W-A, YBL101W-B, 130 WO 2006/024951 PCT/1B2005/002908 YBL1O9W, YBL112C, YBRO92C, YBR191W-A, YBR219C, YCLO19W, YCLQ29C, YCLO65W, YCLO66W, YCL068C, YCLO69W, YCLO73C, YCLO74W, YCLO75W, YCLO76W, YCRO35C, YCRO36W, YCRO38W-A, YCR1O1C, YCR1O4W, YCR1O5W, YCR1O6W, YCR1O7W, YCR1O8C, 5 YDLOO3W, YDLO37C, YDLO64W, YDLO73W, YDLO94C, YDLO95W, YDLO96C, YDL136W, YDL143W, YDL152W, YDL191W, YDL200C, YDL2O1W, YDL247W-A, YDL248W, YDRO14W, YDRO15C, YDRO34C-D, YDRO39C, YDRO45C, YDRO98C-B, YDR16OW, YDR21OC-D, YDR21OW-B, YDR215C, YDR225W, YDR261C-D, YDR261W-B, YDR292C, YDR3O2W, 10 YDR3O4C, YDR3O5C, YDR342C, YDR344C, YDR364C, YDR365W-B, YDR427W, YDR433W, YDR471W, YDR51OC-A, YDR543C, YDR544C, YELO12W, YELO75W-A, YERO39C-A, YERO46W-A, YERO56C-A, YER06OW-A, YERO74W, YER138C, YER187W, YER188C-A, YER19OC-A, YFLOO2W-A, YFLO14W, YFLO19C, YFLO20C, YFLO30W, YFLO31W, 15 YFLO51C, YFLO52W, YFLO53W, YFLO54C, YFLO55W, YFLO56C, YFLO63W, YFLO65C, YFLO66C, YFLO67W, YFRO12W-A, YGLO28C, YGLO41C, YGLO52W, YGL21OW-A, YGL259W, YGL262W, YGL263W, YGRO34W, YGRO38C-B, YGRO89W, YGR1O7W, YGR1O9W-A, YILO82W-A, YGR122C-A, YGR146C, YGR148C, YGR161W-B, YGR182C, YGR183C, 20 YGR271C-A, YGR29OW, YGR295C, YHLOO9W-A, YHLOO9W-B, YHLO15W A, YHLO46W-A, YHLO47C, YHLO48C-A, YHLO48W, YHRO32C-A, YHRO32W-A, YHRO39C-A, YHRO43C, YHR07OC-A, YHRO71C-A, YHRO71W, YHR141C, YHR165W-A, YHR179W, YHR18OC-B, YHR18OW-A, YHR182W, YHR193C, YHR193C-A, YHR2O7C, YHR211W, YHR213W-A, 25 YHR216W, YHR217C, YHR218W-A, YILO29C, YILO52C, YILO69C, YIL148W, YIL171W, YIL174W, YIL176C, YIRO18C-A, YIRO41W, YIRO42C, YIRO43C, YIRO44C, YJLO12C-A, YJLO14W, YJLO62W-A, YJL136C, YJL175W, YJL222W-B, YJRO24C, YJRO27W, YJRO32W, 131 WO 2006/024951 PCT/1B2005/002908 YJRO53W, YJRO54W, YJRO94W-A, YJR1O7W, YJR11OW, YJR111C, YJR14OW-A, YJR151C, YJR152W, YJR153W, YJR154W, YJR155W, YJR162C, YKLO18W, YKLO20C, YKLO44W, YKL224C, YKL225W, YKRO12C, YKRO13W, YKRO17C, YKRO18C, YKRO19C, YKRO20W, 5 YKRO35C, YKRO36C, YKRO40C, YKRO41W, YKRO42W, YKRO52C, YKRO53C, YKRO57W, YKRO62W, YKRO94C, YKR1O2W, YKR1O3W, YKR1O4W, YLLO14W, YLLO3OC, YLLO37W, YLLO38C, YLLO43W, YLLO65W, YLRO29C, YLRO30W, YLRO62C, YLRO98C, YLRO99W-A, YLR1O7W, YLR139C, YLR14OW, YLR142W, YLR144C, YLR145W, 10 YLR154C-G, YLR154W-A, YLR154W-B, YLR154W-C, YLR154W-E, YLR154W-F, YLR155C, YLR156W, YLR157C-B, YLR157W-C, YLR162W, YLR2O5C, YLR2O7W, YLR2O9C, YLR227W-B, YLR236C, YLR237W, YLR238W, YLR245C, YLR251W, YLR271W, YLR278C, YLR287C-A, YLR3O5C, YLR3O6W, YLR311C, YLR317W, YLR338W, YLR344W, 15 YLR345W, YLR354C, YLR364W, YLR38OW, YLR4O1C, YLR4O2W, YLR41OW-B, YLR411W, YLR412C-A,.YLR412W, YLR413W, YLR448W, YLR46OC, YLR461W, YLR463C, YLR465CI YMLOO3W, YMLO39W, YMLO73C, YMRO87W, YMR143W, YMR175W-A, YMR247W-A, YMR268W-A, YMR324C, YMR325W, YNLO20C, YNLO35C, YNLO54W-B, YNL243W, 20 YNRO34W-A, YNRO75C-A, YNRO77C, YOLO38C-A, YOLO53W, YOLl0iC, YOL1O3W-B, YQL162W, YOL163W, YQL164W, YOL164W-A, YOL165C, YOL166C, YOL166W-A, YORO5OC, YORO96W, YQR1O1W, YOR192C-B, YOR192C-C, Y0R225W, Y0R235W, Y0R343W-B, Y0R366W, YOR381W-A, Y0R382W, Y0R383C, Y0R384W, Y0R385W, Y0R386W, Y0R387C, 25 Y0R389W, YPLO03W, YPLO19C, YPLO23C, YPL036W, YPLO48W, YPLO55C, YPL06OC-A, YPL175W, YPL194W, YPL197C, YPL257W-B, YPROO2C-A, YPROO8W, YPRO14C, YPR028W, YPRO43W, YPRO48W, YPRO87W, YPRO94W, YPR1O8W, YPR137C-B, YPR161C, YPR162C, 132 WO 2006/024951 PCT/1B2005/002908 YPR163C, YPR164W, YPR165W, YPR166C, YPR167C, YPR168W, YPR169W. YPR169W-A, YPR17OC, YPR17OW-A, YPR171W, YPR172W, YPR173C, YPR174C, YPR175W, YPR176C, YPR177C, YPR178W, YPR179C, YPR18OW, YPR181C, YPR182W, YPR183W, YPR184W, 5 YPR185W, YPR186C, YPR187W, YPR188C, YPR189W, and YPR190C Group (3) consists of (GenBank Accession No.): AFFX-BioB-5_at (J04423.1), AFFX-BioB-M-at (J04423.1), AFFX-BioB-3_at (J04423.1), AFFX-BioC-5_at (J04423.1), AFFX BioC-3_at (J04423.1), AFFX-BioDn-5_at (J04423.1), AFFX 10 BioDn-3_at (J04423.1), AFFX-CreX-5_at (X03453.1), AFFX CreX-3_at (X03453.1), AFFX-DapX-5_at (L38424.1), AFFX-DapX-M-at (L38424.1), AFFX-DapX-3_at (L38424.1), AFFX LysX-5_at (X17013.1), AFFX-LysX-M-at (X17013.1), AFFX-LysX 3_at (X17013.1), AFFX-PheX-5-at (M24537.1), AFFX-PheX-M-at 15 (M24537.1), AFFX-PheX-3-at (M24537.1), AFFX-ThrX-5_at (X04603.1), AFFX-ThrX-M-at (X04603.1), AFFX-ThrX-3_at (X04603.1), AFFX-TrpnX-5_at (K01391.1), AFFX-TrpnX-M-at (K01391.1), AFFX-TrpnX-3_at (K01391.1), AFFX-r2-Ec-bioB Sat (J04423.1), AFFX-r2-Ec-bioB-M-at (J04423.1) ,AFFX-r2 20 Ec-bioB-3_at (J04423.1), AFFX-r2-Ec-bioC-5_at (J04423.1), AFFX-r2--Ec-bioC-3_at (J04423.1) ,AFFX-r2-Ec-bioD-5_at (J04423.1), AFFX-r2-Ec-bioD-3_at (J04423.1), AFFX-r2-P1 cre-5_at (X03453.1), AFFX-r2-P1-cre-3_at (X03453.1), AFFX r2-Bs-dap-5_at (L38424.1), AFFX-r2-Bs-dap-Mat (L38424.1), 25 AFFX-r2-Bs-dap-3_at (L38424.1), AFFX-r2-Bs-dap-3_at (X17013.1), AFFX-r2-Bs-lys-5_at (X17013.1), AFFX-r2-Bs-lys Mat (X17013.1), AFFX-r2-Bs-phe-5_at (M24537.1), AFFX-r2 Bs-phe-M-at (M24537.1), AFFX-r2-Bs-phe-3_at (M24537.1), 133 WO 2006/024951 PCT/IB2005/002908 AFFX-r2-Bs-thr-5_sat (X04603.1), AFFX-r2-Bs-thr-M_s_at (X04603.1), AFFX-r2-Bs-thr-3_s_at (X04603.1), AFFX YFLO39C5_at (V01288.1), AFFX-YFLO39CM-at (V01288.1), AFFX YFL039C3_at (V01288.1), AFFX-YER148w5_at (X16860.1), AFFX 5 YER148wM-at (X16860.1),AFFX-YER148w3_at (X16860.1), AFFX YERO22w5_at (L12026.1), AFFX-YERO22wM-at (L12026.1), AFFX YERO22w3_at (L12026.1), AFFX-18srRnaa-at (Z75578.1), AFFX 18srRnabat (Z75578.1), AFFX-18srRnac-at (Z75578.1), AFFX 18srRnad-at (Z75578.1), AFFX-18srRnae_at (Z75578.1), AFFX 10 25srRnaa-at (J01355.1), AFFX-25srRnab_at (J01355.1), AFFX 25srRnacat (J01355.1), AFFX-25srRnadat (J01355.1) and AFFX-25srRnaeat (J01355.1). The probes from 6204 DNA sequences of non-Sc type ORFs 15 described as above(1-A) were as follows: The probes having the nucleotide sequence represented by SEQ ID NOS: 6237, 6238, 6239, 6240, 6241, 6242, 6243, 6244, 6245, 6246, 6247 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 33. 20 The probes having the nucleotide sequence represented by SEQ ID NOS: 6248, 6249, 6250, 6251, 6252, 6253, 6254, 6255, 6256, 6257, 6258 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 34. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 6259, 6260, 6261, 6262, 6263, 6264, 6265, 6266, 6267, 6268, 6269 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 35. 134 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 6270, 6271, 6272, 6273, 6274, 6275, 6276, 6277, 6278, 6279, 6280 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 36. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 6281, 6282, 6283, 6284, 6285, 6286, 6287, 6288, 6289, 6290, 6291 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 37. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 6292, 6293, 6294, 6295, 6296, 6297, 6298, 6299, 6300, 6301, 6302 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 38. The probes having the nucleotide sequence represented by SEQ ID NOS: 6303, 6304, 6305, 6306, 6307, 6308, 6309, 6310, 15 6311, 6312, 6313 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 39. The probes having the nucleotide sequence represented by SEQ ID NOS: 6314, 6315, 6316, 6317, 6318, 6319, 6320, 6321, 6322, 6323, 6324 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 40. The probes having the nucleotide sequence represented by SEQ ID NOS: 6325, 6326, 6327, 6328, 6329, 6330, 6331, 6332, 6333, 6334, 6335 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 41. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 6336, 6337, 6338, 6339, 6340, 6341, 6342, 6343, 6344, 6345, 6346 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 42. 135 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 6347, 6348, 6349, 6350, 6351, 6352, 6353, 6354, 6355, 6356, 6357 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 43. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 6358, 6359, 6360, 6361, 6362, 6363, 6364, 6365, 6366, 6367, 6368 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 44. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 6369, 6370, 6371, 6372, 6373, 6374, 6375, 6376, 6377, 6378, 6379 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 45. The probes having the nucleotide sequence represented by SEQ ID NOS: 6380, 6381, 6382, 6383, 6384, 6385, 6386, 6387, 15 6388, 6389, 6390 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 46. The probes having the nucleotide sequence represented by SEQ ID NOS: 6391, 6392, 6393, 6394, 6395, 6396, 6397, 6398, 6399, 6400, 6401 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 47. The probes having the nucleotide sequence represented by SEQ ID NOS: 6402, 6403, 6404, 6405, 6406, 6407, 6408, 6409, 6410, 6411, 6412 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 48. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 6413, 6414, 6415, 6416, 6417, 6418, 6419, 6420, 6421, 6422, 6423 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 49. 136 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 6424, 6425, 6426, 6427, 6428, 6429, 6430, 6431, 6432, 6433, 6434 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 50. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 6435, 6436, 6437, 6438, 6439, 6440, 6441, 6442, 6443, 6444, 6445 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 51. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 6446, 6447, 6448, 6449, 6450, 6451, 6452, 6453, 6454, 6455, 6456 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 52. The probes having the nucleotide sequence represented by SEQ ID NOS: 6457, 6458, 6459, 6460, 6461, 6462, 6463, 6464, 15 6465, 6466, 6467 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 53. The probes having the nucleotide sequence represented by SEQ ID NOS: 6468, 6469, 6470, 6471, 6472, 6473, 6474, 6475, 6476, 6477, 6478 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 54. The probes having the nucleotide sequence represented by SEQ ID NOS: 6479, 6480, 6481, 6482, 6483, 6484, 6485, 6486, 6487, 6488, 6489 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 55. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 6490, 6491, 6492, 6493, 6494, 6495, 6496, 6497, 6498, 6499, 6500 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 56. 137 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 6501, 6502, 6503, 6504, 6505, 6506, 6507, 6508, 6509, 6510, 6511 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 57. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 6512, 6513, 6514, 6515, 6516, 6517, 6518, 6519, 6520, 6521, 6522 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 58. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 6523, 6524, 6525, 6526, 6527, 6528, 6529, 6530, 6531, 6532, 6533 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 59. The probes having the nucleotide sequence represented by SEQ ID NOS: 6534, 6535, 6536, 6537, 6538, 6539, 6540, 6541, 15 6542, 6543, 6544 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 60. The probes having the nucleotide sequence represented by SEQ ID NOS: 6545, 6546, 6547, 6548, 6549, 6550, 6551, 6552, 6553, 6554, 6555 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 61. The probes having the nucleotide sequence represented by SEQ ID NOS: 6556, 6557, 6558, 6559, 6560, 6561, 6562, 6563, 6564, 6565, 6566 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 62. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 6567, 6568, 6569, 6570, 6571, 6572, 6573, 6574, 6575, 6576, 6577 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 63. 138 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 6578, 6579, 6580, 6581, 6582, 6583, 6584, 6585, 6586, 6587, 6588 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 64. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 6589, 6590, 6591, 6592, 6593, 6594, 6595, 6596, 6597, 6598, 6599 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 65. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 6600, 6601, 6602, 6603, 6604, 6605, 6606, 6607, 6608, 6609, 6610 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 66. The probes having the nucleotide sequence represented by SEQ ID NOS: 6611, 6612, 6613, 6614, 6615, 6616, 6617, 6618, 15 6619, 6620, 6621 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 67. The probes having the nucleotide sequence represented by SEQ ID NOS: 6622, 6623, 6624, 6625, 6626, 6627, 6628, 6629, 6630, 6631, 6632 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 68. The probes having the nucleotide sequence represented by SEQ ID NOS: 6633, 6634, 6635, 6636, 6637, 6638, 6639, 6640, 6641, 6642, 6643 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 69. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 6644, 6645, 6646, 6647, 6648, 6649, 6650, 6651, 6652, 6653, 6654 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 70. 139 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 6655, 6656, 6657, 6658, 6659, 6660, 6661, 6662, 6663, 6664, 6665 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 71. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 6666, 6667, 6668, 6669, 6670, 6671, 6672, 6673, 6674, 6675, 6676 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 72. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 6677, 6678, 6679, 6680, 6681, 6682, 6683, 6684, 6685, 6686, 6687 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 73. The probes having the nucleotide sequence represented by SEQ ID NOS: 6688, 6689, 6690, 6691, 6692, 6693, 6694, 6695, 15 6696, 6697, 6698 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 74. The probes having the nucleotide sequence represented by SEQ ID NOS: 6699, 6700, 6701, 6702, 6703, 6704, 6705, 6706, 6707, 6708, 6709 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 75. The probes having the nucleotide sequence represented by SEQ ID NOS: 6710, 6711, 6712, 6713, 6714, 6715, 6716, 6717, 6718, 6719, 6720 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 76. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 6721, 6722, 6723, 6724, 6725, 6726, 6727, 6728, 6729, 6730, 6731 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 77. 140 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 6732, 6733, 6734, 6735, 6736, 6737, 6738, 6739, 6740, 6741, 6742 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 78. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 6743, 6744, 6745, 6746, 6747, 6748, 6749, 6750, 6751, 6752, 6753 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 79. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 6754, 6755, 6756, 6757, 6758, 6759, 6760, 6761, 6762, 6763, 6764 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 80. The probes having the nucleotide sequence represented by SEQ ID NOS: 6765, 6766, 6767, 6768, 6769, 6770, 6771, 6772, 15 6773, 6774, 6775 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 81. The probes having the nucleotide sequence represented by SEQ ID NOS: 6776, 6777, 6778, 6779, 6780, 6781, 6782, 6783, 6784, 6785, 6786 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 82. The probes having the nucleotide sequence represented by SEQ ID NOS: 6787, 6788, 6789, 6790, 6791, 6792, 6793, 6794, 6795, 6796, 6797 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 83. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 6798, 6799, 6800, 6801, 6802, 6803, 6804, 6805, 6806, 6807, 6808 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 84. 141 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 6809, 6810, 6811, 6812, 6813, 6814, 6815, 6816, 6817, 6818, 6819 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 85. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 6820, 6821, 6822, 6823, 6824, 6825, 6826, 6827, 6828, 6829, 6830 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 86. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 6831, 6832, 6833, 6834, 6835, 6836, 6837, 6838, 6839, 6840, 6841 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 87. The probes having the nucleotide sequence represented by SEQ ID NOS: 6842, 6843, 6844, 6845, 6846, 6847, 6848, 6849, 15 6850, 6851, 6852 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 88. The probes having the nucleotide sequence represented by SEQ ID NOS: 6853, 6854, 6855, 6856, 6857, 6858, 6859, 6860, 6861, 6862, 6863 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 89. The probes having the nucleotide sequence represented by SEQ ID NOS: 6864, 6865, 6866, 6867, 6868, 6869, 6870, 6871, 6872, 6873, 6874 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 90. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 6875, 6876, 6877, 6878, 6879, 6880, 6881, 6882, 6883, 6884, 6885 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 91. 142 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 6886, 6887, 6888, 6889, 6890, 6891, 6892, 6893, 6894, 6895, 6896 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 92. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 6897, 6898, 6899, 6900, 6901, 6902, 6903, 6904, 6905, 6906, 6907 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 93. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 6908, 6909, 6910, 6911, 6912, 6913, 6914, 6915, 6916, 6917, 6918 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 94. The probes having the nucleotide sequence represented by SEQ ID NOS: 6919, 6920, 6921, 6922, 6923, 6924, 6925, 6926, 15 6927, 6928, 6929 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 95. The probes having the nucleotide sequence represented by SEQ ID NOS: 6930, 6931, 6932, 6933, 6934, 6935, 6936, 6937, 6938, 6939, 6940 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 96. The probes having the nucleotide sequence represented by SEQ ID NOS: 6941, 6942, 6943, 6944, 6945, 6946, 6947, 6948, 6949, 6950, 6951 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 97. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 6952, 6953, 6954, 6955, 6956, 6957, 6958, 6959, 6960, 6961, 6962 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 98. 143 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 6963, 6964, 6965, 6966, 6967, 6968, 6969, 6970, 6971, 6972, 6973 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 99. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 6974, 6975, 6976, 6977, 6978, 6979, 6980, 6981, 6982, 6983, 6984 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 100. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 6985, 6986, 6987, 6988, 6989, 6990, 6991, 6992, 6993, 6994, 6995 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 101. The probes having the nucleotide sequence represented by SEQ ID NOS: 6996, 6997, 6998, 6999, 7000, 7001, 7002, 7003, 15 7004, 7005, 7006 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 102. The probes having the nucleotide sequence represented by SEQ ID NOS: 7007, 7008, 7009, 7010, 7011, 7012, 7013, 7014, 7015, 7016, 7017 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 103. The probes having the nucleotide sequence represented by SEQ ID NOS: 7018, 7019, 7020, 7021, 7022, 7023, 7024, 7025, 7026, 7027, 7028 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 104. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 7029, 7030, 7031, 7032, 7033, 7034, 7035, 7036, 7037, 7038, 7039 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 105. 144 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 7040, 7041, 7042, 7043, 7044, 7045, 7046, 7047, 7048, 7049, 7050 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 106. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 7051, 7052, 7053, 7054, 7055, 7056, 7057, 7058, 7059, 7060, 7061 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 107. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 7062, 7063, 7064, 7065, 7066, 7067, 7068, 7069, 7070, 7071, 7072 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 108. The probes having the nucleotide sequence represented by SEQ ID NOS: 7073, 7074, 7075, 7076, 7077, 7078, 7079, 7080, 15 7081, 7082, 7083 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 109. The probes having the nucleotide sequence represented by SEQ ID NOS: 7084, 7085, 7086, 7087, 7088, 7089, 7090, 7091, 7092, 7093, 7094 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 110. The probes having the nucleotide sequence represented by SEQ ID NOS: 7095, 7096, 7097, 7098, 7099, 7100, 7101, 7102, 7103, 7104, 7105 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 111. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 7106, 7107, 7108, 7109, 7110, 7111, 7112, 7113, 7114, 7115, 7116 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 112. 145 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 7117, 7118, 7119, 7120, 7121, 7122, 7123, 7124, 7125 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 113. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 7126, 7127, 7128, 7129, 7130, 7131, 7132, 7133, 7134, 7135, 7136 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 114. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 7137, 7138, 7139, 7140, 7141, 7142, 7143, 7144, 7145, 7146, 7147 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 115. The probes having the nucleotide sequence represented by SEQ ID NOS: 7148, 7149, 7150, 7151, 7152, 7153, 7154, 7155, 15 7156, 7157, 7158 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 116. The probes having the nucleotide sequence represented by SEQ ID NOS: 7159, 7160, 7161, 7162, 7163, 7164, 7165, 7166, 7167, 7168, 7169 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 117. The probes having the nucleotide sequence represented by SEQ ID NOS: 7170, 7171, 7172, 7173, 7174, 7175, 7176, 7177, 7178, 7179, 7180 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 118. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 7181, 7182, 7183, 7184, 7185, 7186, 7187, 7188, 7189, 7190, 7191 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 119. 146 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 7192, 7193, 7194, 7195, 7196, 7197, 7198, 7199, 7200, 7201, 7202 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 120. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 7203, 7204, 7205, 7206, 7207, 7208, 7209, 7210, 7211, 7212, 7213 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 121. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 7214, 7215, 7216, 7217, 7218, 7219, 7220, 7221, 7222, 7223, 7224 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 122. The probes having the nucleotide sequence represented by SEQ ID NOS: 7225, 7226, 7227, 7228, 7229, 7230, 7231, 7232, 15 7233, 7234, 7235 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 123. The probes having the nucleotide sequence represented by SEQ ID NOS: 7236, 7237, 7238, 7239, 7240, 7241, 7242, 7243, 7244, 7245, 7246 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 124. The probes having the nucleotide sequence represented by SEQ ID NOS: 7247, 7248, 7249, 7250, 7251, 7252, 7253, 7254, 7255, 7256, 7257 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 125. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 7258, 7259, 7260, 7261, 7262, 7263, 7264, 7265, 7266, 7267, 7268 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 126. 147 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 7269, 7270, 7271, 7272, 7273, 7274, 7275, 7276, 7277, 7278, 7279 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 127. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 7280, 7281, 7282, 7283, 7284, 7285, 7286, 7287, 7288, 7289, 7290 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 128. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 7291, 7292, 7293, 7294, 7295, 7296, 7297, 7298, 7299, 7300, 7301 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 129. The probes having the nucleotide sequence represented by SEQ ID NOS: 7302, 7303, 7304, 7305, 7306, 7307, 7308, 7309, 15 7310, 7311, 7312 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 130. The probes having the nucleotide sequence represented by SEQ ID NOS: 7313, 7314, 7315, 7316, 7317, 7318, 7319, 7320, 7321, 7322, 7323 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 131. The probes having the nucleotide sequence represented by SEQ ID NOS: 7324, 7325, 7326, 7327, 7328, 7329, 7330, 7331, 7332, 7333, 7334 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 132. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 7335, 7336, 7337, 7338, 7339, 7340, 7341, 7342, 7343, 7344, 7345 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 133. 148 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 7346, 7347, 7348,'7349, 7350, 7351, 7352, 7353, 7354, 7355, 7356 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 134. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 7357, 7358, 7359, 7360, 7361, 7362, 7363, 7364, 7365, 7366, 7367 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 135. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 7368, 7369, 7370, 7371, 7372, 7373, 7374, 7375, 7376, 7377, 7378 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 136. The probes having the nucleotide sequence represented by SEQ ID NOS- 7379, 7380, 7381, 7382, 7383, 7384, 7385, 7386, 15 7387, 7388, 7389 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 137. The probes having the nucleotide sequence represented by SEQ ID NOS: 7390, 7391, 7392, 7393, 7394, 7395, 7396, 7397, 7398, 7399, 7400 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 138. The probes having the nucleotide sequence represented by SEQ ID NOS: 7401, 7402, 7403, 7404, 7405, 7406, 7407, 7408, 7409, 7410, 7411 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 139. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 7412, 7413, 7414, 7415, 7416, 7417, 7418, 7419, 7420, 7421, 7422 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 140. 149 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 7423, 7424, 7425, 7426, 7427, 7428, 7429, 7430, 7431, 7432, 7433 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 141. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 7434, 7435, 7436, 7437, 7438, 7439, 7440, 7441, 7442, 7443, 7444 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 142. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 7445, 7446, 7447, 7448, 7449, 7450, 7451, 7452, 7453, 7454, 7455 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 143. The probes having the nucleotide sequence represented by SEQ ID NOS: 7456, 7457, 7458, 7459, 7460, 7461, 7462, 7463, 15 7464, 7465, 7466 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 144. The probes having the nucleotide sequence represented by SEQ ID NOS: 7467, 7468, 7469, 7470, 7471, 7472, 7473, 7474, 7475, 7476, 7477 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 145. The probes having the nucleotide sequence represented by SEQ ID NOS: 7478, 7479, 7480, 7481, 7482, 7483, 7484, 7485, 7486, 7487, 7488 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 146. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 7489, 7490, 7491, 7492, 7493, 7494, 7495, 7496, 7497, 7498, 7499 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 147. 150 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 7500, 7501, 7502, 7503, 7504, 7505, 7506, 7507, 7508, 7509, 7510 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 148. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 7511, 7512, 7513, 7514, 7515, 7516, 7517, 7518, 7519, 7520, 7521 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 149. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 7522, 7523, 7524, 7525, 7526, 7527, 7528, 7529, 7530, 7531, 7532 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 150. The probes having the nucleotide sequence represented by SEQ ID NOS: 7533, 7534, 7535, 7536, 7537, 7538, 7539, 7540, 15 7541, 7542, 7543 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 151. The probes having the nucleotide sequence represented by SEQ ID NOS: 7544, 7545, 7546, 7547, 7548, 7549, 7550, 7551, 7552, 7553, 7554 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 152. The probes having the nucleotide sequence represented by SEQ ID NOS: 7555, 7556, 7557, 7558, 7559, 7560, 7561, 7562, 7563, 7564, 7565 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 153. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 7566, 7567, 7568, 7569, 7570, 7571, 7572, 7573, 7574, 7575, 7576 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 154. 151 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 7577, 7578, 7579, 7580, 7581, 7582, 7583, 7584, 7585, 7586, 7587 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 155. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 7588, 7589, 7590, 7591, 7592, 7593, 7594, 7595, 7596, 7597, 7598 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 156. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 7599, 7600, 7601, 7602, 7603, 7604, 7605, 7606, 7607, 7608, 7609 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 157. The probes having the nucleotide sequence represented by SEQ ID NOS: 7610, 7611, 7612, 7613, 7614, 7615, 7616, 7617, 15 7618, 7619, 7620 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 158. The probes having the nucleotide sequence represented by SEQ ID NOS: 7621, 7622, 7623, 7624, 7625, 7626, 7627, 7628, 7629, 7630, 7631 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 159. The probes having the nucleotide sequence represented by SEQ ID NOS: 7632, 7633, 7634, 7635, 7636, 7637, 7638, 7639, 7640, 7641, 7642 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 160. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 7643, 7644, 7645, 7646, 7647, 7648, 7649, 7650, 7651, 7652, 7653 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 161. 152 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 7654, 7655, 7656, 7657, 7658, 7659, 7660, 7661, 7662, 7663, 7664 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 162. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 7665, 7666, 7667, 7668, 7669, 7670, 7671, 7672, 7673, 7674, 7675 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 163. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 7676, 7677, 7678, 7679, 7680, 7681, 7682, 7683, 7684, 7685, 7686 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 164. The probes.having the nucleotide sequence represented by SEQ ID NOS: 7687, 7688, 7689, 7690, 7691, 7692, 7693, 7694, 15 7695, 7696, 7697 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 165. The probes having the nucleotide sequence represented by SEQ ID NOS: 7698, 7699, 7700, 7701, 7702, 7703, 7704, 7705, 7706, 7707, 7708 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 166. The probes having the nucleotide sequence represented by SEQ ID NOS: 7709, 7710, 7711, 7712, 7713, 7714, 7715, 7716, 7717, 7718, 7719 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 167. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 7720, 7721, 7722, 7723, 7724, 7725, 7726, 7727, 7728, 7729, 7730 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 168. 153 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 7731, 7732, 7733, 7734, 7735, 7736, 7737, 7738, 7739, 7740, 7741 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 169. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 7742, 7743, 7744, 7745, 7746, 7747, 7748, 7749, 7750, 7751, 7752 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 170. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 7753, 7754, 7755, 7756, 7757, 7758, 7759, 7760, 7761, 7762, 7763 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 171. The probes having the nucleotide sequence represented by SEQ ID NOS: 7764, 7765, 7766, 7767, 7768, 7769, 7770, 7771, 15 7772, 7773, 7774 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 172. The probes having the nucleotide sequence represented by SEQ ID NOS: 7775, 7776, 7777, 7778, 7779, 7780, 7781, 7782, 7783, 7784, 7785 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 173. The probes having the nucleotide sequence represented by SEQ ID NOS: 7786, 7787, 7788, 7789, 7790, 7791, 7792, 7793, 7794, 7795, 7796 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 174. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 7797, 7798, 7799, 7800, 7801, 7802, 7803, 7804, 7805, 7806, 7807 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 175. 154 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 7808, 7809, 7810, 7811, 7812, 7813, 7814, 7815, 7816, 7817, 7818 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 176. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 7819, 7820, 7821, 7822, 7823, 7824, 7825, 7826, 7827, 7828, 7829 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 177. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 7830, 7831, 7832, 7833, 7834, 7835, 7836, 7837, 7838, 7839, 7840 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 178. The probes having the nucleotide sequence represented by SEQ ID NOS: 7841, 7842, 7843, 7844, 7845, 7846, 7847, 7848, 15 7849, 7850, 7851 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 179. The probes having the nucleotide sequence represented by SEQ ID NOS: 7852, 7853, 7854, 7855, 7856, 7857, 7858, 7859, 7860, 7861, 7862 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 180. The probes having the nucleotide sequence represented by SEQ ID NOS: 7863, 7864, 7865, 7866, 7867, 7868, 7869, 7870, 7871, 7872, 7873 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 181. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 7874, 7875, 7876, 7877, 7878, 7879, 7880, 7881, 7882, 7883, 7884 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 182. 155 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 7885, 7886, 7887, 7888, 7889, 7890, 7891, 7892, 7893, 7894, 7895 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 183. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 7896, 7897, 7898, 7899, 7900, 7901, 7902, 7903, 7904, 7905, 7906 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 184. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 7907, 7908, 7909, 7910, 7911, 7912, 7913, 7914, 7915, 7916, 7917 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 185. The probes having the nucleotide sequence represented by SEQ ID NOS: 7918, 7919, 7920, 7921, 7922, 7923, 7924, 7925, 15 7926, 7927, 7928 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 186. The probes having the nucleotide sequence represented by SEQ ID NOS: 7929, 7930, 7931, 7932, 7933, 7934, 7935, 7936, 7937, 7938, 7939 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 187. The probes having the nucleotide sequence represented by SEQ ID NOS: 7940, 7941, 7942, 7943, 7944, 7945, 7946, 7947, 7948, 7949, 7950 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 188. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 7951, 7952, 7953, 7954, 7955, 7956, 7957, 7958, 7959, 7960, 7961 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 189. 156 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 7962, 7963, 7964, 7965, 7966, 7967, 7968, 7969, 7970, 7971, 7972 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 190. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 7973, 7974, 7975, 7976, 7977, 7978, 7979, 7980, 7981, 7982, 7983 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 191. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 7984, 7985, 7986, 7987, 7988, 7989, 7990, 7991, 7992, 7993, 7994 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 192. The probes having the nucleotide sequence represented by SEQ ID NOS: 7995, 7996, 7997, 7998, 7999, 8000, 8001, 8002, 15 8003, 8004, 8005 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 193. The probes having the nucleotide sequence represented by SEQ ID NOS: 8006, 8007, 8008, 8009, 8010, 8011, 8012, 8013, 8014, 8015, 8016 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 194. The probes having the nucleotide sequence represented by SEQ ID NOS: 8017, 8018, 8019, 8020, 8021, 8022, 8023, 8024, 8025, 8026, 8027 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 195. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 8028, 8029, 8030, 8031, 8032, 8033, 8034, 8035, 8036, 8037, 8038 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 196. 157 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 8039, 8040, 8041, 8042, 8043, 8044, 8045, 8046, 8047, 8048, 8049 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 197. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 8050, 8051, 8052, 8053, 8054, 8055, 8056, 8057, 8058, 8059, 8060 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 198. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 8061, 8062, 8063, 8064, 8065, 8066, 8067, 8068, 8069, 8070, 8071 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 199. The probes having the nucleotide sequence represented by SEQ ID NOS: 8072, 8073, 8074, 8075, 8076, 8077, 8078, 8079, 15 8080, 8081, 8082 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 200. The probes having the nucleotide sequence represented by SEQ ID NOS: 8083, 8084, 8085, 8086, 8087, 8088, 8089, 8090, 8091, 8092, 8093 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 201. The probes having the nucleotide sequence represented by SEQ ID NOS: 8094, 8095, 8096, 8097, 8098, 8099, 8100, 8101, 8102, 8103, 8104 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 202. 25 The probes having the nucleotide sequence repre.sented by SEQ ID NOS: 8105, 8106, 8107, 8108, 8109, 8110, 8111, 8112, 8113, 8114, 8115 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 203. 158 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 8116, 8117, 8118, 8119, 8120, 8121, 8122, 8123, 8124, 8125, 8126 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 204. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 8127, 8128, 8129, 8130, 8131, 8132, 8133, 8134, 8135, 8136, 8137 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 205. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 8138, 8139, 8140, 8141, 8142, 8143, 8144, 8145, 8146, 8147, 8148 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 206. The probes having the nucleotide sequence represented by SEQ ID NOS: 8149, 8150, 8151, 8152, 8153, 8154, 8155, 8156, 15 8157, 8158, 8159 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 207. The probes having the nucleotide sequence represented by SEQ ID NOS: 8160, 8161, 8162, 8163, 8164, 8165, 8166, 8167, 8168, 8169, 8170 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 208. The probes having the nucleotide sequence represented by SEQ ID NOS: 8171, 8172, 8173, 8174, 8175, 8176, 8177, 8178, 8179, 8180, 8181 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 209. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 8182, 8183, 8184, 8185, 8186, 8187, 8188, 8189, 8190, 8191, 8192 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 210. 159 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 8193, 8194, 8195, 8196, 8197, 8198, 8199, 8200, 8201, 8202, 8203 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 211. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 8204, 8205, 8206, 8207, 8208, 8209, 8210, 8211, 8212, 8213, 8214 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 212. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 8215, 8216, 8217, 8218, 8219, 8220, 8221, 8222, 8223, 8224, 8225 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 213. The probes having the nucleotide sequence represented by SEQ ID NOS: 8226, 8227, 8228, 8229, 8230, 8231, 8232, 8233, 15 8234, 8235, 8236 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 214. The probes having the nucleotide sequence represented by SEQ ID NOS: 8237, 8238, 8239, 8240, 8241, 8242, 8243, 8244, 8245, 8246, 8247 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 215. The probes having the nucleotide sequence represented by SEQ ID NOS: 8248, 8249, 8250, 8251, 8252, 8253, 8254, 8255, 8256, 8257, 8258 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 216. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 8259, 8260, 8261, 8262, 8263, 8264, 8265, 8266, 8267, 8268, 8269 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 217. 160 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 8270, 8271, 8272, 8273, 8274, 8275, 8276, 8277, 8278, 8279, 8280 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 218. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 8281, 8282, 8283, 8284, 8285, 8286, 8287, 8288, 8289, 8290, 8291 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 219. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 8292, 8293, 8294, 8295, 8296, 8297, 8298, 8299, 8300, 8301, 8302 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 220. The probes having the nucleotide sequence represented by SEQ ID NOS: 8303, 8304, 8305, 8306, 8307, 8308, 8309, 8310, 15 8311, 8312, 8313 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 221. The probes having the nucleotide sequence represented by SEQ ID NOS: 8314, 8315, 8316, 8317, 8318, 8319, 8320, 8321, 8322, 8323, 8324 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 222. The probes having the nucleotide sequence represented by SEQ ID NOS: 8325, 8326, 8327, 8328, 8329, 8330, 8331, 8332, 8333, 8334, 8335 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 223. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 8336, 8337, 8338, 8339, 8340, 8341, 8342, 8343, 8344, 8345, 8346 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 224. 161 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 8347, 8348, 8349, 8350, 8351, 8352, 8353, 8354, 8355, 8356, 8357 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 225. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 8358, 8359, 8360, 8361, 8362, 8363, 8364, 8365, 8366, 8367, 8368 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 226. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 8369, 8370, 8371, 8372, 8373, 8374, 8375, 8376, 8377, 8378, 8379 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 227. The probes having the nucleotide sequence represented by SEQ ID NOS: 8380, 8381, 8382, 8383, 8384, 8385, 8386, 8387, 15 8388, 8389, 8390 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 228. The probes having the nucleotide sequence represented by SEQ ID NOS: 8391, 8392, 8393, 8394, 8395, 8396, 8397, 8398, 8399, 8400, 8401 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 229. The probes having the nucleotide sequence represented by SEQ ID NOS: 8402, 8403, 8404, 8405, 8406, 8407, 8408, 8409, 8410, 8411, 8412 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 230. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 8413, 8414, 8415, 8416, 8417, 8418, 8419, 8420, 8421, 8422, 8423 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 231. 162 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 8424, 8425, 8426, 8427, 8428, 8429, 8430, 8431, 8432, 8433, 8434 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 232. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 8435, 8436, 8437, 8438, 8439, 8440, 8441, 8442, 8443, 8444, 8445 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 233. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 8446, 8447, 8448, 8449, 8450, 8451, 8452, 8453, 8454, 8455, 8456 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 234. The probes having the nucleotide sequence represented by SEQ ID NOS: 8457, 8458, 8459, 8460, 8461, 8462, 8463, 8464, 15 8465, 8466, 8467 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 235. The probes having the nucleotide sequence represented by SEQ ID NOS: 8468, 8469, 8470, 8471, 8472, 8473, 8474, 8475, 8476, 8477, 8478 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 236. The probes having the nucleotide sequence represented by SEQ ID NOS: 8479, 8480, 8481, 8482, 8483, 8484, 8485, 8486, 8487, 8488, 8489 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 237. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 8490, 8491, 8492, 8493, 8494, 8495, 8496, 8497, 8498, 8499, 8500 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 238. 163 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 8501, 8502, 8503, 8504, 8505, 8506, 8507, 8508, 8509, 8510, 8511 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 239. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 8512, 8513, 8514, 8515, 8516, 8517, 8518, 8519, 8520, 8521, 8522 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 240. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 8523, 8524, 8525, 8526, 8527, 8528, 8529, 8530, 8531, 8532, 8533 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 241. The probes having the nucleotide sequence represented by SEQ ID NOS: 8534, 8535, 8536, 8537, 8538, 8539, 8540, 8541, 15 8542, 8543, 8544 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 242. The probes having the nucleotide sequence represented by SEQ ID NOS: 8545, 8546, 8547, 8548, 8549, 8550, 8551, 8552, 8553, 8554, 8555 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 243. The probes having the nucleotide sequence represented by SEQ ID NOS: 8556, 8557, 8558, 8559, 8560, 8561, 8562, 8563, 8564, 8565, 8566 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 244. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 8567, 8568, 8569, 8570, 8571, 8572, 8573, 8574, 8575, 8576, 8577 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 245. 164 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 8578, 8579, 8580, 8581, 8582, 8583, 8584, 8585, 8586, 8587, 8588 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 246. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 8589, 8590, 8591, 8592, 8593, 8594, 8595, 8596, 8597, 8598, 8599 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 247. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 8600, 8601, 8602, 8603, 8604, 8605, 8606, 8607, 8608, 8609, 8610 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 248. The probes having the nucleotide sequence represented by SEQ ID NOS: 8611, 8612, 8613, 8614, 8615, 8616, 8617, 8618, 15 8619, 8620, 8621 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 249. The probes having the nucleotide sequence represented by SEQ ID NOS: 8622, 8623, 8624, 8625, 8626, 8627, 8628, 8629, 8630, 8631, 8632 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 250. The probes having the nucleotide sequence represented by SEQ ID NOS: 8633, 8634, 8635, 8636, 8637, 8638, 8639, 8640, 8641, 8642, 8643 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 251. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 8644, 8645, 8646, 8647, 8648, 8649, 8650, 8651, 8652, 8653, 8654 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 252. 165 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 8655, 8656, 8657, 8658, 8659, 8660, 8661, 8662, 8663, 8664, 8665 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 253. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 8666, 8667, 8668, 8669, 8670, 8671, 8672, 8673, 8674, 8675, 8676 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 254. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 8677, 8678, 8679, 8680, 8681, 8682, 8683, 8684, 8685, 8686, 8687 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 255. The probes having the nucleotide sequence represented by SEQ ID NOS: 8688, 8689, 8690, 8691, 8692, 8693, 8694, 8695, 15 8696, 8697, 8698 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 256. The probes having the nucleotide sequence represented by SEQ ID NOS: 8699, 8700, 8701, 8702, 8703, 8704, 8705, 8706, 8707, 8708, 8709 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 257. The probes having the nucleotide sequence represented by SEQ ID NOS: 8710, 8711, 8712, 8713, 8714, 8715, 8716, 8717, 8718, 8719, 8720 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 258. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 8721, 8722, 8723, 8724, 8725, 8726, 8727, 8728, 8729, 8730, 8731 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 259. 166 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 8732, 8733, 8734, 8735, 8736, 8737, 8738, 8739, 8740, 8741, 8742 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 260. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 8743, 8744, 8745, 8746, 8747, 8748, 8749, 8750, 8751, 8752, 8753 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 261. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 8754, 8755, 8756, 8757, 8758, 8759, 8760, 8761, 8762, 8763, 8764 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 262. The probes having the nucleotide sequence represented by SEQ ID NOS: 8765, 8766, 8767, 8768, 8769, 8770, 8771, 8772, 15 8773, 8774, 8775 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 263. The probes having the nucleotide sequence represented by SEQ ID NOS: 8776, 8777, 8778, 8779, 8780, 8781, 8782, 8783, 8784, 8785, 8786 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 264. The probes having the nucleotide sequence represented by SEQ ID NOS: 8787, 8788, 8789, 8790, 8791, 8792, 8793, 8794, 8795, 8796, 8797 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 265. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 8798, 8799, 8800, 8801, 8802, 8803, 8804, 8805, 8806, 8807, 8808 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 266. 167 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 8809, 8810, 8811, 8812, 8813, 8814, 8815, 8816, 8817, 8818, 8819 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 267. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 8820, 8821, 8822, 8823, 8824, 8825, 8826, 8827, 8828, 8829, 8830 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 268. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 8831, 8832, 8833, 8834, 8835, 8836, 8837, 8838, 8839, 8840, 8841 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 269. The probes having the nucleotide sequence represented by SEQ ID NOS: 8842, 8843, 8844, 8845, 8846, 8847, 8848, 8849, 15 8850, 8851, 8852 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 270. The probes having the nucleotide sequence represented by SEQ ID NOS: 8853, 8854, 8855, 8856, 8857, 8858, 8859, 8860, 8861, 8862, 8863 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 271. The probes having the nucleotide sequence represented by SEQ ID NOS: 8864, 8865, 8866, 8867, 8868, 8869, 8870, 8871, 8872, 8873, 8874 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 272. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 8875, 8876, 8877, 8878, 8879, 8880, 8881, 8882, 8883, 8884, 8885 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 273. 168 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 8886, 8887, 8888, 8889, 8890, 8891, 8892, 8893, 8894, 8895, 8896 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 274. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 8897, 8898, 8899, 8900, 8901, 8902, 8903, 8904, 8905, 8906, 8907 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 275. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 8908, 8909, 8910, 8911, 8912, 8913, 8914, 8915, 8916, 8917, 8918 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 276. The probes having the nucleotide sequence represented by SEQ ID NOS: 8919, 8920, 8921, 8922, 8923, 8924, 8925, 8926, 15 8927, 8928, 8929 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 277. The probes having the nucleotide sequence represented by SEQ ID NOS: 8930, 8931, 8932, 8933, 8934, 8935, 8936, 8937, 8938, 8939, 8940 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 278. The probes having the nucleotide sequence represented by SEQ ID NOS: 8941, 8942, 8943, 8944, 8945, 8946, 8947, 8948, 8949, 8950, 8951 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 279. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 8952, 8953, 8954, 8955, 8956, 8957, 8958, 8959, 8960, 8961, 8962 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 280. 169 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 8963, 8964, 8965, 8966, 8967, 8968, 8969, 8970, 8971, 8972, 8973 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 281. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 8974, 8975, 8976, 8977, 8978, 8979, 8980, 8981, 8982, 8983, 8984 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 282. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 8985, 8986, 8987, 8988, 8989, 8990, 8991, 8992, 8993, 8994, 8995 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 283. The probes having the nucleotide sequence represented by SEQ ID NOS: 8996, 8997, 8998, 8999, 9000, 9001, 9002, 9003, 15 9004, 9005, 9006 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 284. The probes having the nucleotide sequence represented by SEQ ID NOS: 9007, 9008, 9009, 9010, 9011, 9012, 9013, 9014, 9015, 9016, 9017 were selected from the, ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 285. The probes having the nucleotide sequence represented by SEQ ID NOS: 9018, 9019, 9020, 9021, 9022, 9023, 9024, 9025, 9026, 9027, 9028 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 286. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 9029, 9030, 9031, 9032, 9033, 9034, 9035, 9036, 9037, 9038, 9039 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 287. 170 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 9040, 9041, 9042, 9043, 9044, 9045, 9046, 9047, 9048, 9049, 9050 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 288. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 9051, 9052, 9053, 9054, 9055, 9056, 9057, 9058, 9059, 9060, 9061 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 289. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 9062, 9063, 9064, 9065, 9066, 9067, 9068, 9069, 9070, 9071, 9072 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 290. The probes having the nucleotide sequence represented by SEQ ID NOS: 9073, 9074, 9075, 9076, 9077, 9078, 9079, 9080, 15 9081, 9082, 9083 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 291. The probes having the nucleotide sequence represented by SEQ ID NOS: 9084, 9085, 9086, 9087, 9088, 9089, 9090, 9091, 9092, 9093, 9094 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 292. The probes having the nucleotide sequence represented by SEQ ID NOS: 9095, 9096, 9097, 9098, 9099, 9100, 9101, 9102, 9103, 9104, 9105 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 293. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 9106, 9107, 9108, 9109, 9110, 9111, 9112, 9113, 9114, 9115, 9116 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 294. 171 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 9117, 9118, 9119, 9120, 9121, 9122, 9123, 9124, 9125, 9126, 9127 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 295. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 9128, 9129, 9130, 9131, 9132, 9133, 9134, 9135, 9136, 9137, 9138 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 296. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 9139, 9140, 9141, 9142, 9143, 9144, 9145, 9146, 9147, 9148, 9149 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 297. The probes having the nucleotide sequence represented by SEQ ID NOS: 9150, 9151, '9152, 9153, 9154, 9155, 9156, 9157, 15 9158, 9159, 9160 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 298. The probes having the nucleotide sequence represented by SEQ ID NOS: 9161, 9162, 9163, 9164, 9165, 9166, 9167, 9168, 9169, 9170, 9171 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 299. The probes having the nucleotide sequence represented by SEQ ID NOS: 9172, 9173, 9174, 9175, 9176, 9177, 9178, 9179, 9180, 9181, 9182 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 300. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 9183, 9184, 9185, 9186, 9187, 9188, 9189, 9190, 9191, 9192, 9193 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 301. 172 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 9194, 9195, 9196, 9197, 9198, 9199, 9200, 9201, 9202, 9203, 9204 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 302. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 9205, 9206, 9207, 9208, 9209, 9210, 9211, 9212, 9213, 9214, 9215 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 303. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 9216, 9217, 9218, 9219, 9220, 9221, 9222, 9223, 9224, 9225, 9226 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 304. The probes having the nucleotide sequence represented by SEQ ID NOS: 9227, 9228, 9229, 9230, 9231, 9232, 9233, 9234, 15 9235, 9236, 9237 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 305. The probes having the nucleotide sequence represented by SEQ ID NOS: 9238, 9239, 9240, 9241, 9242, 9243, 9244, 9245, 9246, 9247, 9248 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 306. The probes having the nucleotide sequence represented by SEQ ID NOS: 9249, 9250, 9251, 9252, 9253, 9254, 9255, 9256, 9257, 9258, 9259 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 307. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 9260, 9261, 9262, 9263, 9264, 9265, 9266, 9267, 9268, 9269, 9270 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 308. 173 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 9271, 9272, 9273, 9274, 9275, 9276, 9277, 9278, 9279, 9280, 9281 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 309. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 9282, 9283, 9284, 9285, 9286, 9287, 9288, 9289, 9290, 9291, 9292 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 310. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 9293, 9294, 9295, 9296, 9297, 9298, 9299, 9300, 9301, 9302, 9303 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 311. The probes having the nucleotide sequence represented by SEQ ID NOS: 9304, 9305, 9306, 9307, 9308, 9309, 9310, 9311, 15 9312, 9313, 9314 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 312. The probes having the nucleotide sequence represented by SEQ ID NOS: 9315, 9316, 9317, 9318, 9319, 9320, 9321, 9322, 9323, 9324, 9325 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 313. The probes having the nucleotide sequence represented by SEQ ID NOS: 9326, 9327, 9328, 9329, 9330, 9331, 9332, 9333, 9334, 9335, 9336 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 314. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 9337, 9338, 9339, 9340, 9341, 9342, 9343, 9344, 9345, 9346, 9347, 9348, 9349, 9350, 9351, 9352, 9353, 9354, 174 WO 2006/024951 PCT/IB2005/002908 9355, 9356, 9357, 9358 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 315. The probes having the nucleotide sequence represented by SEQ ID NOS: 9359, 9360, 9361, 9362, 9363, 9364, 9365, 9366, 5 9367, 9368, 9369 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 316. The probes having the nucleotide sequence represented by SEQ ID NOS: 9370, 9371, 9372, 9373, 9374, 9375, 9376, 9377, 9378, 9379, 9380 were selected from the ORFs having the 10 nucleotide sequence represented by SEQ ID NO: 317. The probes having the nucleotide sequence represented by SEQ ID NOS: 9381, 9382, 9383, 9384, 9385, 9386, 9387, 9388, 9389, 9390, 9391 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 318. 15 The probes having the nucleotide sequence represented by SEQ ID NOS: 9392, 9393, 9394, 9395, 9396, 9397, 9398, 9399, 9400, 9401, 9402 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 319. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 9403, 9404, 9405, 9406, 9407, 9408, 9409, 9410, 9411, 9412, 9413 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 320. The probes having the nucleotide sequence represented by SEQ ID NOS: 9414, 9415, 9416, 9417, 9418, 9419, 9420, 9421, 25 9422, 9423, 9424 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 321. The probes having the nucleotide sequence represented by SEQ ID NOS: 9425, 9426, 9427, 9428, 9429, 9430, 9431, 9432, 175 WO 2006/024951 PCT/IB2005/002908 9433, 9434, 9435 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 322. The probes having the nucleotide sequence represented by SEQ ID NOS: 9436, 9437, 9438, 9439, 9440, 9441, 9442, 9443, 5 9444, 9445, 9446 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 323. The probes having the nucleotide sequence represented by SEQ ID NOS: 9447, 9448, 9449, 9450, 9451, 9452, 9453, 9454, 9455, 9456, 9457 were selected from the ORFs having the 10 nucleotide sequence represented by SEQ ID NO: 324. The probes having the nucleotide sequence represented by SEQ ID NOS: 9458, 9459, 9460, 9461, 9462, 9463, 9464, 9465, 9466, 9467, 9468 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 325. 15 The probes having the nucleotide sequence represented by SEQ ID NOS: 9469, 9470, 9471, 9472, 9473, 9474, 9475, 9476, 9477, 9478, 9479 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 326. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 9480, 9481, 9482, 9483, 9484, 9485, 9486, 9487, 9488, 9489, 9490 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 327. The probes having the nucleotide sequence represented by SEQ ID NOS: 9491, 9492, 9493, 9494, 9495, 9496, 9497, 9498, 25 9499, 9500, 9501 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 328. The probes having the nucleotide sequence represented by SEQ ID NOS: 9502, 9503, 9504, 9505, 9506, 9507, 9508, 9509, 176 WO 2006/024951 PCT/IB2005/002908 9510, 9511, 9512 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 329. The probes having the nucleotide sequence represented by SEQ ID NOS: 9513, 9514, 9515, 9516, 9517, 9518, 9519, 9520, 5 9521, 9522, 9523 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 330. The probes having the nucleotide sequence represented by SEQ ID NOS: 9524, 9525, 9526, 9527, 9528, 9529, 9530, 9531, 9532, 9533, 9534 were selected from the ORFs having the 10 nucleotide sequence represented by SEQ ID.NO: 331. The probes having the nucleotide sequence represented by SEQ ID NOS: 9535, 9536, 9537, 9538, 9539, 9540, 9541, 9542, 9543, 9544, 9545, 9546, 9547, 9548, 9549, 9550, 9551, 9552, 9553, 9554, 9555, 9556 were selected from the ORFs having 15 the nucleotide sequence represented by SEQ ID NO: 332. The probes having the nucleotide sequence represented by SEQ ID NOS: 9557, 9558, 9559, 9560, 9561, 9562, 9563, 9564, 9565, 9566, 9567, 9568, 9569, 9570, 9571, 9572, 9573, 9574, 9575, 9576, 9577, 9578 were selected from the ORFs having 20 the nucleotide sequence represented by SEQ ID NO: 333. The probes having the nucleotide sequence represented by SEQ ID NOS: 9579, 9580, 9581, 9582, 9583, 9584, 9585, 9586, 9587, 9588, 9589 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 334. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 9590, 9591, 9592, 9593, 9594, 9595, 9596, 9597, 9598, 9599, 9600 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 335. 177 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 9601, 9602, 9603, 9604, 9605, 9606, 9607, 9608, 9609, 9610, 9611 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 336.. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 9612, 9613, 9614, 9615, 9616, 9617, 9618, 9619, 9620, 9621, 9622 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 337. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 9623, 9624, 9625, 9626, 9627, 9628, 9629, 9630, 9631, 9632, 9633 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 338. The probes having the nucleotide sequence represented by SEQ ID NOS: 9634, 9635, 9636, 9637, 9638, 9639, 9640, 9641, 15 9642, 9643, 9644 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 339. The probes having the nucleotide sequence represented by SEQ ID NOS: 9645, 9646, 9647, 9648, 9649, 9650, 9651, 9652, 9653, 9654, 9655 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 340. The probes having the nucleotide sequence represented by SEQ ID NOS: 9656, 9657, 9658, 9659, 9660, 9661, 9662, 9663, 9664, 9665, 9666 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 341. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 9667, 9668, 9669, 9670, 9671, 9672, 9673, 9674, 9675, 9676, 9677 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 342. 178 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 9678, 9679, 9680, 9681, 9682, 9683, 9684, 9685, 9686, 9687, 9688 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 343. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 9689, 9690, 9691, 9692, 9693, 9694, 9695, 9696, 9697, 9698, 9699 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 344. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 9700, 9701, 9702, 9703, 9704, 9705, 9706, 9707, 9708, 9709, 9710 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 345. The probes having the nucleotide sequence represented by SEQ ID NOS: 9711, 9712, 9713, 9714, 9715, 9716, 9717, 9718, 15 9719, 9720, 9721 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 346. The probes having the nucleotide sequence represented by SEQ ID NOS: 9722, 9723, 9724, 9725, 9726, 9727, 9728, 9729, 9730, 9731, 9732 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 347. The probes having the nucleotide sequence represented by SEQ ID NOS: 9733, 9734, 9735, 9736, 9737, 9738, 9739, 9740, 9741, 9742, 9743 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 348. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 9744, 9745, 9746, 9747, 9748, 9749, 9750, 9751, 9752, 9753, 9754 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 349. 179 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 9755, 9756, 9757, 9758, 9759, 9760, 9761, 9762, 9763, 9764, 9765 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 350. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 9766, 9767, 9768, 9769, 9770, 9771, 9772, 9773, 9774, 9775, 9776 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 351. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 9777, 9778, 9779, 9780, 9781, 9782, 9783, 9784, 9785, 9786, 9787 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 352. The probes having the nucleotide sequence represented by SEQ ID NOS: 9788, 9789, 9790, 9791, 9792, 9793, 9794, 9795, 15 9796, 9797, 9798 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 353. The probes having the nucleotide sequence represented by SEQ ID NOS: 9799, 9800, 9801, 9802, 9803, 9804, 9805, 9806, 9807, 9808, 9809 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 354. The probes having the nucleotide sequence represented by SEQ ID NOS: 9810, 9811, 9812, 9813, 9814, 9815, 9816, 9817, 9818, 9819, 9820 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 355. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 9821, 9822, 9823, 9824, 9825, 9826, 9827, 9828, 9829, 9830, 9831 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 356. 180 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 9832, 9833, 9834, 9835, 9836, 9837, 9838, 9839, 9840, 9841, 9842 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 357. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 9843, 9844, 9845, 9846, 9847, 9848, 9849, 9850, 9851, 9852, 9853 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 358. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 9854, 9855, 9856, 9857, 9858, 9859, 9860, 9861, 9862, 9863, 9864 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 359. The probes having the nucleotide sequence represented by SEQ ID NOS: 9865, 9866, 9867, 9868, 9869, 9870, 9871, 9872, 15 9873, 9874, 9875 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 360. The probes having the nucleotide sequence represented by SEQ ID NOS: 9876, 9877, 9878, 9879, 9880, 9881, 9882, 9883, 9884, 9885, 9886 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 361. The probes having the nucleotide sequence represented by SEQ ID NOS: 9887, 9888, 9889, 9890, 9891, 9892, 9893, 9894, 9895, 9896, 9897 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 362. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 9898, 9899, 9900, 9901, 9902, 9903, 9904, 9905, 9906, 9907, 9908 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 363. 181 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 9909, 9910, 9911, 9912, 9913, 9914, 9915, 9916, 9917, 9918, 9919 were selected from the ORFs having the nucleotide sequence represented by'SEQ ID NO: 364. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 9920, 9921, 9922, 9923, 9924, 9925, 9926, 9927, 9928, 9929, 9930 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 365. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 9931, 9932, 9933, 9934, 9935, 9936, 9937, 9938, 9939, 9940, 9941 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 366. The probes having the nucleotide sequence represented by SEQ ID NOS: 9942, 9943, 9944, 9945, 9946, 9947, 9948, 9949, 15 9950, 9951, 9952 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 367. The probes having the nucleotide sequence represented by SEQ ID NOS: 9953, 9954, 9955, 9956, 9957, 9958, 9959, 9960, 9961, 9962, 9963 were selected from the ORFs having the 20 nucleotide sequence represented by SEQ ID NO: 368. The probes having the nucleotide sequence represented by SEQ ID NOS: 9964, 9965, 9966, 9967, 9968, 9969, 9970, 9971, 9972, 9973, 9974 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 369. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 9975, 9976, 9977, 9978, 9979, 9980, 9981, 9982, 9983, 9984, 9985 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 370. 182 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 9986, 9987, 9988, 9989, 9990, 9991, 9992, 9993, 9994, 9995, 9996 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 371. 5 The probes having the nucleotide sequence represented by SEQ ID NOS: 9997, 9998, 9999, 10000, 10001, 10002, 10003, 10004, 10005, 10006, 10007 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 372. 10 The probes having the nucleotide sequence represented by SEQ ID NOS: 10008, 10009, 10010, 10011, 10012, 10013, 10014, 10015, 10016, 10017, 10018 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 373. 15 The probes having the nucleotide sequence represented by SEQ ID NOS: 10019, 10020, 10021, 10022, 10023, 10024, 10025, 10026, 10027, 10028, 10029 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 374. 20 The probes having the nucleotide sequence represented by SEQ ID NOS: 10030, 10031, 10032, 10033, 10034, 10035, 10036, 10037, 10038, 10039, 10040 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 375. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 10041, 10042, 10043, 10044, 10045, 10046, 10047, 10048, 10049, 10050, 10051 were selected from the 183 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 376. The probes having the nucleotide sequence represented by SEQ ID NOS: 10052, 10053, 10054, 10055, 10056, 10057, 5 10058, 10059, 10060, 10061, 10062 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 377. The probes having the nucleotide sequence represented by SEQ ID NOS: 10063, 10064, 10065, 10066, 10067, 10068, 10 10069, 10070, 10071, 10072, 10073 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 378. The probes having the nucleotide sequence represented by SEQ ID NOS: 10074, 10075, 10076, 10077, 10078, 10079, 15 10080, 10081, 10082, 10083, 10084 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 379. The probes having the nucleotide sequence represented by SEQ ID NOS: 10085, 10086, 10087, 10088, 10089, 10090, 20 10091, 10092, 10093, 10094, 10095 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 380. The probes having the nucleotide sequence represented by SEQ ID NOS: 10096, 10097, 10098, 10099, 10100, 10101, 25 10102, 10103, 10104, 10105, 10106 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 381. 184 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 10107, 10108, 10109, 10110, 10111, 10112, 10113, 10114, 10115, 10116, 10117 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 382. The probes having the nucleotide sequence represented by SEQ ID NOS: 10118, 10119, 10120, 10121, 10122, 10123, 10124, 10125, 10126, 10127, 10128 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 383. The probes having the nucleotide sequence represented by SEQ ID NOS: 10129, 10130, 10131, 10132, 10133, 10134, 10135, 10136, 10137, 10138, 10139 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 384. The probes having the nucleotide sequence represented by SEQ ID NOS: 10140, 10141, 10142, 10143, 10144, 10145, 10146, 10147, 10148, 10149, 10150 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 385. The probes having the nucleotide sequence represented by SEQ ID NOS: 10151, 10152, 10153, 10154, 10155, 10156, 10157, 10158, 10159, 10160, 10161 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 386. The probes having the nucleotide sequence represented by SEQ ID NOS: 10162, 10163, 10164, 10165, 10166, 10167, 10168, 10169, 10170, 10171, 10172 were selected from the 185 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 387. The probes having the nucleotide sequence represented by SEQ ID NOS: 10173, 10174, 10175, 10176, 10177, 10178, 5 10179, 10180, 10181, 10182, 10183 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 388. The probes having the nucleotide sequence represented by SEQ ID NOS: 10184, 10185, 10186, 10187, 10188, 10189, 10 10190, 10191, 10192, 10193, 10194 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 389. The probes having the nucleotide sequence represented by SEQ ID NOS: 10195, 10196, 10197, 10198, 10199, 10200, 15 10201, 10202, 10203, 10204, 10205 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 390. The probes having the nucleotide sequence represented by SEQ ID NOS: 10206, 10207, 10208, 10209, 10210, 10211, 20 10212, 10213, 10214, 10215, 10216 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 391. The probes having the nucleotide sequence represented by SEQ ID NOS: 10217, 10218, 10219, 10220, 10221, 10222, 25 10223, 10224, 10225, 10226, 10227 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 392. 186 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 10228, 10229, 10230, 10231, 10232, 10233, 10234, 10235, 10236, 10237, 10238 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 393. The probes having the nucleotide sequence represented by SEQ ID NOS: 10239, 10240, 10241, 10242, 10243, 10244, 10245, 10246, 10247, 10248, 10249 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 394. The probes having the nucleotide sequence represented by SEQ ID NOS: 10250, 10251, 10252, 10253, 10254, 10255, 10256, 10257, 10258, 10259, 10260 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 395. The probes having the nucleotide sequence represented by SEQ ID NOS: 10261, 10262, 10263, 10264, 10265, 10266, 10267, 10268, 10269, 10270, 10271 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 396. The probes having the nucleotide sequence represented by SEQ ID NOS: 10272, 10273, 10274, 10275, 10276, 10277, 10278, 10279, 10280, 10281, 10282 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 397. The probes having the nucleotide sequence represented by SEQ ID NOS: 10283, 10284, 10285, 10286, 10287, 10288, 10289, 10290, 10291, 10292, 10293 were selected from the 187 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 398. The probes having the nucleotide sequence represented by SEQ ID NOS: 10294, 10295, 10296, 10297, 10298, 10299, 5 10300, 10301, 10302, 10303, 10304 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 399. The probes having the nucleotide sequence represented by SEQ ID NOS: 10305, 10306, 10307, 10308, 10309, 10310, 10 10311, 10312, 10313, 10314, 10315 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 400. The probes having the nucleotide sequence represented by SEQ ID NOS: 10316, 10317, 10318, 10319, 10320, 10321, 15 10322, 10323, 10324, 10325, 10326 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 401. The probes having the nucleotide sequence represented by SEQ ID NOS: 10327, 10328, 10329, 10330, 10331, 10332, 20 10333, 10334, 10335, 10336, 10337 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 402. The probes having the nucleotide sequence represented by SEQ ID NOS: 10338, 10339, 10340, 10341, 10342, 10343, 25 10344, 10345, 10346, 10347, 10348 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 403. 188 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 10349, 10350, 10351, 10352, 10353, 10354, 10355, 10356, 10357, 10358, 10359 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 404. The probes having the nucleotide sequence represented by SEQ ID NOS: 10360, 10361, 10362, 10363, 10364, 10365, 10366, 10367, 10368, 10369, 10370 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 405. The probes having the nucleotide sequence represented by SEQ ID NOS: 10371, 10372, 10373, 10374, 10375, 10376, 10377, 10378, 10379, 10380, 10381 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 406. The probes having the nucleotide sequence represented by SEQ ID NOS: 10382, 10383, 10384, 10385, 10386, 10387, 10388, 10389, '10390, 10391, 10392 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 407. The probes having the nucleotide sequence represented by SEQ ID NOS: 10393, 10394, 10395, 10396, 10397, 10398, 10399, 10400, 10401, 10402, 10403 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 408. The probes having the nucleotide sequence represented by SEQ ID NOS: 10404, 10405, 10406, 10407, 10408, 10409, 10410, 10411, 10412, 10413, 10414 were selected from the 189 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 409. The probes having the nucleotide sequence represented by SEQ ID NOS: 10415, 10416, 10417, 10418, 10419, 10420, 5 10421, 10422, 10423, 10424, 10425 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 410. The probes having the nucleotide sequence represented by SEQ ID NOS: 10426, 10427, 10428, 10429, 10430, 10431, 10 10432, 10433, 10434, 10435, 10436 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 411. The probes having the nucleotide sequence represented by SEQ ID NOS: 10437, 10438, 10439, 10440, 10441, 10442, 15 10443, 10444, 10445, 10446, 10447 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 412. The probes having the nucleotide sequence represented by SEQ ID NOS: 10448, 10449, 10450, 10451, 10452, 10453, 20 10454, 10455, 10456, 10457, 10458 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 413. The probes having the nucleotide sequence represented by SEQ ID NOS: 10459, 10460, 10461, 10462, 10463, 10464, 25 10465, 10466, 10467, 10468, 10469 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 414. 190 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 10470, 10471, 10472, 10473, 10474, 10475, 10476, 10477, 10478, 10479, 10480 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 415. The probes having the nucleotide sequence represented by SEQ ID NOS: 10481, 10482, 10483, 10484, 10485, 10486, 10487, 10488, 10489, 10490, 10491 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 416. The probes having the nucleotide sequence represented by SEQ ID NOS: 10492, 10493, 10494, 10495, 10496, 10497, 10498, 10499, 10500, 10501, 10502 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 417. The probes having the nucleotide sequence represented by SEQ ID NOS: 10503, 10504, 10505, 10506, 10507, 10508, 10509, 10510, 10511, 10512, 10513 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 418. The probes having the nucleotide sequence represented by SEQ ID NOS: 10514, 10515, 10516, 10517, 10518, 10519, 10520, 10521, 10522, 10523, 10524 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 419. The probes having the nucleotide sequence represented by SEQ ID NOS: 10525, 10526, 10527, 10528, 10529, 10530, 10531, 10532, 10533, 10534, 10535 were selected from the 191 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 420. The probes having the nucleotide sequence represented by SEQ ID NOS: 10536, 10537, 10538, 10539, 10540, 10541, 5 10542, 10543, 10544, 10545, 10546 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 421. The probes having the nucleotide sequence represented by SEQ ID NOS: 10547, 10548, 10549, 10550, 10551, 10552, 10 10553, 10554, 10555, 10556, 10557 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 422. The probes having the nucleotide sequence represented by SEQ ID NOS: 10558, 10559, 10560, 10561, 10562, 10563, 15 10564, 10565, 10566, 10567, 10568 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 423. The probes having the nucleotide sequence represented by SEQ ID NOS: 10569, 10570, 10571, 10572, 10573, 10574, 20 10575, 10576, 10577, 10578, 10579 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 424. The probes having the nucleotide sequence represented by SEQ ID NOS: 10580, 10581, 10582, 10583, 10584, 10585, 25 10586, 10587, 10588, 10589, 10590 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 425. 192 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 10591, 10592, 10593, 10594, 10595, 10596, 10597, 10598, 10599, 10600, 10601 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 426. The probes having the nucleotide sequence represented by SEQ ID NOS: 10602, 10603, 10604, 10605, 10606, 10607, 10608, 10609, 10610, 10611, 10612 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 427. The probes having the nucleotide sequence represented by SEQ ID NOS: 10613, 10614, 10615, 10616, 10617, 10618, 10619, 10620, 10621, 10622, 10623 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 428. The probes having the nucleotide sequence represented by SEQ ID NOS: 10624, 10625, 10626, 10627, 10628, 10629, 10630, 10631, 10632, 10633, 10634 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 429. The probes having the nucleotide sequence represented by SEQ ID NOS: 10635, 10636, 10637, 10638, 10639, 10640, 10641, 10642, 10643, 10644, 10645 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 430. The probes having the nucleotide sequence represented by SEQ ID NOS: 10646, 10647, 10648, 10649, 10650, 10651, 10652, 10653, 10654, 10655, 10656 were selected from the 193 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 431. The probes having the nucleotide sequence represented by SEQ ID NOS: 10657, 10658, 10659, 10660, 10661, 10662, 5 10663, 10664, 10665, 10666, 10667 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 432. The probes having the nucleotide sequence represented by SEQ ID NOS: 10668, 10669, 10670, 10671, 10672, 10673, 10 10674, 10675, 10676, 10677, 10678 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 433. The probes having the nucleotide sequence represented by SEQ ID NOS: 10679, 10680, 10681, 10682, 10683, 10684, 15 10685, 10686, 10687, 10688, 10689 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 434. The probes having the nucleotide sequence represented by SEQ ID NOS: 10690, 10691, 10692, 10693, 10694, 10695, 20 10696, 10697, 10698, 10699, 10700 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 435. The probes having the nucleotide sequence represented by SEQ ID NOS: 10701, 10702, 10703, 10704, 10705, 10706, 25 10707, 10708, 10709, 10710, 10711 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 436. 194 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 10712, 10713, 10714, 10715, 10716, 10717, 10718, 10719, 10720, 10721, 10722 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 437. The probes having the nucleotide sequence represented by SEQ ID NOS: 10723, 10724, 10725, 10726, 10727, 10728, 10729, 10730, 10731, 10732, 10733 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 438. The probes having the nucleotide sequence represented by SEQ ID NOS: 10734, 10735, 10736, 10737, 10738, 10739, 10740, 10741, 10742, 10743, 10744 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 439. The probes having the nucleotide sequence represented by SEQ ID NOS: 10745, 10746, 10747, 10748, 10749, 10750, 10751, 10752, 10753, 10754, 10755 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 440. The probes having the nucleotide sequence represented by SEQ ID NOS: 10756, 10757, 10758, 10759, 10760, 10761, 10762, 10763, 10764, 10765, 10766 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 441. The probes having the nucleotide sequence represented by SEQ ID NOS: 10767, 10768, 10769, 10770, 10771, 10772, 10773, 10774, 10775, 10776, 10777 were selected from the 195 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 442. The probes having the nucleotide sequence represented by SEQ ID NOS: 10778, 10779, 10780, 10781, 10782, 10783, 5 10784, 10785, 10786, 10787, 10788 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 443. The probes having the nucleotide sequence represented by SEQ ID NOS: 10789, 10790, 10791, 10792, 10793, 10794, 10 10795, 10796, 10797, 10798, 10799 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 444. The probes having the nucleotide sequence represented by SEQ ID NOS: 10800, 10801, 10802, 10803, 10804, 10805, 15 10806, 10807, 10808, 10809, 10810 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 445. The probes having the nucleotide sequence represented by SEQ ID NOS: 10811, 10812, 10813, 10814, 10815, 10816, 20 10817, 10818, 10819, 10820, 10821 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 446. The probes having the nucleotide sequence represented by SEQ ID NOS: 10822, 10823, 10824, 10825, 10826, 10827, 25 10828, 10829, 10830, 10831, 10832 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 447. 196 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 10833, 10834, 10835, 10836, 10837, 10838, 10839, 10840, 10841, 10842, 10843 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 448. The probes having the nucleotide sequence represented by SEQ ID NOS: 10844, 10845, 10846, 10847, 10848, 10849, 10850, 10851, 10852, 10853, 10854 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 449. The probes having the nucleotide sequence represented by SEQ ID NOS: 10855, 10856, 10857, 10858, 10859, 10860, 10861, 10862, 10863, 10864, 10865 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 450. The probes having the nucleotide sequence represented by SEQ ID NOS: 10866, 10867, 10868, 10869, 10870, 10871, 10872, 10873, 10874, 10875, 10876 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 451. The probes having the nucleotide sequence represented by SEQ ID NOS: 10877, 10878, 10879, 10880, 10881, 10882, 10883, 10884, 10885, 10886, 10887 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 452. The probes having the nucleotide sequence represented by SEQ ID NOS: 10888, 10889, 10890, 10891, 10892, 10893, 10894, 10895, 10896, 10897, 10898 were selected from the 197 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 453. The probes having the nucleotide sequence represented by SEQ ID NOS: 10899, 10900, 10901, 10902, 10903, 10904, 5 10905, 10906, 10907, 10908, 10909 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 454. The probes having the nucleotide sequence represented by SEQ ID NOS: 10910, 10911, 10912, 10913, 10914, 10915, 10 10916, 10917, 10918, 10919, 10920 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 455. The probes having the nucleotide sequence represented by SEQ ID NOS: 10921, 10922, 10923, 10924, 10925, 10926, 15 10927, 10928, 10929, 10930, 10931 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 456. The probes having the nucleotide sequence represented by SEQ ID NOS: 10932, 10933, 10934, 10935, 10936, 10937, 20 10938, 10939, 10940, 10941, 10942 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 457. The probes having the nucleotide sequence represented by SEQ ID NOS: 10943, 10944, 10945, 10946, 10947, 10948, 25 10949, 10950, 10951, 10952, 10953 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 458. 198 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 10954, 10955, 10956, 10957, 10958, 10959, 10960, 10961, 10962, 10963, 10964 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 459. The probes having the nucleotide sequence represented by SEQ ID NOS: 10965, 10966, 10967, 10968, 10969, 10970, 10971, 10972, 10973, 10974, 10975 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 460. The probes having the nucleotide sequence represented by SEQ ID NOS: 10976, 10977, 10978, 10979, 10980, 10981, 10982, 10983, 10984, 10985, 10986 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 461. The probes having the nucleotide sequence represented by SEQ ID NOS: 10987, 10988, 10989, 10990, 10991, 10992, 10993, 10994, 10995, 10996, 10997 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 462. The probes having the nucleotide sequence represented by SEQ ID NOS: 10998, 10999, 11000, 11001, 11002, 11003, 11004, 11005, 11006, 11007, 11008 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 463. The probes having the nucleotide sequence represented by SEQ ID NOS: 11009, 11010, 11011, 11012, 11013, 11014, 11015, 11016, 11017, 11018, 11019 were selected from the 199 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 464. The probes having the nucleotide sequence represented by SEQ ID NOS: 11020, 11021,'11022, 11023, 11024, 11025, 5 11026, 11027, 11028, 11029, 11030 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 465. The probes having the nucleotide sequence represented by SEQ ID NOS: 11031, 11032, 11033, 11034, 11035, 11036, 10 11037, 11038, 11039, 11040, 11041 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 466. The probes having the nucleotide sequence represented by SEQ ID NOS: 11042, 11043, 11044, 11045, 11046, 11047, 15 11048, 11049, 11050, 11051, 11052 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 467. The probes having the nucleotide sequence represented by SEQ ID NOS: 11053, 11054, 11055, 11056, 11057, 11058, 20 11059, 11060, 11061, 11062, 11063 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 468. The probes having the nucleotide sequence represented by SEQ ID NOS: 11064, 11065, 11066, 11067, 11068, 11069, 25 11070, 11071, 11072, 11073, 11074 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 469. 200 WO 2006/024951 PCT/IB2005/002908 P The probes having the nucleotide sequence represented by SEQ ID NOS: 11075, 11076, 11077, 11078, 11079, 11080, 11081, 11082, 11083, 11084, 11085 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 470. The probes having the nucleotide sequence represented by SEQ ID NOS: 11086, 11087, 11088, 11089, 11090, 11091, 11092, 11093, 11094, 11095, 11096 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 471. The probes having the nucleotide sequence represented by SEQ ID NOS: 11097, 11098, 11099, 11100, 11101, 11102, 11103, 11104, 11105, 11106, 11107 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 472. The probes having the nucleotide sequence represented by SEQ ID NOS: 11108, 11109, 11110, 11111, 11112, 11113, 11114, 11115, 11116, 11117, 11118 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 473. The probes having the nucleotide sequence represented by SEQ ID NOS: 11119, 11120, 11121, 11122, 11123, 11124, 11125, 11126, 11127, 11128, 11129 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 474. The probes having the nucleotide sequence represented by SEQ ID NOS: 11130, 11131, 11132, 11133, 11134, 11135, 11136, 11137, 11138, 11139, 11140 were selected from the 201 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 475. The probes having the nucleotide sequence represented by SEQ ID NOS: 11141, 11142, 11143, 11144, 11145, 11146, 5 11147, 11148, 11149, 11150, 11151 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 476. The probes having the nucleotide sequence represented by SEQ ID NOS: 11152, 11153, 11154, 11155, 11156, 11157, 10 11158, 11159, 11160, 11161, 11162 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 477. The probes having the nucleotide sequence represented by SEQ ID NOS: 11163, 11164, 11165, 11166, 11167, 11168, 15 11169, 11170, 11171, 11172, 11173 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 478. The probes having the nucleotide sequence represented by SEQ ID NOS: 11174, 11175, 11176, 11177, 11178, 11179, 20 11180, 11181, 11182, 11183,.11184 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 479. The probes having the nucleotide sequence represented by SEQ ID NOS: 11185, 11186, 11187, 11188, 11189, 11190, 25 11191, 11192, 11193, 11194, 11195 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 480. 202 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 11196, 11197, 11198, 11199, 11200, 11201, 11202, 11203, 11204, 11205, 11206 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 481. The probes having the nucleotide sequence represented by SEQ ID NOS: 11207, 11208, 11209, 11210, 11211, 11212, 11213, 11214, 11215, 11216, 11217 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 482. The probes having the nucleotide sequence represented by SEQ ID NOS: 11218, 11219, 11220, 11221, 11222, 11223, 11224, 11225, 11226, 11227, 11228 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 483. The probes having the nucleotide sequence represented by SEQ ID NOS: 11229, 11230, 11231, 11232, 11233, 11234, 11235, 11236, 11237, 11238, 11239 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 484. The probes having the nucleotide sequence represented by SEQ ID NOS: 11240, 11241, 11242, 11243, 11244, 11245, 11246, 11247, 11248, 11249, 11250 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 485. The probes having the nucleotide sequence represented by SEQ ID NOS: 11251, 11252, 11253, 11254, 11255, 11256, 11257, 11258, 11259, 11260, 11261 were selected from the 203 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 486. The probes having the nucleotide sequence represented by SEQ ID NOS: 11262, 11263, 11264, 11265, 11266, 11267, 5 11268, 11269, 11270, 11271, 11272 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 487. The probes having the nucleotide sequence represented by SEQ ID NOS: 11273, 11274, 11275, 11276, 11277, 11278, 10 11279, 11280, 11281, 11282, 11283 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 488. The probes having the nucleotide sequence represented by SEQ ID NOS: 11284, 11285, 11286, 11287, 11288, 11289, 15 11290, 11291, 11292, 11293, 11294 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 489. The probes having the nucleotide sequence represented by SEQ ID NOS: 11295, 11296, 11297, 11298, 11299, 11300, 20 11301, 11302, 11303, 11304, 11305 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 490. The probes having the nucleotide sequence represented by SEQ ID NOS: 11306, 11307, 11308, 11309, 11310, 11311, 25 11312, 11313, 11314, 11315, 11316 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 491. 204 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 11317, 11318, 11319, 11320, 11321, 11322, 11323, 11324, 11325, 11326, 11327 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 492. The probes having the nucleotide sequence represented by SEQ ID NOS: 11328, 11329, 11330, 11331, 11332, 11333, 11334, 11335, 11336, 11337, 11338 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 493. The probes having the nucleotide sequence represented by SEQ ID NOS: 11339, 11340, 11341, 11342, 11343, 11344, 11345, 11346, 11347, 11348, 11349 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 494. The probes having the nucleotide sequence represented by SEQ ID NOS: 11350, 11351, 11352, 11353, 11354, 11355, 11356, 11357, 11358, 11359, 11360 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 495. The probes having the nucleotide sequence represented by SEQ ID NOS: 11361, 11362, 11363, 11364, 11365, 11366, 11367, 11368, 11369, 11370, 11371 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 496. The probes having the nucleotide sequence represented by SEQ ID NOS: 11372, 11373, 11374, 11375, 11376, 11377, 11378, 11379, 11380, 11381, 11382 were selected from the 205 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 497. The probes having the nucleotide sequence represented by SEQ ID NOS: 11383, 11384, 11385, 11386, 11387, 11388, 5 11389, 11390, 11391, 11392, 11393 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 498. The probes having the nucleotide sequence represented by SEQ ID NOS: 11394, 11395, 11396, 11397, 11398, 11399, 10 11400, 11401, 11402, 11403, 11404 were selected from the ORFs having the.nucleotide sequence represented by SEQ ID NO: 499. The probes having the nucleotide sequence represented by SEQ ID NOS: 11405, 11406, 11407, 11408, 11409, 11410, 15 11411, 11412, 11413, 11414, 11415 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 500. The probes having the nucleotide sequence represented by SEQ ID NOS: 11416, 11417, 11418, 11419, 11420, 11421, 20 11422, 11423, 11424, 11425, 11426 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 501. The probes having the nucleotide sequence represented by SEQ ID NOS: 11427, 11428, 11429, 11430, 11431, 11432, 25 11433, 11434, 11435, 11436, 11437 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 502. 206 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 11438, 11439, 11440, 11441, 11442, 11443, 11444, 11445, 11446, 11447, 11448 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 503. The probes having the nucleotide sequence represented by SEQ ID NOS: 11449, 11450, 11451, 11452, 11453, 11454, 11455, 11456, 11457, 11458, 11459 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 504. The probes having the nucleotide sequence represented by SEQ ID NOS: 11460, 11461, 11462, 11463, 11464, 11465, 11466, 11467, 11468, 11469, 11470 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 505. The probes having the nucleotide sequence represented by SEQ ID NOS: 11471, 11472, 11473, 11474, 11475, 11476, 11477, 11478, 11479, 11480, 11481 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 506. The probes having the nucleotide sequence represented by SEQ ID NOS: 11482, 11483, 11484, 11485, 11486, 11487, 11488, 11489, 11490, 11491, 11492 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 507. The probes having the nucleotide sequence represented by SEQ ID NOS: 11493, 11494, 11495, 11496, 11497, 11498, 11499, 11500, 11501, 11502, 11503 were selected from the 207 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 508. The probes having the nucleotide sequence represented by SEQ ID NOS: 11504, 11505, 11506, 11507, 11508, 11509, 5 11510, 11511, 11512, 11513, 11514 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 509. The probes having the nucleotide sequence represented by SEQ ID NOS: 11515, 11516, 11517, 11518, 11519, 11520, 10 11521, 11522, 11523, 11524, 11525 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 510. The probes having the nucleotide sequence represented by SEQ ID NOS: 11526, 11527, 11528, 11529, 11530, 11531, 15 11532, 11533, 11534, 11535, 11536 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 511. The probes having the nucleotide sequence represented by SEQ ID NOS: 11537, 11538, 11539, 11540, 11541, 11542, 20 11543, 11544, 11545, 11546, 11547 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 512. The probes having the nucleotide sequence represented by SEQ ID NOS: 11548, 11549, 11550, 11551, 11552, 11553, 25 11554, 11555, 11556, 11557, 11558 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 513. 208 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 11559, 11560, 11561, 11562, 11563, 11564, 11565, 11566, 11567, 11568, 11569 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 514. The probes having the nucleotide sequence represented by SEQ ID NOS: 11570, 11571, 11572, 11573, 11574, 11575, 11576, 11577, 11578, 11579, 11580 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 515. The probes having the nucleotide sequence represented by SEQ ID NOS: 11581, 11582, 11583, 11584, 11585, 11586, 11587, 11588, 11589, 11590, 11591 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 516. The probes having the nucleotide sequence represented by SEQ ID NOS: 11592, 11593, 11594, 11595, 11596, 11597, 11598, 11599, 11600, 11601, 11602 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 517. The probes having the nucleotide sequence represented by SEQ ID NOS: 11603, 11604, 11605, 11606, 11607, 11608, 11609, 11610, 11611, 11612, 11613 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 518. The probes having the nucleotide sequence represented by SEQ ID NOS: 11614, 11615, 11616, 11617, 11618, 11619, 11620, 11621, 11622, 11623, 11624 were selected from the 209 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 519. The probes having the nucleotide sequence represented by SEQ ID NOS: 11625, 11626, 11627, 11628, 11629, 11630, 5 11631, 11632, 11633, 11634, 11635 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 520. The probes having the nucleotide sequence represented by SEQ ID NOS: 11636, 11637, 11638, 11639, 11640, 11641, 10 11642, 11643, 11644, 11645, 11646 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 521. The probes having the nucleotide sequence represented by SEQ ID NOS: 11647, 11648, 11649, 11650, 11651, 11652, 15 11653, 11654, 11655, 11656, 11657 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 522. The probes having the nucleotide sequence represented by SEQ ID NOS: 11658, 11659, 11660, 11661, 11662, 11663, 20 11664, 11665, 11666, 11667, 11668 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 523. The probes having the nucleotide sequence represented by SEQ ID NOS: 11669, 11670, 11671, 11672, 11673, 11674, 25 11675, 11676, 11677, 11678, 11679 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 524. 210 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 11680, 11681, 11682, 11683, 11684, 11685, 11686, 11687, 11688, 11689, 11690 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 525. The probes having the nucleotide sequence represented by SEQ ID NOS: 11691, 11692, 11693, 11694, 11695, 11696, 11697, 11698, 11699, 11700, 11701 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 526. The probes having the nucleotide sequence represented by SEQ ID NOS: 11702, 11703, 11704, 11705, 11706, 11707, 11708, 11709, 11710, 11711, 11712 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 527. The probes having the nucleotide sequence represented by SEQ ID NOS: 11713, 11714, 11715, 11716, 11717, 11718, 11719, 11720, 11721, 11722, 11723 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 528. The probes having the nucleotide sequence represented by SEQ ID NOS: 11724, 11725, 11726, 11727, 11728, 11729, 11730, 11731, 11732, 11733, 11734 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 529. The probes having the nucleotide sequence represented by SEQ ID NOS: 11735, 11736, 11737, 11738, 11739, 11740, 11741, 11742, 11743, 11744, 11745 were selected from the 211 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 530. The probes having the nucleotide sequence represented by SEQ ID NOS: 11746, 11747, 11748, 11749, 11750, 11751, 5 11752, 11753, 11754, 11755, 11756 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 531. The probes having the nucleotide sequence represented by SEQ ID NOS: 11757, 11758, 11759, 11760, 11761, 11762, 10 11763, 11764, 11765, 11766, 11767 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 532. The probes having the nucleotide sequence represented by SEQ ID NOS: 11768, 11769, 11770, 11771, 11772, 11773, 15 11774, 11775, 11776, 11777, 11778 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 533. The probes having the nucleotide sequence represented by SEQ ID NOS: 11779, 11780, 11781, 11782, 11783, 11784, 20 11785, 11786, 11787, 11788, 11789 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 534. The probes having the nucleotide sequence represented by SEQ ID NOS: 11790, 11791, 11792, 11793, 11794, 11795, 25 11796, 11797, 11798, 11799, 11800 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 535. 212 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 11801, 11802, 11803, 11804, 11805, 11806, 11807, 11808, 11809, 11810, 11811 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 536. The probes having the nucleotide sequence represented by SEQ ID NOS: 11812, 11813, 11814, 11815, 11816, 11817, 11818, 11819, 11820, 11821, 11822 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 537. The probes having the nucleotide sequence represented by SEQ ID NOS: 11823, 11824, 11825, 11826, 11827, 11828, 11829, 11830, 11831, 11832, 11833 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 538. The probes having the nucleotide sequence represented by SEQ ID NOS: 11834, 11835, 11836, 11837, 11838, 11839, 11840, 11841, 11842, 11843, 11844 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 539. The probes having the nucleotide sequence represented by SEQ ID NOS: 11845, 11846, 11847, 11848, 11849, 11850, 11851, 11852, 11853, 11854, 11855 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 540. The probes having the nucleotide sequence represented by SEQ ID NOS: 11856, 11857, 11858, 11859, 11860, 11861, 11862, 11863, 11864, 11865, 11866 were selected from the 213 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 541. The probes having the nucleotide sequence represented by SEQ ID NOS: 11867, 11868, 11869, 11870, 11871, 11872, 5 11873, 11874, 11875, 11876, 11877 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 542. The probes having the nucleotide sequence represented by SEQ ID NOS: 11878, 11879, 11880, 11881, 11882, 11883, 10 11884, 11885, 11886, 11887, 11888 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 543. The probes having the nucleotide sequence represented by SEQ ID NOS: 11889, 11890, 11891, 11892, 11893, 11894, 15 11895, 11896, 11897, 11898, 11899 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 544. The probes having the nucleotide sequence represented by SEQ ID NOS: 11900, 11901, 11902, 11903, 11904, 11905, 20 11906, 11907, 11908, 11909, 11910 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 545. The probes having the nucleotide sequence represented by SEQ ID NOS: 11911, 11912, 11913, 11914, 11915, 11916, 25 11917, 11918, 11919, 11920, 11921 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 546. 214 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 11922, 11923, 11924, 11925, 11926, 11927, 11928, 11929, 11930, 11931, 11932 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 547. The probes having the nucleotide sequence represented by SEQ ID NOS: 11933, 11934, 11935, 11936, 11937, 11938, 11939, 11940, 11941, 11942, 11943 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 548. The probes having the nucleotide sequence represented by SEQ ID NOS: 11944, 11945, 11946, 11947, 11948, 11949, 11950, 11951, 11952, 11953, 11954 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 549. The probes having the nucleotide sequence represented by SEQ ID NOS: 11955, 11956, 11957, 11958, 11959, 11960, 11961, 11962, 11963, 11964, 11965 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 550. The probes having the nucleotide sequence represented by SEQ ID NOS: 11966, 11967, 11968, 11969, 11970, 11971, 11972, 11973, 11974, 11975, 11976 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 551. The probes having the nucleotide sequence represented by SEQ ID NOS: 11977, 11978, 11979, 11980, 11981, 11982, 11983, 11984, 11985, 11986, 11987 were selected from the 215 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 552. The probes having the nucleotide sequence represented by SEQ ID NOS: 11988, 11989, 11990, 11991, 11992, 11993, 5 11994, 11995, 11996, 11997, 11998 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 553. The probes having the nucleotide sequence represented by SEQ ID NOS: 11999, 12000, 12001, 12002, 12003, 12004, 10 12005, 12006, 12007, 12008, 12009 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 554. The probes having the nucleotide sequence represented by SEQ ID NOS: 12010, 12011, 12012, 12013, 12014, 12015, 15 12016, 12017, 12018, 12019, 12020 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 555. The probes having the nucleotide sequence represented by SEQ ID NOS: 12021, 12022, 12023, 12024, 12025, 12026, 20 12027, 12028, 12029, 12030, 12031 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 556. The probes having the nucleotide sequence represented by SEQ ID NOS: 12032, 12033, 12034, 12035, 12036, 12037, 25 12038, 12039, 12040, 12041, 12042 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 557. 216 WO 2006/024951 PCT/IB2005/002908 The probes having.the nucleotide sequence represented by SEQ ID NOS: 12043, 12044, 12045, 12046, 12047, 12048, 12049, 12050, 12051, 12052, 12053 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 558. The probes having the nucleotide sequence represented by SEQ ID NOS: 12054, 12055, 12056, 12057, 12058, 12059, 12060, 12061, 12062, 12063, 12064 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 559. The probes having the nucleotide sequence represented by SEQ ID NOS: 12065, 12066, 12067, 12068, 12069, 12070, 12071, 12072, 12073, 12074, 12075 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 560. The probes having the nucleotide sequence represented by SEQ ID NOS: 12076, 12077, 12078, 12079, 12080, 12081, 12082, 12083, 12084, 12085, 12086 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 561. The probes having the nucleotide sequence represented by SEQ ID NOS: 12087, 12088, 12089, 12090, 12091, 12092, 12093, 12094, 12095, 12096, 12097 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 562. The probes having the nucleotide sequence represented by SEQ ID NOS: 12098, 12099, 12100, 12101, 12102, 12103, 12104, 12105, 12106, 12107, 12108 were selected from the 217 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 563. The probes having the nucleotide sequence represented by SEQ ID NOS: 12109, 12110, 12111, 12112, 12113, 12114, 5 12115, 12116, 12117, 12118, 12119 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 564. The probes having the nucleotide sequence represented by SEQ ID NOS: 12120, 12121, 12122, 12123, 12124, 12125, 10 12126, 12127, 12128, 12129, 12130 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 565. The probes having the nucleotide sequence represented by SEQ ID NOS: 12131, 12132, 12133, 12134, 12135, 12136, 15 12137, 12138, 12139, 12140, 12141 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 566. The probes having the nucleotide sequence represented by SEQ ID NOS: 12142, 12143, 12144, 12145, 12146, 12147, 20 12148, 12149, 12150, 12151, 12152 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 567. The probes having the nucleotide sequence represented by SEQ ID NOS: 12153, 12154, 12155, 12156, 12157, 12158, 25 12159, 12160, 12161, 12162, 12163 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 568. 218 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 12164, 12165, 12166, 12167, 12168, 12169, 12170, 12171, 12172, 12173, 12174 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 569. The probes having the nucleotide sequence represented by SEQ ID NOS: 12175, 12176, 12177, 12178, 12179, 12180, 12181, 12182, 12183, 12184, 12185 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 570. The probes having the nucleotide sequence represented by SEQ ID NOS: 12186, 12187, 12188, 12189, 12190, 12191, 12192, 12193, 12194, 12195, 12196 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 571. The probes having the nucleotide sequence represented by SEQ ID NOS: 12197, 12198, 12199, 12200, 12201, 12202, 12203, 12204, 12205, 12206, 12207 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 572. The probes having the nucleotide sequence represented by SEQ ID NOS: 12208, 12209, 12210, 12211, 12212, 12213, 12214, 12215, 12216, 12217, 12218 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 573. The probes having the nucleotide sequence represented by SEQ ID NOS: 12219, 12220, 12221, 12222, 12223, 12224, 12225, 12226, 12227, 12228, 12229 were selected from the 219 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 574. The probes having the nucleotide sequence represented by SEQ ID NOS: 12230, 12231, 12232, 12233, 12234, 12235, 5 12236, 12237, 12238, 12239, 12240 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 575. The probes having the nucleotide sequence represented by SEQ ID NOS: 12241, 12242, 12243, 12244, 12245, 12246, 10 12247, 12248, 12249, 12250, 12251 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 576. The probes having the nucleotide sequence represented by SEQ ID NOS: 12252, 12253, 12254, 12255, 12256, 12257, 15 12258, 12259, 12260, 12261, 12262 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 577. The probes having the nucleotide sequence represented by SEQ ID NOS: 12263, 12264, 12265, 12266, 12267, 12268, 20 12269, 12270, 12271, 12272, 12273 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 578. The probes having the nucleotide sequence represented by SEQ ID NOS: 12274, 12275, 12276, 12277, 12278, 12279, 25 12280, 12281, 12282, 12283, 12284 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 579. 220 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 12285, 12286, 12287, 12288, 12289, 12290, 12291, 12292, 12293, 12294, 12295 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 580. The probes having the nucleotide sequence represented by SEQ ID NOS: 12296, 12297, 12298, 12299, 12300, 12301, 12302, 12303, 12304, 12305, 12306 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 581. The probes having the nucleotide sequence represented by SEQ ID NOS: 12307, 12308, 12309, 12310, 12311, 12312, 12313, 12314, 12315, 12316, 12317 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 582. The probes having the nucleotide sequence represented by SEQ ID NOS: 12318, 12319, 12320, 12321, 12322, 12323, 12324, 12325, 12326, 12327, 12328 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 583. The probes having the nucleotide sequence represented by SEQ ID NOS: 12329, 12330, 12331, 12332, 12333, 12334, 12335, 12336, 12337, 12338, 12339 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 584. The probes having the nucleotide sequence represented by SEQ ID NOS: 12340, 12341, 12342, 12343, 12344, 12345, 12346, 12347, 12348, 12349, 12350 were selected from the 221 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 585. The probes having the nucleotide sequence represented by SEQ ID NOS: 12351, 12352, 12353, 12354, 12355, 12356, 5 12357, 12358, 12359, 12360, 12361 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 586. The probes having the nucleotide sequence represented by SEQ ID NOS: 12362, 12363, 12364, 12365, 12366, 12367, 10 12368, 12369, 12370, 12371, 12372 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 587. The probes having the nucleotide sequence represented by SEQ ID NOS: 12373, 12374, 12375, 12376, 12377, 12378, 15 12379, 12380, 12381, 12382, 12383 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 588. The probes having the nucleotide sequence represented by SEQ ID NOS: 12384, 12385, 12386, 12387, 12388, 12389, 20 12390, 12391, 12392, 12393, 12394 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 589. The probes having the nucleotide sequence represented by SEQ ID NOS: 12395, 12396, 12397, 12398, 12399, 12400, 25 12401, 12402, 12403, 12404, 12405 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 590. 222 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 12406, 12407, 12408, 12409, 12410, 12411, 12412, 12413, 12414, 12415, 12416 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 591. The probes having the nucleotide sequence represented by SEQ ID NOS: 12417, 12418, 12419, 12420, 12421, 12422, 12423, 12424, 12425, 12426, 12427 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 592. The probes having the nucleotide sequence represented by SEQ ID NOS: 12428, 12429, 12430, 12431, 12432, 12433, 12434, 12435, 12436, 12437, 12438 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 593. The probes having the nucleotide sequence represented by SEQ ID NOS: 12439, 12440, 12441, 12442, 12443, 12444, 12445, 12446, 12447, 12448, 12449 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 594. The probes having the nucleotide sequence represented by SEQ ID NOS: 12450, 12451, 12452, 12453, 12454, 12455, 12456, 12457, 12458, 12459, 12460 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 595. The probes having the nucleotide sequence represented by SEQ ID NOS: 12461, 12462, 12463, 12464, 12465, 12466, 12467, 12468, 12469, 12470, 12471 were selected from the 223 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 596. The probes having the nucleotide sequence represented by SEQ ID NOS: 12472, 12473, 12474, 12475, 12476, 12477, 5 12478, 12479, 12480, 12481, 12482 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 597. The probes having the nucleotide sequence represented by SEQ ID NOS: 12483, 12484, 12485, 12486, 12487, 12488, 10 12489, 12490, 12491, 12492, 12493 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 598. The probes having the nucleotide sequence represented by SEQ ID NOS: 12494, 12495, 12496, 12497, 12498, 12499, 15 12500, 12501, 12502, 12503, 12504 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 599. The probes having the nucleotide sequence represented by SEQ ID NOS: 12505, 12506, 12507, 12508, 12509, 12510, 20 12511, 12512, 12513, 12514, 12515 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 600. The probes having the nucleotide sequence represented by SEQ ID NOS: 12516, 12517, 12518, 12519, 12520, 12521, 25 12522, 12523, 12524, 12525, 12526 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 601. 224 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 12527, 12528, 12529, 12530, 12531, 12532, 12533, 12534, 12535, 12536, 12537 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 602. The probes having the nucleotide sequence represented by SEQ ID NOS: 12538, 12539, 12540, 12541, 12542, 12543, 12544, 12545, 12546, 12547, 12548 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 603. The probes having the nucleotide sequence represented by SEQ ID NOS: 12549, 12550, 12551, 12552, 12553, 12554, 12555, 12556, 12557, 12558, 12559 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 604. The probes having the nucleotide sequence represented by SEQ ID NOS: 12560, 12561, 12562, 12563, 12564, 12565, 12566, 12567, 12568, 12569, 12570 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 605. The probes having the nucleotide sequence represented by SEQ ID NOS: 12571, 12572, 12573, 12574, 12575, 12576, 12577, 12578, 12579, 12580, 12581 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 606. The probes having the nucleotide sequence represented by SEQ ID NOS: 12582, 12583, 12584, 12585, 12586, 12587, 12588, 12589, 12590, 12591, 12592 were selected from the 225 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 607. The probes having the nucleotide sequence represented by SEQ ID NOS: 12593, 12594, 12595, 12596, 12597, 12598, 5 12599, 12600, 12601, 12602, 12603 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 608. The probes having the nucleotide sequence represented by SEQ ID NOS: 12604, 12605, 12606, 12607, 12608, 12609, 10 12610, 12611, 12612, 12613, 12614 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 609. The probes having the nucleotide sequence represented by SEQ ID NOS: 12615, 12616, 12617, 12618, 12619, 12620, 15 12621, 12622, 12623, 12624, 12625 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 610. The probes having the nucleotide sequence represented by SEQ ID NOS: 12626, 12627, 12628, 12629, 12630, 12631, 20 12632, 12633, 12634, 12635, 12636 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 611. The probes having the nucleotide sequence represented by SEQ ID NOS: 12637, 12638, 12639, 12640, 12641, 12642, 25 12643, 12644, 12645, 12646, 12647 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 612. 226 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 12648, 12649, 12650, 12651, 12652, 12653, 12654, 12655, 12656, 12657, 12658 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 613. The probes having the nucleotide sequence represented by SEQ ID NOS: 12659, 12660, 12661, 12662, 12663, 12664, 12665, 12666, 12667, 12668, 12669 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 614. The probes having the nucleotide sequence represented by SEQ ID NOS: 12670, 12671, 12672, 12673, 12674, 12675, 12676, 12677, 12678, 12679, 12680 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 615. The probes having the nucleotide sequence represented by SEQ ID NOS: 12681, 12682, 12683, 12684, 12685, 12686, 12687, 12688, 12689, 12690, 12691 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 616. The probes having the nucleotide sequence represented by SEQ ID NOS: 12692, 12693, 12694, 12695, 12696, 12697, 12698, 12699, 12700, 12701, 12702 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 617. The probes having the nucleotide sequence represented by SEQ ID NOS: 12703, 12704, 12705, 12706, 12707, 12708, 12709, 12710, 12711, 12712, 12713 were selected from the 227 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 618. The probes having the nucleotide sequence represented by SEQ ID NOS: 12714, 12715, 12716, 12717, 12718, 12719, 5 12720, 12721, 12722, 12723, 12724 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 619. The probes having the nucleotide sequence represented by SEQ ID NOS: 12725, 12726, 12727, 12728, 12729, 12730, 10 12731, 12732, 12733, 12734, 12735 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 620. The probes having the nucleotide sequence represented by SEQ ID NOS: 12736, 12737, 12738, 12739, 12740, 12741, 15 12742, 12743, 12744, 12745, 12746 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 621. The probes having the nucleotide sequence represented by SEQ ID NOS: 12747, 12748, 12749, 12750, 12751, 12752, 20 12753, 12754, 12755, 12756, 12757 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 622. The probes having the nucleotide sequence represented by SEQ ID NOS: 12758, 12759, 12760, 12761, 12762, 12763, 25 12764, 12765, 12766, 12767, 12768 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 623. 228 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 12769, 12770, 12771, 12772, 12773, 12774, 12775, 12776, 12777, 12778, 12779 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 624. The probes having the nucleotide sequence represented by SEQ ID NOS: 12780, 12781, 12782, 12783, 12784, 12785, 12786, 12787, 12788, 12789, 12790 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 625. The probes having the nucleotide sequence represented by SEQ ID NOS: 12791, 12792, 12793, 12794, 12795, 12796, 12797, 12798, 12799, 12800, 12801 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 626. The probes having the nucleotide sequence represented by SEQ ID NOS: 12802, 12803, 12804, 12805, 12806, 12807, 12808, 12809, 12810, 12811, 12812 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 627. The probes having the nucleotide sequence represented by SEQ ID NOS: 12813, 12814, 12815, 12816, 12817, 12818, 12819, 12820, 12821, 12822, 12823 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 628. The probes having the nucleotide sequence represented by SEQ ID NOS: 12824, 12825, 12826, 12827, 12828, 12829, 12830, 12831, 12832, 12833, 12834 were selected from the 229 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 629. The probes having the nucleotide sequence represented by SEQ ID NOS: 12835, 12836, 12837, 12838, 12839, 12840, 5 12841, 12842, 12843, 12844, 12845 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 630. The probes having the nucleotide sequence represented by SEQ ID NOS: 12846, 12847, 12848, 12849, 12850, 12851, 10 12852, 12853, 12854, 12855, 12856 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 631. The probes having the nucleotide sequence represented by SEQ ID NOS: 12857, 12858, 12859, 12860, 12861, 12862, 15 12863, 12864, 12865, 12866, 12867 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 632. The probes having the nucleotide sequence represented by SEQ ID NOS: 12868, 12869, 12870, 12871, 12872, 12873, 20 12874, 12875, 12876, 12877, 12878 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 633. The probes having the nucleotide sequence represented by SEQ ID NOS: 12879, 12880, 12881, 12882, 12883, 12884, 25 12885, 12886, 12887, 12888, 12889 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 634. 230 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 12890, 12891, 12892, 12893, 12894, 12895, 12896, 12897, 12898, 12899, 12900 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 635. The probes having the nucleotide sequence represented by SEQ ID NOS: 12901, 12902, 12903, 12904, 12905, 12906, 12907, 12908, 12909, 12910, 12911 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 636. The probes having the nucleotide sequence represented by SEQ ID NOS: 12912, 12913, 12914, 12915, 12916, 12917, 12918, 12919, 12920, 12921, 12922 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 637. The probes having the nucleotide sequence represented by SEQ ID NOS: 12923, 12924, 12925, 12926, 12927, 12928, 12929, 12930, 12931, 12932, 12933 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 638. The probes having the nucleotide sequence represented by SEQ ID NOS: 12934, 12935, 12936, 12937, 12938, 12939, 12940, 12941, 12942, 12943, 12944 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 639. The probes having the nucleotide sequence represented by SEQ ID NOS: 12945, 12946, 12947, 12948, 12949, 12950, 12951, 12952, 12953, 12954, 12955 were selected from the 231 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 640. The probes having the nucleotide sequence represented by SEQ ID NOS: 12956, 12957, 12958, 12959, 12960, 12961, 5 12962, 12963, 12964, 12965, 12966 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 641. The probes having the nucleotide sequence represented by SEQ ID NOS: 12967, 12968, 12969, 12970, 12971, 12972, 10 12973, 12974, 12975, 12976, 12977 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 642. The probes having the nucleotide sequence represented by SEQ ID NOS: 12978, 12979, 12980, 12981, 12982, 12983, 15 12984, 12985, 12986, 12987, 12988 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 643. The probes having the nucleotide sequence represented by SEQ ID NOS: 12989, 12990, 12991, 12992, 12993, 12994, 20 12995, 12996, 12997, 12998, 12999 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 644. The probes having the nucleotide sequence represented by SEQ ID NOS: 13000, 13001, 13002, 13003, 13004, 13005, 25 13006, 13007, 13008, 13009, 13010 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 645. 232 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 13011, 13012, 13013, 13014, 13015, 13016, 13017, 13018, 13019, 13020, 13021 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 646. The probes having the nucleotide sequence represented by SEQ ID NOS: 13022, 13023, 13024, 13025, 13026, 13027, 13028, 13029, 13030, 13031, 13032 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 647. The probes having the nucleotide sequence represented by SEQ ID NOS: 13033, 13034, 13035, 13036, 13037, 13038, 13039, 13040, 13041, 13042, 13043 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 648. The probes having the nucleotide sequence represented by SEQ ID NOS: 13044, 13045, 13046, 13047, 13048, 13049, 13050, 13051, 13052, 13053, 13054 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 649. The probes having the nucleotide sequence represented by SEQ ID NOS: 13055, 13056, 13057, 13058, 13059, 13060, 13061, 13062, 13063, 13064, 13065 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 650. The probes having the nucleotide sequence represented by SEQ ID NOS: 13066, 13067, 13068, 13069, 13070, 13071, 13072, 13073, 13074, 13075, 13076 were selected from the 233 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 651. The probes having the nucleotide sequence represented by SEQ ID NOS: 13077, 13078, 13079, 13080, 13081, 13082, 5 13083, 13084, 13085, 13086, 13087 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 652. The probes having the nucleotide sequence represented by SEQ ID NOS: 13088, 13089, 13090, 13091, 13092, 13093, 10 13094, 13095, 13096, 13097, 13098 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 653. The probes having the nucleotide sequence represented by SEQ ID NOS: 13099, 13100, 13101, 13102, 13103, 13104, 15 13105, 13106, 13107, 13108, 13109-were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 654. The probes having the nucleotide sequence represented by SEQ ID NOS: 13110, 13111, 13112, 13113, 13114, 13115, 20 13116, 13117, 13118, 13119, 13120 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 655. The probes having the nucleotide sequence represented by SEQ ID NOS: 13121, 13122, 13123, 13124, 13125, 13126, 25 13127, 13128, 13129, 13130, 13131 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 656. 234 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 13132, 13133, 13134, 13135, 13136, 13137, 13138, 13139, 13140, 13141, 13142 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 657. The probes having the nucleotide sequence represented by SEQ ID NOS: 13143, 13144, 13145, 13146, 13147, 13148, 13149, 13150, 13151, 13152, 13153 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 658. The probes having the nucleotide sequence represented by SEQ ID NOS: 13154, 13155, 13156, 13157, 13158, 13159, 13160, 13161, 13162, 13163, 13164 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 659. The probes having the nucleotide sequence represented by SEQ ID NOS: 13165, 13166, 13167, 13168, 13169, 13170, 13171, 13172, 13173, 13174, 13175 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 660. The probes having the nucleotide sequence represented by SEQ ID NOS: 13176, 13177, 13178, 13179, 13180, 13181, 13182, 13183, 13184, 13185, 13186 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 661.. The probes having the nucleotide sequence represented by SEQ ID NOS: 13187, 13188, 13189, 13190, 13191, 13192, 13193, 13194, 13195, 13196, 13197 were selected from the 235 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 662. The probes having the nucleotide sequence represented by SEQ ID NOS: 13198, 13199, 13200, 13201, 13202, 13203, 5 13204, 13205, 13206, 13207, 13208 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 663. The probes having the nucleotide sequence represented by SEQ ID NOS: 13209, 13210, 13211, 13212, 13213, 13214, 10 13215, 13216, 13217, 13218, 13219 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 664. The probes having the nucleotide sequence represented by SEQ ID NOS: 13220, 13221, 13222, 13223, 13224, 13225, 15 13226, 13227, 13228, 13229, 13230 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 665. The probes having the nucleotide sequence represented by SEQ ID NOS: 13231, 13232, 13233, 13234, 13235, 13236, 20 13237, 13238, 13239, 13240, 13241 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 666. The probes having the nucleotide sequence represented by SEQ ID NOS: 13242, 13243, 13244, 13245, 13246, 13247, 25 13248, 13249, 13250, 13251, 13252 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 667. 236 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 13253, 13254, 13255, 13256, 13257, 13258, 13259, 13260, 13261, 13262, 13263 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 668. The probes having the nucleotide sequence represented by SEQ ID NOS: 13264, 13265, 13266, 13267, 13268, 13269, 13270, 13271, 13272, 13273, 13274 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 669. The probes having the nucleotide sequence represented by SEQ ID NOS: 13275, 13276, 13277, 13278, 13279, 13280, 13281, 13282, 13283, 13284, 13285 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 670. The probes having the nucleotide sequence represented by SEQ ID NOS: 13286, 13287, 13288, 13289, 13290, 13291, 13292, 13293, 13294, 13295, 13296 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 671. The probes having the nucleotide sequence represented by SEQ ID NOS: 13297, 13298, 13299, 13300, 13301, 13302, 13303, 13304, 13305, 13306, 13307 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 672. The probes having the nucleotide sequence represented by SEQ ID NOS: 13308, 13309, 13310, 13311, 13312, 13313, 13314, 13315, 13316, 13317, 13318 were selected from the 237 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 673. The probes having the nucleotide sequence represented by SEQ ID NOS: 13319, 13320, 13321, 13322, 13323, 13324, 5 13325, 13326, 13327, 13328, 13329 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 674. The probes having the nucleotide sequence represented by SEQ ID NOS: 13330, 13331, 13332, 13333, 13334, 13335, 10 13336, 13337, 13338, 13339, 13340 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 675. The probes having the nucleotide sequence represented by SEQ ID NOS: 13341, 13342, 13343, 13344, 13345, 13346, 15 13347, 13348, 13349, 13350, 13351 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 676. The probes having the nucleotide sequence represented by SEQ ID NOS: 13352, 13353, 13354, 13355, 13356, 13357, 20 13358, 13359, 13360, 13361, 13362 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 677. The probes having the nucleotide sequence represented by SEQ ID NOS: 13363, 13364, 13365, 13366, 13367, 13368, 25 13369, 13370, 13371, 13372, 13373 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 678. 238 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 13374, 13375, 13376, 13377, 13378, 13379, 13380, 13381, 13382, 13383, 13384 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 679. The probes having the nucleotide sequence represented by SEQ ID NOS: 13385, 13386, 13387, 13388, 13389, 13390, 13391, 13392, 13393, 13394, 13395 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 680. The probes having the nucleotide sequence represented by SEQ ID NOS: 13396, 13397, 13398, 13399, 13400, 13401, 13402, 13403, 13404, 13405, 13406 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 681. The probes having the nucleotide sequence represented by SEQ ID NOS: 13407, 13408, 13409, 13410, 13411, 13412, 13413, 13414, 13415, 13416, 13417, 13418, 13419, 13420, 13421, 13422, 13423, 13424, 13425, 13426, 13427, 13428 were 20 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 682. The probes having the nucleotide sequence represented by SEQ ID NOS: 13429, 13430, 13431, 13432, 13433, 13434, 13435, 13436, 13437, 13438, 13439 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 683. The probes having the nucleotide sequence represented by SEQ ID NOS: 13440, 13441, 13442, 13443, 13444, 13445, 239 WO 2006/024951 PCT/IB2005/002908 13446, 13447, 13448, 13449, 13450 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 684. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 13451, 13452, 13453, 13454, 13455, 13456, 13457, 13458, 13459, 13460, 13461 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 685. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 13462, 13463, 13464, 13465, 13466, 13467, 13468, 13469, 13470, 13471, 13472 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 686. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 13473, 13474, 13475, 13476, 13477, 13478, 13479, 13480, 13481, 13482, 13483 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 687. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 13484, 13485, 13486, 13487, 13488, 13489, 13490, 13491, 13492, 13493, 13494 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 688. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 13495, 13496, 13497, 13498, 13499, 13500, 13501, 13502, 13503, 13504, 13505 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 689. 240 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 13506, 13507, 13508, 13509, 13510, 13511, 13512, 13513, 13514, 13515, 13516 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 690. The probes having the nucleotide sequence represented by SEQ ID NOS: 13517, 13518, 13519, 13520, 13521, 13522, 13523, 13524, 13525, 13526, 13527 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 691. The probes having the nucleotide sequence represented by SEQ ID NOS: 13528, 13529, 13530, 13531, 13532, 13533, 13534, 13535, 13536, 13537, 13538 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 692. The probes having the nucleotide sequence represented by SEQ ID NOS: 13539, 13540, 13541, 13542, 13543, 13544, 13545, 13546, 13547, 13548, 13549 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 693. The probes having the nucleotide sequence represented by SEQ ID NOS: 13550, 13551, 13552, 13553, 13554, 13555, 13556, 13557, 13558, 13559, 13560 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 694. The probes having the nucleotide sequence represented by SEQ ID NOS: 13561, 13562, 13563, 13564, 13565, 13566, 13567, 13568, 13569, 13570, 13571 were selected from the 241 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 695. The probes having the nucleotide sequence represented by SEQ ID NOS: 13572, 13573, 13574, 13575, 13576, 13577, 5 13578, 13579, 13580, 13581, 13582 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 696. The probes having the nucleotide sequence represented by SEQ ID NOS: 13583, 13584, 13585, 13586, 13587, 13588, 10 13589, 13590, 13591, 13592, 13593 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 697. The probes having the nucleotide sequence represented by SEQ ID NOS: 13594, 13595, 13596, 13597, 13598, 13599, 15 13600, 13601, 13602, 13603, 13604 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 698. The probes having the nucleotide sequence represented by SEQ ID NOS: 13605, 13606, 13607, 13608, 13609, 13610, 20 13611, 13612, 13613, 13614, 13615 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 699. The probes having the nucleotide sequence represented by SEQ ID NOS: 13616, 13617, 13618, 13619, 13620, 13621, 25 13622, 13623, 13624, 13625, 13626 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 700. 242 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 13627, 13628, 13629, 13630, 13631, 13632, 13633, 13634, 13635, 13636, 13637 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 701. The probes having the nucleotide sequence represented by SEQ ID NOS: 13638, 13639, 13640, 13641, 13642, 13643, 13644, 13645, 13646, 13647, 13648 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 702. The probes having the nucleotide sequence represented by SEQ ID NOS: 13649, 13650, 13651, 13652, 13653, 13654, 13655, 13656, 13657, 13658, 13659 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 703. The probes having the nucleotide sequence represented by SEQ ID NOS: 13660, 13661, 13662, 13663, 13664, 13665, 13666, 13667, 13668, 13669, 13670 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 704. The probes having the nucleotide sequence represented by SEQ ID NOS: 13671, 13672, 13673, 13674, 13675, 13676, 13677, 13678, 13679, 13680, 13681 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 705. The probes having the nucleotide sequence represented by SEQ ID NOS: 13682, 13683, 13684, 13685, 13686, 13687, 13688, 13689, 13690, 13691, 13692 were selected from the 243 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 706. The probes having the nucleotide sequence represented by SEQ ID NOS: 13693, 13694, 13695, 13696, 13697, 13698, 5 13699, 13700, 13701, 13702, 13703 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 707. The probes having the nucleotide sequence represented by SEQ ID NOS: 13704, 13705, 13706, 13707, 13708, 13709, 10 13710, 13711, 13712, 13713, 13714 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 708. The probes having the nucleotide sequence represented by SEQ ID NOS: 13715, 13716, 13717, 13718, 13719, 13720, 15 13721, 13722, 13723, 13724, 13725 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 709. The probes having the nucleotide sequence represented by SEQ ID NOS: 13726, 13727, 13728, 13729, 13730, 13731, 20 13732, 13733, 13734, 13735, 13736 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 710. The probes having the nucleotide sequence represented by SEQ ID NOS: 13737, 13738, 13739, 13740, 13741, 13742, 25 13743, 13744, 13745, 13746, 13747 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 711. 244 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 13748, 13749, 13750, 13751, 13752, 13753, 13754, 13755, 13756, 13757, 13758 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 712. The probes having the nucleotide sequence represented by SEQ ID NOS: 13759, 13760, 13761, 13762, 13763, 13764, 13765, 13766, 13767, 13768, 13769 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 713. The probes having the nucleotide sequence represented by SEQ ID NOS: 13770, 13771, 13772, 13773, 13774, 13775, 13776, 13777, 13778, 13779, 13780 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 714. The probes having the nucleotide sequence represented by SEQ ID NOS: 13781, 13782, 13783, 13784, 13785, 13786, 13787, 13788, 13789, 13790, 13791 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 715. The probes having the nucleotide sequence represented by SEQ ID NOS: 13792, 13793, 13794, 13795, 13796, 13797, 13798, 13799, 13800, 13801, 13802 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 716. The probes having the nucleotide sequence represented by SEQ ID NOS: 13803, 13804, 13805, 13806, 13807, 13808, 13809, 13810, 13811, 13812, 13813 were selected from the 245 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 717. The probes having the nucleotide sequence represented by SEQ ID NOS: 13814, 13815, 13816, 13817, 13818, 13819, 5 13820, 13821, 13822, 13823, 13824 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 718. The probes having the nucleotide sequence represented by SEQ ID NOS: 13825, 13826, 13827, 13828, 13829, 13830, 10 13831, 13832, 13833, 13834, 13835 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 719. The probes having the nucleotide sequence represented by SEQ ID NOS: 13836, 13837, 13838, 13839, 13840, 13841, 15 13842, 13843, 13844, 13845, 13846 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 720. The probes having the nucleotide sequence represented by SEQ ID NOS: 13847, 13848, 13849, 13850, 13851, 13852, 20 13853, 13854, 13855, 13856, 13857 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 721. The probes having the nucleotide sequence represented by SEQ ID NOS: 13858, 13859, 13860, 13861, 13862, 13863, 25 13864, 13865, 13866, 13867, 13868 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 722. 246 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 13869, 13870, 13871, 13872, 13873, 13874, 13875, 13876, 13877, 13878, 13879 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 723. The probes having the nucleotide sequence represented by SEQ ID NOS: 13880, 13881, 13882, 13883, 13884, 13885, 13886, 13887, 13888, 13889, 13890 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 724. The probes having the nucleotide sequence represented by SEQ ID NOS: 13891, 13892, 13893, 13894, 13895, 13896, 13897, 13898, 13899, 13900, 13901 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 725. The probes having the nucleotide sequence represented by SEQ ID NOS: 13902, 13903, 13904, 13905, 13906, 13907, 13908, 13909, 13910, 13911, 13912 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 726. The probes having the nucleotide sequence represented by SEQ ID NOS: 13913, 13914, 13915, 13916, 13917, 13918, 13919, 13920, 13921, 13922, 13923 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 727. The probes having the nucleotide sequence represented by SEQ ID NOS: 13924, 13925, 13926, 13927, 13928, 13929, 13930, 13931, 13932, 13933, 13934 were.selected from the 247 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 728. The probes having the nucleotide sequence represented by SEQ ID NOS: 13935, 13936, 13937, 13938, 13939, 13940, 5 13941, 13942, 13943, 13944, 13945 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 729. The probes having the nucleotide sequence represented by SEQ ID NOS: 13946, 13947, 13948, 13949, 13950, 13951, 10 13952, 13953, 13954, 13955, 13956 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 730. The probes having the nucleotide sequence represented by SEQ ID NOS: 13957, 13958, 13959, 13960, 13961, 13962, 15 13963, 13964, 13965, 13966, 13967 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 731. The probes having the nucleotide sequence represented by SEQ ID NOS: 13968, 13969, 13970, 13971, 13972, 13973, 20 13974, 13975, 13976, 13977, 13978 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 732. The probes having the nucleotide sequence represented by SEQ ID NOS: 13979, 13980, 13981, 13982, 13983, 13984, 25 13985, 13986, 13987, 13988, 13989 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 733. 248 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 13990, 13991, 13992, 13993, 13994, 13995, 13996, 13997, 13998, 13999, 14000 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 734. The probes having the nucleotide sequence represented by SEQ ID NOS: 14001, 14002, 14003, 14004, 14005, 14006, 14007, 14008, 14009, 14010, 14011 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 735. The probes having the nucleotide sequence represented by SEQ ID NOS: 14012, 14013, 14014, 14015, 14016, 14017, 14018, 14019, 14020, 14021, 14022 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 736. The probes having the nucleotide sequence represented by SEQ ID NOS: 14023, 14024, 14025, 14026, 14027, 14028, 14029, 14030, 14031, 14032, 14033 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 737. The probes having the nucleotide sequence represented by SEQ ID NOS: 14034, 14035, 14036, 14037, 14038, 14039, 14040, 14041, 14042, 14043, 14044, 14045, 14046, 14047, 14048, 14049, 14050, 14051, 14052, 14053, 14054, 14055 were 25 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 738. The probes having the nucleotide sequence represented by SEQ ID NOS: 14056, 14057, 14058, 14059, 14060, 14061, 249 WO 2006/024951 PCT/IB2005/002908 14062, 14063, 14064, 14065, 14066 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 739. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 14067, 14068, 14069, 14070, 14071, 14072, 14073, 14074, 14075, 14076, 14077 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 740. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 14078, 14079, 14080, 14081, 14082, 14083, 14084, 14085, 14086, 14087, 14088 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 741. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 14089, 14090, 14091, 14092, 14093, 14094, 14095, 14096, 14097, 14098, 14099 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 742. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 14100, 14101, 14102, 14103, 14104, 14105, 14106, 14107, 14108, 14109, 14110 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 743. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 14111, 14112, 14113, 14114, 14115, 14116, 14117, 14118, 14119, 14120, 14121 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 744. 250 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 14122, 14123, 14124, 14125, 14126, 14127, 14128, 14129, 14130, 14131, 14132 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 745. The probes having the nucleotide sequence represented by SEQ ID NOS: 14133, 14134, 14135, 14136, 14137, 14138, 14139, 14140, 14141, 14142, 14143 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 746. The probes having the nucleotide sequence represented by SEQ ID NOS: 14144, 14145, 14146, 14147, 14148, 14149, 14150, 14151, 14152, 14153, 14154 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 747. The probes having the nucleotide sequence represented by SEQ ID NOS: 14155, 14156, 14157, 14158, 14159, 14160, 14161, 14162, 14163, 14164, 14165 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 748. The probes having the nucleotide sequence represented by SEQ ID NOS: 14166, 14167, 14168, 14169, 14170, 14171, 14172, 14173, 14174, 14175, 14176 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 749. The probes having the nucleotide sequence represented by SEQ ID NOS: 14177, 14178, 14179, 14180, 14181, 14182, 14183, 14184, 14185, 14186, 14187 were selected from the 251 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 750. The probes having the nucleotide sequence represented by SEQ ID NOS: 14188, 14189, 14190, 14191, 14192, 14193, 5 14194, 14195, 14196, 14197, 14198 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 751. The probes having the nucleotide sequence represented by SEQ ID NOS: 14199, 14200, 14201, 14202, 14203, 14204, 10 14205, 14206, 14207, 14208, 14209 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 752. The probes having the nucleotide sequence represented by SEQ ID NOS: 14210, 14211, 14212, 14213, 14214, 14215, 15 14216, 14217, 14218, 14219, 14220 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 753. The probes having the nucleotide sequence represented by SEQ ID NOS: 14221, 14222, 14223, 14224, 14225, 14226, 20 14227, 14228, 14229, 14230, 14231 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 754. The probes having the .nucleotide sequence represented by SEQ ID NOS: 14232, 14233, 14234, 14235, 14236, 14237, 25 14238, 14239, 14240, 14241, 14242 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 755. 252 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 14243, 14244, 14245, 14246, 14247, 14248, 14249, 14250, 14251, 14252, 14253 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 756. The probes having the nucleotide sequence represented by SEQ ID NOS: 14254, 14255, 14256, 14257, 14258, 14259, 14260, 14261, 14262, 14263, 14264 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 757. The probes having the nucleotide sequence represented by SEQ ID NOS: 14265, 14266, 14267, 14268, 14269, 14270, 14271, 14272, 14273, 14274, 14275 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 758. The probes having the nucleotide sequence represented by SEQ ID NOS: 14276, 14277, 14278, 14279, 14280, 14281, 14282, 14283, 14284, 14285, 14286 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 759. The probes having the nucleotide sequence represented by SEQ ID NOS: 14287, 14288, 14289, 14290, 14291, 14292, 14293, 14294, 14295, 14296, 14297 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 760. The probes having the nucleotide sequence represented by SEQ ID NOS: 14298, 14299, 14300, 14301, 14302, 14303, 14304, 14305, 14306, 14307, 14308 were selected from the 253 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 761. The probes having the nucleotide sequence represented by SEQ ID NOS: 14309, 14310, 14311, 14312, 14313, 14314, 5 14315, 14316, 14317, 14318, 14319 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 762. The probes having the nucleotide sequence represented by SEQ ID NOS: 14320, 14321, 14322, 14323, 14324, 14325, 10 14326, 14327, 14328, 14329, 14330 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 763. The probes having the nucleotide sequence represented by SEQ ID NOS: 14331, 14332, 14333, 14334, 14335, 14336, 15 14337, 14338, 14339, 14340, 14341 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 764. The probes having the nucleotide sequence represented by SEQ ID NOS: 14342, 14343, 14344, 14345, 14346, 14347, 20 14348, 14349, 14350, 14351, 14352, 14353, 14354, 14355, 14356, 14357, 14358, 14359, 14360, 14361, 14362, 14363 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 765. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 14364, 14365, 14366, 14367, 14368, 14369, 14370, 14371, 14372, 14373, 14374 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 766. 254 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 14375, 14376, 14377, 14378, 14379, 14380, 14381, 14382, 14383, 14384, 14385 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 767. The probes having the nucleotide sequence represented by SEQ ID NOS: 14386, 14387, 14388, 14389, 14390, 14391, 14392, 14393, 14394, 14395, 14396 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 768. The probes having the nucleotide sequence represented by SEQ ID NOS: 14397, 14398, 14399, 14400, 14401, 14402, 14403, 14404, 14405, 14406, 14407 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 769. The probes having the nucleotide sequence represented by SEQ ID NOS: 14408, 14409, 14410, 14411, 14412, 14413, 14414, 14415, 14416, 14417, 14418 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 770. The probes having the nucleotide sequence represented by SEQ ID NOS: 14419, 14420, 14421, 14422, 14423, 14424, 14425, 14426, 14427, 14428, 14429 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 771. The probes having the nucleotide sequence represented by SEQ ID NOS: 14430, 14431, 14432, 14433, 14434, 14435, 14436, 14437, 14438, 14439, 14440 were selected from the 255 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 772. The probes having the nucleotide sequence represented by SEQ ID NOS: 14441, 14442, 14443, 14444, 14445, 14446, 5 14447, 14448, 14449, 14450, 14451 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 773. The probes having the nucleotide sequence represented by SEQ ID NOS: 14452, 14453, 14454, 14455, 14456, 14457, 10 14458, 14459, 14460, 14461, 14462 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 774. The probes having the nucleotide sequence represented by SEQ ID NOS: 14463, 14464, 14465, 14466, 14467, 14468, 15 14469, 14470, 14471, 14472, 14473 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 775. The probes having the nucleotide sequence represented by SEQ ID NOS: 14474, 14475, 14476, 14477, 14478, 14479, 20 14480, 14481, 14482, 14483, 14484 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 776. The probes having the nucleotide sequence represented by SEQ ID NOS: 14485, 14486, 14487, 14488, 14489, 14490, 25 14491, 14492, 14493, 14494, 14495 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 777. 256 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 14496, 14497, 14498, 14499, 14500, 14501, 14502, 14503, 14504, 14505, 14506 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 778. The probes having the nucleotide sequence represented by SEQ ID NOS: 14507, 14508, 14509, 14510, 14511, 14512, 14513, 14514, 14515, 14516, 14517 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 779. The probes having the nucleotide sequence represented by SEQ ID NOS: 14518, 14519, 14520, 14521, 14522, 14523, 14524, 14525, 14526, 14527, 14528 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 780. The probes having the nucleotide sequence represented by SEQ ID NOS: 14529, 14530, 14531, 14532, 14533, 14534, 14535, 14536, 14537, 14538, 14539 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 781. The probes having the nucleotide sequence represented by SEQ ID NOS: 14540, 14541, 14542, 14543, 14544, 14545, 14546, 14547, 14548, 14549, 14550 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 782. The probes having the nucleotide sequence represented by SEQ ID NOS: 14551, 14552, 14553, 14554, 14555, 14556, 14557, 14558, 14559, 14560, 14561 were selected from the 257 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 783. The probes having the nucleotide sequence represented by SEQ ID NOS: 14562, 14563, 14564, 14565, 14566, 14567, 5 14568, 14569, 14570, 14571, 14572 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 784. The probes having the nucleotide sequence represented by SEQ ID NOS: 14573, 14574, 14575, 14576, 14577, 14578, 10 14579, 14580, 14581, 14582, 14583 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 785. The probes having the nucleotide sequence represented by SEQ ID NOS: 14584, 14585, 14586, 14587, 14588, 14589, 15 14590, 14591, 14592, 14593, 14594 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 786. The probes having the nucleotide sequence represented by SEQ ID NOS: 14595, 14596, 14597, 14598, 14599, 14600, 20 14601, 14602, 14603, 14604, 14605 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 787. The probes having the nucleotide sequence represented by SEQ ID NOS: 14606, 14607, 14608, 14609, 14610, 14611, 25 14612, 14613, 14614, 14615, 14616 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 788. 258 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 14617, 14618, 14619, 14620, 14621, 14622, 14623, 14624, 14625, 14626, 14627 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 789. The probes having the nucleotide sequence represented by SEQ ID NOS: 14628, 14629, 14630, 14631, 14632, 14633, 14634, 14635, 14636, 14637, 14638 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 790. The probes having the nucleotide sequence represented by SEQ ID NOS: 14639, 14640, 14641, 14642, 14643, 14644, 14645, 14646, 14647, 14648, 14649 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 791. The probes having the nucleotide sequence represented by SEQ ID NOS: 14650, 14651, 14652, 14653, 14654, 14655, 14656, 14657, 14658, 14659, 14660 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 792. The probes having the nucleotide sequence represented by SEQ ID NOS: 14661, 14662, 14663, 14664, 14665, 14666, 14667, 14668, 14669, 14670, 14671 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 793. The probes having the nucleotide sequence represented by SEQ ID NOS: 14672, 14673, 14674, 14675, 14676, 14677, 14678, 14679, 14680, 14681, 14682 were selected from the 259 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 794. The probes having the nucleotide sequence represented by SEQ ID NOS: 14705, 14706, 14707, 14708, 14709, 14710, 5 14711, 14712, 14713, 14714, 14715 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 795. The probes having the nucleotide sequence represented by SEQ ID NOS: 14683, 14684, 14685, 14686, 14687, 14688, 10 14689, 14690, 14691, 14692, 14693 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 796. The probes having the nucleotide sequence represented by SEQ ID NOS: 14694, 14695, 14696, 14697, 14698, 14699, 15 14700, 14701, 14702, 14703, 14704 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 797. The probes having the nucleotide sequence represented by SEQ ID NOS: 14716, 14717, 14718, 14719, 14720, 14721, 20 14722, 14723, 14724, 14725, 14726 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 798. The probes having the nucleotide sequence represented by SEQ ID NOS: 14727, 14728, 14729, 14730, 14731, 14732, 25 14733, 14734, 14735, 14736, 14737 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 799. 260 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 14738, 14739, 14740, 14741, 14742, 14743, 14744, 14745, 14746, 14747, 14748 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 800. The probes having the nucleotide sequence represented by SEQ ID NOS: 14749, 14750, 14751, 14752, 14753, 14754, 14755, 14756, 14757, 14758, 14759 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 801. The probes having the nucleotide sequence represented by SEQ ID NOS: 14760, 14761, 14762, 14763, 14764, 14765, 14766, 14767, 14768, 14769, 14770 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 802. The probes having the nucleotide sequence represented by SEQ ID NOS: 14771, 14772, 14773, 14774, 14775, 14776, 14777, 14778, 14779, 14780, 14781 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 803. The probes having the nucleotide sequence represented by SEQ ID NOS: 14782, 14783, 14784, 14785, 14786, 14787, 14788, 14789, 14790, 14791, 14792 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 804. The probes having the nucleotide sequence represented by SEQ ID NOS: 14793, 14794, 14795, 14796, 14797, 14798, 14799, 14800, 14801, 14802, 14803 were selected from the 261 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 805. The probes having the nucleotide sequence represented by SEQ ID NOS: 14804, 14805, 14806, 14807, 14808, 14809, 5 14810, 14811, 14812, 14813, 14814 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 806. The probes having the nucleotide sequence represented by SEQ ID NOS: 14815, 14816, 14817, 14818, 14819, 14820, 10 14821, 14822, 14823, 14824, 14825 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 807. The probes having the nucleotide sequence represented by SEQ ID NOS: 14826, 14827, 14828, 14829, 14830, 14831, 15 14832, 14833, 14834, 14835, 14836 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 808. The probes having the nucleotide sequence represented by SEQ ID NOS: 14837, 14838, 14839, 14840, 14841, 14842, 20 14843, 14844, 14845, 14846, 14847 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 809. The probes having the nucleotide sequence represented by SEQ ID NOS: 14848, 14849, 14850, 14851, 14852, 14853, 25 14854, 14855, 14856, 14857, 14858 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 810. 262 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 14859, 14860, 14861, 14862, 14863, 14864, 14865, 14866, 14867, 14868, 14869 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 811. The probes having the nucleotide sequence represented by SEQ ID NOS: 14870, 14871, 14872, 14873, 14874, 14875, 14876, 14877, 14878, 14879, 14880 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 812. The probes having the nucleotide sequence represented by SEQ ID NOS: 14881, 14882, 14883, 14884, 14885, 14886, 14887, 14888, 14889, 14890, 14891 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 813. The probes having the nucleotide sequence represented by SEQ ID NOS: 14892, 14893, 14894, 14895, 14896, 14897, 14898, 14899, 14900, 14901, 14902 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 814. The probes having the nucleotide sequence represented by SEQ ID NOS: 14903, 14904, 14905, 14906, 14907, 14908, 14909, 14910, 14911, 14912, 14913 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 815. The probes having the nucleotide sequence represented by SEQ ID NOS: 14914, 14915, 14916, 14917, 14918, 14919, 14920, 14921, 14922, 14923, 14924 were selected from the 263 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 816. The probes having the nucleotide sequence represented by SEQ ID NOS: 14925, 14926, 14927, 14928, 14929, 14930, 5 14931, 14932, 14933, 14934, 14935 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 817. The probes having the nucleotide sequence represented by SEQ ID NOS: 14936, 14937, 14938, 14939, 14940, 14941, 10 14942, 14943, 14944, 14945, 14946 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 818. The probes having the nucleotide sequence represented by SEQ ID NOS: 14947, 14948, 14949, 14950, 14951, 14952, 15 14953, 14954, 14955, 14956, 14957 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 819. The probes having the nucleotide sequence represented by SEQ ID NOS: 14958, 14959, 14960, 14961, 14962, 14963, 20 14964, 14965, 14966, 14967, 14968 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 820. The probes having the nucleotide sequence represented by SEQ ID NOS: 14969, 14970, 14971, 14972, 14973, 14974, 25 14975, 14976, 14977, 14978, 14979 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 821. 264 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 14980, 14981, 14982, 14983, 14984, 14985, 14986, 14987, 14988, 14989, 14990 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 822. The probes having the nucleotide sequence represented by SEQ ID NOS: 14991, 14992, 14993, 14994, 14995, 14996, 14997, 14998, 14999, 15000, 15001 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 823. The probes having the nucleotide sequence represented by SEQ ID NOS: 15002, 15003, 15004, 15005, 15006, 15007, 15008, 15009, 15010, 15011, 15012 were selected from the ORFs having the nucleotide sequence represented by SEQ-ID 15 NO: 824. The probes having the nucleotide sequence represented by SEQ ID NOS: 15013, 15014, 15015, 15016, 15017, 15018, 15019, 15020, 15021, 15022, 15023 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 825. The probes having the nucleotide sequence represented by SEQ ID NOS: 15024, 15025, 15026, 15027, 15028, 15029, 15030, 15031, 15032, 15033, 15034 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 826. The probes having the nucleotide sequence represented by SEQ ID NOS: 15035, 15036, 15037, 15038, 15039, 15040, 15041, 15042, 15043, 15044, 15045 were selected from the 265 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 827. The probes having the nucleotide sequence represented by SEQ ID NOS: 15046, 15047, 15048, 15049, 15050, 15051, 5 15052, 15053, 15054, 15055, 15056 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 828. The probes having the nucleotide sequence represented by SEQ ID NOS: 15057, 15058, 15059, 15060, 15061, 15062, 10 15063, 15064, 15065, 15066, 15067 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 829. The probes having the nucleotide sequence represented by SEQ ID NOS: 15068, 15069, 15070, 15071, 15072, 15073, 15 15074, 15075, 15076, 15077, 15078 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 830. The probes having the nucleotide sequence represented by SEQ ID NOS: 15079, 15080, 15081, 15082, 15083, 15084, 20 15085, 15086, 15087, 15088, 15089 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 831. The probes having the nucleotide sequence represented by SEQ ID NOS: 15090, 15091, 15092, 15093, 15094, 15095, 25 15096, 15097, 15098, 15099, 15100 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 832. 266 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 15101, 15102, 15103, 15104, 15105, 15106, 15107, 15108, 15109, 15110, 15111 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 833. The probes having the nucleotide sequence represented by SEQ ID NOS: 15112, 15113, 15114, 15115, 15116, 15117, 15118, 15119, 15120, 15121, 15122 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 834. The probes having the nucleotide sequence represented by SEQ ID NOS: 15123, 15124, 15125, 15126, 15127, 15128, 15129, 15130, 15131, 15132, 15133 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 835. The probes having the nucleotide sequence represented by SEQ ID NOS: 15134, 15135, 15136, 15137, 15138, 15139, 15140, 15141, 15142, 15143, 15144 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 836. The probes having the nucleotide sequence represented by SEQ ID NOS: 15145, 15146, 15147, 15148, 15149, 15150, 15151, 15152, 15153, 15154, 15155 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 837. The probes having the nucleotide sequence represented by SEQ ID NOS: 15156, 15157, 15158, 15159, 15160, 15161, 15162, 15163, 15164, 15165, 15166 were selected from the 267 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 838. The probes having the nucleotide sequence represented by SEQ ID NOS: 15167, 15168, 15169, 15170, 15171, 15172, 5 15173, 15174, 15175, 15176, 15177 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 839. The probes having the nucleotide sequence represented by SEQ ID NOS: 15178, 15179, 15180, 15181, 15182, 15183, 10 15184, 15185, 15186, 15187, 15188 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 840. The probes having the nucleotide sequence represented by SEQ ID NOS: 15189, 15190, 15191, 15192, 15193, 15194, 15 15195, 15196, 15197, 15198, 15199 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 841. The probes having the nucleotide sequence represented by SEQ ID NOS: 15200, 15201, 15202, 15203, 15204, 15205, 20 15206, 15207, 15208, 15209, 15210 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 842. The probes having the nucleotide sequence represented by SEQ ID NOS: 15211, 15212, 15213, 15214, 15215, 15216, 25 15217, 15218, 15219, 15220, 15221 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 843. 268 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 15222, 15223, 15224, 15225, 15226, 15227, 15228, 15229, 15230, 15231, 15232 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 844. The probes having the nucleotide sequence represented by SEQ ID NOS: 15233, 15234, 15235, 15236, 15237, 15238, 15239, 15240, 15241, 15242, 15243 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 845. The probes having the nucleotide sequence represented by SEQ ID NOS: 15244, 15245, 15246, 15247, 15248, 15249, 15250, 15251, 15252, 15253, 15254 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 846. The probes having the nucleotide sequence represented by SEQ ID NOS: 15255, 15256, 15257, 15258, 15259, 15260, 15261, 15262, 15263, 15264, 15265 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 847. The probes having the nucleotide sequence represented by SEQ ID NOS: 15266, 15267, 15268, 15269, 15270, 15271, 15272, 15273, 15274, 15275, 15276 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 848. The probes having the nucleotide sequence represented by SEQ ID NOS: 15277, 15278, 15279, 15280, 15281, 15282, 15283, 15284, 15285, 15286, 15287 were selected from the 269 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 849. The probes having the nucleotide sequence represented by SEQ ID NOS: 15288, 15289, 15290, 15291, 15292, 15293, 5 15294, 15295, 15296, 15297, 15298 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 850. The probes having the nucleotide sequence represented by SEQ ID NOS: 15299, 15300, 15301, 15302, 15303, 15304, 10 15305, 15306, 15307, 15308, 15309 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 851. The probes having the nucleotide sequence represented by SEQ ID NOS: 15310, 15311, 15312, 15313, 15314, 15315, 15 15316, 15317, 15318, 15319, 15320 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 852. The probes having the nucleotide sequence represented by SEQ ID NOS: 15321, 15322, 15323, 15324, 15325, 15326, 20 15327, 15328, 15329, 15330, 15331 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 853. The probes having the nucleotide sequence represented by SEQ ID NOS: 15332, 15333, 15334, 15335, 15336, 15337, 25 15338, 15339, 15340, 15341, 15342 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 854. 270 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 15343, 15344, 15345, 15346, 15347, 15348, 15349, 15350, 15351, 15352, 15353 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 855. The probes having the nucleotide sequence represented by SEQ ID NOS: 15354, 15355, 15356, 15357, 15358, 15359, 15360, 15361, 15362, 15363, 15364 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 856. The probes having the nucleotide sequence represented by SEQ ID NOS: 15365, 15366, 15367, 15368, 15369, 15370, 15371, 15372, 15373, 15374, 15375 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 857. The probes having the nucleotide sequence represented by SEQ ID NOS: 15376, 15377, 15378, 15379, 15380, 15381, 15382, 15383, 15384, 15385, 15386 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 858. The probes having the nucleotide sequence represented by SEQ ID NOS: 15387, 15388, 15389, 15390, 15391, 15392, 15393, 15394, 15395, 15396, 15397 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 859. The probes having the nucleotide sequence represented by SEQ ID NOS: 15398, 15399, 15400, 15401, 15402, 15403, 15404, 15405, 15406, 15407, 15408 were selected from the 271 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 860. The probes having the nucleotide sequence represented by SEQ ID NOS: 15409, 15410, 15411, 15412, 15413, 15414, 5 15415, 15416, 15417, 15418, 15419 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 861. The probes having the nucleotide sequence represented by SEQ ID NOS: 15420, 15421, 15422, 15423, 15424, 15425, 10 15426, 15427, 15428, 15429, 15430 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 862. The probes having the nucleotide sequence represented by SEQ ID NOS: 15431, 15432, 15433, 15434, 15435, 15436, 15 15437, 15438, 15439, 15440, 15441 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 863. The probes having the nucleotide sequence represented by SEQ ID NOS: 15442, 15443, 15444, 15445, 15446, 15447, 20 15448, 15449, 15450, 15451, 15452 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 864. The probes having the nucleotide sequence represented by SEQ ID NOS: 15453, 15454, 15455, 15456, 15457, 15458, 25 15459, 15460, 15461, 15462, 15463 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 865. 272 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 15464, 15465, 15466, 15467, 15468, 15469, 15470, 15471, 15472, 15473, 15474 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 866. The probes having the nucleotide sequence represented by SEQ ID NOS: 15475, 15476, 15477, 15478, 15479, 15480, 15481, 15482, 15483, 15484, 15485 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 867. The probes having the nucleotide sequence represented by SEQ ID NOS: 15486, 15487, 15488, 15489, 15490, 15491, 15492, 15493, 15494, 15495, 15496 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 868. The probes having the nucleotide sequence represented by SEQ ID NOS: 15497, 15498, 15499, 15500, 15501, 15502, 15503, 15504, 15505, 15506, 15507 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 869. The probes having the nucleotide sequence represented by SEQ ID NOS: 15508, 15509, 15510, 15511, 15512, 15513, 15514, 15515, 15516, 15517, 15518 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 870. The probes having the nucleotide sequence represented by SEQ ID NOS: 15519, 15520, 15521, 15522, 15523, 15524, 15525, 15526, 15527, 15528, 15529 were selected from the 273 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 871. The probes having the nucleotide sequence represented by SEQ ID NOS: 15530, 15531, 15532, 15533, 15534, 15535, 5 15536, 15537, 15538, 15539, 15540 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 872. The probes having the nucleotide sequence represented by SEQ ID NOS: 15541, 15542, 15543, 15544, 15545, 15546, 10 15547, 15548, 15549, 15550, 15551 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 873. The probes having the nucleotide sequence represented by SEQ ID NOS: 15552, 15553, 15554, 15555, 15556, 15557, 15 15558, 15559, 15560, 15561, 15562 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 874. The probes having the nucleotide sequence represented by SEQ ID NOS: 15563, 15564, 15565, 15566, 15567, 15568, 20 15569, 15570, 15571, 15572, 15573 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 875. The probes having the nucleotide sequence represented by SEQ ID NOS: 15574, 15575, 15576, 15577, 15578, 15579, 25 15580, 15581, 15582, 15583, 15584 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 876. 274 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 15585, 15586, 15587, 15588, 15589, 15590, 15591, 15592, 15593, 15594, 15595 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 877. The probes having the nucleotide sequence represented by SEQ ID NOS: 15596, 15597, 15598, 15599, 15600, 15601, 15602, 15603, 15604, 15605, 15606 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 878. The probes having the nucleotide sequence represented by SEQ ID NOS: 15607, 15608, 15609, 15610, 15611, 15612, 15613, 15614, 15615, 15616, 15617 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 879. The probes having the nucleotide sequence represented by SEQ ID NOS: 15618, 15619, 15620, 15621, 15622, 15623, 15624, 15625, 15626, 15627, 15628 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 880. The probes having the nucleotide sequence represented by SEQ ID NOS: 15629, 15630, 15631, 15632, 15633, 15634, 15635, 15636, 15637, 15638, 15639 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 881. The probes having the nucleotide sequence represented by SEQ ID NOS: 15640, 15641, 15642, 15643, 15644, 15645, 15646, 15647, 15648, 15649, 15650 were selected from the 275 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 882. The probes having the nucleotide sequence represented by SEQ ID NOS: 15651, 15652, 15653, 15654, 15655, 15656, 5 15657, 15658, 15659, 15660, 15661 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 883. The probes having the nucleotide sequence represented by SEQ ID NOS: 15662, 15663, 15664, 15665, 15666, 15667, 10 15668, 15669, 15670, 15671, 15672 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 884. The probes having the nucleotide sequence represented by SEQ ID NOS: 15673, 15674, 15675, 15676, 15677, 15678, 15 15679, 15680, 15681, 15682, 15683 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 885. The probes having the nucleotide sequence represented by SEQ ID NOS: 15684, 15685, 15686, 15687, 15688, 15689, 20 15690, 15691, 15692, 15693, 15694 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 886. The probes having the nucleotide sequence represented by SEQ ID NOS: 15695, 15696, 15697, 15698, 15699, 15700, 25 15701, 15702, 15703, 15704, 15705 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 887. 276 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 15706, 15707, 15708, 15709, 15710, 15711, 15712, 15713, 15714, 15715, 15716 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 888. The probes having the nucleotide sequence represented by SEQ ID NOS: 15717, 15718, 15719, 15720, 15721, 15722, 15723, 15724, 15725, 15726, 15727 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 889. The probes having the nucleotide sequence represented by SEQ ID NOS: 15728, 15729, 15730, 15731, 15732, 15733, 15734, 15735, 15736, 15737, 15738 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 890. The probes having the nucleotide sequence represented by SEQ ID NOS: 15739, 15740, 15741, 15742, 15743, 15744, 15745, 15746, 15747, 15748, 15749 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 891. The probes having the nucleotide sequence represented by SEQ ID NOS: 15750, 15751, 15752, 15753, 15754, 15755, 15756, 15757, 15758, 15759, 15760 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 892. The probes having the nucleotide sequence represented by SEQ ID NOS: 15761, 15762, 15763, 15764, 15765, 15766, 15767, 15768, 15769, 15770, 15771 were selected from the 277 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 893. The probes having the nucleotide sequence represented by SEQ ID NOS: 15772, 15773, 15774, 15775, 15776, 15777, 5 15778, 15779, 15780, 15781, 15782 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 894. The probes having the nucleotide sequence represented by SEQ ID NOS: 15783, 15784, 15785, 15786, 15787, 15788, 10 15789, 15790, 15791, 15792, 15793 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 895. The probes having the nucleotide sequence represented by SEQ ID NOS: 15794, 15795, 15796, 15797, 15798, 15799, 15 15800, 15801, 15802, 15803, 15804 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 896. The probes having the nucleotide sequence represented by SEQ ID NOS: 15805, 15806, 15807, 15808, 15809, 15810, 20 15811, 15812, 15813, 15814, 15815 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 897. The probes having the nucleotide sequence represented by SEQ ID NOS: 15816, 15817, 15818, 15819, 15820, 15821, 25 15822, 15823, 15824, 15825, 15826 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 898. 278 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 15827, 15828, 15829, 15830, 15831, 15832, 15833, 15834, 15835, 15836, 15837 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 899. The probes having the nucleotide sequence represented by SEQ ID NOS: 15838, 15839, 15840, 15841, 15842, 15843, 15844, 15845, 15846, 15847, 15848 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 900. The probes having the nucleotide sequence represented by SEQ ID NOS: 15849, 15850, 15851, 15852, 15853, 15854, 15855, 15856, 15857, 15858, 15859 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 901. The probes having the nucleotide sequence represented by SEQ ID NOS: 15860, 15861, 15862, 15863, 15864, 15865, 15866, 15867, 15868, 15869, 15870 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 902. The probes having the nucleotide sequence represented by SEQ ID NOS: 15871, 15872, 15873, 15874, 15875, 15876, 15877, 15878, 15879, 15880, 15881 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 903. The probes having the nucleotide sequence represented by SEQ ID NOS: 15882, 15883, 15884, 15885, 15886, 15887, 15888, 15889, 15890, 15891, 15892 were selected from the 279 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 904. The probes having the nucleotide sequence represented by SEQ ID NOS: 15893, 15894, 15895, 15896, 15897, 15898, 5 15899, 15900, 15901, 15902, 15903 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 905. The probes having the nucleotide sequence represented by SEQ ID NOS: 15904, 15905, 15906, 15907, 15908, 15909, 10 15910, 15911, 15912, 15913, 15914 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 906. The probes having the nucleotide sequence represented by SEQ ID NOS: 15915, 15916, 15917, 15918, 15919, 15920, 15 15921, 15922, 15923, 15924, 15925 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 907. The probes having the nucleotide sequence represented by SEQ ID NOS: 15926, 15927, 15928, 15929, 15930, 15931, 20 15932, 15933, 15934, 15935, 15936 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 908. The probes having the nucleotide sequence represented by SEQ ID NOS: 15937, 15938, 15939, 15940, 15941, 15942, 25 15943, 15944, 15945, 15946, 15947 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 909. 280 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 15948, 15949, 15950, 15951, 15952, 15953, 15954, 15955, 15956, 15957, 15958 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 910. The probes having the nucleotide sequence represented by SEQ ID NOS: 15959, 15960, 15961, 15962, 15963, 15964, 15965, 15966, 15967, 15968, 15969 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 911. The probes having the nucleotide sequence represented by SEQ ID NOS: 15970, 15971, 15972, 15973, 15974, 15975, 15976, 15977, 15978, 15979, 15980 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 912. The probes having the nucleotide sequence represented by SEQ ID NOS: 15981, 15982, 15983, 15984, 15985, 15986, 15987, 15988, 15989, 15990, 15991 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 913. The probes having the nucleotide sequence represented by SEQ ID NOS: 15992, 15993, 15994, 15995, 15996, 15997, 15998, 15999, 16000, 16001, 16002 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 914. The probes having the nucleotide sequence represented by SEQ ID NOS: 16003, 16004, 16005, 16006, 16007, 16008, 16009, 16010, 16011, 16012, 16013 were selected from the 281 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 915. The probes having the nucleotide sequence represented by SEQ ID NOS: 16014, 16015, 16016, 16017, 16018, 16019, 5 16020, 16021, 16022, 16023, 16024 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 916. The probes having the nucleotide sequence represented by SEQ ID NOS: 16025, 16026, 16027, 16028, 16029, 16030, 10 16031, 16032, 16033, 16034, 16035 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 917. The probes having the nucleotide sequence represented by SEQ ID NOS: 16036, 16037, 16038, 16039, 16040, 16041, 15 16042, 16043, 16044, 16045, 16046 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 918. The probes having the nucleotide sequence represented by SEQ ID NOS: 16047, 16048, 16049, 16050, 16051, 16052, 20 16053, 16054, 16055, 16056, 16057 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 919. The probes having the nucleotide sequence represented by SEQ ID NOS: 16058, 16059, 16060, 16061, 16062, 16063, 25 16064, 16065, 16066, 16067, 16068 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 920. 282 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 16069, 16070, 16071, 16072, 16073, 16074, 16075, 16076, 16077, 16078, 16079 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 921. The probes having the nucleotide sequence represented by SEQ ID NOS: 16080, 16081, 16082, 16083, 16084, 16085, 16086, 16087, 16088, 16089, 16090 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 922. The probes having the nucleotide sequence represented by SEQ ID NOS: 16091, 16092, 16093, 16094, 16095, 16096, 16097, 16098, 16099, 16100, 16101 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 923. The probes having the nucleotide sequence represented by SEQ ID NOS: 16102, 16103, 16104, 16105, 16106, 16107, 16108, 16109, 16110, 16111, 16112 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 924. The probes having the nucleotide sequence represented by SEQ ID NOS: 16113, 16114, 16115, 16116, 16117, 16118, 16119, 16120, 16121, 16122, 16123 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 925. The probes having the nucleotide sequence represented by SEQ ID NOS: 16124, 16125, 16126, 16127, 16128, 16129, 16130, 16131, 16132, 16133, 16134 were selected from the 283 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 926. The probes having the nucleotide sequence represented by SEQ ID NOS: 16135, 16136, 16137, 16138, 16139, 16140, 5 16141, 16142, 16143, 16144, 16145 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 927. The probes having the nucleotide sequence represented by SEQ ID NOS: 16146, 16147, 16148, 16149, 16150, 16151, 10 16152, 16153, 16154, 16155, 16156 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 928. The probes having the nucleotide sequence represented by SEQ ID NOS: 16157, 16158, 16159, 16160, 16161, 16162, 15 16163, 16164, 16165, 16166, 16167 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 929. The probes having the nucleotide sequence represented by SEQ ID NOS: 16168, 16169, 16170, 16171, 16172, 16173, 20 16174, 16175, 16176, 16177, 16178 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 930. The probes having the nucleotide sequence represented by SEQ ID NOS: 16179, 16180, 16181, 16182, 16183, 16184, 25 16185, 16186, 16187, 16188, 16189 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 931. 284 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 16190, 16191, 16192, 16193, 16194, 16195, 16196, 16197, 16198, 16199, 16200 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 932. The probes having the nucleotide sequence represented by SEQ ID NOS: 16201, 16202, 16203, 16204, 16205, 16206, 16207, 16208, 16209, 16210, 16211 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 933. The probes having the nucleotide sequence represented by SEQ ID NOS: 16212, 16213, 16214, 16215, 16216, 16217, 16218, 16219, 16220, 16221, 16222 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 934. The probes having the nucleotide sequence represented by SEQ ID NOS: 16223, 16224, 16225, 16226, 16227, 16228, 16229, 16230, 16231, 16232, 16233 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 935. The probes having the nucleotide sequence represented by SEQ ID NOS: 16234, 16235, 16236, 16237, 16238, 16239, 16240, 16241, 16242, 16243, 16244 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 936. The probes having the nucleotide sequence represented by SEQ ID NOS: 16245, 16246, 16247, 16248, 16249, 16250, 16251, 16252, 16253, 16254, 16255 were selected from the 285 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 937. The probes having the nucleotide sequence represented by SEQ ID NOS: 16256, 16257, 16258, 16259, 16260, 16261, 5 16262, 16263, 16264, 16265, 16266 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 938. The probes having the nucleotide sequence represented by SEQ ID NOS: 16267, 16268, 16269, 16270, 16271, 16272, 10 16273, 16274, 16275, 16276, 16277 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 939. The probes having the nucleotide sequence represented by SEQ ID NOS: 16278, 16279, 16280, 16281, 16282, 16283, 15 16284, 16285, 16286, 16287, 16288 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 940. The probes having the nucleotide sequence represented by SEQ ID NOS: 16289, 16290, 16291, 16292, 16293, 16294, 20 16295, 16296, 16297, 16298, 16299 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 941. The probes having the nucleotide sequence represented by SEQ ID NOS: 16300, 16301, 16302, 16303, 16304, 16305, 25 16306, 16307, 16308, 16309, 16310 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 942. 286 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 16311, 16312, 16313, 16314, 16315, 16316, 16317, 16318, 16319, 16320, 16321 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 943. The probes having the nucleotide sequence represented by SEQ ID NOS: 16322, 16323, 16324, 16325, 16326, 16327, 16328, 16329, 16330, 16331, 16332 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 944. The probes having the nucleotide sequence represented by SEQ ID NOS: 16333, 16334, 16335, 16336, 16337, 16338, 16339, 16340, 16341, 16342, 16343 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 945. The probes having the nucleotide sequence represented by SEQ ID NOS: 16344, 16345, 16346, 16347, 16348, 16349, 16350, 16351, 16352, 16353, 16354 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 946. The probes having the nucleotide sequence represented by SEQ ID NOS: 16355, 16356, 16357, 16358, 16359, 16360, 16361, 16362, 16363, 16364, 16365 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 947. The probes having the nucleotide sequence represented by SEQ ID NOS: 16366, 16367, 16368, 16369, 16370, 16371, 16372, 16373, 16374, 16375, 16376 were selected from the 287 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 948. The probes having the nucleotide sequence represented by SEQ ID NOS: 16377, 16378, 16379, 16380, 16381, 16382, 5 16383, 16384, 16385, 16386, 16387 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 949. The probes having the nucleotide sequence represented by SEQ ID NOS: 16388, 16389, 16390, 16391, 16392, 16393, 10 16394, 16395, 16396, 16397, 16398 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 950. The probes having the nucleotide sequence represented by SEQ ID NOS: 16399, 16400, 16401, 16402, 16403, 16404, 15 16405, 16406, 16407, 16408, 16409 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 951. The probes having the nucleotide sequence represented by SEQ ID NOS: 16410, 16411, 16412, 16413, 16414, 16415, 20 16416, 16417, 16418, 16419, 16420 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 952. The probes having the nucleotide sequence represented by SEQ ID NOS: 16421, 16422, 16423, 16424, 16425, 16426, 25 16427, 16428, 16429, 16430, 16431 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 953. 288 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 16432, 16433, 16434, 16435, 16436, 16437, 16438, 16439,- 16440, 16441, 16442 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 954. The probes having the nucleotide sequence represented by SEQ ID NOS: 16443, 16444, 16445, 16446, 16447, 16448, 16449, 16450, 16451, 16452, 16453 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 955. The probes having the nucleotide sequence represented by SEQ ID NOS: 16454, 16455, 16456, 16457, 16458, 16459, 16460, 16461, 16462, 16463, 16464 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 956. The probes having the nucleotide sequence represented by SEQ ID NOS: 16465, 16466, 16467, 16468, 16469, 16470, 16471, 16472, 16473, 16474 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 20 957. The probes having the nucleotide sequence represented by SEQ ID NOS: 16475, 16476, 16477, 16478, 16479, 16480, 16481, 16482, 16483, 16484, 16485 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 958. The probes having the nucleotide sequence represented by SEQ ID NOS: 16486, 16487, 16488, 16489, 16490, 16491, 16492, 16493, 16494, 16495, 16496 were selected from the 289 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 959. The probes having the nucleotide sequence represented by SEQ ID NOS: 16497, 16498, 16499, 16500, 16501, 16502, 5 16503, 16504, 16505, 16506, 16507 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 960. The probes having the nucleotide sequence represented by SEQ ID NOS: 16508, 16509, 16510, 16511, 16512, 16513, 10 16514, 16515, 16516, 16517, 16518 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 961. The probes having the nucleotide sequence represented by SEQ ID NOS: 16519, 16520, 16521, 16522, 16523, 16524, 15 16525, 16526, 16527, 16528, 16529 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 962. The probes having the nucleotide sequence represented by SEQ ID NOS: 16530, 16531, 16532, 16533, 16534, 16535, 20 16536, 16537, 16538, 16539, 16540 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 963. The probes having the nucleotide sequence represented by SEQ ID NOS: 16541, 16542, 16543, 16544, 16545, 16546, 25 16547, 16548, 16549, 16550, 16551 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 964. 290 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 16552, 16553, 16554, 16555, 16556, 16557, 16558, 16559, 16560, 16561, 16562 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 965. The probes having the nucleotide sequence represented by SEQ ID NOS: 16563, 16564, 16565, 16566, 16567, 16568, 16569, 16570, 16571, 16572, 16573 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 966. The probes having the nucleotide sequence represented by SEQ ID NOS: 16574, 16575, 16576, 16577, 16578, 16579, 16580, 16581, 16582, 16583, 16584 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 967. The probes having the nucleotide sequence represented by SEQ ID NOS: 16585, 16586, 16587, 16588, 16589, 16590, 16591, 16592, 16593, 16594, 16595 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 968. The probes having the nucleotide sequence represented by SEQ ID NOS: 16596, 16597, 16598, 16599, 16600, 16601, 16602, 16603, 16604, 16605, 16606 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 969. The probes having the nucleotide sequence represented by SEQ ID NOS: 16607, 16608, 16609, 16610, 16611, 16612, 16613, 16614, 16615, 16616, 16617 were selected from the 291 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 970. The probes having the nucleotide sequence represented by SEQ ID NOS: 16618, 16619, 16620, 16621, 16622, 16623, 5 16624, 16625, 16626, 16627, 16628 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 971. The probes having the nucleotide sequence represented by SEQ ID NOS: 16629, 16630, 16631, 16632, 16633, 16634, 10 16635, 16636, 16637, 16638, 16639 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 972. The probes having the nucleotide sequence represented by SEQ ID NOS: 16640, 16641, 16642, 16643, 16644, 16645, 15 16646, 16647, 16648, 16649, 16650 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 973. The probes having the nucleotide sequence represented by SEQ ID NOS: 16651, 16652, 16653, 16654, 16655,' 16656, 20 16657, 16658, 16659, 16660, 16661 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 974. The probes having the nucleotide sequence represented by SEQ ID NOS: 16662, 16663, 16664, 16665, 16666, 16667, 25 16668, 16669, 16670, 16671, 16672 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 975. 292 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 16673, 16674, 16675, 16676, 16677, 16678, 16679, 16680, 16681, 16682, 16683 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 976. The probes having the nucleotide sequence represented by SEQ ID NOS: 16684, 16685, 16686, 16687, 16688, 16689, 16690, 16691, 16692, 16693, 16694 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 977. The probes having the nucleotide sequence represented by SEQ ID NOS: 16695, 16696, 16697, 16698, 16699, 16700, 16701, 16702, 16703, 16704, 16705 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 978. The probes having the nucleotide sequence represented by SEQ ID NOS: 16706, 16707, 16708, 16709, 16710, 16711, 16712, 16713, 16714, 16715, 16716 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 979. The probes having the nucleotide sequence represented by SEQ ID NOS: 16717, 16718, 16719, 16720, 16721, 16722, 16723, 16724, 16725, 16726, 16727 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 980. The probes having the nucleotide sequence represented by SEQ ID NOS: 16728, 16729, 16730, 16731, 16732, 16733, 16734, 16735, 16736, 16737, 16738 were selected from the 293 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 981. The probes having the nucleotide sequence represented by SEQ ID NOS: 16739, 16740, 16741, 16742, 16743, 16744, 5 16745, 16746, 16747, 16748, 16749 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 982. The probes having the nucleotide sequence represented by SEQ ID NOS: 16750, 16751, 16752, 16753, 16754, 16755, 10 16756, 16757, 16758, 16759, 16760 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 983. The probes having the nucleotide sequence represented by SEQ ID NOS: 16761, 16762, 16763, 16764, 16765, 16766, 15 16767, 16768, 16769, 16770, 16771 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 984. The probes having the nucleotide sequence represented by SEQ ID NOS: 16772, 16773, 16774, 16775, 16776, 16777, 20 16778, 16779, 16780, 16781, 16782 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 985. The probes having the nucleotide sequence represented by SEQ ID NOS: 16783, 16784, 16785, 16786, 16787, 16788, 25 16789, 16790, 16791, 16792, 16793 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 986. 294 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 16794, 16795, 16796, 16797, 16798, 16799, 16800, 16801, 16802, 16803, 16804 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 987. The probes having the nucleotide sequence represented by SEQ ID NOS: 16805, 16806, 16807, 16808, 16809, 16810, 16811, 16812, 16813, 16814, 16815 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 988. The probes having the nucleotide sequence represented by SEQ ID NOS: 16816, 16817, 16818, 16819, 16820, 16821, 16822, 16823, 16824, 16825, 16826 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 989. The probes having the nucleotide sequence represented by SEQ ID NOS: 16827, 16828, 16829, 16830, 16831, 16832, 16833, 16834, 16835, 16836, 16837 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 990. The probes having the nucleotide sequence represented by SEQ ID NOS: 16838, 16839, 16840, 16841, 16842, 16843, 16844, 16845, 16846, 16847, 16848 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 991. The probes having the nucleotide sequence represented by SEQ ID NOS: 16849, 16850, 16851, 16852, 16853, 16854, 16855, 16856, 16857, 16858, 16859 were selected from the 295 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 992. The probes having the nucleotide sequence represented by SEQ ID NOS: 16860, 16861, 16862, 16863, 16864, 16865, 5 16866, 16867, 16868, 16869, 16870 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 993. The probes having the nucleotide sequence represented by SEQ ID NOS: 16871, 16872, 16873, 16874, 16875, 16876, 10 16877, 16878, 16879, 16880, 16881 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 994. The probes having the nucleotide sequence represented by SEQ ID NOS: 16882, 16883, 16884, 16885, 16886, 16887, 15 16888, 16889, 16890, 16891, 16892 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 995. The probes having the nucleotide sequence represented by SEQ ID NOS: 16893, 16894, 16895, 16896, 16897, 16898, 20 16899, 16900, 16901, 16902, 16903 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 996. The probes having the nucleotide sequence represented by SEQ ID NOS: 16904, 16905, 16906, 16907, 16908, 16909, 25 16910, 16911, 16912, 16913, 16914 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 997. 296 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 16915, 16916, 16917, 16918, 16919, 16920, 16921, 16922, 16923, 16924, 16925 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 998. The probes having the nucleotide sequence represented by SEQ ID NOS: 16926, 16927, 16928, 16929, 16930, 16931, 16932, 16933, 16934, 16935, 16936 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 999. The probes having the nucleotide sequence represented by SEQ ID NOS: 16937, 16938, 16939, 16940, 16941, 16942, 16943, 16944, 16945, 16946, 16947 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1000. The probes having the nucleotide sequence represented by SEQ ID NOS: 16948, 16949, 16950, 16951, 16952, 16953, 16954, 16955, 16956, 16957, 16958 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1001. The probes having the nucleotide sequence represented by SEQ ID NOS: 16959, 16960, 16961, 16962, 16963, 16964, 16965, 16966, 16967, 16968, 16969 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1002. The probes having the nucleotide sequence represented by SEQ ID NOS: 16970, 16971, 16972, 16973, 16974, 16975, 16976, 16977, 16978, 16979, 16980 were selected from the 297 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1003. The probes having the nucleotide sequence represented by SEQ ID NOS: 16981, 16982, 16983, 16984, 16985, 16986, 5 16987, 16988, 16989, 16990, 16991 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1004. The probes having the nucleotide sequence represented by SEQ ID NOS: 16992, 16993, 16994, 16995, 16996, 16997, 10 16998, 16999, 17000, 17001, 17002 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1005. The probes having the nucleotide sequence represented by SEQ ID NOS: 17003, 17004, 17005, 17006, 17007, 17008, 15 17009, 17010, 17011, 17012, 17013 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1006. The probes having the nucleotide sequence represented by SEQ ID NOS: 17014, 17015, 17016, 17017, 17018, 17019, 20 17020, 17021, 17022, 17023, 17024 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1007. The probes having the nucleotide sequence represented by SEQ ID NOS: 17025, 17026, 17027, 17028, 17029, 17030, 25 17031, 17032, 17033, 17034, 17035 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1008. 298 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 17036, 17037, 17038, 17039, 17040, 17041, 17042, 17043, 17044, 17045, 17046 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1009. The probes having the nucleotide sequence represented by SEQ ID NOS: 17047, 17048, 17049, 17050, 17051, 17052, 17053, 17054, 17055, 17056, 17057 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1010. The probes having the nucleotide sequence represented by SEQ ID NOS: 17058, 17059, 17060, 17061, 17062, 17063, 17064, 17065, 17066, 17067, 17068 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1011. The probes having the nucleotide sequence represented by SEQ ID NOS: 17069, 17070, 17071, 17072, 17073, 17074, 17075, 17076, 17077, 17078, 17079 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1012. The probes having the nucleotide sequence represented by SEQ ID NOS: 17080, 17081, 17082, 17083, 17084, 17085, 17086, 17087, 17088, 17089, 17090 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1013. The probes having the nucleotide sequence represented by SEQ ID NOS: 17091, 17092, 17093, 17094, 17095, 17096, 17097, 17098, 17099, 17100, 17101 were selected from the 299 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1014. The probes having the nucleotide sequence represented by SEQ ID NOS: 17102, 17103, 17104, 17105, 17106, 17107, 5 17108, 17109, 17110, 17111, 17112 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1015. The probes having the nucleotide sequence represented by SEQ ID NOS: 17113, 17114, 17115, 17116, 17117, 17118, 10 17119, 17120, 17121, 17122, 17123 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1016. The probes having the nucleotide sequence represented by SEQ ID NOS: 17124, 17125, 17126, 17127, 17128, 17129, 15 17130, 17131, 17132, 17133, 17134 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1017. The probes having the nucleotide sequence represented by SEQ ID NOS: 17135, 17136, 17137, 17138, 17139, 17140, 20 17141, 17142, 17143, 17144, 17145 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1018. The probes having the nucleotide sequence represented by SEQ ID NOS: 17146, 17147, 17148, 17149, 17150, 17151, 25 17152, 17153, 17154, 17155, 17156 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1019. 3100 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 17157, 17158, 17159, 17160, 17161, 17162, 17163, 17164, 17165, 17166, 17167 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1020. The probes having the nucleotide sequence represented by SEQ ID NOS: 17168, 17169, 17170, 17171, 17172, 17173, 17174, 17175, 17176, 17177, 17178 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1021. The probes having the nucleotide sequence represented by SEQ ID NOS: 17179, 17180, 17181, 17182, 17183, 17184, 17185, 17186, 17187, 17188, 17189 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1022. The probes having the nucleotide sequence represented by SEQ ID NOS: 17190, 17191, 17192, 17193, 17194, 17195, 17196, 17197, 17198, 17199, 17200 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1023. The probes having the nucleotide sequence represented by SEQ ID NOS: 17201, 17202, 17203, 17204, 17205, 17206, 17207, 17208, 17209, 17210, 17211 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1024. The probes having the nucleotide sequence represented by SEQ ID NOS: 17212, 17213, 17214, 17215, 17216, 17217, 17218, 17219, 17220, 17221, 17222 were selected from the 301 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide^sequence represented by SEQ ID NO: 1025. The probes having the nucleotide sequence represented by SEQ ID NOS: 17223, 17224, 17225, 17226, 17227, 17228, 5 17229, 17230, 17231, 17232, 17233 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1026. The probes having the nucleotide sequence represented by SEQ ID NOS: 17234, 17235, 17236, 17237, 17238, 17239, 10 17240, 17241, 17242, 17243, 17244 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1027. The probes having the nucleotide sequence represented by SEQ ID NOS: 17245, 17246, 17247, 17248, 17249, 17250, 15 17251, 17252, 17253, 17254, 17255 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1028. The probes having the nucleotide sequence represented by SEQ ID NOS: 17256, 17257, 17258, 17259, 17260, 17261, 20 17262, 17263, 17264, 17265, 17266 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1029. The probes having the nucleotide sequence represented by SEQ ID NOS: 17267, 17268, 17269, 17270, 17271, 17272, 25 17273, 17274, 17275, 17276, 17277 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1030. 302 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 17278, 17279, 17280, 17281, 17282, 17283, 17284, 17285, 17286, 17287, 17288 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1031. The probes having the nucleotide sequence represented by SEQ ID NOS: 17289, 17290, 17291, 17292, 17293, 17294, 17295, 17296, 17297, 17298, 17299 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1032. The probes having the nucleotide sequence represented by SEQ ID NOS: 17300, 17301, 17302, 17303, 17304, 17305, 17306, 17307, 17308, 17309, 17310 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1033. The probes having the nucleotide sequence represented by SEQ ID NOS: 17311, 17312, 17313, 17314, 17315, 17316, 17317, 17318, 17319, 17320, 17321 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1034. The probes having the nucleotide sequence represented by SEQ ID NOS: 17322, 17323, 17324, 17325, 17326, 17327, 17328, 17329, 17330, 17331, 17332 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1035. The probes having the nucleotide sequence represented by SEQ ID NOS: 17333, 17334, 17335, 17336, 17337, 17338, 17339, 17340, 17341, 17342, 17343 were selected from the 303 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1036. The probes having the nucleotide sequence represented by SEQ ID NOS: 17344, 17345, 17346, 17347, 17348, 17349, 5 17350, 17351, 17352, 17353, 17354 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1037. The probes having the nucleotide sequence represented by SEQ ID NOS: 17355, 17356, 17357, 17358, 17359, 17360, 10 17361, 17362, 17363, 17364, 17365 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1038. The probes having the nucleotide sequence represented by SEQ ID NOS: 17366, 17367, 17368, 17369, 17370, 17371, 15 17372, 17373, 17374, 17375, 17376 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1039. The probes having the nucleotide sequence represented by SEQ ID NOS: 17377, 17378, 17379, 17380, 17381, 17382, 20 17383, 17384, 17385, 17386, 17387 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1040. The probes having the nucleotide sequence represented by SEQ ID NOS: 17388, 17389, 17390, 17391, 17392, 17393, 25 17394, 17395, 17396, 17397, 17398 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1041. 304 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 17399, 17400, 17401, 17402, 17403, 17404, 17405, 17406, 17407, 17408, 17409 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1042. The probes .having the nucleotide sequence represented by SEQ ID NOS: 17410, 17411, 17412, 17413, 17414, 17415, 17416, 17417, 17418, 17419, 17420 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1043. The probes having the nucleotide sequence represented by SEQ ID NOS: 17421, 17422, 17423, 17424, 17425, 17426, 17427, 17428, 17429, 17430, 17431 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1044. The probes having the nucleotide sequence represented by SEQ ID NOS: 17432, 17433, 17434, 17435, 17436, 17437, 17438, 17439, 17440, 17441, 17442 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1045. The probes having the nucleotide sequence represented by SEQ ID NOS: 17443, 17444, 17445, 17446, 17447, 17448, 17449, 17450, 17451, 17452, 17453 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1046. The probes having the nucleotide sequence represented by SEQ ID NOS: 17454, 17455, 17456, 17457, 17458, 17459, 17460, 17461, 17462, 17463, 17464 were selected from the 305 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1047. The probes having the nucleotide sequence represented by SEQ ID NOS: 17465, 17466, 17467, 17468, 17469, 17470, 5 17471, 17472, 17473, 17474, 17475 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1048. The probes having the nucleotide sequence represented by SEQ ID NOS: 17476, 17477, 17478, 17479, 17480, 17481, 10 17482, 17483, 17484, 17485, 17486 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1049. The probes having the nucleotide sequence represented by SEQ ID NOS: 17487, 17488, 17489, 17490, 17491, 17492, 15 17493, 17494, 17495, 17496, 17497 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1050. The probes having the nucleotide sequence represented by SEQ ID NOS: 17498, 17499, 17500, 17501, 17502, 17503, 20 17504, 17505, 17506, 17507, 17508 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1051. The probes having the nucleotide sequence represented by SEQ ID NOS: 17509, 17510, 17511, 17512, 17513, 17514, 25 17515, 17516, 17517, 17518, 17519 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1052. 306 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 17520, 17521, 17522, 17523, 17524, 17525, 17526, 17527, 17528, 17529, 17530 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1053. The probes having the nucleotide sequence represented by SEQ ID NOS: 17531, 17532, 17533, 17534, 17535, 17536, 17537, 17538, 17539, 17540, 17541 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1054. The probes having the nucleotide sequence represented by SEQ ID NOS: 17542, 17543, 17544, 17545, 17546, 17547, 17548, 17549, 17550, 17551, 17552 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1055. The probes having the nucleotide sequence represented by SEQ ID NOS: 17553, 17554, 17555, 17556, 17557, 17558, 17559, 17560, 17561, 17562, 17563 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1056. The probes having the nucleotide sequence represented by SEQ ID NOS: 17564, 17565, 17566, 17567, 17568, 17569, 17570, 17571, 17572, 17573, 17574 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1057. The probes having the nucleotide sequence represented by SEQ ID NOS: 17575, 17576, 17577, 17578, 17579, 17580, 17581, 17582, 17583, 17584, 17585 were selected from the 307 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1058. The probes having the nucleotide sequence represented by SEQ ID NOS: 17586, 17587, 17588, 17589, 17590, 17591, 5 17592, 17593, 17594, 17595, 17596 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1059. The probes having the nucleotide sequence represented by SEQ ID NOS: 17597, 17598, 17599, 17600, 17601, 17602, 10 17603, 17604, 17605, 17606, 17607 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1060. The probes having the nucleotide sequence represented by SEQ ID NOS: 17608, 17609, 17610, 17611, 17612, 17613, 15 17614, 17615, 17616, 17617, 17618 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1061. The probes having the nucleotide sequence represented by SEQ ID NOS: 17619, 17620, 17621, 17622, 17623, 17624, 20 17625, 17626, 17627, 17628, 17629 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1062. The probes having the nucleotide sequence represented by SEQ ID NOS: 17630, 17631, 17632, 17633, 17634, 17635, 25 17636, 17637, 17638, 17639, 17640 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1063. 308 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 17641, 17642, 17643, 17644, 17645, 17646, 17647, 17648, 17649, 17650, 17651 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1064. The probes having the nucleotide sequence represented by SEQ ID NOS: 17652, 17653, 17654, 17655, 17656, 17657, 17658, 17659, 17660, 17661, 17662 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1065. The probes having the nucleotide sequence represented by SEQ ID NOS: 17663, 17664, 17665, 17666, 17667, 17668, 17669, 17670, 17671, 17672, 17673 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1066. The probes having the nucleotide sequence represented by SEQ ID NOS: 17674, 17675, 17676, 17677, 17678, 17679, 17680, 17681, 17682, 17683, 17684 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1067. The probes having the nucleotide sequence represented by SEQ ID NOS: 17685, 17686, 17687, 17688, 17689, 17690, 17691, 17692, 17693, 17694, 17695 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1068. The probes having the nucleotide sequence represented by SEQ ID NOS: 17696, 17697, 17698, 17699, 17700, 17701, 17702, 17703, 17704, 17705, 17706 were selected from the 309 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1069. The probes having the nucleotide sequence represented by SEQ ID NOS: 17707, 17708, 17709, 17710, 17711, 17712, 5 17713, 17714, 17715, 17716, 17717 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1070. The probes having the nucleotide sequence represented by SEQ ID NOS: 17718, 17719, 17720, 17721, 17722, 17723, 10 17724, 17725, 17726, 17727, 17728 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1071. The probes having the nucleotide sequence represented by SEQ ID NOS: 17729, 17730, 17731, 17732, 17733, 17734, 15 17735, 17736, 17737, 17738, 17739 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1072. The probes having the nucleotide sequence represented by SEQ ID NOS: 17740, 17741, 17742, 17743, 17744, 17745, 20 17746, 17747, 17748, 17749, 17750 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1073. The probes having the nucleotide sequence represented by SEQ ID NOS: 17751, 17752, 17753, 17754, 17755, 17756, 25 17757, 17758, 17759, 17760, 17761 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1074. 310 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 17762, 17763, 17764, 17765, 17766, 17767, 17768, 17769, 17770, 17771, 17772 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1075. The probes having the nucleotide sequence represented by SEQ ID NOS: 17773, 17774, 17775, 17776, 17777, 17778, 17779, 17780, 17781, 17782, 17783 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1076. The probes having the nucleotide sequence represented by SEQ ID NOS: 17784, 17785, 17786, 17787, 17788, 17789, 17790, 17791, 17792, 17793, 17794 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1077. The probes having the nucleotide sequence represented by SEQ ID NOS: 17795, 17796, 17797, 17798, 17799, 17800, 17801, 17802, 17803, 17804, 17805 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1078. The probes having the nucleotide sequence represented by SEQ ID NOS: 17806, 17807, 17808, 17809, 17810, 17811, 17812, 17813, 17814, 17815, 17816 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1079. The probes having the nucleotide sequence represented by SEQ ID NOS: 17817, 17818, 17819, 17820, 17821, 17822, 17823, 17824, 17825, 17826, 17827 were selected from the 311 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1080. The probes having the nucleotide sequence represented by SEQ ID NOS: 17828, 17829, 17830, 17831, 17832, 17833, 5 17834, 17835, 17836, 17837, 17838 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1081. The probes having the nucleotide sequence represented by SEQ ID NOS: 17839, 17840, 17841, 17842, 17843, 17844, 10 17845, 17846, 17847, 17848, 17849 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1082. The probes having the nucleotide sequence represented by SEQ ID NOS: 17850, 17851, 17852, 17853, 17854, 17855, 15 17856, 17857, 17858, 17859, 17860 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1083. The probes having the nucleotide sequence represented by SEQ ID NOS: 17861, 17862, 17863, 17864, 17865, 17866, 20 17867, 17868, 17869, 17870, 17871 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1084. The probes having the nucleotide sequence represented by SEQ ID NOS: 17872, 17873, 17874, 17875, 17876, 17877, 25 17878, 17879, 17880, 17881, 17882 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1085. 312 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 17883, 17884, 17885, 17886, 17887, 17888, 17889, 17890, 17891, 17892, 17893 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1086. The probes having the nucleotide sequence represented by SEQ ID NOS: 17894, 17895, 17896, 17897, 17898, 17899, 17900, 17901, 17902, 17903, 17904 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1087. The probes having the nucleotide sequence represented by SEQ ID NOS: 17905, 17906, 17907, 17908, 17909, 17910, 17911, 17912, 17913, 17914, 17915 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1088. The probes having the nucleotide sequence represented by SEQ ID NOS: 17916, 17917, 17918, 17919, 17920, 17921, 17922, 17923, 17924, 17925, 17926 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1089. The probes having the nucleotide sequence represented by SEQ ID NOS: 17927, 17928, 17929, 17930, 17931, 17932, 17933, 17934, 17935, 17936, 17937 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1090. The probes having the nucleotide sequence represented by SEQ ID NOS: 17938, 17939, 17940, 17941, 17942, 17943, 17944, 17945, 17946, 17947, 17948 were selected from the 313 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1091. The probes having the nucleotide sequence represented by SEQ ID NOS: 17949, 17950, 17951, 17952, 17953, 17954, 5 17955, 17956, 17957, 17958, 17959 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1092. The probes having the nucleotide sequence represented by SEQ ID NOS: 17960, 17961, 17962, 17963, 17964, 17965, 10 17966, 17967, 17968, 17969, 17970 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1093. The probes having the nucleotide sequence represented by SEQ ID NOS: 17971, 17972, 17973, 17974, 17975, 17976, 15 17977, 17978, 17979, 17980, 17981 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1094. The probes having the nucleotide sequence represented by SEQ ID NOS: 17982, 17983, 17984, 17985, 17986, 17987, 20 17988, 17989, 17990, 17991, 17992 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1095. The probes having the nucleotide sequence represented by SEQ ID NOS: 17993, 17994, 17995, 17996, 17997, 17998, 25 17999, 18000, 18001, 18002, 18003 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1096. 314 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 18004, 18005, 18006, 18007, 18008, 18009, 18010, 18011, 18012, 18013, 18014 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1097. The probes having the nucleotide sequence represented by SEQ ID NOS: 18015, 18016, 18017, 18018, 18019, 18020, 18021, 18022, 18023, 18024, 18025 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1098. The probes having the nucleotide sequence represented by SEQ ID NOS: 18026, 18027, 18028, 18029, 18030, 18031, 18032, 18033, 18034, 18035, 18036 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1099. The probes having the nucleotide sequence represented by SEQ ID NOS: 18037, 18038, 18039, 18040, 18041, 18042, 18043, 18044, 18045, 18046, 18047 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1100. The probes having the nucleotide sequence represented by SEQ ID NOS: 18048, 18049, 18050, 18051, 18052, 18053, 18054, 18055, 18056, 18057, 18058 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1101. The probes having the nucleotide sequence represented by SEQ ID NOS: 18059, 18060, 18061, 18062, 18063, 18064, 18065, 18066, 18067, 18068, 18069 were selected from the 315 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1102. The probes having the nucleotide sequence represented by SEQ ID NOS: 18070, 18071, 18072, 18073, 18074, 18075, 5 18076, 18077, 18078, 18079, 18080 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1103. The probes having the nucleotide sequence represented by SEQ ID NOS: 18081, 18082, 18083, 18084, 18085, 18086, 10 18087, 18088, 18089, 18090, 18091 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1104. The probes having the nucleotide sequence represented by SEQ ID NOS: 18092, 18093, 18094, 18095, 18096, 18097, 15 18098, 18099, 18100, 18101, 18102 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1105. The probes having the nucleotide sequence represented by SEQ ID NOS: 18103, 18104, 18105, 18106, 18107, 18108, 20 18109, 18110, 18111, 18112, 18113 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1106. The probes having the nucleotide sequence represented by SEQ ID NOS: 18114, 18115, 18116, 18117, 18118, 18119, 25 18120, 18121, 18122, 18123, 18124 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1107. 316 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 18125, 18126, 18127, 18128, 18129, 18130, 18131, 18132, 18133, 18134, 18135 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1108. The probes having the nucleotide sequence represented by SEQ ID NOS: 18136, 18137, 18138, 18139, 18140, 18141, 18142, 18143, 18144, 18145, 18146 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1109. The probes having the nucleotide sequence represented by SEQ ID NOS: 18147, 18148, 18149, 18150, 18151, 18152, 18153, 18154, 18155, 18156, 18157 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1110. The probes having the nucleotide sequence represented by SEQ ID NOS: 18158, 18159, 18160, 18161, 18162, 18163, 18164, 18165, 18166, 18167, 18168 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1111. The probes having the nucleotide sequence represented by SEQ ID NOS: 18169, 18170, 18171, 18172, 18173, 18174, 18175, 18176, 18177, 18178, 18179 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1112. The probes having the nucleotide sequence represented by SEQ ID NOS: 18180, 18181, 18182, 18183, 18184, 18185, 18186, 18187, 18188, 18189, 18190 were selected from the 317 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1113. The probes having the nucleotide sequence represented by SEQ ID NOS: 18191, 18192, 18193, 18194, 18195, 18196, 5 18197, 18198, 18199, 18200, 18201 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1114. The probes having the nucleotide sequence represented by SEQ ID NOS: 18202, 18203, 18204, 18205, 18206, 18207, 10 18208, 18209, 18210, 18211, 18212 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1115. The probes having the nucleotide sequence represented by SEQ ID NOS: 18213, 18214, 18215, 18216, 18217, 18218, 15 18219, 18220, 18221, 18222, 18223 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1116. The probes having the nucleotide sequence represented by SEQ ID NOS: 18224, 18225, 18226, 18227, 18228, 18229, 20 18230, 18231, 18232, 18233, 18234 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1117. The probes having the nucleotide sequence represented by SEQ ID NOS: 18235, 18236, 18237, 18238, 18239, 18240, 25 18241, 18242, 18243, 18244, 18245 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1118. 318 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 18246, 18247, 18248, 18249, 18250, 18251, 18252, 18253, 18254, 18255, 18256 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1119. The probes having the nucleotide sequence represented by SEQ ID NOS: 18257, 18258, 18259, 18260, 18261, 18262, 18263, 18264, 18265, 18266, 18267 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1120. The probes having the nucleotide sequence represented by SEQ ID NOS: 18268, 18269, 18270, 18271, 18272, 18273, 18274, 18275, 18276, 18277, 18278 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1121. The probes having the nucleotide sequence represented by SEQ ID NOS: 18279, 18280, 18281, 18282, 18283, 18284, 18285, 18286, 18287, 18288, 18289 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1122. The probes having the nucleotide sequence represented by SEQ ID NOS: 18290, 18291, 18292, 18293, 18294, 18295, 18296, 18297, 18298, 18299, 18300 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1123. The probes having the nucleotide sequence represented by SEQ ID NOS: 18301, 18302, 18303, 18304, 18305, 18306, 18307, 18308, 18309, 18310, 18311 were selected from the 319 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1124. The probes having the nucleotide sequence represented by SEQ ID NOS: 18312, 18313, 18314, 18315, 18316, 18317, 5 18318, 18319, 18320, 18321, 18322 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1125. The probes having the nucleotide sequence represented by SEQ ID NOS: 18323, 18324, 18325, 18326, 18327, 18328, 10 18329, 18330, 18331, 18332, 18333, 18334, 18335, 18336, 18337, 18338, 18339, 18340, 18341, 18342, 18343, 18344 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1126. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 18345, 18346, 18347, 18348, 18349, 18350, 18351, 18352, 18353, 18354, 18355 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1127. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 18356, 18357, 18358, 18359, 18360, 18361, 18362, 18363, 18364, 18365, 18366 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1128. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 18367, 18368, 18369, 18370, 18371, 18372, 18373, 18374, 18375, 18376, 18377 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1129. 320 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 18378, 18379, 18380, 18381, 18382, 18383, 18384, 18385, 18386, 18387, 18388 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1130. The probes having the nucleotide sequence represented by SEQ ID NOS: 18389, 18390, 18391, 18392, 18393, 18394, 18395, 18396, 18397, 18398, 18399, 18400, 18401, 18402, 18403, 18404, 18405, 18406, 18407, 18408, 18409, 18410 were 10 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1131. The probes having the nucleotide sequence represented by SEQ ID NOS: 18411, 18412, 18413, 18414, 18415, 18416, 18417, 18418, 18419, 18420, 18421 were selected from the 15 ORFs having the nucleotide sequence represented by SEQ ID NO: 1132. The probes having the nucleotide sequence represented by SEQ ID NOS: 18422, 18423, 18424, 18425, 18426, 18427, 18428, 18429, 18430, 18431, 18432 were selected from the 20 ORFs having the nucleotide sequence represented by SEQ ID NO: 1133. The probes having the nucleotide sequence represented by SEQ ID NOS: 18433, 18434, 18435, 18436, 18437, 18438, 18439, 18440, 18441, 18442, 18443 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 1134. The probes having the nucleotide sequence represented by SEQ ID NOS: 18444, 18445, 18446, 18447, 18448, 18449, 321 WO 2006/024951 PCT/IB2005/002908 18450, 18451, 18452, 18453, 18454 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1135. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 18455, 18456, 18457, 18458, 18459, 18460, 18461, 18462, 18463, 18464, 18465 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1136. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 18466, 18467, 18468, 18469, 18470, 18471, 18472, 18473, 18474, 18475, 18476 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1137. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 18477, 18478, 18479, 18480, 18481, 18482, 18483, 18484, 18485, 18486, 18487 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1138. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 18488, 18489, 18490, 18491, 18492, 18493, 18494, 18495, 18496, 18497, 18498 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1139. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 18499, 18500, 18501, 18502, 18503, 18504, 18505, 18506, 18507, 18508, 18509 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1140. 322 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 18510, 18511, 18512, 18513, 18514, 18515, 18516, 18517, 18518, 18519, 18520 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1141. The probes having the nucleotide sequence represented by SEQ ID NOS: 18521, 18522, 18523, 18524, 18525, 18526, 18527, 18528, 18529, 18530, 18531 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1142. The probes having the nucleotide sequence represented by SEQ ID NOS: 18532, 18533, 18534, 18535, 18536, 18537, 18538, 18539, 18540, 18541, 18542 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1143. The probes having the nucleotide sequence represented by SEQ ID NOS: 18543, 18544, 18545, 18546, 18547, 18548, 18549, 18550, 18551, 18552, 18553 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1144. The probes having the nucleotide sequence represented by SEQ ID NOS: 18554, 18555, 18556, 18557, 18558, 18559, 18560, 18561, 18562, 18563, 18564 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1145. The probes having the nucleotide sequence represented by SEQ ID NOS: 18565, 18566, 18567, 18568, 18569, 18570, 18571, 18572, 18573, 18574, 18575 were selected from the 323 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1146. The probes having the nucleotide sequence represented by SEQ ID NOS: 18576, 18577, 18578, 18579, 18580, 18581, 5 18582, 18583, 18584, 18585, 18586 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1147. The probes having the nucleotide sequence represented by SEQ ID NOS: 18587, 18588, 18589, 18590, 18591, 18592, 10 18593, 18594, 18595, 18596, 18597 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1148. The probes having the nucleotide sequence represented by SEQ ID NOS: 18598, 18599, 18600, 18601, 18602, 18603, 15 18604, 18605, 18606, 18607, 18608 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1149. The probes having the nucleotide sequence represented by SEQ ID NOS: 18609, 18610, 18611, 18612, 18613, 18614, 20 18615, 18616, 18617, 18618, 18619 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1150. The probes having the nucleotide sequence represented by SEQ ID NOS: 18620, 18621, 18622, 18623, 18624, 18625, 25 18626, 18627, 18628, 18629, 18630 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1151. 324 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 18631, 18632, 18633, 18634, 18635, 18636, 18637, 18638, 18639, 18640, 18641 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1152. The probes having the nucleotide sequence represented by SEQ ID NOS: 18642, 18643, 18644, 18645, 18646, 18647, 18648, 18649, 18650, 18651, 18652 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1153. The probes having the nucleotide sequence represented by SEQ ID NOS: 18653, 18654, 18655, 18656, 18657, 18658, 18659, 18660, 18661, 18662, 18663 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1154. The probes having the nucleotide sequence represented by SEQ ID NOS: 18664, 18665, 18666, 18667, 18668, 18669, 18670, 18671, 18672, 18673, 18674 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1155. The probes having the nucleotide sequence represented by SEQ ID NOS: 18675, 18676, 18677, 18678, 18679, 18680, 18681, 18682, 18683, 18684, 18685 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1156. The probes having the nucleotide sequence represented by SEQ ID NOS: 18686, 18687, 18688, 18689, 18690, 18691, 18692, 18693, 18694, 18695, 18696 were selected from the 325 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1157. The probes having the nucleotide sequence represented by SEQ ID NOS: 18697, 18698, 18699, 18700, 18701, 18702, 5 18703, 18704, 18705, 18706, 18707 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1158. The probes having the nucleotide sequence represented by SEQ ID NOS: 18708, 18709, 18710, 18711, 18712, 18713, 10 18714, 18715, 18716, 18717, 18718 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1159. The probes having the nucleotide sequence represented by SEQ ID NOS: 18719, 18720, 18721, 18722, 18723, 18724, 15 18725, 18726, 18727, 18728, 18729 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1160. The probes having the nucleotide sequence represented by SEQ ID NOS: 18730, 18731, 18732, 18733, 18734, 18735, 20 18736, 18737, 18738, 18739, 18740 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1161. The probes having the nucleotide sequence represented by SEQ ID NOS: 18741, 18742, 18743, 18744, 18745, 18746, 25 18747, 18748, 18749, 18750, 18751 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1162. 326 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 18752, 18753, 18754, 18755, 18756, 18757, 18758, 18759, 18760, 18761, 18762 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1163. The probes having the nucleotide sequence represented by SEQ ID NOS: 18763, 18764, 18765, 18766, 18767, 18768, 18769, 18770, 18771, 18772, 18773 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1164. The probes having the nucleotide sequence represented by SEQ ID NOS: 18774, 18775, 18776, 18777, 18778, 18779, 18780, 18781, 18782, 18783, 18784 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1165. The probes having the nucleotide sequence represented by SEQ ID NOS: 18785, 18786, 18787, 18788, 18789, 18790, 18791, 18792, 18793, 18794, 18795 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1166. The probes having the nucleotide sequence represented by SEQ ID NOS: 18796, 18797, 18798, 18799, 18800, 18801, 18802, 18803, 18804, 18805, 18806 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1167. The probes having the nucleotide sequence represented by SEQ ID NOS: 18807, 18808, 18809, 18810, 18811, 18812, 18813, 18814, 18815, 18816, 18817 were selected from the 327 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1168. The probes having the nucleotide sequence represented by SEQ ID NOS: 18818, 18819, 18820, 18821, 18822, 18823, 5 18824, 18825, 18826, 18827, 18828 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1169. The probes having the nucleotide sequence represented by SEQ ID NOS: 18829, 18830, 18831, 18832, 18833, 18834, 10 18835, 18836, 18837, 18838, 18839 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1170. The probes having the nucleotide sequence represented by SEQ ID NOS: 18840, 18841, 18842, 18843, 18844, 18845, 15 18846, 18847, 18848, 18849, 18850 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1171. The probes having the nucleotide sequence represented by SEQ ID NOS: 18851, 18852, 18853, 18854, 18855, 18856, 20 18857, 18858, 18859, 18860, 18861 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1172. The probes having the nucleotide sequence represented by SEQ ID NOS: 18862, 18863, 18864, 18865, 18866, 18867, 25 18868, 18869, 18870, 18871, 18872 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1173. 328 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 18873, 18874, 18875, 18876, 18877, 18878, 18879, 18880, 18881, 18882, 18883 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1174. The probes having the nucleotide sequence represented by SEQ ID NOS: 18884, 18885, 18886, 18887, 18888, 18889, 18890, 18891, 18892, 18893, 18894 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1175. The probes having the nucleotide sequence represented by SEQ ID NOS: 18895, 18896, 18897, 18898, 18899, 18900, 18901, 18902, 18903, 18904, 18905 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1176. The probes having the nucleotide sequence represented by SEQ ID NOS: 18906, 18907, 18908, 18909, 18910, 18911, 18912, 18913, 18914, 18915, 18916 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1177. The probes having the nucleotide sequence represented by SEQ ID NOS: 18917, 18918, 18919, 18920, 18921, 18922, 18923, 18924, 18925, 18926, 18927 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1178. The probes having the nucleotide sequence represented by SEQ ID NOS: 18928, 18929, 18930, 18931, 18932, 18933, 18934, 18935, 18936, 18937, 18938 were selected from the 329 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1179. The probes having the nucleotide sequence represented by SEQ ID NOS: 18939, 18940, 18941, 18942, 18943, 18944, 5 18945, 18946, 18947, 18948, 18949 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1180. The probes having the nucleotide sequence represented by SEQ ID NOS: 18950, 18951, 18952, 18953, 18954, 18955, 10 18956, 18957, 18958, 18959, 18960.were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1181. The probes having the nucleotide sequence represented by SEQ ID NOS: 18961, 18962, 18963, 18964, 18965, 18966, 15 18967, 18968, 18969, 18970, 18971 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1182. The probes having the nucleotide sequence represented by SEQ ID NOS: 18972, 18973, 18974, 18975, 18976, 18977, 20 18978, 18979, 18980, 18981, 18982 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1183. The probes having the nucleotide sequence represented by SEQ ID NOS: 18983, 18984, 18985, 18986, 18987, 18988, 25 18989, 18990, 18991, 18992, 18993 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1184. 330 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 18994, 18995, 18996, 18997, 18998, 18999, 19000, 19001, 19002, 19003, 19004 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1185. The probes having the nucleotide sequence represented by SEQ ID NOS: 19005, 19006, 19007, 19008, 19009, 19010, 19011, 19012, 19013, 19014, 19015 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1186. The probes having the nucleotide sequence represented by SEQ ID NOS: 19016, 19017, 19018, 19019, 19020, 19021, 19022, 19023, 19024, 19025, 19026 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1187. The probes having the nucleotide sequence represented by SEQ ID NOS: 19027, 19028, 19029, 19030, 19031, 19032, 19033, 19034, 19035, 19036, 19037 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1188. The probes having the nucleotide sequence represented by SEQ ID NOS: 19038, 19039, 19040, 19041, 19042, 19043, 19044, 19045, 19046, 19047, 19048 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1189. The probes having the nucleotide sequence represented by SEQ ID NOS: 19049, 19050, 19051, 19052, 19053, 19054, 19055, 19056, 19057, 19058, 19059 were selected from the 331 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1190. The probes having the nucleotide sequence represented by SEQ ID NOS: 19060, 19061, 19062, 19063, 19064, 19065, 5 19066, 19067, 19068, 19069, 19070 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1191. The probes having the nucleotide sequence represented by SEQ ID NOS: 19071, 19072, 19073, 19074, 19075, 19076, 10 19077, 19078, 19079, 19080, 19081 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1192. The probes having the nucleotide sequence represented by SEQ ID NOS: 19082, 19083, 19084, 19085, 19086, 19087, 15 19088, 19089, 19090, 19091, 19092 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1193. The probes having the nucleotide sequence represented by SEQ ID NOS: 19093, 19094, 19095, 19096, 19097, 19098, 20 19099, 19100, 19101, 19102, 19103 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1194. The probes having the nucleotide sequence represented by SEQ ID NOS: 19104, 19105, 19106, 19107, 19108, 19109, 25 19110, 19111, 19112, 19113, 19114 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1195. 332 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 19115, 19116, 19117, 19118, 19119, 19120, 19121, 19122, 19123, 19124) 19125 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1196. The probes having the nucleotide sequence represented by SEQ ID NOS: 19126, 19127, 19128, 19129, 19130, 19131, 19132, 19133, 19134, 19135, 19136 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1197. The probes having the nucleotide sequence represented by SEQ ID NOS: 19137, 19138, 19139, 19140, 19141, 19142, 19143, 19144, 19145, 19146, 19147 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1198. The probes having the nucleotide sequence represented by SEQ ID NOS: 19148, 19149, 19150, 19151, 19152, 19153, 19154, 19155, 19156, 19157, 19158 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1199. The probes having the nucleotide sequence represented by SEQ ID NOS: 19159, 19160, 19161, 19162, 19163, 19164, 19165, 19166, 19167, 19168, 19169 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1200. The probes having the nucleotide sequence represented by SEQ ID NOS: 19170, 19171, 19172, 19173, 19174, 19175, 19176, 19177, 19178, 19179, 19180 were selected from the 333 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1201. The probes having the nucleotide sequence represented by SEQ ID NOS: 19181, 19182, 19183, 19184, 19185, 19186, 5 19187, 19188, 19189, 19190, 19191 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1202. The probes having the nucleotide sequence represented by SEQ ID NOS: 19192, 19193, 19194, 19195, 19196, 19197, 10 19198, 19199, 19200, 19201, 19202 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1203. The probes having the nucleotide sequence represented by SEQ ID NOS: 19203, 19204, 19205, 19206, 19207, 19208, 15 19209, 19210, 19211, 19212, 19213 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1204. The probes having the nucleotide sequence represented by SEQ ID NOS: 19214, 19215, 19216, 19217, 19218, 19219, 20 19220, 19221, 19222, 19223, 19224 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1205. The probes having the nucleotide sequence represented by SEQ ID NOS: 19225, 19226, 19227, 19228, 19229, 19230, 25 19231, 19232, 19233, 19234, 19235 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1206. 334 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 19236, 19237, 19238, 19239, 19240, 19241, 19242, 19243, 19244, 19245, 19246 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1207. The probes having the nucleotide sequence represented by SEQ ID NOS: 19247, 19248, 19249, 19250, 19251, 19252, 19253, 19254, 19255, 19256, 19257 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1208. The probes having the nucleotide sequence represented by SEQ ID NOS: 19258, 19259, 19260, 19261, 19262, 19263, 19264, 19265, 19266, 19267, 19268 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1209. The probes having the nucleotide sequence represented by SEQ ID NOS: 19269, 19270, 19271, 19272, 19273, 19274, 19275, 19276, 19277, 19278, 19279 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1210. The probes having the nucleotide sequence represented by SEQ ID NOS: 19280, 19281, 19282, 19283, 19284, 19285, 19286, 19287, 19288, 19289, 19290 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1211. The probes having the nucleotide sequence represented by SEQ ID NOS: 19291, 19292, 19293, 19294, 19295, 19296, 19297, 19298, 19299, 19300, 19301 were selected from the 335 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1212. The probes having the nucleotide sequence represented by SEQ ID NOS: 19302, 19303, 19304, 19305, 19306, 19307, 5 19308, 19309, 19310, 19311, 19312 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1213. The probes having the nucleotide sequence represented by SEQ ID NOS: 19313, 19314, 19315, 19316, 19317, 19318, 10 19319, 19320, 19321, 19322, 19323 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1214. The probes having the nucleotide sequence represented by SEQ ID NOS: 19324, 19325, 19326, 19327, 19328, 19329, 15 19330, 19331, 19332, 19333, 19334 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1215. The probes having the nucleotide sequence represented by SEQ ID NOS: 19335, 19336, 19337, 19338, 19339, 19340, 20 19341, 19342, 19343, 19344, 19345 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1216. The probes having the nucleotide sequence represented by SEQ ID NOS: 19346, 19347, 19348, 19349, 19350, 19351, 25 19352, 19353, 19354, 19355, 19356 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1217. 336 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 19357, 19358, 19359, 19360, 19361, 19362, 19363, 19364, 19365, 19366, 19367 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1218. The probes having the nucleotide sequence represented by SEQ ID NOS: 19368, 19369, 19370, 19371, 19372, 19373, 19374, 19375, 19376, 19377, 19378 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1219. The probes having the nucleotide sequence represented by SEQ ID NOS: 19379, 19380, 19381, 19382, 19383, 19384, 19385, 19386, 19387, 19388, 19389 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1220. The probes having the nucleotide sequence represented by SEQ ID NOS: 19390, 19391, 19392, 19393, 19394, 19395, 19396, 19397, 19398, 19399, 19400 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1221. The probes having the nucleotide sequence represented by SEQ ID NOS: 19401, 19402, 19403, 19404, 19405, 19406, 19407, 19408, 19409, 19410, 19411 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1222. The probes having the nucleotide sequence represented by SEQ ID NOS: 19412, 19413, 19414, 19415, 19416, 19417, 19418, 19419, 19420, 19421, 19422 were selected from the 337 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1223. The probes having the nucleotide sequence represented by SEQ ID NOS: 19423, 19424, 19425, 19426, 19427, 19428, 5 19429, 19430, 19431, 19432, 19433 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1224. The probes having the nucleotide sequence represented by SEQ ID NOS: 19434, 19435, 19436, 19437, 19438, 19439, 10 19440, 19441, 19442, 19443, 19444 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1225. The probes having the nucleotide sequence represented by SEQ ID NOS: 19445, 19446, 19447, 19448, 19449, 19450, 15 19451, 19452, 19453, 19454, 19455 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1226. The probes having the nucleotide sequence represented by SEQ ID NOS: 19456, 19457, 19458, 19459, 19460, 19461, 20 19462, 19463, 19464, 19465, 19466 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1227. The probes having the nucleotide sequence represented by SEQ ID NOS: 19467, 19468, 19469, 19470, 19471, 19472, 25 19473, 19474, 19475, 19476, 19477 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1228. 338 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 19478, 19479, 19480, 19481, 19482, 19483, 19484, 19485, 19486, 19487, 19488 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1229. The probes having the nucleotide sequence represented by SEQ ID NOS: 19489, 19490, 19491, 19492, 19493, 19494, 19495, 19496, 19497, 19498, 19499 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1230. The probes having the nucleotide sequence represented by SEQ ID NOS: 19500, 19501, 19502, 19503, 19504, 19505, 19506, 19507, 19508, 19509, 19510 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1231. The probes having the nucleotide sequence represented by SEQ ID NOS: 19511, 19512, 19513, 19514, 19515, 19516, 19517, 19518, 19519, 19520, 19521 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1232. The probes having the nucleotide sequence represented by SEQ ID NOS: 19522, 19523, 19524, 19525, 19526, 19527, 19528, 19529, 19530, 19531, 19532 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1233. The probes having the nucleotide sequence represented by SEQ ID NOS: 19533, 19534, 19535, 19536, 19537, 19538, 19539, 19540, 19541, 19542, 19543 were selected from the 339 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1234. The probes having the nucleotide sequence represented by SEQ ID NOS: 19544, 19545, 19546, 19547, 19548, 19549, 5 19550, 19551, 19552, 19553, 19554 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1235. The probes having the nucleotide sequence represented by SEQ ID NOS: 19555, 19556, 19557, 19558, 19559, 19560, 10 19561, 19562, 19563, 19564, 19565 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1236. The probes having the nucleotide sequence represented by SEQ ID NOS: 19566, 19567, 19568, 19569, 19570, 19571, 15 19572, 19573, 19574, 19575, 19576 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1237. The probes having the nucleotide sequence represented by SEQ ID NOS: 19577, 19578, 19579, 19580, 19581, 19582, 20 19583, 19584, 19585, 19586, 19587 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1238. The probes having the nucleotide sequence represented by SEQ ID NOS: 19588, 19589, 19590, 19591, 19592, 19593, 25 19594, 19595, 19596, 19597, 19598 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1239. 340 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 19599, 19600, 19601, 19602, 19603, 19604, 19605, 19606, 19607, 19608, 19609 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1240. The probes having the nucleotide sequence represented by SEQ ID NOS: 19610, 19611, 19612, 19613, 19614, 19615, 19616, 19617, 19618, 19619, 19620 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1241. The probes having the nucleotide sequence represented by SEQ ID NOS: 19621, 19622, 19623, 19624, 19625, 19626, 19627, 19628, 19629, 19630, 19631 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1242. The probes having the nucleotide sequence represented by SEQ ID NOS: 19632, 19633, 19634, 19635, 19636, 19637, 19638, 19639, 19640, 19641, 19642 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1243. The probes having the nucleotide sequence represented by SEQ ID NOS: 19643, 19644, 19645, 19646, 19647, 19648, 19649, 19650, 19651, 19652, 19653 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1244. The probes having the nucleotide sequence represented by SEQ ID NOS: 19654, 19655, 19656, 19657, 19658, 19659, 19660, 19661, 19662, 19663, 19664 were selected from the 341 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1245. The probes having the nucleotide sequence represented by SEQ ID NOS: 19665, 19666, 19667, 19668, 19669, 19670, 5 19671, 19672, 19673, 19674, 19675 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1246. The probes having the nucleotide sequence represented by SEQ ID NOS: 19676, 19677, 19678, 19679, 19680, 19681, 10 19682, 19683, 19684, 19685, 19686 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1247. The probes having the nucleotide sequence represented by SEQ ID NOS: 19687, 19688, 19689, 19690, 19691, 19692, 15 19693, 19694, 19695, 19696, 19697 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1248. The probes having the nucleotide sequence represented by SEQ ID NOS: 19698, 19699, 19700, 19701, 19702, 19703, 20 19704, 19705, 19706, 19707, 19708 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1249. The probes having the nucleotide sequence represented by SEQ ID NOS: 19709, 19710, 19711, 19712, 19713, 19714, 25 19715, 19716, 19717, 19718, 19719 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1250. 342 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 19720, 19721, 19722, 19723, 19724, 19725, 19726, 19727, 19728, 19729, 19730 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1251. The probes having the nucleotide sequence represented by SEQ ID NOS: 19731, 19732, 19733, 19734, 19735, 19736, 19737, 19738, 19739, 19740, 19741 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1252. The probes having the nucleotide sequence represented by SEQ ID NOS: 19742, 19743, 19744, 19745, 19746, 19747, 19748, 19749, 19750, 19751, 19752 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1253. The probes having the nucleotide sequence represented by SEQ ID NOS: 19753, 19754, 19755, 19756, 19757, 19758, 19759, 19760, 19761, 19762, 19763 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1254. The probes having the nucleotide sequence represented by SEQ ID NOS: 19764, 19765, 19766, 19767, 19768, 19769, 19770, 19771, 19772, 19773, 19774 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1255. The probes having the nucleotide sequence represented by SEQ ID NOS: 19775, 19776, 19777, 19778, 19779, 19780, 19781, 19782, 19783, 19784, 19785 were selected from the 343 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1256. The probes having the nucleotide sequence represented by SEQ ID NOS: 19786, 19787, 19788, 19789, 19790, 19791, 5 19792, 19793, 19794, 19795, 19796 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1257. The probes having the nucleotide sequence represented by SEQ ID NOS: 19797, 19798, 19799, 19800, 19801, 19802, 10 19803, 19804, 19805, 19806, 19807 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1258. The probes having the nucleotide sequence represented by SEQ ID NOS: 19808, 19809, 19810, 19811, 19812, 19813, 15 19814, 19815, 19816, 19817, 19818 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1259. The probes having the nucleotide sequence represented by SEQ ID NOS: 19819, 19820, 19821, 19822, 19823, 19824, 20 19825, 19826, 19827, 19828, 19829 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1260. The probes having the nucleotide sequence represented by SEQ ID NOS: 19830, 19831, 19832, 19833, 19834, 19835, 25 19836, 19837, 19838, 19839, 19840 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1261. 344 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 19841, 19842, 19843, 19844, 19845, 19846, 19847, 19848, 19849, 19850, 19851 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1262. The probes having the nucleotide sequence represented by SEQ ID NOS: 19852, 19853, 19854, 19855, 19856, 19857, 19858, 19859, 19860, 19861, 19862 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1263. The probes having the nucleotide sequence represented by SEQ ID NOS: 19863, 19864, 19865, 19866, 19867, 19868, 19869, 19870, 19871, 19872, 19873 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1264. The probes having the nucleotide sequence represented by SEQ ID NOS: 19874, 19875, 19876, 19877, 19878, 19879, 19880, 19881, 19882, 19883, 19884 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1265. The probes having the nucleotide sequence represented by SEQ ID NOS: 19885, 19886, 19887, 19888, 19889, 19890, 19891, 19892, 19893, 19894, 19895 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1266. The probes having the nucleotide sequence represented by SEQ ID NOS: 19896, 19897, 19898, 19899, 19900, 19901, 19902, 19903, 19904, 19905, 19906 were selected from the 345 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1267. The probes having the nucleotide sequence represented by SEQ ID NOS: 19907, 19908, 19909, 19910, 19911, 19912, 5 19913, 19914, 19915, 19916, 19917 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1268. The probes having the nucleotide sequence represented by SEQ ID NOS: 19918, 19919, 19920, 19921, 19922, 19923, 10 19924, 19925, 19926, 19927, 19928 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1269. The probes having the nucleotide sequence represented by SEQ ID NOS: 19929, 19930, 19931, 19932, 19933, 19934, 15 19935, 19936, 19937, 19938, 19939 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1270. The probes having the nucleotide sequence represented by SEQ ID NOS: 19940, 19941, 19942, 19943, 19944, 19945, 20 19946, 19947, 19948, 19949, 19950 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1271. The probes having the nucleotide sequence represented by SEQ ID NOS: 19951, 19952, 19953, 19954, 19955, 19956, 25 19957, 19958, 19959, 19960, 19961 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1272. 346 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 19962, 19963, 19964, 19965, 19966, 19967, 19968, 19969, 19970, 19971, 19972 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1273. The probes having the nucleotide sequence represented by SEQ ID NOS: 19973, 19974, 19975, 19976, 19977, 19978, 19979, 19980, 19981, 19982, 19983 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1274. The probes having the nucleotide sequence represented by SEQ ID NOS: 19984, 19985, 19986, 19987, 19988, 19989, 19990, 19991, 19992, 19993, 19994 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1275. The probes having the nucleotide sequence represented by SEQ ID NOS: 19995, 19996, 19997, 19998, 19999, 20000, 20001, 20002, 20003, 20004, 20005 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1276. The probes having the nucleotide sequence represented by SEQ ID NOS: 20006, 20007, 20008, 20009, 20010, 20011, 20012, 20013, 20014, 20015, 20016 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1277. The probes having the nucleotide sequence represented by SEQ ID NOS: 20017, 20018, 20019, 20020, 20021, 20022, 20023, 20024, 20025, 20026, 20027 were selected from the 347 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1278. The probes having the nucleotide sequence represented by SEQ ID NOS: 20028, 20029, 20030, 20031, 20032, 20033, 5 20034, 20035, 20036, 20037, 20038 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1279. The probes having the nucleotide sequence represented by SEQ ID NOS: 20039, 20040, 20041, 20042, 20043, 20044, 10 20045, 20046, 20047, 20048, 20049 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1280. The probes having the nucleotide sequence represented by SEQ ID NOS: 20050, 20051, 20052, 20053, 20054, 20055, 15 20056, 20057, 20058, 20059, 20060 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1281. The probes having the nucleotide sequence represented by SEQ ID NOS: 20061, 20062, 20063, 20064, 20065, 20066, 20 20067, 20068, 20069, 20070, 20071 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1282. The probes having the nucleotide sequence represented by SEQ ID NOS: 20072, 20073, 20074, 20075, 20076, 20077, 25 20078, 20079, 20080, 20081, 20082 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1283. 348 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 20083, 20084, 20085, 20086, 20087, 20088, 20089, 20090, 20091, 20092, 20093 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1284. The probes having the nucleotide sequence represented by SEQ ID NOS: 20094, 20095, 2.0096, 20097, 20098, 20099, 20100, 20101, 20102, 20103, 20104 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1285. The probes having the nucleotide sequence represented by SEQ ID NOS: 20105, 20106, 20107, 20108, 20109, 20110, 20111, 20112, 20113, 20114, 20115 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1286. The probes having the nucleotide sequence represented by SEQ ID NOS: 20116, 20117, 20118, 20119, 20120, 20121, 20122, 20123, 20124, 20125, 20126 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1287. The probes having the nucleotide sequence represented by SEQ ID NOS: 20127, 20128, 20129, 20130, 20131, 20132, 20133, 20134, 20135, 20136, 20137 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1288. The probes having the nucleotide sequence represented by SEQ ID NOS: 20138, 20139, 20140, 20141, 20142, 20143, 20144, 20145, 20146, 20147, 20148 were selected from the 349 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1289. The probes having the nucleotide sequence represented by SEQ ID NOS: 20149, 20150, 20151, 20152, 20153, 20154, 5 20155, 20156, 20157, 20158, 20159 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1290. The probes having the nucleotide sequence represented by SEQ ID NOS: 20160, 20161, 20162, 20163, 20164, 20165, 10 20166, 20167, 20168, 20169, 20170 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1291. The probes having the nucleotide sequence represented by SEQ ID NOS: 20171, 20172, 20173, 20174, 20175, 20176, 15 20177, 20178, 20179, 20180, 20181 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1292. The probes having the nucleotide sequence represented by SEQ ID NOS: 20182, 20183, 20184, 20185, 20186, 20187, 20 20188, 20189, 20190, 20191, 20192 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1293. The probes having the nucleotide sequence represented by SEQ ID NOS: 20193, 20194, 20195, 20196, 20197, 20198, 25 20199, 20200, 20201, 20202, 20203 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1294. 350 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 20204, 20205, 20206, 20207, 20208, 20209, 20210, 20211, 20212, 20213, 20214 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1295. The probes having the nucleotide sequence represented by SEQ ID NOS: 20215, 20216, 20217, 20218, 20219, 20220, 20221, 20222, 20223, 20224, 20225 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1296. The probes having the nucleotide sequence represented by SEQ ID NOS: 20226, 20227, 20228, 20229, 20230, 20231, 20232, 20233, 20234, 20235, 20236 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1297. The probes having the nucleotide sequence represented by SEQ ID NOS: 20237, 20238, 20239, 20240, 20241, 20242, 20243, 20244, 20245, 20246, 20247 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1298. The probes having the nucleotide sequence represented by SEQ ID NOS: 20248, 20249, 20250, 20251, 20252, 20253, 20254, 20255, 20256, 20257, 20258 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1299. The probes having the nucleotide sequence represented by SEQ ID NOS: 20259, 20260, 20261, 20262, 20263, 20264, 20265, 20266, 20267, 20268, 20269 were selected from the 351 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1300. The probes having the nucleotide sequence represented by SEQ ID NOS: 20270, 20271, 20272, 20273, 20274, 20275, 5 20276, 20277, 20278, 20279, 20280 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1301. The probes having the nucleotide sequence represented by SEQ ID NOS: 20281, 20282, 20283, 20284, 20285, 20286, 10 20287, 20288, 20289, 20290, 20291 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1302. The probes having the nucleotide sequence represented by SEQ ID NOS: 20292, 20293, 20294, 20295, 20296, 20297, 15 20298, 20299, 20300, 20301, 20302 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1303. The probes having the nucleotide sequence represented by SEQ ID NOS: 20303, 20304, 20305, 20306, 20307, 20308, 20 20309, 20310, 20311, 20312, 20313 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1304. The probes having the nucleotide sequence represented by SEQ ID NOS: 20314, 20315, 20316, 20317, 20318, 20319, 25 20320, 20321, 20322, 20323, 20324 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1305. 352 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 20325, 20326, 20327, 20328, 20329, 20330, 20331, 20332, 20333, 20334, 20335 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1306. The probes having the nucleotide sequence represented by SEQ ID NOS: 20336, 20337, 20338, 20339, 20340, 20341, 20342, 20343, 20344, 20345, 20346 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1307. The probes having the nucleotide sequence represented by SEQ ID NOS: 20347, 20348, 20349, 20350, 20351, 20352, 20353, 20354, 20355, 20356, 20357 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1308. The probes having the nucleotide sequence represented by SEQ ID NOS: 20358, 20359, 20360, 20361, 20362, 20363, 20364, 20365, 20366, 20367, 20368 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1309. The probes having the nucleotide sequence represented by SEQ ID NOS: 20369, 20370, 20371, 20372, 20373, 20374, 20375, 20376, 20377, 20378, 20379 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1310. The probes having the nucleotide sequence represented by SEQ ID NOS: 20380, 20381, 20382, 20383, 20384, 20385, 20386, 20387, 20388, 20389, 20390 were selected from the 353 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1311. The probes having the nucleotide sequence represented by SEQ ID NOS: 20391, 20392, 20393, 20394, 20395, 20396, 5 20397, 20398, 20399, 20400, 20401 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1312. The probes having the nucleotide sequence represented by SEQ ID NOS: 20402, 20403, 20404, 20405, 20406, 20407, 10 20408, 20409, 20410, 20411, 20412 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1313. The probes having the nucleotide sequence represented by SEQ ID NOS: 20413, 20414, 20415, 20416, 20417, 20418, 15 20419, 20420, 20421, 20422, 20423 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1314. The probes having the nucleotide sequence represented by SEQ ID NOS: 20424, 20425, 20426, 20427, 20428, 20429, 20 20430, 20431, 20432, 20433, 20434 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1315. The probes having the nucleotide sequence represented by SEQ ID NOS: 20435, 20436, 20437, 20438, 20439, 20440, 25 20441, 20442, 20443, 20444, 20445 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1316. 354 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 20446, 20447, 20448, 20449, 20450, 20451, 20452, 20453, 20454, 20455, 20456 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1317. The probes having the nucleotide sequence represented by SEQ ID NOS: 20457, 20458, 20459, 20460, 20461, 20462, 20463, 20464, 20465, 20466, 20467 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1318. The probes having the nucleotide sequence represented by SEQ ID NOS: 20468, 20469, 20470, 20471, 20472, 20473, 20474, 20475, 20476, 20477, 20478 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1319. The probes having the nucleotide sequence represented by SEQ ID NOS: 20479, 20480, 20481, 20482, 20483, 20484, 20485, 20486, 20487, 20488, 20489 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1320. The probes having the nucleotide sequence represented by SEQ ID NOS: 20490, 20491, 20492, 20493, 20494, 20495, 20496, 20497, 20498, 20499, 20500 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1321. The probes having the nucleotide sequence represented by SEQ ID NOS: 20501, 20502, 20503, 20504, 20505, 20506, 20507, 20508, 20509, 20510, 20511 were selected from the 355 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1322. The probes having the nucleotide sequence represented by SEQ ID NOS: 20512, 20513, 20514, 20515, 20516, 20517, 5 20518, 20519, 20520, 20521, 20522 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1323. The probes having the nucleotide sequence represented by SEQ ID NOS: 20523, 20524, 20525, 20526, 20527, 20528, 10 20529, 20530, 20531, 20532, 20533 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1324. The probes having the nucleotide sequence represented by SEQ ID NOS: 20534, 20535, 20536, 20537, 20538, 20539, 15 20540, 20541, 20542, 20543, 20544 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1325. The probes having the nucleotide sequence represented by SEQ ID NOS: 20545, 20546, 20547, 20548, 20549, 20550, 20 20551, 20552, 20553, 20554, 20555 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1326. The probes having the nucleotide sequence represented by SEQ ID NOS: 20556, 20557, 20558, 20559, 20560, 20561, 25 20562, 20563, 20564, 20565, 20566 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1327. 356 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 20567, 20568, 20569, 20570, 20571, 20572, 20573, 20574, 20575, 20576, 20577 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1328. The probes having the nucleotide sequence represented by SEQ ID NOS: 20578, 20579, 20580, 20581, 20582, 20583, 20584, 20585, 20586, 20587, 20588 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1329. The probes having the nucleotide sequence represented by SEQ ID NOS: 20589, 20590, 20591, 20592, 20593, 20594, 20595, 20596, 20597, 20598, 20599 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1330. The probes having the nucleotide sequence represented by SEQ ID NOS: 20600, 20601, 20602, 20603, 20604, 20605, 20606, 20607, 20608, 20609, 20610 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1331. The probes having the nucleotide sequence represented by SEQ ID NOS: 20611, 20612, 20613, 20614, 20615, 20616, 20617, 20618, 20619, 20620, 20621 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1332. The probes having the nucleotide sequence represented by SEQ ID NOS: 20622, 20623, 20624, 20625, 20626, 20627, 20628, 20629, 20630, 20631, 20632 were selected from the 357 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1333. The probes having the nucleotide sequence represented by SEQ ID NOS: 20633, 20634, 20635, 20636, 20637, 20638, 5 20639, 20640, 20641, 20642, 20643 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1334. The probes having the nucleotide sequence represented by SEQ ID NOS: 20644, 20645, 20646, 20647, 20648, 20649, 10 20650, 20651, 20652, 20653, 20654 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1335. The probes having the nucleotide sequence represented by SEQ ID NOS: 20655, 20656, 20657, 20658, 20659, 20660, 15 20661, 20662, 20663, 20664, 20665 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1336. The probes having the nucleotide sequence represented by SEQ ID NOS: 20666, 20667, 20668, 20669, 20670, 20671, 20 20672, 20673, 20674, 20675, 20676 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1337. The probes having the nucleotide sequence represented by SEQ ID NOS: 20677, 20678, 20679, 20680, 20681, 20682, 25 20683, 20684, 20685, 20686, 20687 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1338. 358 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 20688, 20689, 20690, 20691, 20692, 20693, 20694, 20695, 20696, 20697, 20698 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1339. The probes having the nucleotide sequence represented by SEQ ID NOS: 20699, 20700, 20701, 20702, 20703, 20704, 20705, 20706, 20707, 20708, 20709 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1340. The probes having the nucleotide sequence represented by SEQ ID NOS: 20710, 20711, 20712, 20713, 20714, 20715, 20716, 20717, 20718, 20719, 20720 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1341. The probes having the nucleotide sequence represented by SEQ ID NOS: 20721, 20722, 20723, 20724, 20725, 20726, 20727, 20728, 20729, 20730, 20731 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1342. The probes having the nucleotide sequence represented by SEQ ID NOS: 20732, 20733, 20734, 20735, 20736, 20737, 20738, 20739, 20740, 20741, 20742 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1343. The probes having the nucleotide sequence represented by SEQ ID NOS: 20743, 20744, 20745, 20746, 20747, 20748, 20749, 20750, 20751, 20752, 20753 were selected from the 359 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1344. The probes having the nucleotide sequence represented by SEQ ID NOS: 20754, 20755, 20756, 20757, 20758, 20759, 5 20760, 20761, 20762, 20763, 20764 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1345. The probes having the nucleotide sequence represented by SEQ ID NOS: 20765, 20766, 20767, 20768, 20769, 20770, 10 20771, 20772, 20773, 20774, 20775 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1346. The probes having the nucleotide sequence represented by SEQ ID NOS: 20776, 20777, 20778, 20779, 20780, 20781, 15 20782, 20783, 20784, 20785, 20786 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1347. The probes having the nucleotide sequence represented by SEQ ID NOS: 20787, 20788, 20789, 20790, 20791, 20792, 20 20793, 20794, 20795, 20796, 20797 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1348. The probes having the nucleotide sequence represented by SEQ ID NOS: 20798, 20799, 20800, 20801, 20802, 20803, 25 20804, 20805, 20806, 20807, 20808 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1349. 360 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 20809, 20810, 20811, 20812, 20813, 20814, 20815, 20816, 20817, 20818, 20819 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1350. The probes having the nucleotide sequence represented by SEQ ID NOS: 20820, 20821, 20822, 20823, 20824, 20825, 20826, 20827, 20828, 20829, 20830 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1351. The probes having the nucleotide sequence represented by SEQ ID NOS: 20831, 20832, 20833, 20834, 20835, 20836, 20837, 20838, 20839, 20840, 20841 were selected from the ORFs having the nucleotide sequence represented by- SEQ ID 15 NO: 1352. The probes having the nucleotide sequence represented by SEQ ID NOS: 20842, 20843, 20844, 20845, 20846, 20847, 20848, 20849, 20850, 20851, 20852 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1353. The probes having the nucleotide sequence represented by SEQ ID NOS: 20853, 20854, 20855, 20856, 20857, 20858, 20859, 20860, 20861, 20862, 20863 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1354. The probes having the nucleotide sequence represented by SEQ ID NOS: 20864, 20865, 20866, 20867, 20868, 20869, 20870, 20871, 20872, 20873, 20874 were selected from the 361 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1355. The probes having the nucleotide sequence represented by SEQ ID NOS: 20875, 20876, 20877, 20878, 20879, 20880, 5 20881, 20882, 20883, 20884, 20885 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1356. The probes having the nucleotide sequence represented by SEQ ID NOS: 20886, 20887, 20888, 20889, 20890, 20891, 10 20892, 20893, 20894, 20895, 20896 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1357. The probes having the nucleotide sequence represented by SEQ ID NOS: 20897, 20898, 20899, 20900, 20901, 20902, 15 20903, 20904, 20905, 20906, 20907 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1358. The probes having the nucleotide sequence represented by SEQ ID NOS: 20908, 20909, 20910, 20911, 20912, 20913, 20 20914, 20915, 20916, 20917, 20918 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1359. The probes having the nucleotide sequence represented by SEQ ID NOS: 20919, 20920, 20921, 20922, 20923, 20924, 25 20925, 20926, 20927, 20928, 20929 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1360. 362 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 20930, 20931, 20932, 20933, 20934, 20935, 20936, 20937, 20938, 20939, 20940 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1361. The probes having the nucleotide sequence represented by SEQ ID NOS: 20941, 20942, 20943, 20944, 20945, 20946, 20947, 20948, 20949, 20950, 20951 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1362. The probes having the nucleotide sequence represented by SEQ ID NOS: 20952, 20953, 20954, 20955, 20956, 20957, 20958, 20959, 20960, 20961, 20962 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1363. The probes having the nucleotide sequence represented by SEQ ID NOS: 20963, 20964, 20965, 20966, 20967, 20968, 20969, 20970, 20971, 20972, 20973 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1364. The probes having the nucleotide sequence represented by SEQ ID NOS: 20974, 20975, 20976, 20977, 20978, 20979, 20980, 20981, 20982, 20983, 20984 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1365. The probes having the nucleotide sequence represented by SEQ ID NOS: 20985, 20986, 20987, 20988, 20989, 20990, 20991, 20992, 20993, 20994, 20995 were selected from the 363 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1366. The probes having the nucleotide sequence represented by SEQ ID NOS: 20996, 20997, 20998, 20999, 21000, 21001, 5 21002, 21003, 21004, 21005, 21006 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1367. The probes having the nucleotide sequence represented by SEQ ID NOS: 21007, 21008, 21009, 21010, 21011, 21012, 10 21013, 21014, 21015, 21016, 21017 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1368. The probes having the nucleotide sequence represented by SEQ ID NOS: 21018, 21019, 21020, 21021, 21022, 21023, 15 21024, 21025, 21026, 21027, 21028 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1369. The probes having the nucleotide sequence represented by SEQ ID NOS: 21029, 21030, 21031, 21032, 21033, 21034, 20 21035, 21036, 21037, 21038, 21039 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1370. The probes having the nucleotide sequence represented by SEQ ID NOS: 21040, 21041, 21042, 21043, 21044, 21045, 25 21046, 21047, 21048, 21049, 21050 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1371. 364 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 21051, 21052, 21053, 21054, 21055, 21056, 21057, 21058, 21059, 21060, 21061 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1372. The probes having the nucleotide sequence represented by SEQ ID NOS: 21062, 21063, 21064, 21065, 21066, 21067, 21068, 21069, 21070, 21071, 21072 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1373. The probes having the nucleotide sequence represented by SEQ ID NOS: 21073, 21074, 21075, 21076, 21077, 21078, 21079, 21080, 21081, 21082, 21083 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1374. The probes having the nucleotide sequence represented by SEQ ID NOS: 21084, 21085, 21086, 21087, 21088, 21089, 21090, 21091, 21092, 21093, 21094 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1375. The probes having the nucleotide sequence represented by SEQ ID NOS: 21095, 21096, 21097, 21098, 21099, 21100, 21101, 21102, 21103, 21104, 21105 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1376. The probes having the nucleotide sequence represented by SEQ ID NOS: 21106, 21107, 21108, 21109, 21110, 21111, 21112, 21113, 21114, 21115, 21116 were selected from the 365 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1377. The probes having the nucleotide sequence represented by SEQ ID NOS: 21117, 21118, 21119, 21120, 21121, 21122, 5 21123, 21124, 21125, 21126, 21127 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1378. The probes having the nucleotide sequence represented by SEQ ID NOS: 21128, 21129, 21130, 21131, 21132, 21133, 10 21134, 21135, 21136, 21137, 21138 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1379. The probes having the nucleotide sequence represented by SEQ ID NOS: 21139, 21140, 21141, 21142, 21143, 21144, 15 21145, 21146, 21147, 21148, 21149 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1380. The probes having the nucleotide sequence represented by SEQ ID NOS: 21150, 21151, 21152, 21153, 21154, 21155, 20 21156, 21157, 21158, 21159, 21160 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1381. The probes having the nucleotide sequence represented by SEQ ID NOS: 21161, 21162, 21163, 21164, 21165, 21166, 25 21167, 21168, 21169, 21170, 21171 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1382. 366 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 21172, 21173, 21174, 21175, 21176, 21177, 21178, 21179, 21180, 21181, 21182 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1383. The probes having the nucleotide sequence represented by SEQ ID NOS: 21183, 21184, 21185, 21186, 21187, 21188, 21189, 21190, 21191, 21192, 21193, 21194, 21195, 21196, 21197, 21198, 21199, 21200, 21201, 21202, 21203, 21204 were 10 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1384. The probes having the nucleotide sequence represented by SEQ ID NOS: 21205, 21206, 21207, 21208, 21209, 21210, 21211, 21212, 21213, 21214, 21215 were selected from the 15 ORFs having the nucleotide sequence represented by SEQ ID NO: 1385. The probes having the nucleotide sequence represented by SEQ ID NOS: 21216, 21217, 21218, 21219, 21220, 21221, 21222, 21223, 21224, 21225, 21226 were selected from the 20 ORFs having the nucleotide sequence represented by SEQ ID NO: 1386. The probes having the nucleotide sequence represented by SEQ ID NOS: 21227, 21228, 21229, 21230, 21231, 21232, 21233, 21234, 21235, 21236, 21237 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 1387. The probes having the nucleotide sequence represented by SEQ ID NOS: 21238, 21239, 21240, 21241, 21242, 21243, 367 WO 2006/024951 PCT/IB2005/002908 21244, 21245, 21246, 21247, 21248 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1388. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 21249, 21250, 21251, 21252, 21253, 21254, 21255, 21256, 21257, 21258, 21259 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1389. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 21260, 21261, 21262, 21263, 21264, 21265, 21266, 21267, 21268, 21269, 21270-were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1390. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 21271, 21272, 21273, 21274, 21275, 21276, 21277, 21278, 21279, 21280, 21281 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1391. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 21282, 21283, 21284, 21285, 21286, 21287, 21288, 21289, 21290, 21291, 21292 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1392. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 21293, 21294, 21295, 21296, 21297, 21298, 21299, 21300, 21301, 21302, 21303 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1393. 368 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 21304, 21305, 21306, 21307, 21308, 21309, 21310, 21311, 21312, 21313, 21314 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1394. The probes having the nucleotide sequence represented by SEQ ID NOS: 21315, 21316, 21317, 21318, 21319, 21320, 21321, 21322, 21323, 21324, 21325 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1395. The probes having the nucleotide sequence represented by SEQ ID NOS: 21326, 21327, 21328,' 21329, 21330, 21331, 21332, 21333, 21334, 21335, 21336 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1396. The probes having the nucleotide sequence represented by SEQ ID NOS: 21337, 21338, 21339, 21340, 21341, 21342, 21343, 21344, 21345, 21346, 21347 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1397. The probes having the nucleotide sequence represented by SEQ ID NOS: 21348, 21349, 21350, 21351, 21352, 21353, 21354, 21355, 21356, 21357, 21358 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1398. The probes having the nucleotide sequence represented by SEQ ID NOS: 21359, 21360, 21361, 21362, 21363, 21364, 21365, 21366, 21367, 21368, 21369 were selected from the 369 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1399. The probes having the nucleotide sequence represented by SEQ ID NOS: 21370, 21371, 21372, 21373, 21374, 21375, 5 21376, 21377, 21378, 21379, 21380 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1400. The probes having the nucleotide sequence represented by SEQ ID NOS: 21381, 21382, 21383, 21384, 21385, 21386, 10 21387, 21388, 21389, 21390, 21391 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1401. The probes having the nucleotide sequence represented by SEQ ID NOS: 21392, 21393, 21394, 21395, 21396, 21397, 15 21398, 21399, 21400, 21401, 21402 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1402. The probes having the nucleotide sequence represented by SEQ ID NOS: 21403, 21404, 21405, 21406, 21407, 21408, 20 21409, 21410, 21411, 21412, 21413 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1403. The probes having the nucleotide sequence represented by SEQ ID NOS: 21414, 21415, 21416, 21417, 21418, 21419, 25 21420, 21421, 21422, 21423, 21424 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1404. 370 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 21425, 21426, 21427, 21428, 21429, 21430, 21431, 21432, 21433, 21434, 21435 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1405. The probes having the nucleotide sequence represented by SEQ ID NOS: 21436, 21437, 21438, 21439, 21440, 21441, 21442, 21443, 21444, 21445, 21446 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1406. The probes having the nucleotide sequence represented by SEQ ID NOS: 21447, 21448, 21449, 21450, 21451, 21452, 21453, 21454, 21455, 21456, 21457 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1407. The probes having the nucleotide sequence represented by SEQ ID NOS: 21458, 21459, 21460, 21461, 21462, 21463, 21464, 21465, 21466, 21467, 21468 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1408. The probes having the nucleotide sequence represented by SEQ ID NOS: 21469, 21470, 21471, 21472, 21473, 21474, 21475, 21476, 21477, 21478, 21479 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1409. The probes having the nucleotide sequence represented by SEQ ID NOS: 21480, 21481, 21482, 21483, 21484, 21485, 21486, 21487, 21488, 21489, 21490 were selected from the 371 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1410. The probes having the nucleotide sequence represented by SEQ ID NOS: 21491, 21492, 21493, 21494, 21495, 21496, 5 21497, 21498, 21499, 21500, 21501 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1411. The probes having the nucleotide sequence represented by SEQ ID NOS: 21502, 21503, 21504, 21505, 21506, 21507, 10 21508, 21509, 21510, 21511, 21512 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1412. The probes having the nucleotide sequence represented by SEQ ID NOS: 21513, 21514, 21515, 21516, 21517, 21518, 15 21519, 21520, 21521, 21522, 21523 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1413. The probes having the nucleotide sequence represented by SEQ ID NOS: 21524, 21525, 21526, 21527, 21528, 21529, 20 21530, 21531, 21532, 21533, 21534 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1414. The probes having the nucleotide sequence represented by SEQ ID NOS: 21535, 21536, 21537, 21538, 21539, 21540, 25 21541, 21542, 21543, 21544, 21545 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1415. 372 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 21546, 21547, 21548, 21549, 21550, 21551, 21552, 21553, 21554, 21555, 21556 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1416. The probes having the nucleotide sequence represented by SEQ ID NOS: 21557, 21558, 21559, 21560, 21561, 21562, 21563, 21564, 21565, 21566, 21567 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1417. The probes having the nucleotide sequence represented by SEQ ID NOS: 21568, 21569, 21570, 21571, 21572, 21573, 21574, 21575, 21576, 21577, 21578 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1418. The probes having the nucleotide sequence represented by SEQ ID NOS: 21579, 21580, 21581, 21582, 21583, 21584, 21585, 21586, 21587, 21588, 21589 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1419. The probes having the nucleotide sequence represented by SEQ ID NOS: 21590, 21591, 21592, 21593, 21594, 21595, 21596, 21597, 21598, 21599, 21600 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1420. The probes having the nucleotide sequence represented by SEQ ID NOS: 21601, 21602, 21603, 21604, 21605, 21606, 21607, 21608, 21609, 21610, 21611 were selected from the 373 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1421. The probes having the nucleotide sequence represented by SEQ ID NOS: 21612, 21613, 21614, 21615, 21616, 21617, 5 21618, 21619, 21620, 21621, 21622 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1422. The probes having the nucleotide sequence represented by SEQ ID NOS: 21623, 21624, 21625, 21626, 21627, 21628, 10 21629, 21630, 21631, 21632, 21633 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1423. The probes having the nucleotide sequence represented by SEQ ID NOS: 21634, 21635, 21636, 21637, 21638, 21639, 15 21640, 21641, 21642, 21643, 21644 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1424. The probes having the nucleotide sequence represented by SEQ ID NOS: 21645, 21646, 21647, 21648, 21649, 21650, 20 21651, 21652, 21653, 21654, 21655 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1425. The probes having the nucleotide sequence represented by SEQ ID NOS: 21656, 21657, 21658, 21659, 21660, 21661, 25 21662, 21663, 21664, 21665, 21666 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1426. 374 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 21667, 21668, 21669, 21670, 21671, 21672, 21673, 21674, 21675, 21676, 21677 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1427. The probes having the nucleotide sequence represented by SEQ ID NOS: 21678, 21679, 21680, 21681, 21682, 21683, 21684, 21685, 21686, 21687, 21688 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1428. The probes having the nucleotide sequence represented by SEQ ID NOS: 21689, 21690, 21691, 21692, 21693, 21694, 21695, 21696, 21697, 21698, 21699 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1429. The probes having the nucleotide sequence represented by SEQ ID NOS: 21700, 21701, 21702, 21703, 21704, 21705, 21706, 21707, 21708, 21709, 21710 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1430. The probes having the nucleotide sequence represented by SEQ ID NOS: 21711, 21712, 21713, 21714, 21715, 21716, 21717, 21718, 21719, 21720, 21721 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1431. The probes having the nucleotide sequence represented by SEQ ID NOS: 21722, 21723, 21724, 21725, 21726, 21727, 21728, 21729, 21730, 21731, 21732 were selected from the 375 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1432. The probes having the nucleotide sequence represented by SEQ ID NOS: 21733, 21734, 21735, 21736, 21737, 21738, 5 21739, 21740, 21741, 21742, 21743 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1433. The probes having the nucleotide sequence represented by SEQ ID NOS: 21744, 21745, 21746, 21747, 21748, 21749, 10 21750, 21751, 21752, 21753, 21754 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1434. The probes having the nucleotide sequence represented by SEQ ID NOS: 21755, 21756, 21757, 21758, 21759, 21760, 15 21761, 21762, 21763, 21764, 21765 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1435. The probes having the nucleotide sequence represented by SEQ ID NOS: 21766, 21767, 21768, 21769, 21770, 21771, 20 21772, 21773, 21774, 21775, 21776 were- selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1436. The probes having the nucleotide sequence represented by SEQ ID NOS: 21777, 21778, 21779, 21780, 21781, 21782, 25 21783, 21784, 21785, 21786, 21787 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1437. 376 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 21788, 21789, 21790, 21791, 21792, 21793, 21794, 21795, 21796, 21797, 21798 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1438. The probes having the nucleotide sequence represented by SEQ ID NOS: 21799, 21800, 21801, 21802, 21803, 21804, 21805, 21806, 21807, 21808, 21809 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1439. The probes having the nucleotide sequence represented by SEQ ID NOS: 21810, 21811, 21812, 21813, 21814, 21815, 21816, 21817, 21818, 21819, 21820 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1440. The probes having the nucleotide sequence represented by SEQ ID NOS: 21821, 21822, 21823, 21824, 21825, 21826, 21827, 21828, 21829, 21830, 21831 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1441. The probes having the nucleotide sequence represented by SEQ ID NOS: 21832, 21833, 21834, 21835, 21836, 21837, 21838, 21839, 21840, 21841, 21842 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1442. The probes having the nucleotide sequence represented by SEQ ID NOS: 21843, 21844, 21845, 21846, 21847, 21848, 21849, 21850, 21851, 21852, 21853 were selected from the 377 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1443. The probes having the nucleotide sequence represented by SEQ ID NOS: 21854, 21855, 21856, 21857, 21858, 21859, 5 21860, 21861, 21862, 21863, 21864 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1444. The probes having the nucleotide sequence represented by SEQ ID NOS: 21865, 21866, 21867, 21868, 21869, 21870, 10 21871, 21872, 21873, 21874, 21875 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1445. The probes having the nucleotide sequence represented by SEQ ID NOS: 21876, 21877, 21878, 21879, 21880, 21881, 15 21882, 21883, 21884, 21885, 21886 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1446. The probes having the nucleotide sequence represented by SEQ ID NOS: 21887, 21888, 21889, 21890, 21891, 21892, 20 21893, 21894, 21895, 21896, 21897 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1447. The probes having the nucleotide sequence represented by SEQ ID NOS: 21898, 21899, 21900, 21901, 21902, 21903, 25 21904, 21905, 21906, 21907, 21908 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1448. 378 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 21909, 21910, 21911, 21912, 21913, 21914, 21915, 21916, 21917, 21918, 21919 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1449. The probes having the nucleotide sequence represented by SEQ ID NOS: 21920, 21921, 21922, 21923, 21924, 21925, 21926, 21927, 21928, 21929, 21930 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1450. The probes having the nucleotide sequence represented by SEQ ID NOS: 21931, 21932, 21933, 21934, 21935, 21936, 21937, 21938, 21939, 21940, 21941 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1451. The probes having the nucleotide sequence represented by SEQ ID NOS: 21942, 21943, 21944, 21945, 21946, 21947, 21948, 21949, 21950, 21951, 21952 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1452. The probes having the nucleotide sequence represented by SEQ ID NOS: 21953, 21954, 21955, 21956, 21957, 21958, 21959, 21960, 21961, 21962, 21963 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1453. The probes having the nucleotide sequence represented by SEQ ID NOS: 21964, 21965, 21966, 21967, 21968, 21969, 21970, 21971, 21972, 21973, 21974 were selected from the 379 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1454. The probes having the nucleotide sequence represented by SEQ ID NOS: 21975, 21976, 21977, 21978, 21979, 21980, 5 21981, 21982, 21983, 21984, 21985 were, selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1455. The probes having the nucleotide sequence represented by SEQ ID NOS: 21986, 21987, 21988, 21989, 21990, 21991, 10 21992, 21993, 21994, 21995, 21996 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1456. The probes having the nucleotide sequence represented by SEQ ID NOS: 21997, 21998, 21999, 22000, 22001, 22002, 15 22003, 22004, 22005, 22006, 22007 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1457. The probes having the nucleotide sequence represented by SEQ ID NOS: 22008, 22009, 22010, 22011, 22012, 22013, 20 22014, 22015, 22016, 22017, 22018 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1458. The probes having the nucleotide sequence represented by SEQ ID NOS: 22019, 22020, 22021, 22022, 22023, 22024, 25 22025, 22026, 22027, 22028, 22029 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1459. 380 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 22030, 22031, 22032, 22033, 22034, 22035, 22036, 22037, 22038, 22039, 22040 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1460. The probes having the nucleotide sequence represented by SEQ ID NOS: 22041, 22042, 22043, 22044, 22045, 22046, 22047, 22048, 22049, 22050, 22051 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1461. The probes having the nucleotide sequence represented by SEQ ID NOS: 22052, 22053, 22054, 22055, 22056, 22057, 22058, 22059, 22060, 22061, 22062 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1462. The probes having the nucleotide sequence represented by SEQ ID NOS: 22063, 22064, 22065, 22066, 22067, 22068, 22069, 22070, 22071, 22072, 22073 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1463. The probes having the nucleotide sequence represented by SEQ ID NOS: 22074, 22075, 22076, 22077, 22078, 22079, 22080, 22081, 22082, 22083, 22084 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1464. The probes having the nucleotide sequence represented by SEQ ID NOS: 22085, 22086, 22087, 22088, 22089, 22090, 22091, 22092, 22093, 22094, 22095 were selected from the 381 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1465. The probes having the nucleotide sequence represented by SEQ ID NOS: 22096, 22097, 22098, 22099, 22100, 22101, 5 22102, 22103, 22104, 22105, 22106 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1466. The probes having the nucleotide sequence represented by SEQ ID NOS: 22107, 22108, 22109, 22110, 22111, 22112, 10 22113, 22114, 22115, 22116, 22117 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1467. The probes having the nucleotide sequence represented by SEQ ID NOS: 22118, 22119, 22120, 22121, 22122, 22123, 15 22124, 22125, 22126, 22127, 22128 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1468. The probes having the nucleotide sequence represented by SEQ ID NOS: 22129, 22130, 22131, 22132, 22133, 22134, 20 22135, 22136, 22137, 22138, 22139 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1469. The probes having the nucleotide sequence represented by SEQ ID NOS: 22140, 22141, 22142, 22143, 22144, 22145, 25 22146, 22147, 22148, 22149, 22150 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1470. 382 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 22151, 22152, 22153, 22154, 22155, 22156, 22157, 22158, 22159, 22160, 22161 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1471. The probes having the nucleotide sequence represented by SEQ ID NOS: 22162, 22163, 22164, 22165, 22166, 22167, 22168, 22169, 22170, 22171, 22172 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1472. The probes having the nucleotide sequence represented by SEQ ID NOS: 22173, 22174, 22175, 22176, 22177, 22178, 22179, 22180, 22181, 22182, 22183 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1473. The probes having the nucleotide sequence represented by SEQ ID NOS: 22184, 22185, 22186, 22187, 22188, 22189, 22190, 22191, 22192, 22193, 22194 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1474. The probes having the nucleotide sequence represented by SEQ ID NOS: 22195, 22196, 22197, 22198, 22199, 22200, 22201, 22202, 22203, 22204, 22205 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1475. The probes having the nucleotide sequence represented by SEQ ID NOS: 22206, 22207, 22208, 22209, 22210, 22211, 22212, 22213, 22214, 22215, 22216 were selected from the 383 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1476. The probes having the nucleotide sequence represented by SEQ ID NOS: 22217, 22218, 22219, 22220, 22221, 22222, 5 22223, 22224, 22225, 22226, 22227 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1477. The probes having the nucleotide sequence represented by SEQ ID NOS: 22228, 22229, 22230, 22231, 22232, 22233, 10 22234, 22235, 22236, 22237, 22238 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1478. The probes having the nucleotide sequence represented by SEQ ID NOS: 22239, 22240, 22241, 22242, 22243, 22244, 15 22245, 22246, 22247, 22248, 22249 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1479. The probes having the nucleotide sequence represented by SEQ ID NOS: 22250, 22251, 22252, 22253, 22254, 22255, 20 22256, 22257, 22258, 22259, 22260 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1480. The probes having the nucleotide sequence represented by SEQ ID NOS: 22261, 22262, 22263, 22264, 22265, 22266, 25 22267, 22268, 22269, 22270, 22271 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1481. 384 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 22272, 22273, 22274, 22275, 22276, 22277, 22278, 22279, 22280, 22281, 22282 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1482. The probes having the nucleotide sequence represented by SEQ ID NOS: 22283, 22284, 22285, 22286, 22287, 22288, 22289, 22290, 22291, 22292, 22293 were selected from the. ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1483. The probes having the nucleotide sequence represented by SEQ ID NOS: 22294, 22295, 22296, 22297, 22298, .22299, 22300, 22301, 22302, 22303, 22304 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1484. The probes having the nucleotide sequence represented by SEQ ID NOS: 22305, 22306, 22307, 22308, 22309, 22310, 22311, 22312, 22313, 22314, 22315 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1485. The probes having the nucleotide sequence represented by SEQ ID NOS: 22316, 22317, 22318, 22319, 22320, 22321, 22322, 22323, 22324, 22325, 22326 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1486. The probes having the nucleotide sequence represented by SEQ ID NOS: 22327, 22328, 22329, 22330, 22331, 22332, 22333, 22334, 22335, 22336, 22337 were selected from the 385 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1487. The probes having the nucleotide sequence represented by SEQ ID NOS: 22338, 22339, 22340, 22341, 22342, 22343, 5 22344, 22345, 22346, 22347, 22348 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1488. The probes having the nucleotide sequence represented by SEQ ID NOS: 22349, 22350, 22351, 22352, 22353, 22354, 10 22355, 22356, 22357, 22358, 22359 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1489. The probes having the nucleotide sequence represented by SEQ ID NOS: 22360, 22361, 22362, 22363, 22364, 22365, 15 22366, 22367, 22368, 22369, 22370 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1490. The probes having the nucleotide sequence represented by SEQ ID NOS: 22371, 22372, 22373, 22374, 22375, 22376, 20 22377, 22378, 22379, 22380, 22381 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1491. The probes having the nucleotide sequence represented by SEQ ID NOS: 22382, 22383, 22384, 22385, 22386, 22387, 25 22388, 22389, 22390, 22391, 22392 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1492. 386 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 22393, 22394, 22395, 22396, 22397, 22398, 22399, 22400, 22401, 22402, 22403 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1493. The probes having the nucleotide sequence represented by SEQ ID NOS: 22404, 22405, 22406, 22407, 22408, 22409, 22410, 22411, 22412, 22413, 22414 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1494. The probes having the nucleotide sequence represented by SEQ ID NOS: 22415, 22416, 22417, 22418, 22419, 22420, 22421, 22422, 22423, 22424, 22425 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1495. The probes having the nucleotide sequence represented by SEQ ID NOS: 22426, 22427, 22428, 22429, 22430, 22431, 22432, 22433, 22434, 22435, 22436 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1496. The probes having the nucleotide sequence represented by SEQ ID NOS: 22437, 22438, 22439, 22440, 22441, 22442, 22443, 22444, 22445, 22446, 22447 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1497. The probes having the nucleotide sequence represented by SEQ ID NOS: 22448, 22449, 22450, 22451, 22452, 22453, 22454, 22455, 22456, 22457, 22458 were selected from the 387 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1498. The probes having the nucleotide sequence represented by SEQ ID NOS: 22459, 22460, 22461, 22462, 22463, 22464, 5 22465, 22466, 22467, 22468, 22469 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1499. The probes having the nucleotide sequence represented by SEQ ID NOS: 22470, 22471, 22472, 22473, 22474, 22475, 10 22476, 22477, 22478, 22479, 22480 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1500. The probes having the nucleotide sequence represented by SEQ ID NOS: 22481, 22482, 22483, 22484, 22485, 22486, 15 22487, 22488, 22489, 22490, 22491 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1501. The probes having the nucleotide sequence represented by SEQ ID NOS: 22492, 22493, 22494, 22495, 22496, 22497, 20 22498, 22499, 22500, 22501, 22502 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1502. The probes having the nucleotide sequence represented by SEQ ID NOS: 22503, 22504, 22505, 22506, 22507, 22508, 25 22509, 22510, 22511, 22512, 22513 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1503. 388 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 22514, 22515, 22516, 22517, 22518, 22519, 22520, 22521, 22522, 22523, 22524 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1504. The probes having the nucleotide sequence represented by SEQ ID NOS: 22525, 22526, 22527, 22528, 22529, 22530, 22531, 22532, 22533, 22534, 22535 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1505. The probes having the nucleotide sequence represented by SEQ ID NOS: 22536, 22537, 22538, 22539, 22540, 22541, 22542, 22543, 22544, 22545, 22546 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1506. The probes having the nucleotide sequence represented by SEQ ID NOS: 22547, 22548, 22549, 22550, 22551, 22552, 22553, 22554, 22555, 22556, 22557 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1507. The probes having the nucleotide sequence represented by SEQ ID NOS: 22558, 22559, 22560, 22561, 22562, 22563, 22564, 22565, 22566, 22567, 22568 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1508. The probes having the nucleotide sequence represented by SEQ ID NOS: 22569, 22570, 22571, 22572, 22573, 22574, 22575, 22576, 22577, 22578, 22579 were selected from the 389 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1509. The probes having the nucleotide sequence represented by SEQ ID NOS: 22580, 22581, 22582, 22583, 22584, 22585, 5 22586, 22587, 22588, 22589, 22590 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1510. The probes having the nucleotide sequence represented by SEQ ID NOS: 22591, 22592, 22593, 22594, 22595, 22596, 10 22597, 22598, 22599, 22600, 22601 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1511. The probes having the nucleotide sequence represented by SEQ ID NOS: 22602, 22603, 22604, 22605, 22606, 22607, 15 22608, 22609, 22610, 22611, 22612 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1512. The probes having the nucleotide sequence represented by SEQ ID NOS: 22613, 22614, 22615, 22616, 22617, 22618, 20 22619, 22620, 22621, 22622, 22623 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1513. The probes having the nucleotide sequence represented by SEQ ID NOS: 22624, 22625, 22626, 22627, 22628, 22629, 25 22630, 22631, 22632, 22633, 22634 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1514. 390 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 22635, 22636, 22637, 22638, 22639, 22640, 22641, 22642, 22643, 22644, 22645 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1515. The probes having the nucleotide sequence represented by SEQ ID NOS: 22646, 22647, 22648, 22649, 22650, 22651, 22652, 22653, 22654, 22655, 22656 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1516. The probes having the nucleotide sequence represented by SEQ ID NOS: 22657, 22658, 22659, 22660, 22661, 22662, 22663, 22664, 22665, 22666, 22667 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1517. The probes having the nucleotide sequence represented by SEQ ID NOS: 22668, 22669, 22670, 22671, 22672, 22673, 22674, 22675, 22676, 22677, 22678 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1518. The probes having the nucleotide sequence represented by SEQ ID NOS: 22679, 22680, 22681, 22682, 22683, 22684, 22685, 22686, 22687, 22688, 22689 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1519. The probes having the nucleotide sequence represented by SEQ ID NOS: 22690, 22691, 22692, 22693, 22694, 22695, 22696, 22697, 22698, 22699, 22700 were selected from the 391 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1520. The probes having the nucleotide sequence represented by SEQ ID NOS: 22701, 22702, 22703, 22704, 22705, 22706, 5 22707, 22708, 22709, 22710, 22711 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1521. The probes having the nucleotide sequence represented by SEQ ID NOS: 22712, 22713, 22714, 22715, 22716, 22717, 10 22718, 22719, 22720, 22721, 22722 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1522. The probes having the nucleotide sequence represented by SEQ ID NOS: 22723, 22724, 22725, 22726, 22727, 22728, 15 22729, 22730, 22731, 22732, 22733 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1523. The probes having the nucleotide sequence represented by SEQ ID NOS: 22734, 22735, 22736, 22737, 22738, 22739, 20 22740, 22741, 22742, 22743, 22744 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1524. The probes having the nucleotide sequence represented by SEQ ID NOS: 22745, 22746, 22747, 22748, 22749, 22750, 25 22751, 22752, 22753, 22754, 22755 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1525. 392 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 22756, 22757, 22758, 22759, 22760, 22761, 22762, 22763, 22764, 22765, 22766 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1526. The probes having the nucleotide sequence represented by SEQ ID NOS: 22767, 22768, 22769, 22770, 22771, 22772, 22773, 22774, 22775, 22776, 22777 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1527. The probes having the nucleotide sequence represented by SEQ ID NOS: 22778, 22779, 22780, 22781, 22782, 22783, 22784, 22785, 22786, 22787, 22788 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1528. The probes having the nucleotide sequence represented by SEQ ID NOS: 22789, 22790, 22791, 22792, 22793, 22794, 22795, 22796, 22797, 22798, 22799 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1529. The probes having the nucleotide sequence represented by SEQ ID NOS: 22800, 22801, 22802, 22803, 22804, 22805, 22806, 22807, 22808, 22809, 22810 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1530. The probes having the nucleotide sequence represented by SEQ ID NOS: 22811, 22812, 22813, 22814, 22815, 22816, 22817, 22818, 22819, 22820, 22821 were selected from the 393 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1531. The probes having the nucleotide sequence represented by SEQ ID NOS: 22822, 22823, 22824, 22825, 22826, 22827, 5 22828, 22829, 22830, 22831, 22832 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1532. The probes having the nucleotide sequence represented by SEQ ID NOS: 22833, 22834, 22835, 22836, 22837, 22838, 10 22839, 22840, 22841, 22842, 22843 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1533. The probes having the nucleotide sequence represented by SEQ ID NOS: 22844, 22845, 22846, 22847, 22848, 22849, 15 22850, 22851, 22852, 22853, 22854 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1534. The probes having the nucleotide sequence represented by SEQ ID NOS: 22855, 22856, 22857, 22858, 22859, 22860, 20 22861, 22862, 22863, 22864, 22865 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1535. The probes having the nucleotide sequence represented by SEQ ID NOS: 22866, 22867, 22868, 22869, 22870, 22871, 25 22872, 22873, 22874, 22875, 22876 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1536. 394 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 22877, 22878, 22879, 22880, 22881, 22882, 22883, 22884, 22885, 22886, 22887 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1537. The probes having the nucleotide sequence represented by SEQ ID NOS: 22888, 22889, 22890, 22891, 22892, 22893, 22894, 22895, 22896, 22897, 22898 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1538. The probes having the nucleotide sequence represented by SEQ ID NOS: 22899, 22900, 22901, 22902, 22903, 22904, 22905, 22906, 22907, 22908, 22909 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1539. The probes having the nucleotide sequence represented by SEQ ID NOS: 22910, 22911, 22912, 22913, 22914, 22915, 22916, 22917, 22918, 22919, 22920 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1540. The probes having the nucleotide sequence represented by SEQ ID NOS: 22921, 22922, 22923, 22924, 22925, 22926, 22927, 22928, 22929, 22930, 22931 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1541. The probes having the nucleotide sequence represented by SEQ ID NOS: 22932, 22933, 22934, 22935, 22936, 22937, 22938, 22939, 22940, 22941, 22942 were selected from the 395 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1542. The probes having the nucleotide sequence represented by SEQ ID NOS: 22943, 22944, 22945, 22946, 22947, 22948, 5 22949, 22950, 22951, 22952, 22953 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1543. The probes having the nucleotide sequence represented by SEQ ID NOS: 22954, 22955, 22956, 22957, 22958, 22959, 10 22960, 22961, 22962, 22963, 22964 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1544. The probes having the nucleotide sequence represented by SEQ ID NOS: 22965, 22966, 22967, 22968, 22969, 22970, 15 22971, 22972, 22973, 22974, 22975 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1545. The probes having the nucleotide sequence represented by SEQ ID NOS: 22976, 22977, 22978, 22979, 22980, 22981, 20 22982, 22983, 22984, 22985, 22986 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1546. The probes having the nucleotide sequence represented by SEQ ID NOS: 22987, 22988, 22989, 22990, 22991, 22992, 25 22993, 22994, 22995, 22996, 22997 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1547. 396 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 22998, 22999, 23000, 23001, 23002, 23003, 23004, 23005, 23006, 23007, 23008 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1548. The probes having the nucleotide sequence represented by SEQ ID NOS: 23009, 23010, 23011, 23012, 23013, 23014, 23015, 23016, 23017, 23018, 23019 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1549. The probes having the nucleotide sequence represented by SEQ ID NOS: 23020, 23021, 23022, 23023, 23024, 23025, 23026, 23027, 23028, 23029, 23030 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1550. The probes having the nucleotide sequence represented by SEQ ID NOS: 23031, 23032, 23033, 23034, 23035, 23036, 23037, 23038, 23039, 23040, 23041 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1551. The probes having the nucleotide sequence represented by SEQ ID NOS: 23042, 23043, 23044, 23045, 23046, 23047, 23048, 23049, 23050, 23051, 23052 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1552. The probes having the nucleotide sequence represented by SEQ ID NOS: 23053, 23054, 23055, 23056, 23057, 23058, 23059, 23060, 23061, 23062, 23063 were selected from the 397 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1553. The probes having the nucleotide sequence represented by SEQ ID NOS: 23064, 23065, 23066, 23067, 23068, 23069, 5 23070, 23071, 23072, 23073, 23074 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1554. The probes having the nucleotide sequence represented by SEQ ID NOS: 23075, 23076, 23077, 23078, 23079, 23080, 10 23081, 23082, 23083, 23084, 23085 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1555. The probes having the nucleotide sequence represented by SEQ ID NOS: 23086, 23087, 23088, 23089, 23090, 23091, 15 23092, 23093, 23094, 23095, 23096 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1556. The probes having the nucleotide sequence represented by SEQ ID NOS: 23097, 23098, 23099, 23100, 23101, 23102, 20 23103, 23104, 23105, 23106, 23107 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1557. The probes having the nucleotide sequence represented by SEQ ID NOS: 23108, 23109, 23110, 23111, 23112, 23113, 25 23114, 23115, 23116, 23117, 23118, 23119, 23120, 23121, 23122, 23123, 23124, 23125, 23126, 23127, 23128, 23129 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1558. 398 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 23130, 23131, 23132, 23133, 23134, 23135, 23136, 23137, 23138, 23139, 23140 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1559. The probes having the nucleotide sequence represented by SEQ ID NOS: 23141, 23142, 23143, 23144, 23145, 23146, 23147, 23148, 23149, 23150, 23151 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1560. The probes having the nucleotide sequence represented by SEQ ID NOS: 23152, 23153, 23154, 23155, 23156, 23157, 23158, 23159, 23160, 23161, 23162 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1561. The probes having the nucleotide sequence represented by SEQ ID NOS: 23163, 23164, 23165, 23166, 23167, 23168, 23169, 23170, 23171, 23172, 23173 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1562. The probes having the nucleotide sequence represented by SEQ ID NOS: 23174, 23175, 23176, 23177, 23178, 23179, 23180, 23181, 23182, 23183, 23184 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1563. The probes having the nucleotide sequence represented by SEQ ID NOS: 23185, 23186, 23187, 23188, 23189, 23190, 23191, 23192, 23193, 23194, 23195 were selected from the 399 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1564. The probes having the nucleotide sequence represented by SEQ ID NOS: 23196, 23197, 23198, 23199, 23200, 23201, 5 23202, 23203, 23204, 23205, 23206 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1565. The probes having the nucleotide sequence represented by SEQ ID NOS: 23207, 23208, 23209, 23210, 23211, 23212, 10 23213, 23214, 23215, 23216, 23217 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1566. The probes having the nucleotide sequence represented by SEQ ID NOS: 23218, 23219, 23220, 23221, 23222, 23223, 15 23224, 23225, 23226, 23227, 23228 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1567. The probes having the nucleotide sequence represented by SEQ ID NOS: 23229, 23230, 23231, 23232, 23233, 23234, 20 23235, 23236, 23237, 23238, 23239 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1568. The probes having the nucleotide sequence represented by SEQ ID NOS: 23240, 23241, 23242, 23243, 23244, 23245, 25 23246, 23247, 23248, 23249, 23250 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1569. 400 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 23251, 23252, 23253, 23254, 23255, 23256, 23257, 23258, 23259, 23260, 23261 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1570. The probes having the nucleotide sequence represented by SEQ ID NOS: 23262, 23263, 23264, 23265, 23266, 23267, 23268, 23269, 23270, 23271, 23272 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1571. The probes having the nucleotide sequence represented by SEQ ID NOS: 23273, 23274, 23275, 23276, 23277, 23278, 23279, 23280, 23281, 23282, 23283 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1572. The probes having the nucleotide sequence represented by SEQ ID NOS: 23284, 23285, 23286, 23287, 23288, 23289, 23290, 23291, 23292, 23293, 23294 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1573. The probes having the nucleotide sequence represented by SEQ ID NOS: 23295, 23296, 23297, 23298, 23299, 23300, 23301, 23302, 23303, 23304, 23305 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1574. The probes having the nucleotide sequence represented by SEQ ID NOS: 23306, 23307, 23308, 23309, 23310, 23311, 23312, 23313, 23314, 23315, 23316 were selected from the 401 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1575. The probes having the nucleotide sequence represented by SEQ ID NOS: 23317, 23318, 23319, 23320, 23321, 23322, 5 23323, 23324, 23325, 23326, 23327 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1576. The probes having the nucleotide sequence represented by SEQ ID NOS: 23328, 23329, 23330, 23331, 23332, 23333, 10 23334, 23335, 23336, 23337, 23338 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1577. The probes having the nucleotide sequence represented by SEQ ID NOS: 23339, 23340, 23341, 23342, 23343, 23344, 15 23345, 23346, 23347, 23348, 23349 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1578. The probes having the nucleotide sequence represented by SEQ ID NOS: 23350, 23351, 23352, 23353, 23354, 23355, 20 23356, 23357, 23358, 23359, 23360 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1579. The probes having the nucleotide sequence represented by SEQ ID NOS: 23361, 23362, 23363, 23364, 23365, 23366, 25 23367, 23368, 23369, 23370, 23371 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1580. 402 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 23372, 23373, 23374, 23375, 23376, 23377, 23378, 23379, 23380, 23381, 23382 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1581. The probes having the nucleotide sequence represented by SEQ ID NOS: 23383, 23384, 23385, 23386, 23387, 23388, 23389, 23390, 23391, 23392, 23393 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1582. The probes having the nucleotide sequence represented by SEQ ID NOS: 23394, 23395, 23396, 23397, 23398, 23399, 23400, 23401, 23402, 23403, 23404 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1583. The probes having the nucleotide sequence represented by SEQ ID NOS: 23405, 23406, 23407, 23408, 23409, 23410, 23411, 23412, 23413, 23414, 23415 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1584. The probes having the nucleotide sequence represented by SEQ ID NOS: 23416, 23417, 23418, 23419, 23420, 23421, 23422, 23423, 23424, 23425, 23426 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1585. The probes having the nucleotide sequence represented by SEQ ID NOS: 23427, 23428, 23429, 23430, 23431, 23432, 23433, 23434, 23435, 23436, 23437 were selected from the 403 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1586. The probes having the nucleotide sequence represented by SEQ ID NOS: 23438, 23439, 23440, 23441, 23442, 23443, 5 23444, 23445, 23446, 23447, 23448 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1587. The probes having the nucleotide sequence represented by SEQ ID NOS: 23449, 23450, 23451, 23452, 23453, 23454, 10 23455, 23456, 23457, 23458, 23459 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1588. The probes having the nucleotide sequence represented by SEQ ID NOS: 23460, 23461, 23462, 23463, 23464, 23465, 15 23466, 23467, 23468, 23469, 23470 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1589. The probes having the nucleotide sequence represented by SEQ ID NOS: 23471, 23472, 23473, 23474, 23475, 23476, 20 23477, 23478, 23479, 23480, 23481 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1590. The probes having the nucleotide sequence represented by SEQ ID NOS: 23482, 23483, 23484, 23485, 23486, 23487, 25 23488, 23489, 23490, 23491, 23492 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1591. 404 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 23493, 23494, 23495, 23496, 23497, 23498, 23499, 23500, 23501, 23502, 23503 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1592. The probes having the nucleotide sequence represented by SEQ ID NOS: 23504, 23505, 23506, 23507, 23508, 23509, 23510, 23511, 23512, 23513, 23514 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1593. The probes having the nucleotide sequence represented by SEQ ID NOS: 23515, 23516, 23517, 23518, 23519, 23520, 23521, 23522, 23523, 23524, 23525 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1594. The probes having the nucleotide sequence represented by SEQ ID NOS: 23526, 23527, 23528, 23529, 23530, 23531, 23532, 23533, 23534, 23535, 23536 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1595. The probes having the nucleotide sequence represented by SEQ ID NOS: 23537, 23538, 23539, 23540, 23541, 23542, 23543, 23544, 23545, 23546, 23547 were selected from.the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1596. The probes having the nucleotide sequence represented by SEQ ID NOS: 23548, 23549, 23550, 23551, 23552, 23553, 23554, 23555, 23556, 23557, 23558 were selected from the 405 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1597. The probes having the nucleotide sequence represented by SEQ ID NOS: 23559, 23560, 23561, 23562, 23563, 23564, 5 23565, 23566, 23567, 23568, 23569 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1598. The probes having the nucleotide sequence represented by SEQ ID NOS: 23570, 23571, 23572, 23573, 23574, 23575, 10 23576, 23577, 23578, 23579, 23580 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1599. The probes having the nucleotide sequence represented by SEQ ID NOS: 23581, 23582, 23583, 23584, 23585, 23586, 15 23587, 23588, 23589, 23590, 23591 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1600. The probes having the nucleotide sequence represented by SEQ ID NOS: 23592, 23593, 23594, 23595, 23596, 23597, 20 23598, 23599, 23600, 23601, 23602 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1601. The probes having the nucleotide sequence represented by SEQ ID NOS: 23603, 23604, 23605, 23606, 23607, 23608, 25 23609, 23610, 23611, 23612, 23613 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1602. 406 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 23614, 23615, 23616, 23617, 23618, 23619, 23620, 23621, 23622, 23623, 23624 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1603. The probes having the nucleotide sequence represented by SEQ ID NOS: 23625, 23626, 23627, 23628, 23629, 23630, 23631, 23632, 23633, 23634, 23635 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1604. The probes having the nucleotide sequence represented by SEQ ID NOS: 23636, 23637, 23638, 23639, 23640, 23641, 23642, 23643, 23644, 23645, 23646 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1605. The probes having the nucleotide sequence represented by SEQ ID NOS: 23647, 23648, 23649, 23650, 23651, 23652, 23653, 23654, 23655, 23656, 23657 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1606. The probes having the nucleotide sequence represented by SEQ ID NOS: 23658, 23659, 23660, 23661, 23662, 23663, 23664, 23665, 23666, 23667, 23668 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1607. The probes having the nucleotide sequence represented by SEQ ID NOS: 23669, 23670, 23671, 23672, 23673, 23674, 23675, 23676, 23677, 23678, 23679 were selected from the 407 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1608. The probes having the nucleotide sequence represented by SEQ ID NOS: 23680, 23681, 23682, 23683, 23684, 23685, 5 23686, 23687, 23688, 23689, 23690 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1609. The probes having the nucleotide sequence represented by SEQ ID NOS: 23691, 23692, 23693, 23694, 23695, 23696, 10 23697, 23698, 23699, 23700, 23701 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1610. The probes having the nucleotide sequence represented by SEQ ID NOS: 23702, 23703, 23704, 23705, 23706, 23707, 15 23708, 23709, 23710, 23711, 23712 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1611. The probes having the nucleotide sequence represented by SEQ ID NOS: 23713, 23714, 23715, 23716, 23717, 23718, 20 23719, 23720, 23721, 23722, 23723 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1612. The probes having the nucleotide sequence represented by SEQ ID NOS: 23724, 23725, 23726, 23727, 23728, 23729, 25 23730, 23731, 23732, 23733, 23734 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1613. 408 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 23735, 23736, 23737, 23738, 23739, 23740, 23741, 23742, 23743, 23744, 23745 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1614. The probes having the nucleotide sequence represented by SEQ ID NOS: 23746, 23747, 23748, 23749, 23750, 23751, 23752, 23753, 23754, 23755, 23756 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1615. The probes having the nucleotide sequence represented by SEQ ID NOS: 23757, 23758, 23759, 23760, 23761, 23762, 23763, 23764, 23765, 23766, 23767 were selected from the ORFs having the nucleotide sequence .represented by SEQ ID 15 NO: 1616. The probes having the nucleotide sequence represented by SEQ ID NOS: 23768, 23769, 23770, 23771, 23772, 23773, 23774, 23775, 23776, 23777, 23778.were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1617. The probes having the nucleotide sequence represented by SEQ ID NOS: 23779, 23780,, 23781, 23782, 23783, 23784, 23785, 23786, 23787, 23788, 23789 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1618. The probes having the nucleotide sequence represented by SEQ ID NOS: 23790, 23791, 23792, 23793, 23794, 23795, 23796, 23797, 23798, 23799, 23800 were selected from the 409 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1619. The probes having the nucleotide sequence represented by SEQ ID NOS: 23801, 23802, 23803, 23804, 23805, 23806, 5 23807, 23808, 23809, 23810, 23811 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1620. The probes having the nucleotide sequence represented by SEQ ID NOS: 23812, 23813, 23814, 23815, 23816, 23817, 10 23818, 23819, 23820, 23821, 23822 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1621. The probes having the nucleotide sequence represented by SEQ ID NOS: 23823, 23824, 23825, 23826, 23827, 23828, 15 23829, 23830, 23831, 23832, 23833 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1622. The probes having the nucleotide sequence represented by SEQ ID NOS: 23834, 23835, 23836, 23837, 23838, 23839, 20 23840, 23841, 23842, 23843, 23844 were -selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1623. The probes having the nucleotide sequence represented by SEQ ID NOS: 23845, 23846, 23847, 23848, 23849, 23850, 25 23851, 23852, 23853, 23854, 23855 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1624. 410 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 23856, 23857, 23858, 23859, 23860, 23861, 23862, 23863, 23864, 23865, 23866 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1625. The probes having the nucleotide sequence represented by SEQ ID NOS: 23867, 23868, 23869, 23870, 23871, 23872, 23873, 23874, 23875, 23876, 23877 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1626. The probes having the nucleotide sequence represented by SEQ ID NOS: 23878, 23879, 23880, 23881, 23882, 23883, 23884, 23885, 23886, 23887, 23888 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1627. The probes having the nucleotide sequence represented by SEQ ID NOS: 23889, 23890, 23891, 23892, 23893, 23894, 23895, 23896, 23897, 23898, 23899 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1628. The probes having the nucleotide sequence represented by SEQ ID NOS: 23900, 23901, 23902, 23903, 23904, 23905, 23906, 23907, 23908, 23909, 23910 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1629. The probes having the nucleotide sequence represented by SEQ ID NOS: 23911, 23912, 23913, 23914, 23915, 23916, 23917, 23918, 23919, 23920, 23921 were selected from the 411 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1630. The probes having the nucleotide sequence represented by SEQ ID NOS: 23922, 23923, 23924, 23925, 23926, 23927, 5 23928, 23929, 23930, 23931, 23932 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1631. The probes having the nucleotide sequence represented by SEQ ID NOS: 23933, 23934, 23935, 23936, 23937, 23938, 10 23939, 23940, 23941, 23942, 23943 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1632. The probes having the nucleotide sequence represented by SEQ ID NOS: 23944, 23945, 23946, 23947, 23948, 23949, 15 23950, 23951, 23952, 23953, 23954 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1633. The probes having the nucleotide sequence represented by SEQ ID NOS: 23955, 23956, 23957, 23958, 23959, 23960, 20 23961, 23962, 23963, 23964, 23965 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1634. The probes having the nucleotide sequence represented by SEQ ID NOS: 23966, 23967, 23968, 23969, 23970, 23971, 25 23972, 23973, 23974, 23975, 23976 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1635. 412 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 23977, 23978, 23979, 23980, 23981, 23982, 23983, 23984, 23985, 23986, 23987 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1636. The probes having the nucleotide sequence represented by SEQ ID NOS: 23988, 23989, 23990, 23991, 23992, 23993, 23994, 23995, 23996, 23997, 23998 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1637. The probes having the nucleotide sequence represented by SEQ ID NOS: 23999, 24000, 24001, 24002, 24003, 24004, 24005, 24006, 24007, 24008, 24009 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1638. The probes having the nucleotide sequence represented by SEQ ID NOS: 24010, 24011, 24012, 24013, 24014, 24015, 24016, 24017, 24018, 24019, 24020 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1639. The probes having the nucleotide sequence represented by SEQ ID NOS: 24021, 24022, 24023, 24024, 24025, 24026, 24027, 24028, 24029, 24030, 24031 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1640. The probes having the nucleotide sequence represented by SEQ ID NOS: 24032, 24033, 24034, 24035, 24036, 24037, 24038, 24039, 24040, 24041, 24042 were selected from the 413 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1641. The probes having the nucleotide sequence represented by SEQ ID NOS: 24043, 24044, 24045, 24046, 24047, 24048, 5 24049, 24050, 24051, 24052, 24053 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1642. The probes having the nucleotide sequence represented by SEQ ID NOS: 24054, 24055, 24056, 24057, 24058, 24059, 10 24060, 24061, 24062, 24063, 24064 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1643. The probes having the nucleotide sequence represented by SEQ ID NOS: 24065, 24066, 24067, 24068, 24069, 24070, 15 24071, 24072, 24073, 24074, 24075 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1644. The probes having the nucleotide sequence represented by SEQ ID NOS: 24076, 24077, 24078, 24079, 24080, 24081, 20 24082, 24083, 24084, 24085, 24086 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1645. The probes having the nucleotide sequence represented by SEQ ID NOS: 24087, 24088, 24089, 24090, 24091, 24092, 25 24093, 24094, 24095, 24096, 24097 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1646. 414 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 24098, 24099, 24100, 24101, 24102, 24103, 24104, 24105, 24106, 24107, 24108 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1647. The probes having the nucleotide sequence represented by SEQ ID NOS: 24109, 24110, 24111, 24112, 24113, 24114, 24115, 24116, 24117, 24118, 24119 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1648. The probes having the nucleotide sequence represented by SEQ ID NOS: 24120, 24121, 24122, 24123, 24124, 24125, 24126, 24127, 24128, 24129, 24130 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1649. The probes having the nucleotide sequence represented by SEQ ID NOS: 24131, 24132, 24133, 24134, 24135, 24136, 24137, 24138, 24139, 24140, 24141 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1650. The probes having the nucleotide sequence represented by SEQ ID NOS: 24142, 24143, 24144, 24145, 24146, 24147, 24148, 24149, 24150, 24151, 24152 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1651. The probes having the nucleotide sequence represented by SEQ ID NOS: 24153, 24154, 24155, 24156, 24157, 24158, 24159, 24160, 24161, 24162, 24163 were selected from the 415 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1652. The probes having the nucleotide sequence represented by SEQ ID NOS: 24164, 24165, 24166, 24167, 24168, 24169, 5 24170, 24171, 24172, 24173, 24174 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1653. The probes having the nucleotide sequence represented by SEQ ID NOS: 24175, 24176, 24177, 24178, 24179, 24180, 10 24181, 24182, 24183, 24184, 24185 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1654. The probes having the nucleotide sequence represented by SEQ ID NOS: 24186, 24187, 24188, 24189, 24190, 24191, 15 24192, 24193, 24194, 24195, 24196 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1655. The probes having the nucleotide sequence represented by SEQ ID NOS: 24197, 24198, 24199, 24200, 24201, 24202, 20 24203, 24204, 24205, 24206, 24207 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1656. The probes having the nucleotide sequence represented by SEQ ID NOS: 24208, 24209, 24210, 24211, 24212, 24213, 25 24214, 24215, 24216, 24217, 24218 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1657. 416 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 24219, 24220, 24221, 24222, 24223, 24224, 24225, 24226, 24227, 24228, 24229 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1658. The probes having the nucleotide sequence represented by SEQ ID NOS: 24230, 24231, 24232, 24233, 24234, 24235, 24236, 24237, 24238, 24239, 24240 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1659. The probes having the nucleotide sequence represented by SEQ ID NOS: 24241, 24242, 24243, 24244, 24245, 24246, 24247, 24248, 24249, 24250, 24251 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1660. The probes having the nucleotide sequence represented by SEQ ID NOS: 24252, 24253, 24254, 24255, 24256, 24257, 24258, 24259, 24260, 24261, 24262 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1661. The probes having the nucleotide sequence represented by SEQ ID NOS: 24263, 24264, 24265, 24266, 24267, 24268, 24269, 24270, 24271, 24272, 24273 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1662. The probes having the nucleotide sequence represented by SEQ ID NOS: 24274, 24275, 24276, 24277, 24278, 24279, 24280, 24281, 24282, 24283, 24284, 24285, 24286, 24287, 417 WO 2006/024951 PCT/IB2005/002908 24288, 24289, 24290, 24291, 24292, 24293, 24294, 24295 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1663. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 24296, 24297, 24298, 24299, 24300, 24301, 24302, 24303, 24304, 24305, 24306 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1664. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 24307, 24308, 24309, 24310, 24311, 24312, 24313, 24314, 24315, 24316, 24317 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1665. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 24318, 24319, 24320, 24321, 24322, 24323, 24324, 24325, 24326, 24327, 24328 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1666. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 24329, 24330, 24331, 24332, 24333, 24334, 24335, 24336, 24337, 24338, 24339 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1667. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 24340, 24341, 24342, 24343, 24344, 24345, 24346, 24347, 24348, 24349, 24350 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1668. 418 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 24351, 24352, 24353, 24354, 24355, 24356, 24357, 24358, 24359, 24360, 24361 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1669. The probes having the nucleotide sequence represented by SEQ ID NOS: 24362, 24363, 24364, 24365, 24366, 24367, 24368, 24369, 24370, 24371, 24372 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1670. The probes having the nucleotide sequence represented by SEQ ID NOS: 24373, 24374, 24375, 24376, 24377, 24378, 24379, 24380, 24381, 24382, 24383 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1671. The probes having the nucleotide sequence represented by SEQ ID NOS: 24384, 24385, 24386, 24387, 24388, 24389, 24390, 24391, 24392, 24393, 24394 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1672. The probes having the nucleotide sequence represented by SEQ ID NOS: 24395, 24396, 24397, 24398, 24399, 24400, 24401, 24402, 24403, 24404, 24405 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1673. The probes having the nucleotide sequence represented by SEQ ID NOS: 24406, 24407, 24408, 24409, 24410, 24411, 24412, 24413, 24414, 24415, 24416 were selected from the 419 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1674. The probes having the nucleotide sequence represented by SEQ ID NOS: 24417, 24418, 24419, 24420, 24421, 24422, 5 24423, 24424, 24425, 24426, 24427 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1675. The probes having the nucleotide sequence represented by SEQ ID NOS: 24428, 24429, 24430, 24431, 24432, 24433, 10 24434, 24435, 24436, 24437, 24438 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1676. The probes having the nucleotide sequence represented by SEQ ID NOS: 24439, 24440, 24441, 24442, 24443, 24444, 15 24445, 24446, 24447, 24448, 24449 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1677. The probes having the nucleotide sequence represented by SEQ ID NOS: 24450, 24451, 24452, 24453, 24454, 24455, 20 24456, 24457, 24458, 24459, 24460 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1678. The probes having the nucleotide sequence represented by SEQ ID NOS: 24461, 24462, 24463, 24464, 24465, 24466, 25 24467, 24468, 24469, 24470, 24471 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1679. 420 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 24472, 24473, 24474, 24475, 24476, 24477, 24478, 24479, 24480, 24481, 24482 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1680. The probes having the nucleotide sequence represented by SEQ ID NOS: 24483, 24484, 24485, 24486, 24487, 24488, 24489, 24490, 24491, 24492, 24493 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1681. The probes having the nucleotide sequence represented by SEQ ID NOS: 24494, 24495, 24496, 24497, 24498, 24499, 24500, 24501, 24502, 24503, 24504 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1682. The probes having the nucleotide sequence represented by SEQ ID NOS: 24505, 24506, 24507, 24508, 24509, 24510, 24511, 24512, 24513, 24514, 24515 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1683. The probes having the nucleotide sequence represented by SEQ ID NOS: 24516, 24517, 24518, 24519, 24520, 24521, 24522, 24523, 24524, 24525, 24526 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1684. The probes having the nucleotide sequence represented by SEQ ID NOS: 24527, 24528, 24529, 24530, 24531, 24532, 24533, 24534, 24535, 24536, 24537 were selected from the 421.

WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1685. The probes having the nucleotide sequence represented by SEQ ID NOS: 24538, 24539, 24540, 24541, 24542, 24543, 5 24544, 24545, 24546, 24547, 24548 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1686. The probes having the nucleotide sequence represented by SEQ ID NOS: 24549, 24550, 24551, 24552, 24553, 24554, 10 24555, 24556, 24557, 24558, 24559 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1687. The probes having the nucleotide sequence represented by SEQ ID NOS: 24560, 24561, 24562, 24563, 24564, 24565, 15 24566, 24567, 24568, 24569, 24570 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1688. The probes having the nucleotide sequence represented by SEQ ID NOS: 24571, 24572, 24573, 24574, 24575, 24576, 20 24577, 24578, 24579, 24580, 24581 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1689. The probes having the nucleotide sequence represented by SEQ ID NOS: 24582, 24583, 24584, 24585, 24586, 24587, 25 24588, 24589, 24590, 24591, 24592 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1690. 422 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 24593, 24594, 24595, 24596, 24597, 24598, 24599, 24600, 24601, 24602, 24603 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1691. The probes having the nucleotide sequence represented by SEQ ID NOS: 24604, 24605, 24606, 24607, 24608, 24609, 24610, 24611, 24612, 24613, 24614 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1692. The probes having the nucleotide sequence represented by SEQ ID NOS: 24615, 24616, 24617, 24618, 24619, 24620, 24621, 24622, 24623, 24624, 24625 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1693. The probes having the nucleotide sequence represented by SEQ ID NOS: 24626, 24627, 24628, 24629, 24630, 24631, 24632, 24633, 24634, 24635, 24636 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1694. The probes having the nucleotide sequence represented by SEQ ID NOS: 24637, 24638, 24639, 24640, 24641, 24642, 24643, 24644, 24645, 24646, 24647 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1695. The probes having the nucleotide sequence represented by SEQ ID NOS: 24648, 24649, 24650, 24651, 24652, 24653, 24654, 24655, 24656, 24657, 24658 were selected from the 423 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1696. The probes having the nucleotide sequence represented by SEQ ID NOS: 24659, 24660, 24661, 24662, 24663, 24664, 5 24665, 24666, 24667, 24668, 24669 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1697. The probes having the nucleotide sequence represented by SEQ ID NOS: 24670, 24671, 24672, 24673, 24674, 24675, 10 24676, 24677, 24678, 24679, 24680 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1698. The probes having the nucleotide sequence represented by SEQ ID NOS: 24681, 24682, 24683, 24684, 24685, 24686, 15 24687, 24688, 24689, 24690, 24691 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1699. The probes having the nucleotide sequence represented by SEQ ID NOS: 24692, 24693, 24694, 24695, 24696, 24697, 20 24698, 24699, 24700, 24701, 24702 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1700. The probes having the nucleotide sequence represented by SEQ ID NOS: 24703, 24704, 24705, 24706, 24707, 24708, 25 24709, 24710, 24711, 24712, 24713 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1701. 424 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 24714, 24715, 24716, 24717, 24718, 24719, 24720, 24721, 24722, 24723, 24724 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1702. The probes having the nucleotide sequence represented by SEQ ID NOS: 24725, 24726, 24727, 24728, 24729, 24730, 24731, 24732, 24733, 24734, 24735 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1703. The probes having the nucleotide sequence represented by SEQ ID NOS: 24736, 24737, 24738, 24739, 24740, 24741, 24742, 24743, 24744, 24745, 24746 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1704. The probes having the nucleotide sequence represented by SEQ ID NOS: 24747, 24748, 24749, 24750, 24751, 24752, 24753, 24754, 24755, 24756, 24757 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1705. The probes having the nucleotide sequence represented by SEQ ID NOS: 24758, 24759, 24760, 24761, 24762, 24763, 24764, 24765, 24766, 24767, 24768 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1706. The probes having the nucleotide sequence represented by SEQ ID NOS: 24769, 24770, 24771, 24772, 24773, 24774, 24775, 24776, 24777, 24778, 24779 were selected from the 425 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1707. The probes having the nucleotide sequence represented by SEQ ID NOS: 24780, 24781, 24782, 24783, 24784, 24785, 5 24786, 24787, 24788, 24789, 24790 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1708. The probes having the nucleotide sequence represented by SEQ ID NOS: 24791, 24792, 24793, 24794, 24795, 24796, 10 24797, 24798, 24799, 24800, 24801 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1709. The probes having the nucleotide sequence represented by SEQ ID NOS: 24802, 24803, 24804, 24805, 24806, 24807, 15 24808, 24809, 24810, 24811, 24812 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1710. The probes having the nucleotide sequence represented by SEQ ID NOS: 24813, 24814, 24815, 24816, 24817, 24818, 20 24819, 24820, 24821, 24822, 24823 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1711. The probes having the nucleotide sequence represented by SEQ ID NOS: 24824, 24825, 24826, 24827, 24828, 24829, 25 24830, 24831, 24832, 24833, 24834 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1712. 426 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 24835, 24836, 24837, 24838, 24839, 24840, 24841, 24842, 24843, 24844, 24845 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1713. The probes having the nucleotide sequence represented by SEQ ID NOS: 24846, 24847, 24848, 24849, 24850, 24851, 24852, 24853, 24854, 24855, 24856 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1714. The probes having the nucleotide sequence represented by SEQ ID NOS: 24857, 24858, 24859, 24860, 24861, 24862, 24863, 24864, 24865, 24866, 24867 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1715. The probes having the nucleotide sequence represented by SEQ ID NOS: 24868, 24869, 24870, 24871, 24872, 24873, 24874, 24875, 24876, 24877, 24878 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1716. The probes having the nucleotide sequence represented by SEQ ID NOS: 24879, 24880, 24881, 24882, 24883, 24884, 24885, 24886, 24887, 24888, 24889 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1717. The probes having the nucleotide sequence represented by SEQ ID NOS: 24890, 24891, 24892, 24893, 24894, 24895, 24896, 24897, 24898, 24899, 24900 were selected from the 427 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1718. The probes having the nucleotide sequence represented by SEQ ID NOS: 24901, 24902, 24903, 24904, 24905, 24906, 5 24907, 24908, 24909, 24910, 24911 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1719. The probes having the nucleotide sequence represented by SEQ ID NOS: 24912, 24913, 24914, 24915, 24916, 24917, 10 24918, 24919, 24920, 24921, 24922 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1720. The probes having the nucleotide sequence represented by SEQ ID NOS: 24923, 24924, 24925, 24926, 24927, 24928, 15 24929, 24930, 24931, 24932, 24933 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1721. The probes having the nucleotide sequence represented by SEQ ID NOS: 24934, 24935, 24936, 24937, 24938, 24939, 20 24940, 24941, 24942, 24943, 24944 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1722. The probes having the nucleotide sequence represented by SEQ ID NOS: 24945, 24946, 24947, 24948, 24949, 24950, 25 24951, 24952, 24953, 24954, 24955 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1723. 428 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 24956, 24957, 24958, 24959, 24960, 24961, 24962, 24963, 24964, 24965, 24966 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1724. The probes having the nucleotide sequence represented by SEQ ID NOS: 24967, 24968, 24969, 24970, 24971, 24972, 24973, 24974, 24975, 24976, 24977 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1725. The probes having the nucleotide sequence represented by SEQ ID NOS: 24978, 24979, 24980, 24981, 24982, 24983, 24984, 24985, 24986, 24987, 24988 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1726. The probes having the nucleotide sequence represented by SEQ ID NOS: 24989, 24990, 24991, 24992, 24993, 24994, 24995, 24996, 24997, 24998, 24999 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1727. The probes having the nucleotide sequence represented by SEQ ID NOS: 25000, 25001, 25002, 25003, 25004, 25005, 25006, 25007, 25008, 25009, 25010 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1728. The probes having the nucleotide sequence represented by SEQ ID NOS: 25011, 25012, 25013, 25014, 25015, 25016, 25017, 25018, 25019, 25020, 25021 were selected from the 429 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1729. The probes having the nucleotide sequence represented by SEQ ID NOS: 25022, 25023, 25024, 25025, 25026, 25027, 5 25028, 25029, 25030, 25031, 25032 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1730. The probes having the nucleotide sequence represented by SEQ ID NOS: 25033, 25034, 25035, 25036, 25037, 25038, 10 25039, 25040, 25041, 25042, 25043 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1731. The probes having.the nucleotide sequence represented by SEQ ID NOS: 25044, 25045, 25046, 25047, 25048, 25049, 15 25050, 25051, 25052, 25053, 25054 were selected from the ORFs having.the nucleotide sequence represented by SEQ ID NO: 1732. The probes having the nucleotide sequence represented by SEQ ID NOS: 25055, 25056, 25057, 25058, 25059, 25060, 20 25061, 25062, 25063, 25064, 25065 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1733. The probes having the nucleotide sequence represented by SEQ ID NOS: 25066, 25067, 25068, 25069, 25070, 25071, 25 25072, 25073, 25074, 25075, 25076 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1734. 430 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 25077, 25078, 25079, 25080, 25081, 25082, 25083, 25084, 25085, 25086, 25087 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1735. The probes having the nucleotide sequence represented by SEQ ID NOS: 25088, 25089, 25090, 25091, 25092, 25093, 25094, 25095, 25096, 25097, 25098 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1736. The probes having the nucleotide sequence represented by SEQ ID NOS: 25099, 25100, 25101, 25102, 25103, 25104, 25105, 25106, 25107, 25108, 25109 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1737. The probes having the nucleotide sequence represented by SEQ ID NOS: 25110, 25111, 25112, 25113, 25114, 25115, 25116, 25117, 25118, 25119, 25120 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1738. The probes having the nucleotide sequence represented by SEQ ID NOS: 25121, 25122, 25123, 25124, 25125, 25126, 25127, 25128, 25129, 25130, 25131 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1739. The probes having the nucleotide sequence represented by SEQ ID NOS: 25132, 25133, 25134, 25135, 25136, 25137, 25138, 25139, 25140, 25141, 25142 were selected from the 431 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1740. The probes having the nucleotide sequence represented by SEQ ID NOS: 25143, 25144, 25145, 25146, 25147, 25148, 5 25149, 25150, 25151, 25152, 25153 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1741. The probes having the nucleotide sequence represented by SEQ ID NOS: 25154, 25155, 25156, 25157, 25158, 25159, 10 25160, 25161, 25162, 25163, 25164 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1742. The probes having the nucleotide sequence represented by SEQ ID NOS: 25165, 25166, 25167, 25168, 25169, 25170, 15 25171, 25172, 25173, 25174, 25175 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1743. The probes having the nucleotide sequence represented by SEQ ID NOS: 25176, 25177, 25178, 25179, 25180, 25181, 20 25182, 25183, 25184, 25185, 25186 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1744. The probes having the nucleotide sequence represented by SEQ ID NOS: 25187, 25188, 25189, 25190, 25191, 25192, 25 25193, 25194, 25195, 25196, 25197 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1745. 432 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 25198, 25199, 25200, 25201, 25202, 25203, 25204, 25205, 25206, 25207, 25208 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1746. The probes having the nucleotide sequence represented by SEQ ID NOS: 25209, 25210, 25211, 25212, 25213, 25214, 25215, 25216, 25217, 25218, 25219 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1747. The probes having the nucleotide sequence represented by SEQ ID NOS: 25220, 25221, 25222, 25223, 25224, 25225, 25226, 25227, 25228, 25229, 25230 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1748. The probes having the nucleotide sequence represented by SEQ ID NOS: 25231, 25232, 25233, 25234, 25235, 25236, 25237, 25238, 25239, 25240, 25241 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1749. The probes having the nucleotide sequence represented by SEQ ID NOS: 25242, 25243, 25244, 25245, 25246, 25247, 25248, 25249, 25250, 25251, 25252 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1750. The probes having the nucleotide sequence represented by SEQ ID NOS: 25253, 25254, 25255, 25256, 25257, 25258, 25259, 25260, 25261, 25262, 25263 were selected from the 433 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1751. The probes having the nucleotide sequence represented by SEQ ID NOS: 25264, 25265, 25266, 25267, 25268, 25269, 5 25270, 25271, 25272, 25273, 25274 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1752. The probes having the nucleotide sequence represented by SEQ ID NOS: 25275, 25276, 25277, 25278, 25279, 25280, 10 25281, 25282, 25283, 25284, 25285 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1753. The probes having the nucleotide sequence represented by SEQ ID NOS: 25286, 25287, 25288, 25289, 25290, 25291, 15 25292, 25293, 25294, 25295, 25296 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1754. The probes having the nucleotide sequence represented by SEQ ID NOS: 25297, 25298, 25299, 25300, 25301, 25302, 20 25303, 25304, 25305, 25306, 25307 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1755. The probes having the nucleotide sequence represented by SEQ ID NOS: 25308, 25309, 25310, 25311, 25312, 25313, 25 25314, 25315, 25316, 25317, 25318, 25319, 25320, 25321, 25322, 25323, 25324, 25325, 25326, 25327, 25328, 25329 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1756. 434 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 25330, 25331, 25332, 25333, 25334, 25335, 25336, 25337, 25338, 25339, 25340 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1757. The probes having the nucleotide sequence represented by SEQ ID NOS: 25341, 25342, 25343, 25344, 25345, 25346, 25347, 25348, 25349, 25350, 25351 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1758. The probes having the nucleotide sequence represented by SEQ ID NOS: 25352, 25353, 25354, 25355, 25356, 25357, 25358, 25359, 25360, 25361, 25362 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1759. The probes having the nucleotide sequence represented by SEQ ID NOS: 25363, 25364, 25365, 25366, 25367, 25368, 25369, 25370, 25371, 25372, 25373 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1760. The probes having the nucleotide sequence represented by SEQ ID NOS: 25374, 25375, 25376, 25377, 25378, 25379, 25380, 25381, 25382, 25383, 25384 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1761. The probes having the nucleotide sequence represented by SEQ ID NOS: 25385, 25386, 25387, 25388, 25389, 25390, 25391, 25392, 25393, 25394, 25395 were selected from the 435 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO:. 1762. The probes having the nucleotide sequence represented by SEQ ID NOS: 25396, 25397, 25398, 25399, 25400, 25401, 5 25402, 25403, 25404, 25405, 25406 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1763. The probes having the nucleotide sequence represented by SEQ ID NOS: 25407, 25408, 25409, 25410, 25411, 25412, 10 25413, 25414, 25415, 25416, 25417 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1764. The probes having the nucleotide sequence represented by SEQ ID NOS: 25418, 25419, 25420, 25421, 25422, 25423, 15 25424, 25425, 25426, 25427, 25428 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1765. The probes having the nucleotide sequence represented by SEQ ID NOS: 25429, 25430, 25431, 25432, 25433, 25434, 20 25435, 25436, 25437, 25438, 25439 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1766. The probes having the nucleotide sequence represented by SEQ ID NOS: 25440, 25441, 25442, 25443, 25444, 25445, 25 25446, 25447, 25448, 25449, 25450 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1767. 436 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 25451, 25452, 25453, 25454, 25455, 25456, 25457, 25458, 25459, 25460, 25461 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1768. The probes having the nucleotide sequence represented by SEQ ID NOS: 25462, 25463, 25464, 25465, 25466, 25467, 25468, 25469, 25470, 25471, 25472 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1769. The probes having the nucleotide sequence represented by SEQ ID NOS: 25473, 25474, 25475, 25476, 25477, 25478, 25479, 25480, 25481, 25482, 25483 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1770. The probes having the nucleotide sequence represented by SEQ ID NOS: 25484, 25485, 25486, 25487, 25488, 25489, 25490, 25491, 25492, 25493, 25494 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1771. The probes having the nucleotide sequence represented by SEQ ID NOS: 25495, 25496, 25497, 25498, 25499, 25500, 25501, 25502, 25503, 25504, 25505 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1772. The probes having the nucleotide sequence represented by SEQ ID NOS: 25506, 25507, 25508, 25509, 25510, 25511, 25512, 25513, 25514, 25515, 25516 were selected from the 437 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1773. The probes having the nucleotide sequence represented by SEQ ID NOS: 25517, 25518, 25519, 25520, 25521, 25522, 5 25523, 25524, 25525, 25526, 25527 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1774. The probes having the nucleotide sequence represented by SEQ ID NOS: 25528, 25529, 25530, 25531, 25532, 25533, 10 25534, 25535, 25536, 25537, 25538 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1775. The probes having the nucleotide sequence represented by SEQ ID NOS: 25539, 25540, 25541, 25542, 25543, 25544, 15 25545, 25546, 25547, 25548, 25549 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1776. The probes having the nucleotide sequence represented by SEQ ID NOS: 25550, 25551, 25552, 25553, 25554, 25555, 20 25556, 25557, 25558, 25559, 25560 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1777. The probes having the nucleotide sequence represented by SEQ ID NOS: 25561, 25562, 25563, 25564, 25565, 25566, 25 25567, 25568, 25569, 25570, 25571 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1778. 438 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 25572, 25573, 25574, 25575, 25576, 25577, 25578, 25579, 25580, 25581, 25582 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1779. The probes having the nucleotide sequence represented by SEQ ID NOS: 25583, 25584, 25585, 25586, 25587, 25588, 25589, 25590, 25591, 25592, 25593 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1780. The probes having the nucleotide sequence represented by SEQ ID NOS: 25594, 25595, 25596, 25597, 25598, 25599, 25600, 25601, 25602, 25603, 25604 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1781. The probes having the nucleotide sequence represented by SEQ ID NOS: 25605, 25606, 25607, 25608, 25609, 25610, 25611, 25612, 25613, 25614, 25615 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1782. The probes having the nucleotide sequence represented by SEQ ID NOS: 25616, 25617, 25618, 25619, 25620, 25621, 25622, 25623, 25624, 25625, 25626 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1783. The probes having the nucleotide sequence represented by SEQ ID NOS: 25627, 25628, 25629, 25630, 25631, 25632, 25633, 25634, 25635, 25636, 25637 were selected from the 439 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1784. The probes having the nucleotide sequence represented by SEQ ID NOS: 25638, 25639, 25640, 25641, 25642, 25643, 5 25644, 25645, 25646, 25647, 25648 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1785. The probes having the nucleotide sequence represented by SEQ ID NOS: 25649, 25650, 25651, 25652, 25653, 25654, 10 25655, 25656, 25657, 25658, 25659 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1786. The probes having the nucleotide sequence represented by SEQ ID NOS: 25660, 25661, 25662, 25663, 25664, 25665, 15 25666, 25667, 25668, 25669, 25670 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1787. The probes having the nucleotide sequence represented by SEQ ID NOS: 25671, 25672, 25673, 25674, 25675, 25676, 20 25677, 25678, 25679, 25680, 25681 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1788. The probes having the nucleotide sequence represented by SEQ ID NOS: 25682, 25683, 25684, 25685, 25686, 25687, 25 25688, 25689, 25690, 25691, 25692 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1789. 440 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 25693, 25694, 25695, 25696, 25697, 25698, 25699, 25700, 25701, 25702, 25703 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1790. The probes having the nucleotide sequence represented by SEQ ID NOS: 25704, 25705, 25706, 25707, 25708, 25709, 25710, 25711, 25712, 25713, 25714 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1791. The probes having the nucleotide sequence represented by SEQ ID NOS: 25715, 25716, 25717, 25718, 25719, 25720, 25721, 25722, 25723, 25724, 25725 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1792. The probes having the nucleotide sequence represented by SEQ ID NOS: 25726, 25727, 25728, 25729, 25730, 25731, 25732, 25733, 25734, 25735, 25736 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1793. The probes having the nucleotide sequence represented by SEQ ID NOS: 25737, 25738, 25739, 25740, 25741, 25742, 25743, 25744, 25745, 25746, 25747, 25748, 25749, 25750, 25751, 25752, 25753, 25754, 25755, 25756, 25757, 25758 were 25 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1794. The probes having the nucleotide sequence represented by SEQ ID NOS: 25759, 25760, 25761, 25762, 25763, 25764, 441 WO 2006/024951 PCT/IB2005/002908 25765, 25766, 25767, 25768, 25769 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1795. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 25770, 25771, 25772, 25773, 25774, 25775, 25776, 25777, 25778, 25779, 25780 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1796. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 25781, 25782, 25783, 25784, 25785, 25786, 25787, 25788, 25789, 25790, 25791 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1797. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 25792, 25793, 25794, 25795, 25796, 25797, 25798, 25799, 25800, 25801, 25802 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1798. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 25803, 25804, 25805, 25806, 25807, 25808, 25809, 25810, 25811, 25812, 25813 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1799. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 25814, 25815, 25816, 25817, 25818, 25819, 25820, 25821, 25822, 25823, 25824 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1800. 442 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 25825, 25826, 25827, 25828, 25829, 25830, 25831, 25832, 25833, 25834, 25835 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1801. The probes having the nucleotide sequence represented by SEQ ID NOS: 25836, 25837, 25838, 25839, 25840, 25841, 25842, 25843, 25844, 25845, 25846 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1802. The probes having the nucleotide sequence represented by SEQ ID NOS: 25847, 25848, 25849, 25850, 25851, 25852, 25853, 25854, 25855, 25856, 25857 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1803. The probes having the nucleotide sequence represented by SEQ ID NOS: 25858, 25859, 25860, 25861, 25862, 25863, 25864, 25865, 25866, 25867, 25868 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1804. The probes having the nucleotide sequence represented by SEQ ID NOS: 25869, 25870, 25871, 25872, 25873, 25874, 25875, 25876, 25877, 25878, 25879 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1805. The probes having the nucleotide sequence represented by SEQ ID NOS: 25880, 25881, 25882, 25883, 25884, 25885, 25886, 25887, 25888, 25889, 25890 were selected from the 443 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1806. The probes having the nucleotide sequence represented by SEQ ID NOS: 25891, 25892, 25893, 25894, 25895, 25896, 5 25897, 25898, 25899, 25900, 25901 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1807. The probes having the nucleotide sequence represented by SEQ ID NOS: 25902, 25903, 25904, 25905, 25906, 25907, 10 25908, 25909, 25910, 25911, 25912 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1808. The probes having the nucleotide sequence represented by SEQ ID NOS: 25913, 25914, 25915, 25916, 25917, 25918, 15 25919, 25920, 25921, 25922, 25923 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1809. The probes having the nucleotide sequence represented by SEQ ID NOS: 25924, 25925, 25926, 25927, 25928, 25929, 20 25930, 25931, 25932, 25933, 25934 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1810. The probes having the nucleotide sequence represented by SEQ ID NOS: 25935, 25936, 25937, 25938, 25939, 25940, 25 25941, 25942, 25943, 25944, 25945 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1811. 444 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 25946, 25947, 25948, 25949, 25950, 25951, 25952, 25953, 25954, 25955, 25956 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1812. The probes having the nucleotide sequence represented by SEQ ID NOS: 25957, 25958, 25959, 25960, 25961, 25962, 25963, 25964, 25965, 25966, 25967 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1813. The probes having the nucleotide sequence represented by SEQ ID NOS: 25968, 25969, 25970, 25971, 25972, 25973, 25974, 25975, 25976, 25977, 25978 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1814. The probes having the nucleotide sequence represented by SEQ ID NOS: 25979, 25980, 25981, 25982, 25983, 25984, 25985, 25986, 25987, 25988, 25989 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1815. The probes having the nucleotide sequence represented by SEQ ID NOS: 25990, 25991, 25992, 25993, 25994, 25995, 25996, 25997, 25998, 25999, 26000 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1816. The probes having the nucleotide sequence represented by SEQ ID NOS: 26001, 26002, 26003, 26004, 26005, 26006, 26007, 26008, 26009, 26010, 26011 were selected from the 445 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1817. The probes having the nucleotide sequence represented by SEQ ID NOS: 26012, 26013, 26014, 26015, 26016, 26017, 5 26018, 26019, 26020, 26021, 26022 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1818. The probes having the nucleotide sequence represented by SEQ ID NOS: 26023, 26024, 26025, 26026, 26027, 26028, 10 26029, 26030, 26031, 26032, 26033 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1819. The probes having the nucleotide sequence represented by SEQ ID NOS: 26034, 26035, 26036, 26037, 26038, 26039, 15 26040, 26041, 26042, 26043, 26044 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1820. The probes having the nucleotide sequence represented by SEQ ID NOS: 26045, 26046, 26047, 26048, 26049, 26050, 20 26051, 26052, 26053, 26054, 26055 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1821. The probes having the nucleotide sequence represented by SEQ ID NOS: 26056, 26057, 26058, 26059, 26060, 26061, 25 26062, 26063, 26064, 26065, 26066 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1822. 446 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 26067, 26068, 26069, 26070, 26071, 26072, 26073, 26074, 26075, 26076, 26077 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1823. The probes having the nucleotide sequence represented by SEQ ID NOS: 26078, 26079, 26080, 26081, 26082, 26083, 26084, 26085, 26086, 26087, 26088 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1824. The probes having the nucleotide sequence represented by SEQ ID NOS: 26089, 26090, 26091, 26092, 26093, 26094, 26095, 26096, 26097, 26098, 26099 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1825. The probes having the nucleotide sequence represented by SEQ ID NOS: 26100, 26101, 26102, 26103, 26104, 26105, 26106, 26107, 26108, 26109, 26110 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1826. The probes having the nucleotide sequence represented by SEQ ID NOS: 26111, 26112, 26113, 26114, 26115, 26116, 26117, 26118, 26119, 26120, 26121 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1827. The probes having the nucleotide sequence represented by SEQ ID NOS: 26122, 26123, 26124, 26125, 26126, 26127, 26128, 26129, 26130, 26131, 26132 were selected from the 447 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1828. The probes having the nucleotide sequence represented by SEQ ID NOS: 26133, 26134, 26135, 26136, 26137, 26138, 5 26139, 26140, 26141, 26142, 26143 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1829. The probes having the nucleotide sequence represented by SEQ ID NOS: 26144, 26145, 26146, 26147, 26148, 26149, 10 26150, 26151, 26152, 26153, 26154 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1830. The probes having the nucleotide sequence represented by SEQ ID NOS: 26155, 26156, 26157, 26158, 26159, 26160, 15 26161, 26162, 26163, 26164, 2'6165 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1831. The probes having the nucleotide sequence represented by SEQ ID NOS: 26166, 26167, 26168, 26169, 26170, 26171, 20 26172, 26173, 26174, 26175, 26176 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1832. The probes having the nucleotide sequence represented by SEQ ID NOS: 26177, 26178, 26179, 26180, 26181, 26182, 25 26183, 26184, 26185, 26186, 26187 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1833. 448 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 26188, 26189, 26190, 26191, 26192, 26193, 26194, 26195, 26196, 26197, 26198 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1834. The probes having the nucleotide sequence represented by SEQ ID NOS: 26199, 26200, 26201, 26202, 26203, 26204, 26205, 26206, 26207, 26208, 26209 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1835. The probes having the nucleotide sequence represented by SEQ ID NOS: 26210, 26211, 26212, 26213, 26214, 26215, 26216, 26217, 26218, 26219, 26220 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1836. The probes having the nucleotide sequence represented by SEQ ID NOS: 26221, 26222, 26223, 26224, 26225, 26226, 26227, 26228, 26229, 26230, 26231 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1837. The probes having the nucleotide sequence represented by SEQ ID NOS: 26232, 26233, 26234, 26235, 26236, 26237, 26238, 26239, 26240, 26241, 26242 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1838. The probes having the nucleotide sequence represented by SEQ ID NOS: 26243, 26244, 26245, 26246, 26247, 26248, 26249, 26250, 26251, 26252, 26253 were selected from the 449 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1839. The probes having the nucleotide sequence represented by SEQ ID NOS: 26254, 26255, 26256, 26257, 26258, 26259, 5 26260, 26261, 26262, 26263, 26264 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1840. The probes having the nucleotide sequence represented by SEQ ID NOS:. 26265, 26266, 26267, 26268, 26269, 26270, 10 26271, 26272, 26273, 26274, 26275 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1841. The probes having the nucleotide sequence represented by SEQ ID NOS: 26276, 26277, 26278, 26279, 26280, 26281, 15 26282, 26283, 26284, 26285, 26286 were selected from the ORFs having the nucleotide- sequence represented by SEQ ID NO: 1842. The probes having the nucleotide sequence represented by SEQ ID NOS: 26287, 26288, 26289, 26290, 26291, 26292, 20 26293, 26294, 26295, 26296, 26297 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1843. The probes having the nucleotide sequence represented by SEQ ID NOS: 26298, 26299, 26300, 26301, 26302, 26303, 25 26304, 26305, 26306, 26307, 26308 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1844. 450 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 26309, 26310, 26311, 26312, 26313, 26314, 26315, 26316, 26317, 26318, 26319 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1845. The probes having the nucleotide sequence represented by SEQ ID NOS: 26320, 26321, 26322, 26323, 26324, 26325, 26326, 26327, 26328, 26329, 26330 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1846. The probes having the nucleotide sequence represented by SEQ ID NOS: 26331, 26332, 26333, 26334, 26335, 26336, 26337, 26338, 26339, 26340, 26341 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1847. The probes having the nucleotide sequence represented by SEQ ID NOS: 26342, 26343, 26344, 26345, 26346, 26347, 26348, 26349, 26350, 26351, 26352 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1848. The probes having the nucleotide sequence represented by SEQ ID NOS: 26353, 26354, 26355, 26356, 26357, 26358, 26359, 26360, 26361, 26362, 26363 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1849. The probes having the nucleotide sequence represented by SEQ ID NOS: 26364, 26365, 26366, 26367, 26368, 26369, 26370, 26371, 26372, 26373, 26374 were selected from the 451 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1850. The probes having the nucleotide sequence represented by SEQ ID NOS: 26375, 26376, 26377, 26378, 26379, 26380, 5 26381, 26382, 26383, 26384, 26385 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1851. The probes having the nucleotide sequence represented by SEQ ID NOS: 26386, 26387, 26388, 26389, 26390, 26391, 10 26392, 26393, 26394, 26395, 26396 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1852. The probes having the nucleotide sequence represented by SEQ ID NOS: 26397, 26398, 26399, 26400, 26401, 26402, 15 26403, 26404, 26405, 26406, 26407 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1853. The probes having the nucleotide sequence represented by SEQ ID NOS: 26408, 26409, 26410, 26411, 26412, 26413, 20 26414, 26415, 26416, 26417, 26418 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1854. The probes having the nucleotide sequence represented by SEQ ID NOS: 26419, 26420, 26421, 26422, 26423, 26424, 25 26425, 26426, 26427, 26428, 26429 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1855. 452 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID -NOS: 26430, 26431, 26432, 26433, 26434, 26435, 26436, 26437, 26438, 26439, 26440 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1856. The probes having the nucleotide sequence represented by SEQ ID NOS: 26441, 26442, 26443, 26444, 26445, 26446, 26447, 26448, 26449, 26450, 26451 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1857. The probes having the nucleotide sequence represented by SEQ ID NOS: 26452, 26453, 26454, 26455, 26456, 26457, 26458, 26459, 26460, 26461, 26462 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1858. The probes having the nucleotide sequence represented by SEQ ID NOS: 26463, 26464, 26465, 26466, 26467, 26468, 26469, 26470, 26471, 26472, 26473 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1859. The probes having the nucleotide sequence represented by SEQ ID NOS: 26474, 26475, 26476, 26477, 26478, 26479, 26480, 26481, 26482, 26483, 26484 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1860. The probes having the nucleotide sequence represented by SEQ ID NOS: 26485, 26486, 26487, 26488, 26489, 26490, 26491, 26492, 26493, 26494, 26495 were selected from the 453 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1861. The probes having the nucleotide sequence represented by SEQ ID NOS: 26496, 26497, 26498, 26499, 26500, 26501, 5 26502, 26503, 26504, 26505, 26506 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1862. The probes having the nucleotide sequence represented by SEQ ID NOS: 26507, 26508, 26509, 26510, 26511, 26512, 10 26513, 26514, 26515, 26516, 26517 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1863. The probes having the nucleotide sequence represented by SEQ ID NOS: 26518, 26519, 26520, 26521, 26522, 26523, 15 26524, 26525, 26526, 26527, 26528 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1864. The probes having the nucleotide sequence represented by SEQ ID NOS: 26529, 26530, 26531, 26532, 26533, 26534, 20 26535, 26536, 26537, 26538, 26539 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1865. The probes having the nucleotide sequence represented by SEQ ID NOS: 26540, 26541, 26542, 26543, 26544, 26545, 25 26546, 26547, 26548, 26549, 26550 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1866. 454 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 26551, 26552, 26553, 26554, 26555, 26556, 26557, 26558, 26559, 26560, 26561 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1867. The probes having the nucleotide sequence represented by SEQ ID NOS: 26562, 26563, 26564, 26565, 26566, 26567, 26568, 26569, 26570, 26571, 26572 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1868. The probes having the nucleotide sequence represented by SEQ ID NOS: 26573, 26574, 26575, 26576, 26577, 26578, 26579, 26580, 26581, 26582, 26583 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1869. The probes having the nucleotide sequence represented by SEQ ID NOS: 26584, 26585, 26586,' 26587, 26588, 26589, 26590, 26591, 26592, 26593, 26594 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1870. The probes having the nucleotide sequence represented by SEQ ID NOS: 26595, 26596, 26597, 26598, 26599, 26600, 26601, 26602, 26603, 26604, 26605 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1871. The probes having the nucleotide sequence represented by SEQ ID NOS: 26606, 26607, 26608, 26609, 26610, 26611, 26612, 26613, 26614, 26615, 26616 were selected from the 455 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1872. The probes having the nucleotide sequence represented by SEQ ID NOS: 26617, 26618, 26619, 26620, 26621, 26622, 5 26623, 26624, 26625, 26626, 26627 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1873. The probes having the nucleotide sequence represented by SEQ ID NOS: 26628, 26629, 26630, 26631, 26632, 26633, 10 26634, 26635, 26636, 26637, 26638 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1874. The probes having the nucleotide sequence represented by SEQ ID NOS: 26639, 26640, 26641, 26642, 26643, 26644, 15 26645, 26646, 26647, 26648, 26649 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1875. The probes having the nucleotide sequence represented by SEQ ID NOS: 26650, 26651, 26652, 26653, 26654, 26655, 20 26656, 26657, 26658, 26659, 26660 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1876. The probes having the nucleotide sequence represented by SEQ ID NOS: 26661, 26662, 26663, 26664, 26665, 26666, 25 26667, 26668, 26669, 26670, 26671 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1877. 456 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 26672, 26673, 26674, 26675, 26676, 26677, 26678, 26679, 26680, 26681, 26682 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1878. The probes having the nucleotide sequence represented by SEQ ID NOS: 26683, 26684, 26685, 26686, 26687, 26688, 26689, 26690, 26691, 26692, 26693, 26694, 26695, 26696, 26697, 26698, 26699, 26700, 26701, 26702, 26703, 26704 were 10 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1879. The probes having the nucleotide sequence represented by SEQ ID NOS: 26705,.26706, 26707, 26708, 26709, 26710, 26711, 26712, 26713, 26714, 26715 were selected from the 15 ORFs having the nucleotide sequence represented by SEQ ID NO: 1880. The probes having the nucleotide sequence represented by SEQ ID NOS: 26716, 26717, 26718, 26719, 26720, 26721, 26722, 26723, 26724, 26725, 26726 were selected from the 20 ORFs having the nucleotide sequence represented by SEQ ID NO: 1881. The probes having the nucleotide sequence represented by SEQ ID NOS: 26727, 26728, 26729, 26730, 26731, 26732, 26733, 26734, 26735, 26736, 26737 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 1882. The probes having the nucleotide sequence represented by SEQ ID NOS: 26738, 26739, 26740, 26741, 26742, 26743, 457 WO 2006/024951 PCT/IB2005/002908 26744, 26745, 26746, 26747, 26748 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1883. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 26749, 26750, 26751, 26752, 26753, 26754, 26755, 26756, 26757, 26758, 26759 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1884. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 26760, 26761, 26762, 26763, 26764, 26765, 26766, 26767, 26768, 26769, 26770 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1885. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 26771, 26772, 26773, 26774, 26775, 26776, 26777, 26778, 26779, 26780, 26781 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1886. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 26782, 26783, 26784, 26785, 26786, 26787, 26788, 26789, 26790, 26791, 26792 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1887. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 26793, 26794, 26795, 26796, 26797, 26798, 26799, 26800, 26801, 26802, 26803 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1888. 458 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 26804, 26805, 26806, 26807, 26808, 26809, 26810, 26811, 26812, 26813, 26814 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1889. The probes having the nucleotide sequence represented by SEQ ID NOS: 26815, 26816, 26817, 26818, 26819, 26820, 26821, 26822, 26823, 26824, 26825 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1890. The probes having the nucleotide sequence represented by SEQ ID NOS: 26826, 26827, 26828, 26829, 26830, 26831, 26832, 26833, 26834, 26835, 26836 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1891. The probes having the nucleotide sequence represented by SEQ ID NOS: 26837, 26838, 26839, 26840, 26841, 26842, 26843, 26844, 26845, 26846, 26847 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1892. The probes having the nucleotide sequence represented by SEQ ID NOS: 26848, 26849, 26850, 26851, 26852, 26853, 26854, 26855, 26856, 26857, 26858 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1893. The probes having the nucleotide sequence represented by SEQ ID NOS: 26859, 26860, 26861, 26862, 26863, 26864, 26865, 26866, 26867, 26868, 26869 were selected from the 459 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1894. The probes having the nucleotide sequence represented by SEQ ID NOS: 26870, 26871, 26872, 26873, 26874, 26875, 5 26876, 26877, 26878, 26879, 26880 were selected from the. ORFs having the nucleotide sequence represented by SEQ ID NO: 1895. The probes having the nucleotide sequence represented by SEQ ID NOS: 26881, 26882, 26883, 26884, 26885, 26886, 10 26887, 26888, 26889, 26890, 26891 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1896. The probes having the nucleotide sequence represented by SEQ ID NOS: 26892, 26893, 26894, 26895, 26896, 26897, 15 26898, 26899, 26900, 26901, 26902, 26903, 26904, 26905, 26906, 26907, 26908, 26909, 26910, 26911, 26912, 26913 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1897. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 26914, 26915, 26916, 26917, 26918, 26919, 26920, 26921, 26922, 26923, 26924 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1898. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 26925, 26926, 26927, 26928, 26929, 26930, 26931, 26932, 26933, 26934, 26935 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1899. 460 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 26936, 26937, 26938, 26939, 26940, 26941, 26942, 26943, 26944, 26945, 26946 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1900. The probes having the nucleotide sequence represented by SEQ ID NOS: 26947, 26948, 26949, 26950, 26951, 26952, 26953, 26954, 26955, 26956, 26957 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1901. The probes having the nucleotide sequence represented by SEQ ID NOS: 26958, 26959, 26960, 26961, 26962, 26963, 26964, 26965, 26966, 26967, 26968 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1902. The probes having the nucleotide sequence represented by SEQ ID NOS: 26969, 26970, 26971, 26972, 26973, 26974, 26975, 26976, 26977, 26978, 26979 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1903. The probes having the nucleotide sequence represented by SEQ ID NOS: 26980, 26981, 26982, 26983, 26984, 26985, 26986, 26987, 26988, 26989, 26990 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1904. The probes having the nucleotide sequence represented by SEQ ID NOS: 26991, 26992, 26993, 26994, 26995, 26996, 26997, 26998, 26999, 27000, 27001 were selected from the 461 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1905. The probes having the nucleotide sequence represented by SEQ ID NOS: 27002, 27003, 27004, 27005, 27006, 27007, 5 27008, 27009, 27010, 27011, 27012 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1906. The probes having the nucleotide sequence represented by SEQ ID NOS: 27013, 27014, 27015, 27016, 27017, 27018, 10 27019, 27020, 27021, 27022, 27023 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1907. The probes having the nucleotide sequence represented by SEQ ID NOS: 27024, 27025, 27026, 27027, 27028, 27029, 15 27030, 27031, 27032, 27033, 27034 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1908. The probes having the nucleotide sequence represented by SEQ ID NOS: 27035, 27036, 27037, 27038, 27039, 27040, 20 27041, 27042, 27043, 27044, 27045 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1909. The probes having the nucleotide sequence represented by SEQ ID NOS: 27046, 27047, 27048, 27049, 27050, 27051, 25 27052, 27053, 27054, 27055, 27056 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1910. 462 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 27057, 27058, 27059, 27060, 27061, 27062, 27063, 27064, 27065, 27066, 27067 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1911. The probes having the nucleotide sequence represented by SEQ ID NOS: 27068, 27069, 27070, 27071, 27072, 27073, 27074, 27075, 27076, 27077, 27078 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1912. The probes having the nucleotide sequence represented by SEQ ID NOS: 27079, 27080, 27081, 27082, 27083, 27084, 27085, 27086, 27087, 27088, 27089 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1913. The probes having the nucleotide sequence represented by SEQ ID NOS: 27090, 27091, 27092, 27093, 27094, 27095, 27096, 27097, 27098, 27099, 27100 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1914. The probes having the nucleotide sequence represented by SEQ ID NOS: 27101, 27102, 27103, 27104, 27105, 27106, 27107, 27108, 27109, 27110, 27111 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1915. The probes having the nucleotide sequence represented by SEQ ID NOS: 27112, 27113, 27114, 27115, 27116, 27117, 27118, 27119, 27120, 27121, 27122 were selected from the 463 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1916. The probes having the nucleotide sequence represented by SEQ ID NOS: 27123, 27124, 27125, 27126, 27127, 27128, 5 27129, 27130, 27131, 27132, 27133 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1917. The probes having the nucleotide sequence represented by SEQ ID NOS: 27134, 27135, 27136, 27137, 27138, 27139, 10 27140, 27141, 27142, 27143, 27144, 27145, 27146, 27147, 27148, 27149, 27150, 27151, 27152, 27153, 27154, 27155 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1918. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 27156, 27157, 27158, 27159, 27160, 27161, 27162, 27163, 27164, 27165, 27166 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1919. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 27167, 27168, 27169, 27170, 27171, 27172, 27173, 27174, 27175, 27176, 27177 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1920. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 27178, 27179, 27180, 27181, 27182, 27183, 27184, 27185, 27186, 27187, 27188 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1921. 464 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 27189, 27190, 27191, 27192, 27193, 27194, 27195, 27196, 27197, 27198, 27199 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1922. The probes having the nucleotide sequence represented by SEQ ID NOS: 27200, 27201, 27202, 27203, 27204, 27205, 27206, 27207, 27208, 27209, 27210 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1923. The probes having the nucleotide sequence represented by SEQ ID NOS: 27211, 27212, 27213, 27214, 27215, 27216, 27217, 27218, 27219, 27220, 27221 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1924. The probes having the nucleotide sequence represented by SEQ ID NOS: 27222, 27223, 27224, 27225, 27226, 27227, 27228, 27229, 27230, 27231, 27232 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1925. The probes having the nucleotide sequence represented by SEQ ID NOS: 27233, 27234, 27235, 27236, 27237, 27238, 27239, 27240, 27241, 27242, 27243 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1926. The probes having the nucleotide sequence represented by SEQ ID NOS: 27244, 27245, 27246, 27247, 27248, 27249, 27250, 27251, 27252, 27253, 27254 were selected from the 465 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1927. The probes having the nucleotide sequence represented by SEQ ID NOS: 27255, 27256, 27257, 27258, 27259, 27260, 5 27261, 27262, 27263, 27264, 27265 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1928. The probes having the nucleotide sequence represented by SEQ ID NOS: 27266, 27267, 27268, 27269, 27270, 27271, 10 27272, 27273, 27274, 27275, 27276 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1929. The probes having the nucleotide sequence represented by SEQ ID NOS: 27277, 27278, 27279, 27280, 27281, 27282, 15 27283, 27284, 27285, 27286, 27287 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1930. The probes having the nucleotide sequence represented by SEQ ID NOS: 27288, 27289, 27290, 27291, 27292, 27293, 20 27294, 27295, 27296, 27297, 27298 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1931. The probes having the nucleotide sequence represented by SEQ ID NOS: 27299, 27300, 27301, 27302, 27303, 27304, 25 27305, 27306, 27307, 27308, 27309 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1932. 466 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 27310, 27311, 27312, 27313, 27314, 27315, 27316, 27317, 27318, 27319, 27320 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1933. The probes having the nucleotide sequence represented by SEQ ID NOS: 27321, 27322, 27323, 27324, 27325, 27326, 27327, 27328, 27329, 27330, 27331 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1934. The probes having the nucleotide sequence represented by SEQ ID NOS: 27332, 27333, 27334, 27335, 27336, 27337, 27338, 27339, 27340, 27341, 27342 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1935. The probes having the nucleotide sequence represented by SEQ ID NOS: 27343, 27344, 27345, 27346, 27347, 27348, 27349, 27350, 27351, 27352, 27353 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1936. The probes having the nucleotide sequence represented by SEQ ID NOS: 27354, 27355, 27356, 27357, 27358, 27359, 27360, 27361, 27362, 27363, 27364 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1937. The probes having the nucleotide sequence represented by SEQ ID NOS: 27365, 27366, 27367, 27368, 27369, 27370, 27371, 27372, 27373, 27374, 27375 were selected from the 467 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1938. The probes having the nucleotide sequence represented by SEQ ID NOS: 27376, 27377, 27378, 27379, 27380, 27381, 5 27382, 27383, 27384, 27385, 27386 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1939. The probes having the nucleotide sequence represented by SEQ ID NOS: 27387, 27388, 27389, 27390, 27391, 27392, 10 27393, 27394, 27395, 27396, 27397 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1940. The probes having the nucleotide sequence represented by SEQ ID NOS: 27398, 27399, 27400, 27401, 27402, 27403, 15 27404, 27405, 27406, 27407, 27408 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1941. The probes having the nucleotide sequence represented by SEQ ID NOS: 27409, 27410, 27411, 27412, 27413, 27414, 20 27415, 27416, 27417, 27418, 27419 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1942. The probes having the nucleotide sequence represented by SEQ ID NOS: 27420, 27421, 27422, 27423, 27424, 27425, 25 27426, 27427, 27428, 27429, 27430 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1943. 468 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 27431, 27432, 27433, 27434, 27435, 27436, 27437, 27438, 27439, 27440, 27441 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1944. The probes having the nucleotide sequence represented by SEQ ID NOS: 27442, 27443, 27444, 27445, 27446, 27447, 27448, 27449, 27450, 27451, 27452 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1945. The probes having the nucleotide sequence represented by SEQ ID NOS: 27453, 27454, 27455, 27456, 27457, 27458, 27459, 27460, 27461, 27462, 27463 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1946. The probes having the nucleotide sequence represented by SEQ ID NOS: 27464, 27465, 27466, 27467, 27468, 27469, 27470, 27471, 27472, 27473, 27474 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1947. The probes having the nucleotide sequence represented by SEQ ID NOS: 27475, 27476, 27477, 27478, 27479, 27480, 27481, 27482, 27483, 27484, 27485 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1948. The probes having the nucleotide sequence represented by SEQ ID NOS: 27486, 27487, 27488, 27489, 27490, 27491, 27492, 27493, 27494, 27495, 27496 were selected from the 469 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1949. The probes having the nucleotide sequence represented by SEQ ID NOS: 27497, 27498, 27499, 27500, 27501, 27502, 5 27503, 27504, 27505, 27506, 27507 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1950. The probes having the nucleotide sequence represented by SEQ ID NOS: 27508, 27509, 27510, 27511, 27512, 27513, 10 27514, 27515, 27516, 27517, 27518 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1951. The probes having the nucleotide sequence represented by SEQ ID NOS: 27519, 27520, 27521, 27522, 27523, 27524, 15 27525, 27526, 27527, 27528, 27529 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1952. The probes having the nucleotide sequence represented by SEQ ID NOS: 27530, 27531, 27532, 27533, 27534, 27535, 20 27536, 27537, 27538, 27539, 27540 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1953. The probes having the nucleotide sequence represented by SEQ ID NOS: 27541, 27542, 27543, 27544, 27545, 27546, 25 27547, 27548, 27549, 27550, 27551 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1954. 470 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 27552, 27553, 27554, 27555, 27556, 27557, 27558, 27559, 27560, 27561, 27562 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1955. The probes having the nucleotide sequence represented by SEQ ID NOS: 27563, 27564, 27565, 27566, 27567, 27568, 27569, 27570, 27571, 27572, 27573 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1956. The probes having the nucleotide sequence represented by SEQ ID NOS: 27574, 27575, 27576, 27577, 27578, 27579, 27580, 27581, 27582, 27583, 27584 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1957. The probes having the nucleotide sequence represented by SEQ ID NOS: 27585, 27586, 27587, 27588, 27589, 27590, 27591, 27592, 27593, 27594, 27595 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1958. The probes having the nucleotide sequence represented by SEQ ID NOS: 27596, 27597, 27598, 27599, 27600, 27601, 27602, 27603, 27604, 27605, 27606 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1959. The probes having the nucleotide sequence represented by SEQ ID NOS: 27607, 27608, 27609, 27610, 27611, 27612, 27613, 27614, 27615, 27616, 27617 were selected from the 471 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1960. The probes having the nucleotide sequence represented by SEQ ID NOS: 27618, 27619, 27620, 27621, 27622, 27623, 5 -27624, 27625, 27626, 27627, 27628 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1961. The probes having the nucleotide sequence represented by SEQ ID NOS: 27629, 27630, 27631, 27632, 27633, 27634, 10 27635, 27636, 27637, 27638, 27639 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1962. The probes having the nucleotide sequence represented by SEQ ID NOS: 27640, 27641, 27642, 27643, 27644, 27645, 15 27646, 27647, 27648, 27649, 27650 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1963. The probes having the nucleotide sequence represented by SEQ ID NOS: 27651, 27652, 27653, 27654, 27655, 27656, 20 27657, 27658, 27659, 27660, 27661 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1964. The probes having the nucleotide sequence represented by SEQ ID NOS: 27662, 27663, 27664, 27665, 27666, 27667, 25 27668, 27669, 27670, 27671, 27672 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1965. 472 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 27673, 27674', 27675, 27676, 27677, 27678, 27679, 27680, 27681, 27682, 27683 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1966. The probes having the nucleotide sequence represented by SEQ ID NOS: 27684, 27685, 27686, 27687, 27688, 27689, 27690, 27691, 27692, 27693, 27694 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1967. The probes having the nucleotide sequence represented by SEQ ID NOS: 27695, 27696, 27697, 27698, 27699, 27700, 27701, 27702, 27703, 27704, 27705 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1968. The probes having the nucleotide sequence represented by SEQ ID NOS: 27706, 27707, 27708, 27709, 27710, 27711, 27712, 27713, 27714, 27715, 27716 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1969. The probes having the nucleotide sequence represented by SEQ ID NOS: 27717, 27718, 27719, 27720, 27721, 27722, 27723, 27724, 27725, 27726, 27727 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1970. The probes having the nucleotide sequence represented by SEQ ID NOS: 27728, 27729, 27730, 27731, 27732, 27733, 27734, 27735, 27736, 27737, 27738 were selected from the 473 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1971. The probes having the nucleotide sequence represented by SEQ ID NOS: 27739, 27740, 27741, 27742, 27743, 27744, 5 27745, 27746, 27747, 27748, 27749 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1972. The probes having the nucleotide sequence represented by SEQ ID NOS: 27750, 27751, 27752, 27753, 27754, 27755, 10 27756, 27757, 27758, 27759, 27760 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1973. The probes having the nucleotide sequence represented by SEQ ID NOS: 27761, 27762, 27763, 27764, 27765, 27766, 15 27767, 27768, 27769, 27770, 27771 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1974. The probes having the nucleotide sequence represented by SEQ ID NOS: 27772, 27773, 27774, 27775, 27776, 27777, 20 27778, 27779, 27780, 27781, 27782 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1975. The probes having the nucleotide sequence represented by SEQ ID NOS: 27783, 27784, 27785, 27786, 27787, 27788, 25 27789, 27790, 27791, 27792, 27793 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1976. 474 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 27794, 27795, 27796, 27797, 27798, 27799, 27800, 27801, 27802, 27803, 27804 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1977. The probes having the nucleotide sequence represented by SEQ ID NOS: 27805, 27806, 27807, 27808, 27809, 27810, 27811, 27812, 27813, 27814, 27815 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1978. The probes having the nucleotide sequence represented by SEQ ID NOS: 27816, 27817, 27818, 27819, 27820, 27821, 27822, 27823, 27824, 27825, 27826 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1979. The probes having the nucleotide sequence represented by SEQ ID NOS:'27827, 27828, 27829, 27830, 27831, 27832, 27833, 27834, 27835, 27836, 27837 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1980. The probes having the nucleotide sequence represented by SEQ ID NOS: 27838, 27839, 27840, 27841, 27842, 27843, 27844, 27845, 27846, 27847, 27848 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1981. The probes having the nucleotide sequence represented by SEQ ID NOS: 27849, 27850, 27851, 27852, 27853, 27854, 27855, 27856, 27857, 27858, 27859 were selected from the 475 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1982. The probes having the nucleotide sequence represented by SEQ ID NOS: 27860, 27861, 27862, 27863, 27864, 27865, 5 27866, 27867, 27868, 27869, 27870 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1983. The probes having the nucleotide sequence represented by SEQ ID NOS: 27871, 27872, 27873, 27874, 27875, 27876, 10 27877, 27878, 27879, 27880, 27881 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1984. The probes having the nucleotide sequence represented by SEQ ID NOS: 27882, 27883, 27884, 27885, 27886, 27887, 15 27888, 27889, 27890, 27891, 27892 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1985. The probes having the nucleotide sequence represented by SEQ ID NOS: 27893, 27894, 27895, 27896, 27897, 27898, 20 27899, 27900, 27901, 27902, 27903 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1986. The probes having the nucleotide sequence represented by SEQ ID NOS: 27904, 27905, 27906, 27907, 27908, 27909, 25 27910, 27911, 27912, 27913, 27914 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1987. 476 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 27915, 27916, 27917, 27918, 27919, 27920, 27921, 27922, 27923, 27924, 27925 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1988. The probes having the nucleotide sequence represented by SEQ ID NOS: 27926, 27927, 27928, 27929, 27930, 27931, 27932, 27933, 27934, 27935, 27936 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 1989. The probes having the nucleotide sequence represented by SEQ ID NOS: 27937, 27938, 27939, 27940, 27941, 27942, 27943, 27944, 27945, 27946, 27947 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 1990. The probes having the nucleotide sequence represented by SEQ ID NOS: 27948, 27949, 27950, 27951, 27952, 27953, 27954, 27955, 27956, 27957, 27958 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 1991. The probes having the nucleotide sequence represented by SEQ ID NOS: 27959, 27960, 27961, 27962, 27963, 27964, 27965, 27966, 27967, 27968, 27969 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 1992. The probes having the nucleotide sequence represented by SEQ ID NOS: 27970, 27971, 27972, 27973, 27974, 27975, 27976, 27977, 27978, 27979, 27980 were selected from the 477 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 1993. The probes having the nucleotide sequence represented by SEQ ID NOS: 27981, 27982, 27983, 27984, 27985, 27986, 5 27987, 27988, 27989, 27990 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1994. The probes having the nucleotide sequence represented by SEQ ID NOS: 27991, 27992, 27993, 27994, 27995, 27996, 10 27997, 27998, 27999, 28000, 28001 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1995. The probes having the nucleotide sequence represented by SEQ ID NOS: 28002, 28003, 28004, 28005, 28006, 28007, 15 28008, 28009, 28010, 28011, 28012 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1996. The probes having the nucleotide sequence represented by SEQ ID NOS: 28013, 28014, 28015, 28016, 28017, 28018, 20 28019, 28020, 28021, 28022, 28023 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1997. The probes having the nucleotide sequence represented by SEQ ID NOS: 28024, 28025, 28026, 28027, 28028, 28029, 25 28030, 28031, 28032, 28033, 28034 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 1998. 478 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 28035, 28036, 28037, 28038, 28039, 28040, 28041, 28042, 28043, 28044, 28045 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 1999. The probes having the nucleotide sequence represented by SEQ ID NOS: 28046, 28047, 28048, 28049, 28050, 28051, 28052, 28053, 28054, 28055, 28056 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2000. The probes having the nucleotide sequence represented by SEQ ID NOS: 28057, 28058, 28059, 28060, 28061, 28062, 28063, 28064, 28065, 28066, 28067 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2001. The probes having the nucleotide sequence represented by SEQ ID NOS: 28068, 28069, 28070, 28071, 28072, 28073, 28074, 28075, 28076, 28077, 28078 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2002. The probes having the nucleotide sequence represented by SEQ ID NOS: 28079, 28080, 28081, 28082, 28083, 28084, 28085, 28086, 28087, 28088, 28089 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2003. The probes having the nucleotide sequence represented by SEQ ID NOS: 28090, 28091, 28092, 28093, 28094, 28095, 28096, 28097, 28098, 28099, 28100 were selected from the 479 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2004. The probes having the nucleotide sequence represented by SEQ ID NOS: 28101, 28102, 28103, 28104, 28105, 28106, 5 28107, 28108, 28109, 28110, 28111 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2005. The probes having the nucleotide sequence represented by SEQ ID NOS: 28112, 28113, 28114, 28115, 28116, 28117, 10 28118, 28119, 28120, 28121, 28122 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2006. The probes having the nucleotide sequence represented by SEQ ID NOS: 28123, 28124, 28125, 28126, 28127, 28128, 15 28129, 28130, 28131, 28132, 28133 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2007. The probes having the nucleotide sequence represented by SEQ ID NOS: 28134, 28135, 28136, 28137, 28138, 28139, 20 28140, 28141, 28142, 28143, 28144 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2008. The probes having the nucleotide sequence represented by SEQ ID NOS: 28145, 28146, 28147, 28148, 28149, 28150, 25 28151, 28152, 28153, 28154, 28155 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2009. 480 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 28156, 28157, 28158, 28159, 28160, 28161, 28162, 28163, 28164, 28165, 28166 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2010. The probes having the nucleotide sequence represented by SEQ ID NOS: 28167, 28168, 28169, 28170, 28171, 28172, 28173, 28174, 28175, 28176, 28177 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2011. The probes having the nucleotide sequence represented by SEQ ID NOS: 28178, 28179, 28180, 28181, 28182, 28183, 28184, 28185, 28186, 28187, 28188 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2012. The probes having the nucleotide sequence represented by SEQ ID NOS: 28189, 28190, 28191, 28192, 28193, 28194, 28195, 28196, 28197, 28198, 28199 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2013. The probes having the nucleotide sequence represented by SEQ ID NOS: 28200, 28201, 28202, 28203, 28204, 28205, 28206, 28207, 28208, 28209, 28210 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2014. The probes having the nucleotide sequence represented by SEQ ID NOS: 28211, 28212, 28213, 28214, 28215, 28216, 28217, 28218, 28219, 28220, 28221 were selected from the 481 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2015. The probes having the nucleotide sequence represented by SEQ ID NOS: 28222, 28223, 28224, 28225, 28226, 28227, 5 28228, 28229, 28230, 28231, 28232 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2016. The probes having the nucleotide sequence represented by SEQ ID NOS: 28233, 28234, 28235, 28236, 28237, 28238, 10 28239, 28240, 28241, 28242, 28243 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2017. The probes having the nucleotide sequence represented by SEQ ID NOS: 28244, 28245, 28246, 28247, 28248, 28249, 15 28250, 28251, 28252, 28253, 28254 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2018. The probes having the nucleotide sequence represented by SEQ ID NOS: 28255, 28256, 28257, 28258, 28259, 28260, 20 28261, 28262, 28263, 28264, 28265 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2019. The probes having the nucleotide sequence represented by SEQ ID NOS: 28266, 28267, 28268, 28269, 28270, 28271, 25 28272, 28273, 28274, 28275, 28276 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2020. 482 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 28277, 28278, 28279, 28280, 28281, 28282, 28283, 28284, 28285, 28286, 28287 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2021. The probes having the nucleotide sequence represented by SEQ ID NOS: 28288, 28289, 28290, 28291, 28292, 28293, 28294, 28295, 28296, 28297, 28298 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2022. The probes having the nucleotide sequence represented by SEQ ID NOS: 28299, 28300, 28301, 28302, 28303, 28304, 28305, 28306, 28307, 28308, 28309 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2023. The probes having the nucleotide sequence represented by SEQ ID NOS: 28310, 28311, 28312, 28313, 28314, 28315, 28316, 28317, 28318, 28319, 28320 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2024. The probes having the nucleotide sequence represented by SEQ ID NOS: 28321, 28322, 28323, 28324, 28325, 28326, 28327, 28328, 28329, 28330, 28331 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2025. The probes having the nucleotide sequence represented by SEQ ID NOS: 28332, 28333, 28334, 28335, 28336, 28337, 28338, 28339, 28340, 28341, 28342 were selected from the 483 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2026. The probes having the nucleotide sequence represented by SEQ ID NOS: 28343, 28344, 28345, 28346, 28347, 28348, 5 28349, 28350, 28351, 28352, 28353 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2027. The probes having the nucleotide sequence represented by SEQ ID NOS: 28354, 28355, 28356, 28357, 28358, 28359, 10 28360, 28361, 28362, 28363, 28364 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2028. The probes having the nucleotide sequence represented by SEQ ID NOS: 28365, 28366, 28367, 28368, 28369, 28370, 15 28371, 28372, 28373, 28374, 28375 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2029. The probes having the nucleotide sequence represented by SEQ ID NOS: 28376, 28377, 28378, 28379, 28380, 28381, 20 28382, 28383, 28384, 28385, 28386 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2030. The probes having the nucleotide sequence represented by SEQ ID NOS: 28387, 28388, 28389, 28390, 28391, 28392, 25 28393, 28394, 28395, 28396, 28397 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2031. 484 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 28398, 28399, 28400, 28401, 28402, 28403, 28404, 28405, 28406, 28407, 28408 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2032. The probes having the nucleotide sequence represented by SEQ ID NOS: 28409, 28410, 28411, 28412, 28413, 28414, 28415, 28416, 28417, 28418, 28419 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2033. The probes having the nucleotide sequence represented by SEQ ID NOS: 28420, 28421, 28422, 28423, 28424, 28425, 28426, 28427, 28428, 28429, 28430 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2034. The probes having the nucleotide sequence represented by SEQ ID NOS: 28431, 28432, 28433, 28434, 28435, 28436, 28437, 28438, 28439, 28440, 28441 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2035. The probes having the nucleotide sequence represented by SEQ ID NOS: 28442, 28443, 28444, 28445, 28446, 28447, 28448, 28449, 28450, 28451, 28452 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2036. The probes having the nucleotide sequence represented by SEQ ID NOS: 28453, 28454, 28455, 28456, 28457, 28458, 28459, 28460, 28461, 28462, 28463 were selected from the 485 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2037. The probes having the nucleotide sequence represented by SEQ ID NOS: 28464, 28465, 28466, 28467, 28468, 28469, 5 28470, 28471, 28472, 28473, 28474 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2038. The probes having the nucleotide sequence represented by SEQ ID NOS: 28475, 28476, 28477, 28478, 28479, 28480, 10 28481, 28482, 28483, 28484, 28485 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2039. The probes having the nucleotide sequence represented by SEQ ID NOS: 28486, 28487, 28488, 28489, 28490, 28491, 15 28492, 28493, 28494, 28495, 28496 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2040. The probes having the nucleotide sequence represented by SEQ ID NOS: 28497, 28498, 28499, 28500, 28501, 28502, 20 28503, 28504, 28505, 28506, 28507 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2041. The probes having the nucleotide sequence represented by SEQ ID NOS: 28508, 28509, 28510, 28511, 28512, 28513, 25 28514, 28515, 28516, 28517, 28518 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2042. 486 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 28519, 28520, 28521, 28522, 28523, 28524, 28525, 28526, 28527, 28528, 28529 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2043. The probes having the nucleotide sequence represented by SEQ ID NOS: 28530, 28531, 28532, 28533, 28534, 28535, 28536, 28537, 28538, 28539, 28540 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2044. The probes having the nucleotide sequence represented by SEQ ID NOS: 28541, 28542, 28543, 28544, 28545, 28546, 28547, 28548, 28549, 28550, 28551 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2045. The probes having the nucleotide sequence represented by SEQ ID NOS: 28552, 28553, 28554, 28555, 28556, 28557, 28558, 28559, 28560, 28561, 28562 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2046. The probes having the nucleotide sequence represented by SEQ ID NOS: 28563, 28564, 28565, 28566, 28567, 28568, 28569, 28570, 28571, 28572, 28573 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2047. The probes having the nucleotide sequence represented by SEQ ID NOS: 28574, 28575, 28576, 28577, 28578, 28579, 28580, 28581, 28582, 28583, 28584 were selected from the 487 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2048. The probes having the nucleotide sequence represented by SEQ ID NOS: 28585, 28586, 28587, 28588, 28589, 28590, 5 28591, 28592, 28593, 28594, 28595 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2049. The probes having the nucleotide sequence represented by SEQ ID NOS: 28596, 28597, 28598, 28599, 28600, 28601, 10 28602, 28603, 28604, 28605, 28606 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2050. The probes having the nucleotide sequence represented by SEQ ID NOS: 28607, 28608, 28609, 28610, 28611, 28612, 15 28613, 28614, 28615, 28616, 28617 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2051. The probes having the nucleotide sequence represented by SEQ ID NOS: 28618, 28619, 28620, 28621, 28622, 28623, 20 28624, 28625, 28626, 28627, 28628 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2052. The probes having the nucleotide sequence represented by SEQ ID NOS: 28629, 28630, 28631, 28632, 28633, 28634, 25 28635, 28636, 28637, 28638, 28639 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2053. 488 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 28640, 28641, 28642, 28643, 28644, 28645, 28646, 28647, 28648, 28649, 28650 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2054. The probes having the nucleotide sequence represented by SEQ ID NOS: 28651, 28652, 28653, 28654, 28655, 28656, 28657, 28658, 28659, 28660, 28661 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2055. The probes having the nucleotide sequence represented by SEQ ID NOS: 28662, 28663, 28664, 28665, 28666, 28667, 28668, 28669, 28670, 28671, 28672 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2056. The probes having the nucleotide sequence represented by SEQ ID NOS: 28673, 28674, 28675, 28676, 28677, 28678, 28679, 28680, 28681, 28682, 28683 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2057. The probes having the nucleotide sequence represented by SEQ ID NOS: 28684, 28685, 28686, 28687, 28688, 28689, 28690, 28691, 28692, 28693, 28694 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2058. The probes having the nucleotide sequence represented by SEQ ID NOS: 28695, 28696, 28697, 28698, 28699, 28700, 28701, 28702, 28703, 28704, 28705 were selected from the 489 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2059. The probes having the nucleotide sequence represented by SEQ ID NOS: 28706, 28707, 28708, 28709, 28710, 28711, 5 28712, 28713, 28714, 28715, 28716 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2060. The probes having the nucleotide sequence represented by SEQ ID NOS: 28717, 28718, 28719, 28720, 28721, 28722, 10 28723, 28724, 28725, 28726, 28727 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2061. The probes having the nucleotide sequence represented by SEQ ID NOS: 28728, 28729, 28730, 28731, 28732, 28733, 15 28734, 28735, 28736, 28737, 28738 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2062. The probes having the nucleotide sequence represented by SEQ ID NOS: 28739, 28740, 28741, 28742, 28743, 28744, 20 28745, 28746, 28747, 28748, 28749 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2063. The probes having the nucleotide sequence represented by SEQ ID NOS: 28750, 28751, 28752, 28753, 28754, 28755, 25 28756, 28757, 28758, 28759, 28760 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2064. 490 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 28761, 28762, 28763, 28764, 28765, 28766, 28767, 28768, 28769, 28770, 28771 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2065. The probes having the nucleotide sequence represented by SEQ ID NOS: 28772, 28773, 28774, 28775, 28776, 28777, 28778, 28779, 28780, 28781, 28782 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2066. The probes having the nucleotide sequence represented by SEQ ID NOS: 28783, 28784, 28785, 28786, 28787, 28788, 28789, 28790, 28791, 28792, 28793 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2067. The probes having the nucleotide sequence represented by SEQ ID NOS: 28794, 28795, 28796, 28797, 28798, 28799, 28800, 28801, 28802, 28803, 28804 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2068. The probes having the nucleotide sequence represented by SEQ ID NOS: 28805, 28806, 28807, 28808, 28809, 28810, 28811, 28812, 28813, 28814, 28815 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2069. The probes having the nucleotide sequence represented by SEQ ID NOS: 28816, 28817, 28818, 28819, 28820, 28821, 28822, 28823, 28824, 28825, 28826 were selected from the 491 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2070. The probes having the nucleotide sequence represented by SEQ ID NOS: 28827, 28828, 28829, 28830, 28831, 28832, 5 28833, 28834, 28835, 28836, 28837 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2071. The probes having the nucleotide sequence represented by SEQ ID NOS: 28838, 28839, 28840, 28841, 28842, 28843, 10 28844, 28845, 28846, 28847, 28848 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2072. The probes having the nucleotide sequence represented by SEQ ID NOS: 28849, 28850, 28851, 28852, 28853, 28854, 15 28855, 28856, 28857, 28858, 28859 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2073. The probes having the nucleotide sequence represented by SEQ ID NOS: 28860, 28861, 28862, 28863, 28864, 28865, 20 28866, 28867, 28868, 28869, 28870 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2074. The probes having the nucleotide sequence represented by SEQ ID NOS: 28871, 28872, 28873, 28874, 28875, 28876, 25 28877, 28878, 28879, 28880, 28881 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2075. 492 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 28882, 28883, 28884, 28885, 28886, 28887, 28888, 28889, 28890, 28891, 28892 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2076. The probes having the nucleotide sequence represented by SEQ ID NOS: 28893, 28894, 28895, 28896, 28897, 28898, 28899, 28900, 28901, 28902, 28903 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2077. The probes having the nucleotide sequence represented by SEQ ID NOS: 28904, 28905, 28906, 28907, 28908, 28909, 28910, 28911, 28912, 28913, 28914 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2078. The probes having the nucleotide sequence represented by SEQ ID NOS: 28915, 28916, 28917, 28918, 28919, 28920, 28921, 28922, 28923, 28924, 28925 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2079. The probes having the nucleotide sequence represented by SEQ ID NOS: 28926, 28927, 28928, 28929, 28930, 28931, 28932, 28933, 28934, 28935, 28936 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2080. The probes having the nucleotide sequence represented by SEQ ID NOS: 28937, 28938, 28939, 28940, 28941, 28942, 28943, 28944, 28945, 28946, 28947 were selected from the 493 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2081. The probes having the nucleotide sequence represented by SEQ ID NOS: 28948, 28949, 28950, 28951, 28952, 28953, 5 28954, 28955, 28956, 28957, 28958 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2082. The probes having the nucleotide sequence represented by SEQ ID NOS: 28959, 28960, 28961, 28962, 28963, 28964, 10 28965, 28966, 28967, 28968, 28969 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2083. The probes having the nucleotide sequence represented by SEQ ID NOS: 28970, 28971, 28972, 28973, 28974, 28975, 15 28976, 28977, 28978, 28979, 28980 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2084. The probes having the nucleotide sequence represented by SEQ ID NOS: 28981, 28982, 28983, 28984, 28985, 28986, 20 28987, 28988, 28989, 28990, 28991 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2085. The probes having the nucleotide sequence represented by SEQ ID NOS: 28992, 28993, 28994, 28995, 28996, 28997, 25 28998, 28999, 29000, 29001, 29002 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2086. 494 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 29003, 29004, 29005, 29006, 29007, 29008, 29009, 29010, 29011, 29012, 29013 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2087. The probes having the nucleotide sequence represented by SEQ ID NOS: 29014, 29015, 29016, 29017, 29018, 29019, 29020, 29021, 29022, 29023, 29024 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2088. The probes having the nucleotide sequence represented by SEQ ID NOS: 29025, 29026, 29027, 29028, 29029, 29030, 29031, 29032, 29033, 29034, 29035 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2089. The probes having the nucleotide sequence represented by SEQ ID NOS: 29036, 29037, 29038, 29039, 29040, 29041, 29042, 29043, 29044, 29045, 29046 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2090. The probes having the nucleotide sequence represented by SEQ ID NOS: 29047, 29048, 29049, 29050, 29051, 29052, 29053, 29054, 29055, 29056, 29057 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2091. The probes having the nucleotide sequence represented by SEQ ID NOS: 29058, 29059, 29060, 29061, 29062, 29063, 29064, 29065, 29066, 29067, 29068 were selected from the 495 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2092. The probes having the nucleotide sequence represented by SEQ ID NOS: 29069, 29070, 29071, 29072, 29073, 29074, 5 29075, 29076, 29077, 29078, 29079 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2093. The probes having the nucleotide sequence represented by SEQ ID NOS: 29080, 29081, 29082, 29083, 29084, 29085, 10 29086, 29087, 29088, 29089, 29090 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2094. The probes having the nucleotide sequence represented by SEQ ID NOS: 29091, 29092, 29093, 29094, 29095, 29096, 15 29097, 29098, 29099, 29100, 29101 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2095. The probes having the nucleotide sequence represented by SEQ ID NOS: 29102, 29103, 29104, 29105, 29106, 29107, 20 29108, 29109, 29110, 29111, 29112 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2096. The probes having the nucleotide sequence represented by SEQ ID NOS: 29113, 29114, 29115, 29116, 29117, 29118, 25 29119, 29120, 29121, 29122, 29123 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2097. 496 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 29124, 29125, 29126, 29127, 29128, 29129, 29130, 29131, 29132, 29133, 29134 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2098. The probes having the nucleotide sequence represented by SEQ ID NOS: 29135, 29136, 29137, 29138, 29139, 29140, 29141, 29142, 29143, 29144, 29145 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2099. The probes having the nucleotide sequence represented by SEQ ID NOS: 29146, 29147, 29148, 29149, 29150, 29151, 29152, 29153, 29154, 29155, 29156 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2100. The probes having the nucleotide sequence represented by SEQ ID NOS: 29157, 29158, 29159, 29160, 29161, 29162, 29163, 29164, 29165, 29166, 29167 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2101. The probes having the nucleotide sequence represented by SEQ ID NOS: 29168, 29169, 29170, 29171, 29172, 29173, 29174, 29175, 29176, 29177, 29178 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2102. The probes having the nucleotide sequence represented by SEQ ID NOS: 29179, 29180, 29181, 29182, 29183, 29184, 29185, 29186, 29187, 29188, 29189 were selected from the 497 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2103. The probes having the nucleotide sequence represented by SEQ ID NOS: 29190, 29191, 29192, 29193, 29194, 29195, 5 29196, 29197, 29198, 29199, 29200 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2104. The probes having the nucleotide sequence represented by SEQ ID NOS: 29201, 29202, 29203, 29204, 29205, 29206, 10 29207, 29208, 29209, 29210, 29211 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2105. The probes having the nucleotide sequence represented by SEQ ID NOS: 29212, 29213, 29214, 29215, 29216, 29217, 15 29218, 29219, 29220, 29221, 29222 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2106. The probes having the nucleotide sequence represented by SEQ ID NOS: 29223, 29224, 29225, 29226, 29227, 29228, 20 29229, 29230, 29231, 29232, 29233 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2107. The probes having the nucleotide sequence represented by SEQ ID NOS: 29234, 29235, 29236, 29237, 29238, 29239, 25 29240, 29241, 29242, 29243, 29244 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2108. 498 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 29245, 29246, 29247, 29248, 29249, 29250, 29251, 29252, 29253, 29254, 29255 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2109. The probes having the nucleotide sequence represented by SEQ ID NOS: 29256, 29257, 29258, 29259, 29260, 29261, 29262, 29263, 29264, 29265, 29266 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2110. The probes having the nucleotide sequence represented by SEQ ID NOS: 29267, 29268, 29269, 29270, 29271, 29272, 29273, 29274, 29275, 29276, 29277 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2111. The probes having the nucleotide sequence represented by SEQ ID NOS: 29278, 29279, 29280, 29281, 29282, 29283, 29284, 29285, 29286, 29287, 29288 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2112. The probes having the nucleotide sequence represented by SEQ ID NOS: 29289, 29290, 29291, 29292, 29293, 29294, 29295, 29296, 29297, 29298, 29299 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2113. The probes having the nucleotide sequence represented by SEQ ID NOS: 29300, 29301, 29302, 29303, 29304, 29305, 29306, 29307, 29308, 29309, 29310 were selected from the 499 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2114. The probes having the nucleotide sequence represented by SEQ ID NOS: 29311, 29312, 29313, 29314, 29315, 29316, 5 29317, 29318, 29319, 29320, 29321 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2115. The probes having the nucleotide sequence represented by SEQ ID NOS: 29322, 29323, 29324, 29325, 29326, 29327, 10 29328, 29329, 29330, 29331, 29332 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2116. The probes having the nucleotide sequence represented by SEQ ID NOS: 29333, 29334, 29335, 29336, 29337, 29338, 15 29339, 29340, 29341, 29342, 29343 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2117. The probes having the nucleotide sequence represented by SEQ ID NOS: 29344, 29345, 29346, 29347, 29348, 29349, 20 29350, 29351, 29352, 29353, 29354 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2118. The probes having the nucleotide sequence represented by SEQ ID NOS: 29355, 29356, 29357, 29358, 29359, 29360, 25 29361, 29362, 29363, 29364, 29365 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2119. 500 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 29366, 29367, 29368, 29369, 29370, 29371, 29372, 29373, 29374, 29375; 29376 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2120. The probes having the nucleotide sequence represented by SEQ ID NOS: 29377, 29378, 29379, 29380, 29381, 29382, 29383, 29384, 29385, 29386, 29387 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2121. The probes having the nucleotide sequence represented by SEQ ID NOS: 29388, 29389, 29390, 29391, 29392, 29393, 29394, 29395, 29396, 29397, 29398 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2122. The probes having the nucleotide sequence represented by SEQ ID NOS: 29399, 29400, 29401, 29402, 29403, 29404, 29405, 29406, 29407, 29408, 29409 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2123. The probes having the nucleotide sequence represented by SEQ ID NOS: 29410, 29411, 29412, 29413, 29414, 29415, 29416, 29417, 29418, 29419, 29420 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2124. The probes having the nucleotide sequence represented by SEQ ID NOS: 29421, 29422, 29423, 29424, 29425, 29426, 29427, 29428, 29429, 29430, 29431 were selected from the 501 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2125. The probes having the nucleotide sequence represented by SEQ ID NOS: 29432, 29433, 29434, 29435, 29436, 29437, 5 29438, 29439, 29440, 29441, 29442 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2126. The probes having the nucleotide sequence represented by SEQ ID NOS: 29443, 29444, 29445, 29446, 29447, 29448, 10 29449, 29450, 29451, 29452, 29453 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2127. The probes having the nucleotide sequence represented by SEQ ID NOS: 29454, 29455, 29456, 29457, 29458, 29459, 15 29460, 29461, 29462, 29463, 29464 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2128. The probes having the nucleotide sequence represented by SEQ ID NOS: 29465, 29466, 29467, 29468, 29469, 29470, 20 29471, 29472, 29473, 29474, 29475 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2129. The probes having the nucleotide sequence represented by SEQ ID NOS: 29476, 29477, 29478, 29479, 29480, 29481, 25 29482, 29483, 29484, 29485, 29486 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2130. 502 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 29487, 29488, 29489, 29490, 29491, 29492, 29493, 29494, 29495, 29496, 29497 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2131. The probes having the nucleotide sequence represented by SEQ ID NOS: 29498, 29499, 29500, 29501, 29502, 29503, 29504, 29505, 29506, 29507, 29508 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2132. The probes having the nucleotide sequence represented by SEQ ID NOS: 29509, 29510, 29511, 29512, 29513, 29514, 29515, 29516, 29517, 29518, 29519 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2133. The probes having the nucleotide sequence represented by SEQ ID NOS: 29520, 29521, 29522, 29523, 29524, 29525, 29526, 29527, 29528, 29529, 29530 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2134. The probes having the nucleotide sequence represented by SEQ ID NOS: 29531, 29532, 29533, 29534, 29535, 29536, 29537, 29538, 29539, 29540, 29541 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2135. The probes having the nucleotide sequence represented by SEQ ID NOS: 29542, 29543, 29544, 29545, 29546, 29547, 29548, 29549, 29550, 29551, 29552 were selected from the 503 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2136. The probes having the nucleotide sequence represented by SEQ ID NOS: 29553, 29554, 29555, 29556, 29557, 29558, 5 29559, 29560, 29561, 29562, 29563 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2137. The probes having the nucleotide sequence represented by SEQ ID NOS: 29564, 29565, 29566, 29567, 29568, 29569, 10 29570, 29571, 29572, 29573, 29574 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2138. The probes having the nucleotide sequence represented by SEQ ID NOS: 29575, 29576, 29577, 29578, 29579, 29580, 15 29581, 29582, 29583, 29584, 29585 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2139. The probes having the nucleotide sequence represented by SEQ ID NOS: 29586, 29587, 29588, 29589, 29590, 29591, 20 29592, 29593, 29594, 29595, 29596 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2140. The probes having the nucleotide sequence represented by SEQ ID NOS: 29597, 29598, 29599, 29600, 29601, 29602, 25 29603, 29604, 29605, 29606, 29607 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2141. 504 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 29608, 29609, 29610, 29611, 29612, 29613, 29614, 29615, 29616, 29617, 29618 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2142. The probes having the nucleotide sequence represented by SEQ ID NOS: 29619, 29620, 29621, 29622, 29623, 29624, 29625, 29626, 29627, 29628, 29629 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2143. The probes having the nucleotide sequence represented by SEQ ID NOS: 29630, 29631, 29632, 29633, 29634, 29635, 29636, 29637, 29638, 29639, 29640 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2144. The probes having the nucleotide sequence represented by SEQ ID NOS: 29641, 29642, 29643, 29644, 29645, 29646, 29647, 29648, 29649, 29650, 29651 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2145. The probes having the nucleotide sequence represented by SEQ ID NOS: 29652, 29653, 29654, 29655, 29656, 29657, 29658, 29659, 29660, 29661, 29662 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2146. The probes having the nucleotide sequence represented by SEQ ID NOS: 29663, 29664, 29665, 29666, 29667, 29668, 29669, 29670, 29671, 29672, 29673 were selected from the 505 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2147. The probes having the nucleotide sequence represented by SEQ ID NOS: 29674, 29675, 29676, 29677, 29678, 29679, 5 29680, 29681, 29682, 29683, 29684 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2148. The probes having the nucleotide sequence represented by SEQ ID NOS: 29685, 29686, 29687, 29688, 29689, 29690, 10 29691, 29692, 29693, 29694, 29695 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2149. The probes having the nucleotide sequence represented by SEQ ID NOS: 29696, 29697, 29698, 29699, 29700, 29701, 15 29702, 29703, 29704, 29705, 29706 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2150. The probes having the nucleotide sequence represented by SEQ ID NOS: 29707, 29708, 29709, 29710, 29711, 29712, 20 29713, 29714, 29715, 29716, 29717 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2151. The probes having the nucleotide sequence represented by SEQ ID NOS: 29718, 29719, 29720, 29721, 29722, 29723, 25 29724, 29725, 29726, 29727, 29728 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2152. 506 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 29729, 29730, 29731, 29732, 29733, 29734, 29735, 29736, 29737, 29738, 29739 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2153. The probes having the nucleotide sequence represented by SEQ ID NOS: 29740, 29741, 29742, 29743, 29744, 29745, 29746, 29747, 29748, 29749, 29750 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2154. The probes having the nucleotide sequence represented by SEQ ID NOS: 29751, 29752, 29753, 29754, 29755, 29756, 29757, 29758, 29759, 29760, 29761 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2155. The probes having the nucleotide sequence represented by SEQ ID NOS: 29762, 29763, 29764, 29765, 29766, 29767, 29768, 29769, 29770, 29771, 29772 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2156. The probes having the nucleotide sequence represented by SEQ ID NOS: 29773, 29774, 29775, 29776, 29777, 29778, 29779, 29780, 29781, 29782, 29783 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2157. The probes having the nucleotide sequence represented by SEQ ID NOS: 29784, 29785, 29786, 29787, 29788, 29789, 29790, 29791, 29792, 29793, 29794 were selected from the 507 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2158. The probes having the nucleotide sequence represented by SEQ ID NOS: 29795, 29796, 29797, 29798, 29799, 29800, 5 29801, 29802, 29803, 29804, 29805 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2159. The probes having the nucleotide sequence represented by SEQ ID NOS: 29806, 29807, 29808, 29809, 29810, 29811, 10 29812, 29813, 29814, 29815, 29816 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2160. The probes having the nucleotide sequence represented by SEQ ID NOS: 29817, 29818, 29819, 29820, 29821, 29822, 15 29823, 29824, 29825, 29826, 29827 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2161. The probes having the nucleotide sequence represented by SEQ ID NOS: 29828, 29829, 29830, 29831, 29832, 29833, 20 29834, 29835, 29836, 29837, 29838 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2162. The probes having the nucleotide sequence represented by SEQ ID NOS: 29839, 29840, 29841, 29842, 29843, 29844, 25 29845, 29846, 29847, 29848, 29849 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2163. 508 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 29850, 29851, 29852, 29853, 29854, 29855, 29856, 29857, 29858, 29859, 29860 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2164. The probes having the nucleotide sequence represented by SEQ ID NOS: 29861, 29862, 29863, 29864, 29865, 29866, 29867, 29868, 29869, 29870, 29871 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2165. The probes having the nucleotide sequence represented by SEQ ID NOS: 29872, 29873, 29874, 29875, 29876, 29877, 29878, 29879, 29880, 29881, 29882 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2166. The probes having the nucleotide sequence represented by SEQ ID NOS: 29883, 29884, 29885, 29886, 29887, 29888, 29889, 29890, 29891, 29892, 29893 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2167. The probes having the nucleotide sequence represented by SEQ ID NOS: 29894, 29895, 29896, 29897, 29898, 29899, 29900, 29901, 29902, 29903, 29904 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2168. The probes having the nucleotide sequence represented by SEQ ID NOS: 29905, 29906, 29907, 29908, 29909, 29910, 29911, 29912, 29913, 29914, 29915 were selected from the 509 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2169. The probes having the nucleotide sequence represented by SEQ ID NOS: 29916, 29917, 29918, 29919, 29920, 29921, 5 29922, 29923, 29924, 29925, 29926 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2170. The probes having the nucleotide sequence represented by SEQ ID NOS: 29927, 29928, 29929, 29930, 29931, 29932, 10 29933, 29934, 29935, 29936, 29937 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2171. The probes having the nucleotide sequence represented by SEQ ID NOS: 29938, 29939, 29940, 29941, 29942, 29943, 15 29944, 29945, 29946, 29947, 29948 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2172. The probes having the nucleotide sequence represented by SEQ ID NOS: 29949, 29950, 29951, 29952, 29953, 29954, 20 29955, 29956, 29957, 29958, 29959 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2173. The probes having the nucleotide sequence represented by SEQ ID NOS: 29960, 29961, 29962, 29963, 29964, 29965, 25 29966, 29967, 29968, 29969, 29970 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2174. 510 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 29971, 29972, 29973, 29974, 29975, 29976, 29977, 29978, 29979, 29980, 29981 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2175. The probes having the nucleotide sequence represented by SEQ ID NOS: 29982, 29983, 29984, 29985, 29986, 29987, 29988, 29989, 29990, 29991, 29992 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2176. The probes having the nucleotide sequence represented by SEQ ID NOS: 29993, 29994, 29995, 29996, 29997, 29998, 29999, 30000, 30001, 30002, 30003 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2177. The probes having the nucleotide sequence represented by SEQ ID NOS: 30004, 30005, 30006, 30007, 30008, 30009, 30010, 30011, 30012, 30013, 30014 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2178. The probes having the nucleotide sequence represented by SEQ ID NOS: 30015, 30016, 30017, 30018, 30019, 30020, 30021, 30022, 30023, 30024, 30025 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2179. The probes having the nucleotide sequence represented by SEQ ID NOS: 30026, 30027, 30028, 30029, 30030, 30031, 30032, 30033, 30034, 30035, 30036 were selected from the 511 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2180. The probes having the nucleotide sequence represented by SEQ ID NOS: 30037, 30038, 30039, 30040, 30041, 30042, 5 30043, 30044, 30045, 30046, 30047 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2181. The probes having the nucleotide sequence represented by SEQ ID NOS: 30048, 30049, 30050, 30051, 30052, 30053, 10 30054, 30055, 30056, 30057, 30058 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2182. The probes having the nucleotide sequence represented by SEQ ID NOS: 30059, 30060, 30061, 30062, 30063, 30064, 15 30065, 30066, 30067, 30068, 30069 were-selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2183. The probes having the nucleotide sequence represented by SEQ ID NOS: 30070, 30071, 30072, 30073, 30074, 30075, 20 30076, 30077, 30078, 30079, 30080 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2184. The probes having the nucleotide sequence represented by SEQ ID NOS: 30081, 30082, 30083, 30084, 30085, 30086, 25 30087, 30088, 30089, 30090, 30091 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2185. 512 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 30092, 30093, 30094, 30095, 30096, 30097, 30098, 30099, 30100, 30101, 30102 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2186. The probes having the nucleotide sequence represented by SEQ ID NOS: 30103, 30104, 30105, 30106, 30107, 30108, 30109, 30110, 30111, 30112, 30113 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2187. The probes having the nucleotide sequence represented by SEQ ID NOS: 30114, 30115, 30116, 30117, 30118, 30119, 30120, 30121, 30122, 30123, 30124 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2188. The probes having the nucleotide sequence represented by SEQ ID NOS: 30125, 30126, 30127, 30128, 30129, 30130, 30131, 30132, 30133, 30134, 30135 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2189. The probes having the nucleotide sequence represented by SEQ ID NOS: 30136, 30137, 30138, 30139, 30140, 30141, 30142, 30143, 30144, 30145, 30146 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2190. The probes having the nucleotide sequence represented by SEQ ID NOS: 30147, 30148, 30149, 30150, 30151, 30152, 30153, 30154, 30155, 30156, 30157 were selected from the 513 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2191. The probes having the nucleotide sequence represented by SEQ ID NOS: 30158, 30159, 30160, 30161, 30162, 30163, 5 30164, 30165, 30166, 30167, 30168 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2192. The probes having the nucleotide sequence represented by SEQ ID NOS: 30169, 30170, 30171, 30172, 30173, 30174, 10 30175, 30176, 30177, 30178, 30179 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2193. The probes having the nucleotide sequence represented by SEQ ID NOS: 30180, 30181, 30182, 30183, 30184, 30185, 15 30186, 30187, 30188, 30189, 30190 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2194. The probes having the nucleotide sequence represented by SEQ ID NOS: 30191, 30192, 30193, 30194, 30195, 30196, 20 30197, 30198, 30199, 30200, 30201 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2195. The probes having the nucleotide sequence represented by SEQ ID NOS: 30202, 30203, 30204, 30205, 30206, 30207, 25 30208, 30209, 30210, 30211, 30212 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2196. 514 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 30213, 30214, 30215, 30216, 30217, 30218, 30219, 30220, 30221, 30222, 30223 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2197. The probes having the nucleotide sequence represented by SEQ ID NOS: 30224, 30225, 30226, 30227, 30228, 30229, 30230, 30231, 30232, 30233, 30234 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2198. The probes having the nucleotide sequence represented by SEQ ID NOS: 30235, 30236, 30237, 30238, 30239, 30240, 30241, 30242, 30243, 30244, 30245 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2199. The probes having the nucleotide sequence represented by SEQ ID NOS: 30246, 30247, 30248, 30249, 30250, 30251, 30252, 30253, 30254, 30255, 30256 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2200. The probes having the nucleotide sequence represented by SEQ ID NOS: 30257, 30258, 30259, 30260, 30261, 30262, 30263, 30264, 30265, 30266, 30267, 30268, 30269, 30270, 30271, 30272, 30273, 30274, 30275, 30276, 30277, 30278 were 25 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2201. The probes having the nucleotide sequence represented by SEQ ID NOS: 30279, 30280, 30281, 30282, 30283, 30284, 515 WO 2006/024951 PCT/IB2005/002908 30285, 30286, 30287, 30288, 30289 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2202. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 30290, 30291, 30292, 30293, 30294, 30295, 30296, 30297, 30298, 30299, 30300 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2203. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 30301, 30302, 30303, 30304, 30305, 30306, 30307, 30308, 30309, 30310, 30311 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2204. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 30312, 30313, 30314, 30315, 30316, 30317, 30318, 30319, 30320, 30321, 30322 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2205. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 30323, 30324, 30325, 30326, 30327, 30328, 30329, 30330, 30331, 30332, 30333 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2206. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 30334, 30335, 30336, 30337, 30338, 30339, 30340, 30341, 30342, 30343, 30344 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2207. 516 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 30345, 30346, 30347, 30348, 30349, 30350, 30351, 30352, 30353, 30354, 30355 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2208. The probes having the nucleotide sequence represented by SEQ ID NOS: 30356, 30357, 30358, 30359, 30360, 30361, 30362, 30363, 30364, 30365, 30366 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2209. The probes having the nucleotide sequence represented by SEQ ID NOS: 30367, 30368, 30369, 30370, 30371, 30372, 30373, 30374, 30375, 30376, 30377 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2210. The probes having the nucleotide sequence represented by SEQ ID NOS: 30378, 30379, 30380, 30381, 30382, 30383, 30384, 30385, 30386, 30387, 30388 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2211. The probes having the nucleotide sequence represented by SEQ ID NOS: 30389, 30390, 30391, 30392, 30393, 30394, 30395, 30396, 30397, 30398, 30399 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2212. The probes having the nucleotide sequence represented by SEQ ID NOS: 30400, 30401, 30402, 30403, 30404, 30405, 30406, 30407, 30408, 30409, 30410 were selected from the 517 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2213. The probes having the nucleotide sequence represented by SEQ ID NOS: 30411, 30412, 30413, 30414, 30415, 30416, 5 30417, 30418, 30419, 30420, 30421 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2214. The probes having the nucleotide sequence represented by SEQ ID NOS: 30422, 30423, 30424, 30425, 30426, 30427, 10 30428, 30429, 30430, 30431, 30432 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2215. The probes having the nucleotide sequence represented by SEQ ID NOS: 30433, 30434, 30435, 30436, 30437, 30438, 15 30439, 30440, 30441, 30442, 30443 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2216. The probes having the nucleotide sequence represented by SEQ ID NOS: 30444, 30445, 30446, 30447, 30448, 30449, 20 30450, 30451, 30452, 30453, 30454 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2217. The probes having the nucleotide sequence represented by SEQ ID NOS: 30455, 30456, 30457, 30458, 30459, 30460, 25 30461, 30462, 30463, 30464, 30465 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2218. 518 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 30466, 30467, 30468, 30469, 30470, 30471, 30472, 30473, 30474, 30475, 30476 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2219. The probes having the nucleotide sequence represented by SEQ ID NOS: 30477, 30478, 30479, 30480, 30481, 30482, 30483, 30484, 30485, 30486, 30487 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2220. The probes having the nucleotide sequence represented by SEQ ID NOS: 30488, 30489, 30490, 30491, 30492, 30493, 30494, 30495, 30496, 30497, 30498 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2221. The probes having the nucleotide sequence represented by SEQ ID NOS: 30499, 30500, 30501, 30502, 30503, 30504, 30505, 30506, 30507, 30508, 30509 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2222. The probes having the nucleotide sequence represented by SEQ ID NOS: 30510, 30511, 30512, 30513, 30514, 30515, 30516, 30517, 30518, 30519, 30520 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2223. The probes having the nucleotide sequence represented by SEQ ID NOS: 30521, 30522, 30523, 30524, 30525, 30526, 30527, 30528, 30529, 30530, 30531 were selected from the 519 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2224. The probes having the nucleotide sequence represented by SEQ ID NOS: 30532, 30533, 30534, 30535, 30536, 30537, 5 30538, 30539, 30540, 30541, 30542 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2225. The probes having the nucleotide sequence represented by SEQ ID NOS: 30543, 30544, 30545, 30546, 30547, 30548, 10 30549, 30550, 30551, 30552, 30553 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2226. The probes having the nucleotide sequence represented by SEQ ID NOS: 30554, 30555, 30556, 30557, 30558, 30559, 15 30560, 30561, 30562, 30563, 30564 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2227. The probes having the nucleotide sequence represented by SEQ ID NOS: 30565, 30566, 30567, 30568, 30569, 30570, 20 30571, 30572, 30573, 30574, 30575 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2228. The probes having the nucleotide sequence represented by SEQ ID NOS: 30576, 30577, 30578, 30579, 30580, 30581, 25 30582, 30583, 30584, 30585, 30586 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2229. 520 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 30587, 30588, 30589, 30590, 30591, 30592, 30593, 30594, 30595, 30596, 30597 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2230. The probes having the nucleotide sequence represented by SEQ ID NOS: 30598, 30599, 30600, 30601, 30602, 30603, 30604, 30605, 30606, 30607, 30608 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2231. The probes having the nucleotide sequence represented by SEQ ID NOS: 30609, 30610, 30611, 30612, 30613, 30614, 30615, 30616, 30617, 30618, 30619 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2232. The probes having the nucleotide sequence represented by SEQ ID NOS: 30620, 30621, 30622, 30623, 30624, 30625, 30626, 30627, 30628, 30629, 30630 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2233. The probes having the nucleotide sequence represented by SEQ ID NOS: 30631, 30632, 30633, 30634, 30635, 30636, 30637, 30638, 30639, 30640, 30641 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2234. The probes having the nucleotide sequence represented by SEQ ID NOS: 30642, 30643, 30644, 30645, 30646, 30647, 30648, 30649, 30650, 30651, 30652 were selected from the 521 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2235. The probes having the nucleotide sequence represented by SEQ ID NOS: 30653, 30654, 30655, 30656, 30657, 30658, 5 30659, 30660, 30661, 30662, 30663 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2236. The probes having the nucleotide sequence represented by SEQ ID NOS: 30664, 30665, 30666, 30667, 30668, 30669, 10 30670, 30671, 30672, 30673, 30674 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2237. The probes having the nucleotide sequence represented by SEQ ID NOS: 30675, 30676, 30677, 30678, 30679, 30680, 15 30681, 30682, 30683, 30684, 30685 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2238. The probes having the nucleotide sequence represented by SEQ ID NOS: 30686, 30687, 30688, 30689, 30690, 30691, 20 30692, 30693, 30694, 30695, 30696 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2239. The probes having the nucleotide sequence represented by SEQ ID NOS: 30697, 30698, 30699, 30700, 30701, 30702, 25 30703, 30704, 30705, 30706, 30707 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2240. 522 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 30708, 30709, 30710, 30711, 30712, 30713, 30714, 30715, 30716, 30717, 30718 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2241. The probes having the nucleotide sequence represented by SEQ ID NOS: 30719, 30720, 30721, 30722, 30723, 30724, 30725, 30726, 30727, 30728, 30729 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2242. The probes having the nucleotide sequence represented by SEQ ID NOS: 30730, 30731, 30732, 30733, 30734, 30735, 30736, 30737, 30738, 30739, 30740 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2243. The probes having the nucleotide sequence represented by SEQ ID NOS: 30741, 30742, 30743, 30744, 30745, 30746, 30747, 30748, 30749, 30750, 30751 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2244. The probes having the nucleotide sequence represented by SEQ ID NOS: 30752, 30753, 30754, 30755, 30756, 30757, 30758, 30759, 30760, 30761, 30762 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2245. The probes having the nucleotide sequence represented by SEQ ID NOS: 30763, 30764, 30765, 30766, 30767, 30768, 30769, 30770, 30771, 30772, 30773 were selected from the 523 WO 2006/024951 PCT/IB2005/002908 'ORFs having the nucleotide sequence represented by SEQ ID NO: 2246. The probes having the nucleotide sequence represented by SEQ ID NOS: 30774, 30775, 30776, 30777, 30778, 30779, 5 30780, 30781, 30782, 30783, 30784 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2247. The probes having the nucleotide sequence represented by SEQ ID NOS: 30785, 30786, 30787, 30788, 30789, 30790, 10 30791, 30792, 30793, 30794, 30795 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2248. The probes having the nucleotide sequence represented by SEQ ID NOS: 30796, 30797, 30798, 30799, 30800, 30801, 15 30802, 30803, 30804, 30805, 30806 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2249. The probes having the nucleotide sequence represented by SEQ ID NOS: 30807, 30808, 30809, 30810, 30811, 30812, 20 30813, 30814, 30815, 30816, 30817 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2250. The probes having the nucleotide sequence represented by SEQ ID NOS: 30818, 30819, 30820, 30821, 30822, 30823, 25 30824, 30825, 30826, 30827, 30828 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2251. 524 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 30829, 30830, 30831, 30832, 30833, 30834, 30835, 30836, 30837, 30838, 30839 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2252. The probes having the nucleotide sequence represented by SEQ ID NOS: 30840, 30841, 30842, 30843, 30844, 30845, 30846, 30847, 30848, 30849, 30850 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2253. The probes having the nucleotide sequence represented by SEQ ID NOS: 30851, 30852, 30853, 30854, 30855, 30856, 30857, 30858, 30859, 30860, 30861 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2254. The probes having the nucleotide sequence represented by SEQ ID NOS: 30862, 30863, 30864, 30865, 30866, 30867, 30868, 30869, 30870, 30871, 30872 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2255. The probes having the nucleotide sequence represented by SEQ ID NOS: 30873, 30874, 30875, 30876, 30877, 30878, 30879, 30880, 30881, 30882, 30883 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2256. The probes having the nucleotide sequence represented by SEQ ID NOS: 30884, 30885, 30886, 30887, 30888, 30889, 30890, 30891, 30892, 30893, 30894 were selected from the 525 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2257. The probes having the nucleotide sequence represented by SEQ ID NOS: 30895, 30896, 30897, 30898, 30899, 30900, 5 30901, 30902, 30903, 30904, 30905 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2258. The probes having the nucleotide sequence represented by SEQ ID NOS: 30906, 30907, 30908, 30909, 30910, 30911, 10 30912, 30913, 30914, 30915, 30916 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2259. The probes having the nucleotide sequence represented by SEQ ID NOS: 30917, 30918, 30919, 30920, 30921, 30922, 15 30923, 30924, 30925, 30926, 30927 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2260. The probes having the nucleotide sequence represented by SEQ ID NOS: 30928, 30929, 30930, 30931, 30932, 30933, 20 30934, 30935, 30936, 30937, 30938 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2261. The probes having the nucleotide sequence represented by SEQ ID NOS: 30939, 30940, 30941, 30942, 30943, 30944, 25 30945, 30946, 30947, 30948, 30949 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2262. 526 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 30950, 30951, 30952, 30953, 30954, 30955, 30956, 30957, 30958, 30959, 30960 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2263. The probes having the nucleotide sequence represented by SEQ ID NOS: 30961, 30962, 30963, 30964, 30965, 30966, 30967, 30968, 30969, 30970, 30971 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2264. The probes having the nucleotide sequence represented by SEQ ID NOS: 30972, 30973, 30974, 30975, 30976, 30977, 30978, 30979, 30980, 30981, 30982 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2265. The probes having the nucleotide sequence represented by SEQ ID NOS: 30983, 30984, 30985, 30986, 30987, 30988, 30989, 30990, 30991, 30992, 30993 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2266. The probes having the nucleotide sequence represented by SEQ ID NOS: 30994, 30995, 30996, 30997, 30998, 30999, 31000, 31001, 31002, 31003, 31004 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2267. The probes having the nucleotide sequence represented by SEQ ID NOS: 31005, 31006, 31007, 31008, 31009, 31010, 31011, 31012, 31013, 31014, 31015 were selected from the 527 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2268. The probes having the nucleotide sequence represented by SEQ ID NOS: 31016,-31017, 31018, 31019, 31020, 31021, 5 31022, 31023, 31024, 31025, 31026 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2269. The probes having the nucleotide sequence represented by SEQ ID NOS: 31027, 31028, 31029, 31030, 31031, 31032, 10 31033, 31034, 31035, 31036, 31037 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2270. The probes having the nucleotide sequence represented by SEQ ID NOS: 31038, 31039, 31040, 31041, 31042, 31043, 15 31044, 31045, 31046, 31047, 31048, 31049, 31050, 31051, 31052, 31053, 31054, 31055, 31056, 31057, 31058, 31059 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2271. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 31060, 31061, 31062, 31063, 31064, 31065, 31066, 31067, 31068, 31069, 31070 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2272. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 31071, 31072, 31073, 31074, 31075, 31076, 31077, 31078, 31079, 31080, 31081 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2273. 528 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 31082, 31083, 31084, 31085, 31086, 31087, 31088, 31089, 31090, 31091, 31092 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2274. The probes having the nucleotide sequence represented by SEQ ID NOS: 31093, 31094, 31095, 31096, 31097, 31098, 31099, 31100, 31101, 31102, 31103 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2275. The probes having the nucleotide sequence represented by SEQ ID NOS: 31104, 31105, 31106, 31107, 31108, 31109, 31110, 31111, 31112, 31113, 31114 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2276. The probes having the nucleotide sequence represented by SEQ ID NOS: 31115, 31116, 31117, 31118, 31119, 31120, 31121, 31122, 31123, 31124, 31125 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2277. The probes having the nucleotide sequence represented by SEQ ID NOS: 31126, 31127, 31128, 31129, 31130, 31131, 31132, 31133, 31134, 31135, 31136 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2278. The probes having the nucleotide sequence represented by SEQ ID NOS: 31137, 31138, 31139, 31140, 31141, 31142, 31143, 31144, 31145, 31146, 31147 were selected from the 529 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2279. The probes having the nucleotide sequence represented by SEQ ID NOS: 31148, 31149, 31150, 31151, 31152, 31153, 5 31154, 31155, 31156, 31157, 31158 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2280. The probes having the nucleotide sequence represented by SEQ ID NOS: 31159, 31160, 31161, 31162, 31163, 31164, 10 31165, 31166, 31167, 31168, 31169 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2281. The probes having the nucleotide sequence represented by SEQ ID NOS: 31170, 31171, 31172, 31173, 31174, 31175, 15 31176, 31177, 31178, 31179, 31180 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2282. The probes having the nucleotide sequence represented by SEQ ID NOS: 31181, 31182, 31183, 31184, 31185, 31186, 20 31187, 31188, 31189, 31190, 31191 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2283. The probes having the nucleotide sequence represented by SEQ ID NOS: 31192, 31193, 31194, 31195, 31196, 31197, 25 31198, 31199, 31200, 31201, 31202 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2284. 530 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 31203, 31204, 31205, 31206, 31207, 31208, 31209, 31210, 31211, 31212, 31213 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2285. The probes having the nucleotide sequence represented by SEQ ID NOS: 31214, 31215, 31216, 31217, 31218, 31219, 31220, 31221, 31222, 31223, 31224 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2286. The probes having the nucleotide sequence represented by SEQ ID NOS: 31225, 31226, 31227, 31228, 31229, 31230, 31231, 31232, 31233, 31234, 31235 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2287. The probes having the nucleotide sequence represented by SEQ ID NOS: 31236, 31237, 31238, 31239, 31240, 31241, 31242, 31243, 31244, 31245, 31246 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2288. The probes having the nucleotide sequence represented by SEQ ID NOS: 31247, 31248, 31249, 31250, 31251, 31252, 31253, 31254, 31255, 31256, 31257 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2289. The probes having the nucleotide sequence represented by SEQ ID NOS: 31258, 31259, 31260, 31261, 31262, 31263, 31264, 31265, 31266, 31267, 31268 were selected from the 531 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2290. The probes having the nucleotide sequence represented by SEQ ID NOS: 31269, 31270, 31271, 31272, 31273, 31274, 5 31275, 31276, 31277, 31278, 31279 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2291. The probes having the nucleotide sequence represented by SEQ ID NOS: 31280, 31281, 31282, 31283, 31284, 31285, 10 31286, 31287, 31288, 31289, 31290 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2292. The probes having the nucleotide sequence represented by SEQ ID NOS: 31291, 31292, 31293, 31294, 31295, 31296, 15 31297, 31298, 31299, 31300, 31301 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2293. The probes having the nucleotide sequence represented by SEQ ID NOS: 31302, 31303, 31304, 31305, 31306, 31307, 20 31308, 31309, 31310, 31311, 31312 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2294. The probes having the nucleotide sequence represented by SEQ ID NOS: 31313, 31314, 31315, 31316, 31317, 31318, 25 31319, 31320, 31321, 31322, 31323 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2295. 532 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 31324, 31325, 31326, 31327, 31328, 31329, 31330, 31331, 31332, 31333, 31334 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2296. The probes having the nucleotide sequence represented by SEQ ID NOS: 31335, 31336, 31337, 31338, 31339, 31340, 31341, 31342, 31343, 31344, 31345 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2297. The probes having the nucleotide sequence represented by SEQ ID NOS: 31346, 31347, 31348, 31349, 31350, 31351, 31352, 31353, 31354, 31355, 31356 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2298. The probes having the nucleotide sequence represented by SEQ ID NOS: 31357, 31358, 31359, 31360, 31361, 31362, 31363, 31364, 31365, 31366, 31367 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2299. The probes having the nucleotide sequence represented by SEQ ID NOS: 31368, 31369, 31370, 31371, 31372, 31373, 31374, 31375, 31376, 31377, 31378 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2300. The probes having the nucleotide sequence represented by SEQ ID NOS: 31379, 31380, 31381, 31382, 31383, 31384, 31385, 31386, 31387, 31388, 31389 were selected from the 533 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2301. The probes having the nucleotide sequence represented by SEQ ID NOS: 31390, 31391, 31392, 31393, 31394, 31395, 5 31396, 31397, 31398, 31399, 31400 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2302. The probes having the nucleotide sequence represented by SEQ ID NOS: 31401, 31402, 31403, 31404, 31405, 31406, 10 31407, 31408, 31409, 31410, 31411 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2303. The probes having the nucleotide sequence represented by SEQ ID NOS: 31412, 31413, 31414, 31415, 31416, 31417, 15 31418, 31419, 31420, 31421, 31422 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2304. The probes having the nucleotide sequence represented by SEQ ID NOS: 31423, 31424, 31425, 31426, 31427, 31428, 20 31429, 31430, 31431, 31432, 31433 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2305. The probes having the nucleotide sequence represented by SEQ ID NOS: 31434, 31435, 31436, 31437, 31438, 31439, 25 31440, 31441, 31442, 31443, 31444 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2306. 534 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 31445, 31446, 31447, 31448, 31449, 31450, 31451, 31452, 31453, 31454, 31455 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2307. The probes having the nucleotide sequence represented by SEQ ID NOS: 31456, 31457, 31458, 31459, 31460, 31461, 31462, 31463, 31464, 31465, 31466 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2308. The probes having the nucleotide sequence represented by SEQ ID NOS: 31467, 31468, 31469, 31470, 31471, 31472, 31473, 31474, 31475, 31476, 31477 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2309. The probes having the nucleotide sequence represented by SEQ ID NOS: 31478, 31479, 31480, 31481, 31482, 31483, 31484, 31485, 31486, 31487, 31488 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2310. The probes having the nucleotide sequence represented by SEQ ID NOS: 31489, 31490, 31491, 31492, 31493, 31494, 31495, 31496, 31497, 31498, 31499 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2311. The probes having the nucleotide sequence represented by SEQ ID NOS: 31500, 31501, 31502, 31503, 31504, 31505, 31506, 31507, 31508, 31509, 31510 were selected from the 535 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2312. The probes having the nucleotide sequence represented by SEQ ID NOS: 31511, 31512, 31513, 31514, 31515, 31516, 5 31517, 31518, 31519, 31520, 31521 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2313. The probes having the nucleotide sequence represented by SEQ ID NOS: 31522, 31523, 31524, 31525, 31526, 31527, 10 31528, 31529, 31530, 31531, 31532 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2314. The probes having the nucleotide sequence represented by SEQ ID NOS: 31533, 31534, 31535, 31536, 31537, 31538, 15 31539, 31540, 31541, 31542, 31543 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2315. The probes having the nucleotide sequence represented by SEQ ID NOS: 31544, 31545, 31546, 31547, 31548, 31549, 20 31550, 31551, 31552, 31553, 31554 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2316. The probes having the nucleotide sequence represented by SEQ ID NOS: 31555, 31556, 31557, 31558, 31559, 31560, 25 31561, 31562, 31563, 31564, 31565 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2317. 536 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 31566, 31567, 31568,' 31569, 31570, 31571, 31572, 31573, 31574, 31575, 31576 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2318. The probes having the nucleotide sequence represented by SEQ ID NOS: 31577, 31578, 31579, 31580, 31581, 31582, 31583, 31584, 31585, 31586, 31587 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2319. The probes having the nucleotide sequence represented by SEQ ID NOS: 31588, 31589, 31590, 31591, 31592, 31593, 31594, 31595, 31596, 31597, 31598 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2320. The probes having the nucleotide sequence represented by SEQ ID NOS: 31599, 31600, 31601, 31602, 31603, 31604, 31605, 31606, 31607, 31608, 31609 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2321. The probes having the nucleotide sequence represented by SEQ ID NOS: 31610, 31611, 31612, 31613, 31614, 31615, 31616, 31617, 31618, 31619, 31620 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2322. The probes having the nucleotide sequence represented by SEQ ID NOS: 31621, 31622, 31623, 31624, 31625, 31626, 31627, 31628, 31629, 31630, 31631 were selected from the 537 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2323. The probes having the nucleotide sequence represented by SEQ ID NOS: 31632, 31633, 31634, 31635, 31636, 31637, 5 31638, 31639, 31640, 31641, 31642 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2324. The probes having the nucleotide sequence represented by SEQ ID NOS: 31643, 31644, 31645, 31646, 31647, 31648, 10 31649, 31650, 31651, 31652, 31653 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2325. The probes having the nucleotide sequence represented by SEQ ID NOS: 31654, 31655, 31656, 31657, 31658, 31659, 15 31660, 31661, 31662, 31663, 31664 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2326. The probes having the nucleotide sequence represented by SEQ ID NOS: 31665, 31666, 31667, 31668, 31669, 31670, 20 31671, 31672, 31673, 31674, 31675 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2327. The probes having the nucleotide sequence represented by SEQ ID NOS: 31676, 31677, 31678, 31679, 31680, 31681, 25 31682, 31683, 31684, 31685, 31686 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2328. 538 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 31687, 31688, 31689, 31690, 31691, 31692, 31693, 31694, 31695, 31696, 31697 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2329. The probes having the nucleotide sequence represented by SEQ ID NOS: 31698, 31699, 31700, 31701, 31702, 31703, 31704, 31705, 31706, 31707, 31708 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2330. The probes having the nucleotide sequence represented by SEQ ID NOS: 31709, 31710, 31711, 31712, 31713, 31714, 31715, 31716, 31717, 31718, 31719, 31720, 31721, 31722, 31723, 31724, 31725, 31726, 31727, 31728, 31729, 31730 were 15 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2331. The probes having the nucleotide sequence represented by SEQ ID NOS: 31731, 31732, 31733, 31734, 31735, 31736, 31737, 31738, 31739, 31740, 31741 were selected from the 20 ORFs having the nucleotide sequence represented by SEQ ID NO: 2332. The probes having the nucleotide sequence represented by SEQ ID NOS: 31742, 31743, 31744, 31745, 31746, 31747, 31748, 31749, 31750, 31751, 31752 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 2333. The probes having the nucleotide sequence represented by SEQ ID NOS: 31753, 31754, 31755, 31756, 31757, 31758, 539 WO 2006/024951 PCT/IB2005/002908 31759, 31760, 31761, 31762, 31763 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2334. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 31764, 31765, 31766, 31767, 31768, 31769, 31770, 31771, 31772, 31773, 31774 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2335. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 31775, 31776, 31777, 31778, 31779, 31780, 31781, 31782, 31783, 31784, 31785 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2336. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 31786, 31787, 31788, 31789, 31790, 31791, 31792, 31793, 31794, 31795, 31796 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2337. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 31797, 31798, 31799, 31800, 31801, 31802, 31803, 31804, 31805, 31806, 31807 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2338. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 31808, 31809, 31810, 31811, 31812, 31813, 31814, 31815, 31816, 31817, 31818 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2339. 540 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 31819, 31820, 31821, 31822, 31823, 31824, 31825, 31826, 31827, 31828, 31829 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2340. The probes having the nucleotide sequence represented by SEQ ID NOS: 31830, 31831, 31832, 31833, 31834, 31835, 31836, 31837, 31838, 31839, 31840 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2341. The probes having the nucleotide sequence represented by SEQ ID NOS: 31841, 31842, 31843, 31844, 31845, 31846, 31847, 31848, 31849, 31850, 31851 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2342. The probes having the nucleotide sequence represented by SEQ ID NOS: 31852, 31853, 31854, 31855, 31856, 31857, 31858, 31859, 31860, 31861, 31862 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2343. The probes having the nucleotide sequence represented by SEQ ID NOS: 31863, 31864, 31865, 31866, 31867, 31868, 31869, 31870, 31871, 31872, 31873 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2344. The probes having the nucleotide sequence represented by SEQ ID NOS: 31874, 31875, 31876, 31877, 31878, 31879, 31880, 31881, 31882, 31883, 31884 were selected from the 541 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2345. The probes having the nucleotide sequence represented by SEQ ID NOS: 31885, 31886, 31887, 31888, 31889, 31890, 5 31891, 31892, 31893, 31894, 31895 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2346. The probes having the nucleotide sequence represented by SEQ ID NOS: 31896, 31897, 31898, 31899, 31900, 31901, 10 31902, 31903, 31904, 31905, 31906 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2347. The probes having the nucleotide sequence represented by SEQ ID NOS: 31907, 31908, 31909, 31910, 31911, 31912, 15 31913, 31914, 31915, 31916, 31917 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2348. The probes having the nucleotide sequence represented by SEQ ID NOS: 31918, 31919, 31920, 31921, 31922, 31923, 20 31924, 31925, 31926, 31927, 31928 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2349. The probes having the nucleotide sequence represented by SEQ ID NOS: 31929, 31930, 31931, 31932, 31933, 31934, 25 31935, 31936, 31937, 31938, 31939 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2350. 542 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 31940, 31941, 31942, 31943, 31944, 31945, 31946, 31947, 31948, 31949, 31950 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2351. The probes having the nucleotide sequence represented by SEQ ID NOS: 31951, 31952, 31953, 31954, 31955, 31956, 31957, 31958, 31959, 31960, 31961 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2352. The probes having the nucleotide sequence represented by SEQ ID NOS: 31962, 31963, 31964, 31965, 31966, 31967, 31968, 31969, 31970, 31971, 31972 were selected from the ORFs having.the nucleotide sequence represented by SEQ ID 15 NO: 2353. The probes having the nucleotide sequence represented by SEQ ID NOS: 31973, 31974, 31975, 31976, 31977, 31978, 31979, 31980, 31981, 31982, 31983 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2354. The probes having the nucleotide sequence represented by SEQ ID NOS: 31984, 31985, 31986, 31987, 31988, 31989, 31990, 31991, 31992, 31993, 31994 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2355. The probes having the nucleotide sequence represented by SEQ ID NOS: 31995, 31996, 31997, 31998, 31999, 32000, 32001, 32002, 32003, 32004, 32005 were selected from the 543 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2356. The probes having the nucleotide sequence represented by SEQ ID NOS: 32006, 32007, 32008, 32009, 32010, 32011, 5 32012, 32013, 32014, 32015, 32016 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2357. The probes having the nucleotide sequence represented by SEQ ID NOS: 32017, 32018, 32019, 32020, 32021, 32022, 10 32023, 32024, 32025, 32026, 32027 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2358. The probes having the nucleotide sequence represented by SEQ ID NOS: 32028, 32029, 32030, 32031, 32032, 32033, 15 32034, 32035, 32036, 32037, 32038 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2359. The probes having the nucleotide sequence represented by SEQ ID NOS: 32039, 32040, 32041, 32042, 32043, 32044, 20 32045, 32046, 32047, 32048, 32049 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2360. The probes having the nucleotide sequence represented by SEQ ID NOS: 32050, 32051, 32052, 32053, 32054, 32055, 25 32056, 32057, -32058, 32059, 32060 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2361. 544 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 32061, 32062, 32063, 32064, 32065, 32066, 32067, 32068, 32069, 32070, 32071 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2362. The probes having the nucleotide sequence represented by SEQ ID NOS: 32072, 32073, 32074, 32075, 32076, 32077, 32078, 32079, 32080, 32081, 32082 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2363. The probes having the nucleotide sequence represented by SEQ ID NOS: 32083, 32084, 32085, 32086, 32087, 32088, 32089, 32090, 32091, 32092, 32093 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2364. The probes having the nucleotide sequence represented by SEQ ID NOS: 32094, 32095, 32096, 32097, 32098, 32099, 32100, 32101, 32102, 32103, 32104 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2365. The probes having the nucleotide sequence represented by SEQ ID NOS: 32105, 32106, 32107, 32108, 32109, 32110, 32111, 32112, 32113, 32114, 32115 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2366. The probes having the nucleotide sequence represented by SEQ ID NOS: 32116, 32117, 32118, 32119, 32120, 32121, 32122, 32123, 32124, 32125, 32126 were selected from the 545 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2367. The probes having the nucleotide sequence represented by SEQ ID NOS: 32127, 32128, 32129, 32130, 32131, 32132, 5 32133, 32134, 32135, 32136, 32137 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2368. The probes having the nucleotide sequence represented by SEQ ID NOS: 32138, 32139, 32140, 32141, 32142, 32143, 10 32144, 32145, 32146, 32147, 32148 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2369. The probes having the nucleotide sequence represented by SEQ ID NOS: 32149, 32150, 32151, 32152, 32153, 32154, 15 32155, 32156, 32157, 32158, 32159 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2370. The probes having the nucleotide sequence represented by SEQ ID NOS: 32160, 32161, 32162, 32163, 32164, 32165, 20 32166, 32167, 32168, 32169, 32170 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2371. The probes having the nucleotide sequence represented by SEQ ID NOS: 32171, 32172, 32173, 32174, 32175, 32176, 25 32177, 32178, 32179, 32180, 32181 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2372. 546 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 32182, 32183, 32184, 32185, 32186, 32187, 32188, 32189, 32190, 32191, 32192 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2373. The probes having the nucleotide sequence represented by SEQ ID NOS: 32193, 32194, 32195, 32196, 32197, 32198, 32199, 32200, 32201, 32202, 32203 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2374. The probes having the nucleotide sequence represented by SEQ ID NOS: 32204, 32205, 32206, 32207, 32208, 32209, 32210, 32211, 32212, 32213, 32214 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2375. The probes having the nucleotide sequence represented by SEQ ID NOS: 32215, 32216, 32217, 32218, 32219, 32220, 32221, 32222, 32223, 32224, 32225 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2376. The probes having the nucleotide sequence represented by SEQ ID NOS: 32226, 32227, 32228, 32229, 32230, 32231, 32232, 32233, 32234, 32235, 32236 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2377. The probes having the nucleotide sequence represented by SEQ ID NOS: 32237, 32238, 32239, 32240, 32241, 32242, 32243, 32244, 32245, 32246, 32247 were selected from the 547 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2378. The probes having the nucleotide sequence represented by SEQ ID NOS: 32248, 32249, 32250, 32251, 32252, 32253, 5 32254, 32255, 32256, 32257, 32258 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2379. The probes having the nucleotide sequence represented by SEQ ID NOS: 32259, 32260, 32261, 32262, 32263, 32264, 10 32265, 32266, 32267, 32268, 32269 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2380. The probes having the nucleotide sequence represented by SEQ ID NOS: 32270, 32271, 32272, 32273, 32274, 32275, 15 32276, 32277, 32278, 32279, 32280 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2381. The probes having the nucleotide sequence represented by SEQ ID NOS: 32281, 32282, 32283, 32284, 32285, 32286, 20 32287, 32288, 32289, 32290, 32291 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2382. The probes having the nucleotide sequence represented by SEQ ID NOS: 32292, 32293, 32294, 32295, 32296, 32297, 25 32298, 32299, 32300, 32301, 32302 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2383. 548 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 32303, 32304, 32305, 32306, 32307, 32308, 32309, 32310, 32311, 32312, 32313 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2384. The probes having the nucleotide sequence represented by SEQ ID NOS: 32314, 32315, 32316, 32317, 32318, 32319, 32320, 32321, 32322, 32323, 32324 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2385. The probes having the nucleotide sequence represented by SEQ ID NOS: 32325, 32326, 32327, 32328, 32329, 32330, 32331, 32332, 32333, 32334, 32335 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2386. The probes having the nucleotide sequence represented by SEQ ID NOS: 32336, 32337, 32338, 32339, 32340, 32341, 32342, 32343, 32344, 32345, 32346 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2387. The probes having the nucleotide sequence represented by SEQ ID NOS: 32347, 32348, 32349, 32350, 32351, 32352, 32353, 32354, 32355, 32356, 32357 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2388. The probes having the nucleotide sequence represented by SEQ ID NOS: 32358, 32359, 32360, 32361, 32362, 32363, 32364, 32365, 32366, 32367, 32368 were selected from the 549 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2389. The probes having the nucleotide sequence represented by SEQ -ID NOS: 32369, 32370, 32371, 32372, 32373, 32374, 5 32375, 32376, 32377, 32378, 32379 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2390. The probes having the nucleotide sequence represented by SEQ ID NOS: 32380, 32381, 32382, 32383, 32384, 32385, 10 32386, 32387, 32388, 32389, 32390 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2391. The probes having the nucleotide sequence represented by SEQ ID NOS: 32391, 32392, 32393, 32394, 32395, 32396, 15 32397, 32398, 32399, 32400, 32401 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2392. The probes having the nucleotide sequence represented by SEQ ID NOS: 32402, 32403, 32404, 32405, 32406, 32407, 20 32408, 32409, 32410, 32411, 32412 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2393. The probes having the nucleotide sequence represented by SEQ ID NOS: 32413, 32414, 32415, 32416, 32417, 32418, 25 32419, 32420, 32421, 32422, 32423 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2394. 550 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 32424, 32425, 32426, 32427, 32428, 32429, 32430, 32431, 32432, 32433, 32434 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2395. The probes having the nucleotide sequence represented by SEQ ID NOS: 32435, 32436, 32437, 32438, 32439, 32440, 32441, 32442, 32443, 32444, 32445 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2396. The probes having the nucleotide sequence represented by SEQ ID NOS: 32446, 32447, 32448, 32449, 32450, 32451, 32452, 32453, 32454, 32455, 32456 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2397. The probes having the nucleotide sequence represented by SEQ ID NOS: 32457, 32458, 32459, 32460, 32461, 32462, 32463, 32464, 32465, 32466, 32467 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2398. The probes having the nucleotide sequence represented by SEQ ID NOS: 32468, 32469, 32470, 32471, 32472, 32473, 32474, 32475, 32476, 32477, 32478 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2399. The probes having the nucleotide sequence represented by SEQ ID NOS: 32479, 32480, 32481, 32482, 32483, 32484, 32485, 32486, 32487, 32488, 32489 were selected from the 551 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2400. The probes having the nucleotide sequence represented by SEQ ID NOS: 32490, 32491, 32492, 32493, 32494, 32495, 5 32496, 32497, 32498, 32499, 32500 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2401. The probes having the nucleotide sequence represented by SEQ ID NOS: 32501, 32502, 32503, 32504, 32505, 32506, 10 32507, 32508, 32509, 32510, 32511 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2402. The probes having the nucleotide sequence represented by SEQ ID NOS: 32512, 32513, 32514, 32515, 32516, 32517, 15 32518, 32519, 32520, 32521, 32522 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2403. The probes having the nucleotide sequence represented by SEQ ID NOS: 32523, 32524, 32525, 32526, 32527, 32528, 20 32529, 32530, 32531, 32532, 32533 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2404. The probes having the nucleotide sequence represented by SEQ ID NOS: 32534, 32535, 32536, 32537, 32538, 32539, 25 32540, 32541, 32542, 32543, 32544 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2405. 552 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 32545, 32546, 32547, 32548, 32549, 32550, 32551, 32552, 32553, 32554, 32555 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2406. The probes having the nucleotide sequence represented by SEQ ID NOS: 32556, 32557, 32558, 32559, 32560, 32561, 32562, 32563, 32564, 32565, 32566 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2407. The probes having the nucleotide sequence represented by SEQ ID NOS: 32567, 32568, 32569, 32570, 32571, 32572, 32573, 32574, 32575, 32576, 32577 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2408. The probes having the nucleotide sequence represented by SEQ ID NOS: 32578, 32579, 32580, 32581, 32582, 32583, 32584, 32585, 32586, 32587, 32588 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2409. The probes having the nucleotide sequence represented by SEQ ID NOS: 32589, 32590, 32591, 32592, 32593, 32594, 32595, 32596, 32597, 32598, 32599 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2410. The probes having the nucleotide sequence represented by SEQ ID NOS: 32600, 32601, 32602, 32603, 32604, 32605, 32606, 32607, 32608, 32609, 32610 were selected from the 553 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2411. The probes having the nucleotide sequence represented by SEQ ID NOS: 32611, 32612, 32613, 32614, 32615, 32616, 5 32617, 32618, 32619, 32620, 32621 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2412. The probes having the nucleotide sequence represented by SEQ ID NOS: 32622, 32623, 32624, 32625, 32626, 32627, 10 32628, 32629, 32630, 32631, 32632 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2413. The probes having the nucleotide sequence represented by SEQ ID NOS: 32633, 32634, 32635, 32636, 32637, 32638, 15 32639, 32640, 32641, 32642, 32643 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2414. The probes having the nucleotide sequence represented by SEQ ID NOS: 32644, 32645, 32646, 32647, 32648, 32649, 20 32650, 32651, 32652, 32653, 32654 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2415. The probes having the nucleotide sequence represented by SEQ ID NOS: 32655, 32656, 32657, 32658, 32659, 32660, 25 32661, 32662, 32663, 32664, 32665 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2416. 554 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 32666, 32667, 32668, 32669, 32670, 32671, 32672, 32673, 32674, 32675, 32676 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2417. The probes having the nucleotide sequence represented by SEQ ID NOS: 32677, 32678, 32679, 32680, 32681, 32682, 32683, 32684, 32685, 32686, 32687 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2418. The probes having the nucleotide sequence represented by SEQ ID NOS: 32688, 32689, 32690, 32691, 32692, 32693, 32694, 32695, 32696, 32697, 32698 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2419. The probes having the nucleotide sequence represented by SEQ ID NOS: 32699, 32700, 32701, 32702, 32703, 32704, 32705, 32706, 32707, 32708, 32709 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2420. The probes having the nucleotide sequence represented by SEQ ID NOS: 32710, 32711, 32712, 32713, 32714, 32715, 32716, 32717, 32718, 32719, 32720 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2421. The probes having the nucleotide sequence represented by SEQ ID NOS: 32721, 32722, 32723, 32724, 32725, 32726, 32727, 32728, 32729, 32730, 32731 were selected from the 555 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2422. The probes having the nucleotide sequence represented by SEQ ID NOS: 32732, 32733, 32734, 32735, 32736, 32737, 5 32738, 32739, 32740, 32741, 32742 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2423. The probes having the nucleotide sequence represented by SEQ ID NOS: 32743, 32744, 32745, 32746, 32747, 32748, 10 32749, 32750, 32751 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2424. The probes having the nucleotide sequence represented by SEQ ID NOS: 32752, 32753, 32754, 32755, 32756, 32757, 32758, 32759, 32760, 32761, 32762 were selected from the 15 ORFs having the nucleotide sequence represented by SEQ ID NO: 2425. The probes having the nucleotide sequence represented by SEQ ID NOS: 32763, 32764, 32765, 32766, 32767, 32768, 32769, 32770, 32771, 32772, 32773 were selected from the 20 ORFs having the nucleotide sequence represented by SEQ ID NO: 2426. The probes having the nucleotide sequence represented by SEQ ID NOS: 32774, 32775, 32776, 32777, 32778, 32779, 32780, 32781, 32782, 32783, 32784 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 2427. The probes having the nucleotide sequence represented by SEQ ID NOS: 32785, 32786, 32787, 32788, 32789, 32790, 556 WO 2006/024951 PCT/IB2005/002908 32791, 32792, 32793, 32794, 32795 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2428. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 32796, 32797, 32798, 32799, 32800, 32801, 32802, 32803, 32804, 32805, 32806 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2429. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 32807, 32808, 32809, 32810, 32811, 32812, 32813, 32814, 32815, 32816, 32817 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2430. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 32818, 32819, 32820, 32821, 32822, 32823, 32824, 32825, 32826, 32827, 32828 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2431. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 32829, 32830, 32831, 32832, 32833, 32834, 32835, 32836, 32837, 32838, 32839 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2432. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 32840, 32841, 32842, 32843, 32844, 32845, 32846, 32847, 32848, 32849, 32850 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2433. 557 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide ssequence represented by SEQ ID NOS: 32851, 32852, 32853, 32854, 32855, 32856, 32857, 32858, 32859, 32860, 32861 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2434. The probes having the nucleotide sequence represented by SEQ ID NOS: 32862, 32863, 32864, 32865, 32866, 32867, 32868, 32869, 32870, 32871, 32872 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2435. The probes having the nucleotide sequence represented by SEQ ID NOS: 32873, 32874, 32875, 32876, 32877, 32878, 32879, 32880, 32881, 32882, 32883 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2436. The probes having the nucleotide sequence represented by SEQ ID NOS: 32884, 32885, 32886, 32887, 32888, 32889, 32890, 32891, 32892, 32893, 32894 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2437. The probes having the nucleotide sequence represented by SEQ ID NOS: 32895, 32896, 32897, 32898, 32899, 32900, 32901, 32902, 32903, 32904, 32905 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2438. The probes having the nucleotide sequence represented by SEQ ID NOS: 32906, 32907, 32908, 32909, 32910, 32911, 32912, 32913, 32914, 32915, 32916 were selected from the 558 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2439. The probes having the nucleotide sequence represented by SEQ ID NOS: 32917, 32918, 32919, 32920, 32921, 32922, 5 32923, 32924, 32925, 32926, 32927 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2440. The probes having the nucleotide sequence represented by SEQ ID NOS: 32928, 32929, 32930, 32931, 32932, 32933, 10 32934, 32935, 32936, 32937, 32938 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2441. The probes having the nucleotide sequence represented by SEQ ID NOS: 32939, 32940, 32941, 32942, 32943, 32944, 15 32945, 32946, 32947, 32948, 32949 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2442. The probes having the nucleotide sequence represented by SEQ ID NOS: 32950, 32951, 32952, 32953, 32954, 32955, 20 32956, 32957, 32958, 32959, 32960 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2443. The probes having the nucleotide sequence represented by SEQ ID NOS: 32961, 32962, 32963, 32964, 32965, 32966, 25 32967, 32968, 32969, 32970, 32971 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2444. 559 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 32972, 32973, 32974, 32975, 32976, 32977, 32978, 32979, 32980, 32981, 32982 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2445. The probes having the nucleotide sequence represented by SEQ ID NOS: 32983, 32984, 32985, 32986, 32987, 32988, 32989, 32990, 32991, 32992, 32993 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2446. The probes having the nucleotide sequence represented by SEQ ID NOS: 32994, 32995, 32996, 32997, 32998, 32999, 33000, 33001, 33002, 33003, 33004 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2447. The probes having the nucleotide sequence represented by SEQ ID NOS: 33005, 33006, 33007, 33008, 33009, 33010, 33011, 33012, 33013, 33014, 33015 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2448. The probes having the nucleotide sequence represented by SEQ ID NOS: 33016, 33017, 33018, 33019, 33020, 33021, 33022, 33023, 33024, 33025, 33026 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2449. The probes having the nucleotide sequence represented by SEQ ID NOS: 33027, 33028, 33029, 33030, 33031, 33032, 33033, 33034, 33035, 33036, 33037 were selected from the 560 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2450. The probes having the nucleotide sequence represented by SEQ ID NOS: 33038, 33039, 33040, 33041, 33042, 33043, 5 33044, 33045, 33046, 33047, 33048 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2451. The probes having the nucleotide sequence represented by SEQ ID NOS: 33049, 33050, 33051, 33052, 33053, 33054, 10 33055, 33056, 33057, 33058, 33059 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2452. The probes having the nucleotide sequence represented by SEQ ID NOS: 33060, 33061, 33062, 33063, 33064, 33065, 15 33066, 33067, 33068, 33069, 33070 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2453. The probes having the nucleotide sequence represented by SEQ ID NOS: 33071, 33072, 33073, 33074, 33075, 33076, 20 33077, 33078, 33079, 33080, 33081 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2454. The probes having the nucleotide sequence represented by SEQ ID NOS: 33082, 33083, 33084, 33085, 33086, 33087, 25 33088, 33089, 33090, 33091, 33092 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2455. 561 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 33093, 33094, 33095, 33096, 33097, 33098, 33099, 33100, 33101, 33102, 33103 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2456. The probes having the nucleotide sequence represented by SEQ ID NOS: 33104, 33105, 33106, 33107, 33108, 33109, 33110, 33111, 33112, 33113, 33114 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2457. The probes having the nucleotide sequence represented by SEQ ID NOS: 33115, 33116, 33117, 33118, 33119, 33120, 33121, 33122, 33123, 33124, 33125 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2458. The probes having the nucleotide sequence represented by SEQ ID NOS: 33126, 33127, 33128, 33129, 33130, 33131, 33132, 33133, 33134, 33135, 33136 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2459. The probes having the nucleotide sequence represented by SEQ ID NOS: 33137, 33138, 33139, 33140, 33141, 33142, 33143, 33144, 33145, 33146, 33147 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2460. The probes having the nucleotide sequence represented by SEQ ID NOS: 33148, 33149, 33150, 33151, 33152, 33153, 33154, 33155, 33156, 33157, 33158 were selected from the 562 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2461. The probes having the nucleotide sequence represented by SEQ ID NOS: 33159, 33160, 33161, 33162, 33163, 33164, 5 33165, 33166, 33167, 33168, 33169 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2462. The probes having the nucleotide sequence represented by SEQ ID NOS: 33170, 33171, 33172, 33173, 33174, 33175, 10 33176, 33177, 33178, 33179, 33180 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2463. The probes having the nucleotide sequence represented by SEQ ID NOS: 33181, 33182, 33183, 33184, 33185, 33186, 15 33187, 33188, 33189, 33190, 33191 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2464. The probes having the nucleotide sequence represented by SEQ ID NOS: 33192, 33193, 33194, 33195, 33196, 33197, 20 33198, 33199, 33200, 33201, 33202 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2465. The probes having the nucleotide sequence represented by SEQ ID NOS: 33203, 33204, 33205, 33206, 33207, 33208, 25 33209, 33210, 33211, 33212, 33213 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2466. 563 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 33214, 33215, 33216, 33217, 33218, 33219, 33220, 33221, 33222, 33223, 33224 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2467. The probes having the nucleotide sequence represented by SEQ ID NOS: 33225, 33226, 33227, 33228, 33229, 33230, 33231, 33232, 33233, 33234, 33235 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2468. The probes having the nucleotide sequence represented by SEQ ID NOS: 33236, 33237, 33238, 33239, 33240, 33241, 33242, 33243, 33244, 33245, 33246 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2469. The probes having the nucleotide sequence represented by SEQ ID NOS: 33247, 33248, 33249, 33250, 33251, 33252, 33253, 33254, 33255, 33256, 33257 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2470. The probes having the nucleotide sequence represented by SEQ ID NOS: 33258, 33259, 33260, 33261, 33262, 33263, 33264, 33265, 33266, 33267, 33268 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2471. The probes having the nucleotide sequence represented by SEQ ID NOS: 33269, 33270, 33271, 33272, 33273, 33274, 33275, 33276, 33277, 33278, 33279 were selected from the 564 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2472. The probes having the nucleotide sequence represented by SEQ ID NOS: 33280, 33281, 33282, 33283, 33284, 33285, 5 33286, 33287, 33288, 33289, 33290 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2473. The probes having the nucleotide sequence represented by SEQ ID NOS: 33291, 33292, 33293, 33294, 33295, 33296, 10 33297, 33298, 33299, 33300, 33301 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2474. The probes having the nucleotide sequence represented by SEQ ID NOS: 33302, 33303, 33304, 33305, 33306, 33307, 15 33308, 33309, 33310, 33311, 33312 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2475. The probes having the nucleotide sequence represented by SEQ ID NOS: 33313, 33314, 33315, 33316, 33317, 33318, 20 33319, 33320, 33321, 33322, 33323 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2476. The probes having the nucleotide sequence represented by SEQ ID NOS: 33324, 33325, 33326, 33327, 33328, 33329, 25 33330, 33331, 33332, 33333, 33334 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2477. 565 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 33335, 33336, 33337; 33338, 33339, 33340, 33341, 33342, 33343, 33344, 33345 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2478. The probes having the nucleotide sequence represented by SEQ ID NOS: 33346, 33347, 33348, 33349, 33350, 33351, 33352, 33353, 33354, 33355, 33356 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2479. The probes having the nucleotide sequence represented by SEQ ID NOS: 33357, 33358, 33359, 33360, 33361, 33362, 33363, 33364, 33365, 33366, 33367 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2480. The probes having the nucleotide sequence represented by SEQ ID NOS: 33368, 33369, 33370, 33371, 33372, 33373, 33374, 33375, 33376, 33377, 33378 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2481. The probes having the nucleotide sequence represented by SEQ ID NOS: 33379, 33380, 33381, 33382, 33383, 33384, 33385, 33386, 33387, 33388, 33389 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2482. The probes having the nucleotide sequence represented by SEQ ID NOS: 33390, 33391, 33392, 33393, 33394, 33395, 33396, 33397, 33398, 33399, 33400 were selected from the 566 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2483. The probes having the nucleotide sequence represented by SEQ ID NOS: 33401, 33402, 33403, 33404, 33405, 33406, 5 33407, 33408, 33409, 33410, 33411 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2484. The probes having the nucleotide sequence represented by SEQ ID NOS: 33412, 33413, 33414, 33415, 33416, 33417, 10 33418, 33419, 33420, 33421, 33422 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2485. The probes having the nucleotide sequence represented by SEQ ID NOS: 33423, 33424, 33425, 33426, 33427, 33428, 15 33429, 33430, 33431, 33432, 33433 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2486. The probes having the nucleotide sequence represented by SEQ ID NOS: 33434, 33435, 33436, 33437, 33438, 33439, 20 33440, 33441, 33442, 33443, 33444 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2487. The probes having the nucleotide sequence represented by SEQ ID NOS: 33445, 33446, 33447, 33448, 33449, 33450, 25 33451, 33452, 33453, 33454, 33455 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2488. 567 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 33456, 33457, 33458, 33459, 33460, 33461, 33462, 33463, 33464, 33465, 33466 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2489. The probes having the nucleotide sequence represented by SEQ ID NOS: 33467, 33468, 33469, 33470, 33471, 33472, 33473, 33474 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2490. 10 The probes having the nucleotide sequence represented by SEQ ID NOS: 33475, 33476, 33477, 33478, 33479, 33480, 33481, 33482, 33483, 33484, 33485 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2491. 15 The probes having the nucleotide sequence represented by SEQ ID NOS: 33486, 33487, 33488, 33489, 33490, 33491, 33492, 33493, 33494, 33495, 33496 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2492. 20 The probes having the nucleotide sequence represented by SEQ ID NOS: 33497, 33498, 33499, 33500, 33501, 33502, 33503, 33504, 33505, 33506, 33507 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2493. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 33508, 33509, 33510, 33511, 33512, 33513, 33514, 33515, 33516, 33517, 33518 were selected from the 568 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2494. The probes having the nucleotide sequence represented by SEQ ID NOS: 33519, 33520, 33521, 33522, 33523, 33524, 5 33525, 33526, 33527, 33528, 33529 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2495. The probes having the nucleotide sequence represented by SEQ ID NOS: 33530, 33531, 33532, 33533, 33534, 33535, 10 33536, 33537, 33538, 33539, 33540 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2496. The probes having the nucleotide sequence represented by SEQ ID NOS: 33541, 33542, 33543, 33544, 33545, 33546, 15 33547, 33548, 33549, 33550, 33551 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2497. The probes having the nucleotide sequence represented by SEQ ID NOS: 33552, 33553, 33554, 33555, 33556, 33557, 20 33558, 33559, 33560, 33561, 33562 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2498. The probes having the nucleotide sequence represented by SEQ ID NOS: 33563, 33564, 33565, 33566, 33567, 33568, 25 33569, 33570, 33571, 33572, 33573 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2499. 569 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 33574, 33575, 33576, 33577, 33578, 33579, 33580, 33581, 33582, 33583, 33584 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2500. The probes having the nucleotide sequence represented by SEQ ID NOS: 33585, 33586, 33587, 33588, 33589, 33590, 33591, 33592, 33593, 33594, 33595 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2501. The probes having the nucleotide sequence represented by SEQ ID NOS: 33596, 33597, 33598, 33599, 33600, 33601, 33602, 33603, 33604, 33605, 33606 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2502. The probes having the nucleotide sequence represented by SEQ ID NOS: 33607, 33608, 33609, 33610, 33611, 33612, 33613, 33614, 33615, 33616, 33617 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2503. The probes having the nucleotide sequence represented by SEQ ID NOS: 33618, 33619, 33620, 33621, 33622, 33623, 33624, 33625, 33626, 33627, 33628 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2504. The probes having the nucleotide sequence represented by SEQ ID NOS: 33629, 33630, 33631, 33632, 33633, 33634, 33635, 33636, 33637, 33638, 33639 were selected from the 570 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2505. The probes having the nucleotide sequence represented by SEQ ID NOS: 33640, 33641, 33642, 33643, 33644, 33645, 5 33646, 33647, 33648, 33649, 33650 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2506. The probes having the nucleotide sequence represented by SEQ ID NOS: 33651, 33652, 33653, 33654, 33655, 33656, 10 33657, 33658, 33659, 33660, 33661 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2507. The probes having the nucleotide sequence represented by SEQ ID NOS: 33662, 33663, 33664, 33665, 33666, 33667, 15 33668, 33669, 33670, 33671, 33672 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2508. The probes having the nucleotide sequence represented by SEQ ID NOS: 33673, 33674, 33675, 33676, 33677, 33678, 20 33679, 33680, 33681, 33682, 33683 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2509. The probes having the nucleotide sequence represented by SEQ ID NOS: 33684, 33685, 33686, 33687, 33688, 33689, 25 33690, 33691, 33692, 33693, 33694 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2510. 571 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 33695, 33696, 33697, 33698, 33699, 33700, 33701, 33702, 33703, 33704, 33705 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2511. The probes having the nucleotide sequence represented by SEQ ID NOS: 33706, 33707, 33708, 33709, 33710, 33711, 33712, 33713, 33714, 33715, 33716 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2512. The probes having the nucleotide sequence represented by SEQ ID NOS: 33717, 33718, 33719, 33720, 33721, 33722, 33723, 33724, 33725, 33726, 33727 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2513. The probes having the nucleotide sequence represented by SEQ ID NOS: 33728, 33729, 33730, 33731, 33732, 33733, 33734, 33735, 33736, 33737, 33738 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2514. The probes having the nucleotide sequence represented by SEQ ID NOS: 33739, 33740, 33741, 33742, 33743, 33744, 33745, 33746, 33747, 33748, 33749 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2515. The probes having the nucleotide sequence represented by SEQ ID NOS: 33750, 33751, 33752, 33753, 33754, 33755, 33756, 33757, 33758, 33759, 33760 were selected from the 572 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2516. The probes having the nucleotide sequence represented by SEQ ID NOS: 33761, 33762, 33763, 33764, 33765, 33766, 5 33767, 33768, 33769, 33770, 33771 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2517. The probes having the nucleotide sequence represented by SEQ ID NOS: 33772, 33773, 33774, 33775, 33776, 33777, 10 33778, 33779, 33780, 33781, 33782 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2518. The probes having the nucleotide sequence represented by SEQ ID NOS: 33783, 33784, 33785, 33786, 33787, 33788, 15 33789, 33790, 33791, 33792, 33793 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2519. The probes having the nucleotide sequence represented by SEQ ID NOS: 33794, 33795, 33796, 33797, 33798, 33799, 20 33800, 33801, 33802, 33803, 33804 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2520. The probes having the nucleotide sequence represented by SEQ ID NOS: 33805, 33806, 33807, 33808, 33809, 33810, 25 33811, 33812, 33813, 33814, 33815 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2521. 573 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 33816, 33817, 33818, 33819, 33820, 33821, 33822, 33823, 33824, 33825, 33826 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2522. The probes having the nucleotide sequence represented by SEQ ID NOS: 33827, 33828, 33829, 33830, 33831, 33832, 33833, 33834, 33835, 33836, 33837 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2523. The probes having the nucleotide sequence represented by SEQ ID NOS: 33838, 33839, 33840, 33841, 33842, 33843, 33844, 33845, 33846, 33847, 33848 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2524. The probes having the nucleotide sequence represented by SEQ ID NOS: 33849, 33850, 33851, 33852, 33853, 33854, 33855, 33856, 33857, 33858, 33859 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2525. The probes having the nucleotide sequence represented by SEQ ID NOS: 33860, 33861, 33862, 33863, 33864, 33865, 33866, 33867, 33868, 33869, 33870 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2526. The probes having the nucleotide sequence represented by SEQ ID NOS: 33871, 33872, 33873, 33874, 33875, 33876, 33877, 33878, 33879, 33880, 33881 were selected from the 574 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2527. The probes having the nucleotide sequence represented by SEQ ID NOS: 33882, 33883, 33884, 33885, 33886, 33887, 5 33888, 33889, 33890, 33891, 33892 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2528. The probes having the nucleotide sequence represented by SEQ ID NOS: 33893, 33894, 33895, 33896, 33897, 33898, 10 33899, 33900, 33901, 33902, 33903 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2529. The probes having the nucleotide sequence represented by SEQ ID NOS: 33904, 33905, 33906, 33907, 33908, 33909, 15 33910, 33911, 33912, 33913, 33914 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2530. The probes having the nucleotide sequence represented by SEQ ID NOS: 33915, 33916, 33917, 33918, 33919, 33920, 20 33921, 33922, 33923, 33924, 33925 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2531. The probes having the nucleotide sequence represented by SEQ ID NOS: 33926, 33927, 33928, 33929, 33930, 33931, 25 33932, 33933, 33934, 33935, 33936 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2532. 575 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 33937, 33938, 33939, 33940, 33941, 33942, 33943, 33944, 33945, 33946, 33947 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2533. The probes having the nucleotide sequence represented by SEQ ID NOS': 33948, 33949, 33950, 33951, 33952, 33953, 33954, 33955, 33956, 33957, 33958 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2534. The probes having the nucleotide sequence represented by SEQ ID NOS: 33959, 33960, 33961, 33962, 33963, 33964, 33965, 33966, 33967, 33968, 33969 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2535. The probes having the nucleotide sequence represented by SEQ ID NOS: 33970, 33971, 33972, 33973, 33974, 33975, 33976, 33977, 33978, 33979, 33980 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2536. The probes having the nucleotide sequence represented by SEQ ID NOS: 33981, 33982, 33983, 33984, 33985, 33986, 33987, 33988, 33989, 33990, 33991 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2537. The probes having the nucleotide sequence represented by SEQ ID NOS: 33992, 33993, 33994, 33995, 33996, 33997, 33998, 33999, 34000, 34001, 34002 were selected from the 576 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2538. The probes having the nucleotide sequence represented by SEQ ID NOS: 34003, 34004, 34005, 34006, 34007, 34008, 5 34009, 34010, 34011, 34012, 34013 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2539. The probes having the nucleotide sequence represented by SEQ ID NOS: 34014, 34015, 34016, 34017, 34018, 34019, 10 34020, 34021, 34022, 34023, 34024 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2540. The probes having the nucleotide sequence represented by SEQ ID NOS: 34025, 34026, 34027, 34028, 34029, 34030, 15 34031, 34032, 34033, 34034, 34035 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2541. The probes having the nucleotide sequence represented by SEQ ID NOS: 34036, 34037, 34038, 34039, 34040, 34041, 20 34042, 34043, 34044, 34045, 34046 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2542. The probes having the nucleotide sequence represented by SEQ ID NOS: 34047, 34048, 34049, 34050, 34051, 34052, 25 34053, 34054, 34055, 34056, 34057 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2543. 577 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 34058, 34059, 34060, 34061, 34062, 34063, 34064, 34065, 34066, 34067, 34068 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2544. The probes having the nucleotide sequence represented by SEQ ID NOS: 34069, 34070, 34071, 34072, 34073, 34074, 34075, 34076, 34077, 34078, 34079 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2545. The probes having the nucleotide sequence represented by SEQ ID NOS: 34080, 34081, 34082, 34083, 34084, 34085, 34086, 34087, 34088, 34089, 34090 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2546. The probes having the nucleotide sequence represented by SEQ ID NOS: 34091, 34092, 34093, 34094, 34095, 34096, 34097, 34098, 34099, 34100, 34101 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2547. The probes having the nucleotide sequence represented by SEQ ID NOS: 34102, 34103, 34104, 34105, 34106, 34107, 34108, 34109, 34110, 34111, 34112 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2548. The probes having the nucleotide sequence represented by SEQ ID NOS: 34113, 34114, 34115, 34116, 34117, 34118, 34119, 34120, 34121, 34122, 34123 were selected from the 578 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2549. The probes having the nucleotide sequence represented by SEQ ID NOS: 34124, 34125, 34126, 34127, 34128, 34129, 5 34130, 34131, 34132, 34133, 34134 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2550. The probes having the nucleotide sequence represented by SEQ ID NOS: 34135, 34136, 34137, 34138, 34139, 34140, 10 34141, 34142, 34143, 34144, 34145 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2551. The probes having the nucleotide sequence represented by SEQ ID NOS: 34146, 34147, 34148, 34149, 34150, 34151, 15 34152, 34153, 34154, 34155, 34156 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2552. The probes having the nucleotide sequence represented by SEQ ID NOS: 34157, 34158, 34159, 34160, 34161, 34162, 20 34163, 34164, 34165, 34166, 34167 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2553. The probes having the nucleotide sequence represented by SEQ ID NOS: 34168, 34169, 34170, 34171, 34172, 34173, 25 34174, 34175, 34176, 34177, 34178 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2554. 579 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 34179, 34180, 34181, 34182, 34183, 34184, 34185, 34186, 34187, 34188, 34189 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2555. The probes having the nucleotide sequence represented by SEQ ID NOS: 34190, 34191, 34192, 34193, 34194, 34195, 34196, 34197, 34198, 34199, 34200 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2556. The probes having the nucleotide sequence represented by SEQ ID NOS: 34201, 34202, 34203, 34204, 34205, 34206, 34207, 34208, 34209, 34210, 34211 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2557. The probes having the nucleotide sequence represented by SEQ ID NOS: 34212, 34213, 34214, 34215, 34216, 34217, 34218, 34219, 34220, 34221, 34222, 34223, 34224, 34225, 34226, 34227, 34228, 34229, 34230, 34231, 34232, 34233 were 20 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2558. The probes having the nucleotide sequence represented by SEQ ID NOS: 34234, 34235, 34236, 34237, 34238, 34239, 34240, 34241, 34242, 34243, 34244 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 2559. The probes having the nucleotide sequence represented by SEQ ID NOS: 34245, 34246, 34247, 34248, 34249, 34250, 580 WO 2006/024951 PCT/IB2005/002908 34251, 34252, 34253, 34254, 34255 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2560. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 34256, 34257, 34258, 34259, 34260, 34261, 34262, 34263, 34264, 34265, 34266 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2561. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 34267, 34268, 34269, 34270, 34271, 34272, 34273, 34274, 34275, 34276, 34277 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2562. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 34278, 34279, 34280, 34281, 34282, 34283, 34284, 34285, 34286, 34287, 34288 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2563. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 34289, 34290, 34291, 34292, 34293, 34294, 34295, 34296, 34297, 34298, 34299 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2564. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 34300, 34301, 34302, 34303, 34304, 34305, 34306, 34307, 34308, 34309, 34310 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2565. 581 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 34311, 34312, 34313, 34314, 34315, 34316, 34317, 34318, 34319, 34320, 34321 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2566. The probes having the nucleotide sequence represented by SEQ ID NOS: 34322, 34323, 34324, 34325, 34326, 34327, 34328, 34329, 34330, 34331, 34332 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2567. The probes having the nucleotide sequence represented by SEQ ID NOS: 34333, 34334, 34335, 34336, 34337, 34338, 34339, 34340, 34341, 34342, 34343 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2568. The probes having the nucleotide sequence represented by SEQ ID NOS: 34344, 34345, 34346, 34347, 34348, 34349, 34350, 34351, 34352, 34353, 34354 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2569. The probes having the nucleotide sequence represented by SEQ ID NOS: 34355, 34356, 34357, 34358, 34359, 34360, 34361, 34362, 34363, 34364, 34365 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2570. The probes having the nucleotide sequence represented by SEQ ID NOS: 34366, 34367, 34368, 34369, 34370, 34371, 34372, 34373, 34374, 34375, 34376 were selected from the 582 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2571. The probes having the nucleotide sequence represented by SEQ ID NOS: 34377, 34378, 34379, 34380, 34381, 34382, 5 34383, 34384, 34385, 34386, 34387 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2572. The probes having the nucleotide sequence represented by SEQ ID NOS: 34388, 34389, 34390, 34391, 34392, 34393, 10 34394, 34395, 34396, 34397, 34398 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2573. The probes having the nucleotide sequence represented by SEQ ID NOS: 34399, 34400, 34401, 34402, 34403, 34404, 15 34405, 34406, 34407, 34408, 34409 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2574. The probes having the nucleotide sequence represented by SEQ ID NOS: 34410, 34411, 34412, 34413, 34414, 34415, 20 34416, 34417, 34418, 34419, 34420 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2575. The probes having the nucleotide sequence represented by SEQ ID NOS: 34421, 34422, 34423, 34424, 34425, 34426, 25 34427, 34428, 34429, 34430, 34431 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2576. 583 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 34432, 34433, 34434, 34435, 34436, 34437, 34438, 34439, 34440, 34441, 34442 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2577. The probes having the nucleotide sequence represented by SEQ ID NOS: 34443, 34444, 34445, 34446, 34447, 34448, 34449, 34450, 34451, 34452, 34453 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2578. The probes having the nucleotide sequence represented by SEQ ID NOS: 34454, 34455, 34456, 34457, 34458, 34459, 34460, 34461, 34462, 34463, 34464 were selected from the ORFs having the nucleotide -sequence represented by SEQ ID 15 NO: 2579. The probes having the nucleotide sequence represented by SEQ ID NOS: 34465, 34466, 34467, 34468, 34469, 34470, 34471, 34472, 34473, 34474, 34475 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2580. The probes having the nucleotide sequence represented by SEQ ID NOS: 34476, 34477, 34478, 34479, 34480, 34481, 34482, 34483, 34484, 34485, 34486 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2581. The probes having the nucleotide sequence represented by SEQ ID NOS: 34487, 34488, 34489, 34490, 34491, 34492, 34493, 34494, 34495, 34496, 34497 were selected from the 584 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2582. The probes having the nucleotide sequence represented by SEQ ID NOS: 34498, 34499, 34500, 34501, 34502, 34503, 5 34504, 34505, 34506, 34507, 34508 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2583. The probes having the nucleotide sequence represented by SEQ ID NOS: 34509, 34510, 34511, 34512, 34513, 34514, 10 34515, 34516, 34517, 34518, 34519 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2584. The probes having the nucleotide sequence represented by SEQ ID NOS: 34520, 34521, 34522, 34523, 34524, 34525, 15 34526, 34527, 34528, 34529, 34530 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2585. The probes having the nucleotide sequence represented by SEQ ID NOS: 34531, 34532, 34533, 34534, 34535, 34536, 20 34537, 34538, 34539, 34540, 34541 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2586. The probes having the nucleotide sequence represented by SEQ ID NOS: 34542, 34543, 34544, 34545, 34546, 34547, 25 34548, 34549, 34550, 34551, 34552 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2587. 585 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 34553, 34554, 34555, 34556, 34557, 34558, 34559, 34560, 34561, 34562, 34563 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2588. The probes having the nucleotide sequence represented by SEQ ID NOS: 34564, 34565, 34566, 34567, 34568, 34569, 34570, 34571, 34572, 34573, 34574 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2589. The probes having the nucleotide sequence represented by SEQ ID NOS: 34575, 34576, 3457-7, 34578, 34579, 34580, 34581, 34582, 34583, 34584, 34585 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2590. The probes having the nucleotide sequence represented by SEQ ID NOS: 34586, 34587, 34588, 34589, 34590, 34591, 34592, 34593, 34594, 34595, 34596 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2591. The probes having the nucleotide sequence represented by SEQ ID NOS: 34597, 34598, 34599, 34600, 34601, 34602, 34603, 34604, 34605, 34606, 34607 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2592. The probes having the nucleotide sequence represented by SEQ ID NOS: 34608, 34609, 34610, 34611, 34612, 34613, 34614, 34615, 34616, 34617, 34618 were selected from the 586 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2593. The probes having the nucleotide sequence represented by SEQ ID NOS: 34619, 34620, 34621, 34622, 34623, 34624, 5 34625, 34626, 34627, 34628, 34629 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2594. The probes having the nucleotide sequence represented by SEQ ID NOS: 34630, 34631, 34632, 34633, 34634, 34635, 10 34636, 34637, 34638, 34639, 34640 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2595. The probes having the nucleotide sequence represented by SEQ ID NOS: 34641, 34642, 34643, 34644, 34645, 34646, 15 34647, 34648, 34649, 34650, 34651 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2596. The probes having the nucleotide sequence represented by SEQ ID NOS: 34652, 34653, 34654, 34655, 34656, 34657, 20 34658, 34659, 34660, 34661, 34662 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2597. The probes having the nucleotide sequence represented by SEQ ID NOS: 34663, 34664, 34665, 34666, 34667, 34668, 25 34669, 34670, 34671, 34672, 34673 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2598. 587 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 34674, 34675, 34676, 34677, 34678, 34679, 34680, 34681, 34682, 34683, 34684 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2599. The probes having the nucleotide sequence represented by SEQ ID NOS: 34685, 34686, 34687, 34688, 34689, 34690, 34691, 34692, 34693, 34694, 34695 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2600. The probes having the nucleotide sequence represented by SEQ ID NOS: 34696, 34697, 34698, 34699, 34700, 34701, 34702, 34703, 34704, 34705, 34706 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2601. The probes having the nucleotide sequence represented by SEQ ID NOS: 34707, 34708, 34709, 34710, 34711, 34712, 34713, 34714, 34715, 34716, 34717 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2602. The probes having the nucleotide sequence represented by SEQ ID NOS: 34718, 34719, 34720, 34721, 34722, 34723, 34724, 34725, 34726, 34727, 34728 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2603. The probes having the nucleotide sequence represented by SEQ ID NOS: 34729, 34730, 34731, 34732, 34733, 34734, 34735, 34736, 34737, 34738, 34739 were selected from the 588 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2604. The probes having the nucleotide sequence represented by SEQ ID NOS: 34740, 34741, 34742, 34743, 34744, 34745, 5 34746, 34747, 34748, 34749, 34750 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2605. The probes having the nucleotide sequence represented by SEQ ID NOS: 34751, 34752, 34753, 34754, 34755, 34756, 10 34757, 34758, 34759, 34760, 34761 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2606. The probes having the nucleotide sequence represented by SEQ ID NOS: 34762, 34763, 34764, 34765, 34766, 34767, 15 34768, 34769, 34770, 34771, 34772 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2607. The probes having the nucleotide sequence represented by SEQ ID NOS: 34773, 34774, 34775, 34776, 34777, 34778, 20 34779, 34780, 34781, 34782, 34783 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2608. The probes having the nucleotide sequence represented by SEQ ID NOS: 34784, 34785, 34786, 34787, 34788, 34789, 25 34790, 34791, 34792, 34793, 34794 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2609. 589 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 34795, 34796, 34797, 34798, 34799, 34800, 34801, 34802, 34803, 34804, 34805 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2610. The probes having the nucleotide sequence represented by SEQ ID NOS: 34806, 34807, 34808, 34809, 34810, 34811, 34812, 34813, 34814, 34815, 34816 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2611. The probes having the nucleotide sequence represented by SEQ ID NOS: 34817, 34818, 34819, 34820, 34821, 34822, 34823, 34824, 34825, 34826, 34827 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2612. The probes having the nucleotide sequence represented by SEQ ID NOS: 34828, 34829, 34830, 34831, 34832, 34833, 34834, 34835, 34836, 34837, 34838 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2613. The probes having the nucleotide sequence represented by SEQ ID NOS: 34839, 34840, 34841, 34842, 34843, 34844, 34845, 34846, 34847, 34848, 34849 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2614. The probes having the nucleotide sequence represented by SEQ ID NOS: 34850, 34851, 34852, 34853, 34854, 34855, 34856, 34857, 34858, 34859, 34860 were selected from the 590 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2615. The probes having the nucleotide sequence represented by SEQ ID NOS: 34861, 34862, 34863, 34864, 34865, 34866, 5 34867, 34868, 34869, 34870, 34871 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2616. The probes having the nucleotide sequence represented by SEQ ID NOS: 34872, 34873, 34874, 34875, 34876, 34877, 10 34878, 34879, 34880, 34881, 34882 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2617. The probes having the nucleotide sequence represented by SEQ ID NOS: 34883, 34884, 34885, 34886, 34887, 34888, 15 34889, 34890, 34891, 34892, 34893 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2618. The probes having the nucleotide sequence represented by SEQ ID NOS: 34894, 34895, 34896, 34897, 34898, 34899, 20 34900, 34901, 34902, 34903, 34904 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2619. The probes having the nucleotide sequence represented by SEQ ID NOS: 34905, 34906, 34907, 34908, 34909, 34910, 25 34911, 34912, 34913, 34914, 34915 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2620. 591 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 34916, 34917, 34918, 34919, 34920, 34921, 34922, 34923, 34924, 34925, 34926 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2621. The probes having the nucleotide sequence represented by SEQ ID NOS: 34927, 34928, 34929, 34930, 34931, 34932, 34933, 34934, 34935, 34936, 34937 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2622. The probes having the nucleotide sequence represented by SEQ ID NOS: 34938, 34939, 34940, 34941, 34942, 34943, 34944, 34945, 34946, 34947, 34948 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2623. The probes having the nucleotide sequence represented by SEQ ID NOS: 34949, 34950, 34951, 34952, 34953, 34954, 34955, 34956, 34957, 34958, 34959 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2624. The probes having the nucleotide sequence represented by SEQ ID NOS: 34960, 34961, 34962, 34963, 34964, 34965, 34966, 34967, 34968, 34969, 34970 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2625. The probes having the nucleotide sequence represented by SEQ ID NOS: 34971, 34972, 34973, 34974, 34975, 34976, 34977, 34978, 34979, 34980, 34981 were selected from the 592 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2626. The probes having the nucleotide sequence represented by SEQ ID NOS: 34982, 34983, 34984, 34985, 34986, 34987, 5 34988, 34989, 34990, 34991, 34992 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2627. The probes having the nucleotide sequence represented by SEQ ID NOS: 34993, 34994, 34995, 34996, 34997, 34998, 10 34999, 35000, 35001, 35002, 35003 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2628. The probes having the nucleotide sequence represented by SEQ ID NOS: 35004, 35005, 35006, 35007, 35008, 35009, 15 35010, 35011, 35012, 35013, 35014 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2629. The probes having the nucleotide sequence represented by SEQ ID NOS: 35015, 35016, 35017, 35018, 35019, 35020, 20 35021, 35022, 35023, 35024, 35025 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2630. The probes having the nucleotide sequence represented by SEQ ID NOS: 35026, 35027, 35028, 35029, 35030, 35031, 25 35032, 35033, 35034, 35035, 35036 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2631. 593 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 35037, 35038, 35039, 35040, 35041, 35042, 35043, 35044, 35045, 35046, 35047 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2632. The probes having the nucleotide sequence represented by SEQ ID NOS: 35048, 35049, 35050, 35051, 35052, 35053, 35054, 35055, 35056, 35057, 35058 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2633. The probes having the nucleotide sequence represented by SEQ ID NOS: 35059, 35060, 35061, 35062, 35063, 35064, 35065, 35066, 35067, 35068, 35069 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2634. The probes having the nucleotide sequence represented by SEQ ID NOS: 35070, 35071, 35072, 35073, 35074, 35075, 35076, 35077, 35078, 35079, 35080 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2635. The probes having the nucleotide sequence represented by SEQ ID NOS: 35081, 35082, 35083, 35084, 35085, 35086, 35087, 35088, 35089, 35090, 35091 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2636. The probes having the nucleotide sequence represented by SEQ ID NOS: 35092, 35093, 35094, 35095, 35096, 35097, 35098, 35099, 35100, 35101, 35102 were selected from the 594 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2637. The probes having the nucleotide sequence represented by SEQ ID NOS: 35103, 35104, 35105, 35106, 35107, 35108, 5 35109, 35110, 35111, 35112, 35113 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2638. The probes having the nucleotide sequence represented by SEQ ID NOS: 35114, 35115, 35116, 35117, 35118, 35119, 10 35120, 35121, 35122, 35123, 35124 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2639. The probes having the nucleotide sequence represented by SEQ ID NOS: 35125, 35126, 35127, 35128, 35129, 35130, 15 35131, 35132, 35133, 35134, 35135 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2640. The probes having the nucleotide sequence represented by SEQ ID NOS: 35136, 35137, 35138, 35139, 35140, 35141, 20 35142, 35143, 35144, 35145, 35146 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2641. The probes having the nucleotide sequence represented by SEQ ID NOS: 35147, 35148, 35149, 35150, 35151, 35152, 25 35153, 35154, 35155, 35156, 35157 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2642. 595 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 35158, 35159, 35160, 35161, 35162, 35163, 35164, 35165, 35166, 35167, 35168 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2643. The probes having the nucleotide sequence represented by SEQ ID NOS: 35169, 35170, 35171, 35172, 35173, 35174, 35175, 35176, 35177, 35178, 35179 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2644. The probes having the nucleotide sequence represented by SEQ ID NOS: 35180, 35181, 35182, 35183, 35184, 35185, 35186, 35187, 35188, 35189, 35190 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2645. The probes having the nucleotide sequence represented by SEQ ID NOS: 35191, 35192, 35193, 35194, 35195, 35196, 35197, 35198, 35199, 35200, 35201 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2646. The probes having the nucleotide sequence represented by SEQ ID NOS: 35202, 35203, 35204, 35205, 35206, 35207, 35208, 35209, 35210, 35211, 35212 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2647. The probes having the nucleotide sequence represented by SEQ ID NOS: 35213, 35214, 35215, 35216, 35217, 35218, 35219, 35220, 35221, 35222, 35223 were selected from the 596 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2648. The probes having the nucleotide sequence represented by SEQ ID NOS: 35224, 35225, 35226, 35227, 35228, 35229, 5 35230, 35231, 35232, 35233, 35234 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2649. The probes having the nucleotide sequence represented by SEQ ID NOS: 35235, 35236, 35237, 35238, 35239, 35240, 10 35241, 35242, 35243, 35244, 35245 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2650. The probes having the nucleotide sequence represented by SEQ ID NOS: 35.246, 35247, 35248, 35249, 35250, 35251, 15 35252, 35253, 35254, 35255, 35256 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2651. The probes having the nucleotide sequence represented by SEQ ID NOS: 35257, 35258, 35259, 35260, 35261, 35262, 20 35263, 35264, 35265, 35266, 35267 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2652. The probes having the nucleotide sequence represented by SEQ ID NOS: 35268, 35269, 35270, 35271, 35272, 35273, 25 35274, 35275, 35276, 35277, 35278 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2653. 597 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 35279, 35280, 35281, 35282, 35283, 35284, 35285, 35286, 35287, 35288, 35289 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2654. The probes having the nucleotide sequence represented by SEQ ID NOS: 35290, 35291, 35292, 35293, 35294, 35295, 35296, 35297, 35298, 35299, 35300 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2655. The probes having the nucleotide sequence represented by SEQ ID NOS: 35301, 35302, 35303, 35304, 35305, 35306, 35307, 35308, 35309, 35310, 35311 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2656. The probes having the nucleotide sequence represented by SEQ ID NOS: 35312, 35313, 35314, 35315, 35316, 35317, 35318, 35319, 35320, 35321, 35322 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2657. The probes having the nucleotide sequence represented by SEQ ID NOS: 35323, 35324, 35325, 35326, 35327, 35328, 35329, 35330, 35331, 35332, 35333 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2658. The probes having the nucleotide sequence represented by SEQ ID NOS: 35334, 35335, 35336, 35337, 35338, 35339, 35340, 35341, 35342, 35343, 35344 were selected from the 598 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2659. The probes having the nucleotide sequence represented by SEQ ID NOS: 35345, 35346, 35347, 35348, 35349, 35350, 5 35351, 35352, 35353, 35354, 35355 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2660. The probes having the nucleotide sequence represented by SEQ ID NOS: 35356, 35357, 35358, 35359, 35360, 35361, 10 35362, 35363, 35364, 35365, 35366 were selected from the ORFs having the nucleotide -sequence represented by SEQ ID NO: 2661. The probes having the nucleotide sequence represented by SEQ ID NOS: 35367, 35368, 35369, 35370, 35371, 35372, 15 35373, 35374, 35375, 35376, 35377 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2662. The probes having the nucleotide sequence represented by SEQ ID NOS: 35378, 35379, 35380, 35381, 35382, 35383, 20 35384, 35385, 35386, 35387, 35388 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2663. The probes having the nucleotide sequence represented by SEQ ID NOS: 35389, 35390, 35391, 35392, 35393, 35394, 25 35395, 35396, 35397, 35398, 35399 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2664. 599 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 35400, 35401, 35402, 35403, 35404, 35405, 35406, 35407, 35408, 35409, 35410 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2665. The probes having the nucleotide sequence represented by SEQ ID NOS: 35411, 35412, 35413, 35414, 35415, 35416, 35417, 35418, 35419, 35420, 35421 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2666. The probes having the nucleotide sequence represented by SEQ ID NOS: 35422, 35423, 35424, 35425, 35426, 35427, 35428, 35429, 35430, 35431, 35432 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2667. The probes having the nucleotide sequence represented by SEQ ID NOS: 35433, 35434, 35435, 35436, 35437, 35438, 35439, 35440, 35441, 35442, 35443 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2668. The probes having the nucleotide sequence represented by SEQ ID NOS: 35444, 35445, 35446, 35447, 35448, 35449, 35450, 35451, 35452, 35453, 35454 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2669. The probes having the nucleotide sequence represented by SEQ ID NOS: 35455, 35456, 35457, 35458, 35459, 35460, 35461, 35462, 35463, 35464, 35465 were selected from the 600 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2670. The probes having the nucleotide sequence represented by SEQ ID NOS: 35466, 35467, 35468, 35469, 35470, 35471, 5 35472, 35473, 35474, 35475, 35476 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2671. The probes having the nucleotide sequence represented by SEQ ID NOS: 35477, 35478, 35479, 35480, 35481, 35482, 10 35483, 35484, 35485, 35486, 35487 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2672. The probes having the nucleotide sequence represented by SEQ ID NOS: 35488, 35489, 35490, 35491, 35492, 35493, 15 35494, 35495, 35496, 35497, 35498 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2673. The probes having the nucleotide sequence represented by SEQ ID NOS: 35499, 35500, 35501, 35502, 35503, 35504, 20 35505, 35506, 35507, 35508, 35509 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2674. The probes having the nucleotide sequence represented by SEQ ID NOS: 35510, 35511, 35512, 35513, 35514, 35515, 25 35516, 35517, 35518, 35519, 35520 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2675. 601 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 35521, 35522, 35523, 35524, 35525, 35526, 35527, 35528, 35529, 35530, 35531 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2676. The probes having the nucleotide sequence represented by SEQ ID NOS: 35532, 35533, 35534, 35535, 35536, 35537, 35538, 35539, 35540, 35541, 35542 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2677. The probes having the nucleotide sequence represented by SEQ ID NOS: 35543, 35544, 35545, 35546, 35547, 35548, 35549, 35550, 35551, 35552, 35553 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2678. The probes having the nucleotide sequence represented by SEQ ID NOS: 35554, 35555, 35556, 35557, 35558, 35559, 35560, 35561, 35562, 35563, 35564 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2679. The probes having the nucleotide sequence represented by SEQ ID NOS: 35565, 35566, 35567, 35568, 35569, 35570, 35571, 35572, 35573, 35574, 35575 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2680. The probes having the nucleotide sequence represented by SEQ ID NOS: 35576, 35577, 35578, 35579, 35580, 35581, 35582, 35583, 35584, 35585, 35586 were selected from the 602 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2681. The probes having the nucleotide sequence represented by SEQ ID NOS: 35587, 35588, 35589, 35590, 35591, 35592, 5 35593, 35594, 35595, 35596, 35597 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2682. The probes having the nucleotide sequence represented by SEQ ID NOS: 35598, 35599, 35600, 35601, 35602, 35603, 10 35604, 35605, 35606, 35607, 35608 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2683. The probes having the nucleotide sequence represented by SEQ ID NOS: 35609, 35610, 35611, 35612, 35613, 35614, 15 35615, 35616, 35617, 35618, 35619 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2684. The probes having the nucleotide sequence represented by SEQ ID NOS: 35620, 35621, 35622, 35623, 35624, 35625, 20 35626, 35627, 35628, 35629, 35630 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2685. The probes having the nucleotide sequence represented by SEQ ID NOS: 35631, 35632, 35633, 35634, 35635, 35636, 25 35637, 35638, 35639, 35640, 35641 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2686. 603 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 35642, 35643, 35644, 35645, 35646, 35647, 35648, 35649, 35650, 35651, 35652 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2687. The probes having the nucleotide sequence represented by SEQ ID NOS: 35653, 35654, 35655, 35656, 35657, 35658, 35659, 35660, 35661, 35662, 35663 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2688. The probes having the nucleotide sequence represented by SEQ ID NOS: 35664, 35665, 35666, 35667, 35668, 35669, 35670, 35671, 35672, 35673, 35674 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2689. The probes having the nucleotide sequence represented by SEQ ID NOS: 35675, 35676, 35677, 35678, 35679, 35680, 35681, 35682, 35683, 35684, 35685 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2690. The probes having the nucleotide sequence represented by SEQ ID NOS: 35686, 35687, 35688, 35689, 35690, 35691, 35692, 35693, 35694, 35695, 35696 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2691. The probes having the nucleotide sequence represented by SEQ ID NOS: 35697, 35698, 35699, 35700, 35701, 35702, 35703, 35704, 35705, 35706, 35707 were selected from the 604 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2692. The probes having the nucleotide sequence represented by SEQ ID NOS: 35708, 35709, 35710, 35711, 35712, 35713, 5 35714, 35715, 35716, 35717, 35718 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2693. The probes having the nucleotide sequence represented by SEQ ID NOS: 35719, 35720, 35721, 35722, 35723, 35724, 10 35725, 35726, 35727, 35728, 35729 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2694. The probes having the nucleotide sequence represented by SEQ ID NOS: 35730, 35731, 35732, 35733, 35734, 35735, 15 35736, 35737, 35738, 35739, 35740 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2695. The probes having the nucleotide sequence represented by SEQ ID NOS: 35741, 35742, 35743, 35744, 35745, 35746, 20 35747, 35748, 35749, 35750, 35751 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2696. The probes having the nucleotide sequence represented by SEQ ID NOS: 35752, 35753, 35754, 35755, 35756, 35757, 25 35758, 35759, 35760, 35761, 35762 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2697. 605 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 35763, 35764, 35765, 35766, 35767, 35768, 35769, 35770, 35771, 35772, 35773, 35774, 35775, 35776, 35777, 35778, 35779, 35780, 35781, 35782, 35783, 35784 were 5 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2698. The probes having the nucleotide sequence represented by SEQ ID NOS: 35785, 35786, 35787, 35788, 35789, 35790, 35791, 35792, 35793, 35794, 35795 were selected from the 10 ORFs having the nucleotide sequence represented by SEQ ID NO: 2699. The probes having the nucleotide sequence represented by SEQ ID NOS: 35796, 35797, 35798, 35799, 35800, 35801, 35802, 35803, 35804, 35805, 35806 were selected from the 15 ORFs having the nucleotide sequence represented by SEQ ID NO: 2700. The probes having the nucleotide sequence represented by SEQ ID NOS: 35807, 35808, 35809, 35810, 35811, 35812, 35813, 35814, 35815, 35816, 35817 were selected from the 20 ORFs having the nucleotide sequence represented by SEQ ID NO: 2701. The probes having the nucleotide sequence represented by SEQ ID NOS: 35818, 35819, 35820, 35821, 35822, 35823, 35824, 35825, 35826, 35827, 35828 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 2702. The probes having the nucleotide sequence represented by SEQ ID NOS: 35829, 35830, 35831, 35832, 35833, 35834, 606 WO 2006/024951 PCT/IB2005/002908 35835, 35836, 3.5837, 35838, 35839 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2703. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 35840, 35841, 35842, 35843, 35844, 35845, 35846, 35847, 35848, 35849, 35850 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2704. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 35851, 35852, 35853, 35854, 35855, 35856, 35857, 35858, 35859, 35860, 35861 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2705. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 35862, 35863, 35864, 35865, 35866, 35867, 35868, 35869, 35870, 35871, 35872 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2706. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 35873, 35874, 35875, 35876, 35877, 35878, 35879, 35880, 35881, 35882, 35883 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2707. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 35884, 35885, 35886, 35887, 35888, 35889, 35890, 35891, 35892, 35893, 35894 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2708. 607 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 35895, 35896, 35897, 35898, 35899, 35900, 35901, 35902, 35903, 35904, 35905 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2709. The probes having the nucleotide sequence represented by SEQ ID NOS: 35906, 35907, 35908, 35909, 35910, 35911, 35912, 35913, 35914, 35915, 35916 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2710. The probes having the nucleotide sequence represented by SEQ ID NOS: 35917, 35918, 35919, 35920, 35921, 35922, 35923, 35924, 35925, 35926, 35927 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2711. The probes having the nucleotide sequence represented by SEQ ID NOS: 35928, 35929, 35930, 35931, 35932, 35933, 35934, 35935, 35936, 35937, 35938 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2712. The probes having the nucleotide sequence represented by SEQ ID NOS: 35939, 35940, 35941, 35942, 35943, 35944, 35945, 35946, 35947, 35948, 35949 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2713. The probes having the nucleotide sequence represented by SEQ ID NOS: 35950, 35951, 35952, 35953, 35954, 35955, 35956, 35957, 35958, 35959, 35960 were selected from the 608 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2714. The probes having the nucleotide sequence represented by SEQ ID NOS: 35961, 35962, 35963, 35964, 35965, 35966, 5 35967, 35968, 35969, 35970, 35971 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2715. The probes having the nucleotide sequence represented by SEQ ID NOS: 35972, 35973, 35974, 35975, 35976, 35977, 10 35978, 35979, 35980, 35981, 35982 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2716. The probes having the nucleotide sequence represented by SEQ ID NOS: 35983, 35984, 35985, 35986, 35987, 35988, 15 35989, 35990, 35991, 35992, 35993 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2717. The probes having the nucleotide sequence represented by SEQ ID NOS: 35994, 35995, 35996, 35997, 35998, 35999, 20 36000, 36001, 36002, 36003, 36004 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2718. The probes having the nucleotide sequence represented by SEQ ID NOS: 36005, 36006, 36007, 36008, 36009, 36010, 25 36011, 36012, 36013, 36014, 36015 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2719. 609 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 36016, 36017, 36018, 36019, 36020, 36021, 36022, 36023, 36024, 36025, 36026 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2720. The probes having the nucleotide sequence represented by SEQ ID NOS: 36027, 36028, 36029, 36030, 36031, 36032, 36033, 36034, 36035, 36036, 36037 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2721. The probes having the nucleotide sequence represented by SEQ ID NOS: 36038, 36039, 36040, 36041, 36042, 36043, 36044, 36045, 36046, 36047, 36048 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2722. The probes having the nucleotide sequence represented by SEQ ID NOS: 36049, 36050, 36051, 36052, 36053, 36054, 36055, 36056, 36057, 36058, 36059 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2723. The probes having the nucleotide sequence represented by SEQ ID NOS: 36060, 36061, 36062, 36063, 36064, 36065, 36066, 36067, 36068, 36069, 36070 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2724. The probes having the nucleotide sequence represented by SEQ ID NOS: 36071, 36072, 36073, 36074, 36075, 36076, 36077, 36078, 36079, 36080, 36081 were selected from the 610 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2725. The probes having the nucleotide sequence represented by SEQ ID NOS: 36082, 36083, 36084, 36085, 36086, 36087, 5 36088, 36089, 36090, 36091, 36092 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2726. The probes having the nucleotide sequence represented by SEQ ID NOS: 36093, 36094, 36095, 36096, 36097, 36098, 10 36099, 36100, 36101, 36102, 36103 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2727. The probes having the nucleotide sequence represented by SEQ ID NOS: 36104, 36105, 36106, 36107, 36108, 36109, 15 36110, 36111, 36112, 36113, 36114 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2728. The probes having the nucleotide sequence represented by SEQ ID NOS: 36115, 36116, 36117, 36118, 36119, 36120, 20 36121, 36122, 36123, 36124, 36125 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2729. The probes having the nucleotide sequence represented by SEQ ID NOS: 36126, 36127, 36128, 36129, 36130, 36131, 25 36132, 36133, 36134, 36135, 36136 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2730. 611 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 36137, 36138, 36139, 36140, 36141, 36142, 36143, 36144, 36145, 36146, 36147 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2731. The probes having the nucleotide sequence represented by SEQ ID NOS: 36148, 36149, 36150, 36151, 36152, 36153, 36154, 36155, 36156, 36157, 36158 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2732. The probes having the nucleotide sequence represented by SEQ ID NOS: 36159, 36160, 36161, 36162, 36163, 36164, 36165, 36166, 36167, 36168, 36169 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2733. The probes having the nucleotide sequence represented by SEQ ID NOS: 36170, 36171, 36172, 36173, 36174, 36175, 36176, 36177, 36178, 36179, 36180 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2734. The probes having the nucleotide sequence represented by SEQ ID NOS: 36181, 36182, 36183, 36184, 36185, 36186, 36187, 36188, 36189, 36190, 36191 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2735. The probes having the nucleotide sequence represented by SEQ ID NOS: 36192, 36193, 36194, 36195, 36196, 36197, 36198, 36199, 36200, 36201, 36202 were selected from the 612 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2736. The probes having the nucleotide sequence represented by SEQ ID NOS: 36203, 36204, 36205, 36206, 36207, 36208, 5 36209, 36210, 36211, 36212, 36213 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2737. The probes having the nucleotide sequence represented by SEQ ID NOS: 36214, 36215, 36216, 36217, 36218, 36219, 10 36220, 36221, 36222, 36223, 36224 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2738. The probes having the nucleotide sequence represented by SEQ ID NOS: 36225, 36226, 36227, 36228, 36229, 36230, 15 36231, 36232, 36233, 36234, 36235 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2739. The probes having the nucleotide sequence represented by SEQ ID NOS: 36236, 36237, 36238, 36239, 36240, 36241, 20 36242, 36243, 36244, 36245, 36246 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2740. The probes having the nucleotide sequence represented by SEQ ID NOS: 36247, 36248, 36249, 36250, 36251, 36252, 25 36253, 36254, 36255, 36256, 36257 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2741. 613 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 36258, 36259, 36260, 36261, 36262, 36263, 36264, 36265, 36266, 36267, 36268 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2742. The probes having the nucleotide sequence represented by SEQ ID NOS: 36269, 36270, 36271, 36272, 36273, 36274, 36275, 36276, 36277, 36278, 36279 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2743. The probes having the nucleotide sequence represented by SEQ ID NOS: 36280, 36281, 36282, 36283, 36284, 36285, 36286, 36287, 36288, 36289, 36290 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2744. The probes having the nucleotide sequence represented by SEQ ID NOS: 36291, 36292, 36293, 36294, 36295, 36296, 36297, 36298, 36299, 36300, 36301 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2745. The probes having the nucleotide sequence represented by SEQ ID NOS: 36302, 36303, 36304, 36305, 36306, 36307, 36308, 36309, 36310, 36311, 36312 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2746. The probes having the nucleotide sequence represented by SEQ ID NOS: 36313, 36314, 36315, 36316, 36317, 36318, 36319, 36320, 36321, 36322, 36323 were selected from the 614 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2747. The probes having the nucleotide sequence represented by SEQ ID NOS: 36324, 36325, 36326, 36327, 36328, 36329, 5 36330, 36331, 36332, 36333, 36334 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2748. The probes having the nucleotide sequence represented by SEQ ID NOS: 36335, 36336, 36337, 36338, 36339, 36340, 10 36341, 36342, 36343, 36344, 36345 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2749. The probes having the nucleotide sequence represented by SEQ ID NOS: 36346, 36347, 36348, 36349, 36350, 36351, 15 36352, 36353, 36354, 36355, 36356 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2750. The probes having the nucleotide sequence represented by SEQ ID NOS: 36357, 36358, 36359, 36360, 36361, 36362, 20 36363, 36364, 36365, 36366, 36367 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2751. The probes having the nucleotide sequence represented by SEQ ID NOS: 36368, 36369, 36370, 36371, 36372, 36373, 25 36374, 36375, 36376, 36377, 36378 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2752. 615 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 36379, 36380, 36381, 36382, 36383, 36384, 36385, 36386, 36387, 36388, 36389 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2753. The probes having the nucleotide sequence represented by SEQ ID NOS: 36390, 36391, 36392, 36393, 36394, 36395, 36396, 36397, 36398, 36399, 36400 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2754. The probes having the nucleotide sequence represented by SEQ ID NOS: 36401, 36402, 36403, 36404, 36405, 36406, 36407, 36408, 36409, 36410, 36411 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2755. The probes having the nucleotide sequence represented by SEQ ID NOS: 36412, 36413, 36414, 36415, 36416, 36417, 36418, 36419, 36420, 36421, 36422 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2756. The probes having the nucleotide sequence represented by SEQ ID NOS: 36423, 36424, 36425, 36426, 36427, 36428, 36429, 36430, 36431, 36432, 36433 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2757. The probes having the nucleotide sequence represented by SEQ ID NOS: 36434, 36435, 36436, 36437, 36438, 36439, 36440, 36441, 36442, 36443, 36444 were selected from the 616 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2758. The probes having the nucleotide sequence represented by SEQ ID NOS: 36445, 36446, 36447, 36448, 36449, 36450, 5 36451, 36452, 36453, 36454, 36455 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2759. The probes having the nucleotide sequence represented by SEQ ID NOS: 36456, 36457, 36458, 36459, 36460, 36461, 10 36462, 36463, 36464, 36465, 36466 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2760. The probes having the nucleotide sequence represented by SEQ ID NOS: 36467, 36468, 36469, 36470, 36471, 36472, 15 36473, 36474, 36475, 36476, 36477 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2761. The probes having the nucleotide sequence represented by SEQ ID NOS: 36478, 36479, 36480, 36481, 36482, 36483, 20 36484, 36485, 36486, 36487, 36488 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2762. The probes having the nucleotide sequence represented by SEQ ID NOS: 36489, 36490, 36491, 36492, 36493, 36494, 25 36495, 36496, 36497, 36498, 36499 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2763. 617 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 36500, 36501, 36502, 36503, 36504, 36505, 36506, 36507, 36508, 36509, 36510 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2764. The probes having the nucleotide sequence represented by SEQ ID NOS: 36511, 36512, 36513, 36514, 36515, 36516, 36517, 36518, 36519, 36520, 36521 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2765. The probes having the nucleotide sequence represented by SEQ ID NOS: 36522, 36523, 36524, 36525, 36526, 36527, 36528, 36529, 36530, 36531, 36532 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2766. The probes having the nucleotide sequence represented by SEQ ID NOS: 36533, 36534, 36535, 36536, 36537, 36538, 36539, 36540, 36541, 36542, 36543 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2767. The probes having the nucleotide sequence represented by SEQ ID NOS: 36544, 36545, 36546, 36547, 36548, 36549, 36550, 36551, 36552, 36553, 36554 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2768. The probes having the nucleotide sequence represented by SEQ ID NOS: 36555, 36556, 36557, 36558, 36559, 36560, 36561, 36562, 36563, 36564, 36565 were selected from the 618 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2769. The probes having the nucleotide sequence represented by SEQ ID NOS: 36566, 36567, 36568, 36569, 36570, 36571, 5 36572, 36573, 36574, 36575, 36576 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2770. The probes having the nucleotide sequence represented by SEQ ID NOS: 36577, 36578, 36579, 36580, 36581, 36582, 10 36583, 36584, 36585, 36586, 36587 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2771. The probes having the nucleotide sequence represented by SEQ ID NOS: 36588, 36589, 36590, 36591, 36592, 36593, 15 36594, 36595, 36596, 36597, 36598 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2772. The probes having the nucleotide sequence represented by SEQ ID NOS: 36599, 36600, 36601, 36602, 36603, 36604, 20 36605, 36606, 36607, 36608, 36609 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2773. The probes having the nucleotide sequence represented by SEQ ID NOS: 36610, 36611, 36612, 36613, 36614, 36615, 25 36616, 36617, 36618, 36619, 36620 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2774. 619 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 36621, 36622, 36623, 36624, 36625, 36626, 36627, 36628, 36629, 36630, 36631 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2775. The probes having the nucleotide sequence represented by SEQ ID NOS: 36632, 36633, 36634, 36635, 36636, 36637, 36638, 36639, 36640, 36641, 36642 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2776. The probes having the nucleotide sequence represented by SEQ ID NOS: 36643, 36644, 36645, 36646, 36647, 36648, 36649, 36650, 36651, 36652, 36653 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2777. The probes having the nucleotide sequence represented by SEQ ID NOS: 36654, 36655, 36656, 36657, 36658, 36659, 36660, 36661, 36662, 36663, 36664 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2778. The probes having the nucleotide sequence represented by SEQ ID NOS: 36665, 36666, 36667, 36668, 36669, 36670, 36671, 36672, 36673, 36674, 36675 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2779. The probes having the nucleotide sequence represented by SEQ ID NOS: 36676, 36677, 36678, 36679, 36680, 36681, 36682, 36683, 36684, 36685, 36686 were selected from the 620 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2780. The probes having the nucleotide sequence represented by SEQ ID NOS: 36687, 36688, 36689, 36690, 36691, 36692, 5 36693, 36694, 36695, 36696, 36697 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2781. The probes having the nucleotide sequence represented by SEQ ID NOS: 36698, 36699, 36700, 36701, 36702, 36703, 10 36704, 36705, 36706, 36707, 36708 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2782. The probes having the nucleotide sequence represented by SEQ ID NOS: 36709, 36710, 36711, 36712, 36713, 36714, 15 36715, 36716, 36717, 36718, 36719 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2783. The probes having the nucleotide sequence represented by SEQ ID NOS: 36720, 36721, 36722, 36723, 36724, 36725, 20 36726, 36727, 36728, 36729, 36730 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2784. The probes having the nucleotide sequence represented by SEQ ID NOS: 36731, 36732, 36733, 36734, 36735, 36736, 25 36737, 36738, 36739, 36740, 36741 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2785. 621 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 36742, 36743, 36744, 36745, 36746, 36747, 36748, 36749, 36750, 36751, 36752 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2786. The probes having the nucleotide sequence represented by SEQ ID NOS: 36753, 36754, 36755, 36756, 36757, 36758, 36759, 36760, 36761, 36762, 36763 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2787. The probes having the nucleotide sequence represented by SEQ ID NOS: 36764, 36765, 36766, 36767, 36768, 36769, 36770, 36771, 36772, 36773, 36774 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2788. The probes having the nucleotide sequence represented by SEQ ID NOS: 36775, 36776, 36777, 36778, 36779, 36780, 36781, 36782, 36783, 36784, 36785 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2789. The probes having the nucleotide sequence represented by SEQ ID NOS: 36786, 36787, 36788, 36789, 36790, 36791, 36792, 36793, 36794, 36795, 36796 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2790. The probes having the nucleotide sequence represented by SEQ ID NOS: 36797, 36798, 36799, 36800, 36801, 36802, 36803, 36804, 36805, 36806, 36807 were selected from the 622 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2791. The probes having the nucleotide sequence represented by SEQ ID NOS: 36808, 36809, 36810, 36811, 36812, 36813, 5 36814, 36815, 36816, 36817, 36818 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2792. The probes having the nucleotide sequence represented by SEQ ID NOS: 36819, 36820, 36821, 36822, 36823, 36824, 10 36825, 36826, 36827, 36828, 36829 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2793. The probes having the nucleotide sequence represented by SEQ ID NOS: 36830, 36831, 36832, 36833, 36834, 36835, 15 36836, 36837, 36838, 36839, 36840 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2794. The probes having the nucleotide sequence represented by SEQ ID NOS: 36841, 36842, 36843, 36844, 36845, 36846, 20 36847, 36848, 36849, 36850, 36851 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2795. The probes having the nucleotide sequence represented by SEQ ID NOS: 36852, 36853, 36854, 36855, 36856, 36857, 25 36858, 36859, 36860, 36861, 36862 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2796. 623 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 36863, 36864, 36865, 36866, 36867, 36868, 36869, 36870, 36871, 36872, 36873 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2797. The probes having the nucleotide sequence represented by SEQ ID NOS: 36874, 36875, 36876, 36877, 36878, 36879, 36880, 36881, 36882, 36883, 36884 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2798. The probes having the nucleotide sequence represented by SEQ ID NOS: 36885, 36886, 36887, 36888, 36889, 36890, 36891, 36892, 36893, 36894, 36895 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2799. The probes having the nucleotide sequence represented by SEQ ID NOS: 36896, 36897, 36898, 36899, 36900, 36901, 36902, 36903, 36904, 36905, 36906 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2800. The probes having the nucleotide sequence represented by SEQ ID NOS: 36907, 36908, 36909, 36910, 36911, 36912, 36913, 36914, 36915, 36916, 36917 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2801. The probes having the nucleotide sequence represented by SEQ ID NOS: 36918, 36919, 36920, 36921, 36922, 36923, 36924, 36925, 36926, 36927, 36928 were selected from the 624 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2802. The probes having the nucleotide sequence represented by SEQ ID NOS: 36929, 36930, 36931, 36932, 36933, 36934, 5 36935, 36936, 36937, 36938, 36939 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2803. The probes having the nucleotide sequence represented by SEQ ID NOS: 36940, 36941, 36942, 36943, 36944, 36945, 10 36946, 36947, 36948, 36949, 36950 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2804. The probes having the nucleotide sequence represented by SEQ ID NOS: 36951, 36952, 36953, 36954, 36955, 36956, 15 36957, 36958, 36959, 36960, 36961 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2805. The probes having the nucleotide sequence represented by SEQ ID NOS: 36962, 36963, 36964, 36965, 36966, 36967, 20 36968, 36969, 36970, 36971, 36972 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2806. The probes having the nucleotide sequence represented by SEQ ID NOS: 36973, 36974, 36975, 36976, 36977, 36978, 25 36979, 36980, 36981, 36982, 36983 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2807. 625 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 36984, 36985, 36986, 36987, 36988, 36989, 36990, 36991, 36992, 36993, 36994 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2808. The probes having the nucleotide sequence represented by SEQ ID NOS: 36995, 36996, 36997, 36998, 36999, 37000, 37001, 37002, 37003, 37004, 37005 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2809. The probes having the nucleotide sequence represented by SEQ ID NOS: 37006, 37007, 37008, 37009, 37010, 37011, 37012, 37013, 37014, 37015, 37016 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2810. The probes having the nucleotide sequence represented by SEQ ID NOS: 37017, 37018, 37019, 37020, 37021, 37022, 37023, 37024, 37025, 37026, 37027 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2811. The probes having the nucleotide sequence represented by SEQ ID NOS: 37028, 37029, 37030, 37031, 37032, 37033, 37034, 37035, 37036, 37037, 37038 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2812. The probes having the nucleotide sequence represented by SEQ ID NOS: 37039, 37040, 37041, 37042, 37043, 37044, 37045, 37046, 37047, 37048, 37049 were selected from the 626 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2813. The probes having the nucleotide sequence represented by SEQ ID NOS: 37050, 37051, 37052, 37053, 37054, 37055, 5 37056, 37057, 37058, 37059, 37060 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2814. The probes having the nucleotide sequence represented by SEQ ID NOS: 37061, 37062, 37063, 37064, 37065, 37066, 10 37067, 37068, 37069, 37070, 37071 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2815. The probes having the nucleotide sequence represented by SEQ ID NOS: 37072, 37073, 37074, 37075, 37076, 37077, 15 37078, 37079, 37080, 37081, 37082 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2816. The probes having the nucleotide sequence represented by SEQ ID NOS: 37083, 37084, 37085, 37086, 37087, 37088, 20 37089, 37090, 37091, 37092, 37093 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2817. The probes having the nucleotide sequence represented by SEQ ID NOS: 37094, 37095, 37096, 37097, 37098, 37099, 25 37100, 37101, 37102, 37103, 37104 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2818. 627 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 37105, 37106, 37107, 37108, 37109, 37110, 37111, 37112, 37113, 37114, 37115 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2819. The probes having the nucleotide sequence represented by SEQ ID NOS: 37116, 37117, 37118, 37119, 37120, 37121, 37122, 37123, 37124, 37125, 37126 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2820. The probes having the nucleotide sequence represented by SEQ ID NOS: 37127, 37128, 37129, 37130, 37131, 37132, 37133, 37134, 37135, 37136, 37137 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2821. .The probes having the nucleotide sequence represented by SEQ ID NOS: 37138, 37139, 37140, 37141, 37142, 37143, 37144, 37145, 37146, 37147, 37148 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2822. The probes having the nucleotide sequence represented by SEQ ID NOS: 37149, 37150, 37151, 37152, 37153, 37154, 37155, 37156, 37157, 37158, 37159 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2823. The probes having the nucleotide sequence represented by SEQ ID NOS: 37160, 37161, 37162, 37163, 37164, 37165, 37166, 37167, 37168, 37169, 37170 were selected from the 628 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2824. The probes having the nucleotide sequence represented by SEQ ID NOS: 37171, 37172, 37173, 37174, 37175, 37176, 5 37177, 37178, 37179, 37180, 37181 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2825. The probes having the nucleotide sequence represented by SEQ ID NOS: 37182, 37183, 37184, 37185, 37186, 37187, 10 37188, 37189, 37190, 37191, 37192 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2826. The probes having the nucleotide sequence represented by SEQ ID NOS: 37193, 37194, 37195, 37196, 37197, 37198, 15 37199, 37200, 37201, 37202, 37203 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2827. The probes having the nucleotide sequence represented by SEQ ID NOS: 37204, 37205, 37206, 37207, 37208, 37209, 20 37210, 37211, 37212, 37213, 37214 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2828. The probes having the nucleotide sequence represented by SEQ ID NOS: 37215, 37216, 37217, 37218, 37219, 37220, 25 37221, 37222, 37223, 37224, 37225 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2829. 629 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 37226, 37227, 37228, 37229, 37230, 37231, 37232, 37233, 37234, 37235, 37236 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2830. The probes having the nucleotide sequence represented by SEQ ID NOS: 37237, 37238, 37239, 37240, 37241, 37242, 37243, 37244, 37245, 37246, 37247 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2831. The probes having the nucleotide sequence represented by SEQ ID NOS: 37248, 37249, 37250, 37251, 37252, 37253, 37254, 37255, 37256, 37257, 37258 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2832. The probes having the nucleotide sequence represented by SEQ ID NOS: 37259, 37260, 37261, 37262, 37263, 37264, 37265, 37266, 37267, 37268, 37269 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2833. The probes having the nucleotide sequence represented by SEQ ID NOS: 37270., 37271, 37272, 37273, 37274, 37275, 37276, 37277, 37278, 37279, 37280 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2834. The probes having the nucleotide sequence represented by SEQ ID NOS: 37281, 37282, 37283, 37284, 37285, 37286, 37287, 37288, 37289, 37290, 37291 were selected from the 630 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2835. The probes having the nucleotide sequence represented by SEQ ID NOS: 37292, 37293, 37294, 37295, 37296, 37297, 5 37298, 37299, 37300, 37301, 37302 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2836. The probes having the nucleotide sequence represented by SEQ ID NOS: 37303, 37304, 37305, 37306, 37307, 37308, 10 37309, 37310, 37311, 37312, 37313 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2837. The probes having the nucleotide sequence represented by SEQ ID NOS: 37314, 37315, 37316, 37317, 37318, 37319, 15 37320, 37321, 37322, 37323, 37324 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2838. The probes having the nucleotide sequence represented by SEQ ID NOS: 37325, 37326, 37327, 37328, 37329, 37330, 20 37331, 37332, 37333, 37334, 37335 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2839. The probes having the nucleotide sequence represented by SEQ ID NOS: 37336, 37337, 37338, 37339, 37340, 37341, 25 37342, 37343, 37344, 37345, 37346 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2840. 631 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 37347, 37348, 37349, 37350, 37351, 37352, 37353, 37354, 37355, 37356, 37357 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2841. The probes having the nucleotide sequence represented by SEQ ID NOS: 37358, 37359, 37360, 37361, 37362, 37363, 37364, 37365, 37366, 37367, 37368 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2842. The probes having the nucleotide sequence represented by SEQ ID NOS: 37369, 37370, 37371, 37372, 37373, 37374, 37375, 37376, 37377, 37378, 37379 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2843. The probes having the nucleotide sequence represented by SEQ ID NOS: 37380, 37381, 37382, 37383, 37384, 37385, 37386, 37387, 37388, 37389, 37390 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2844. The probes having the nucleotide sequence represented by SEQ ID NOS: 37391, 37392, 37393, 37394, 37395, 37396, 37397, 37398, 37399, 37400, 37401 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2845. The probes having the nucleotide sequence represented by SEQ ID NOS: 37402, 37403, 37404, 37405, 37406, 37407, 37408, 37409, 37410, 37411, 37412 were selected from the 632 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2846. The probes having the nucleotide sequence represented by SEQ ID NOS: 37413, 37414, 37415, 37416, 37417, 37418, 5 37419, 37420, 37421, 37422, 37423 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2847. The probes having the nucleotide sequence represented by SEQ ID NOS: 37424, 37425, 37426, 37427, 37428, 37429, 10 37430, 37431, 37432, 37433, 37434 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2848. The probes having the nucleotide sequence represented by SEQ ID NOS: 37435, 37436, 37437, 37438, 37439, 37440, 15 37441, 37442, 37443, 37444, 37445 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2849. The probes having the nucleotide sequence represented by SEQ ID NOS: 37446, 37447, 37448, 37449, 37450, 37451, 20 37452, 37453, 37454, 37455, 37456 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2850. The probes having the nucleotide sequence represented by SEQ ID NOS: 37457, 37458, 37459, 37460, 37461, 37462, 25 37463, 37464, 37465, 37466, 37467 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2851. 633 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 37468, 37469, 37470, 37471, 37472, 37473, 37474, 37475, 37476, 37477, 37478 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2852. The probes having the nucleotide sequence represented by SEQ ID NOS: 37479, 37480, 37481, 37482, 37483, 37484, 37485, 37486, 37487, 37488, 37489 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2853. The probes having the nucleotide sequence represented by SEQ ID NOS: 37490, 37491, 37492, 37493, 37494, 37495, 37496, 37497, 37498, 37499, 37500 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2854. The probes having the nucleotide sequence represented by SEQ ID NOS: 37501, 37502, 37503, 37504, 37505, 37506, 37507, 37508, 37509, 37510, 37511 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2855. The probes having the nucleotide sequence representedby SEQ ID NOS: 37512, 37513, 37514, 37515, 37516, 37517, 37518, 37519, 37520, 37521, 37522 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2856. The probes having the nucleotide sequence represented by SEQ ID NOS: 37523, 37524, 37525, 37526, 37527, 37528, 37529, 37530, 37531, 37532, 37533 were selected from the 634 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2857. The probes having the nucleotide sequence represented by SEQ ID NOS: 37534, 37535, 37536, 37537, 37538, 37539, 5 37540, 37541, 37542, 37543, 37544 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2858. The probes having the nucleotide sequence represented by SEQ ID NOS: 37545, 37546, 37547, 37548, 37549, 37550, 10 37551, 37552, 37553, 37554, 37555 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2859. The probes having the nucleotide sequence represented by SEQ ID NOS: 37556, 37557, 37558, 37559, 37560, 37561, 15 37562, 37563, 37564, 37565, 37566 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2860. The probes having the nucleotide sequence represented by SEQ ID NOS: 37567, 37568, 37569, 37570, 37571, 37572, 20 37573, 37574, 37575, 37576, 37577 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2861. The probes having the nucleotide sequence represented by SEQ ID NOS: 37578, 37579, 37580, 37581, 37582, 37583, 25 37584, 37585, 37586, 37587, 37588 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2862. 635 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 37589, 37590, 37591, 37592, 37593, 37594, 37595, 37596, 37597, 37598, 37599 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2863. The probes having the nucleotide sequence represented by SEQ ID NOS: 37600, 37601, 37602, 37603, 37604, 37605, 37606, 37607, 37608, 37609, 37610 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2864. The probes having the nucleotide sequence represented by SEQ ID NOS: 37611, 37612, 37613, 37614, 37615, 37616, 37617, 37618, 37619, 37620, 37621 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2865. The probes having the nucleotide sequence represented by SEQ ID NOS: 37622, 37623, 37624, 37625, 37626, 37627, 37628, 37629, 37630, 37631, 37632 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2866. The probes having the nucleotide sequence represented by SEQ ID NOS: 37633, 37634, 37635, 37636, 37637, 37638, 37639, 37640, 37641, 37642, 37643 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2867. The probes having the nucleotide sequence represented by SEQ ID NOS: 37644, 37645, 37646, 37647, 37648, 37649, 37650, 37651, 37652, 37653, 37654 were selected from the 636 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2868. The probes having the nucleotide sequence represented by SEQ ID NOS: 37655, 37656, 37657, 37658, 37659, 37660, 5 37661, 37662, 37663, 37664, 37665 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2869. The probes having the nucleotide sequence represented by SEQ ID NOS: 37666, 37667, 37668, 37669, 37670, 37671, 10 37672, 37673, 37674, 37675, 37676 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2870. The probes having the nucleotide sequence represented by SEQ ID NOS: 37677, 37678, 37679, 37680, 37681, 37682, 15 37683, 37684, 37685, 37686, 37687 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2871. The probes having the nucleotide sequence represented by SEQ ID NOS: 37688, 37689, 37690, 37691, 37692, 37693, 20 37694, 37695, 37696, 37697, 37698 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2872. The probes having the nucleotide sequence represented by SEQ ID NOS: 37699, 37700, 37701, 37702, 37703, 37704, 25 37705, 37706, 37707, 37708, 37709 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2873. 637 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 37710, 37711, 37712, 37713, 37714, 37715, 37716, 37717, 37718, 37719, 37720 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2874. The probes having the nucleotide sequence represented by SEQ ID NOS: 37721, 37722, 37723, 37724, 37725, 37726, 37727, 37728, 37729, 37730, 37731 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2875. The probes having the nucleotide sequence represented by SEQ ID NOS: 37732, 37733, 37734, 37735, 37736, 37737, 37738, 37739, 37740, 37741, 37742 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2876. The probes having the nucleotide sequence represented by SEQ ID NOS: 37743, 37744, 37745, 37746, 37747, 37748, 37749, 37750, 37751, 37752, 37753 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2877. The probes having the nucleotide sequence represented by SEQ ID NOS: 37754, 37755, 37756, 37757, 37758, 37759, 37760, 37761, 37762, 37763, 37764 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2878. The probes having the nucleotide sequence represented by SEQ ID NOS: 37765, 37766, 37767, 37768, 37769, 37770, 37771, 37772, 37773, 37774, 37775 were selected from the 638 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2879. The probes having the nucleotide sequence represented by SEQ ID NOS: 37776, 37777, 37778, 37779, 37780, 37781, 5 37782, 37783, 37784, 37785, 37786 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2880. The probes having the nucleotide sequence represented by SEQ ID NOS: 37787, 37788, 37789, 37790, 37791, 37792, 10 37793, 37794, 37795, 37796, 37797 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2881. The probes having the nucleotide sequence represented by SEQ ID NOS: 37798, 37799, 37800, 37801, 37802, 37803, 15 37804, 37805, 37806, 37807, 37808 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2882. The probes having the nucleotide sequence represented by SEQ ID NOS: 37809, 37810, 37811, 37812, 37813, 37814, 20 37815, 37816, 37817, 37818, 37819 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2883. The probes having the nucleotide sequence represented by SEQ ID NOS: 37820, 37821, 37822, 37823, 37824, 37825, 25 37826, 37827, 37828, 37829, 37830 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2884. 639 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 37831, 37832, 37833, 37834, 37835, 37836, 37837, 37838, 37839, 37840, 37841 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2885. The probes having the nucleotide sequence represented by SEQ ID NOS: 37842, 37843, 37844, 37845, 37846, 37847, 37848, 37849, 37850, 37851, 37852 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2886. The probes having the nucleotide sequence represented by SEQ ID NOS: 37853, 37854, 37855, 37856, 37857, 37858, 37859, 37860, 37861, 37862, 37863 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2887. The probes having the nucleotide sequence represented by SEQ ID NOS: 37864, 37865, 37866, 37867, 37868, 37869, 37870, 37871, 37872, 37873, 37874 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2888. The probes having the nucleotide sequence represented by SEQ ID NOS: 37875, 37876, 37877, 37878, 37879, 37880, 37881, 37882, 37883, 37884, 37885 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2889. The probes having the nucleotide sequence represented by SEQ ID NOS: 37886, 37887, 37888, 37889, 37890, 37891, 37892, 37893, 37894, 37895, 37896 were selected from the 640 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2890. The probes having the nucleotide sequence represented by SEQ ID NOS: 37897, 37898, 37899, 37900, 37901, 37902, 5 37903, 37904, 37905, 37906, 37907 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2891. The probes having the nucleotide sequence represented by SEQ ID NOS: 37908, 37909, 37910, 37911, 37912, 37913, 10 37914, 37915, 37916, 37917, 37918 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2892. The probes having the nucleotide sequence represented by SEQ ID NOS: 37919, 37920, 37921, 37922, 37923, 37924, 15 37925, 37926, 37927, 37928, 37929 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2893. The probes having the nucleotide sequence represented by SEQ ID NOS: 37930, 37931, 37932, 37933, 37934, 37935, 20 37936, 37937, 37938, 37939, 37940 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2894. The probes having the nucleotide sequence represented by SEQ ID NOS: 37941, 37942, 37943, 37944, 37945, 37946, 25 37947, 37948, 37949, 37950, 37951 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2895. 641 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 37952, 37953, 37954, 37955, 37956, 37957, 37958, 37959, 37960, 37961, 37962 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2896. The probes having the nucleotide sequence represented by SEQ ID NOS: 37963, 37964, 37965, 37966, 37967, 37968, 37969, 37970, 37971, 37972, 37973, 37974, 37975, 37976, 37977, 37978, 37979, 37980, 37981, 37982, 37983, 37984 were 10 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2897. The probes having the nucleotide sequence represented by SEQ ID NOS: 37985, 37986, 37987, 37988, 37989, 37990, 37991, 37992, 37993, 37994, 37995 were selected from the 15 ORFs having the nucleotide sequence represented by SEQ ID NO: 2898. The probes having the nucleotide sequence represented by SEQ ID NOS: 37996, 37997, 37998, 37999, 38000, 38001, 38002, 38003, 38004, 38005, 38006 were selected from the 20 ORFs having the nucleotide sequence represented by SEQ ID NO: 2899. The probes having the nucleotide sequence represented by SEQ ID NOS: 38007, 38008, 38009, 38010, 38011, 38012, 38013, 38014, 38015, 38016, 38017 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 2900. The probes having the nucleotide sequence represented by SEQ ID NOS: 38018, 38019, 38020, 38021, 38022, 38023, 642 WO 2006/024951 PCT/IB2005/002908 38024, 38025, 38026, 38027, 38028 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2901. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 38029, 38030, 38031, 38032, 38033, 38034, 38035, 38036, 38037, 38038, 38039 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2902. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 38040, 38041, 38042, 38043, 38044, 38045, 38046, 38047, 38048, 38049, 38050 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2903. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 38051, 38052, 38053, 38054, 38055, 38056, 38057, 38058, 38059, 38060, 38061 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2904. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 38062, 38063, 38064, 38065, 38066, 38067, 38068, 38069, 38070, 38071, 38072 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2905. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 38073, 38074, 38075, 38076, 38077, 38078, 38079, 38080, 38081, 38082, 38083 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2906. 643 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 38084, 38085, 38086, 38087, 38088, 38089, 38090, 38091, 38092, 38093, 38094 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2907. The probes having the nucleotide sequence represented by SEQ ID NOS: 38095, 38096, 38097, 38098, 38099, 38100, 38101, 38102, 38103, 38104, 38105 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2908. The probes having the nucleotide sequence represented by SEQ ID NOS: 38106, 38107, 38108, 38109, 38110, 38111, 38112, 38113, 38114, 38115, 38116 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2909. The probes having the nucleotide sequence represented by SEQ ID NOS: 38117, 38118, 38119, 38120, 38121, 38122, 38123, 38124, 38125, 38126, 38127 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2910. The probes having the nucleotide sequence represented by SEQ ID NOS: 38128, 38129, 38130, 38131, 38132, 38133, 38134, 38135, 38136, 38137, 38138 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2911. The probes having the nucleotide sequence represented by SEQ ID NOS: 38139, 38140, 38141, 38142, 38143, 38144, 38145, 38146, 38147, 38148, 38149 were selected from the 644 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2912. The probes having the nucleotide sequence represented by SEQ ID NOS: 38150, 38151, 38152, 38153, 38154, 38155, 5 38156, 38157, 38158, 38159, 38160 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2913. The probes having the nucleotide sequence represented by SEQ ID NOS: 38161, 38162, 38163, 38164, 38165, 38166, 10 38167, 38168, 38169, 38170, 38171 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2914. The probes having the nucleotide sequence represented by SEQ ID NOS: 38172, 38173, 38174, 38175, 38176, 38177, 15 38178, 38179, 38180, 38181, 38182 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2915. The probes having the nucleotide sequence represented by SEQ ID NOS: 38183, 38184, 38185, 38186, 38187, 38188, 20 38189, 38190, 38191, 38192, 38193 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2916. The probes having the nucleotide sequence represented by SEQ ID NOS: 38194, 38195, 38196, 38197, 38198, 38199, 25 38200, 38201, 38202, 38203, 38204 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2917. 645 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 38205, 38206, 38207, 38208, 38209, 38210, 38211, 38212, 38213, 38214, 38215 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2918. The probes having the nucleotide sequence represented by SEQ ID NOS: 38216, 38217, 38218, 38219, 38220, 38221, 38222, 38223, 38224, 38225, 38226 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2919. The probes having the nucleotide sequence represented by SEQ ID NOS: 38227, 38228, 38229, 38230, 38231, 38232, 38233, 38234, 38235, 38236, 38237 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2920. The probes having the nucleotide sequence represented by SEQ ID NOS: 38238, 38239, 38240, 38241, 38242, 38243, 38244, 38245, 38246, 38247, 38248 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2921. The probes having the nucleotide sequence represented by SEQ ID NOS: 38249, 38250, 38251, 38252, 38253, 38254, 38255, 38256, 38257, 38258, 38259 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2922. The probes having the nucleotide sequence represented by SEQ ID NOS: 38260, 38261, 38262, 38263, 38264, 38265, 38266, 38267, 38268, 38269, 38270 were selected from the 646 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2923. The probes having the nucleotide sequence represented by SEQ ID NOS: 38271, 38272, 38273, 38274, 38275, 38276, 5 38277, 38278, 38279, 38280, 38281 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2924. The probes having the nucleotide sequence represented by SEQ ID NOS: 38282, 38283, 38284, 38285, 38286, 38287, 10 38288, 38289, 38290, 38291, 38292 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2925. The probes having the nucleotide sequence represented by SEQ ID NOS: 38293, 38294, 38295, 38296, 38297, 38298, 15 38299, 38300, 38301, 38302, 38303 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2926. The probes having the nucleotide sequence represented by SEQ ID NOS: 38304, 38305, 38306, 38307, 38308, 38309, 20 38310, 38311, 38312, 38313, 38314 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2927. The probes having the nucleotide sequence represented by SEQ ID NOS: 38315, 38316, 38317, 38318, 38319, 38320, 25 38321, 38322, 38323, 38324, 38325 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2928. 647 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 38326, 38327, 38328, 38329, 38330, 38331, 38332, 38333, 38334, 38335, 38336 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2929. The probes having the nucleotide sequence represented by SEQ ID NOS: 38337, 38338, 38339, 38340, 38341, 38342, 38343, 38344, 38345, 38346, 38347 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2930. The probes having the nucleotide sequence represented by SEQ ID NOS: 38348, 38349, 38350, 38351, 38352, 38353, 38354, 38355, 38356, 38357, 38358 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2931. The probes having the nucleotide sequence represented by SEQ ID NOS: 38359, 38360, 38361, 38362, 38363, 38364, 38365, 38366, 38367, 38368, 38369 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2932. The probes having the nucleotide sequence represented by SEQ ID NOS: 38370, 38371, 38372, 38373, 38374, 38375, 38376, 38377, 38378, 38379, 38380 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2933. The probes having the nucleotide sequence represented by SEQ ID NOS: 38381, 38382, 38383, 38384, 38385, 38386, 38387, 38388, 38389, 38390, 38391 were selected from the 648 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2934. The probes having the nucleotide sequence represented by SEQ ID NOS: 38392, 38393, 38394, 38395, 38396, 38397, 5 38398, 38399, 38400, 38401, 38402 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2935. The probes having the nucleotide sequence represented by SEQ ID NOS: 38403, 38404, 38405, 38406, 38407, 38408, 10 38409, 38410, 38411, 38412, 38413 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2936. The probes having the nucleotide sequence represented by SEQ ID NOS: 38414, 38415, 38416, 38417, 38418, 38419, 15 38420, 38421, 38422, 38423, 38424 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2937. The probes having the nucleotide sequence represented by SEQ ID NOS: 38425, 38426, 38427, 38428, 38429, 38430, 20 38431, 38432, 38433, 38434, 38435 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2938. The probes having the nucleotide sequence represented by SEQ ID NOS: 38436, 38437, 38438, 38439, 38440, 38441, 25 38442, 38443, 38444, 38445, 38446 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2939. 649 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 38447, 38448, 38449, 38450, 38451, 38452, 38453, 38454, 38455, 38456, 38457 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2940. The probes having the nucleotide sequence represented by SEQ ID NOS: 38458, 38459, 38460, 38461, 38462, 38463, 38464, 38465, 38466, 38467, 38468 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2941. The probes having the nucleotide sequence represented by SEQ ID NOS: 38469, 38470, 38471, 38472, 38473, 38474, 38475, 38476, 38477, 38478, 38479 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2942. The probes having the nucleotide sequence represented by SEQ ID NOS: 38480, 38481, 38482, 38483, 38484,. 38485, 38486, 38487, 38488, 38489, 38490 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2943. The probes having the nucleotide sequence represented by SEQ ID NOS: 38491, 38492, 38493, 38494, 38495, 38496, 38497, 38498, 38499, 38500, 38501 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2944. The probes having the nucleotide sequence represented by SEQ ID NOS: 38502, 38503, 38504, 38505, 38506, 38507, 38508, 38509, 38510, 38511, 38512 were selected from the 650 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2945. The probes having the nucleotide sequence represented by SEQ ID NOS: 38513, 38514, 38515, 38516, 38517, 38518, 5 38519, 38520, 38521, 38522, 38523 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2946. The probes having the nucleotide sequence represented by SEQ ID NOS: 38524, 38525, 38526, 38527, 38528, 38529, 10 38530, 38531, 38532, 38533, 38534 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2947. The probes having the nucleotide sequence represented by SEQ ID NOS: 38535, 38536, 38537, 38538, 38539, 38540, 15 38541, 38542, 38543, 38544, 38545 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2948. The probes having the nucleotide sequence represented by SEQ ID NOS: 38546, 38547, 38548, 38549, 38550, 38551, 20 38552, 38553, 38554, 38555, 38556 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2949. The probes having the nucleotide sequence represented by SEQ ID NOS: 38557, 38558, 38559, 38560, 38561, 38562, 25 38563, 38564, 38565, 38566, 38567 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2950. 651 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 38568, 38569, 38570, 38571, 38572, 38573, 38574, 38575, 38576, 38577, 38578 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2951. The probes having the nucleotide sequence represented by SEQ ID NOS: 38579, 38580, 38581, 38582, 38583, 38584, 38585, 38586, 38587, 38588, 38589 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2952. The probes having the nucleotide sequence represented by SEQ ID NOS: 38590, 38591, 38592, 38593, 38594, 38595, 38596, 38597, 38598, 38599, 38600 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2953. The probes having the nucleotide sequence represented by SEQ ID NOS: 38601, 38602, 38603, 38604, 38605, 38606, 38607, 38608, 38609, 38610, 38611 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2954. The probes having the nucleotide sequence represented by SEQ ID NOS: 38612, 38613, 38614, 38615, 38616, 38617, 38618, 38619, 38620, 38621, 38622 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2955. The probes having the nucleotide sequence represented by SEQ ID NOS: 38623, 38624, 38625, 38626, 38627, 38628, 38629, 38630, 38631, 38632, 38633 were selected from the 652 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2956. The probes having the nucleotide sequence represented by SEQ ID NOS: 38634, 38635, 38636, 38637, 38638, 38639, 5 38640, 38641, 38642, 38643, 38644 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2957. The probes having the nucleotide sequence represented by SEQ ID NOS: 38645, 38646, 38647, 38648, 38649, 38650, 10 38651, 38652, 38653, 38654, 38655 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2958. The probes having the nucleotide sequence represented by SEQ ID NOS: 38656, 38657, 38658, 38659, 38660, 38661, 15 38662, 38663, 38664, 38665, 38666 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2959. The probes having the nucleotide sequence represented by SEQ ID NOS: 38667, 38668, 38669, 38670, 38671, 38672, 20 38673, 38674, 38675, 38676, 38677 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2960. The probes having the nucleotide sequence represented by SEQ ID NOS: 38678, 38679, 38680, 38681, 38682, 38683, 25 38684, 38685, 38686, 38687, 38688 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2961. 653 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 38689, 38690, 38691, 38692, 38693, 38694, 38695, 38696, 38697, 38698, 38699 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2962. The probes having the nucleotide sequence represented by SEQ ID NOS: 38700, 38701, 38702, 38703, 38704, 38705, 38706, 38707, 38708, 38709, 38710 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2963. The probes having the nucleotide sequence represented by SEQ ID NOS: 38711, 38712, 38713, 38714, 38715, 38716, 38717, 38718, 38719, 38720, 38721 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2964. The probes having the nucleotide sequence represented by SEQ ID NOS: 38722, 38723, 38724, 38725, 38726, 38727, 38728, 38729, 38730, 38731, 38732 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2965. The probes having the nucleotide sequence represented by SEQ ID NOS: 38733, 38734, 38735, 38736, 38737, 38738, 38739, 38740, 38741, 38742, 38743 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2966. The probes having the nucleotide sequence represented by SEQ ID NOS: 38744, 38745, 38746, 38747, 38748, 38749, 38750, 38751, 38752, 38753, 38754 were selected from the 654 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2967. The probes having the nucleotide sequence represented by SEQ ID NOS: 38755, 38756, 38757, 38758, 38759, 38760, 5 38761, 38762, 38763, 38764, 38765 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2968. The probes having the nucleotide sequence represented by SEQ ID NOS: 38766, 38767, 38768, 38769, 38770, 38771, 10 38772, 38773, 38774, 38775, 38776 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2969. The probes having the nucleotide sequence represented by SEQ ID NOS: 38777, 38778, 38779, 38780, 38781, 38782, 15 38783, 38784, 38785, 38786, 38787 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2970. The probes having the nucleotide sequence represented by SEQ ID NOS: 38788, 38789, 38790, 38791, 38792, 38793, 20 38794, 38795, 38796, 38797, 38798 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2971. The probes having the nucleotide sequence represented by SEQ ID NOS: 38799, 38800, 38801, 38802, 38803, 38804, 25 38805, 38806, 38807, 38808, 38809 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2972. 655 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 38810, 38811, 38812, 38813, 38814, 38815, 38816, 38817, 38818, 38819, 38820 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2973. The probes having the nucleotide sequence represented by SEQ ID NOS: 38821, 38822, 38823, 38824, 38825, 38826, 38827, 38828, 38829, 38830, 38831 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2974. The probes having the nucleotide sequence represented by SEQ ID NOS: 38832, 38833, 38834, 38835, 38836, 38837, 38838, 38839, 38840, 38841, 38842 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2975. The probes having the nucleotide sequence represented by SEQ ID NOS: 38843, 38844, 38845, 38846, 38847, 38848, 38849, 38850, 38851, 38852, 38853 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2976. The probes having the nucleotide sequence represented by SEQ ID NOS: 38854, 38855, 38856, 38857, 38858, 38859, 38860, 38861, 38862, 38863, 38864 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2977. The probes having the nucleotide sequence represented by SEQ ID NOS: 38865, 38866, 38867, 38868, 38869, 38870, 38871, 38872, 38873, 38874, 38875 were selected from the 656

'

WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2978. The probes having the nucleotide sequence represented by SEQ ID NOS: 38876, 38877, 38878, 38879, 38880, 38881, 5 38882, 38883, 38884, 38885, 38886 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2979. The probes having the nucleotide sequence represented by SEQ ID NOS: 38887, 38888, 38889, 38890, 38891, 38892, 10 38893, 38894, 38895, 38896, 38897 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2980. The probes having the nucleotide sequence represented by SEQ ID NOS: 38898, 38899, 38900, 38901, 38902, 38903, 15 38904, 38905, 38906, 38907, 38908 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2981. The probes having the nucleotide sequence represented by SEQ ID NOS: 38909, 38910, 38911, 38912, 38913, 38914, 20 38915, 38916, 38917, 38918, 38919 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2982. The probes having the nucleotide sequence represented by SEQ ID NOS: 38920, 38921, 38922, 38923, 38924, 38925, 25 38926, 38927, 38928, 38929, 38930 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2983. 657 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 38931, 38932, 38933, 38934, 38935, 38936, 38937, 38938, 38939, 38940, 38941 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2984. The probes having the nucleotide sequence represented by SEQ ID NOS: 38942, 38943, 38944, 38945, 38946, 38947, 38948, 38949, 38950, 38951, 38952 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2985. The probes having the nucleotide sequence represented by SEQ ID NOS: 38953, 38954, 38955, 38956, 38957, 38958, 38959, 38960, 38961, 38962, 38963 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2986. The probes having the nucleotide sequence represented by SEQ ID NOS: 38964, 38965, 38966, 38967, 38968, 38969, 38970, 38971, 38972, 38973, 38974 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2987. The probes having the nucleotide sequence represented by SEQ ID NOS: 38975, 38976, 38977, 38978, 38979, 38980, 38981, 38982, 38983, 38984, 38985 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2988. The probes having the nucleotide sequence represented by SEQ ID NOS: 38986, 38987, 38988, 38989, 38990, 38991, 38992, 38993, 38994, 38995, 38996 were selected from the 658 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 2989. The probes having the nucleotide sequence represented by SEQ ID NOS: 38997, 38998, 38999, 39000, 39001, 39002, 5 39003, 39004, 39005, 39006, 39007 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2990. The probes having the nucleotide sequence represented by SEQ ID NOS: 39008, 39009, 39010, 39011, 39012, 39013, 10 39014, 39015, 39016, 39017, 39018 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2991. The probes having the nucleotide sequence represented by SEQ ID NOS: 39019, 39020, 39021, 39022, 39023, 39024, 15 39025, 39026, 39027, 39028, 39029 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2992. The probes having the nucleotide sequence represented by SEQ ID NOS: 39030, 39031, 39032, 39033, 39034, 39035, 20 39036, 39037, 39038, 39039, 39040 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2993. The probes having the nucleotide sequence represented by SEQ ID NOS: 39041, 39042, 39043, 39044, 39045, 39046, 25 39047, 39048, 39049, 39050, 39051 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 2994. 659 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 39052, 39053, 39054, 39055, 39056, 39057, 39058, 39059, 39060, 39061, 39062 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 2995. The probes having the nucleotide sequence represented by SEQ ID NOS: 39063, 39064, 39065, 39066, 39067, 39068, 39069, 39070, 39071, 39072, 39073 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 2996. The probes having the nucleotide sequence represented by SEQ ID NOS: 39074, 39075, 39076, 39077, 39078, 39079, 39080, 39081, 39082, 39083, 39084 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 2997. The probes having the nucleotide sequence represented by SEQ ID NOS: 39085, 39086, 39087, 39088, 39089, 39090, 39091, 39092, 39093, 39094, 39095 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 2998. The probes having the nucleotide sequence represented by SEQ ID NOS: 39096, 39097, 39098, 39099, 39100, 39101, 39102, 39103, 39104, 39105, 39106 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 2999. The probes having the nucleotide sequence represented by SEQ ID NOS: 39107, 39108, 39109, 39110, 39111, 39112, 39113, 39114, 39115, 39116, 39117 were selected from the 660 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3000. The probes having the nucleotide sequence represented by SEQ ID NOS: 39118, 39119, 39120, 39121, 39122, 39123, 5 39124, 39125, 39126, 39127, 39128 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3001. The probes having the nucleotide sequence represented by SEQ ID NOS: 39129, 39130, 39131, 39132, 39133, 39134, 10 39135, 39136, 39137, 39138, 39139 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3002. The probes having the nucleotide sequence represented by SEQ ID NOS: 39140, 39141, 39142, 39143, 39144, 39145, 15 39146, 39147, 39148, 39149, 39150 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3003. The probes having the nucleotide sequence represented by SEQ ID NOS: 39151, 39152, 39153, 39154, 39155, 39156, 20 39157, 39158, 39159, 39160, 39161 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3004. The probes having the nucleotide sequence represented by SEQ ID NOS: 39162, 39163, 39164, 39165, 39166, 39167, 25 39168, 39169, 39170, 39171, 39172 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3005. 661 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 39173, 39174, 39175, 39176, 39177, 39178, 39179, 39180, 39181, 39182, 39183 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3006. The probes having the nucleotide sequence represented by SEQ ID NOS: 39184, 39185, 39186, 39187, 39188, 39189, 39190, 39191, 39192, 39193, 39194 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3007. The probes having the nucleotide sequence represented by SEQ ID NOS: 39195, 39196, 39197, 39198, 39199, 39200, 39201, 39202, 39203, 39204, 39205 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3008. The probes having the nucleotide sequence represented by SEQ ID NOS: 39206, 39207, 39208, 39209, 39210, 39211, 39212, 39213, 39214, 39215, 39216 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3009. The probes having the nucleotide sequence represented by SEQ ID NOS: 39217, 39218, 39219, 39220, 39221, 39222, 39223, 39224, 39225, 39226, 39227 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3010. The probes having the nucleotide sequence represented by SEQ ID NOS: 39228, 39229, 39230, 39231, 39232, 39233, 39234, 39235, 39236, 39237, 39238 were selected from the 662 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence ,represented by SEQ ID NO: 3011. The probes having the nucleotide sequence represented by SEQ ID NOS: 39239, 39240, 39241, 39242, 39243, 39244, 5 39245, 39246, 39247, 39248, 39249 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3012. The probes having the nucleotide sequence represented by SEQ ID NOS: 39250, 39251, 39252, 39253, 39254, 39,255, 10 39256, 39257, 39258, 39259, 39260 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3013. The probes having the nucleotide sequence represented by SEQ ID NOS: 39261, 39262, 39263, 39264, 39265, 39266, 15 39267, 39268, 39269, 39270, 39271 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3014. The probes having the nucleotide sequence represented by SEQ ID NOS: 39272, 39273, 39274, 39275, 39276, 39277, 20 39278, 39279, 39280, 39281, 39282 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3015. The probes having the nucleotide sequence represented by SEQ ID NOS: 39283, 39284, 39285, 39286, 39287, 39288, 25 39289, 39290, 39291, 39292, 39293 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3016. 663 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 39294, 39295, 39296, 39297, 39298, 39299, 39300, 39301, 39302, 39303, 39304 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3017. The probes having the nucleotide sequence represented by SEQ ID NOS: 39305, 39306, 39307, 39308, 39309, 39310, 39311, 39312, 39313, 39314, 39315 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3018. The probes having the nucleotide sequence represented by SEQ ID NOS: 39316, 39317, 39318, 39319, 39320, 39321, 39322, 39323, 39324, 39325, 39326 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3019. The probes having the nucleotide sequence represented by SEQ ID NOS: 39327, 39328, 39329, 39330, 39331, 39332, 39333, 39334, 39335, 39336, 39337 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3020. The probes having the nucleotide sequence represented by SEQ ID NOS: 39338, 39339, 39340, 39341, 39342, 39343, 39344, 39345, 39346, 39347, 39348 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3021. The probes having the nucleotide sequence represented by SEQ ID NOS: 39349, 39350, 39351, 39352, 39353, 39354, 39355, 39356, 39357, 39358, 39359 were selected from the 664 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3022. The probes having the nucleotide sequence represented by SEQ ID NOS: 39360, 39361, 39362, 39363, 39364, 39365, 5 39366, 39367, 39368, 39369, 39370 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3023. The probes having the nucleotide sequence represented by SEQ ID NOS: 39371, 39372, 39373, 39374, 39375, 39376, 10 39377, 39378, 39379, 39380, 39381 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3024. The probes having the nucleotide sequence represented by SEQ ID NOS: 39382, 39383, 39384, 39385, 39386, 39387, 15 39388, 39389, 39390, 39391, 39392 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3025. The probes having the nucleotide sequence represented by SEQ ID NOS: 39393, 39394, 39395, 39396, 39397, 39398, 20 39399, 39400, 39401, 39402, 39403 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3026. The probes having the nucleotide sequence represented by SEQ ID NOS: 39404, 39405, 39406, 39407, 39408, 39409, 25 39410, 39411, 39412, 39413, 39414 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3027. 665 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 39415, 39416, 39417, 39418, 39419, 39420, 39421, 39422, 39423, 39424, 39425 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3028. The probes having the nucleotide sequence represented by SEQ ID NOS: 39426, 39427, 39428, 39429, 39430, 39431, 39432, 39433, 39434, 39435, 39436 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3029. The probes having the nucleotide sequence represented by SEQ ID NOS: 39437, 39438, 39439, 39440, 39441, 39442, 39443, 39444, 39445, 39446, 39447 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3030. The probes having the nucleotide sequence represented by SEQ ID NOS: 39448, 39449, 39450, 39451, 39452, 39453, 39454, 39455, 39456, 39457, 39458 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3031. The probes having the nucleotide sequence represented by SEQ ID NOS: 39459, 39460, 39461, 39462, 39463, 39464, 39465, 39466, 39467, 39468, 39469 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3032. The probes having the nucleotide sequence represented by SEQ ID NOS: 39470, 39471, 39472, 39473, 39474, 39475, 39476, 39477, 39478, 39479, 39480 were selected from the 666 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3033. The probes having the nucleotide sequence represented by SEQ ID NOS: 39481, 39482, 39483, 39484, 39485, 39486, 5 39487, 39488, 39489, 39490, 39491 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3034. The probes having the nucleotide sequence represented by SEQ ID NOS: 39492, 39493, 39494, 39495, 39496, 39497, 10 39498, 39499, 39500, 39501, 39502 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3035. The probes having the nucleotide.sequence represented by SEQ ID NOS: 39503, 39504, 39505, 39506, 39507, 39508, 15 39509, 39510, 39511, 39512, 39513 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3036. The probes having the nucleotide sequence represented by SEQ ID NOS: 39514, 39515, 39516, 39517, 39518, 39519, 20 39520, 39521, 39522, 39523, 39524 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3037. The probes having the nucleotide sequence represented by SEQ ID NOS: 39525, 39526, 39527, 39528, 39529, 39530, 25 39531, 39532, 39533, 39534, 39535 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3038. 667 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 39536, 39537, 39538, 39539, 39540, 39541, 39542, 39543, 39544, 39545, 39546 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3039. The probes having the nucleotide sequence represented by SEQ ID NOS: 39547, 39548, 39549, 39550, 39551, 39552, 39553, 39554, 39555, 39556, 39557 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3040. The probes having the nucleotide sequence represented by SEQ ID NOS: 39558, 39559, 39560, 39561, 39562, 39563, 39564, 39565, 39566, 39567, 39568 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3041. The probes having the nucleotide sequence represented by. SEQ ID NOS: 39569, 39570, 39571, 39572, 39573, 39574, 39575, 39576, 39577, 39578, 39579 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3042. The probes having the nucleotide sequence represented by SEQ ID NOS: 39580, 39581, 39582, 39583, 39584, 39585, 39586, 39587, 39588, 39589, 39590 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3043. The probes having the nucleotide sequence represented by SEQ ID NOS: 39591, 39592, 39593, 39594, 39595, 39596, 39597, 39598, 39599, 39600, 39601 were selected from the 668 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3044. The probes having the nucleotide sequence represented by SEQ ID NOS: 39602, 39603, 39604, 39605, 39606, 39607, 5 39608, 39609, 39610, 39611, 39612 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3045. The probes having the nucleotide sequence represented by SEQ ID NOS: 39613, 39614, 39615, 39616, 39617, 39618, 10 39619, 39620, 39621, 39622, 39623 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3046. The probes having the nucleotide sequence represented by SEQ ID NOS: 39624, 39625, 39626, 39627, 39628, 39629, 15 39630, 39631, 39632, 39633, 39634 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3047. The probes having the nucleotide sequence represented by SEQ ID NOS: 39635, 39636, 39637, 39638, 39639, 39640, 20 39641, 39642, 39643, 39644, 39645 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3048. The probes having the nucleotide sequence represented by SEQ ID NOS: 39646, 39647, 39648, 39649, 39650, 39651, 25 39652, 39653, 39654, 39655, 39656 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3049. 669 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 39657, 39658, 39659, 39660, 39661, 39662, 39663, 39664, 39665, 39666, 39667 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3050. The probes having the nucleotide sequence represented by SEQ ID NOS: 39668, 39669, 39670, 39671, 39672, 39673, 39674, 39675, 39676, 39677, 39678 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3051. The probes having the nucleotide sequence represented by SEQ ID NOS: 39679, 39680, 39681, 39682, 39683, 39684, 39685, 39686, 39687, 39688, 39689 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3052. The probes having the nucleotide sequence represented by SEQ ID NOS: 39690, 39691, 39692, 39693, 39694, 39695, 39696, 39697, 39698, 39699, 39700 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3053. The probes having the nucleotide sequence represented by SEQ ID NOS: 39701, 39702, 39703, 39704, 39705, 39706, 39707, 39708, 39709, 39710, 39711 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3054. The probes having the nucleotide sequence represented by SEQ ID NOS: 39712, 39713, 39714, 39715, 39716, 39717, 39718, 39719, 39720, 39721, 39722 were selected from the 670 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3055. The probes having the nucleotide sequence represented by SEQ ID NOS: 39723, 39724, 39725, 39726, 39727, 39728, 5 39729, 39730, 39731, 39732, 39733 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3056. The probes having the nucleotide sequence represented by SEQ ID NOS: 39734, 39735, 39736, 39737, 39738, 39739, 10 39740, 39741, 39742, 39743, 39744 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3057. The probes having the nucleotide sequence represented by SEQ ID NOS: 39745, 39746, 39747, 39748, 39749, 39750, 15 39751, 39752, 39753, 39754, 39755 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3058. The probes having the nucleotide sequence represented by SEQ ID NOS: 39756, 39757, 39758, 39759, 39760, 39761, 20 39762, 39763, 39764, 39765, 39766 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3059. The probes having the nucleotide sequence represented by SEQ ID NOS: 39767, 39768, 39769, 39770, 39771, 39772, 25 39773, 39774, 39775, 39776, 39777 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3060. 671 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 39778, 39779, 39780, 39781, 39782, 39783, 39784, 39785, 39786, 39787, 39788 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3061. The probes having the nucleotide sequence represented by SEQ ID NOS: 39789, 39790, 39791, 39792, 39793, 39794, 39795, 39796, 39797, 39798, 39799 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3062. The probes having the nucleotide sequence represented by SEQ ID NOS: 39800, 39801, 39802, 39803, 39804, 39805, 39806, 39807, 39808, 39809, 39810 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3063. The probes having the nucleotide sequence represented by SEQ ID NOS: 39811, 39812, 39813, 39814, 39815, 39816, 39817, 39818, 39819, 39820, 39821 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3064. The probes having the nucleotide sequence represented by SEQ ID NOS: 39822, 39823, 39824, 39825, 39826, 39827, 39828, 39829, 39830, 39831, 39832 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3065. The probes having the nucleotide sequence represented by SEQ ID NOS: 39833, 39834, 39835, 39836, 39837, 39838, 39839, 39840, 39841, 39842, 39843 were selected from the 672 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3066. The probes having the nucleotide sequence represented by SEQ ID NOS: 39844, 39845, 39846, 39847, 39848, 39849, 5 39850, 39851, 39852, 39853, 39854 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3067. The probes having the nucleotide sequence represented by SEQ ID NOS: 39855, 39856, 39857, 39858, 39859, 39860, 10 39861, 39862, 39863, 39864, 39865 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3068. The probes having the nucleotide sequence represented by SEQ ID NOS: 39866, 39867, 39868, 39869, 39870, 39871, 15 39872, 39873, 39874, 39875, 39876 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3069. The probes having the nucleotide sequence represented by SEQ ID NOS: 39877, 39878, 39879, 39880, 39881, 39882, 20 39883, 39884, 39885, 39886, 39887 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3070. The probes having the nucleotide sequence represented by SEQ ID NOS: 39888, 39889, 39890, 39891, 39892, 39893, 25 39894, 39895, 39896, 39897, 39898 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3071. 673 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 39899, 39900, 39901, 39902, 39903, 39904, 39905, 39906, 39907, 39908, 39909 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3072. The probes having the nucleotide sequence represented by SEQ ID NOS: 39910, 39911, 39912, 39913, 39914, 39915, 39916, 39917, 39918, 39919, 39920 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3073. The probes having the nucleotide sequence represented by SEQ ID NOS: 39921, 39922, 39923, 39924, 39925, 39926, 39927, 39928, 39929, 39930, 39931 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3074. The probes having the nucleotide sequence represented by SEQ ID NOS: 39932, 39933, 39934, 39935, 39936, 39937, 39938, 39939, 39940, 39941, 39942 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3075. The probes having the nucleotide sequence represented by SEQ ID NOS: 39943, 39944, 39945, 39946, 39947, 39948, 39949, 39950, 39951, 39952, 39953 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3076. The probes having the nucleotide sequence represented by SEQ ID NOS: 39954, 39955, 39956, 39957, 39958, 39959, 39960, 39961, 39962, 39963, 39964 were selected from the 674 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3077. The probes having the nucleotide sequence represented by SEQ ID NOS: 39965, 39966, 39967, 39968, 39969, 39970, 5 39971, 39972, 39973, 39974, 39975 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3078. The probes having the nucleotide sequence represented by SEQ ID NOS: 39976, 39977, 39978, 39979, 39980, 39981, 10 39982, 39983, 39984, 39985, 39986 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3079. The probes having the nucleotide sequence represented by SEQ ID NOS: 39987, 39988, 39989, 39990, 39991, 39992, 15 39993, 39994, 39995, 39996, 39997 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3080. The probes having the nucleotide sequence represented by SEQ ID NOS: 39998, 39999, 40000, 40001, 40002, 40003, 20 40004, 40005, 40006, 40007, 40008 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3081. The probes having the nucleotide sequence represented by SEQ ID NOS: 40009, 40010, 40011, 40012, 40013, 40014, 25 40015, 40016, 40017, 40018, 40019 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3082. 675 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 40020, 40021, 40022, 40023, 40024, 40025, 40026, 40027, 40028, 40029, 40030 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3083. The probes having the nucleotide sequence represented by SEQ ID NOS: 40031, 40032, 40033, 40034, 40035, 40036, 40037, 40038, 40039, 40040, 40041 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3084. The probes having the nucleotide sequence represented by SEQ ID NOS: 40042, 40043, 40044, 40045, 40046, 40047, 40048, 40049, 40050, 40051, 40052 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3085. The probes having the nucleotide sequence represented by SEQ ID NOS: 40053, 40054, 40055, 40056, 40057, 40058, 40059, 40060, 40061, 40062, 40063 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3086. The probes having the nucleotide sequence represented by SEQ ID NOS: 40064, 40065, 40066, 40067, 40068, 40069, 40070, 40071, 40072, 40073, 40074 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3087. The probes having the nucleotide sequence represented by SEQ ID NOS: 40075, 40076, 40077, 40078, 40079, 40080, 40081, 40082, 40083, 40084, 40085 were selected from the 676 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3088. The probes having the nucleotide sequence represented by SEQ ID NOS: 40086, 40087, 40088, 40089, 40090, 40091, 5 40092, 40093, 40094, 40095, 40096 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3089. The probes having the nucleotide sequence represented by SEQ ID NOS: 40097, 40098, 40099, 40100, 40101, 40102, 10 40103, 40104, 40105, 40106, 40107 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3090. The probes having the nucleotide sequence represented by SEQ ID NOS: 40108, 40109, 40110, 40111, 40112, 40113, 15 40114, 40115, 40116, 40117, 40118 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3091. The probes having the nucleotide sequence represented by SEQ ID NOS: 40119, 40120, 40121, 40122, 40123, 40124, 20 40125, 40126, 40127, 40128, 40129 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3092. The probes having the nucleotide sequence represented by SEQ ID NOS: 40130, 40131, 40132, 40133, 40134, 40135, 25 40136, 40137, 40138, 40139, 40140 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3093. 677 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 40141, 40142, 40143, 40144, 40145, 40146, 40147, 40148, 40149, 40150, 40151 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3094. The probes having the nucleotide sequence represented by SEQ ID NOS: 40152, 40153, 40154, 40155, 40156, 40157, 40158, 40159, 40160, 40161, 40162 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3095. The probes having the nucleotide sequence represented by SEQ ID NOS: 40163, 40164, 40165, 40166, 40167, 40168, 40169, 40170, 40171, 40172, 40173 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3096. The probes having the nucleotide sequence represented by SEQ ID NOS: 40174, 40175, 40176, 40177, 40178, 40179, 40180, 40181, 40182, 40183, 40184 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3097. The probes having the nucleotide sequence represented by SEQ ID NOS: 40185, 40186, 40187, 40188, 40189, 40190, 40191, 40192, 40193, 40194, 40195 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3098. The probes having the nucleotide sequence represented by SEQ ID NOS: 40196, 40197, 40198, 40199, 40200, 40201, 40202, 40203, 40204, 40205, 40206 were selected from the 678 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3099. The probes having the nucleotide sequence represented by SEQ ID NOS: 40207, 40208, 40209, 40210, 40211, 40212, 5 40213, 40214, 40215, 40216, 40217 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3100. The probes having the nucleotide sequence represented by SEQ ID NOS: 40218, 40219, 40220, 40221, 40222, 40223, 10 40224, 40225, 40226, 40227, 40228 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3101. The probes having the nucleotide sequence represented by SEQ ID NOS: 40229, 40230, 40231, 40232, 40233, 40234, 15 40235, 40236, 40237, 40238, 40239 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3102. The probes having the nucleotide sequence represented by SEQ ID NOS: 40240, 40241, 40242, 40243, 40244, 40245, 20 40246, 40247, 40248, 40249, 40250 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3103. The probes having the nucleotide sequence represented by SEQ ID NOS: 40251, 40252, 40253, 40254, 40255, 40256, 25 40257, 40258, 40259, 40260, 40261 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3104. 679 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 40262, 40263, 40264, 40265, 40266, 40267, 40268, 40269, 40270, 40271, 40272 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3105. The probes having the nucleotide sequence represented by SEQ ID NOS: 40273, 40274, 40275, 40276, 40277, 40278, 40279, 40280, 40281, 40282, 40283 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3106. The probes having the nucleotide sequence represented by SEQ ID NOS: 40284, 40285, 40286, 40287, 40288, 40289, 40290, 40291, 40292, 40293, 40294 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3107. The probes having the nucleotide sequence represented by SEQ ID NOS: 40295, 40296, 40297, 40298, 40299, 40300, 40301, 40302, 40303, 40304, 40305 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3108. The probes having the nucleotide sequence represented by SEQ ID NOS: 40306, 40307, 40308, 40309, 40310, 40311, 40312, 40313, 40314, 40315, 40316 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3109. The probes having the nucleotide sequence represented by SEQ ID NOS: 40317, 40318, 40319, 40320, 40321, 40322, 40323, 40324, 40325, 40326, 40327 were selected from the 680 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3110. The probes having the nucleotide sequence represented by SEQ ID NOS: 40328, 40329, 40330, 40331, 40332, 40333, 5 40334, 40335, 40336, 40337, 40338 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3111. The probes having the nucleotide sequence represented by SEQ ID NOS: 40339, 40340, 40341, 40342, 40343, 40344, 10 40345, 40346, 40347, 40348, 40349 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3112. The probes having the nucleotide sequence represented by SEQ ID NOS: 40350, 40351, 40352, 40353, 40354, 40355, 15 40356, 40357, 40358, 40359, 40360 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3113. The probes having the nucleotide sequence represented by SEQ ID NOS: 40361, 40362, 40363, 40364, 40365, 40366, 20 40367, 40368, 40369, 40370, 40371 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3114. The probes having the nucleotide sequence represented by SEQ ID NOS: 40372, 40373, 40374, 40375, 40376, 40377, 25 40378, 40379, 40380, 40381, 40382 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3115. 681 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 40383, 40384, 40385, 40386, 40387, 40388, 40389, 40390, 40391, 40392, 40393 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3116. The probes having the nucleotide sequence represented by SEQ ID NOS: 40394, 40395, 40396, 40397, 40398, 40399, 40400, 40401, 40402, 40403, 40404 were selected from the ORFs having the nucleotide sequence represented by SEQ .ID 10 NO: 3117. The probes having the nucleotide sequence represented by SEQ ID NOS: 40405, 40406, 40407, 40408, 40409, 40410, 40411, 40412, 40413, 40414, 40415 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3118. The probes having the nucleotide sequence represented by SEQ ID NOS: 40416, 40417, 40418, 40419, 40420, 40421, 40422, 40423, 40424, 40425, 40426 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3119. The probes having the nucleotide sequence represented by SEQ ID NOS: 40427, 40428, 40429, 40430, 40431, 40432, 40433, 40434, 40435, 40436, 40437 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3120. The probes having the nucleotide sequence represented by SEQ ID NOS: 40438, 40439, 40440, 40441, 40442, 40443, 40444, 40445, 40446, 40447, 40448 were selected from the 682 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3121. The 'probes having the nucleotide sequence represented by SEQ ID NOS: 40449, 40450, 40451, 40452, 40453, 40454, 5 40455, 40456, 40457, 40458, 40459 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3122. The probes having the nucleotide sequence represented by SEQ ID NOS: 40460, 40461, 40462, 40463, 40464, 40465, 10 40466, 40467, 40468, 40469, 40470 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3123. The probes having the nucleotide sequence represented by SEQ ID NOS: 40471, 40472, 40473, 40474, 40475, 40476, 15 40477, 40478, 40479, 40480, 40481 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3124. The probes having the nucleotide sequence represented by SEQ ID NOS: 40482, 40483, 40484, 40485, 40486, 40487, 20 40488, 40489, 40490, 40491, 40492 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3125. The probes having the nucleotide sequence represented by SEQ ID NOS: 40493, 40494, 40495, 40496, 40497, 40498, 25 40499, 40500, 40501, 40502, 40503 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3126. 683 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 40504, 40505, 40506, 40507, 40508, 40509, 40510, 40511, 40512, 40513, 40514 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3127. The probes having the nucleotide sequence represented by SEQ ID NOS: 40515, 40516, 40517, 40518, 40519, 40520, 40521, 40522, 40523, 40524, 40525 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3128. The probes having the nucleotide sequence represented by SEQ ID NOS: 40526, 40527, 40528, 40529, 40530, 40531, 40532, 40533, 40534, 40535, 40536 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3129. The probes having the nucleotide sequence represented by SEQ ID NOS: 40537, 40538, 40539, 40540, 40541, 40542, 40543, 40544, 40545, 40546, 40547 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3130. The probes having the nucleotide sequence represented by SEQ ID NOS: 40548, 40549, 40550, 40551, 40552, 40553, 40554, 40555, 40556, 40557, 40558 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3131. The probes having the nucleotide sequence represented by SEQ ID NOS: 40559, 40560, 40561, 40562, 40563, 40564, 40565, 40566, 40567, 40568, 40569 were selected from the 684 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3132. The probes having the nucleotide sequence represented by SEQ ID NOS: 40570, 40571, 40572, 40573, 40574, 40575, 5 40576, 40577, 40578, 40579, 40580 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3133. The probes having the nucleotide sequence represented by SEQ ID NOS: 40581, 40582, 40583, 40584, 40585, 40586, 10 40587, 40588, 40589, 40590, 40591 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3134. The probes having the nucleotide sequence represented by SEQ ID NOS: 40592, 40593, 40594, 40595, 40596, 40597, 15 40598, 40599, 40600, 40601, 40602 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3135. The probes having the nucleotide sequence represented by SEQ ID NOS: 40603, 40604, 40605, 40606, 40607, 40608, 20 40609, 40610, 40611, 40612, 40613 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3136. The probes having the nucleotide sequence represented by SEQ ID NOS: 40614, 40615, 40616, 40617, 40618, 40619, 25 40620, 40621, 40622, 40623, 40624 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3137. 685 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 40625, 40626, 40627, 40628, 40629, 40630, 40631, 40632, 40633, 40634, 40635 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3138. The probes having the nucleotide sequence represented by SEQ ID NOS: 40636, 40637, 40638, 40639, 40640, 40641, 40642, 40643, 40644, 40645, 40646 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3139. The probes having the nucleotide sequence represented by SEQ ID NOS: 40647, 40648, 40649, 40650, 40651, 40652, 40653, 40654, 40655, 40656, 40657 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3140. The probes having the nucleotide sequence represented by SEQ ID NOS: 40658, 40659, 40660, 40661, 40662, 40663, 40664, 40665, 40666, 40667, 40668 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3141. The probes having the nucleotide sequence represented by SEQ ID NOS: 40669, 40670, 40671, 40672, 40673, 40674, 40675, 40676, 40677, 40678, 40679 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3142. The probes having the nucleotide sequence represented by SEQ ID NOS: 40680, 40681, 40682, 40683, 40684,.40685, 40686, 40687, 40688, 40689, 40690 were selected from the 686 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3143. The probes having the nucleotide sequence represented by SEQ ID NOS: 40691, 40692, 40693, 40694, 40695, 40696, 5 40697, 40698, 40699, 40700, 40701 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3144. The probes having the nucleotide sequence represented by SEQ ID NOS: 40702, 40703, 40704, 40705, 40706, 40707, 10 40708, 40709, 40710, 40711, 40712 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3145. The probes having the nucleotide sequence represented by SEQ ID NOS: 40713, 40714, 40715, 40716, 40717, 40718, 15 40719, 40720, 40721, 40722, 40723 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3146. The probes having the nucleotide sequence represented by SEQ ID NOS: 40724, 40725, 40726, 40727, 40728, 40729, 20 40730, 40731, 40732, 40733, 40734 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3147. The probes having the nucleotide sequence represented by SEQ ID NOS: 40735, 40736, 40737, 40738, 40739, 40740, 25 40741, 40742, 40743, 40744, 40745 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3148. 687 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 40746, 40747, 40748, 40749, 40750, 40751, 40752, 40753, 40754, 40755, 40756 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3149. The probes having the nucleotide sequence represented by SEQ ID NOS: 40757, 40758, 40759, 40760, 40761, 40762, 40763, 40764, 40765, 40766, 40767 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3150. The probes having the nucleotide sequence represented by SEQ ID NOS: 40768, 40769, 40770, 40771, 40772, 40773, 40774, 40775, 40776, 40777, 40778 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3151. The probes having the nucleotide sequence represented by SEQ ID NOS: 40779, 40780, 40781, 40782, 40783, 40784, 40785, 40786, 40787, 40788, 40789 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3152. The probes having the nucleotide sequence represented by SEQ ID NOS: 40790, 40791, 40792, 40793, 40794, 40795, 40796, 40797, 40798, 40799, 40800 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3153. The probes having the nucleotide sequence represented by SEQ ID NOS: 40801, 40802, 40803, 40804, 40805, 40806, 40807, 40808, 40809, 40810, 40811 were selected from the 688 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3154. The probes having the nucleotide sequence represented by SEQ ID NOS: 40812, 40813, 40814, 40815, 40816, 40817, 5 40818, 40819, 40820, 40821, 40822 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3155. The probes having the nucleotide sequence represented by SEQ ID NOS: 40823, 40824, 40825, 40826, 40827, 40828, 10 40829, 40830, 40831, 40832, 40833 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3156. The probes having the nucleotide sequence represented by SEQ ID NOS: 40834, 40835, 40836, 40837, 40838, 40839, 15 40840, 40841, 40842, 40843, 40844 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3157. . The probes having the nucleotide sequence represented by SEQ ID NOS: 40845, 40846, 40847, 40848, 40849, 40850, 20 40851, 40852, 40853, 40854, 40855 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3158. The probes having the nucleotide sequence represented by SEQ ID NOS: 40856, 40857, 40858, 40859, 40860, 40861, 25 40862, 40863, 40864, 40865, 40866 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3159. 689 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 40867, 40868, 40869, 40870, 40871, 40872, 40873, 40874, 40875, 40876, 40877 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3160. The probes having the nucleotide sequence represented by SEQ ID NOS: 40878, 40879, 40880, 40881, 40882, 40883, 40884, 40885, 40886, 40887, 40888 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3161. The probes having the nucleotide sequence represented by SEQ ID NOS: 40889, 40890, 40891, 40892, 40893, 40894, 40895, 40896, 40897, 40898, 40899 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3162. The probes having the nucleotide sequence represented by SEQ ID NOS: 40900, 40901, 40902, 40903, 40904, 40905, 40906, 40907, 40908, 40909, 40910 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3163. The probes having the nucleotide sequence represented by SEQ ID NOS: 40911, 40912, 40913, 40914, 40915, 40916, 40917, 40918, 40919, 40920, 40921 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3164. The probes having the nucleotide sequence represented by SEQ ID NOS: 40922, 40923, 40924, 40925, 40926, 40927, 40928, 40929, 40930, 40931, 40932 were selected from the 690 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3165. The probes having the nucleotide sequence represented by SEQ ID NOS: 40933, 40934, 40935, 40936, 40937, 40938, 5 40939, 40940, 40941, 40942, 40943 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3166. The probes having the nucleotide sequence represented by SEQ ID NOS: 40944, 40945, 40946, 40947, 40948, 40949, 10 40950, 40951, 40952, 40953, 40954 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3167. The probes having the nucleotide sequence represented by SEQ ID NOS: 40955, 40956, 40957, 40958, 40959, 40960, 15 40961, 40962, 40963, 40964, 40965 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3168. The probes having the nucleotide sequence represented by SEQ ID NOS: 40966, 40967, 40968, 40969, 40970, 40971, 20 40972, 40973, 40974, 40975, 40976 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3169. The probes having the nucleotide sequence represented by SEQ ID NOS: 40977, 40978, 40979, 40980, 40981, 40982, 25 40983, 40984, 40985, 40986, 40987 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3170. 691 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 40988, 40989, 40990, 40991, 40992, 40993, 40994, 40995, 40996, 40997, 40998 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3171. The probes having the nucleotide sequence represented by SEQ ID NOS: 40999, 41000, 41001, 41002, 41003, 41004, 41005, 41006, 41007, 41008, 41009 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3172. The probes having the nucleotide sequence represented by SEQ ID NOS: 41010, 41011, 41012, 41013, 41014, 41015, 41016, 41017, 41018, 41019, 41020 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3173. The probes having the nucleotide sequence represented by SEQ ID NOS: 41021, 41022, 41023, 41024, 41025, 41026, 41027, 41028, 41029, 41030, 41031 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3174. The probes having the nucleotide sequence represented by SEQ ID NOS: 41032, 41033, 41034, 41035, 41036, 41037, 41038, 41039, 41040, 41041, 41042 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3175. The probes having the nucleotide sequence represented by SEQ ID NOS: 41043, 41044, 41045, 41046, 41047, 41048, 41049, 41050, 41051, 41052, 41053 were selected from the 692 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3176. The probes having the nucleotide sequence represented by SEQ ID NOS: 41054, 41055, 41056, 41057, 41058, 41059, 5 41060, 41061, 41062, 41063, 41064 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3177. The probes having the nucleotide sequence represented by SEQ ID NOS: 41065, 41066, 41067, 41068, 41069, 41070, 10 41071, 41072, 41073, 41074, 41075 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3178. The probes having the nucleotide sequence represented by SEQ ID NOS: 41076, 41077, 41078, 41079, 41080, 41081, 15 41082, 41083, 41084, 41085, 41086 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3179. The probes having the nucleotide sequence represented by SEQ ID NOS: 41087, 41088, 41089, 41090, 41091, 41092, 20 41093, 41094, 41095, 41096, 41097 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3180. The probes having the nucleotide sequence represented by SEQ ID NOS: 41098, 41099, 41100, 41101, 41102, 41103, 25 41104, 41105, 41106, 41107, 41108 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3181. 693 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 41109, 41110, 41111, 41112, 41113, 41114, 41115, 41116, 41117, 41118, 41119 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3182. The probes having the nucleotide sequence represented by SEQ ID NOS: 41120, 41121, 41122, 41123, 41124, 41125, 41126, 41127, 41128, 41129, 41130 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3183. The probes having the nucleotide sequence represented by SEQ ID NOS: 41131, 41132, 41133, 41134, 41135, 41136, 41137, 41138, 41139, 41140, 41141 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3184. The probes having the nucleotide sequence represented by SEQ ID NOS: 41142, 41143, 41144, 41145, 41146, 41147, 41148, 41149, 41150, 41151, 41152 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3185. The probes having the nucleotide sequence represented by SEQ ID NOS: 41153, 41154, 41155, 41156, 41157, 41158, 41159, 41160, 41161, 41162, 41163 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3186. The probes having the nucleotide sequence represented by SEQ ID NOS: 41164, 41165, 41166, 41167, 41168, 41169, 41170, 41171, 41172, 41173, 41174 were selected from the 694 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3187. The probes having the nucleotide sequence represented by SEQ ID NOS: 41175, 41176, 41177, 41178, 41179, 41180, 5 41181, 41182, 41183, 41184, 41185 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3188. The probes having the nucleotide sequence represented by SEQ ID NOS: 41186, 41187, 41188, 41189, 41190, 41191, 10 41192, 41193, 41194, 41195, 41196 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3189. The probes having the nucleotide sequence represented by SEQ ID NOS: 41197, 41198, 41199, 41200, 41201, 41202, 15 41203, 41204, 41205, 41206, 41207 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3190. The probes having the nucleotide sequence represented by SEQ ID NOS: 41208, 41209, 41210, 41211, 41212, 41213, 20 41214, 41215, 41216, 41217, 41218 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3191. The probes having the nucleotide sequence represented by SEQ ID NOS: 41219, 41220, 41221, 41222, 41223, 41224, 25 41225, 41226, 41227, 41228, 41229 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3192. 695 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 41230, 41231, 41232, 41233, 41234, 41235, 41236, 41237, 41238, 41239, 41240 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3193. The probes having the nucleotide sequence represented by SEQ ID NOS: 41241, 41242, 41243, 41244, 41245, 41246, 41247, 41248, 41249, 41250, 41251 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3194. The probes having the nucleotide sequence represented by SEQ ID NOS: 41252, 41253, 41254, 41255, 41256, 41257, 41258, 41259, 41260, 41261, 41262 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3195. The probes having the nucleotide sequence represented by SEQ ID NOS: 41263, 41264, 41265, 41266, 41267, 41268, 41269, 41270, 41271, 41272, 41273 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3196. The probes having the nucleotide sequence represented by SEQ ID NOS: 41274, 41275, 41276, 41277, 41278, 41279, 41280, 41281, 41282, 41283, 41284 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3197. The probes having the nucleotide sequence represented by SEQ ID NOS: 41285, 41286, 41287, 41288, 41289, 41290, 41291, 41292, 41293, 41294, 41295 were selected from the 696 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3198. The probes having the nucleotide sequence represented by SEQ ID NOS: 41296, 41297, 41298, 41299, 41300, 41301, 5 41302, 41303, 41304, 41305, 41306 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3199. The probes having the nucleotide sequence represented by SEQ ID NOS: 41307, 41308, 41309, 41310, 41311, 41312, 10 41313, 41314, 41315, 41316, 41317 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3200. The probes having the nucleotide sequence represented by SEQ ID NOS: 41318, 41319, 41320, 41321, 41322, 41323, 15 41324, 41325, 41326, 41327, 41328 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3201. The probes having the nucleotide sequence represented by SEQ ID NOS: 41329, 41330, 41331, 41332, 41333, 41334, 20 41335, 41336, 41337, 41338, 41339 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3202. The probes having the nucleotide sequence represented by SEQ ID NOS: 41340, 41341, 41342, 41343, 41344, 41345, 25 41346, 41347, 41348, 41349, 41350 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3203. 697 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 41351, 41352, 41353, 41354, 41355, 41356, 41357, 41358, 41359, 41360, 41361 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3204. The probes having the nucleotide sequence represented by SEQ ID NOS: 41362, 41363, 41364, 41365, 41366, 41367, 41368, 41369, 41370, 41371, 41372 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3205. The probes having the nucleotide sequence represented by SEQ ID NOS: 41373, 41374, 41375, 41376, 41377, 41378, 41379, 41380, 41381, 41382, 41383 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3206. The probes having the nucleotide sequence represented by SEQ ID NOS: 41384, 41385, 41386, 41387, 41388, 41389, 41390, 41391, 41392, 41393, 41394 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3207. The probes having the nucleotide sequence represented by SEQ ID NOS: 41395, 41396, 41397, 41398, 41399, 41400, 41401, 41402, 41403, 41404, 41405 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3208. The probes having the nucleotide sequence represented by SEQ ID NOS: 41406, 41407, 41408, 41409, 41410, 41411, 41412, 41413, 41414, 41415, 41416 were selected from the 698 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3209. The probes having the nucleotide sequence represented by SEQ ID NOS: 41417, 41418, 41419, 41420, 41421, 41422, 5 41423, 41424, 41425, 41426, 41427 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3210. The probes having the nucleotide sequence represented by SEQ ID NOS: 41428, 41429, 41430, 41431, 41432, 41433, 10 41434, 41435, 41436, 41437, 41438 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3211. The probes having the nucleotide sequence represented by SEQ ID NOS: 41439, 41440, 41441, 41442, 41443, 41444, 15 41445, 41446, 41447, 41448, 41449 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3212. The probes having the nucleotide sequence represented by SEQ ID NOS: 41450, 41451, 41452, 41453, 41454, 41455, 20 41456, 41457, 41458, 41459, 41460 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3213. The probes having the nucleotide sequence represented by SEQ ID NOS: 41461, 41462, 41463, 41464, 41465, 41466, 25 41467, 41468, 41469, 41470, 41471 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3214. 699 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 41472, 41473, 41474, 41475, 41476, 41477, 41478, 41479, 41480, 41481, 41482 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3215. The probes having the nucleotide sequence represented by SEQ ID NOS: 41483, 41484, 41485, 41486, 41487, 41488, 41489, 41490, 41491, 41492, 41493 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3216. The probes having the nucleotide sequence represented by SEQ ID NOS: 41494, 41495, 41496, 41497, 41498, 41499, 41500, 41501, 41502, 41503, 41504 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3217. The probes having the nucleotide sequence represented by SEQ ID NOS: 41505, 41506, 41507, 41508, 41509, 41510, 41511, 41512, 41513, 41514, 41515 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3218. The probes having the nucleotide sequence represented by SEQ ID NOS: 41516, 41517, 41518, 41519, 41520, 41521, 41522, 41523, 41524, 41525, 41526 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3219. The probes having the nucleotide sequence represented by SEQ ID NOS: 41527, 41528, 41529, 41530, 41531, 41532, 41533, 41534, 41535, 41536, 41537 were selected from the 700 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3220. The probes having the nucleotide sequence represented by SEQ ID NOS: 41538, 41539, 41540, 41541, 41542, 41543, 5 41544, 41545, 41546, 41547, 41548 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3221. The probes having the nucleotide sequence represented by SEQ ID NOS: 41549, 41550, 41551, 41552, 41553, 41554, 10 41555, 41556, 41557, 41558, 41559 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3222. The probes having the nucleotide sequence represented by SEQ ID NOS: 41560, 41561, 41562, 41563, 41564, 41565, 15 41566, 41567, 41568, 41569, 41570 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3223. The probes having the nucleotide sequence represented by SEQ ID NOS: 41571, 41572, 41573, 41574, 41575, 41576, 20 41577, 41578, 41579, 41580, 41581 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3224. The probes having the nucleotide sequence represented by SEQ ID NOS: 41582, 41583, 41584, 41585, 41586, 41587, 25 41588, 41589, 41590, 41591, 41592 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3225. 701 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 41593, 41594, 41595, 41596, 41597, 41598, 41599, 41600, 41601, 41602, 41603 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3226. The probes having the nucleotide sequence represented by SEQ ID NOS: 41604, 41605, 41606, 41607, 41608, 41609, 41610, 41611, 41612, 41613, 41614 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3227. The probes having the nucleotide sequence represented by SEQ ID NOS: 41615, 41616, 41617, 41618, 41619, 41620, 41621, 41622, 41623, 41624, 41625 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3228. The probes having the nucleotide sequence represented by SEQ ID NOS: 41626, 41627, 41628, 41629, 41630, 41631, 41632, 41633, 41634, 41635, 41636 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3229. The probes having the nucleotide sequence represented by SEQ ID NOS: 41637, 41638, 41639, 41640, 41641, 41642, 41643, 41644, 41645, 41646, 41647 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3230. The probes having the nucleotide sequence represented by SEQ ID NOS: 41648, 41649, 41650, 41651, 41652, 41653, 41654, 41655, 41656, 41657, 41658 were selected from the 702 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3231. The probes having the nucleotide sequence represented by SEQ ID NOS: 41659, 41660, 41661, 41662, 41663, 41664, 5 41665, 41666, 41667, 41668, 41669 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3232. The probes having the nucleotide sequence represented by SEQ ID NOS: 41670, 41671, 41672, 41673, 41674, 41675, 10 41676, 41677, 41678, 41679, 41680 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3233. The probes having the nucleotide sequence represented by SEQ ID NOS: 41681, 41682, 41683, 41684, 41685, 41686, 15 41687, 41688, 41689, 41690, 41691 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3234. The probes having the nucleotide sequence represented by SEQ ID NOS: 41692, 41693, 41694, 41695, 41696, 41697, 20 41698, 41699, 41700, 41701, 41702 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3235. The probes having the nucleotide sequence represented by SEQ ID NOS: 41703, 41704, 41705, 41706, 41707, 41708, 25 41709, 41710, 41711, 41712, 41713 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3236. 703 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 41714, 41715, 41716, 41717, 41718, 41719, 41720, 41721, 41722, 41723, 41724 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3237. The probes having the nucleotide sequence represented by SEQ ID NOS: 41725, 41726, 41727, 41728, 41729, 41730, 41731, 41732, 41733, 41734, 41735 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3238. The probes having the nucleotide sequence represented by SEQ ID NOS: 41736, 41737, 41738, 41739, 41740, 41741, 41742, 41743, 41744, 41745, 41746 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3239. The probes having the nucleotide sequence represented by SEQ ID NOS: 41747, 41748, 41749, 41750, 41751, 41752, 41753, 41754, 41755, 41756, 41757 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3240. The probes having the nucleotide sequence represented by SEQ ID NOS: 41758, 41759, 41760, 41761, 41762, 41763, 41764, 41765, 41766, 41767, 41768 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3241. The probes having the nucleotide sequence represented by SEQ ID NOS: 41769, 41770, 41771, 41772, 41773, 41774, 41775, 41776, 41777, 41778, 41779 were selected from the 704 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3242. The probes having the nucleotide sequence represented by SEQ ID NOS: 41780, 41781, 41782, 41783, 41784, 41785, 5 41786, 41787, 41788, 41789, 41790 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3243. The probes having the nucleotide sequence represented by SEQ ID NOS: 41791, 41792, 41793, 41794, 41795, 41796, 10 41797, 41798, 41799, 41800, 41801 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3244. The probes having the nucleotide sequence represented by SEQ ID NOS: 41802, 41803, 41804, 41805, 41806, 41807, 15 41808, 41809, 41810, 41811, 41812 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3245. The probes having the nucleotide sequence represented by SEQ ID NOS: 41813, 41814, 41815, 41816, 41817, 41818, 20 41819, 41820, 41821, 41822, 41823 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3246. The probes having the nucleotide sequence represented by SEQ ID NOS: 41824, 41825, 41826, 41827, 41828, 41829, 25 41830, 41831, 41832, 41833, 41834 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3247. 705 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 41835, 41836, 41837, 41838, 41839, 41840, 41841, 41842, 41843, 41844, 41845 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3248. The probes having the nucleotide sequence represented by SEQ ID NOS: 41846, 41847, 41848, 41849, 41850, 41851, 41852, 41853, 41854, 41855, 41856 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3249. The probes having the nucleotide sequence represented by SEQ ID NOS: 41857, 41858, 41859, 41860, 41861, 41862, 41863, 41864, 41865, 41866, 41867 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3250. The probes having the nucleotide sequence represented by SEQ ID NOS: 41868, 41869, 41870, 41871, 41872, 41873, 41874, 41875, 41876, 41877, 41878 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3251. The probes having the nucleotide sequence represented by SEQ ID NOS: 41879, 41880, 41881, 41882, 41883, 41884, 41885, 41886, 41887, 41888, 41889 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3252. The probes having the nucleotide sequence represented by SEQ ID NOS: 41890, 41891, 41892, 41893, 41894, 41895, 41896, 41897, 41898, 41899, 41900 were selected from the 706 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3253. The probes having the nucleotide sequence represented by SEQ ID NOS: 41901, 41902, 41903, 41904, 41905, 41906, 5 41907, 41908, 41909, 41910, 41911 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3254. The probes having the nucleotide sequence represented by SEQ ID NOS: 41912, 41913, 41914, 41915, 41916, 41917, 10 41918, 41919, 41920, 41921, 41922 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3255. The probes having the nucleotide sequence represented by SEQ ID NOS: 41923, 41924, 41925, 41926, 41927, 41928, 15 41929, 41930, 41931, 41932, 41933 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3256. The probes having the nucleotide sequence represented by SEQ ID NOS: 41934, 41935, 41936, 41937, 41938, 41939, 20 41940, 41941, 41942, 41943, 41944 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3257. The probes having the nucleotide sequence represented by SEQ ID NOS: 41945, 41946, 41947, 41948, 41949, 41950, 25 41951, 41952, 41953, 41954, 41955 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3258. 707 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 41956, 41957, 41958, 41959, 41960, 41961, 41962, 41963, 41964, 41965, 41966 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3259. The probes having the nucleotide sequence represented by SEQ ID NOS: 41967, 41968, 41969, 41970, 41971, 41972, 41973, 41974, 41975, 41976, 41977 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3260. The probes having the nucleotide sequence represented by SEQ ID NOS: 41978, 41979, 41980, 41981, 41982, 41983, 41984, 41985, 41986, 41987, 41988 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3261. The probes having the nucleotide sequence represented by SEQ ID NOS: 41989, 41990, 41991, 41992, 41993, 41994, 41995, 41996, 41997, 41998, 41999 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3262. The probes having the nucleotide sequence represented by SEQ ID NOS: 42000, 42001, 42002, 42003, 42004, 42005, 42006, 42007, 42008, 42009, 42010 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3263. The probes having the nucleotide sequence represented by SEQ ID NOS: 42011, 42012, 42013, 42014, 42015, 42016, 42017, 42018, 42019, 42020, 42021 were selected from the 708 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3264. The probes having the nucleotide sequence represented by SEQ ID NOS: 42022, 42023, 42024, 42025, 42026, 42027, 5 42028, 42029, 42030, 42031, 42032 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3265. The probes having the nucleotide sequence represented by SEQ ID NOS: 42033, 42034, 42035, 42036, 42037, 42038, 10 42039, 42040, 42041, 42042, 42043 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3266. The probes having the nucleotide sequence represented by SEQ ID NOS: 42044, 42045, 42046, 42047, 42048, 42049, 15 42050, 42051, 42052, 42053, 42054 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3267. The probes having the nucleotide sequence represented by SEQ ID NOS: 42055, 42056, 42057, 42058, 42059, 42060, 20 42061, 42062, 42063, '42064, 42065 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3268. The probes having the nucleotide sequence represented by SEQ ID NOS: 42066, 42067, 42068, 42069, 42070, 42071, 25 42072, 42073, 42074, 42075, 42076 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3269. 709 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 42077, 42078, 42079, 42080, 42081, 42082, 42083, 42084, 42085, 42086, 42087 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3270. The probes having the nucleotide sequence represented by SEQ ID NOS: 42088, 42089, 42090, 42091, 42092, 42093, 42094, 42095, 42096, 42097, 42098 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3271. The probes having the nucleotide sequence represented by SEQ ID NOS: 42099, 42100, 42101, 42102, 42103, 42104, 42105, 42106, 42107, 42108, 42109 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3272. The probes having the nucleotide sequence represented by SEQ ID NOS: 42110, 42111, 42112, 42113, 42114, 42115, 42116, 42117, 42118, 42119, 42120 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3273. The probes having the nucleotide sequence represented by SEQ ID NOS: 42121, 42122, 42123, 42124, 42125, 42126, 42127, 42128, 42129, 42130, 42131 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3274. The probes having the nucleotide sequence represented by SEQ ID NOS: 42132, 42133, 42134, 42135, 42136, 42137, 42138, 42139, 42140, 42141, 42142 were selected from the 710 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3275. The probes having the nucleotide sequence represented by SEQ ID NOS: 42143, 42144, 42145, 42146, 42147, 42148, 5 42149, 42150, 42151, 42152, 42153 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3276. The probes having the nucleotide sequence represented by SEQ ID NOS: 42154, 42155, 42156, 42157, 42158, 42159, 10 42160, 42161, 42162, 42163, 42164 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3277. The probes having the nucleotide sequence represented by SEQ ID NOS: 42165, 42166, 42167, 42168, 42169, 42170, 15 42171, 42172, 42173, 42174, 42175 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3278. The probes having the nucleotide sequence represented by SEQ ID NOS: 42176, 42177, 42178, 42179, 42180, 42181, 20 42182, 42183, 42184, 42185, 42186 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3279. The probes having the nucleotide sequence represented by SEQ ID NOS: 42187, 42188, 42189, 42190, 42191, 42192, 25 42193, 42194, 42195, 42196, 42197 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3280. 711 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 42198, 42199, 42200, 42201, 42202, 42203, 42204, 42205, 42206, 42207, 42208 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3281. The probes having the nucleotide sequence represented by SEQ ID NOS: 42209, 42210, 42211, 42212, 42213, 42214, 42215, 42216, 42217, 42218, 42219 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3282. The probes having the nucleotide sequence represented by SEQ ID NOS: 42220, 42221, 42222, 42223, 42224, 42225, 42226, 42227, 42228, 42229, 42230 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3283. The probes having the nucleotide sequence represented by SEQ ID NOS: 42231, 42232, 42233, 42234, 42235, 42236, 42237, 42238, 42239, 42240, 42241 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3284. The probes having the nucleotide sequence represented by SEQ ID NOS: 42242, 42243, 42244, 42245, 42246, 42247, 42248, 42249, 42250, 42251, 42252 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3285. The probes having the nucleotide sequence represented by SEQ ID NOS: 42253, 42254, 42255, 42256, 42257, 42258, 42259, 42260, 42261, 42262, 42263 were selected from the 712 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3286. The probes having the nucleotide sequence represented by SEQ ID NOS: 42264, 42265, 42266, 42267, 42268, 42269, 5 42270, 42271, 42272, 42273, 42274 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3287. The probes having the nucleotide sequence represented by SEQ ID NOS: 42275, 42276, 42277, 42278, 42279, 42280, 10 42281, 42282, 42283, 42284, 42285 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3288. The probes having the nucleotide sequence represented by SEQ ID NOS: 42286, 42287, 42288, 42289, 42290, 42291, 15 42292, 42293, 42294, 42295, 42296 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3289. The probes having the nucleotide sequence represented by SEQ ID NOS: 42297, 4229,8, 42299, 42300, 42301, 42302, 20 42303, 42304, 42305, 42306, 42307 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3290. The probes having the nucleotide sequence represented by SEQ ID NOS: 42308, 42309, 42310, 42311, 42312, 42313, 25 42314, 42315, 42316, 42317, 42318 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3291. 713 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 42319, 42320, 42321, 42322, 42323, 42324, 42325, 42326, 42327, 42328, 42329 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3292. The probes having the nucleotide sequence represented by SEQ ID NOS: 42330, 42331, 42332, 42333, 42334, 42335, 42336, 42337, 42338, 42339, 42340 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3293. The probes having the nucleotide sequence represented by SEQ ID NOS: 42341, 42342, 42343, 42344, 42345, 42346, 42347, 42348, 42349, 42350, 42351 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3294. The probes having the nucleotide sequence represented by SEQ ID NOS: 42352, 42353, 42354, 42355, 42356, 42357, 42358, 42359, 42360, 42361, 42362 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3295. The probes having the nucleotide sequence represented by SEQ ID NOS: 42363, 42364, 42365, 42366, 42367, 42368, 42369, 42370, 42371, 42372, 42373 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3296. The probes having the nucleotide sequence represented by SEQ ID NOS: 42374, 42375, 42376, 42377, 42378, 42379, 42380, 42381, 42382, 42383, 42384 were selected from the 714 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3297. The probes having the nucleotide sequence represented by SEQ ID NOS: 42385, 42386, 42387, 42388, 42389, 42390, 5 42391, 42392, 42393, 42394, 42395 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3298. The probes having the nucleotide sequence represented by SEQ ID NOS: 42396, 42397, 42398, 42399, 42400, 42401, 10 42402, 42403, 42404, 42405, 42406 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3299. The probes having the nucleotide sequence represented by SEQ ID NOS: 42407, 42408, 42409, 42410, 42411, 42412, 15 42413, 42414, 42415, 42416, 42417 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3300. The probes having the nucleotide sequence represented by SEQ ID NOS: 42418, 42419, 42420, 42421, 42422, 42423, 20 42424, 42425, 42426, 42427, 42428 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3301. The probes having the nucleotide sequence represented by SEQ ID NOS: 42429, 42430, 42431, 42432, 42433, 42434, 25 42435, 42436, 42437, 42438, 42439 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3302. 715 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 42440, 42441, 42442, 42443, 42444, 42445, 42446, 42447, 42448, 42449, 42450 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3303. The probes having the nucleotide sequence represented by SEQ ID NOS: 42451, 42452, 42453, 42454, 42455, 42456, 42457, 42458, 42459, 42460, 42461 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3304. The probes having the nucleotide sequence represented by SEQ ID NOS: 42462, 42463, 42464, 42465, 42466, 42467, 42468, 42469, 42470, 42471, 42472 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3305. The probes having the nucleotide sequence represented by SEQ ID NOS: 42473, 42474, 42475, 42476, 42477, 42478, 42479, 42480, 42481, 42482, 42483 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3306. The probes having the nucleotide sequence represented by SEQ ID NOS: 42484, 42485, 42486, 42487, 42488, 42489, 42490, 42491, 42492, 42493, 42494 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3307. The probes having the nucleotide sequence represented by SEQ ID NOS: 42495, 42496, 42497, 42498, 42499, 42500, 42501, 42502, 42503, 42504, 42505 were selected from the 716 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3308. The probes having the nucleotide sequence represented by SEQ ID NOS: 42506, 42507, 42508, 42509, 42510, 42511, 5 42512, 42513, 42514, 42515, 42516 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3309. The probes having the nucleotide sequence represented by SEQ ID NOS: 42517, 42518, 42519, 42520, 42521, 42522, 10 42523, 42524, 42525, 42526, 42527 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3310. The probes having the nucleotide sequence represented by SEQ ID NOS: 42528, 42529, 42530, 42531, 42532, 42533, 15 42534, 42535, 42536, 42537, 42538 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3311. The probes having the nucleotide sequence represented by SEQ ID NOS: 42539, 42540, 42541, 42542, 42543, 42544, 20 42545, 42546, 42547, 42548, 42549 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3312. The probes having the nucleotide sequence represented by SEQ ID NOS: 42550, 42551, 42552, 42553, 42554, 42555, 25 42556, 42557, 42558, 42559, 42560 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3313. 717 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 42561, 42562, 42563, 42564, 42565, 42566, 42567, 42568, 42569, 42570, 42571 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3314. The probes having the nucleotide sequence represented by SEQ ID NOS: 42572, 42573, 42574, 42575, 42576, 42577, 42578, 42579, 42580, 42581, 42582 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3315. The probes having the nucleotide sequence represented by SEQ ID NOS: 42583, 42584, 42585, 42586, 42587, 42588, 42589, 42590, 42591, 42592, 42593 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3316. The probes having the nucleotide sequence represented by SEQ ID NOS: 42594, 42595, 42596, 42597, 42598, 42599, 42600, 42601, 42602, 42603, 42604 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3317. The probes having the nucleotide sequence represented by SEQ ID NOS: 42605, 42606, 42607, 42608, 42609, 42610, 42611, 42612, 42613, 42614, 42615 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3318. The probes having the nucleotide sequence represented by SEQ ID NOS: 42616, 42617, 42618, 42619, 42620, 42621, 42622, 42623, 42624, 42625, 42626 were selected from the 718 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3319. The probes having the nucleotide sequence represented by SEQ ID NOS: 42627, 42628, 42629, 42630, 42631, 42632, 5 42633, 42634, 42635, 42636, 42637 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3320. The probes having the nucleotide sequence represented by SEQ ID NOS: 42638, 42639, 42640, 42641, 42642, 42643, 10 42644, 42645, 42646, 42647, 42648 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3321. The probes having the nucleotide sequence represented by SEQ ID NOS: 42649, 42650, 42651, 42652, 42653, 42654, 15 42655, 42656, 42657, 42658, 42659 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3322. The probes having the nucleotide sequence represented by SEQ ID NOS: 42660, 42661, 42662, 42663, 42664, 42665, 20 42666, 42667, 42668, 42669, 42670 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3323. The probes having the nucleotide sequence represented by SEQ ID NOS: 42671, 42672, 42673, 42674, 42675, 42676, 25 42677, 42678, 42679, 42680, 42681 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3324. 719 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 42682, 42683, 42684, 42685, 42686, 42687, 42688, 42689, 42690, 42691, 42692 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3325. The probes having the nucleotide sequence represented by SEQ ID NOS: 42693, 42694, 42695, 42696, 42697, 42698, 42699, 42700, 42701, 42702, 42703 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3326. The probes having the nucleotide sequence represented by SEQ ID NOS: 42704, 42705, 42706, 42707, 42708, 42709, 42710, 42711, 42712, 42713, 42714 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3327. The probes having the nucleotide sequence represented by SEQ ID NOS: 42715, 42716, 42717, 42718, 42719, 42720, 42721, 42722, 42723, 42724, 42725 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3328. The probes having the nucleotide sequence represented by SEQ ID NOS: 42726, 42727, 42728, 42729, 42730, 42731, 42732, 42733, 42734, 42735, 42736 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3329. The probes having the nucleotide sequence represented by SEQ ID NOS: 42737, 42738, 42739, 42740, 42741, 42742, 42743, 42744, 42745, 42746, 42747 were selected from the 720 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3330. The probes having the nucleotide sequence represented by SEQ ID NOS: 42748, 42749, 42750, 42751, 42752, 42753, 5 42754, 42755, 42756, 42757, 42758 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3331. The probes having the nucleotide sequence represented by SEQ ID NOS: 42759, 42760, 42761, 42762, 42763, 42764, 10 42765, 42766, 42767, 42768, 42769 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3332. The probes having the nucleotide sequence represented by SEQ ID NOS: 42770, 42771, 42772, 42773, 42774, 42775, 15 42776, 42777, 42778, 42779, 42780 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3333. The probes having the nucleotide sequence represented by SEQ ID NOS: 42781, 42782, 42783, 42784, 42785, 42786, 20 42787, 42788, 42789, 42790, 42791 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3334. The probes having the nucleotide sequence represented by SEQ ID NOS: 42792, 42793, 42794, 42795, 42796, 42797, 25 42798, 42799, 42800, 42801, 42802 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3335. 721 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 42803, 42804, 42805, 42806, 42807, 42808, 42809, 42810, 42811, 42812, 42813 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3336. The probes having the nucleotide sequence represented by SEQ ID NOS: 42814, 42815, 42816, 42817, 42818, 42819, 42820, 42821, 42822, 42823, 42824 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3337. The probes having the nucleotide sequence represented by SEQ ID NOS: 42825, 42826, 42827, 42828, 42829, 42830, 42831, 42832, 42833, 42834, 42835 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3338. The probes having the nucleotide sequence represented by SEQ ID NOS: 42836, 42837, 42838, 42839, 42840, 42841, 42842, 42843, 42844, 42845, 42846 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3339. The probes having the nucleotide sequence represented by SEQ ID NOS: 42847, 42848, 42849, 42850, 42851, 42852, 42853, 42854, 42855, 42856, 42857 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3340. The probes having the nucleotide sequence represented by SEQ ID NOS: 42858, 42859, 42860, 42861, 42862, 42863, 42864, 42865, 42866, 42867, 42868 were selected from the 722 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3341. The probes having the nucleotide sequence represented by SEQ ID NOS: 42869, 42870, 42871, 42872, 42873, 42874, 5 42875, 42876, 42877, 42878, 42879 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3342. The probes having the nucleotide sequence represented by SEQ ID NOS: 42880, 42881, 42882, 42883, 42884, 42885, 10 42886, 42887, 42888, 42889, 42890 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3343. The probes having the nucleotide sequence represented by SEQ ID NOS: 42891, 42892, 42893, 42894, 42895, 42896, 15 42897, 42898, 42899, 42900, 42901 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3344. The probes having the nucleotide sequence represented by SEQ ID NOS: 42902, 42903, 42904, 42905, 42906, 42907, 20 42908, 42909, 42910, 42911, 42912 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3345. The probes having the nucleotide sequence represented by SEQ ID NOS: 42913, 42914, 42915, 42916, 42917, 42918, 25 42919, 42920, 42921, 42922, 42923 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3346. 723 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 42924, 42925, 42926, 42927, 42928, 42929, 42930, 42931, 42932, 42933, 42934 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3347. The probes having the nucleotide sequence represented by SEQ ID NOS: 42935, 42936, 42937, 42938, 42939, 42940, 42941, 42942, 42943, 42944, 42945 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3348. The probes having the nucleotide sequence represented by SEQ ID NOS: 42946, 42947, 42948, 42949, 42950, 42951, 42952, 42953, 42954, 42955, 42956 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3349. The probes having the nucleotide sequence represented by SEQ ID NOS: 42957, 42958, 42959, 42960, 42961, 42962, 42963, 42964, 42965, 42966, 42967 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3350. The probes having the nucleotide sequence represented by SEQ ID NOS: 42968, 42969, 42970, 42971, 42972, 42973, 42974, 42975, 42976, 42977, 42978 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3351. The probes having the nucleotide sequence represented by SEQ ID NOS: 42979, 42980, 42981, 42982, 42983, 42984, 42985, 42986, 42987, 42988, 42989 were selected from the 724 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3352. The probes having the nucleotide sequence represented by SEQ ID NOS: 42990, 42991, 42992, 42993, 42994, 42995, 5 42996, 42997, 42998, 42999, 43000 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3353. The probes having the nucleotide sequence represented by SEQ ID NOS: 43001, 43002, 43003, 43004, 43005, 43006, 10 43007, 43008, 43009, 43010, 43011 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3354. The probes having the nucleotide sequence represented by SEQ ID NOS: 43012, 43013, 43014, 43015, 43016, 43017, 15 43018, 43019, 43020, 43021, 43022 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3355. The probes having the nucleotide sequence represented by SEQ ID NOS: 43023, 43024, 43025, 43026, 43027, 43028, 20 43029, 43030, 43031, 43032, 43033 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3356. The probes having the nucleotide sequence represented by SEQ ID NOS: 43034, 43035, 43036, 43037, 43038, 43039, 25 43040, 43041, 43042, 43043, 43044 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3357. 725 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 43045, 43046, 43047, 43048, 43049, 43050, 43051, 43052, 43053, 43054, 43055 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3358. The probes having the nucleotide sequence represented by SEQ ID NOS: 43056, 43057, 43058, 43059, 43060, 43061, 43062, 43063, 43064, 43065, 43066 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3359. The probes having the nucleotide sequence represented by SEQ ID NOS: 43067, 43068, 43069, 43070, 43071, 43072, 43073, 43074, 43075, 43076, 43077 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3360. The probes having the nucleotide sequence represented by SEQ ID NOS: 43078, 43079, 43080, 43081, 43082, 43083, 43084, 43085, 43086, 43087, 43088 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3361. The probes having the nucleotide sequence represented by SEQ ID NOS: 43089, 43090, 43091, 43092, 43093, 43094, 43095, 43096, 43097, 43098, 43099 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3362. The probes having the nucleotide sequence represented by SEQ ID NOS: 43100, 43101, 43102, 43103, 43104, 43105, 43106, 43107, 43108, 43109, 43110 were selected from the 726 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3363. The probes having the nucleotide sequence represented by SEQ ID NOS: 43111, 43112, 43113, 43114, 43115, 43116, 5 43117, 43118, 43119, 43120, 43121 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3364. The probes having the nucleotide sequence represented by SEQ ID NOS: 43122, 43123, 43124, 43125, 43126, 43127, 10 43128, 43129, 43130, 43131, 43132 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3365. The probes having the nucleotide sequence represented by SEQ ID NOS: 43133, 43134, 43135, 43136, 43137, 43138, 15 43139, 43140, 43141, 43142, 43143 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3366. The probes having the nucleotide sequence represented by SEQ ID NOS: 43144, 43145, 43146, 43147, 43148, 43149, 20 43150, 43151, 43152, 43153, 43154 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3367. The probes having the nucleotide sequence represented by SEQ ID NOS: 43155, 43156, 43157, 43158, 43159, 43160, 25 43161, 43162, 43163, 43164, 43165 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3368. 727 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 43166, 43167, 43168, 43169, 43170, 43171, 43172, 43173, 43174, 43175, 43176 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3369. The probes having the nucleotide sequence represented by SEQ ID NOS: 43177, 43178, 43179, 43180, 43181, 43182, 43183, 43184, 43185, 43186, 43187 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3370. The probes having the nucleotide sequence represented by SEQ ID NOS: 43188, 43189, 43190, 43191, 43192, 43193, 43194, 43195, 43196, 43197, 43198 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3371. The probes having the nucleotide sequence represented by SEQ ID NOS: 43199, 43200, 43201, 43202, 43203, 43204, 43205, 43206, 43207, 43208, 43209 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3372. The probes having the nucleotide sequence represented by SEQ ID NOS: 43210, 43211, 43212, 43213, 43214, 43215, 43216, 43217, 43218, 43219, 43220 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3373. The probes having the nucleotide sequence represented by SEQ ID NOS: 43221, 43222, 43223, 43224, 43225, 43226, 43227, 43228, 43229, 43230, 43231 were selected from the 728 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3374. The probes having the nucleotide sequence represented by SEQ ID NOS: 43232, 43233, 43234, 43235, 43236, 43237, 5 43238, 43239, 43240, 43241, 43242 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3375. The probes having the nucleotide sequence represented by SEQ ID NOS: 43243, 43244, 43245, 43246, 43247, 43248, 10 43249, 43250, 43251, 43252, 43253 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3376. The probes having the nucleotide sequence represented by SEQ ID NOS: 43254, 43255, 43256, 43257, 43258, 43259, 15 43260, 43261, 43262, 43263, 43264 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3377. The probes having the nucleotide sequence represented by SEQ ID NOS: 43265, 43266, 43267, 43268, 43269, 43270, 20 43271, 43272, 43273, 43274, 43275 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3378. The probes having the nucleotide sequence represented by SEQ ID NOS: 43276, 43277, 43278, 43279, 43280, 43281, 25 43282, 43283, 43284, 43285, 43286 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3379. 729 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 43287, 43288, 43289, 43290, 43291, 43292, 43293, 43294, 43295, 43296, 43297 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3380. The probes having the nucleotide sequence represented by SEQ ID NOS: 43298, 43299, 43300, 43301, 43302, 43303, 43304, 43305, 43306, 43307, 43308 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3381. The probes having the nucleotide sequence represented by SEQ ID NOS: 43309, 43310, 43311, 43312, 43313, 43314, 43315, 43316, 43317, 43318, 43319 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3382. The probes having the nucleotide sequence represented by SEQ ID NOS: 43320, 43321, 43322, 43323, 43324, 43325, 43326, 43327, 43328, 43329, 43330 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3383. The probes having the nucleotide sequence represented by SEQ ID NOS: 43331, 43332, 43333, 43334, 43335, 43336, 43337, 43338, 43339, 43340, 43341 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3384. The probes having the nucleotide sequence represented by SEQ ID NOS: 43342, 43343, 43344, 43345, 43346, 43347, 43348, 43349, 43350, 43351, 43352 were selected from the 730 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3385. The probes having the nucleotide sequence represented by SEQ ID NOS: 43353, 43354, 43355, 43356, 43357, 43358, 5 43359, 43360, 43361, 43362, 43363 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3386. The probes having the nucleotide sequence represented by SEQ ID NOS: 43364, 43365, 43366, 43367, 43368, 43369, 10 43370, 43371, 43372, 43373, 43374 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3387. The probes having the nucleotide sequence represented by SEQ ID NOS: 43375, 43376, 43377, 43378, 43379, 43380, 15 43381, 43382, 43383, 43384, 43385 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3388. The probes having the nucleotide sequence represented by SEQ ID NOS: 43386, 43387, 43388, 43389, 43390, 43391, 20 43392, 43393, 43394, 43395, 43396 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3389. The probes having the nucleotide sequence represented by SEQ ID NOS: 43397, 43398, 43399, 43400, 43401, 43402, 25 43403, 43404, 43405, 43406, 43407 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3390. 731 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 43408, 43409, 43410, 43411, 43412, 43413, 43414, 43415, 43416, 43417, 43418 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3391. The probes having the nucleotide sequence represented by SEQ ID NOS: 43419, 43420, 43421, 43422, 43423, 43424, 43425, 43426, 43427, 43428, 43429 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3392. The probes having the nucleotide sequence represented by SEQ ID NOS: 43430, 43431, 43432, 43433, 43434, 43435, 43436, 43437, 43438, 43439, 43440 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3393. The probes having the nucleotide sequence represented by SEQ ID NOS: 43441, 43442, 43443, 43444, 43445, 43446, 43447, 43448, 43449, 43450, 43451 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3394. The probes having the nucleotide sequence represented by SEQ ID NOS: 43452, 43453, 43454, 43455, 43456, 43457, 43458, 43459, 43460, 43461, 43462 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3395. The probes having the nucleotide sequence represented by SEQ ID NOS: 43463, 43464, 43465, 43466, 43467, 43468, 43469, 43470, 43471, 43472, 43473 were selected from the 732 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3396. The probes having the nucleotide sequence represented by SEQ ID NOS: 43474, 43475, 43476, 43477, 43478, 43479, 5 43480, 43481, 43482, 43483, 43484 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3397. The probes having the nucleotide sequence represented by SEQ ID NOS: 43485, 43486, 43487, 43488, 43489, 43490, 10 43491, 43492, 43493, 43494, 43495 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3398. The probes having the nucleotide sequence represented by SEQ ID NOS: 43496, 43497, 43498, 43499, 43500, 43501, 15 43502, 43503, 43504, 43505, 43506 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3399. The probes having the nucleotide sequence represented by SEQ ID NOS: 43507, 43508, 43509, 43510, 43511, 43512, 20 43513, 43514, 43515, 43516, 43517 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3400. The probes having the nucleotide sequence represented by SEQ ID NOS: 43518, 43519, 43520, 43521, 43522, 43523, 25 43524, 43525, 43526, 43527, 43528 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3401. 733 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 43529, 43530, 43531, 43532, 43533, 43534, 43535, 43536, 43537, 43538, 43539, 43540, 43541, 43542, 43543, 43544, 43545, 43546, 43547, 43548, 43549, 43550 were 5 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3402. The probes having the nucleotide sequence represented by SEQ ID NOS: 43551, 43552, 43553, 43554, 43555, 43556, 43557, 43558, 43559, 43560, 43561 were selected from the 10 ORFs having the nucleotide sequence represented by SEQ ID NO: 3403. The probes having the nucleotide sequence represented by SEQ ID NOS: 43562, 43563, 43564, 43565, 43566, 43567, 43568, 43569, 43570, 43571, 43572 were selected from the 15 ORFs having the nucleotide sequence represented by SEQ ID NO: 3404. The probes having the nucleotide sequence represented by SEQ ID NOS: 43573, 43574, 43575, 43576, 43577, 43578, 43579, 43580, 43581, 43582, 43583 were selected from the 20 ORFs having the nucleotide sequence represented by SEQ ID NO: 3405. The probes having the nucleotide sequence represented by SEQ ID NOS: 43584, 43585, 43586, 43587, 43588, 43589, 43590, 43591, 43592, 43593, 43594 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 3406. The probes having the nucleotide sequence represented by SEQ ID NOS: 43595, 43596, 43597, 43598, 43599, 43600, 734 WO 2006/024951 PCT/IB2005/002908 43601, 43602, 43603, 43604, 43605 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3407. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 43606, 43607, 43608, 43609, 43610, 43611, 43612, 43613, 43614, 43615, 43616 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3408. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 43617, 43618, 43619, 43620, 43621, 43622, 43623, 43624, 43625, 43626, 43627 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3409. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 43628, 43629, 43630, 43631, 43632, 43633, 43634, 43635, 43636, 43637, 43638 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3410. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 43639, 43640, 43641, 43642, 43643, 43644, 43645, 43646, 43647, 43648, 43649 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3411. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 43650, 43651, 43652, 43653, 43654, 43655, 43656, 43657, 43658, 43659, 43660, 43661, 43662, 43663, 43664, 43665, 43666, 43667, 43668, 43669, 43670, 43671 were 735 WO 2006/024951 PCT/IB2005/002908 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3412. The probes having the nucleotide sequence represented by SEQ ID NOS: 43672, 43673, 43674, 43675, 43676, 43677, 5 43678, 43679, 43680, 43681, 43682 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3413. The probes having the nucleotide sequence represented by SEQ ID NOS: 43683, 43684, 43685, 43686, 43687, 43688, 10 43689, 43690, 43691, 43692, 43693 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3414. The probes having the nucleotide sequence represented by SEQ ID NOS: 43694, 43695, 43696, 43697, 43698, 43699, 15 43700, 43701, 43702, 43703, 43704 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3415. The probes having the nucleotide sequence represented by SEQ ID NOS: 43705, 43706, 43707, 43708, 43709, 43710, 20 43711, 43712, 43713, 43714, 43715 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3416. The probes having the nucleotide sequence represented by SEQ ID NOS: 43716, 43717, 43718, 43719, 43720, 43721, 25 43722, 43723, 43724, 43725, 43726 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3417. 736 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 43727, 43728, 43729, 43730, 43731, 43732, 43733, 43734, 43735, 43736, 43737 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3418. The probes having the nucleotide sequence represented by SEQ ID NOS: 43738, 43739, 43740, 43741, 43742, 43743, 43744, 43745, 43746, 43747, 43748 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3419. The probes having the nucleotide sequence represented by SEQ ID NOS: 43749, 43750, 43751, 43752, 43753, 43754, 43755, 43756, 43757, 43758, 43759 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3420. The probes having the nucleotide sequence represented by SEQ ID NOS: 43760, 43761, 43762, 43763, 43764, 43765, 43766, 43767, 43768, 43769, 43770 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3421. The probes having the nucleotide sequence represented by SEQ ID NOS: 43771, 43772, 43773, 43774, 43775, 43776, 43777, 43778, 43779, 43780, 43781 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3422. The probes having the nucleotide sequence represented by SEQ ID NOS: 43782, 43783, 43784, 43785, 43786, 43787, 43788, 43789, 43790, 43791, 43792 were selected from the 737 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3423. The probes having the nucleotide sequence represented by SEQ ID NOS: 43793, 43794, 43795, 43796, 43797, 43798, 5 43799, 43800, 43801, 43802, 43803, 43804, 43805, 43806, 43807, 43808, 43809, 43810, 43811, 43812, 43813, 43814 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3424. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 43815, 43816, 43817, 43818, 43819, 43820, 43821, 43822, 43823, 43824, 43825 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3425. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 43826, 43827, 43828, 43829, 43830, 43831, 43832, 43833, 43834, 43835, 43836 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3426. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 43837, 43838, 43839, 43840, 43841, 43842, 43843, 43844, 43845, 43846, 43847 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3427. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 43848, 43849, 43850, 43851, 43852, 43853, 43854, 43855, 43856, 43857, 43858 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3428. 738 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 43859, 43860, 43861, 43862, 43863, 43864, 43865, 43866, 43867, 43868, 43869 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3429. The probes having the nucleotide sequence represented by SEQ ID NOS: 43870, 43871, 43872, 43873, 43874, 43875, 43876, 43877, 43878, 43879, 43880 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3430. The probes having the nucleotide sequence represented by SEQ ID NOS: 43881, 43882, 43883, 43884, 43885, 43886, 43887, 43888, 43889, 43890, 43891 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3431. The probes having the nucleotide sequence represented by SEQ ID NOS: 43892, 43893, 43894, 43895, 43896, 43897, 43898, 43899, 43900, 43901, 43902 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3432. The probes having the nucleotide sequence represented by SEQ ID NOS: 43903, 43904, 43905, 43906, 43907, 43908, 43909, 43910, 43911, 43912, 43913 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3433. The probes having the nucleotide sequence represented by SEQ ID NOS: 43914, 43915, 43916, 43917, 43918, 43919, 43920, 43921, 43922, 43923, 43924 were selected from the 739 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3434. The probes having the nucleotide sequence represented by SEQ ID NOS: 43925, 43926, 43927, 43928, 43929, 43930, 5 43931, 43932, 43933, 43934, 43935 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3435. The probes having the nucleotide sequence represented by SEQ ID NOS: 43936, 43937, 43938, 43939, 43940, 43941, 10 43942, 43943, 43944, 43945, 43946 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3436. The probes having the nucleotide sequence represented by SEQ ID NOS: 43947, 43948, 43949, 43950, 43951, 43952, 15 43953, 43954, 43955, 43956, 43957 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3437. The probes having the nucleotide sequence represented by SEQ ID NOS: 43958, 43959, 43960, 43961, 43962, 43963, 20 43964, 43965, 43966, 43967, 43968 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3438. The probes having the nucleotide sequence represented by SEQ ID NOS: 43969, 43970, 43971, 43972, 43973, 43974, 25 43975, 43976, 43977, 43978, 43979 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3439. 740 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 43980, 43981, 43982, 43983, 43984, 43985, 43986, 43987, 43988, 43989, 43990 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3440. The probes having the nucleotide sequence represented by SEQ ID NOS: 43991, 43992, 43993,.43994, 43995, 43996, 43997, 43998, 43999, 44000, 44001 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3441. The probes having the nucleotide sequence represented by SEQ ID NOS: 44002, 44003, 44004, 44005, 44006, 44007, 44008, 44009, 44010, 44011, 44012 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3442. The probes having the nucleotide sequence represented by SEQ ID NOS: 44013, 44014, 44015, 44016, 44017, 44018, 44019, 44020, 44021, 44022, 44023 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3443. The probes having the nucleotide sequence represented by SEQ ID NOS: 44024, 44025, 44026, 44027, 44028, 44029, 44030, 44031, 44032, 44033, 44034 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3444. The probes having the nucleotide sequence represented by SEQ ID NOS: 44035, 44036, 44037, 44038, 44039, 44040, 44041, 44042, 44043, 44044, 44045 were selected from the 741 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3445. The probes having the nucleotide sequence represented by SEQ ID NOS: 44046, 44047, 44048, 44049, 44050, 44051, 5 44052, 44053, 44054, 44055, 44056 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3446. The probes having the nucleotide sequence represented by SEQ ID NOS: 44057, 44058, 44059, 44060, 44061, 44062, 10 44063, 44064, 44065, 44066, 44067 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3447. The probes having the nucleotide sequence represented by SEQ ID NOS: 44068, 44069, 44070, 44071, 44072, 44073, 15 44074, 44075, 44076, 44077, 44078 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3448. The probes having the nucleotide sequence represented by SEQ ID NOS: 44079, 44080, 44081, 44082, 44083, 44084, 20 44085, 44086, 44087, 44088, 44089 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3449. The probes having the nucleotide sequence represented by SEQ ID NOS: 44090, 44091, 44092, 44093, 44094, 44095, 25 44096, 44097, 44098, 44099, 44100 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3450. 742 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 44101, 44102, 44103, 44104, 44105, 44106, 44107, 44108, 44109, 44110, 44111 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3451. The probes having the nucleotide sequence represented by SEQ ID NOS: 44112, 44113, 44114, 44115, 44116, 44117, 44118, 44119, 44120, 44121, 44122 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3452. The probes having the nucleotide sequence represented by SEQ ID NOS: 44123, 44124, 44125, 44126, 44127, 44128, 44129, 44130, 44131, 44132, 44133 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3453. The probes having the nucleotide sequence represented by SEQ ID NOS: 44134, 44135, 44136, 44137, 44138, 44139, 44140, 44141, 44142, 44143, 44144 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3454. The probes having the nucleotide sequence represented by SEQ ID NOS: 44145, 44146, 44147, 44148, 44149, 44150, 44151, 44152, 44153, 44154, 44155 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3455. The probes having the nucleotide sequence represented by SEQ ID NOS: 44156, 44157, 44158, 44159, 44160, 44161, 44162, 44163, 44164, 44165, 44166 were selected from the 743 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3456. The probes having the nucleotide sequence represented by SEQ ID NOS: 44167, 44168, 44169, 44170, 44171, 44172, 5 44173, 44174, 44175, 44176, 44177 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3457. The probes having the nucleotide sequence represented by SEQ ID NOS: 44178, 44179, 44180, 44181, 44182, 44183, 10 44184, 44185, 44186, 44187, 44188 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3458. The probes having the nucleotide sequence represented by SEQ ID NOS: 44189, 44190, 44191, 44192, 44193, 44194, 15 44195, 44196, 44197, 44198, 44199 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3459. The probes having the nucleotide sequence represented by SEQ ID NOS: 44200, 44201, 44202, 44203, 44204, 44205, 20 44206, 44207, 44208, 44209, 44210 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3460. The probes having the nucleotide sequence represented by SEQ ID NOS: 44211, 44212, 44213, 44214, 44215, 44216, 25 44217, 44218, 44219, 44220, 44221 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3461. 744 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 44222, 44223, 44224, 44225, 44226, 44227, 44228, 44229, 44230, 44231, 44232 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3462. The probes having the nucleotide sequence represented by SEQ ID NOS: 44233, 44234, 44235, 44236, 44237, 44238, 44239, 44240, 44241, 44242, 44243 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3463. The probes having the nucleotide sequence represented by SEQ ID NOS: 44244, 44245, 44246, 44247, 44248, 44249, 44250, 44251, 44252, 44253, 44254 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3464. The probes having the nucleotide sequence represented by SEQ ID NOS: 44255, 44256, 44257, 44258, 44259, 44260, 44261, 44262, 44263, 44264, 44265 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3465. The probes having the nucleotide sequence represented by SEQ ID NOS: 44266, 44267, 44268, 44269, 44270, 44271, 44272, 44273, 44274, 44275, 44276 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3466. The probes having the nucleotide sequence represented by SEQ ID NOS: 44277, 44278, 44279, 44280, 44281, 44282, 44283, 44284, 44285, 44286, 44287 were selected from the 745 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3467. The probes having the nucleotide sequence represented by SEQ ID NOS: 44288, 44289, 44290, 44291, 44292, 44293, 5 44294, 44295, 44296, 44297, 44298 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3468. The probes having the nucleotide sequence represented by SEQ ID NOS: 44299, 44300, 44301, 44302, 44303, 44304, 10 44305, 44306, 44307, 44308, 44309 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3469. The probes having the nucleotide sequence represented by SEQ ID NOS: 44310, 44311, 44312, 44313, 44314, 44315, 15 44316, 44317, 44318, 44319, 44320 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3470. The probes having the nucleotide sequence represented by SEQ ID NOS: 44321, 44322, 44323, 44324, 44325, 44326, 20 44327, 44328, 44329, 44330, 44331 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3471. The probes having the nucleotide sequence represented by SEQ ID NOS: 44332, 44333, 44334, 44335, 44336, 44337, 25 44338, 44339, 44340, 44341, 44342 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3472. 746 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 44343, 44344, 44345, 44346, 44347, 44348, 44349, 44350, 44351, 44352, 44353 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3473. The probes having the nucleotide sequence represented by SEQ ID NOS: 44354, 44355, 44356, 44357, 44358,- 44359, 44360, 44361, 44362, 44363, 44364 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3474. The probes having the nucleotide sequence represented by SEQ ID NOS: 44365, 44366, 44367, 44368, 44369, 44370, 44371, 44372, 44373, 44374, 44375 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3475. The probes having the nucleotide sequence represented by SEQ ID NOS: 44376, 44377, 44378, 44379, 44380, 44381, 44382, 44383, 44384, 44385, 44386 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3476. The probes having the nucleotide sequence represented by SEQ ID NOS: 44387, 44388, 44389, 44390, 44391, 44392, 44393, 44394, 44395, 44396, 44397 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3477. The probes having the nucleotide sequence represented by SEQ ID NOS: 44398, 44399, 44400, 44401, 44402, 44403, 44404, 44405, 44406, 44407, 44408 were selected from the 747 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3478. The probes having the nucleotide sequence represented by SEQ ID NOS: 44409, 44410, 44411, 44412, 44413, 44414, 5 44415, 44416, 44417, 44418, 44419 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3479. The probes having the nucleotide sequence represented by SEQ ID NOS: 44420, 44421, 44422, 44423, 44424, 44425, 10 44426, 44427, 44428, 44429, 44430 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3480. The probes having the nucleotide sequence represented by SEQ ID NOS: 44431, 44432, 44433, 44434, 44435, 44436, 15 44437, 44438, 44439, 44440, 44441 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3481. The probes having the nucleotide sequence represented by SEQ ID NOS: 44442, 44443, 44444, 44445, 44446, 44447, 20 44448, 44449, 44450, 44451, 44452 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3482. The probes having the nucleotide sequence represented by SEQ ID NOS: 44453, 44454, 44455, 44456, 44457, 44458, 25 44459, 44460, 44461, 44462, 44463 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3483. 748 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 44464, 44465, 44466, 44467, 44468, 44469, 44470, 44471, 44472, 44473, 44474 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3484. The probes having the nucleotide sequence represented by SEQ ID NOS: 44475, 44476, 44477, 44478, 44479, 44480, 44481, 44482, 44483, 44484, 44485 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3485. The probes having the nucleotide sequence represented by SEQ ID NOS: 44486, 44487, 44488, 44489, 44490, 44491, 44492, 44493, 44494, 44495, 44496 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3486. The probes having the nucleotide sequence represented by SEQ ID NOS: 44497, 44498, 44499, 44500, 44501, 44502, 44503, 44504, 44505, 44506, 44507 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3487. The probes having the nucleotide sequence represented by SEQ ID NOS: 44508, 44509, 44510, 44511, 44512, 44513, 44514, 44515, 44516, 44517, 44518 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3488. The probes having the nucleotide sequence represented by SEQ ID NOS: 44519, 44520, 44521, 44522, 44523, 44524, 44525, 44526, 44527, 44528, 44529 were selected from the 749 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3489. The probes having the nucleotide sequence represented by SEQ ID NOS: 44530, 44531, 44532, 44533, 44534, 44535, 5 44536, 44537, 44538, 44539, 44540 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3490. The probes having the nucleotide sequence represented by SEQ ID NOS: 44541, 44542, 44543, 44544, 44545, 44546, 10 44547, 44548, 44549, 44550, 44551 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3491. The probes having the nucleotide sequence represented by SEQ ID NOS: 44552, 44553, 44554, 44555, 44556, 44557, 15 44558, 44559, 44560, 44561, 44562 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3492. The probes having the nucleotide sequence represented by SEQ ID NOS: 44563, 44564, 44565, 44566, 44567, 44568, 20 44569, 44570, 44571, 44572, 44573 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3493. The probes having the nucleotide sequence represented by SEQ ID NOS: 44574, 44575, 44576, 44577, 44578, 44579, 25 44580, 44581, 44582, 44583, 44584 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3494. 750 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 44585, 44586, 44587, 44588, 44589, 44590, 44591, 44592, 44593, 44594, 44595 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3495. The probes having the nucleotide sequence represented by SEQ ID NOS: 44596, 44597, 44598, 44599, 44600, 44601, 44602, 44603, 44604, 44605, 44606 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3496. The probes having the nucleotide sequence represented by SEQ ID NOS: 44607, 44608, 44609, 44610, 44611, 44612, 44613, 44614, 44615, 44616, 44617 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3497. The probes having the nucleotide sequence represented by SEQ ID NOS: 44618, 44619, 44620, 44621, 44622, 44623, 44624, 44625, 44626, 44627, 44628 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3498. The probes having the nucleotide sequence represented by SEQ ID NOS: 44629, 44630, 44631, 44632, 44633, 44634, 44635, 44636, 44637, 44638, 44639 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3499. The probes having the nucleotide sequence represented by SEQ ID NOS: 44640, 44641, 44642, 44643, 44644, 44645, 44646, 44647, 44648, 44649, 44650 were selected from the 751 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3500. The probes having the nucleotide sequence represented by SEQ ID NOS: 44651, 44652, 44653, 44654, 44655, 44656, 5 44657, 44658, 44659, 44660, 44661, 44662, 44663, 44664, 44665, 44666, 44667, 44668, 44669, 44670, 44671, 44672 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3501. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 44673, 44674, 44675, 44676, 44677, 44678, 44679, 44680, 44681, 44682, 44683 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3502. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 44684, 44685, 44686, 44687, 44688, 44689, 44690, 44691, 44692, 44693, 44694 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3503. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 44695, 44696, 44697, 44698, 44699, 44700, 44701, 44702, 44703, 44704, 44705 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3504. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 44706, 44707, 44708, 44709, 44710, 44711, 44712, 44713, 44714, 44715, 44716 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3505. 752 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 44717, 44718, 44719, 44720, 44721, 44722, 44723, 44724, 44725, 44726, 44727 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3506. The probes having the nucleotide sequence represented by SEQ ID NOS: 44728, 44729, 44730, 44731, 44732, 44733, 44734, 44735, 44736, 44737, 44738 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3507. The probes having the nucleotide sequence represented by SEQ ID NOS: 44739, 44740, 44741, 44742, 44743, 44744,. 44745, 44746, 44747, 44748, 44749 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3508. The probes having the nucleotide sequence represented by SEQ ID NOS: 44750, 44751, 44752, 44753, 44754, 44755, 44756, 44757, 44758, 44759, 44760 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3509. The probes having the nucleotide sequence represented by SEQ ID NOS: 44761, 44762, 44763, 44764, 44765, 44766, 44767, 44768, 44769, 44770, 44771 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3510. The probes having the nucleotide sequence represented by SEQ ID NOS: 44772, 44773, 44774, 44775, 44776, 44777, 44778, 44779, 44780, 44781, 44782 were selected from the 753 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3511. The probes having the nucleotide sequence represented by SEQ ID NOS: 44783, 44784, 44785, 44786, 44787, 44788, 5 44789, 44790, 44791, 44792, 44793 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3512. The probes having the nucleotide sequence represented by SEQ ID NOS: 44794, 44795, 44796, 44797, 44798, 44799, 10 44800, 44801, 44802, 44803, 44804 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3513. The probes having the nucleotide sequence represented by SEQ ID NOS: 44805, 44806, 44807, 44808, 44809, 44810, 15 44811, 44812, 44813, 44814, 44815 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3514. The probes having the nucleotide sequence represented by SEQ ID NOS: 44816, 44817, 44818, 44819, 44820, 44821, 20 44822, 44823, 44824, 44825, 44826 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3515. The probes having the nucleotide sequence represented by SEQ ID NOS: 44827, 44828, 44829, 44830, 44831, 44832, 25 44833, 44834, 44835, 44836, 44837 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3516. 754 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 44838, 44839, 44840, 44841, 44842, 44843, 44844, 44845, 44846, 44847, 44848 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3517. The probes having the nucleotide sequence represented by SEQ ID NOS: 44849, 44850, 44851, 44852, 44853, 44854, 44855, 44856, 44857, 44858, 44859 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3518. The probes having the nucleotide sequence represented by SEQ ID NOS: 44860, 44861, 44862, 44863, 44864, 44865, 44866, 44867, 44868, 44869, 44870 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3519. The probes having the nucleotide sequence represented by SEQ ID NOS: 44871, 44872, 44873, 44874, 44875, 44876, 44877, 44878, 44879, 44880, 44881 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3520. The probes having the nucleotide sequence represented by SEQ ID NOS: 44882, 44883, 44884, 44885, 44886, 44887, 44888, 44889, 44890, 44891, 44892 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3521. The probes having the nucleotide sequence represented by SEQ ID NOS: 44893, 44894, 44895, 44896, 44897, 44898, 44899, 44900, 44901, 44902, 44903 were selected from the 755 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3522. The probes having the nucleotide sequence represented by SEQ ID NOS: 44904, 44905, 44906, 44907, 44908, 44909, 5 44910, 44911, 44912, 44913, 44914 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3523. The probes having the nucleotide sequence represented by SEQ ID NOS: 44915, 44916, 44917, 44918, 44919, 44920, 10 44921, 44922, 44923, 44924, 44925 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3524. The probes having the nucleotide sequence represented by SEQ ID NOS: 44926, 44927, 44928, 44929, 44930, 44931, 15 44932, 44933, 44934, 44935, 44936 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3525. The probes having the nucleotide sequence represented by SEQ ID NOS: 44937, 44938, 44939, 44940, 44941, 44942, 20 44943, 44944, 44945, 44946, 44947 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3526. The probes having the nucleotide sequence represented by SEQ ID NOS: 44948, 44949, 44950, 44951, 44952, 44953, 25 44954, 44955, 44956, 44957, 44958 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3527. 756 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 44959, 44960, 44961, 44962, 44963, 44964, 44965, 44966, 44967, 44968, 44969 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3528. The probes having the nucleotide sequence represented by SEQ ID NOS: 44970, 44971, 44972, 44973, 44974, 44975, 44976, 44977, 44978, 44979, 44980 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3529. The probes having the nucleotide sequence represented by SEQ ID NOS: 44981, 44982, 44983, 44984, 44985, 44986, 44987, 44988, 44989, 44990, 44991 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3530. The probes having the nucleotide sequence represented by SEQ ID NOS: 44992, 44993, 44994, 44995, 44996, 44997, 44998, 44999, 45000, 45001, 45002 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3531. The probes having the nucleotide sequence represented by SEQ ID NOS: 45003, 45004, 45005, 45006, 45007, 45008, 45009, 45010, 45011, 45012, 45013 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3532. The probes having the nucleotide sequence represented by SEQ ID NOS: 45014, 45015, 45016, 45017, 45018, 45019, 45020, 45021, 45022, 45023, 45024 were selected from the 757 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3533. The probes having the nucleotide sequence represented by SEQ ID NOS: 45025, 45026, 45027, 45028, 45029, 45030, 5 45031, 45032, 45033, 45034, 45035 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3534. The probes having the nucleotide sequence represented by SEQ ID NOS: 45036, 45037, 45038, 45039, 45040, 45041, 10 45042, 45043, 45044, 45045, 45046 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3535. The probes having the nucleotide sequence represented by SEQ ID NOS: 45047, 45048, 45049, 45050, 45051, 45052, 15 45053, 45054, 45055, 45056, 45057 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3536. The probes having the nucleotide sequence represented by SEQ ID NOS: 45058, 45059, 45060, 45061, 45062, 45063, 20 45064, 45065, 45066, 45067, 45068 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3537. The probes having the nucleotide sequence represented by SEQ ID NOS: 45069, 45070, 45071, 45072, 45073, 45074, 25 45075, 45076, 45077, 45078, 45079 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3538. 758 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 45080, 45081, 45082, 45083, 45084, 45085, 45086, 45087, 45088, 45089, 45090 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3539. The probes having the nucleotide sequence represented by SEQ ID NOS: 45091, 45092, 45093, 45094, 45095, 45096, 45097, 45098, 45099, 45100, 45101 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3540. The probes having the nucleotide sequence represented by SEQ ID NOS: 45102, 45103, 45104, 45105, 45106, 45107, 45108, 45109, 45110, 45111, 45112 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3541. The probes having the nucleotide sequence represented by SEQ ID NOS: 45113, 45114, 45115, 45116, 45117, 45118, 45119, 45120, 45121, 45122, 45123 were selected from the ORFs having the nucleotide sequence represented.by SEQ ID 20 NO: 3542. The probes having the nucleotide sequence represented by SEQ ID NOS: 45124, 45125, 45126, 45127, 45128, 45129, 45130, 45131, 45132, 45133, 45134 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3543. The probes having the nucleotide sequence represented by SEQ ID NOS: 45135, 45136, 45137, 45138, 45139, 45140, 45141, 45142, 45143, 45144, 45145 were selected from the 759 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3544. The probes having the nucleotide sequence represented by SEQ ID NOS: 45146, 45147, 45148, 45149, 45150, 45151, 5 45152, 45153, 45154, 45155, 45156 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3545. The probes having the nucleotide sequence represented by SEQ ID NOS: 45157, 45158, 45159, 45160, 45161, 45162, 10 45163, 45164, 45165, 45166, 45167 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3546. The probes having the nucleotide sequence represented by SEQ ID NOS: 45168, 45169, 45170, 45171, 45172, 45173, 15 45174, 45175, 45176, 45177, 45178 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3547. The probes having the nucleotide sequence represented by SEQ ID NOS: 45179, 45180, 45181, 45182, 45183, 45184, 20 45185, 45186, 45187, 45188, 45189 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3548. The probes having the nucleotide sequence represented by SEQ ID NOS: 45190, 45191, 45192, 45193; 45194, 45195, 25 45196, 45197, 45198-, 45199, 45200 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3549. 760 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 45201, 45202, 45203, 45204, 45205, 45206, 45207, 45208, 45209, 45210, 45211 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3550. The probes having the nucleotide sequence represented by SEQ ID NOS: 45212, 45213, 45214, 45215, 45216, 45217, 45218, 45219, 45220, 45221, 45222 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3551. The probes having the nucleotide sequence represented by SEQ ID NOS: 45223, 45224, 45225, 45226, 45227, 45228, 45229, 45230, 45231, 45232, 45233 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3552. The probes having the nucleotide sequence represented by SEQ ID NOS: 45234, 45235, 45236, 45237, 45238, 45239, 45240, 45241, 45242, 45243, 45244 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3553. The probes having the nucleotide sequence represented by SEQ ID NOS: 45245, 45246, 45247, 45248, 45249, 45250, 45251, 45252, 45253, 45254, 45255 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3554. The probes having the nucleotide sequence represented by SEQ ID NOS: 45256, 45257, 45258, 45259, 45260, 45261, 45262, 45263, 45264, 45265, 45266 were selected from the 761 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3555. The probes having the nucleotide sequence represented by SEQ ID NOS: 45267, 45268, 45,269, 45270, 45271, 45272, 5 45273, 45274, 45275, 45276, 45277 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3556. The probes having the nucleotide sequence represented by SEQ ID NOS: 45278, 45279, 45280, 45281, 45282, 45283, 10 45284, 45285, 45286, 45287, 45288 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3557. The probes having the nucleotide sequence represented by SEQ ID NOS: 45289, 45290, 45291, 45292, 45293, 45294, 15 45295, 45296, 45297, 45298, 45299 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3558. The probes having the nucleotide sequence represented by SEQ ID NOS: 45300, 45301, 45302, 45303, 45304, 45305, 20 45306, 45307, 45308, 45309, 45310 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3559. The probes having the nucleotide sequence represented by SEQ ID NOS: 45311, 45312, 45313, 45314, 45315, 45316, 25 45317, 45318, 45319, 45320, 45321 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3560. 762 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 45322, 45323, 45324, 45325, 45326, 45327, 45328, 45329, 45330, 45331, 45332 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3561. The probes having the nucleotide sequence represented by SEQ ID NOS: 45333, 45334, 45335, 45336, 45337, 45338, 45339, 45340, 45341, 45342, 45343 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3562. The probes having the nucleotide sequence represented by SEQ ID NOS: 45344, 45345, 45346, 45347, 45348, 45349, 45350, 45351, 45352, 45353, 45354 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3563. The probes having the nucleotide sequence represented by SEQ ID NOS: 45355, 45356, 45357, 45358, 45359, 45360, 45361, 45362, 45363, 45364, 45365 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3564. The probes having the nucleotide sequence represented by SEQ ID NOS: 45366, 45367, 45368, 45369, 45370, 45371, 45372, 45373, 45374, 45375, 45376 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3565. The probes having the nucleotide sequence represented by SEQ ID NOS: 45377, 45378, 45379, 45380, 45381, 45382, 45383, 45384, 45385, 45386, 45387 were selected from the 763 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3566. The probes having the nucleotide sequence represented by SEQ ID NOS: 45388, 45389, 45390, 45391, 45392, 45393, 5 45394, 45395, 45396, 45397, 45398 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3567. The probes having the nucleotide sequence represented by SEQ ID NOS: 45399, 45400, 45401, 45402, 45403, 45404, 10 45405, 45406, 45407, 45408, 45409 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3568. The probes having the nucleotide sequence represented by SEQ ID NOS: 45410, 45411, 45412, 45413, 45414, 45415, 15 45416, 45417, 45418, 45419, 45420 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3569. The probes having the nucleotide sequence represented by SEQ ID NOS: 45421, 45422, 45423, 45424, 4.5425, 45426, 20 45427, 45428, 45429, 45430, 45431 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3570. The probes having the nucleotide sequence represented by SEQ ID NOS: 45432, 45433, 45434, 45435, 45436, 45437, 25 45438, 45439, 45440, 45441, 45442 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3571. 764 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 45443, 45444, 45445, 45446, 45447, 45448, 45449, 45450, 45451, 45452, 45453 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3572. The probes having the nucleotide sequence represented by SEQ ID NOS: 45454, 45455, 45456, 45457, 45458, 45459, 45460, 45461, 45462, 45463, 45464 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3573. The probes having the nucleotide sequence represented by SEQ ID NOS: 45465, 45466, 45467, 45468, 45469, 45470, 45471, 45472, 45473, 45474, 45475 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3574. The probes having the nucleotide sequence represented by SEQ ID NOS: 45476, 45477, 45478, 45479, 45480, 45481, 45482, 45483, 45484, 45485, 45486 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3575. The probes having the nucleotide sequence represented by SEQ ID NOS: 45487, 45488, 45489, 45490, 45491, 45492, 45493, 45494, 45495, 45496, 45497 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3576. The probes having the nucleotide sequence represented by SEQ ID NOS: 45498, 45499, 45500, 45501, 45502, 45503, 45504, 45505, 45506, 45507, 45508 were selected from the 765 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3577. The probes having the nucleotide sequence represented by SEQ ID NOS: 45509, 45510, 45511, 45512, 45513, 45514, 5 45515, 45516, 45517, 45518, 45519 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3578. The probes having the nucleotide sequence represented by SEQ ID NOS: 45520, 45521, 45522, 45523, 45524, 45525, 10 45526, 45527, 45528, 45529, 45530 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3579. The probes having the nucleotide sequence represented by SEQ ID NOS: 45531, 45532, 45533, 45534, 45535, 45536, 15 45537, 45538, 45539, 45540, 45541 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3580. The probes having the nucleotide sequence represented by SEQ ID NOS: 45542, 45543, 45544, 45545, 45546, 45547, 20 45548, 45549, 45550, 45551, 45552 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3581. The probes having the nucleotide sequence represented by SEQ ID NOS: 45553, 45554, 45555, 45556, 45557, 45558, 25 45559, 45560, 45561, 45562, 45563 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3582. 766 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 45564, 45565, 45566, 45567, 45568, 45569, 45570, 45571, 45572, 45573, 45574 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3583. The probes having the nucleotide sequence represented by SEQ ID NOS: 45575, 45576, 45577, 45578, 45579, 45580, 45581, 45582, 45583, 45584, 45585 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3584. The probes having the nucleotide sequence represented by SEQ ID NOS: 45586, 45587, 45588, 45589, 45590, 45591, 45592, 45593, 45594, 45595, 45596 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3585. The probes having the nucleotide sequence represented by SEQ ID NOS: 45597, 45598, 45599, 45600, 45601, 45602, 45603, 45604, 45605, 45606, 45607 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3586. The probes having the nucleotide sequence represented by SEQ ID NOS: 45608, 45609, 45610, 45611, 45612, 45613, 45614, 45615, 45616, 45617, 45618 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3587. The probes having the nucleotide sequence represented by SEQ ID NOS: 45619, 45620, 45621, 45622, 45623, 45624, 45625, 45626, 45627, 45628, 45629 were selected from the 767 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3588. The probes having the nucleotide sequence represented by SEQ ID NOS: 45630, 45631, 45632, 45633, 45634, 45635, 5 45636, 45637, 45638, 45639, 45640 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3589. The probes having the nucleotide sequence represented by SEQ ID NOS: 45641, 45642, 45643, 45644, 45645, 45646, 10 45647, 45648, 45649, 45650, 45651 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3590. The probes having the nucleotide sequence represented by SEQ ID NOS: 45652, 45653, 45654, 45655, 45656, 45657, 15 45658, 45659, 45660, 45661, 45662 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3591. The probes having the nucleotide sequence represented by SEQ ID NOS: 45663, 45664, 45665, 45666, 45667, 45668, 20 45669, 45670, 45671, 45672, 45673 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3592. The probes having the nucleotide sequence represented by SEQ ID NOS: 45674, 45675, 45676, 45677, 45678, 45679, 25 45680, 45681, 45682, 45683, 45684 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3593. 768 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 45685, 45686, 45687, 45688, 45689, 45690, 45691, 45692, 45693, 45694, 45695 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3594. The probes having the nucleotide sequence represented by SEQ ID NOS: 45696, 45697, 45698, 45699, 45700, 45701, 45702, 45703, 45704, 45705, 45706 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3595. The probes having the nucleotide sequence represented by SEQ ID NOS: 45707, 45708, 45709, 45710, 45711, 45712, 45713, 45714, 45715, 45716, 45717 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3596. The probes having the nucleotide sequence represented by SEQ ID NOS: 45718, 45719, 45720, 45721, 45722, 45723, 45724, 45725, 45726, 45727, 45728 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3597. The probes having the nucleotide sequence represented by SEQ ID NOS: 45729, 45730, 45731, 45732, 45733, 45734, 45735, 45736, 45737, 45738, 45739 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3598. The probes having the nucleotide sequence represented by SEQ ID NOS: 45740, 45741, 45742, 45743, 45744, 45745, 45746, 45747, 45748, 45749, 45750 were selected from the 769 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3599. The probes having the nucleotide sequence represented by SEQ ID NOS: 45751, 45752, 45753, 45754, 45755, 45756, 5 45757, 45758, 45759, 45760, 45761 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3600. The probes having the nucleotide sequence represented by SEQ ID NOS: 45762, 45763, 45764, 45765, 45766, 45767, 10 45768, 45769, 45770, 45771, 45772 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3601. The probes having the nucleotide sequence represented by SEQ ID NOS: 45773, 45774, 45775, 45776, 45777, 45778, 15 45779, 45780, 45781, 45782, 45783 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3602. The probes having the nucleotide sequence represented by SEQ ID NOS: 45784, 45785, 45786, 45787, 45788, 45789, 20 45790, 45791, 45792, 45793, 45794 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3603. The probes having the nucleotide sequence represented by SEQ ID NOS: 45795, 45796, 45797, 45798, 45799, 45800, 25 45801, 45802, 45803, 45804, 45805 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3604. 770 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 45806, 45807, 45808, 45809, 45810, 45811, 45812, 45813, 45814, 45815, 45816 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3605. The probes having the nucleotide sequence represented by SEQ ID NOS: 45817, 45818, 45819, 45820, 45821, 45822, 45823, 45824, 45825, 45826, 45827 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3606. The probes having the nucleotide sequence represented by SEQ ID NOS: 45828, 45829, 45830, 45831, 45832, 45833, 45834, 45835, 45836, 45837, 45838 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3607. The probes having the nucleotide sequence represented by SEQ ID NOS: 45839, 45840, 45841, 45842, 45843, 45844, 45845, 45846, 45847, 45848, 45849 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3608. The probes having the nucleotide sequence represented by SEQ ID NOS: 45850, 45851, 45852, 45853, 45854, 45855, 45856, 45857, 45858, 45859, 45860 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3609. The probes having the nucleotide sequence represented by SEQ ID NOS: 45861, 45862, 45863, 45864, 45865, 45866, 45867, 45868, 45869, 45870, 45871 were selected from the 771 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3610. The probes having the nucleotide sequence represented by SEQ ID NOS: 45872, 45873, 45874, 45875, 45876, 45877, 5 45878, 45879, 45880, 45881, 45882 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3611. The probes having the nucleotide sequence represented by SEQ ID NOS: 45883, 45884, 45885, 45886, 45887, 45888, 10 45889, 45890, 45891, 45892, 45893 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3612. The probes having the nucleotide sequence represented by SEQ ID NOS: 45894, 45895, 45896, 45897, 45898, 45899, 15 45900, 45901, 45902, 45903, 45904 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3613. The probes having the nucleotide sequence represented by SEQ ID NOS: 45905, 45906, 45907, 45908, 45909, 45910, 20 45911, 45912, 45913, 45914, 45915 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3614. The probes having the nucleotide sequence represented by SEQ ID NOS: 45916, 45917, 45918, 45919, 45920, 45921, 25 45922, 45923, 45924, 45925, 45926 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3615. 772 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 45927, 45928, 45929, 45930, 45931, 45932, 45933, 45934, 45935, 45936, 45937 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3616. The probes having the nucleotide sequence represented by SEQ ID NOS: 45938, 45939, 45940, 45941, 45942, 45943, 45944, 45945, 45946, 45947, 45948 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3617. The probes having the nucleotide sequence represented by SEQ ID NOS: 45949, 45950, 45951, 45952, 45953, 45954, 45955, 45956, 45957, 45958, 45959 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3618. The probes having the nucleotide sequence represented by SEQ ID NOS: 45960, 45961, 45962, 45963, 45964, 45965, 45966, 45967, 45968, 45969, 45970 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3619. The probes having the nucleotide sequence represented by SEQ ID NOS: 45971, 45972, 45973, 45974, 45975, 45976, 45977, 45978, 45979, 45980, 45981 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3620. The probes having the nucleotide sequence represented by SEQ ID NOS: 45982, 45983, 45984, 45985, 45986, 45987, 45988, 45989, 45990, 45991, 45992 were selected from the 773 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3621. The probes having the nucleotide sequence represented by SEQ ID NOS: 45993, 45994, 45995, 45996, 45997, 45998, 5 45999, 46000, 46001, 46002, 46003 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3622. The probes having the nucleotide sequence represented by SEQ ID NOS: 46004, 46005, 46006, 46007, 46008, 46009, 10 46010, 46011, 46012, 46013, 46014 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3623. The probes having the nucleotide sequence represented by SEQ ID NOS: 46015, 46016, 46017, 46018, 46019, 46020, 15 46021, 46022, 46023, 46024, 46025 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3624. The probes having the nucleotide sequence represented by SEQ ID NOS: 46026, 46027, 46028, 46029, 46030, 46031, 20 46032, 46033, 46034, 46035, 46036 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3625. The probes having the nucleotide sequence represented by SEQ ID NOS: 46037, 46038, 46039, 46040, 46041, 46042, 25 46043, 46044, 46045, 46046, 46047 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3626. 774 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 46048, 46049, 46050, 46051, 46052, 46053, 46054, 46055, 46056, 46057, 46058 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3627. The probes having the nucleotide sequence represented by SEQ ID NOS: 46059, 46060, 46061, 46062, 46063, 46064, 46065, 46066, 46067, 46068, 46069 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3628. The probes having the nucleotide sequence represented by SEQ ID NOS: 46070, 46071, 46072, 46073, 46074, 46075, 46076, 46077, 46078, 46079, 46080 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3629. The probes having the nucleotide sequence represented by SEQ ID NOS: 46081, 46082, 46083, 46084, 46085, 46086, 46087, 46088, 46089, 46090, 46091 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3630. The probes having the nucleotide sequence represented by SEQ ID NOS: 46092, 46093, 46094, 46095, 46096, 46097, 46098, 46099, 46100, 46101, 46102 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3631. The probes having the nucleotide sequence represented by SEQ ID NOS: 46103, 46104, 46105, 46106, 46107, 46108, 46109, 46110, 46111, 46112, 46113 were selected from the 775 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3632. The probes having the nucleotide sequence represented by SEQ ID NOS: 46114, 46115, 46116, 46117, 46118, 46119, 5 46120, 46121, 46122, 46123, 46124 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3633. The probes having the nucleotide sequence represented by SEQ ID NOS: 46125, 46126, 46127, 46128, 46129, 46130, 10 46131, 46132, 46133, 46134, 46135 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3634. The probes having the nucleotide sequence represented by SEQ ID NOS: 46136, 46137, 46138, 46139, 46140, 46141, 15 46142, 46143, 46144, 46145, 46146 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3635. The probes having the nucleotide sequence represented by SEQ ID NOS: 46147, 46148, 46149, 46150, 46151, 46152, 20 46153, 46154, 46155, 46156, 46157 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3636. The probes having the nucleotide sequence represented by SEQ ID NOS: 46158, 46159, 46160, 46161, 46162, 46163, 25 46164, 46165, 46166, 46167, 46168, 46169, 46170, 46171, 46172, 46173, 46174, 46175, 46176, 46177, 46178, 46179 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3637. 776 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 46180, 46181, 46182, 46183, 46184, 46185, 46186, 46187, 46188, 46189, 46190 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3638. The probes having the nucleotide sequence represented by SEQ ID NOS: 46191, 46192, 46193, 46194, 46195, 46196, 46197, 46198, 46199, 46200, 46201 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3639. The probes having the nucleotide sequence represented by SEQ ID NOS: 46202, 46203, 46204, 46205, 46206, 46207, 46208, 46209, 46210, 46211, 46212 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3640. The probes having the nucleotide sequence represented by SEQ ID NOS: 46213, 46214, 46215, 46216, 46217, 46218, 46219, 46220, 46221, 46222, 46223 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3641. The probes having the nucleotide sequence represented by SEQ ID NOS: 46224, 46225, 46226, 46227, 46228, 46229, 46230, 46231, 46232, 46233, 46234 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3642. The probes having the nucleotide sequence represented by SEQ ID NOS: 46235, 46236, 46237, 46238, 46239, 46240, 46241, 46242, 46243, 46244, 46245 were selected from the 777 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3643. The probes having the nucleotide sequence represented by SEQ ID NOS: 46246, 46247, 46248, 46249, 46250, 46251, 5 46252, 46253, 46254, 46255, 46256 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3644. The probes having the nucleotide sequence represented by SEQ ID NOS: 46257, 46258, 46259, 46260, 46261, 46262, 10 46263, 46264, 46265, 46266, 46267 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3645. The probes having the nucleotide sequence represented by SEQ ID NOS: 46268, 46269, 46270, 46271, 46272, 46273, 15 46274, 46275, 46276, 46277, 46278 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3646. The probes having the nucleotide sequence represented by SEQ ID NOS: 46279, 46280, 46281, 46282, 46283, 46284, 20 46285, 46286, 46287, 46288, 46289 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3647. The probes having the nucleotide sequence represented by SEQ ID NOS: 46290, 46291, 46292, 46293, 46294, 46295, 25 46296, 46297, 46298, 46299, 46300 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3648. 778 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 46301, 46302, 46303, 46304, 46305, 46306, 46307, 46308, 46309, 46310, 46311 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3649. The probes having the nucleotide sequence represented by SEQ ID NOS: 46312, 46313, 46314, 46315, 46316, 46317, 46318, 46319, 46320, 46321, 46322 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3650. The probes having the nucleotide sequence represented by SEQ ID NOS: 46323, 46324, 46325, 46326, 46327, 46328, 46329, 46330, 46331, 46332, 46333 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3651. The probes having the nucleotide sequence represented by SEQ ID NOS: 46334, 46335, 46336, 46337, 46338, 46339, 46340, 46341, 46342, 46343, 46344 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3652. The probes having the nucleotide sequence represented by SEQ ID NOS: 46345, 46346, 46347, 46348, 46349, 46350, 46351, 46352, 46353, 46354, 46355 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3653. The probes having the nucleotide sequence represented by SEQ ID NOS: 46356, 46357, 46358, 46359, 46360, 46361, 46362, 46363, 46364, 46365, 46366 were selected from the 779 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3654. The probes having the nucleotide sequence represented by SEQ ID NOS: 46367, 46368, 46369, 46370, 46371, 46372, 5 46373, 46374, 46375, 46376, 46377 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3655. The probes having the nucleotide sequence represented by SEQ ID NOS: 46378, 46379, 46380, 46381, 46382, 46383, 10 46384, 46385, 46386, 46387, 46388 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3656. The probes having the nucleotide sequence represented by SEQ ID NOS: 46389, 46390, 46391, 46392, 46393, 46394, 15 46395, 46396, 46397, 46398, 46399 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3657. The probes having the nucleotide sequence represented by SEQ ID NOS: 46400, 46401, 46402, 46403, 46404, 46405, 20 46406, 46407, 46408, 46409, 46410 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3658. The probes having the nucleotide sequence represented by SEQ ID NOS: 46411, 46412, 46413, 46414, 46415, 46416, 25 46417, 46418, 46419, 46420, 46421 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3659. 780 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 46422, 46423, 46424, 46425, 46426, 46427, 46428, 46429, 46430, 46431, 46432 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3660. The probes having the nucleotide sequence represented by SEQ ID NOS: 46433, 46434, 46435, 46436, 46437, 46438, 46439, 46440, 46441, 46442, 46443 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3661. The probes having the nucleotide sequence represented by SEQ ID NOS: 46444, 46445, 46446, 46447, 46448, 46449, 46450, 46451, 46452, 46453, 46454 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3662. The probes having the nucleotide sequence represented by SEQ ID NOS: 46455, 46456, 46457, 46458, 46459, 46460, 46461, 46462, 46463, 46464, 46465 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3663. The probes having the nucleotide sequence represented by SEQ ID NOS: 46466, 46467, 46468, 46469, 46470, 46471, 46472, 46473, 46474, 46475, 46476 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3664. The probes having the nucleotide sequence represented by SEQ ID NOS: 46477, 46478, 46479, 46480, 46481, 46482, 46483, 46484, 46485, 46486, 46487 were selected from the 781 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3665. The probes having the nucleotide sequence represented by SEQ ID NOS: 46488, 46489, 46490, 46491, 46492, 46493, 5 46494, 46495, 46496, 46497, 46498 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3666. The probes having the nucleotide sequence represented by SEQ ID NOS: 46499, 46500, 46501, 46502, 46503, 46504, 10 46505, 46506, 46507, 46508, 46509 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3667. The probes having the nucleotide sequence represented by SEQ ID NOS: 46510, 46511, 46512, 46513, 46514, 46515, 15 46516, 46517, 46518, 46519, 46520 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3668. The probes having the nucleotide sequence represented by SEQ ID NOS: 46521, 46522, 46523, 46524, 46525, 46526, 20 46527, 46528, 46529, 46530, 46531 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3669. The probes having the nucleotide sequence represented by SEQ ID NOS: 46532, 46533, 46534, 46535, 46536, 46537, 25 46538, 46539, 46540, 46541, 46542 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3670. 782 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 46543, 46544, 46545, 46546, 46547, 46548, 46549, 46550, 46551, 46552, 46553 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3671. The probes having the nucleotide sequence represented by SEQ ID NOS: 46554, 46555, 46556, 46557, 46558, 46559, 46560, 46561, 46562, 46563, 46564 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3672. The probes having the nucleotide sequence represented by SEQ ID NOS: 46565, 46566, 46567, 46568, 46569, 46570, 46571, 46572, 46573, 46574, 46575 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3673. The probes having the nucleotide sequence represented by SEQ ID NOS: 46576, 46577, 46578, 46579, 46580, 46581, 46582, 46583, 46584, 46585, 46586 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3674. The probes having the nucleotide sequence represented by SEQ ID NOS: 46587, 46588, 46589, 46590, 46591, 46592, 46593, 46594, 46595, 46596, 46597 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3675. The probes having the nucleotide sequence represented by SEQ ID NOS: 46598, 46599, 46600, 46601, 46602, 46603, 46604, 46605, 46606, 46607, 46608 were selected from the 783 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3676. The probes having the nucleotide sequence represented by SEQ ID NOS: 46609, 46610, 46611, 46612, 46613, 46614, 5 46615, 46616, 46617, 46618, 46619 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3677. The probes having the nucleotide sequence represented by SEQ ID NOS: 46620, 46621, 46622, 46623, 46624, 46625, 10 46626, 46627, 46628, 46629, 46630 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3678. The probes having the nucleotide sequence represented by SEQ ID NOS: 46631, 46632, 46633, 46634, 46635, 46636, 15 46637, 46638, 46639, 46640, 46641 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3679. The probes having the nucleotide sequence represented by SEQ ID NOS: 46642, 46643, 46644, 46645, 46646, 46647, 20 46648, 46649, 46650, 46651, 46652 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3680. The probes having the nucleotide sequence represented by SEQ ID NOS: 46653, 46654, 46655, 46656, 46657, 46658, 25 46659, 46660, 46661, 46662, 46663 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3681. 784 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 46664, 46665, 46666, 46667, 46668, 46669, 46670, 46671, 46672, 46673, 46674 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3682. The probes having the nucleotide sequence represented by SEQ ID NOS: 46675, 46676, 46677, 46678, 46679, 46680, 46681, 46682, 46683, 46684, 46685 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3683. The probes having the nucleotide sequence represented by SEQ ID NOS: 46686, 46687, 46688, 46689, 46690, 46691, 46692, 46693, 46694, 46695, 46696 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3684. The probes having the nucleotide sequence represented by SEQ ID NOS: 46697, 46698, 46699, 46700, 46701, 46702, 46703, 46704, 46705, 46706, 46707 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3685. The probes having the nucleotide sequence represented by SEQ ID NOS: 46708, 46709, 46710, 46711, 46712, 46713, 46714, 46715, 46716, 46717, 46718 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3686. The probes having the nucleotide sequence represented by SEQ ID NOS: 46719, 46720, 46721, 46722, 46723, 46724, 46725, 46726, 46727, 46728, 46729 were selected from the 785 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3687. The probes having the nucleotide sequence represented by SEQ ID NOS: 46730, 46731, 46732, 46733, 46734, 46735, 5 46736, 46737, 46738, 46739, 46740 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3688. The probes having the nucleotide sequence represented by SEQ ID NOS: 46741, 46742, 46743, 46744, 46745, 46746, 10 46747, 46748, 46749, 46750, 46751 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3689. The probes having the nucleotide sequence represented by SEQ ID NOS: 46752, 46753, 46754, 46755, 46756, 46757, 15 46758, 46759, 46760, 46761, 46762 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3690. The probes having the nucleotide sequence represented by SEQ ID NOS: 46763, 46764, 46765, 46766, 46767, 46768, 20 46769, 46770, 46771, 46772, 46773 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3691. The probes having the nucleotide sequence represented by SEQ ID NOS: 46774, 46775, 46776, 46777, 46778, 46779, 25 46780, 46781, 46782, 46783, 46784 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3692. 786 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 46785, 46786, 46787, 46788, 46789, 46790, 46791, 46792, 46793, 46794, 46795 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3693. The probes having the nucleotide sequence represented by SEQ ID NOS: 46796, 46797, 46798, 46799, 46800, 46801, 46802, 46803, 46804, 46805, 46806 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3694. The probes having the nucleotide sequence represented by SEQ ID NOS: 46807, 46808, 46809, 46810, 46811, 46812, 46813, 46814, 46815, 46816, 46817 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3695. The probes having the nucleotide sequence represented by SEQ ID NOS: 46818, 46819, 46820, 46821, 46822, 46823, 46824, 46825, 46826, 46827, 46828 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3696. The probes having the nucleotide sequence represented by SEQ ID NOS: 46829, 46830, 46831, 46832, 46833, 46834, 46835, 46836, 46837, 4.6838, 46839 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3697. The probes having the nucleotide sequence represented by SEQ ID NOS: 46840, 46841, 46842, 46843, 46844, 46845, 46846, 46847, 46848, 46849, 46850 were selected from the 787 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3698. The probes having the nucleotide sequence represented by SEQ ID NOS: 46851, 46852, 46853, 46854, 46855, 46856, 5 46857, 46858, 46859, 46860, 46861 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3699. The probes having the nucleotide sequence represented by SEQ ID NOS: 46862, 46863, 46864, 46865, 46866, 46867, 10 46868, 46869, 46870, 46871, 46872 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3700. The probes having the nucleotide sequence represented by SEQ ID NOS: 46873, 46874, 46875, 46876, 46877, 46878, 15 46879, 46880, 46881, 46882, 46883 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3701. The probes having the nucleotide sequence represented by SEQ ID NOS: 46884, 46885, 46886, 46887, 46888, 46889, 20 46890, 46891, 46892, 46893, 46894 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3702. The probes having the nucleotide sequence represented by SEQ ID NOS: 46895, 46896, 46897, 46898, 46899, 46900, 25 46901, 46902, 46903, 46904, 46905 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3703. 788 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 46906, 46907, 46908, 46909, 46910, 46911, 46912, 46913, 46914, 46915, 46916, 46917, 46918, 46919, 46920, 46921, 46922, 46923, 46924, 46925, 46926, 46927 were 5 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3704. The probes having the nucleotide sequence represented by SEQ ID NOS: 46928, 46929, 46930, 46931, 46932, 46933, 46934, 46935, 46936, 46937, 46938 were selected from the 10 ORFs having the nucleotide sequence represented by SEQ ID NO: 3705. The probes having the nucleotide sequence represented by SEQ ID NOS: 46939, 46940, 46941, 46942, 46943, 46944, 46945, 46946, 46947, 46948, 46949 were selected from the 15 ORFs having the nucleotide sequence represented by SEQ ID NO: 3706. The probes having the nucleotide sequence represented by SEQ ID NOS: 46950, 46951, 46952, 46953, 46954, 46955, 46956, 46957, 46958, 46959, 46960 were selected from the 20 ORFs having the nucleotide sequence represented by SEQ ID NO: 3707. The probes having the nucleotide sequence represented by SEQ ID NOS: 46961, 46962, 46963, 46964, 46965, 46966, 46967, 46968, 46969, 46970, 46971 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 3708. The probes having the nucleotide sequence represented by SEQ ID NOS: 46972, 46973, 46974, 46975, 46976, 46977, 789 WO 2006/024951 PCT/IB2005/002908 46978, 46979, 46980, 46981, 46982 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3709. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 46983, 46984, 46985, 46986, 46987, 46988, 46989, 46990, 46991, 46992, 46993 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3710. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 46994, 46995, 46996, 46997, 46998, 46999, 47000, 47001, 47002, 47003, 47004 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3711. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 47005, 47006, 47007, 47008, 47009, 47010, 47011, 47012, 47013, 47014, 47015 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3712. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 47016, 47017, 47018, 47019, 47020, 47021, 47022, 47023, 47024, 47025, 47026 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3713. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 47027, 47028, 47029, 47030, 47031, 47032, 47033, 47034, 47035, 47036, 47037, 47038, 47039, 47040, 47041, 47042, 47043, 47044, 47045, 47046, 47047, 47048 were 790 WO 2006/024951 PCT/IB2005/002908 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3714. The probes having the nucleotide sequence represented by SEQ ID NOS: 47049, 47050, 47051, 47052, 47053, 47054, 5 47055, 47056, 47057, 47058, 47059 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3715. The probes having the nucleotide sequence represented by SEQ ID NOS: 47060, 47061, 47062, 47063, 47064, 47065, 10 47066, 47067, 47068, 47069, 47070 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3716. The probes having the nucleotide sequence represented by SEQ ID NOS: 47071, 47072, 47073, 47074, 47075, 47076, 15 47077, 47078, 47079, 47080, 47081 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3717. The probes having the nucleotide sequence represented by SEQ ID NOS: 47082, 47083, 47084, 47085, 47086, 47087, 20 47088, 47089, 47090, 47091, 47092 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3718. The probes having the nucleotide sequence represented by SEQ ID NOS: 47093, 47094, 47095, 47096, 47097, 47098, 25 47099, 47100, 47101, 47102, 47103 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3719. 791 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 47104, 47105, 47106, 47107, 47108, 47109, 47110, 47111, 47112, 47113, 47114, 47115, 47116, 47117, 47118, 47119, 47120, 47121, 47122, 47123, 47124, 47125 were 5 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3720. The probes having the nucleotide sequence represented by SEQ ID NOS: 47126, 47127, 47128, 47129, 47130, 47131, 47132, 47133, 47134, 47135, 47136 were selected from the 10 ORFs having the nucleotide sequence represented by SEQ ID NO: 3721. The probes having the nucleotide sequence represented by SEQ ID NOS: 47137, 47138, 47139, 47140, 47141, 47142, 47143, 47144, 47145, 47146, 47147 were selected from the 15 ORFs having the nucleotide sequence represented by SEQ ID NO: 3722. The probes having the nucleotide sequence represented by SEQ ID NOS: 47148, 47149, 47150, 47151, 47152, 47153, 47154, 47155, 47156, 47157, 47158 were selected from the 20 ORFs having the nucleotide sequence represented by SEQ ID NO: 3723. The probes having the nucleotide sequence represented by SEQ ID NOS: 47159, 47160, 47161, 47162, 47163, 47164, 47165, 47166, 47167, 47168, 47169 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 3724. The probes having the nucleotide sequence represented by SEQ ID NOS: 47170, 47171, 47172, 47173, 47174, 47175, 792 WO 2006/024951 PCT/IB2005/002908 47176, 47177, 47178, 47179, 47180 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3725. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 47181, 47182, 47183, 47184, 47185, 47186, 47187, 47188, 47189, 47190, 47191 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3726. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 47192, 47193, 47194, 47195, 47196, 47197, 47198, 47199, 47200, 47201, 47202 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3727. . The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 47203, 47204, 47205, 47206, 47207, 47208, 47209, 47210, 47211, 47212, 47213 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3728. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 47214, 47215, 47216, 47217, 47218, 47219, 47220, 47221, 47222, 47223, 47224 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3729. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 47225, 47226, 47227, 47228, 47229, 47230, 47231, 47232, 47233, 47234, 47235 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3730. 793 WO 2006/024951 PCT/IB2005/002908 The probes having .the nucleotide sequence represented by SEQ ID NOS: 47236, 47237, 47238, 47239, 47240, 47241, 47242, 47243, 47244, 47245, 47246 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3731. The probes having the nucleotide sequence represented by SEQ ID NOS: 47247, 47248, 47249, 47250, 47251, 47252, 47253, 47254, 47255, 47256, 47257 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3732. The probes having the nucleotide sequence represented by SEQ ID NOS: 47258, 47259, 47260, 47261, 47262, 47263, 47264, 47265, 47266, 47267, 47268 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3733. The probes having the nucleotide sequence represented by SEQ ID NOS: 47269, 47270, 47271, 47272, 47273, 47274, 47275, 47276, 47277, 47278, 47279 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3734. The probes having the nucleotide sequence represented by SEQ ID NOS: 47280, 47281, 47282, 47283, 47284, 47285, 47286, 47287, 47288, 47289, 47290 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3735. The probes having the nucleotide sequence represented by SEQ ID NOS: 47291, 47292, 47293, 47294, 47295, 47296, 47297, 47298, 47299, 47300, 47301 were selected from the 794 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3736. The probes having the nucleotide sequence represented by SEQ ID NOS: 47302, 47303, 47304, 47305, 47306, 47307, 5 47308, 47309, 47310, 47311, 47312 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3737. The probes having the nucleotide sequence represented by SEQ ID NOS: 47313, 47314, 47315, 47316, 47317, 47318, 10 47319, 47320, 47321, 47322, 47323 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3738. The probes having the nucleotide sequence represented by SEQ ID NOS: 47324, 47325, 47326, 47327, 47328, 47329, 15 47330, 47331, 47332, 47333, 47334 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3739. The probes having the nucleotide sequence represented by SEQ ID NOS: 47335, 47336, 47337, 47338, 47339, 47340, 20 47341, 47342, 47343, 47344, 47345 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3740. The probes having the nucleotide sequence represented by SEQ ID NOS: 47346, 47347, 47348, 47349, 47350, 47351, 25 47352, 47353, 47354, 47355, 47356 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3741. 795 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 47357, 47358, 47359, 47360, 47361, 47362, 47363, 47364, 47365, 47366, 47367 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3742. The probes having the nucleotide sequence represented by SEQ ID NOS: 47368, 47369, 47370, 47371, 47372, 47373, 47374, 47375, 47376, 47377, 47378 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3743. The probes having the nucleotide sequence represented by SEQ ID NOS: 47379, 47380, 47381, 47382, 47383, 47384, 47385, 47386, 47387, 47388, 47389 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3744. The probes having the nucleotide sequence represented by SEQ ID NOS: 47390, 47391, 47392, 47393, 47394, 47395, 47396, 47397, 47398, 47399, 47400 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3745. The probes having the nucleotide sequence represented by SEQ ID NOS: 47401, 47402, 47403, 47404, 47405, 47406, 47407, 47408, 47409, 47410, 47411 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3746. The probes having the nucleotide sequence represented by SEQ ID NOS: 47412, 47413, 47414, 47415, 47416, 47417, 47418, 47419, 47420, 47421, 47422 were selected from the 796 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3747. The probes having the nucleotide sequence represented by SEQ ID NOS: 47423, 47424, 47425, 47426, 47427, 47428, 5 47429, 47430, 47431, 47432, 47433 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3748. The probes having the nucleotide sequence represented by SEQ ID NOS: 47434, 47435, 47436, 47437, 47438, 47439, 10 47440, 47441, 47442, 47443, 47444 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3749. The probes having the nucleotide sequence represented by SEQ ID NOS: 47445, 47446, 47447, 47448, 47449, 47450, 15 47451, 47452, 47453, 47454, 47455 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3750. The probes having the nucleotide sequence represented by SEQ ID NOS: 47456, 47457, 47458, 47459, 47460, 47461, 20 47462, 47463, 47464, 47465, 47466 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3751. The probes having the nucleotide sequence represented by SEQ ID NOS: 47467, 47468, 47469, 47470, 47471, 47472, 25 47473, 47474, 47475, 47476, 47477 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3752. 797 WO 2006/024951 PCT/IB2005/002908 PC The probes having the nucleotide sequence represented by SEQ ID NOS: 47478, 47479, 47480, 47481, 47482, 47483, 47484, 47485, 47486, 47487, 47488 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3753. The probes having the nucleotide sequence represented by SEQ ID NOS: 47489, 47490, 47491, 47492, 47493, 47494, 47495, 47496, 47497, 47498, 47499 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3754. The probes having the nucleotide sequence represented by SEQ ID NOS: 47500, 47501, 47502, 47503, 47504, 47505, 47506, 47507, 47508, 47509, 47510 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3755. The probes having the nucleotide sequence represented by SEQ ID NOS: 47511, 47512, 47513, 47514, 47515, 47516, 47517, 47518, 47519, 47520, 47521 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3756. The probes having the nucleotide sequence represented by SEQ ID NOS: 47522, 47523, 47524, 47525, 47526, 47527, 47528, 47529, 47530, 47531, 47532 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3757. The probes having the nucleotide sequence represented by SEQ ID NOS: 47533, 47534, 47535, 47536, 47537, 47538, 47539, 47540, 47541, 47542, 47543 were selected from the 798 WO 2006/024951 PCT/IB2005/002908 PI ORFs having the nucleotide sequence represented by SEQ ID NO: 3758. The probes having the nucleotide sequence represented by SEQ ID NOS: 47544, 47545, 47546, 47547, 47548, 47549, 5 47550, 47551, 47552, 47553, 47554 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3759. The probes having the nucleotide sequence represented by SEQ ID NOS: 47555, 47556, 47557, 47558, 47559, 47560, 10 47561, 47562, 47563, 47564, 47565 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3760. The probes having the nucleotide sequence represented by SEQ ID NOS: 47566, 47567, 47568, 47569, 47570, 47571, 15 47572, 47573, 47574, 47575, 47576 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3761. The probes having the nucleotide sequence represented by SEQ ID NOS: 47577, 47578, 47579, 47580, 47581, 47582, 20 47583, 47584, 47585, 47586, 47587 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3762. The probes having the nucleotide sequence represented by SEQ ID NOS: 47588, 47589, 47590, 47591, 47592, 47593, 25 47594, 47595, 47596, 47597, 47598 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3763. 799 WO 2006/024951 PCT/IB2005/002908 F The probes having the nucleotide sequence represented by SEQ ID NOS: 47599, 47600, 47601, 47602, 47603, 47604, 47605, 47606, 47607, 47608, 47609 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3764. The probes having the nucleotide sequence represented by SEQ ID NOS: 47610, 47611, 47612, 47613, 47614, 47615, 47616, 47617, 47618, 47619, 47620 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3765. The probes having the nucleotide sequence represented by SEQ ID NOS: 47621, 47622, 47623, 47624, 47625, 47626, 47627, 47628, 47629, 47630, 47631 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3766. The probes having the nucleotide sequence represented by SEQ ID NOS: 47632, 47633, 47634, 47635, 47636, 47637, 47638, 47639, 47640, 47641, 47642 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3767. The probes having the nucleotide sequence represented by SEQ ID NOS: 47643, 47644, 47645, 47646, 47647, 47648, 47649, 47650, 47651, 47652, 47653 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3768. The probes having the nucleotide sequence represented by SEQ ID NOS: 47654, 47655, 47656, 47657, 47658, 47659, 47660, 47661, 47662, 47663, 47664 were selected from the 800 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3769. The probes having the nucleotide sequence represented by SEQ ID NOS: 47665, 47666, 47667, 47668, 47669, 47670, 5 47671, 47672, 47673, 47674, 47675 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3770. The probes having the nucleotide sequence represented by SEQ ID NOS: 47676, 47677, 47678, 47679, 47680, 47681, 10 47682, 47683, 47684, 47685, 47686 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3771. The probes having the nucleotide sequence represented by SEQ ID NOS: 47687, 47688, 47689, 47690, 47691, 47692, 15 47693, 47694, 47695, 47696, 47697 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3772. The probes having the nucleotide sequence represented by, SEQ ID NOS: 47698, 47699, 47700, 47701, 47702, 47703, 20 47704, 47705, 47706, 47707, 47708 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3773. The probes having the nucleotide sequence represented by SEQ ID NOS: 47709, 47710, 47711, 47712, 47713, 47714, 25 47715, 47716, 47717, 47718, 47719 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3774. 801 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 47720, 47721, 47722, 47723, 47724, 47725, 47726, 47727, 47728, 47729, 47730 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3775. The probes having the nucleotide sequence represented by SEQ ID NOS: 47731, 47732, 47733, 47734, 47735, 47736, 47737, 47738, 47739, 47740, 47741 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3776. The probes having the nucleotide sequence represented by SEQ ID NOS: 47742, 47743, 47744, 47745, 47746, 47747, 47748, 47749, 47750, 47751, 47752, 47753, 47754, 47755, 47756, 47757, 47758, 47759, 47760, 47761, 47762, 47763 were 15 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3777. The probes having the nucleotide sequence represented by SEQ ID NOS: 47764, 47765, 47766, 47767, 47768, 47769, 47770, 47771, 47772, 47773, 47774 were selected from the 20 ORFs having the nucleotide sequence represented by SEQ ID NO: 3778. The probes having the nucleotide sequence represented by SEQ ID NOS: 47775, 47776, 47777, 47778, 47779, 47780, 47781, 47782, 47783, 47784, 47785 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 3779. The probes having the nucleotide sequence represented by SEQ ID NOS: 47786, 47787, 47788, 47789, 47790, 47791, 802 WO 2006/024951 PCT/IB2005/002908 47792, 47793, 47794, 47795, 47796 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3780. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 47797, 47798, 47799, 47800, 47801, 47802, 47803, 47804, 47805, 47806, 47807 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3781. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 47808, 47809, 47810, 47811, 47812, 47813, 47814, 47815, 47816, 47817, 47818 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3782. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 47819, 47820, 47821, 47822, 47823, 47824, 47825, 47826, 47827, 47828, 47829 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3783. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 47830, 47831, 47832, 47833, 47834, 47835, 47836, 47837, 47838, 47839, 47840 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3784. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 47841, 47842, 47843, 47844, 47845, 47846, 47847, 47848, 47849, 47850, 47851 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3785. 803 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 47852, 47853, 47854, 47855, 47856, 47857, 47858, 47859, 47860, 47861, 47862 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3786. The probes having the nucleotide sequence represented by SEQ ID NOS: 47863, 47864, 47865, 47866, 47867, 47868, 47869, 47870, 47871, 47872, 47873 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3787. The probes having the nucleotide sequence represented by SEQ ID NOS: 47874, 47875, 47876, 47877, 47878, 47879, 47880, 47881, 47882, 47883, 47884 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3788. The probes having the nucleotide sequence represented by SEQ ID NOS: 47885, 47886, 47887, 47888, 47889, 47890, 47891, 47892, 47893, 47894, 47895 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3789. The probes having the nucleotide sequence represented by SEQ ID NOS: 47896, 47897, 47898, 47899, 47900, 47901, 47902, 47903, 47904, 47905, 47906 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3790. The probes having the nucleotide sequence represented by SEQ ID NOS: 47907, 47908, 47909, 47910, 47911, 47912, 47913, 47914, 47915, 47916, 47917 were selected from the 804 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3791. The probes having the nucleotide sequence represented by SEQ ID NOS: 47918, 47919, 47920, 47921, 47922, 47923, 5 47924, 47925, 47926, 47927, 47928 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3792. The probes having the nucleotide~sequence represented by SEQ ID NOS: 47929, 47930, 47931, 47932, 47933, 47934, 10 47935, 47936, 47937, 47938, 47939 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3793. The probes having the nucleotide sequence represented by SEQ ID NOS: 47940, 47941, 47942, 47943, 47944, 47945, 15 47946, 47947, 47948, 47949, 47950 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3794. The probes having the nucleotide sequence represented by SEQ ID NOS: 47951, 47952, 47953, 47954, 47955, 47956, 20 47957, 47958, 47959, 47960, 47961 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3795. The probes having the nucleotide sequence represented by SEQ ID NOS: 47962, 47963, 47964, 47965, 47966, 47967, 25 47968, 47969, 47970, 47971, 47972 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3796. 805 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 47973, 47974, 47975, 47976, 47977, 47978, 47979, 47980, 47981, 47982, 47983 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3797. The probes having the nucleotide sequence represented by SEQ ID NOS: 47984, 47985, 47986, 47987, 47988, 47989, 47990, 47991, 47992, 47993, 47994 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3798. The probes having the nucleotide sequence represented by SEQ ID NOS: 47995, 47996, 47997, 47998, 47999, 48000, 48001, 48002, 48003, 48004, 48005 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3799. The probes having the nucleotide sequence represented by SEQ ID NOS: 48006, 48007, 48008, 48009, 48010, 48011, 48012, 48013, 48014, 48015, 48016 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3800. The probes having the nucleotide sequence represented by SEQ ID NOS: 48017, 48018, 48019, 48020, 48021, 48022, 48023, 48024, 48025, 48026, 48027 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3801. The probes having the nucleotide sequence represented by SEQ ID NOS: 48028, 48029, 48030, 48031, 48032, 48033, 48034, 48035, 48036, 48037, 48038 were selected from the 806 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3802. The probes having the nucleotide sequence represented by SEQ ID NOS: 48039, 48040, 48041, 48042, 48043, 48044, 5 48045, 48046, 48047, 48048, 48049 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3803. The probes having the nucleotide sequence represented by SEQ ID NOS: 48050, 48051, 48052, 48053, 48054, 48055, 10 48056, 48057, 48058, 48059, 48060 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3804. The probes having the nucleotide sequence represented by SEQ ID NOS: 48061, 48062, 48063, 48064, 48065, 48066, 15 48067, 48068, 48069, 48070, 48071 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3805. The probes having the nucleotide sequence represented by SEQ ID NOS: 48072, 48073, 48074, 48075, 48076, 48077, 20 48078, 48079, 48080, 48081, 48082 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3806. The probes having the nucleotide sequence represented by SEQ ID NOS: 48083, 48084, 48085, 48086, 48087, 48088, 25 48089, 48090, 48091, 48092, 48093 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3807. 807 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 48094, 48095, 48096, 48097, 48098, 48099, 48100, 48101, 48102, 48103, 48104 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3808. The probes having the nucleotide sequence represented by SEQ ID NOS: 48105, 48106, 48107, 48108, 48109, 48110, 48111, 48112, 48113, 48114, 48115 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3809. The probes having the nucleotide sequence represented by SEQ ID NOS: 48116, 48117, 48118, 48119, 48120, 48121, 48122, 48123, 48124, 48125, 48126 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3810. The probes having the nucleotide sequence represented by SEQ ID NOS: 48127, 48128, 48129, 48130, 48131, 48132, 48133, 48134, 48135, 48136, 48137 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3811. The probes having the nucleotide sequence represented by SEQ ID NOS: 48138, 48139, 48140, 48141, 48142, 48143, 48144, 48145, 48146, 48147, 48148 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3812. The probes having the nucleotide sequence represented by SEQ ID NOS: 48149, 48150, 48151, 48152, 48153, 48154, 48155, 48156, 48157, 48158, 48159 were selected from the 808 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3813. The probes having the nucleotide sequence represented by SEQ ID NOS: 48160, 48161, 48162, 48163, 48164, 48165, 5 48166, 48167, 48168, 48169, 48170 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3814. The probes having the nucleotide sequence represented by SEQ ID NOS: 48171, 48172, 48173, 48174, 48175, 48176, 10 48177, 48178, 48179, 48180, 48181 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3815. The probes having the nucleotide sequence represented by SEQ ID NOS: 48182, 48183, 48184, 48185, 48186, 48187, 15 48188, 48189, 48190, 48191, 48192 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3816. The probes having the nucleotide sequence represented by SEQ ID NOS: 48193, 48194, 48195, 48196, 48197, 48198, 20 48199, 48200, 48201, 48202, 48203 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3817. The probes having the nucleotide sequence represented by SEQ ID NOS: 48204, 48205, 48206, 48207, 48208, 48209, 25 48210, 48211, 48212, 48213, 48214 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3818. 809 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 48215, 48216, 48217, 48218, 48219, 48220, 48221, 48222, 48223, 48224, 48225 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3819. The probes having the nucleotide sequence represented by SEQ ID NOS: 48226, 48227, 48228, 48229, 48230, 48231, 48232, 48233, 48234, 48235, 48236 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3820. The probes having the nucleotide sequence represented by SEQ ID NOS: 48237, 48238, 48239, 48240, 48241, 48242, 48243, 48244, 48245, 48246, 48247 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3821. The probes having the nucleotide sequence represented by SEQ ID NOS: 48248, 48249, 48250, 48251, 48252, 48253, 48254, 48255, 48256, 48257, 48258 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3822. The probes having the nucleotide sequence represented by SEQ ID NOS: 48259, 48260, 48261, 48262, 48263, 48264, 48265, 48266, 48267, 48268, 48269 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3823. The probes having the nucleotide sequence represented by SEQ ID NOS: 48270, 48271, 48272, 48273, 48274, 48275, 48276, 48277, 48278, 48279, 48280 were selected from the 810 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3824. The probes having the nucleotide sequence represented by SEQ ID NOS: 48281, 48282, 48283, 48284, 48285, 48286, 5 48287, 48288, 48289, 48290, 48291 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3825. The probes having the nucleotide sequence represented by SEQ ID NOS: 48292, 48293, 48294, 48295, 48296, 48297, 10 48298, 48299, 48300, 48301, 48302 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3826. The probes having the nucleotide sequence represented by SEQ ID NOS: 48303, 48304, 48305, 48306, 48307, 48308, 15 48309, 48310, 48311, 48312, 48313, 48314, 48315, 48316, 48317, 48318, 48319, 48320, 48321, 48322, 48323, 48324 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3827. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 48325, 48326, 48327, 48328, 48329, 48330, 48331, 48332, 48333, 48334, 48335 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3828. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 48336, 48337, 48338, 48339, 48340, 48341, 48342, 48343, 48344, 48345, 48346 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3829. 811 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 48347, 48348, 48349, 48350, 48351, 48352, 48353, 48354, 48355, 48356, 48357 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3830. The probes having the nucleotide sequence represented by SEQ ID NOS: 48358, 48359, 48360, 48361, 48362, 48363, 48364, 48365, 48366, 48367, 48368 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3831. The probes having the nucleotide sequence represented by SEQ ID NOS: 48369, 48370, 48371, 48372, 48373, 48374, 48375, 48376, 48377, 48378, 48379 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3832. The probes having the nucleotide sequence represented by SEQ ID NOS: 48380, 48381, 48382, 48383, 48384, 48385, 48386, 48387, 48388, 48389, 48390 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3833. The probes having the nucleotide sequence represented by SEQ ID NOS: 48391, 48392, 48393, 48394, 48395, 48396, 48397, 48398, 48399, 48400, 48401 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3834. The probes having the nucleotide sequence represented by SEQ ID NOS: 48402, 48403, 48404, 48405, 48406, 48407, 48408, 48409, 48410, 48411, 48412 were selected from the 812 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3835. The probes having the nucleotide sequence represented by SEQ ID NOS: 48413, 48414, 48415, 48416, 48417, 48418, 5 48419, 48420, 48421, 48422, 48423 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3836. The probes having the nucleotide sequence represented by SEQ ID NOS: 48424, 48425, 48426, 48427, 48428, 48429, 10 48430, 48431, 48432, 48433, 48434 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3837. The probes having the nucleotide sequence represented by SEQ ID NOS: 48435, 48436, 48437, 48438, 48439, 48440, 15 48441, 48442, 48443, 48444, 48445, 48446, 48447, 48448, 48449, 48450, 48451, 48452, 48453, 48454, 48455, 48456 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3838. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 48457, 48458, 48459, 48460, 48461, 48462, 48463, 48464, 48465, 48466, 48467 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3839. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: -48468, 48469, 48470, 48471, 48472, 48473, 48474, 48475, 48476, 48477, 48478 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3840. 813 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 48479, 48480, 48481, 48482, 48483, 48484, 48485, 48486, 48487, 48488, 48489 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3841. The probes having the nucleotide sequence represented by SEQ ID NOS: 48490, 48491, 48492, 48493, 48494, 48495, 48496, 48497, 48498, 48499, 48500 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3842. The probes having the nucleotide sequence represented by SEQ ID NOS: 48501, 48502, 48503, 48504, 48505, 48506, 48507, 48508, 48509, 48510, 48511 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3843. The probes having the nucleotide sequence- represented by SEQ ID NOS: 48512, 48513, 48514, 48515, 48516, 48517, 48518, 48519, 48520, 48521, 48522 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3844. The probes having the nucleotide sequence represented by SEQ ID NOS: 48523, 48524, 48525, 48526, 48527, 48528, 48529, 48530, 48531, 48532, 48533 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3845. The probes having the nucleotide sequence represented by SEQ ID NOS: 48534, 48535, 48536, 48537, 48538, 48539, 48540, 48541, 48542, 48543, 48544, 48545, 48546, 48547, 814 WO 2006/024951 PCT/IB2005/002908 48548, 48549, 48550, 48551, 48552, 48553, 48554, 48555 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3846. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 48556, 48557, 48558, 48559, 48560, 48561, 48562, 48563, 48564, 48565, 48566 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3847. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 48567, 48568, 48569, 48570, 48571, 48572, 48573, 48574, 48575, 48576, 48577 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3848. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 48578, 48579, 48580, 48581, 48582, 48583, 48584, 48585, 48586, 48587, 48588 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3849. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 48589, 48590, 48591, 48592, 48593, 48594, 48595, 48596, 48597, 48598, 48599 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3850. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 48600, 48601, 48602, 48603, 48604, 48605, 48606, 48607, 48608, 48609, 48610 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3851. 815 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 48611, 48612, 48613, 48614, 48615, 48616, 48617, 48618, 48619, 48620, 48621 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3852. The probes having the nucleotide sequence represented by SEQ ID NOS: 48622, 48623, 48624, 48625, 48626, 48627, 48628, 48629, 48630, 48631, 48632 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3853. The probes having the nucleotide sequence represented by SEQ ID NOS: 48633, 48634, 48635, 48636, 48637, 48638, 48639, 48640, 48641, 48642, 48643 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3854. The probes having the nucleotide sequence represented by SEQ ID NOS: 48644, 48645, 48646, 48647, 48648, 48649, 48650, 48651, 48652, 48653, 48654 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3855. The probes having the nucleotide sequence represented by SEQ ID NOS: 48655, 48656, 48657, 48658, 48659, 48660, 48661, 48662, 48663, 48664, 48665 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3856. The probes having the nucleotide sequence represented by SEQ ID NOS: 48666, 48667, 48668, 48669, 48670, 48671, 48672, 48673, 48674, 48675, 48676 were selected from the 816 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3857. The probes having the nucleotide sequence represented by SEQ ID NOS: 48677, 48678, 48679, 48680, 48681, 48682, 5 48683, 48684, 48685, 48686, 48687 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3858. The probes having the nucleotide sequence represented by SEQ ID NOS: 48688, 48689, 48690, 48691, 48692, 48693, 10 48694, 48695, 48696, 48697, 48698 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3859. The probes having the nucleotide sequence represented by SEQ ID NOS: 48699, 48700, 48701, 48702, 48703, 48704, 15 48705, 48706, 48707, 48708, 48709 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3860. The probes having the nucleotide sequence represented by SEQ ID NOS: 48710, 48711, 48712, 48713, 48714, 48715, 20 48716, 48717, 48718, 48719, 48720 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3861. The probes having the nucleotide sequence represented by SEQ ID NOS: 48721, 48722, 48723, 48724, 48725, 48726, 25 48727, 48728, 48729, 48730, 48731 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3862. 817 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 48732, 48733, 48734, 48735, 48736, 48737, 48738, 48739, 48740, 48741, 48742 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3863. The probes having the nucleotide sequence represented by SEQ ID NOS: 48743, 48744, 48745, 48746, 48747, 48748, 48749, 48750, 48751, 48752, 48753 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3864. The probes having the nucleotide sequence represented by SEQ ID NOS: 48754, 48755, 48756, 48757, 48758, 48759, 48760, 48761, 48762, 48763, 48764 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3865. The probes having the nucleotide sequence represented by SEQ ID NOS: 48765, 48766, 48767, 48768, 48769, 48770, 48771, 48772, 48773, 48774, 48775 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3866. The probes having the nucleotide sequence represented by SEQ ID NOS: 48776, 48777, 48778, 48779, 48780, 48781, 48782, 48783, 48784, 48785, 48786 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3867. The probes having the nucleotide sequence represented by SEQ ID NOS: 48787, 48788, 48789, 48790, 48791, 48792, 48793, 48794, 48795, 48796, 48797 were selected from the 818 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3868. The probes having the nucleotide sequence represented by SEQ ID NOS: 48798, 48799, 48800, 48801, 48802, 48803, 5 48804, 48805, 48806, 48807, 48808 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3869. The probes having the nucleotide sequence represented by SEQ ID NOS: 48809, 48810, 48811, 48812, 48813, 48814, 10 48815, 48816, 48817, 48818, 48819 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3870. The probes having the nucleotide sequence represented by SEQ ID NOS: 48820, 48821, 48822, 48823, 48824, 48825, 15 48826, 48827, 48828, 48829, 48830 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3871. The probes having the nucleotide sequence represented by SEQ ID NOS: 48831, 48832, 48833, 48834, 48835, 48836, 20 48837, 48838, 48839, 48840, 48841, 48842, 48843, 48844, 48845, 48846, 48847, 48848, 48849, 48850, 48851, 48852 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3872. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 48853, 48854, 48855, 48856, 48857, 48858, 48859, 48860, 48861, 48862, 48863, 48864, 48865, 48866, 48867, 48868, 48869, 48870, 48871, 48872, 48873, 48874 were 819 WO 2006/024951 PCT/IB2005/002908 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3873. The probes having the nucleotide sequence represented by SEQ ID NOS: 48875, 48876, 48877, 48878, 48879, 48880, 5 48881, 48882, 48883, 48884, 48885 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3874. The probes having the nucleotide sequence represented by SEQ ID NOS: 48886, 48887, 48888, 48889, 48890, 48891, 10 48892, 48893, 48894, 48895, 48896 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3875. The probes having the nucleotide sequence represented by SEQ ID NOS: 48897, 48898, 48899, 48900, 48901, 48902, 15 48903, 48904, 48905, 48906, 48907 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3876. The probes having the nucleotide sequence represented by SEQ ID NOS: 48908, 48909, 48910, 48911, 48912, 48913, 20 48914, 48915, 48916, 48917, 48918 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3877. The probes having the nucleotide sequence represented by SEQ ID NOS: 48919, 48920, 48921, 48922, 48923, 48924, 25 48925, 48926, 48927, 48928, 48929 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3878. 820 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 48930, 48931, 48932, 48933, 48934, 48935, 48936, 48937, 48938, 48939, 48940 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3879. The probes having the nucleotide sequence represented by SEQ ID NOS: 48941, 48942, 48943, 48944, 48945, 48946, 48947, 48948, 48949, 48950, 48951 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3880. The probes having the nucleotide sequence represented by SEQ ID NOS: 48952, 48953, 48954, 48955, 48956, 48957, 48958, 48959, 48960, 48961, 48962 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3881. The probes having the nucleotide sequence represented by SEQ ID NOS: 48963, 48964, 48965, 48966, 48967, 48968, 48969, 48970, 48971, 48972, 48973 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3882. The probes having the nucleotide sequence represented by SEQ ID ,NOS: 48974, 48975, 48976, 48977, 48978, 48979, 48980, 48981, 48982, 48983, 48984 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3883. The probes having the nucleotide sequence represented by SEQ ID NOS: 48985, 48986, 48987, 48988, 48989, 48990, 48991, 48992, 48993, 48994, 48995 were selected from the 821 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3884. The probes having the nucleotide sequence represented by SEQ ID NOS: 48996, 48997, 48998, 48999, 49000, 49001, 5 49002, 49003, 49004, 49005, 49006 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3885. The probes having the nucleotide sequence represented by SEQ ID NOS: 49007, 49008, 49009, 49010, 49011, 49012, 10 49013, 49014, 49015, 49016, 49017 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3886. The probes having the nucleotide sequence represented by SEQ ID NOS: 49018, 49019, 49020, 49021, 49022, 49023, 15 49024, 49025, 49026, 49027, 49028 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3887. The probes having the nucleotide sequence represented by SEQ ID NOS: 49029, 49030, 49031, 49032, 49033, 49034, 20 49035, 49036, 49037, 49038, 49039 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3888. The probes having the nucleotide sequence represented by SEQ ID NOS: 49040, 49041, 49042, 49043, 49044, 49045, 25 49046, 49047, 49048, 49049, 49050 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3889. 822 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 49051, 49052, 49053, 49054, 49055, 49056, 49057, 49058, 49059, 49060 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 5 3890. The probes having the nucleotide sequence represented by SEQ ID NOS: 49061, 49062, 49063, 49064, 49065, 49066, 49067, 49068, 49069, 49070, 49071 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3891. The probes having the nucleotide sequence represented by SEQ ID NOS: 49072, 49073, 49074, 49075, 49076, 49077, 49078, 49079, 49080, 49081, 49082 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3892. The probes having the nucleotide sequence represented by SEQ ID NOS: 49083, 49084, 49085, 49086, 49087, 49088, 49089, 49090, 49091, 49092, 49093, 49094, 49095, 49096, 49097, 49098, 49099, 49100, 49101, 49102, 49103, 49104 were 20 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3893. The probes having the nucleotide sequence represented by SEQ ID NOS: 49105, 49106, 49107, 49108, 49109, 49110, 49111, 49112, 49113, 49114, 49115 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 3894. The probes having the nucleotide sequence represented by SEQ ID NOS: 49116, 49117, 49118, 49119, 49120, 49121, 823 WO 2006/024951 PCT/IB2005/002908 49122, 49123, 49124, 49125, 49126 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3895. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 49127, 49128, 49129, 49130, 49131, 49132, 49133, 49134, 49135, 49136, 49137 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3896. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 49138, 49139, 49140, 49141, 49142, 49143, 49144, 49145, 49146, 49147, 49148 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3897. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 49149, 49150, 49151, 49152, 49153, 49154, 49155, 49156, 49157, 49158, 49159 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3898. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 49160, 49161, 49162, 49163, 49164, 49165, 49166, 49167, 49168, 49169, 49170 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3899. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 49171, 49172, 49173, 49174, 49175, 49176, 49177, 49178, 49179, 49180, 49181 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3900. 824 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 49182, 49183, 49184, 49185, 49186, 49187, 49188, 49189, 49190, 49191, 49192 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3901. The probes having the nucleotide sequence represented by SEQ ID NOS: 49193, 49194, 49195, 49196, 49197, 49198, 49199, 49200, 49201, 49202, 49203 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3902. The probes having the nucleotide sequence represented by SEQ ID NOS: 49204, 49205, 49206, 49207, 49208, 49209, 49210, 49211, 49212, 49213, 49214 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3903. The probes having the nucleotide sequence represented by SEQ ID NOS: 49215, 49216, 49217, 49218, 49219, 49220, 49221, 49222, 49223, 49224, 49225 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3904. The probes having the nucleotide sequence represented by SEQ ID NOS: 49226, 49227, 49228, 49229, 49230, 49231, 49232, 49233, 49234, 49235, 49236, 49237, 49238, 49239, 49240, 49241, 49242, 49243, 49244, 49245, 49246, 49247 were 25 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3905. The probes having the nucleotide sequence represented by SEQ ID NOS: 49248, 49249, 49250, 49251, 49252, 49253, 825 WO 2006/024951 PCT/IB2005/002908 49254, 49255, 49256, 49257, 49258 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3906. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 49259, 49260, 49261, 49262, 49263, 49264, 49265, 49266, 49267, 49268, 49269 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3907. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 49270, 49271, 49272, 49273, 49274, 49275, 49276, 49277, 49278, 49279, 49280 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3908. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 49281, 49282, 49283, 49284, 49285, 49286, 49287, 49288, 49289, 49290, 49291 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3909. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 49292, 49293, 49294, 49295, 49296, 49297, 49298, 49299, 49300, 49301, 49302 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3910. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 49303, 49304, 49305, 49306, 49307, 49308, 49309, 49310, 49311, 49312, 49313 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3911. 826 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 49314, 49315, 49316, 49317, 49318, 49319, 49320, 49321, 49322, 49323, 49324 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3912. The probes having the nucleotide sequence represented by SEQ ID NOS: 49325, 49326, 49327, 49328, 49329, 49330, 49331, 49332, 49333, 49334, 49335 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3913. The probes having the nucleotide sequence represented by SEQ ID NOS: 49336, 49337, 49338, 49339, 49340, 49341, 49342, 49343, 49344, 49345, 49346 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3914. The probes having the nucleotide sequence represented by SEQ ID NOS: 49347, 49348, 49349, 49350, 49351, 49352, 49353, 49354, 49355, 49356, 49357 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3915. The probes having the nucleotide sequence represented by SEQ ID NOS: 49358, 49359, 49360, 49361, 49362, 49363, 49364, 49365, 49366, 49367, 49368 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3916. The probes having the nucleotide sequence represented by SEQ ID NOS: 49369, 49370, 49371, 49372, 49373, 49374, 49375, 49376, 49377, 49378, 49379 were selected from the 827 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3917. The probes having the nucleotide sequence represented by SEQ ID NOS: 49380, 49381, 49382, 49383, 49384, 49385, 5 49386, 49387, 49388, 49389, 49390 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3918. The probes having the nucleotide sequence represented by SEQ ID NOS: 49391, 49392, 49393, 49394, 49395, 49396, 10 49397, 49398, 49399, 49400, 49401 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3919. The probes having the nucleotide sequence represented by SEQ ID NOS: 49402, 49403, 49404, 49405, 49406, 49407, 15 49408, 49409, 49410, 49411, 49412 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3920. The probes having the nucleotide sequence represented by SEQ ID NOS: 49413, 49414, 49415, 49416, 49417, 49418, 20 49419, 49420, 49421, 49422, 49423 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3921. The probes having the nucleotide sequence represented by SEQ ID NOS: 49424, 49425, 49426, 49427, 49428, 49429, 25 49430, 49431, 49432, 49433, 49434 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3922. 828 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 49435, 49436, 49437, 49438, 49439, 49440, 49441, 49442, 49443, 49444, 49445 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3923. The probes having the nucleotide sequence represented by SEQ ID NOS: 49446, 49447, 49448, 49449, 49450, 49451, 49452, 49453, 49454, 49455, 49456 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3924. The probes having the nucleotide sequence represented by SEQ ID NOS: 49457, 49458, 49459, 49460, 49461, 49462, 49463, 49464, 49465, 49466, 49467 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3925. The probes having the nucleotide sequence represented by SEQ ID NOS: 49468, 49469, 49470, 49471, 49472, 49473, 49474, 49475, 49476, 49477, 49478 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3926. The probes having the nucleotide sequence represented by SEQ ID NOS: 49479, 49480, 49481, 49482, 49483, 49484, 49485, 49486, 49487, 49488, 49489 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3927. The probes having the nucleotide sequence represented by SEQ ID NOS: 49490, 49491, 49492, 49493, 49494, 49495, 49496, 49497, 49498, 49499, 49500 were selected from the 829 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3928. The probes having the nucleotide sequence represented by SEQ ID NOS: 49501, 49502, 49503, 49504, 49505, 49506, 5 49507, 49508, 49509, 49510, 49511 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3929. The probes having the nucleotide sequence represented by SEQ ID NOS: 49512, 49513, 49514, 49515, 49516, 49517, 10 49518, 49519, 49520, 49521, 49522 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3930. The probes having the nucleotide sequence represented by SEQ ID NOS: 49523, 49524, 49525, 49526, 49527, 49528, 15 49529, 49530, 49531, 49532, 49533 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3931. The probes having the nucleotide sequence represented by SEQ ID NOS: 49534, 49535, 49536, 49537, 49538, 49539, 20 49540, 49541, 49542, 49543, 49544 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3932. The probes having the nucleotide sequence represented by SEQ ID NOS: 49545, 49546, 49547, 49548, 49549, 49550, 25 49551, 49552, 49553, 49554, 49555 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3933. 830 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 49556, 49557, 49558, 49559, 49560, 49561, 49562, 49563, 49564, 49565, 49566 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3934. The probes having the nucleotide sequence represented by SEQ ID NOS: 49567, 49568, 49569, 49570, 49571, 49572, 49573, 49574, 49575, 49576, 49577 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3935. The probes having the nucleotide sequence represented by SEQ ID NOS: 49578, 49579, 49580, 49581, 49582, 49583, 49584, 49585, 49586, 49587, 49588 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3936. The probes having the nucleotide sequence represented by SEQ ID NOS: 49589, 49590, 49591, 49592, 49593, 4'9594, 49595, 49596, 49597, 49598, 49599 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3937. The probes having the nucleotide sequence represented by SEQ ID NOS: 49600, 49601, 49602, 49603, 49604, 49605, 49606, 49607, 49608, 49609, 49610 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3938. The probes having the nucleotide sequence represented by SEQ ID NOS: 49611, 49612, 49613, 49614, 49615, 49616, 49617, 49618, 49619, 49620, 49621 were selected from the 831 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3939. The probes having the nucleotide sequence represented by SEQ ID NOS: 49622, 49623, 49624, 49625, 49626, 49627, 5 49628, 49629, 49630, 49631, 49632 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3940. The probes having the nucleotide sequence represented by SEQ ID NOS: 49633, 49634, 49635, 49636, 49637, 49638, 10 49639, 49640, 49641, 49642, 49643 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3941. The probes having the nucleotide sequence represented by SEQ ID NOS: 49644, 49645, 49646, 49647, 49648, 49649, 15 49650, 49651, 49652, 49653, 49654 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3942. The probes having the nucleotide sequence represented by SEQ ID NOS: 49655, 49656, 49657, 49658, 49659, 49660, 20 49661, 49662, 49663, 49664, 49665 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3943. The probes having the nucleotide sequence represented by SEQ ID NOS: 49666, 49667, 49668, 49669, 49670, 49671, 25 49672, 49673, 49674, 49675, 49676 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3944. 832 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 49677, 49678, 49679, 49680, 49681, 49682, 49683, 49684, 49685, 49686, 49687 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3945. The probes having the nucleotide sequence represented by SEQ ID NOS: 49688, 49689, 49690, 49691, 49692, 49693, 49694, 49695, 49696, 49697, 49698 wereselected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3946. The probes having the nucleotide sequence represented by SEQ ID NOS: 49699, 49700, 49701, 49702, 49703, 49704, 49705, 49706, 49707, 49708, 49709 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3947. The probes having the nucleotide sequence represented by SEQ ID NOS: 49710, 49711, 49712, 49713, 49714, 49715, 49716, 49717, 49718, 49719, 49720 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3948. The probes having the nucleotide sequence represented by SEQ ID NOS: 49721, 49722, 49723, 49724, 49725, 49726, 49727, 49728, 49729, 49730, 49731 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3949. The probes having the nucleotide sequence represented by SEQ ID NOS: 49732, 49733, 49734, 49735, 49736, 49737, 49738, 49739, 49740, 49741, 49742 were selected from the 833 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3950. The probes having the nucleotide sequence represented by SEQ ID NOS: 49743, 49744, 49745, 49746, 49747, 49748, 5 49749, 49750, 49751, 49752, 49753 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3951. The probes having the nucleotide sequence represented by SEQ ID NOS: 49754, 49755, 49756, 49757, 49758, 49759, 10 49760, 49761, 49762, 49763, 49764 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3952. The probes having the nucleotide sequence represented by SEQ ID NOS: 49765, 49766, 49767, 49768, 49769, 49770, 15 49771, 49772, 49773, 49774, 49775 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3953. The probes having the nucleotide sequence represented by SEQ ID NOS: 49776, 49777, 49778, 49779, 49780, 49781, 20 49782, 49783, 49784, 49785, 49786 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3954. The probes having the nucleotide sequence represented by SEQ ID NOS: 49787, 49788, 49789, 49790, 49791, 49792, 25 49793, 49794, 49795, 49796, 49797 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3955. 834 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 49798, 49799, 49800, 49801, 49802, 49803, 49804, 49805, 49806, 49807, 49808 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3956. The probes having the nucleotide sequence represented by SEQ ID NOS: 49809, 49810, 49811, 49812, 49813, 49814, 49815, 49816, 49817, 49818, 49819 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3957. The probes having the nucleotide sequence represented by SEQ ID NOS: 49820, 49821, 49822, 49823, 49824, 49825, 49826, 49827, 49828, 49829, 49830 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3958. The probes having the nucleotide sequence represented by SEQ ID NOS: 49831, 49832, 49833, 49834, 49835, 49836, 49837, 49838, 49839, 49840, 49841 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3959. The probes having the nucleotide sequence represented by SEQ ID NOS: 49842, 49843, 49844, 49845, 49846, 49847, 49848, 49849, 49850, 49851, 49852 were selected from the ORFs having the nucleotide sequence represented by, SEQ ID 25 NO: 3960. The probes having the nucleotide sequence represented by SEQ ID NOS: 49853, 49854, 49855, 49856, 49857, 49858, 49859, 49860, 49861, 49862, 49863, 49864, 49865, 49866, 835 WO 2006/024951 PCT/IB2005/002908 49867, 49868, 49869, 49870, 49871, 49872, 49873, 49874 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3961. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 49875, 49876, 49877, 49878, 49879, 49880, 49881, 49882, 49883, 49884, 49885 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3962. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 49886, 49887, 49888, 49889, 49890, 49891, 49892, 49893, 49894, 49895, 49896 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3963. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 49897, 49898, 49899, 49900, 49901, 49902, 49903, 49904, 49905, 49906, 49907 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3964. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 49908, 49909, 49910, 49911, 49912, 49913, 49914, 49915, 49916, 49917, 49918 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3965. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 49919, 49920, 49921, 49922, 49923, 49924, 49925, 49926, 49927, 49928, 49929 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3966. 836 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 49930, 49931, 49932, 49933, 49934, 49935, 49936, 49937, 49938, 49939, 49940 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3967. The probes having the nucleotide sequence represented by SEQ ID NOS: 49941, 49942, 49943, 49944, 49945, 49946, 49947, 49948, 49949, 49950, 49951 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3968. The probes having the nucleotide sequence represented by SEQ ID NOS: 49952, 49953, 49954, 49955, 49956, 49957, 49958, 49959, 49960, 49961, 49962 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3969. The probes having the nucleotide sequence represented by SEQ ID NOS: 49963, 49964, 49965, 49966, 49967, 49968, 49969, 49970, 49971, 49972, 49973 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3970. The probes having the nucleotide sequence represented by SEQ ID NOS: 49974, 49975, 49976, 49977, 49978, 49979, 49980, 49981, 49982, 49983, 49984 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3971. The probes having the nucleotide sequence represented by SEQ ID NOS: 49985, 49986, 49987, 49988, 49989, 49990, 49991, 49992, 49993, 49994, 49995 were selected from the 837 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3972. The probes having the nucleotide sequence represented by SEQ ID NOS: 49996, 49997, 49998, 49999, 50000, 50001, 5 50002, 50003, 50004, 50005, 50006 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3973. The probes having the nucleotide sequence represented by SEQ ID NOS: 50007, 50008, 50009, 50010, 50011, 50012, 10 50013, 50014, 50015, 50016, 50017 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3974. The probes having the nucleotide sequence represented by SEQ ID NOS: 50018, 50019, 50020, 50021, 50022, 50023, 15 50024, 50025, 50026, 50027, 50028 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3975. The probes having the nucleotide sequence represented by SEQ ID NOS: 50029, 50030, 50031, 50032, 50033, 50034, 20 50035, 50036, 50037, 50038, 50039 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3976. The probes having the nucleotide sequence represented by SEQ ID NOS: 50040, 50041, 50042, 50043, 50044, 50045, 25 50046, 50047, 50048, 50049, 50050 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3977. 838 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 50051, 50052, 50053, 50054, 50055, 50056, 50057, 50058, 50059, 50060, 50061 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3978. The probes having the nucleotide sequence represented by SEQ ID NOS: 50062, 50063, 50064, 50065, 50066, 50067, 50068, 50069, 50070, 50071, 50072 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3979. The probes having the nucleotide sequence represented by SEQ ID NOS: 50073, 50074, 50075, 50076, 50077, 50078, 50079, 50080, 50081, 50082, 50083 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3980. The probes having the nucleotide sequence represented by SEQ ID NOS: 50084, 50085, 50086, 50087, 50088, 50089, 50090, 50091, 50092, 50093, 50094 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3981. The probes having the nucleotide sequence represented by SEQ ID NOS: 50095, 50096, 50097, 50098, 50099, 50100, 50101, 50102, 50103, 50104, 50105 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3982. The probes having the nucleotide sequence represented by SEQ ID NOS: 50106, 50107, 50108, 50109, 50110, 50111, 50112, 50113, 50114, 50115, 50116 were selected from the 839 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3983. The probes having the nucleotide sequence represented by SEQ ID NOS: 50117, 50118, 50119, 50120, 50121, 50122, 5 50123, 50124, 50125, 50126, 50127 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3984. The probes having the nucleotide sequence represented by SEQ ID NOS: 50128, 50129, 50130, 50131, 50132, 50133, 10 50134, 50135, 50136, 50137, 50138 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3985. The probes having the nucleotide sequence represented by SEQ ID NOS: 50139, 50140, 50141, 50142, 50143, 50144, 15 50145, 50146, 50147, 50148, 50149 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3986. The probes having the nucleotide sequence represented by SEQ ID NOS: 50150, 50151, 50152, 50153, 50154, 50155, 20 50156, 50157, 50158, 50159, 50160 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3987. The probes having the nucleotide sequence represented by SEQ ID NOS: 50161, 50162, 50163, 50164, 50165, 50166, 25 50167, 50168, 50169, 50170, 50171 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3988. 840 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 50172, 50173, 50174, 50175, 50176, 50177, 50178, 50179, 50180, 50181, 50182 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 3989. The probes having the nucleotide sequence represented by SEQ ID NOS: 50183, 50184, 50185, 50186, 50187, 50188, 50189, 50190, 50191, 50192, 50193 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 3990. The probes having the nucleotide sequence represented by SEQ ID NOS: 50194, 50195, 50196, 50197, 50198, 50199, 50200, 50201, 50202, 50203, 50204 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 3991. The probes having the nucleotide sequence represented by SEQ ID NOS: 50205, 50206, 50207, 50208, 50209, 50210, 50211, 50212, 50213, 50214, 50215 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 3992. The probes having the nucleotide sequence represented by SEQ ID NOS: 50216, 50217, 50218, 50219, 50220, 50221, 50222, 50223, 50224, 50225, 50226 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 3993. The probes having the nucleotide sequence represented by SEQ ID NOS: 50227, 50228, 50229, 50230, 50231, 50232, 50233, 50234, 50235, 50236, 50237 were selected from the 841 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 3994. The probes having the nucleotide sequence represented by SEQ ID NOS: 50238, 50239, 50240, 50241, 50242, 50243, 5 50244, 50245, 50246, 50247, 50248 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3995. The probes having the nucleotide sequence represented by SEQ ID NOS: 50249, 50250, 50251, 50252, 50253, 50254, 10 50255, 50256, 50257, 50258, 50259 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3996. The probes having the nucleotide sequence represented by SEQ ID NOS: 50260, 50261, 50262, 50263, 50264, 50265, 15 50266, 50267, 50268, 50269, 50270 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3997. The probes having the nucleotide sequence represented by SEQ ID NOS: 50271, 50272, 50273, 50274, 50275, 50276, 20 50277, 50278, 50279, 50280, 50281 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3998. The probes having the nucleotide sequence represented by SEQ ID NOS: 50282, 50283, 50284, 50285, 50286, 50287, 25 50288, 50289, 50290, 50291, 50292 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 3999. 842 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 50293, 50294, 50295, 50296, 50297, 50298, 50299, 50300, 50301, 50302, 50303 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4000. The probes having the nucleotide sequence represented by SEQ ID NOS: 50304, 50305, 50306, 50307, 50308, 50309, 50310, 50311, 50312, 50313, 50314 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4001. The probes having the nucleotide sequence represented by SEQ ID NOS: 50315, 50316, 50317, 50318, 50319, 50320, 50321, 50322, 50323, 50324, 50325 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4002. The probes having the nucleotide sequence represented by SEQ ID NOS: 50326, 50327, 50328, 50329, 50330, 50331, 50332, 50333, 50334, 50335, 50336 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4003. The probes having the nucleotide sequence represented by SEQ ID NOS: 50337, 50338, 50339, 50340, 50341, 50342, 50343, 50344, 50345, 50346, 50347 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4004. The probes having the nucleotide sequence represented by SEQ ID NOS: 50348, 50349, 50350, 50351, 50352, 50353, 50354, 50355, 50356, 50357, 50358 were selected from the 843 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4005. The probes having the nucleotide sequence represented by SEQ ID NOS: 50359, 50360, 50361, 50362, 50363, 50364, 5 50365, 50366, 50367, 50368, 50369 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4006. The probes having the nucleotide sequence represented by SEQ ID NOS: 50370, 50371, 50372, 50373, 50374, 50375, 10 50376, 50377, 50378, 50379, 50380 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4007. The probes having the nucleotide sequence represented by SEQ ID NOS: 50381, 50382, 50383, 50384, 50385, 50386, 15 50387, 50388, 50389, 50390, 50391 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4008. The probes having the nucleotide sequence represented by SEQ ID NOS: 50392, 50393, 50394, 50395, 50396, 50397, 20 50398, 50399, 50400, 50401, 50402 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4009. The probes having the nucleotide sequence represented by SEQ ID NOS: 50403, 50404, 50405, 50406, 50407, 50408, 25 50409, 50410, 50411, 50412, 50413 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4010. 844 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 50414, 50415, 50416, 50417, 50418, 50419, 50420, 50421, 50422, 50423, 50424 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4011. The probes having the nucleotide sequence represented by SEQ ID NOS: 50425, 50426, 50427, 50428, 50429, 50430, 50431, 50432, 50433, 50434, 50435 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4012. The probes having the nucleotide sequence represented by SEQ ID NOS: 50436, 50437, 50438, 50439, 50440, 50441, 50442, 50443, 50444, 50445, 50446 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4013. The probes having the nucleotide sequence represented by SEQ ID NOS: 50447, 50448, 50449, 50450, 50451, 50452, 50453, 50454, 50455, 50456, 50457 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4014. The probes having the nucleotide sequence represented by SEQ ID NOS: 50458, 50459, 50460, 50461, 50462, 50463, 50464, 50465, 50466, 50467, 50468 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4015. The probes having the nucleotide sequence represented by SEQ ID NOS: 50502, 50503, 50504, 50505, 50506, 50507, 50508, 50509, 50510, 50511, 50512, 50513, 50514, 50515, 845 WO 2006/024951 PCT/IB2005/002908 50516, 50517, 50518, 50519, 50520, 50521, 50522, 50523 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4016. The probes having the nucleotide sequence represented by 5 SEQ ID'NOS: 50469, 50470, 50471, 50472, 50473, 50474, 50475, 50476, 50477, 50478, 50479 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4017. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 50480, 50481, 50482, 50483, 50484, 50485, 50486, 50487, 50488, 50489, 50490, 50491, 50492, 50493, 50494, 50495, 50496, 50497, 50498, 50499, 50500, 50501 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4018. 15 The probes having the nucleotide sequence represented by SEQ ID NOS: 50524, 50525, 50526, 50527, 50528, 50529, 50530, 50531, 50532, 50533, 50534 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4019. 20 The probes having the nucleotide sequence represented by SEQ ID NOS: 50535, 50536, 50537, 50538, 50539, 50540, 50541, 50542, 50543, 50544, 50545 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4020. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 50546, 50547, 50548, 50549, 50550, 50551, 50552, 50553, 50554, 50555, 50556 were selected from the 846 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4021. The probes having the nucleotide sequence represented by SEQ ID NOS: 50557, 50558, 50559, 50560, 50561, 50562, 5 50563, 50564, 50565, 50566, 50567 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4022. The probes having the nucleotide sequence represented by SEQ ID NOS: 50568, 50569, 50570, 50571, 50572, 50573, 10 50574, 50575, 50576, 50577, 50578 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4023. The probes having the nucleotide sequence represented by SEQ ID NOS: 50579, 50580, 50581, 50582, 50583, 50584, 15 50585, 50586, 50587, 50588, 50589 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4024. The probes having the nucleotide sequence represented by SEQ ID NOS: 50590, 50591, 50592, 50593, 50594, 50595, 20 50596, 50597, 50598, 50599, 50600 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4025. The probes having the nucleotide sequence represented by SEQ ID NOS: 50601, 50602, 50603, 50604, 50605, 50606, 25 50607, 50608, 50609, 50610, 50611 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4026. 847 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 50612, 50613, 50614, 50615, 50616, 50617, 50618, 50619, 50620, 50621, 50622 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4027. The probes having the nucleotide sequence represented by SEQ ID NOS: 50623, 50624, 50625, 50626, 50627, 50628, 50629, 50630, 50631, 50632, 50633 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4028. The probes having the nucleotide sequence represented by SEQ ID NOS: 50634, 50635, 50636, 50637, 50638, 50639, 50640, 50641, 50642, 50643, 50644 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4029. The probes having the nucleotide sequence represented by SEQ ID NOS: 50645, 50646, 50647, 50648, 50649, 50650, 50651, 50652, 50653, 50654, 50655 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4030. The probes having the nucleotide sequence represented by SEQ ID NOS: 50656, 50657, 50658, 50659, 50660, 50661, 50662, 50663, 50664, 50665, 50666 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4031. The probes having the nucleotide sequence represented by SEQ ID NOS: 50667, 50668, 50669, 50670, 50671, 50672, 50673, 50674, 50675, 50676, 50677 were selected from the 848 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4032. The probes having the nucleotide sequence represented by SEQ ID NOS: 50678, 50679, 50680, 50681, 50682, 50683, 5 50684, 50685, 50686, 50687, 50688 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4033. The probes having the nucleotide sequence represented by SEQ ID NOS: 50689, 50690, 50691, 50692, 50693, 50694, 10 50695, 50696, 50697, 50698, 50699 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4034. The probes having the nucleotide sequence represented by SEQ ID NOS: 50700, 50701, 50702, 50703, 50704, 50705, 15 50706, 50707, 50708, 50709, 50710 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4035. The probes having the nucleotide sequence represented by SEQ ID NOS: 50711, 50712, 50713, 50714, 50715, 50716, 20 50717, 50718, 50719, 50720, 50721 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4036. The probes having the nucleotide sequence represented by SEQ ID NOS: 50722, 50723, 50724, 50725, 50726, 50727, 25 50728, 50729, 50730, 50731, 50732 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4037. 849 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 50733, 50734, 50735, 50736, 50737, 50738, 50739, 50740, 50741, 50742, 50743 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4038. The probes having the nucleotide sequence represented by SEQ ID NOS: 50744, 50745, 50746, 50747, 50748, 50749, 50750, 50751, 50752, 50753, 50754 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4039. The probes having the nucleotide sequence represented by SEQ ID NOS: 50755, 50756, 50757, 50758, 50759, 50760, 50761, 50762, 50763, 50764, 50765 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4040. The probes having the nucleotide sequence represented by SEQ ID NOS: 50766, 50767, 50768, 50769, 50770, 50771, 50772, 50773, 50774, 50775, 50776 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4041. The probes having the nucleotide sequence represented by SEQ ID NOS: 50777, 50778, 50779, 50780, 50781, 50782, 50783, 50784, 50785, 50786, 50787 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4042. The probes having the nucleotide sequence represented by SEQ ID NOS: 50788, 50789, 50790, 50791, 50792, 50793, 50794, 50795, 50796, 50797, 50798 were selected from the 850 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4043. The probes having the nucleotide sequence represented by SEQ ID NOS: 50799, 50800, 50801, 50802, 50803, 50804, 5 50805, 50806, 50807, 50808, 50809 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4044. The probes having the nucleotide sequence represented by SEQ ID NOS: 50810, 50811, 50812, 50813, 50814, 50815, 10 50816, 50817, 50818, 50819, 50820 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4045. The probes having the nucleotide sequence represented by SEQ ID NOS: 50821, 50822, 50823, 50824, 50825, 50826, 15 50827, 50828, 50829, 50830, 50831 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4046. The probes having the nucleotide sequence represented by SEQ ID NOS: 50832, 50833, 50834, 50835, 50836, 50837, 20 50838, 50839, 50840, 50841, 50842 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4047. The probes having the nucleotide sequence represented by SEQ ID NOS: 50843, 50844, 50845, 50846, 50847, 50848, 25 50849, 50850, 50851, 50852, 50853 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4048. 851 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 50854, 50855, 50856, 50857, 50858, 50859, 50860, 50861, 50862, 50863 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 5 4049. The probes having the nucleotide sequence represented by SEQ ID NOS: 50864, 50865, 50866, 50867, 50868, 50869, 50870, 50871, 50872, 50873, 50874 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4050. The probes having the nucleotide sequence represented by SEQ ID NOS: 50875, 50876, 50877, 50878, 50879, 50880, 50881, 50882, 50883, 50884, 50885 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4051. The probes having the nucleotide sequence represented by SEQ ID NOS: 50886, 50887, 50888, 50889, 50890, 50891, 50892, 50893, 50894, 50895, 50896 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4052. The probes having the nucleotide sequence represented by SEQ ID NOS: 50897, 50898, 50899, 50900, 50901, 50902, 50903, 50904, 50905, 50906, 50907 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4053. The probes having the nucleotide sequence represented by SEQ ID NOS: 50908, 50909, 50910, 50911, 50912, 50913, 50914, 50915, 50916, 50917, 50918 were selected from the 852 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4054. The probes having the nucleotide sequence represented by SEQ ID NOS: 50919, 50920, 50921, 50922, 50923, 50924, 5 50925, 50926, 50927, 50928, 50929 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4055. The probes having the nucleotide sequence represented by SEQ ID NOS: 50930, 50931, 50932, 50933, 50934, 50935, 10 50936, 50937, 50938, 50939, 50940 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4056. The probes having the nucleotide sequence represented by SEQ ID NOS: 50941, 50942, 50943, 50944, 50945, 50946, 15 50947, 50948, 50949, 50950, 50951 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4057. The probes having the nucleotide sequence represented by SEQ ID NOS: 50952, 50953, 50954, 50955, 50956, 50957, 20 50958, 50959, 50960, 50961, 50962 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4058. The probes having the nucleotide sequence represented by SEQ ID NOS: 50963, 50964, 50965, 50966, 50967, 50968, 25 50969, 50970, 50971, 50972, 50973 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4059. 853 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 50974, 50975, 50976, 50977, 50978, 50979, 50980, 50981, 50982, 50983, 50984 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4060. The probes having the nucleotide sequence represented by SEQ ID NOS: 50985, 50986, 50987, 50988, 50989, 50990, 50991, 50992, 50993, 50994, 50995 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4061. The probes having the nucleotide sequence represented by SEQ ID NOS: 50996, 50997, 50998, 50999, 51000, 51001, 51002, 51003, 51004, 51005, 51006 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4062. The probes having the nucleotide sequence represented by SEQ ID NOS: 51007, 51008, 51009, 51010, 51011, 51012, 51013, 51014, 51015, 51016, 51017 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4063. The probes having the nucleotide sequence represented by SEQ ID NOS: 51018, 51019, 51020, 51021, 51022, 51023, 51024, 51025, 51026, 51027, 51028 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4064. The probes having the nucleotide sequence represented by SEQ ID NOS: 51029, 51030, 51031, 51032, 51033, 51034, 51035, 51036, 51037, 51038, 51039 were selected from the 854 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4065. The probes having the nucleotide sequence represented by SEQ ID NOS: 51040, 51041, 51042, 51043, 51044, 51045, 5 51046, 51047, 51048, 51049, 51050 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4066. The probes having the nucleotide sequence represented by SEQ ID NOS: 51051, 51052, 51053, 51054, 51055, 51056, 10 51057, 51058, 51059, 51060, 51061 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4067. The probes having the nucleotide sequence represented by SEQ ID NOS: 51062, 51063, 51064, 51065, 51066, 51067, 15 51068, 51069, 51070, 51071, 51072 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4068. The probes having the nucleotide sequence represented by SEQ ID NOS: 51073, 51074, 51075, 51076, 51077, 51078, 20 51079, 51080, 51081, 51082, 51083 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4069. The probes having the nucleotide' sequence represented by SEQ ID NOS: 51084, 51085, 51086, 51087, 51088, 51089, 25 51090, 51091, 51092, 51093, 51094 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4070. 855 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 51095, 51096, 51097, 51098, 51099, 51100, 51101, 51102, 51103, 51104, 51105 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4071. The probes having the nucleotide sequence represented by SEQ ID NOS: 51106, 51107, 51108, 51109, 51110, 51111, 51112, 51113, 51114, 51115, 51116 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4072. The probes having the nucleotide sequence represented by SEQ ID NOS: 51117, 51118, 51119, 51120, 51121, 51122, 51123, 51124, 51125, 51126, 51127 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4073. The probes having the nucleotide sequence represented by SEQ ID NOS: 51128, 51129, 51130, 51131, 51132, 51133, 51134, 51135, 51136, 51137, 51138, 51139, 51140, 51141, 51142, 51143, 51144, 51145, 51146, 51147, 51148, 51149 were 20 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4074. The probes having the nucleotide sequence represented by SEQ ID NOS: 51150, 51151, 51152, 51153, 51154, 51155, 51156, 51157, 51158, 51159, 51160, 51161, 51162, 51163, 25 51164, 51165, 51166, 51167, 51168, 51169 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4075. 856 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 51170, 51171, 51172, 51173, 51174, 51175, 51176, 51177, 51178, 51179, 51180 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4076. The probes having the nucleotide sequence represented by SEQ ID NOS: 51181, 51182, 51183, 51184, 51185, 51186, 51187, 51188, 51189, 51190, 51191 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4077. The probes having the nucleotide sequence represented by SEQ ID NOS: 51192, 51193, 51194, 51195, 51196, 51197, 51198, 51199, 51200, 51201, 51202 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4078. The probes having the nucleotide sequence represented by SEQ ID NOS: 51203, 51204, 51205, 51206, 51207, 51208, 51209, 51210, 51211, 51212, 51213 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4079. The probes having the nucleotide sequence represented by SEQ ID NOS: 51214, 51215, 51216, 51217, 51218, 51219, 51220, 51221, 51222, 51223, 51224 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4080. The probes having the nucleotide sequence represented by SEQ ID NOS: 51225, 51226, 51227, 51228, 51229, 51230, 51231, 51232, 51233, 51234, 51235 were selected from the 857 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4081. The probes having the nucleotide sequence represented by SEQ ID NOS: 51236, 51237, 51238, 51239, 51240, 51241, 5 51242, 51243, 51244, 51245, 51246 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4082. The probes having the nucleotide sequence represented by SEQ ID NOS: 51247, 51248, 51249, 51250, 51251, 51252, 10 51253, 51254, 51255, 51256, 51257 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4083. The probes having the nucleotide sequence represented by SEQ ID NOS: 51258, 51259, 51260, 51261, 51262, 51263, 15 51264, 51265, 51266, 51267, 51268 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4084. The probes having the nucleotide sequence represented by SEQ ID NOS: 51269, 51270, 51271, 51272, 51273, 51274, 20 51275, 51276, 51277, 51278, 51279 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4085. The probes having the nucleotide sequence represented by SEQ ID NOS: 51280, 51281, 51282, 51283, 51284, 51285, 25 51286, 51287, 51288, 51289, 51290 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4086. 858 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 51291, 51292, 51293, 51294, 51295, 51296, 51297, 51298, 51299, 51300, 51301 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4087. The probes having the nucleotide sequence represented by SEQ ID- NOS: 51302, 51303, 51304, 51305, 51306, 51307, 51308, 51309, 51310, 51311, 51312 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4088. The probes having the nucleotide sequence represented by SEQ ID NOS: 51313, 51314, 51315, 51316, 51317, 51318, 51319, 51320, 51321, 51322, 51323 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4089. The probes having the nucleotide sequence represented by SEQ ID NOS: 51324, 51325, 51326, 51327, 51328, 51329, 51330, 51331, 51332, 51333, 51334 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4090. The probes having the nucleotide sequence represented by SEQ ID NOS: 51335, 51336, 51337, 51338, 51339, 51340, 51341, 51342, 51343, 51344, 51345 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4091. The probes having the nucleotide sequence represented by SEQ ID NOS: 51346, 51347, 51348, 51349, 51350, 51351, 51352, 51353, 51354, 51355, 51356 were selected from the 859 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4092. The probes having the nucleotide sequence represented by SEQ ID NOS: 51357, 51358, 51359, 51360, 51361, 51362, 5 51363, 51364, 51365, 51366, 51367 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4093. The probes having the nucleotide sequence represented by SEQ ID NOS: 51368, 51369, 51370, 51371, 51372, 51373, 10 51374, 51375, 51376, 51377, 51378 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4094. The probes having the nucleotide sequence represented by SEQ ID NOS: 51379, 51380, 51381, 51382, 51383, 51384, 15 51385, 51386, 51387, 51388, 51389 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4095. The probes having the nucleotide sequence represented by SEQ ID NOS: 51390, 51391, 51392, 51393, 51394, 51395, 20 51396, 51397, 51398, 51399, 51400 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4096. The probes having the nucleotide sequence represented by SEQ ID NOS: 51401, 51402, 51403, 51404, 51405, 51406, 25 51407, 51408, 51409, 51410, 51411 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4097. 860 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 51412, 51413, 51414, 51415, 51416, 51417, 51418, 51419, 51420, 51421, 51422 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4098. The probes having the nucleotide sequence represented by SEQ ID NOS: 51423, 51424, 51425, 51426, 51427, 51428, 51429, 51430, 51431, 51432, 51433 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4099. The probes having the nucleotide sequence represented by SEQ ID NOS: 51434, 51435, 51436, 51437, 51438, 51439, 51440, 51441, 51442, 51443, 51444 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4100. The probes having the nucleotide sequence represented by SEQ ID NOS: 51445, 51446, 51447, 51448, 51449, 51450, 51451, 51452, 51453, 51454, 51455 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4101. The probes having the nucleotide sequence represented by SEQ ID NOS: 51456, 51457, 51458, 51459, 51460, 51461, 51462, 51463, 51464, 51465, 51466 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4102. The probes having the nucleotide sequence represented by SEQ ID NOS: 51467, 51468, 51469, 51470, 51471, 51472, 51473, 51474, 51475, 51476, 51477 were selected from the 861 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4103. The probes having the nucleotide sequence represented by SEQ ID NOS: 51478, 51479, 51480, 51481, 51482, 51483, 5 51484, 51485, 51486, 51487, 51488 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4104. The probes having the nucleotide sequence represented by SEQ ID NOS: 51489, 51490, 51491, 51492, 51493, 51494, 10 51495, 51496, 51497, 51498, 51499 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4105. The probes having the nucleotide sequence represented by SEQ ID NOS: 51500, 51501, 51502, 51503, 51504, 51505, 15 51506, 51507, 51508, 51509, 51510 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4106. The probes having the nucleotide sequence represented by SEQ ID NOS: 51511, 51512, 51513, 51514, 51515, 51516, 20 51517, 51518, 51519, 51520, 51521 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4107. The probes having the nucleotide sequence represented by SEQ ID NOS: 51522, 51523, 51524, 51525, 51526, 51527, 25 51528, 51529, 51530, 51531, 51532 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4108. 862 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 51533, 51534, 51535, 51536, 51537, 51538, 51539, 51540, 51541, 51542, 51543 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4109. The probes having the nucleotide sequence represented by SEQ ID NOS: 51544, 51545, 51546, 51547, 51548, 51549, 51550, 51551, 51552, 51553, 51554 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4110. The probes having the nucleotide sequence represented by SEQ ID NOS: 51555, 51556, 51557, 51558, 51559, 51560, 51561, 51562, 51563, 51564, 51565 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4111. The probes having the nucleotide sequence represented by SEQ ID NOS: 51566, 51567, 51568, 51569, 51570, 51571, 51572, 51573, 51574, 51575, 51576 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4112. The probes having the nucleotide sequence represented by SEQ ID NOS: 51577, 51578, 51579, 51580, 51581, 51582, 51583, 51584, 51585, 51586, 51587 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4113. The probes having the nucleotide sequence represented by SEQ ID NOS: 51588, 51589, 51590, 51591, 51592, 51593, 51594, 51595, 51596, 51597, 51598 were selected from the 863 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4114. The probes having the nucleotide sequence represented by SEQ ID NOS: 51599, 51600, 51601, 51602, 51603, 51604, 5 51605, 51606, 51607, 51608, 51609 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4115. The probes having the nucleotide sequence represented by SEQ ID NOS: 51610, 51611, 51612, 51613, 51614, 51615, 10 51616, 51617, 51618, 51619, 51620 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4116. The probes having the nucleotide sequence represented by SEQ ID NOS: 51621, 51622, 51623, 51624, 51625, 51626, 15 51627, 51628, 51629, 51630, 51631 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4117. The probes having the nucleotide sequence represented by SEQ ID NOS: 51632, 51633, 51634, 51635, 51636, 51637, 20 51638, 51639, 51640, 51641, 51642 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4118. The probes having the nucleotide sequence represented by SEQ ID NOS: 51643, 51644, 51645, 51646, 51647, 51648, 25 51649, 51650, 51651, 51652, 51653 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4119. 864 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 51654, 51655, 51656, 51657, 51658, 51659, 51660, 51661, 51662, 51663, 51664 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4120. The probes having the nucleotide sequence represented by SEQ ID NOS: 51665, 51666, 51667, 51668, 51669, 51670, 51671, 51672, 51673, 51674, 51675 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4121. The probes having the nucleotide sequence represented by SEQ ID NOS: 51676, 51677, 51678, 51679, 51680, 51681, 51682, 51683, 51684, 51685, 51686 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4122. The probes having the nucleotide sequence represented by SEQ ID NOS: 51687, 51688, 51689, 51690, 51691, 51692, 51693, 51694, 51695, 51696, 51697 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4123. The probes having the nucleotide sequence represented by SEQ ID NOS: 51698, 51699, 51700, 51701, 51702, 51703, 51704, 51705, 51706, 51707, 51708 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4124. The probes having the nucleotide sequence represented by SEQ ID NOS: 51709, 51710, 51711, 51712, 51713, 51714, 51715, 51716, 51717, 51718, 51719 were selected from the 865 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4125. The probes having the nucleotide sequence represented by SEQ ID NOS: 51720, 51721, 51722, 51723, 51724, 51725, 5 51726, 51727, 51728, 51729, 51730 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4126. The probes having the nucleotide sequence represented by SEQ ID NOS: 51731, 51732, 51733, 51734, 51735, 51736, 10 51737, 51738, 51739, 51740, 51741 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4127. The probes having the nucleotide sequence represented by SEQ ID NOS: 51742, 51743, 51744, 51745, 51746, 51747, 15 51748, 51749, 51750, 51751, 51752 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4128. The probes having the nucleotide sequence represented by SEQ ID NOS: 51753, 51754, 51755, 51756, 51757, 51758, 20 51759, 51760, 51761, 51762, 51763 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4129. The probes having the nucleotide sequence represented by SEQ ID NOS: 51764, 51765, 51766, 51767, 51768, 51769, 25 51770, 51771, 51772, 51773, 51774 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4130. 866 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 51775, 51776, 51777, 51778, 51779, 51780, 51781, 51782, 51783, 51784, 51785 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4131. The probes having the nucleotide sequence represented by SEQ ID NOS: 51786, 51787, 51788, 51789, 51790, 51791, 51792, 51793, 51794, 51795, 51796 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4132. The probes having the nucleotide sequence represented by SEQ ID NOS: 51797, 51798, 51799, 51800, 51801, 51802, 51803, 51804, 51805, 51806, 51807 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4133. The probes having the nucleotide sequence represented by SEQ ID NOS: 51808, 51809, 51810, 51811, 51812, 51813, 51814, 51815, 51816, 51817, 51818 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4134. The probes having the nucleotide sequence represented by SEQ ID NOS: 51819, 51820, 51821, 51822, 51823, 51824, 51825, 51826, 51827, 51828, 51829 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4135. The probes having the nucleotide sequence represented by SEQ ID NOS: 51830, 51831, 51832, 51833, 51834, 51835, 51836, 51837, 51838, 51839, 51840 were selected from the 867 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4136. The probes having the nucleotide sequence represented by SEQ ID NOS: 51841, 51842, 51843, 51844, 51845, 51846, 5 51847, 51848, 51849, 51850, 51851, 51852, 51853, 51854, 51855, 51856, 51857, 51858, 51859, 51860, 51861, 51862 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4137. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 51863, 51864, 51865, 51866, 51867, 51868, 51869, 51870, 51871, 51872, 51873 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4138. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 51874, 51875, 51876, 51877, 51878, 51879, 51880, 51881, 51882, 51883, 51884 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4139. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 51885, 51886, 51887, 51888, 51889, 51890, 51891, 51892, 51893, 51894, 51895 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4140. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 51896, 51897, 51898, 51899, 51900, 51901, 51902, 51903, 51904, 51905, 51906 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4141. 868 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 51907, 51908, 51909, 51910, 51911, 51912, 51913, 51914, 51915, 51916, 51917 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4142. The probes having the nucleotide sequence represented by SEQ ID NOS: 51918, 51919, 51920, 51921, 51922, 51923, 51924, 51925, 51926, 51927, 51928 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4143. The probes having the nucleotide sequence represented by SEQ ID NOS: 51929, 51930, 51931, 51932, 51933, 51934, 51935, 51936, 51937, 51938, 51939 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4144. The probes having the nucleotide sequence represented by SEQ ID NOS: 51940, 51941, 51942, 51943, 51944, 51945, 51946, 51947, 51948, 51949, 51950 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4145. The probes having the nucleotide sequence represented by SEQ ID NOS: 51951, 51952, 51953, 51954, 51955, 51956, 51957, 51958, 51959, 51960, 51961 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4146. The probes having the nucleotide sequence represented by SEQ ID NOS: 51962, 51963, 51964, 51965, 51966, 51967, 51968, 51969, 51970, 51971, 51972 were selected from the 869 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4147. The probes having the nucleotide sequence represented by SEQ ID NOS: 51973, 51974, 51975, 51976, 51977, 51978, 5 51979, 51980, 51981, 51982, 51983 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4148. The probes having the nucleotide sequence represented by SEQ ID NOS: 51984, 51985, 51986, 51987, 51988, 51989, 10 51990, 51991, 51992, 51993, 51994 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4149. The probes having the nucleotide sequence represented by SEQ ID NOS: 51995, 51996, 51997, 51998, 51999, 52000, 15 52001, 52002, 52003, 52004, 52005 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4150. The probes having the nucleotide sequence represented by SEQ ID NOS: 52006, 52007, 52008, 52009, 52010, 52011, 20 52012, 52013, 52014, 52015, 52016 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4151. The probes having the nucleotide sequence represented by SEQ ID NOS: 52017, 52018, 52019, 52020, 52021, 52022, 25 52023, 52024, 52025, 52026, 52027 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4152. 870 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 52028, 52029, 52030, 52031, 52032, 52033, 52034, 52035, 52036, 52037, 52038 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4153. The probes having the nucleotide sequence represented by SEQ ID NOS: 52039, 52040, 52041, 52042, 52043, 52044, 52045, 52046, 52047, 52048, 52049 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4154. The probes having the nucleotide sequence represented by SEQ ID NOS: 52050, 52051, 52052, 52053, 52054, 52055, 52056, 52057, 52058, 52059, 52060 were selected from the ORFs having the nucleotide sequence represented by SEQ-ID 15 NO: 4155. The probes having the nucleotide sequence represented by SEQ ID NOS: 52061, 52062, 52063, 52064, 52065, 52066, 52067, 52068, 52069, 52070, 52071 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4156. The probes having the nucleotide sequence represented by SEQ ID NOS: 52072, 52073, 52074, 52075, 52076, 52077, 52078, 52079, 52080, 52081, 52082 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4157. The probes having the nucleotide sequence represented by SEQ ID NOS: 52083, 52084, 52085, 52086, 52087, 52088, 52089, 52090, 52091, 52092, 52093 were selected from the 871 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4158. The probes having the nucleotide sequence represented by SEQ ID NOS: 52094, 52095, 52096, 52097, 52098, 52099, 5 52100, 52101, 52102, 52103, 52104 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4159. The probes having the nucleotide sequence represented by SEQ ID NOS: 52105, 52106, 52107, 52108, 52109, 52110, 10 52111, 52112, 52113, 52114, 52115 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4160. The probes having the nucleotide sequence represented by SEQ ID NOS: 52116, 52117, 52118, 52119, 52120, 52121, 15 52122, 52123, 52124, 52125, 52126 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4161. The probes having the nucleotide sequence represented by SEQ ID NOS: 52127, 52128, 52129, 52130, 52131, 52132, 20 52133, 52134, 52135, 52136, 52137 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4162. The probes having the nucleotide sequence represented by SEQ ID NOS: 52138, 52139, 52140, 52141, 52142, 52143, 25 52144, 52145, 52146, 52147, 52148 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4163. 872 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 52149, 52150, 52151, 52152, 52153, 52154, 52155, 52156, 52157, 52158, 52159 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4164. The probes having the nucleotide sequence represented by SEQ ID NOS: 52160, 52161, 52162, 52163, 52164, 52165, 52166, 52167, 52168, 52169, 52170 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4165. The probes having the nucleotide sequence represented by SEQ ID NOS: 52171, 52172, 52173, 52174, 52175, 52176, 52177, 52178, 52179, 52180, 52181 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4166. The probes having the nucleotide sequence represented by SEQ ID NOS: 52182, 52183, 52184, 52185, 52186, 52187, 52188, 52189, 52190, 52191, 52192 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4167. The probes having the nucleotide sequence represented by SEQ ID NOS: 52193, 52194, 52195, 52196, 52197, 52198, 52199, 52200, 52201, 52202, 52203 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4168. The probes having the nucleotide sequence represented by SEQ ID NOS: 52204, 52205, 52206, 52207, 52208, 52209, 52210, 52211, 52212, 52213, 52214 were selected from the 873 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4169. The probes having the nucleotide sequence represented by SEQ ID NOS: 52215, 52216, 52217, 52218, 52219, 52220, 5 52221, 52222, 52223, 52224, 52225 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4170. The probes having the nucleotide sequence represented by SEQ ID NOS: 52226, 52227, 52228, 52229, 52230, 52231, 10 52232, 52233, 52234, 52235, 52236 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4171. The probes having the nucleotide sequence represented by SEQ ID NOS: 52237, 52238, 52239, 52240, 52241, 52242, 15 52243, 52244, 52245, 52246, 52247 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4172. The probes having the nucleotide sequence represented by SEQ ID NOS: 52248, 52249, 52250, 52251, 52252, 52253, 20 52254, 52255, 52256, 52257, 52258 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4173. The probes having the nucleotide sequence represented by SEQ ID NOS: 52259, 52260, 52261, 52262, 52263, 52264, 25 52265, 52266, 52267, 52268, 52269 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4174. 874 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 52270, 52271, 52272, 52273, 52274, 52275, 52276, 52277, 52278, 52279, 52280 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4175. The probes having the nucleotide sequence represented by SEQ ID NOS: 52281, 52282, 52283, 52284, 52285, 52286, 52287, 52288, 52289, 52290, 52291 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4176. The probes having the nucleotide sequence represented by SEQ ID NOS: 52292, 52293, 52294, 52295, 52296, 52297, 52298, 52299, 52300, 52301, 52302, 52303, 52304, 52305, 52306, 52307, 52308, 52309, 52310, 52311, 52312, 52313 were 15 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4177. The probes having the nucleotide sequence represented by SEQ ID NOS: 52314, 52315, 52316, 52317, 52318, 52319, 52320, 52321, 52322, 52323, 52324 were selected from the 20 ORFs having the nucleotide sequence represented by SEQ ID NO: 4178. The probes having the nucleotide sequence represented by SEQ ID NOS: 52325, 52326, 52327, 52328, 52329, 52330, 52331, 52332, 52333, 52334, 52335 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 4179. The probes having the nucleotide sequence represented by SEQ ID NOS: 52336, 52337, 52338, 52339, 52340, 52341, 875 WO 2006/024951 PCT/IB2005/002908 52342, 52343, 52344, 52345, 52346 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO.: 4180. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 52347, 52348, 52349, 52350, 52351, 52352, 52353, 52354, 52355, 52356, 52357 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4181. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 52358, 52359, 52360, 52361, 52362, 52363, 52364, 52365, 52366, 52367, 52368 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4182. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 52369, 52370, 52371, 52372, 52373, 52374, 52375, 52376, 52377, 52378, 52379 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4183. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 52380, 52381, 52382, 52383, 52384, 52385, 52386, 52387, 52388, 52389, 52390 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4184. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 52391, 52392, 52393, 52394, 52395, 52396, 52397, 52398, 52399, 52400, 52401 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4185. 876 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 52402, 52403, 52404, 52405, 52406, 52407, 52408, 52409, 52410, 52411, 52412 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4186. The probes having the nucleotide sequence represented by SEQ ID NOS: 52413, 52414, 52415, 52416, 52417, 52418, 52419, 52420, 52421, 52422, 52423 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4187. The probes having the nucleotide sequence represented by SEQ ID NOS: 52424, 52425, 52426, 52427, 52428, 52429, 52430, 52431, 52432, 52433, 52434 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4188. The probes having the nucleotide sequence represented by SEQ ID NOS: 52435, 52436, 52437, 52438, 52439, 52440, 52441, 52442, 52443, 52444, 52445 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4189. The probes having the nucleotide sequence represented by SEQ ID NOS: 52446, 52447, 52448, 52449, 52450, 52451, 52452, 52453, 52454, 52455, 52456 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4190. The probes having the nucleotide sequence represented by SEQ ID NOS: 52457, 52458, 52459, 52460, 52461, 52462, 52463, 52464, 52465, 52466, 52467 were selected from the 877 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4191. The probes having the nucleotide sequence represented by SEQ ID NOS: 52468, 52469, 52470, 52471, 52472, 52473, 5 52474, 52475, 52476, 52477, 52478 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4192. The probes having the nucleotide sequence represented by SEQ ID NOS: 52479, 52480, 52481, 52482, 52483, 52484, 10 52485, 52486, 52487, 52488, 52489 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4193. The probes having the nucleotide sequence represented by SEQ ID NOS: 52490, 52491, 52492, 52493, 52494, 52495, 15 52496, 52497, 52498, 52499, 52500 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4194. The probes having the nucleotide sequence represented by SEQ ID NOS: 52501, 52502, 52503, 52504, 52505, 52506, 20 52507, 52508, 52509, 52510, 52511 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4195. The probes having the nucleotide sequence represented by SEQ ID NOS: 52512, 52513, 52514, 52515, 52516, 52517, 25 52518, 52519, 52520, 52521, 52522 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4196. 878 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 52523, 52524, 52525, 52526, 52527, 52528, 52529, 52530, 52531, 52532, 52533 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4197. The probes having the nucleotide sequence represented by SEQ ID NOS: 52534, 52535, 52536, 52537, 52538, 52539, 52540, 52541, 52542, 52543, 52544 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4198. The probes having the nucleotide sequence represented by SEQ ID NOS: 52545, 52546, 52547, 52548, 52549, 52550, 52551, 52552, 52553, 52554, 52555 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4199. The probes having the nucleotide sequence represented by SEQ ID NOS: 52556, 52557, 52558, 52559, 52560, 52561, 52562, 52563, 52564, 52565, 52566 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4200. The probes having the nucleotide sequence represented by SEQ ID NOS: 52567, 52568, 52569, 52570, 52571, 52572, 52573, 52574, 52575, 52576, 52577 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4201. The probes having the nucleotide sequence represented by SEQ ID NOS: 52578, 52579, 52580, 52581, 52582, 52583, 52584, 52585, 52586, 52587, 52588 were selected from the 879 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4202. The probes having the nucleotide sequence represented by SEQ ID NOS: 52589, 52590, 52591, 52592, 52593, 52594, 5 52595, 52596, 52597, 52598, 52599 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4203. The probes having the nucleotide sequence represented by SEQ ID NOS: 52600, 52601, 52602, 52603, 52604, 52605, 10 52606, 52607, 52608, 52609, 52610 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4204. The probes having the nucleotide sequence represented by SEQ ID NOS: 52611, 52612, 52613, 52614, 52615, 52616, 15 52617, 52618, 52619, 52620, 52621 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4205. The probes having the nucleotide sequence represented by SEQ ID NOS: 52622, 52623, 52624, 52625, 52626, 52627, 20 52628, 52629, 52630, 52631, 52632 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4206. The probes having the nucleotide sequence represented by SEQ ID NOS: 52633, 52634, 52635, 52636, 52637, 52638, 25 52639, 52640, 52641, 52642, 52643 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4207. 880 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 52644, 52645, 52646, 52647, 52648, 52649, 52650, 52651, 52652, 52653, 52654 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4208. The probes having the nucleotide sequence represented by SEQ ID NOS: 52655, 52656, 52657, 52658, 52659, 52660, 52661, 52662, 52663, 52664, 52665 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4209. The probes having the nucleotide sequence represented by SEQ ID NOS: 52666, 52667, 52668, 52669, 52670, 52671, 52672, 52673, 52674, 52675, 52676 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4210. The probes having the nucleotide sequence represented by SEQ ID NOS: 52677, 52678, 52679, 52680, 52681, 52682, 52683, 52684, 52685, 52686, 52687 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4211. The probes having the nucleotide sequence represented by SEQ ID NOS: 52688, 52689, 52690, 52691, 52692, 52693, 52694, 52695, 52696, 52697, 52698 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4212. The probes having the nucleotide sequence represented by SEQ ID NOS: 52699, 52700, 52701, 52702, 52703, 52704, 52705, 52706, 52707, 52708, 52709 were selected from the 881 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4213. The probes having the nucleotide sequence represented by SEQ ID NOS: 52710, 52711, 52712, 52713, 52714, 52715, 5 52716, 52717, 52718, 52719, 52720 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4214. The probes having the nucleotide sequence represented by SEQ ID NOS: 52721, 52722, 52723, 52724, 52725, 52726, 10 52727, 52728, 52729, 52730, 52731 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4215. The probes having the nucleotide sequence represented by SEQ ID NOS: 52732, 52733, 52734, 52735, 52736, 52737, 15 52738, 52739, 5274.0, 52741, 52742 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4216. The probes having the nucleotide sequence represented by SEQ ID NOS: 52743, 52744, 52745, 52746, 52747, 52748, 20 52749, 52750, 52751, 52752, 52753 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4217. The probes having the nucleotide sequence represented by SEQ ID NOS: 52754, 52755, 52756, 52757, 52758, 52759, 25 52760, 52761, 52762, 52763, 52764 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4218. 882 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 52765, 52766, 52767, 52768, 52769, 52770, 52771, 52772, 52773, 52774, 52775 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4219. The probes having the nucleotide sequence represented by SEQ ID NOS: 52776, 52777, 52778, 52779, 52780, 52781, 52782, 52783, 52784, 52785, 52786 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4220. The probes having the nucleotide sequence represented by SEQ ID NOS: 52787, 52788, 52789, 52790, 52791, 52792, 52793, 52794, 52795, 52796, 52797 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4221. The probes having the nucleotide sequence represented by SEQ ID NOS: 52798, 52799, 52800, 52801, 52802, 52803, 52804, 52805, 52806, 52807, 52808 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4222. The probes having the nucleotide sequence represented by SEQ ID NOS: 52809, 52810, 52811, 52812, 52813, 52814, 52815, 52816, 52817, 52818, 52819 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4223. The probes having the nucleotide sequence represented by SEQ ID NOS: 52820, 52821, 52822, 52823, 52824, 52825, 52826, 52827, 52828, 52829, 52830 were selected from the 883 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4224. The probes having the nucleotide sequence represented by SEQ ID NOS: 52831, 52832, 52833, 52834, 52835, 52836, 5 52837, 52838, 52839, 52840, 52841 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4225. The probes having the nucleotide sequence represented by SEQ ID NOS: 52842, 52843, 52844, 52845, 52846, 52847, 10 52848, 52849, 52850, 52851, 52852 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4226. The probes having the nucleotide sequence represented by SEQ ID NOS: 52853, 52854, 52855, 52856, 52857, 52858, 15 52859, 52860, 52861, 52862, 52863 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4227. The probes having the nucleotide sequence represented by SEQ ID NOS: 52864, 52865, 52866, 52867, 52868, 52869, 20 52870, 52871, 52872, 52873, 52874 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4228. The probes having the nucleotide sequence represented by SEQ ID NOS: 52875, 52876, 52877, 52878, 52879, 52880, 25 52881, 52882, 52883, 52884, 52885 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4229. 884 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 52886, 52887, 52888, 52889, 52890, 52891, 52892, 52893, 52894, 52895, 52896 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4230. The probes having the nucleotide sequence represented by SEQ ID NOS: 52897, 52898, 52899, 52900, 52901, 52902, 52903, 52904, 52905, 52906, 52907 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4231. The probes having the nucleotide sequence represented by SEQ ID NOS: 52908, 52909, 52910, 52911, 52912, 52913, 52914, 52915, 52916, 52917, 52918 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4232. The probes having the nucleotide sequence represented by SEQ ID NOS: 52919, 52920, 52921, 52922, 52923, 52924, 52925, 52926, 52927, 52928, 52929 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4233. The probes having the nucleotide sequence represented by SEQ ID NOS: 52930, 52931, 52932, 52933, 52934, 52935, 52936, 52937, 52938, 52939, 52940 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4234. The probes having the nucleotide sequence represented by SEQ ID NOS: 52941, 52942, 52943, 52944, 52945, 52946, 52947, 52948, 52949, 52950, 52951 were selected from the 885 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4235. The probes having the nucleotide sequence represented by SEQ ID NOS: 52952, 52953, 52954, 52955, 52956, 52957, 5 52958, 52959, 52960, 52961, 52962 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4236. The probes having the nucleotide sequence represented by SEQ ID NOS: 52963, 52964, 52965, 52966, 52967, 52968, 10 52969, 52970, 52971, 52972, 52973 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4237. The probes having the nucleotide sequence represented by SEQ ID NOS: 52974, 52975, 52976, 52977, 52978, 52979, 15 52980, 52981, 52982, 52983, 52984 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4238. The probes having the nucleotide sequence represented by SEQ ID NOS: 52985, 52986, 52987, 52988, 52989, 52990, 20 52991, 52992, 52993, 52994, 52995 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4239. The probes having the nucleotide sequence represented by SEQ ID NOS: 52996, 52997, 52998, 52999, 53000, 53001, 25 53002, 53003, 53004, 53005, 53006 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4240. 886 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 53007, 53008, 53009, 53010, 53011, 53012, 53013, 53014, 53015, 53016, 53017 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4241. The probes having the nucleotide sequence represented by SEQ ID NOS: 53018, 53019, 53020, 53021, 53022, 53023, 53024, 53025, 53026, 53027, 53028 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4242. The probes having the nucleotide sequence represented by SEQ ID NOS: 53029, 53030, 53031, 53032, 53033, 53034, 53035, 53036, 53037, 53038, 53039 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4243. The probes having the nucleotide sequence represented by SEQ ID NOS: 53040, 53041, 53042, 53043, 53044, 53045, -53046, 53047, 53048, 53049, 53050 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4244. The probes having the nucleotide sequence represented by SEQ ID NOS: 53051, 53052, 53053, 53054, 53055, 53056, 53057, 53058, 53059, 53060, 53061 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4245. The probes having the nucleotide sequence represented by SEQ ID NOS: 53062, 53063, 53064, 53065, 53066, 53067, 53068, 53069, 53070, 53071, 53072 were selected from the 887 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4246. The probes having the nucleotide sequence represented by SEQ ID NOS: 53073, 53074, 53075, 53076, 53077, 53078, 5 53079, 53080, 53081, 53082, 53083 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4247. The probes having the nucleotide sequence represented by SEQ ID NOS: 53084, 53085, 53086, 53087, 53088, 53089, 10 53090, 53091, 53092, 53093, 53094 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4248. The probes having the nucleotide sequence represented by SEQ ID NOS: 53095, 53096, 53097, 53098, 53099, 53100, 15 53101, 53102, 53103, 53104, 53105 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4249. The probes having the nucleotide sequence represented by SEQ ID NOS: 53106, 53107, 53108, 53109, 53110, 53111, 20 53112, 53113, 53114, 53115, 53116 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4250. The probes having the nucleotide sequence represented by SEQ ID NOS: 53117, 53118, 53119, 53120, 53121, 53122, 25 53123, 53124, 53125, 53126, 53127 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4251. 888 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 53128, 53129, 53130, 53131, 53132, 53133, 53134, 53135, 53136, 53137, 53138 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4252. The probes having the nucleotide sequence represented by SEQ ID NOS: 53139, 53140, 53141, 53142, 53143, 53144, 53145, 53146, 53147, 53148, 53149 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4253. The probes having the nucleotide sequence represented by SEQ ID NOS: 53150, 53151, 53152, 53153, 53154, 53155, 53156, 53157, 53158, 53159, 53160 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4254. The probes having the nucleotide sequence represented by SEQ ID NOS: 53161, 53162, 53163, 53164, 53165, 53166, 53167, 53168, 53169, 53170, 53171 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4255. The probes having the nucleotide sequence represented by SEQ ID NOS: 53172, 53173, 53174, 53175, 53176, 53177, 53178, 53179, 53180, 53181, 53182 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4256. The probes having the nucleotide sequence represented by SEQ ID NOS: 53183, 53184, 53185, 53186, 53187, 53188, 53189, 53190, 53191, 53192, 53193 were selected from the 889 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4257. The probes having the nucleotide sequence represented by SEQ ID NOS: 53194, 53195, 53196, 53197, 53198, 53199, 5 53200, 53201, 53202, 53203, 53204 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4258. The probes having the nucleotide sequence represented by SEQ ID NOS: 53205, 53206, 53207, 53208, 53209, 53210, 10 53211, 53212, 53213, 53214, 53215 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4259. The probes having the nucleotide sequence represented by SEQ ID NOS: 53216, 53217, 53218, 53219, 53220, 53221, 15 53222, 53223, 53224, 53225, 53226 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4260. The probes having the nucleotide sequence represented by SEQ ID NOS: 53227, 53228, 53229, 53230, 53231, 53232, 20 53233, 53234, 53235, 53236, 53237 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4261. The probes having the nucleotide sequence represented by SEQ ID NOS: 53238, 53239, 53240, 53241, 53242, 53243, 25 53244, 53245, 53246, 53247, 53248 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4262. 890 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 53249, 53250, 53251, 53252, 53253, 53254, 53255, 53256, 53257, 53258, 53259 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4263. The probes having the nucleotide sequence represented by SEQ ID NOS: 53260, 53261, 53262, 53263, 53264, 53265, 53266, 53267, 53268, 53269, 53270 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4264. The probes having the nucleotide sequence represented by SEQ ID NOS: 53271, 53272, 53273, 53274, 53275, 53276, 53277, 53278, 53279, 53280, 53281 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4265. The probes having the nucleotide sequence represented by SEQ ID NOS: 53282, 53283, 53284, 53285, 53286, 53287, 53288, 53289, 53290, 53291, 53292 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4266. The probes having the nucleotide sequence represented by SEQ ID NOS: 53293, 53294, 53295, 53296, 53297, 53298, 53299, 53300, 53301, 53302, 53303 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4267. The probes having the nucleotide sequence represented by SEQ ID NOS: 53304, 53305, 53306, 53307, 53308, 53309, 53310, 53311, 53312, 53313, 53314 were selected from the 891 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4268. The probes having the nucleotide sequence represented by SEQ ID NOS: 53315, 53316, 53317, 53318, 53319, 53320, 5 53321, 53322, 53323, 53324, 53325 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4269. The probes having the nucleotide sequence represented by SEQ ID NOS: 53326, 53327, 53328, 53329, 53330, 53331, 10 53332, 53333, 53334, 53335, 53336 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4270. The probes having the nucleotide sequence represented by SEQ ID NOS: 53337, 53338, 53339, 53340, 53341, 53342, 15 53343, 53344, 53345, 53346, 53347 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4271. The probes having the nucleotide sequence represented by SEQ ID NOS: 53348, 53349, 53350, 53351, 53352, 53353, 20 53354, 53355, 53356, 53357, 53358 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4272. The probes having the nucleotide sequence represented by SEQ ID NOS: 53359, 53360, 53361, 53362, 53363, 53364, 25 53365, 53366, 53367, 53368, 53369 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4273. 892 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 53370, 53371, 53372, 53373, 53374, 53375, 53376, 53377, 53378, 53379, 53380 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4274. The probes having the nucleotide sequence represented by SEQ ID NOS: 53381, 53382, 53383, 53384, 53385, 53386, 53387, 53388, 53389, 53390, 53391, 53392, 53393, 53394, 53395, 53396, 53397, 53398, 53399, 53400, 53401, 53402, 10 53403, 53404, 53405, 53406, 53407, 53408, 53409, 53410, 53411, 53412, 53413 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4275. The probes having the nucleotide sequence represented by SEQ ID NOS: 53414, 53415, 53416, 53417, 53418, 53419, 15 53420, 53421, 53422, 53423, 53424 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4276. The probes having the nucleotide sequence represented by SEQ ID NOS: 53425, 53426, 53427, 53428, 53429, 53430, 20 53431, 53432, 53433, 53434, 53435 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4277. The probes having the nucleotide sequence represented by SEQ ID NOS: 53436, 53437, 53438, 53439, 53440, 53441, 25 53442, 53443, 53444, 53445, 53446 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4278. 893 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 53447, 53448, 53449, 53450, 53451, 53452, 53453, 53454, 53455, 53456, 53457, 53458, 53459, 53460, 53461, 53462, 53463, 53464, 53465, 53466, 53467, 53468 were 5 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4279. The probes having the nucleotide sequence represented by SEQ ID NOS: 53469, 53470, 53471, 53472, 53473, 53474, 53475, 53476, 53477, 53478, 53479 were selected from the 10 ORFs having the nucleotide sequence represented by SEQ ID NO: 4280. The probes having the nucleotide sequence represented by SEQ ID NOS: 53480, 53481, 53482, 53483, 53484, 53485, 53486, 53487, 53488, 53489, 53490 were selected from the 15 ORFs having the nucleotide sequence represented by SEQ ID NO: 4281. The probes having the nucleotide sequence represented by SEQ ID NOS: 53491, 53492, 53493, 53494, 53495, 53496, 53497, 53498, 53499, 53500, 53501 were selected from the 20 ORFs having the nucleotide sequence represented by SEQ ID NO: 4282. The probes having the nucleotide sequence represented by SEQ ID NOS: 53502, 53503, 53504, 53505, 53506, 53507, 53508, 53509, 53510, 53511, 53512 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 4283. The probes having the nucleotide sequence represented by SEQ ID NOS: 53513, 53514, 53515, 53516, 53517, 53518, 894 WO 2006/024951 PCT/IB2005/002908 53519, 53520, 53521, 53522, 53523 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4284. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 53524, 53525, 53526, 53527, 53528, 53529, 53530, 53531, 53532, 53533, 53534 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4285. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 53535, 53536, 53537, 53538, 53539, 53540, 53541, 53542, 53543, 53544, 53545 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4286. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 53546, 53547, 53548, 53549, 53550, 53551, 53552, 53553, 53554, 53555, 53556 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4287. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 53557, 53558, 53559, 53560, 53561, 53562, 53563, 53564, 53565, 53566, 53567 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4288. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 53568, 53569, 53570, 53571, 53572, 53573, 53574, 53575, 53576, 53577, 53578 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4289. 895 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 53579, 53580, 53581, 53582, 53583, 53584, 53585, 53586, 53587, 53588, 53589 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4290. The probes having the nucleotide sequence represented by SEQ ID NOS: 53590, 53591, 53592, 53593, 53594, 53595, 53596, 53597, 53598, 53599, 53600 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4291. The probes having the nucleotide sequence represented by SEQ ID NOS: 53601, 53602, 53603, 53604, 53605, 53606, 53607, 53608, 53609, 53610, 53611 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4292. The probes having the nucleotide sequence represented by SEQ ID NOS: 53612, 53613, 53614, 53615, 53616, 53617, 53618, 53619, 53620, 53621, 53622 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4293. The probes having the nucleotide sequence represented by SEQ ID NOS: 53623, 53624, 53625, 53626, 53627, 53628, 53629, 53630, 53631, 53632, 53633, 53634, 53635, 53636, 53637, 53638, 53639, 53640, 53641, 53642, 53643, 53644 were 25 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4294. The probes having the nucleotide sequence represented by SEQ ID NOS: 53645, 53646, 53647, 53648, 53649, 53650, 896 WO 2006/024951 PCT/IB2005/002908 53651, 53652, 53653, 53654, 53655 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4295. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 53656, 53657, 53658, 53659, 53660, 53661, 53662, 53663, 53664, 53665, 53666 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4296. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 53667, 53668, 53669, 53670, 53671, 53672, 53673, 53674, 53675, 53676, 53677 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4297. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 53678, 53679, 53680, 53681, 53682, 53683, 53684, 53685, 53686, 53687, 53688 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4298. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 53689, 53690, 53691, 53692, 53693, 53694, 53695, 53696, 53697, 53698, 53699 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4299. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 53700, 53701, 53702, 53703, 53704, 53705, 53706, 53707, 53708, 53709, 53710 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4300. 897 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 53711, 53712, 53713, 53714, 53715, 53716, 53717, 53718, 53719, 53720, 53721 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4301. The probes having the nucleotide sequence represented by SEQ ID NOS: 53722, 53723, 53724, 53725, 53726, 53727, 53728, 53729, 53730, 53731, 53732 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4302. The probes having the nucleotide sequence represented by SEQ ID NOS: 53733, 53734, 53735, 53736, 53737, 53738, 53739, 53740, 53741, 53742, 53743 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4303. The probes having the nucleotide sequence represented by SEQ ID NOS: 53744, 53745, 53746, 53747, 53748, 53749, 53750, 53751, 53752, 53753, 53754 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4304. The probes having the nucleotide sequence represented by SEQ ID NOS: 53755, 53756, 53757, 53758, 53759, 53760, 53761, 53762, 53763, 53764, 53765 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4305. The probes having the nucleotide sequence represented by SEQ ID NOS: 53766, 53767, 53768, 53769, 53770, 53771, 53772, 53773, 53774, 53775, 53776 were selected from the 898 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4306. The probes having the nucleotide sequence represented by SEQ ID NOS: 53777, 53778, 53779, 53780, 53781, 53782, 5 53783, 53784, 53785, 53786, 53787 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4307. The probes having the nucleotide sequence represented by SEQ ID NOS: 53788, 53789, 53790, 53791, 53792, 53793, 10 53794, 53795, 53796, 53797, 53798 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4308. The probes having the nucleotide sequence represented by SEQ ID NOS: 53799, 53800, 53801, 53802, 53803, 53804, 15 53805, 53806, 53807, 53808, 53809 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4309. The probes having the nucleotide sequence represented by SEQ ID NOS: 53810, 53811, 53812, 53813, 53814, 53815, 20 53816, 53817, 53818, 53819, 53820 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4310. The probes having the nucleotide sequence represented by SEQ ID NOS: 53821, 53822, 53823, 53824, 53825, 53826, 25 53827, 53828, 53829, 53830, 53831 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4311. 899 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 53832, 53833, 53834, 53835, 53836, 53837, 53838, 53839, 53840, 53841, 53842 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4312. The probes having the nucleotide sequence represented by SEQ ID NOS: 53843, 53844, 53845, 53846, 53847, 53848, 53849, 53850, 53851, 53852, 53853 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4313. The probes having the nucleotide sequence represented by SEQ ID NOS: 53854, 53855, 53856, 53857, 53858, 53859, 53860, 53861, 53862, 53863, 53864 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4314. The probes having the nucleotide sequence represented by SEQ ID NOS: 53865, 53866, 53867, 53868, 53869, 53870, 53871, 53872, 53873, 53874, 53875 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4315. The probes having the nucleotide sequence represented by SEQ ID NOS: 53876, 53877, 53878, 53879, 53880, 53881, 53882, 53883, 53884, 53885, 53886 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4316. The probes having the nucleotide sequence represented by SEQ ID NOS: 53887, 53888, 53889, 53890, 53891, 53892, 53893, 53894, 53895, 53896, 53897 were selected from the 900 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4317. The probes having the nucleotide sequence represented by SEQ ID NOS: 53898, 53899, 53900, 53901, 53902, 53903, 5 53904, 53905, 53906, 53907, 53908 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4318. The probes having the nucleotide sequence represented by SEQ ID NOS: 53909, 53910, 53911, 53912, 53913, 53914, 10 53915, 53916, 53917, 53918, 53919 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4319. The probes having the nucleotide sequence represented by SEQ ID NOS: 53920, 53921, 53922, 53923, 53924, 53925, 15 53926, 53927, 53928, 53929, 53930 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4320. The probes having the nucleotide sequence represented by SEQ ID NOS: 53931, 53932, 53933, 53934, 53935, 53936, 20 53937, 53938, 53939, 53940, 53941 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4321. The probes having the nucleotide sequence represented by SEQ ID NOS: 53942, 53943, 53944, 53945, 53946, 53947, 25 53948, 53949, 53950, 53951, 53952 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4322. 901 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 53953, 53954, 53955, 53956, 53957, 53958, 53959, 53960, 53961, 53962, 53963 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4323. The probes having the nucleotide sequence represented by SEQ ID NOS: 53964, 53965, 53966, 53967, 53968, 53969, 53970, 53971, 53972, 53973, 53974, 53975, 53976, 53977, 53978, 53979, 53980, 53981, 53982, 53983, 53984, 53985 were 10 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4324. The probes having the nucleotide sequence represented by SEQ ID NOS.: 53986, 53987, 53988, 53989, 53990, 53991, 53992, 53993, 53994, 53995, 53996 were selected from the 15 ORFs having the nucleotide sequence represented by SEQ ID NO: 4325. The probes having the nucleotide sequence represented by SEQ ID NOS: 53997, 53998,,53999, 54000, 54001, 54002, 54003, 54004, 54005, 54006, 54007 were selected from the 20 ORFs having the nucleotide sequence represented by SEQ ID NO: 4326. The probes having the nucleotide sequence represented by SEQ ID NOS: 54008, 54009, 54010, 54011, 54012, 54013, 54014, 54015, 54016, 54017, 54018 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 4327. The probes having the nucleotide sequence represented by SEQ ID NOS: 54019, 54020, 54021, 54022, 54023, 54024, 902 WO 2006/024951 PCT/IB2005/002908 54025, 54026, 54027, 54028, 54029 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4328. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 54030, 54031, 54032, 54033, 54034, 54035, 54036, 54037, 54038, 54039, 54040 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4329. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 54041, 54042, 54043, 54044, 54045, 54046, 54047, 54048, 54049, 54050, 54051 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4330. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 54052, 54053, 54054, 54055, 54056, 54057, 54058, 54059, 54060, 54061, 54062 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4331. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 54063, 54064, 54065, 54066, 54067, 54068, 54069, 54070, 54071, 54072, 54073 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4332. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 54074, 54075, 54076, 54077, 54078, 54079, 54080, 54081, 54082, 54083, 54084 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4333. 903 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 54085, 54086, 54087, 54088, 54089, 54090, 54091, 54092, 54093, 54094, 54095 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4334. The probes having the nucleotide sequence represented by SEQ ID NOS: 54096, 54097, 54098, 54099, 54100, 54101, 54102, 54103, 54104, 54105, 54106 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4335. The probes having the nucleotide sequence represented by SEQ ID NOS: 54107, 54108, 54109, 54110, 54111, 54112, 54113, 54114, 54115, 54116, 54117 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4336. The probes having the nucleotide sequence represented by SEQ ID NOS: 54118, 54119, 54120, 54121, 54122, 54123, 54124, 54125, 54126, 54127, 54128 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4337. The probes having the nucleotide sequence represented by SEQ ID NOS: 54129, 54130, 54131, 54132, 54133, 54134, 54135, 54136, 54137, 54138, 54139 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4338. The probes having the nucleotide sequence represented by SEQ ID NOS: 54140, 54141, 54142, 54143, 54144, 54145, 54146, 54147, 54148, 54149, 54150 were selected from the 904 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4339. The probes having the nucleotide sequence represented by SEQ ID NOS: 54151, 54152, 54153, 54154, 54155, 54156, 5 54157, 54158, 54159, 54160, 54161 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4340. The probes having the nucleotide sequence represented by SEQ ID NOS: 54162, 54163, 54164, 54165, 54166, 54167, 10 54168, 54169, 54170, 54171, 54172 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4341. The probes having the nucleotide sequence represented by SEQ ID NOS: 54173, 54174, 54175, 54176, 54177, 54178, 15 54179, 54180, 54181, 54182, 54183 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4342. The probes having the nucleotide sequence represented by SEQ ID NOS: 54184, 54185, 54186, 54187, 54188, 54189, 20 54190, 54191, 54192, 54193, 54194 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4343. The probes having the nucleotide sequence represented by SEQ ID NOS: 54195, 54196, 54197, 54198, 54199, 54200, 25 54201, 54202, 54203, 54204, 54205 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4344. 905 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 54206, 54207, 54208, 54209, 54210, 54211, 54212, 54213, 54214, 54215, 54216 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4345. The probes having the nucleotide sequence represented by SEQ ID NOS: 54217, 54218, 54219, 54220, 54221, 54222, 54223, 54224, 54225, 54226, 54227 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4346. The probes having the nucleotide sequence represented by SEQ ID NOS: 54228, 54229, 54230, 54231, 54232, 54233, 54234, 54235, 54236, 54237, 54238 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4347. The probes having the nucleotide sequence represented by SEQ ID NOS: 54239, 54240, 54241, 54242, 54243, 54244, 54245, 54246, 54247, 54248, 54249 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4348. The probes having the nucleotide sequence represented by SEQ ID NOS: 54250, 54251, 54252, 54253, 54254, 54255, 54256, 54257, 54258, 54259, 54260 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4349. The probes having the nucleotide sequence represented by SEQ ID NOS: 54261, 54262, 54263, 54264, 54265, 54266, 54267, 54268, 54269, 54270, 54271 were selected from the 906 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4350. The probes having the nucleotide sequence represented by SEQ ID NOS: 54272, 54273, 54274, 54275, 54276, 54277, 5 54278, 54279, 54280, 54281, 54282 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4351. The probes having the nucleotide sequence represented by SEQ ID NOS: 54283, 54284, 54285, 54286, 54287, 54288, 10 54289, 54290, 54291, 54292, 54293 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4352. The probes having the nucleotide sequence represented by SEQ ID NOS: 54294, 54295, 54296, 54297, 54298, 54299, 15 54300, 54301, 54302, 54303, 54304 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4353. The probes having the nucleotide sequence represented by SEQ ID NOS: 54305, 54306, 54307, 54308, 54309, 54310, 20 54311, 54312, 54313, 54314, 54315 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4354. The probes having the nucleotide sequence represented by SEQ ID NOS: 54316, 54317, 54318, 54319, 54320, 54321, 25 54322, 54323, 54324, 54325, 54326 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4355. 907 WO 2006/024951 PCT/IB2005/002908 F The probes having the nucleotide sequence represented by SEQ ID NOS: 54327, 54328, 54329, 54330, 54331, 54332, 54333, 54334, 54335, 54336, 54337 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4356. The probes having the nucleotide sequence represented by SEQ ID NOS: 54338, 54339, 54340, 54341, 54342, 54343, 54344, 54345, 54346, 54347, 54348 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4357. The probes having the nucleotide sequence represented by SEQ ID NOS: 54349, 54350, 54351, 54352, 54353, 54354, 54355, 54356, 54357, 54358, 54359 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4358. The probes having the nucleotide sequence represented by SEQ ID NOS: 54360, 54361, 54362, 54363, 54364, 54365, 54366, 54367, 54368, 54369, 54370 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4359. The probes having the nucleotide sequence represented by SEQ ID NOS: 54371, 54372, 54373, 54374, 54375, 54376, 54377, 54378, 54379, 54380, 54381 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4360. The probes having the nucleotide sequence represented by SEQ ID NOS: 54382, 54383, 54384, 54385, 54386, 54387, 54388, 54389, 54390, 54391, 54392 were selected from the 908 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4361. The probes having the nucleotide sequence represented by SEQ ID NOS: 54393, 54394, 54395, 54396, 54397, 54398, 5 54399, 54400, 54401, 54402, 54403 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4362. The probes having the nucleotide sequence represented by SEQ ID NOS: 54404, 54405, 54406, 54407, 54408, 54409, 10 54410, 54411, 54412, 54413, 54414 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4363. The probes having the nucleotide sequence represented by SEQ ID NOS: 54415, 54416, 54417, 54418, 54419, 54420, 15 54421, 54422, 54423, 54424, 54425 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4364. The probes having the nucleotide sequence represented by SEQ ID NOS: 54426, 54427, 54428, 54429, 54430, 54431, 20 54432, 54433, 54434, 54435, 54436 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4365. The probes having the nucleotide sequence represented by SEQ ID NOS: 54437, 54438, 54439, 54440, 54441, 54442, 25 54443, 54444, 54445, 54446, 54447 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4366. 909 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 54448, 54449, 54450, 54451, 54452, 54453, 54454, 54455, 54456, 54457, 54458 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4367. The probes having the nucleotide sequence represented by SEQ ID NOS: 54459, 54460, 54461, 54462, 54463, 54464, 54465, 54466, 54467, 54468, 54469 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4368. The probes having the nucleotide sequence represented by SEQ ID NOS: 54470, 54471, 54472, 54473, 54474, 54475, 54476, 54477, 54478, 54479, 54480 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4369. The probes having the nucleotide sequence represented by SEQ ID NOS: 54481, 54482, 54483, 54484, 54485, 54486, 54487, 54488, 54489, 54490, 54491 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4370. The probes having the nucleotide sequence represented by SEQ ID NOS: 54492, 54493, 54494, 54495, 54496, 54497, 54498, 54499, 54500, 54501, 54502 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4371. The probes having the nucleotide sequence represented by SEQ ID NOS: 54503, 54504, 54505, 54506, 54507, 54508, 54509, 54510, 54511, 54512, 54513 were selected from the 910 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4372. The probes having the nucleotide sequence represented by SEQ ID NOS: 54514, 54515, 54516, 54517, 54518, 54519, 5 54520, 54521, 54522, 54523, 54524 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4373. The probes having the nucleotide sequence represented by SEQ ID NOS: 54525, 54526, 54527, 54528, 54529, 54530, 10 54531, 54532, 54533, 54534, 54535 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4374. The probes having the nucleotide sequence represented by SEQ ID NOS-: 54536, 54537, 54538, 54539, 54540, 54541, 15 54542, 54543, 54544, 54545, 54546 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4375. The probes having the nucleotide sequence represented by SEQ ID NOS: 54547, 54548, 54549, 54550, 54551, 54552, 20 54553, 54554, 54555, 54556, 54557 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4376. The probes having the nucleotide sequence represented by SEQ ID NOS: 54558, 54559, 54560, 54561, 54562, 54563, 25 54564, 54565, 54566, 54567, 54568 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4377. 911 WO 2006/024951 PCT/IB2005/002908 PC The probes having the nucleotide sequence represented by SEQ ID NOS: 54569, 54570, 54571, 54572, 54573, 54574, 54575, 54576, 54577, 54578, 54579 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4378. The probes having the nucleotide sequence represented by SEQ ID NOS: 54580, 54581, 54582, 54583, 54584, 54585, 54586, 54587, 54588, 54589, 54590 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4379. The probes having the nucleotide sequence represented by SEQ ID NOS: 54591, 54592, 54593, 54594, 54595, 54596, 54597, 54598, 54599, 54600, 54601 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4380. The probes having the nucleotide sequence represented by SEQ ID NOS: 54602, 54603, 54604, 54605, 54606, 54607, 54608, 54609, 54610, 54611, 54612 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4381. The probes having the nucleotide sequence represented by SEQ ID NOS: 54613, 54614, 54615, 54616, 54617, 54618, 54619, 54620, 54621, 54622, 54623 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4382. The probes having the nucleotide sequence represented by SEQ ID NOS: 54624, 54625, 54626, 54627, 54628, 54629, 54630, 54631, 54632, 54633, 54634 were selected from the 912 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4383. The probes having the nucleotide sequence represented by SEQ ID NOS: 54635, 54636, 54637, 54638, 54639, 54640, 5 54641, 54642, 54643, 54644, 54645 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4384. The probes having the nucleotide sequence represented by SEQ ID NOS: 54646, 54647, 54648, 54649, 54650, 54651, 10 54652, 54653, 54654, 54655, 54656 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4385. The probes having the nucleotide sequence represented by SEQ ID NOS: 54657, 54658, 54659, 54660, 54661, 54662, 15 54663, 54664, 54665, 54666, 54667 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4386. The probes having the nucleotide sequence represented by SEQ ID NOS: 54668, 54669, 54670, 54671, 54672, 54673, 20 54674, 54675, 54676, 54677, 54678 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4387. The probes having the nucleotide sequence represented by SEQ ID NOS: 54679, 54680, 54681, 54682, 54683, 54684, 25 54685, 54686, 54687, 54688, 54689 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4388. 913 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 54690, 54691, 54692, 54693, 54694, 54695, 54696, 54697, 54698, 54699, 54700 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4389. The probes having the nucleotide sequence represented by SEQ ID NOS: 54701, 54702, 54703, 54704, 54705, 54706, 54707, 54708, 54709, 54710, 54711 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4390. The probes having the nucleotide sequence represented by SEQ ID NOS: 54712, 54713, 54714, 54715, 54716, 54717, 54718, 54719, 54720, 54721, 54722 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4391. The probes having the nucleotide sequence represented by SEQ ID NOS: 54723, 54724, 54725, 54726, 54727, 54728, 54729, 54730, 54731, 54732, 54733 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4392. The probes having the nucleotide sequence represented by SEQ ID NOS: 54734, 54735, 54736, 54737, 54738, 54739, 54740, 54741, 54742, 54743, 54744 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4393. The probes having the nucleotide sequence represented by SEQ ID NOS: 54745, 54746, 54747, 54748, 54749, 54750, 54751, 54752, 54753, 54754, 54755 were selected from the 914 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4394. The probes having the nucleotide sequence represented by SEQ ID NOS: 54756, 54757, 54758, 54759, 54760, 54761, 5 54762, 54763, 54764, 54765, 54766 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4395. The probes having the nucleotide sequence represented by SEQ ID NOS: 54767, 54768, 54769, 54770, 54771, 54772, 10 54773, 54774, 54775, 54776, 54777 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4396. The probes having the nucleotide sequence represented by SEQ ID NOS: 54778, 54779, 54780, 54781, 54782, 54783, 15 54784, 54785, 54786, 54787, 54788 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4397. The probes having the nucleotide sequence represented by SEQ ID NOS: 54789, 54790, 54791, 54792, 54793, 54794, 20 54795, 54796, 54797, 54798, 54799 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4398. The probes having the nucleotide sequence represented by SEQ ID NOS: 54800, 54801, 54802, 54803, 54804, 54805, 25 54806, 54807, 54808, 54809, 54810 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4399. 915 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 54811, 54812, 54813, 54814, 54815, 54816, 54817, 54818, 54819, 54820, 54821 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4400. The probes having the nucleotide sequence represented by SEQ ID NOS: 54822, 54823, 54824, 54825, 54826, 54827, 54828, 54829, 54830, 54831, 54832 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4401. The probes having the nucleotide sequence represented by SEQ ID NOS: 54833, 54834, 54835, 54836, 54837, 54838, 54839, 54840, 54841, 54842, 54843 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4402. The probes having the nucleotide sequence represented by SEQ ID NOS: 54844, 54845, 54846, 54847, 54848, 54849, 54850, 54851, 54852, 54853, 54854 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4403. The probes having the nucleotide sequence represented by SEQ ID NOS: 54855, 54856, 54857, 54858, 54859, 54860, 54861, 54862, 54863, 54864, 54865 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4404. The probes having the nucleotide sequence represented by SEQ ID NOS: 54866, 54867, 54868, 54869, 54870, 54871, 54872, 54873, 54874, 54875, 54876 were selected from the 916 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4405. The probes having the nucleotide sequence represented by SEQ ID NOS: 54877, 54878, 54879, 54880, 54881, 54882, 5 54883, 54884, 54885, 54886, 54887, 54888, 54889, 54890, 54891, 54892, 54893, 54894, 54895, 54896, 54897, 54898 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4406. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 54899, 54900, 54901, 54902, 54903, 54904, 54905, 54906, 54907, 54908, 54909 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4407. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 54910, 54911, 54912, 54913, 54914, 54915, 54916, 54917, 54918, 54919, 54920 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4408. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 54921, 54922, 54923, 54924, 54925, 54926, 54927, 54928, 54929, 54930, 54931 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4409. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 54932, 54933, 54934, 54935, 54936, 54937, 54938, 54939, 54940, 54941, 54942 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4410. 917 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 54943, 54944, 54945, 54946, 54947, 54948, 54949, 54950, 54951, 54952, 54953 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4411. The probes having the nucleotide sequence represented by SEQ ID NOS: 54954, 54955, 54956, 54957, 54958, 54959, 54960, 54961, 54962, 54963, 54964 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4412. The probes having the nucleotide sequence represented by SEQ ID NOS: 54965, 54966, 54967, 54968, 54969, 54970, 54971, 54972, 54973, 54974, 54975 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4413. The probes having the nucleotide sequence represented by SEQ ID NOS: 54976, 54977, 54978, 54979, 54980, 54981, 54982, 54983, 54984, 54985, 54986 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4414. The probes having the nucleotide sequence represented by SEQ ID NOS: 54987, 54988, 54989, 54990, 54991, 54992, 54993, 54994, 54995, 54996, 54997 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4415. The probes having the nucleotide sequence represented by SEQ ID NOS: 54998, 54999, 55000, 55001, 55002, 55003, 55004, 55005, 55006, 55007, 55008 were selected from the 918 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4416. The probes having the nucleotide sequence represented by SEQ ID NOS: 55009, 55010, 55011, 55012, 55013, 55014, 5 55015, 55016, 55017, 55018, 55019 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4417. The probes having the nucleotide sequence represented by SEQ ID NOS: 55020, 55021, 55022, 55023, 55024, 55025, 10 55026, 55027, 55028, 55029, 55030 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4418. The probes having the nucleotide sequence represented by SEQ ID NOS: 55031, 55032, 55033, 55034, 55035, 55036, 15 55037, 55038, 55039, 55040, 55041, 55042, 55043, 55044, 55045, 55046, 55047, 55048, 55049, 55050, 55051, 55052 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4419. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 55053, 55054, 55055, 55056, 55057, 55058, 55059, 55060, 55061, 55062, 55063 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4420. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 55064, 55065, 55066, 55067, 55068, 55069, 55070, 55071, 55072, 55073, 55074 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4421. 919 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 55075, 55076, 55077, 55078, 55079, 55080, 55081, 55082, 55083, 55084, 55085 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4422. The probes having the nucleotide sequence represented by SEQ ID NOS: 55086, 55087, 55088, 55089, 55090, 55091, 55092, 55093, 55094 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4423. 10 The probes having the nucleotide sequence represented by SEQ ID NOS: 55095, 55096, 55097, 55098, 55099, 55100, 55101, 55102, 55103, 55104, 55105 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4424. 15 The probes having the nucleotide sequence represented by SEQ ID NOS: 55106, 55107, 55108, 55109, 55110, 55111, 55112, 55113, 55114, 55115, 55116 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4425. 20 The probes having the nucleotide sequence represented by SEQ ID NOS: 55117, 55118, 55119, 55120, 55121, 55122, 55123, 55124, 55125, 55126, 55127 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4426. 25 The probes having the nucleotide sequence represented by SEQ ID NOS: 55128, 55129, 55130, 55131, 55132, 55133, 55134, 55135, 55136, 55137, 55138 were selected from the 920 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4427. The probes having the nucleotide sequence represented by SEQ ID NOS: 55139, 55140, 55141, 55142, 55143, 55144, 5 55145, 55146, 55147, 55148, 55149 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4428. The probes having the nucleotide sequence represented by SEQ ID NOS: 55150, 55151, 55152, 55153, 55154, 55155, 10 55156, 55157, 55158, 55159, 55160 were- selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4429. The probes having the nucleotide sequence represented by SEQ ID NOS: 55161, 55162, 55163, 55164, 55165, 55166, 15 55167, 55168, 55169, 55170, 55171 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4430. The probes having the nucleotide sequence represented by SEQ ID NOS: 55172, 55173, 55174, 55175, 55176, 55177, 20 55178, 55179, 55180, 55181, 55182 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4431. The probes having the nucleotide sequence represented by SEQ ID NOS: 55183, 55184, 55185, 55186, 55187, 55188, 25 55189, 55190, 55191, 55192, 55193 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4432. 921 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequeT mpredeh1HD-1y SEQ ID NOS: 55194, 55195, 55196, 55197, 55198, 55199, 55200, 55201, 55202, 55203, 55204 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4433. The probes having the nucleotide sequence represented by SEQ ID NOS: 55205, 55206, 55207, 55208, 55209, 55210, 55211, 55212, 55213, 55214, 55215 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4434. The probes having the nucleotide sequence represented by SEQ ID NOS: 55216, 55217, 55218, 55219, 55220, 55221, 55222, 55223, 55224, 55225, 55226 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4435. The probes having the nucleotide sequence represented by SEQ ID NOS: 55227, 55228, 55229, 55230, 55231, 55232, 55233, 55234, 55235, 55236, 55237 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4436. The probes having the nucleotide sequence represented by SEQ ID NOS: 55238, 55239, 55240, 55241, 55242, 55243, 55244, 55245, 55246, 55247, 55248 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4437. The probes having the nucleotide sequence represented by SEQ ID NOS: 55249, 55250, 55251, 55252, 55253, 55254, 55255, 55256, 55257, 55258, 55259 were selected from the 922 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4438. The probes having the nucleotide sequence represented by SEQ ID NOS: 55260, 55261, 55262, 55263, 55264, 55265, 5 55266, 55267, 55268, 55269, 55270 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4439. The probes having the nucleotide sequence represented by SEQ ID NOS: 55271, 55272, 55273, 55274, 55275, 55276, 10 55277, 55278, 55279, 55280, 55281 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4440. The probes having the nucleotide sequence represented by SEQ ID NOS: 55282, 55283, 55284, 55285, 55286, 55287, 15 55288, 55289, 55290, 55291, 55292 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4441. The probes having the nucleotide sequence represented by SEQ ID NOS: 55293, 55294, 55295, 55296, 55297, 55298, 20 55299, 55300, 55301, 55302, 55303 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4442. The probes having the nucleotide sequence represented by SEQ ID NOS: 55304, 55305, 55306, 55307, 55308, 55309, 25 55310, 55311, 55312, 55313, 55314 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4443. 923 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 55315, 55316, 55317, 55318, 55319, 55320, 55321, 55322, 55323, 55324, 55325 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4444. The probes having the nucleotide sequence represented by SEQ ID NOS: 55326, 55327, 55328, 55329, 55330, 55331, 55332, 55333, 55334, 55335, 55336 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4445. The probes having the nucleotide sequence represented by SEQ ID NOS: 55337, 55338, 55339, 55340, 55341, 55342, 55343, 55344, 55345, 55346, 55347 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4446. The probes having the nucleotide sequence represented by SEQ ID NOS: 55348, 55349, 55350, 55351, 55352, 55353, 55354, 55355, 55356, 55357, 55358 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4447. The probes having the nucleotide sequence represented by SEQ ID NOS: 55359, 55360, 55361, 55362, 55363, 55364, 55365, 55366, 55367, 55368, 55369 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4448. The probes having the nucleotide sequence represented by SEQ ID NOS: 55370, 55371, 55372, 55373, 55374, 55375, 55376, 55377, 55378, 55379, 55380 were selected from the 924 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4449. The probes having the nucleotide sequence represented by SEQ ID NOS: 55381, 55382, 55383, 55384, 55385, 55386, 5 55387, 55388, 55389, 55390, 55391 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4450. The probes having the nucleotide sequence represented by SEQ ID NOS: 55392, 55393, 55394, 55395, 55396, 55397, 10 55398, 55399, 55400, 55401, 55402 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4451. The probes having the nucleotide sequence represented by SEQ ID NOS: 55403, 55404, 55405, 55406, 55407, 55408, 15 55409, 55410, 55411, 55412, 55413 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4452. The probes having the nucleotide sequence represented by SEQ ID NOS: 55414, 55415, 55416, 55417, 55418, 55419, 20 55420, 55421, 55422, 55423, 55424 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4453. The probes having the nucleotide sequence represented by SEQ ID NOS: 55425, 55426, 55427, 55428, 55429, 55430, 25 55431, 55432, 55433, 55434, 55435 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4454. 925 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 55436, 55437, 55438, 55439, 55440, 55441, 55442, 55443, 55444, 55445, 55446 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4455. The probes having the nucleotide sequence represented by SEQ ID NOS: 55447, 55448, 55449, 55450, 55451, 55452, 55453, 55454, 55455, 55456, 55457 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4456. The probes having the nucleotide sequence represented by SEQ ID NOS: 55458, 55459, 55460, 55461, 55462, 55463, 55464, 55465, 55466, 55467, 55468 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4457. The probes having the nucleotide sequence represented by SEQ ID NOS: 55469, 55470, 55471, 55472, 55473, 55474, 55475, 55476, 55477, 55478, 55479 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4458. The probes having the nucleotide sequence represented by SEQ ID NOS: 55480, 55481, 55482, 55483, 55484, 55485, 55486, 55487, 55488, 55489, 55490 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4459. The probes having the nucleotide sequence represented by SEQ ID NOS: 55491, 55492, 55493, 55494, 55495, 55496, 55497, 55498, 55499, 55500, 55501 were selected from the 926 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4460. The probes having the nucleotide sequence represented by SEQ ID NOS: 55502, 55503, 55504, 55505, 55506, 55507, 5 55508, 55509, 55510, 55511, 55512 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4461. The probes having the nucleotide sequence represented by SEQ ID NOS: 55513, 55514, 55515, 55516, 55517, 55518, 10 55519, 55520, 55521, 55522, 55523 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4462. The probes having the nucleotide sequence represented by SEQ ID NOS: 55524, 55525, 55526, 55527, 55528, 55529, 15 55530, 55531, 55532, 55533, 55534 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4463. The probes having the nucleotide sequence represented by SEQ ID NOS: 55535, 55536, 55537, 55538, 55539, 55540, 20 55541, 55542, 55543, 55544, 55545 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4464. The probes having the nucleotide sequence represented by SEQ ID NOS: 55546, 55547, 55548, 55549, 55550, 55551, 25 55552, 55553, 55554, 55555, 55556 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4465. 927 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 55557, 55558, 55559, 55560, 55561, 55562, 55563, 55564, 55565, 55566, 55567 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4466. The probes having the nucleotide sequence represented by SEQ ID NOS: 55568, 55569, 55570, 55571, 55572, 55573, 55574, 55575, 55576, 55577, 55578 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4467. The probes having the nucleotide sequence represented by SEQ ID NOS: 55579, 55580, 55581, 55582, 55583, 55584, 55585, 55586, 55587, 55588, 55589 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4468. The probes having the nucleotide sequence represented by SEQ ID NOS: 55590, 55591, 55592, 55593, 55594, 55595, 55596, 55597, 55598, 55599, 55600 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4469. The probes having the nucleotide sequence represented by SEQ ID NOS: 55601, 55602, 55603, 55604, 55605, 55606, 55607, 55608, 55609, 55610, 55611 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4470. The probes having the nucleotide sequence represented by SEQ ID NOS: 55612, 55613, 55614, 55615, 55616, 55617, 55618, 55619, 55620, 55621, 55622 were selected from the 928 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4471. The probes having the nucleotide sequence represented by SEQ ID NOS: 55623, 55624, 55625, 55626, 55627, 55628, 5 55629, 55630, 55631, 55632, 55633 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4472. The probes having the nucleotide sequence represented by SEQ ID NOS: 55634, 55635, 55636, 55637, 55638, 55639, 10 55640, 55641, 55642, 55643, 55644 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4473. The probes having the nucleotide sequence represented by SEQ ID NOS: 55645, 55646, 55647, 55648, 55649, 55650, 15 55651, 55652, 55653, 55654, 55655, 55656, 55657, 55658, 55659, 55660, 55661, 55662, 55663, 55664, 55665, 55666 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4474. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 55667, 55668, 55669, 55670, 55671, 55672, 55673, 55674, 55675, 55676, 55677 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4475. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 55678, 55679, 55680, 55681, 55682, 55683, 55684, 55685, 55686, 55687, 55688 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4476. 929 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 55689, 55690, 55691, 55692, 55693, 55694, 55695, 55696, 55697, 55698, 55699 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4477. The probes having the nucleotide sequence represented by SEQ ID NOS: 55700, 55701, 55702, 55703, 55704, 55705, 55706, 55707, 55708, 55709, 55710 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4478. The probes having the nucleotide sequence represented by SEQ ID NOS: 55711, 55712, 55713, 55714, 55715, 55716, 55717, 55718, 55719, 55720, 55721 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4479. The probes having the nucleotide sequence represented by SEQ ID NOS: 55722, 55723, 55724, 55725, 55726, 55727, 55728, 55729, 55730, 55731, 55732 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4480. The probes having the nucleotide sequence represented by SEQ ID NOS: 55733, 55734, 55735, 55736, 55737, 55738, 55739, 55740, 55741, 55742, 55743 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4481. The probes having the nucleotide sequence represented by SEQ ID NOS: 55744, 55745, 55746, 55747, 55748, 55749, 55750, 55751, 55752, 55753, 55754 were selected from the 930 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4482. The probes having the nucleotide sequence represented by SEQ ID NOS: 55755, 55756, 55757, 55758, 55759, 55760, 5 55761, 55762, 55763, 55764, 55765 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4483. The probes having the nucleotide sequence represented by SEQ ID NOS: 55766, 55767, 55768, 55769, 55770, 55771, 10 55772, 55773, 55774, 55775, 55776 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4484. The probes having the nucleotide sequence represented by SEQ ID NOS: 55777, 55778, 55779, 55780, 55781, 55782, 15 55783, 55784, 55785, 55786, 55787 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4485. The probes having the nucleotide sequence represented by SEQ ID NOS: 55788, 55789, 55790, 55791, 55792, 55793, 20 55794, 55795, 55796, 55797, 55798 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4486. The probes having the nucleotide sequence represented by SEQ ID NOS: 55799, 55800, 55801, 55802, 55803, 55804, 25 55805, 55806, 55807, 55808, 55809 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4487. 931 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 55810, 55811, 55812, 55813, 55814, 55815, 55816, 55817, 55818, 55819, 55820 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4488. The probes having the nucleotide sequence represented by SEQ ID NOS: 55821, 55822, 55823, 55824, 55825, 55826, 55827, 55828, 55829, 55830, 55831 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4489. The probes having the nucleotide sequence represented by SEQ ID NOS: 55832, 55833, 55834, 55835, 55836, 55837, 55838, 55839, 55840, 55841, 55842 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4490. The probes having the nucleotide sequence represented by SEQ ID NOS: 55843, 55844, 55845, 55846, 55847, 55848, 55849, 55850, 55851, 55852, 55853 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4491. The probes having the nucleotide sequence represented by SEQ ID NOS: 55854, 55855, 55856, 55857, 55858, 55859, 55860, 55861, 55862, 55863, 55864 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4492. The probes having the nucleotide sequence represented by SEQ ID NOS: 55865, 55866, 55867, 55868, 55869, 55870, 55871, 55872, 55873, 55874, 55875 were selected from the 932 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4493. The probes having the nucleotide sequence represented by SEQ ID NOS: 55876, 55877, 55878, 55879, 55880, 55881, 5 55882, 55883, 55884, 55885, 55886 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4494. The probes having the nucleotide sequence represented by SEQ ID NOS: 55887, 55888, 55889, 55890, 55891, 55892, 10 55893, 55894, 55895, 55896, 55897 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4495. The probes having the nucleotide sequence represented by SEQ ID NOS: 55898, 55899, 55900, 55901, 55902, 55903, 15 55904, 55905, 55906, 55907, 55908 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4496. The probes having the nucleotide sequence represented by SEQ ID NOS: 55909, 55910, 55911, 55912, 55913, 55914, 20 55915, 55916, 55917, 55918, 55919 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4497. The probes having the nucleotide sequence represented by SEQ ID NOS: 55920, 55921, 55922, 55923, 55924, 55925, 25 55926, 55927, 55928, 55929, 55930 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4498. 933 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 55931, 55932, 55933, 55934, 55935, 55936, 55937, 55938, 55939, 55940, 55941 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4499. The probes having the nucleotide sequence represented by SEQ ID NOS: 55942, 55943, 55944, 55945, 55946, 55947, 55948, 55949, 55950, 55951, 55952 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4500. The probes having the nucleotide sequence represented by SEQ ID NOS: 55953, 55954, 55955, 55956, 55957, 55958, 55959, 55960, 55961, 55962, 55963 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4501. The probes having the nucleotide sequence represented by SEQ ID NOS: 55964, 55965, 55966, 55967, 55968, 55969, 55970, 55971, 55972, 55973, 55974 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4502. The probes having the nucleotide sequence represented by SEQ ID NOS: 55975, 55976, 55977, 55978, 55979, 55980, 55981, 55982, 55983, 55984, 55985 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4503. The probes having the nucleotide sequence represented by SEQ ID NOS: 55986, 55987, 55988, 55989, 55990, 55991, 55992, 55993, 55994, 55995, 55996 were selected from the 934 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4504. The probes having the nucleotide sequence represented by SEQ ID NOS: 55997, 55998, 55999, 56000, 56001, 56002, 5 56003, 56004, 56005, 56006, 56007 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4505. The probes having the nucleotide sequence represented by SEQ ID NOS: 56008, 56009, 56010, 56011, 56012, 56013, 10 56014, 56015, 56016, 56017, 56018 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4506. The probes having the nucleotide sequence represented by SEQ ID NOS: 56019, 56020, 56021, 56022, 56023, 56024, 15 56025, 56026, 56027, 56028, 56029 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4507. The probes having the nucleotide sequence represented by SEQ ID NOS: 56030, 56031, 56032, 56033, 56034, 56035, 20 56036, 56037, 56038, 56039, 56040 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4508. The probes having the nucleotide sequence represented by SEQ ID NOS: 56041, 56042, 56043, 56044, 56045, 56046, 25 56047, 56048, 56049, 56050, 56051 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4509. 935 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 56052, 56053, 56054, 56055, 56056, 56057, 56058, 56059, 56060, 56061, 56062 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4510. The probes having the nucleotide sequence represented by SEQ ID NOS: 56063, 56064, 56065, 56066, 56067, 56068, 56069, 56070, 56071, 56072, 56073 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4511. The probes having the nucleotide sequence represented by SEQ ID NOS: 56074, 56075, 56076, 56077, 56078, 56079, 56080, 56081, 56082, 56083, 56084 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4512. The probes having the nucleotide sequence represented by SEQ ID NOS: 56085, 56086, 56087, 56088, 56089, 56090, 56091, 56092, 56093, 56094, 56095 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4513. The probes having the nucleotide sequence represented by SEQ ID NOS: 56096, 56097, 56098, 56099, 56100, 56101, 56102, 56103, 56104, 56105, 56106 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4514. The probes having the nucleotide sequence represented by SEQ ID NOS: 56107, 56108, 56109, 56110, 56111, 56112, 56113, 56114, 56115, 56116, 56117 were selected from the 936 WO 2006/024951 PCT/IB2005/002908 ORys having the nucleotide sequence represented by SEQ ID NO: 4515. The probes having the nucleotide sequence represented by SEQ ID NOS: 56118, 56119, 56120, 56121, 56122, 56123, 5 56124, 56125, 56126, 56127, 56128 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4516. The probes having the nucleotide sequence represented by SEQ ID NOS: 56129, 56130, 56131, 56132, 56133, 56134, 10 56135, 56136, 56137, 56138, 56139 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4517. The probes having the nucleotide sequence represented by SEQ ID NOS: 56140, 56141, 56142, 56143, 56144, 56145, 15 56146, 56147, 56148, 56149, 56150 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4518. The probes having the nucleotide sequence represented by SEQ ID NOS: 56151, 56152, 56153, 56154, 56155, 56156, 20 56157, 56158, 56159, 56160, 56161 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4519. The probes having the nucleotide sequence represented by SEQ ID NOS: 56162, 56163, 56164, 56165, 56166, 56167, 25 56168, 56169, 56170, 56171, 56172 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4520. 937 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 56173, 56174, 56175, 56176, 56177, 56178, 56179, 56180, 56181, 56182, 56183 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4521. The probes having the nucleotide sequence represented by SEQ ID NOS: 56184, 56185, 56186, 56187, 56188, 56189, 56190, 56191, 56192, 56193, 56194 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4522. The probes having the nucleotide sequence represented by SEQ ID NOS: 56195, 56196, 56197, 56198, 56199, 56200, 56201, 56202, 56203, 56204, 56205 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4523. The probes having the nucleotide sequence represented by SEQ ID NOS: 56206, 56207, 56208, 56209, 56210, 56211, 56212, 56213, 56214, 56215, 56216 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4524. The probes having the nucleotide sequence represented by SEQ ID NOS: 56217, 56218, 56219, 56220, 56221, 56222, 56223, 56224, 56225, 56226, 56227 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4525. The probes having the nucleotide sequence represented by SEQ ID NOS: 56228, 56229, 56230, 56231, 56232, 56233, 56234, 56235, 56236, 56237, 56238 were selected from the 938 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4526. The probes having the nucleotide sequence represented by SEQ ID NOS: 56239, 56240, 56241, 56242, 56243, 56244, 5 56245, 56246, 56247, 56248, 56249 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4527. The probes having the nucleotide sequence represented by SEQ ID NOS: 56250, 56251, 56252, 56253, 56254, 56255, 10 56256, 56257, 56258, 56259, 56260 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4528. The probes having the nucleotide sequence represented by SEQ ID NOS: 56261, 56262, 56263, 56264, 56265, 56266, 15 56267, 56268, 56269, 56270, 56271 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4529. The probes having the nucleotide sequence represented by SEQ ID NOS: 56272, 56273, 56274, 56275, 56276, 56277, 20 56278, 56279, 56280, 56281, 56282 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4530. The probes having the nucleotide sequence represented by SEQ ID NOS: 56283, 56284, 56285, 56286, 56287, 56288, 25 56289, 56290, 56291, 56292, 56293, 56294, 56295, 56296, 56297, 56298, 56299, 56300, 56301, 56302, 56303, 56304 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4531. 939 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 56305, 56306, 56307, 56308, 56309, 56310, 56311, 56312, 56313, 56314, 56315 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4532. The probes having the nucleotide sequence represented by SEQ ID NOS: 56316, 56317, 56318, 56319, 56320, 56321, 56322, 56323, 56324, 56325, 56326 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4533. The probes having the nucleotide sequence represented by SEQ ID NOS: 56327, 56328, 56329, 56330, 56331, 56332, 56333, 56334, 56335, 56336, 56337 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4534. The probes having the nucleotide sequence represented by SEQ ID NOS: 56338, 56339, 56340, 56341, 56342, 56343, 56344, 56345, 56346, 56347, 56348 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4535. The probes having the nucleotide sequence represented by SEQ ID NOS: 56349, 56350, 56351, 56352, 56353, 56354, 56355, 56356, 56357, 56358, 56359 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4536. The probes having the nucleotide sequence represented by SEQ ID NOS: 56360, 56361, 56362, 56363, 56364, 56365, 56366, 56367, 56368, 56369, 56370 were selected from the 940 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4537. The probes having the nucleotide sequence represented by SEQ ID NOS: 56371, 56372, 56373, 56374, 56375, 56376, 5 56377, 56378, 56379, 56380, 56381 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4538. The probes having the nucleotide sequence represented by SEQ ID NOS: 56382, 56383, 56384, 56385, 56386, 56387, 10 56388, 56389, 56390, 56391, 56392 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4539. The probes having the nucleotide sequence represented by SEQ ID NOS: 56393, 56394, 56395, 56396, 56397, 56398, 15 56399, 56400, 56401, 56402, 56403 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4540. The probes having the nucleotide sequence represented by SEQ ID NOS: 56404, 56405, 56406, 56407, 56408, 56409, 20 56410, 56411, 56412, 56413, 56414 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4541. The probes having the nucleotide sequence represented by SEQ ID NOS: 56415, 56416, 56417, 56418, 56419, 56420, 25 56421, 56422, 56423, 56424, 56425 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4542. 9.41 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 56426, 56427, 56428, 56429, 56430, 56431, 56432, 56433, 56434, 56435, 56436 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4543. The probes having the nucleotide sequence represented by SEQ ID NOS: 56437, 56438, 56439, 56440, 56441, 56442, 56443, 56444, 56445, 56446, 56447 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4544. The probes having the nucleotide sequence represented by SEQ ID NOS: 56448, 56449, 56450, 56451, 56452, 56453, 56454, 56455, 56456, 56457, 56458 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4545. The probes having the nucleotide sequence represented by SEQ ID NOS: 56459, 56460, 56461, 56462, 56463, 56464, 56465, 56466, 56467, 56468, 56469 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4546. The probes having the nucleotide sequence represented by SEQ ID NOS: 56470, 56471, 56472, 56473, 56474, 56475, 56476, 56477, 56478, 56479, 56480 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4547. The probes having the nucleotide sequence represented by SEQ ID NOS: 56481, 56482, 56483, 56484, 56485, 56486, 56487, 56488, 56489, 56490, 56491 were selected from the 942 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4548. The probes having the nucleotide sequence represented by SEQ ID NOS: 56492, 56493, 56494, 56495, 56496, 56497, 5 56498, 56499, 56500, 56501, 56502 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4549. The probes having the nucleotide sequence represented by SEQ ID NOS: 56503, 56504, 56505, 56506, 56507, 56508, 10 56509, 56510, 56511, 56512, 56513 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4550. The probes having the nucleotide sequence represented by SEQ ID NOS: 56514, 56515, 56516, 56517, 56518, 56519, 15 56520, 56521, 56522, 56523, 56524 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4551. The probes having the nucleotide sequence represented by SEQ ID NOS: 56525, 56526, 56527, 56528, 56529, 56530, 20 56531, 56532, 56533, 56534, 56535, 56536, 56537, 56538, 56539, 56540, 56541, 56542, 56543, 56544, 56545, 56546 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4552. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 56547, 56548, 56549, 56550, 56551, 56552, 56553, 56554, 56555, 56556, 56557 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4553. 943 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 56558, 56559, 56560, 56561, 56562, 56563, 56564, 56565, 56566, 56567, 56568 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4554. The probes having the nucleotide sequence represented by SEQ ID NOS: 56569, 56570, 56571, 56572, 56573, 56574, 56575, 56576, 56577, 56578, 56579 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4555. The probes having the nucleotide sequence represented by SEQ ID NOS: 56580, 56581, 56582, 56583, 56584, 56585, 56586, 56587, 56588, 56589, 56590 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4556. The probes having the nucleotide sequence represented by SEQ ID NOS: 56591, 56592, 56593, 56594, 56595, 56596, 56597, 56598, 56599, 56600, 56601 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4557. The probes having the nucleotide sequence represented by SEQ ID NOS: 56602, 56603, 56604, 56605, 56606, 56607, 56608, 56609, 56610, 56611, 56612 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4558. The probes having the nucleotide sequence represented by SEQ ID NOS: 56613, 56614, 56615, 56616, 56617, 56618, 56619, 56620, 56621, 56622, 56623 were selected from the 944 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4559. The probes having the nucleotide sequence represented by SEQ ID NOS: 56624, 56625, 56626, 56627, 56628, 56629, 5 56630, 56631, 56632, 56633, 56634 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4560. The probes having the nucleotide sequence represented by SEQ ID NOS: 56635, 56636, 56637, 56638, 56639, 56640, 10 56641, 56642, 56643, 56644, 56645 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4561. The probes having the nucleotide sequence represented by SEQ ID NOS: 56646, 56647, 56648, 56649, 56650, 56651, 15 56652, 56653, 56654, 56655, 56656 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4562. The probes having the nucleotide sequence represented by SEQ ID NOS: 56657, 56658, 56659, 56660, 56661, 56662, 20 56663, 56664, 56665, 56666, 56667 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4563. The probes having the nucleotide sequence represented by SEQ ID NOS: 56668, 56669, 56670, 56671, 56672, 56673, 25 56674, 56675, 56676, 56677, 56678 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4564. 945 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 56679, 56680, 56681., 56682, 56683, 56684, 56685, 56686, 56687, 56688, 56689 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4565. The probes having the nucleotide sequence represented by SEQ ID NOS: 56690, 56691, 56692, 56693, 56694, 56695, 56696, 56697, 56698, 56699, 56700 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4566. The probes having the nucleotide sequence represented by SEQ ID NOS: 56701, 56702, 56703, 56704, 56705, 56706, 56707, 56708, 56709, 56710, 56711 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4567. The probes having the nucleotide sequence represented by SEQ ID NOS: 56712, 56713, 56714, 56715, 56716, 56717, 56718, 56719, 56720, 56721, 56722, 56723, 56724, 56725, 56726, 56727, 56728, 56729, 56730, 56731, 56732, 56733 were 20 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4568. The probes having the nucleotide sequence represented by SEQ ID NOS: 56734, 56735, 56736, 56737, 56738, 56739, 56740, 56741, 56742, 56743, 56744 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 4569. The probes having the nucleotide sequence represented by SEQ ID NOS: 56745, 56746, 56747, 56748, 56749, 56750, 946 WO 2006/024951 PCT/IB2005/002908 56751, 56752, 56753, 56754, 56755 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4570. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 56756, 56757, 56758, 56759, 56760, 56761, 56762, 56763, 56764, 56765, 56766 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4571. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 56767, 56768, 56769, 56770, 56771, 56772, 56773, 56774, 56775, 56776, 56777 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4572. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 56778, 56779, 56780, 56781, 56782, 56783, 56784, 56785, 56786, 56787, 56788 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4573. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 56789, 56790, 56791, 56792, 56793, 56794, 56795, 56796, 56797, 56798, 56799 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4574. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 56800, 56801, 56802, 56803, 56804, 56805, 56806, 56807, 56808, 56809, 56810 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4575. 947 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 56811, 56812, 56813, 56814, 56815, 56816, 56817, 56818, 56819, 56820, 56821 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4576. The probes having the nucleotide sequence represented by SEQ ID NOS: 56822, 56823, 56824, 56825, 56826, 56827, .56828, 56829, 56830, 56831, 56832 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4577. The probes having the nucleotide sequence represented by SEQ ID NOS: 56833, 56834, 56835, 56836, 56837, 56838, 56839, 56840, 56841, 56842, 56843 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4578. The probes having the nucleotide sequence represented by SEQ ID NOS: 56844, 56845, 56846, 56847, 56848, 56849, 56850, 56851, 56852, 56853, 56854 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4579. The probes having the nucleotide sequence represented by SEQ ID NOS: 56855, 56856, 56857, 56858, 56859, 56860, 56861, 56862, 56863, 56864, 56865 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4580. The probes having the nucleotide sequence represented by SEQ ID NOS: 56866, 56867, 56868, 56869, 56870, 56871, 56872, 56873, 56874, 56875, 56876 were selected from the 948 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4581. The probes having the nucleotide sequence represented by SEQ ID NOS: 56877, 56878, 56879, 56880, 56881, 56882, 5 56883, 56884, 56885, 56886, 56887 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4582. The probes having the nucleotide sequence represented by SEQ ID NOS: 56888, 56889, 56890, 56891, 56892, 56893, 10 56894, 56895, 56896, 56897, 56898 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4583. The probes having the nucleotide sequence represented by SEQ ID NOS: 56899, 56900, 56901, 56902, 56903, 56904, 15 56905, 56906, 56907, 56908, 56909 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4584. The probes having the nucleotide sequence represented by SEQ ID NOS: 56910, 56911, 56912, 56913, 56914, 56915, 20 56916, 56917, 56918, 56919, 56920 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4585. The probes having the nucleotide sequence represented by SEQ ID NOS: 56921, 56922, 56923, 56924, 56925, 56926, 25 56927, 56928, 56929, 56930, 56931 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4586. 949 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 56932, 56933, 56934, 56935, 56936, 56937, 56938, 56939, 56940, 56941, 56942 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4587. The probes having the nucleotide sequence represented by SEQ ID NOS: 56943, 56944, 56945, 56946, 56947, 56948, 56949, 56950, 56951, 56952, 56953 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4588. The probes having the nucleotide sequence represented by SEQ ID NOS: 56954, 56955, 56956, 56957, 56958, 56959, 56960, 56961, 56962, 56963, 56964 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4589. The probes having the nucleotide sequence represented by SEQ ID NOS: 56965, 56966, 56967, 56968, 56969, 56970, 56971, 56972, 56973, 56974, 56975 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4590. The probes having the nucleotide sequence represented by SEQ ID NOS: 56976, 56977, 56978, 56979, 56980, 56981, 56982, 56983, 56984, 56985, 56986 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4591. The probes having the nucleotide sequence represented by SEQ ID NOS: 56987, 56988, 56989, 56990, 56991, 56992, 56993, 56994, 56995, 56996, 56997 were selected from the 950 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4592. The probes having the nucleotide sequence represented by SEQ ID NOS: 56998, 56999, 57000, 57001, 57002, 57003, 5 57004, 57005, 57006, 57007, 57008 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4593. The probes having the nucleotide sequence represented by SEQ ID NOS: 57009, 57010, 57011, 57012, 57013, 57014, 10 57015, 57016, 57017, 57018, 57019 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4594. The probes having the nucleotide sequence represented by SEQ ID NOS: 57020, 57021, 57022, 57023, 57024, 57025, 15 57026, 57027, 57028, 57029, 57030 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4595. The probes having the nucleotide sequence represented by SEQ ID NOS: 57031, 57032, 57033, 57034, 57035, 57036, 20 57037, 57038, 57039, 57040, 57041 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4596. The probes having the nucleotide sequence represented by SEQ ID NOS: 57042, 57043, 57044, 57045, 57046, 57047, 25 57048, 57049, 57050, 57051, 57052 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4597. 951 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 57053, 57054, 57055, 57056, 57057, 57058, 57059, 57060, 57061, 57062, 57063 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4598. The probes having the nucleotide sequence represented by SEQ ID NOS: 57064, 57065, 57066, 57067, 57068, 57069, 57070, 57071, 57072, 57073, 57074 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4599. The probes having the nucleotide sequence represented by SEQ ID NOS: 57075, 57076, 57077, 57078, 57079, 57080, 57081, 57082, 57083, 57084, 57085 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4600. The probes having the nucleotide sequence represented by SEQ ID NOS: 57086, 57087, 57088, 57089, 57090, 57091, 57092, 57093, 57094, 57095, 57096, 57097, 57098, 57099, 57100, 57101, 57102, 57103, 57104, 57105, 57106, 57107 were 20 selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4601. The probes having the nucleotide sequence represented by SEQ ID NOS: 57108, 57109, 57110, 57111, 57112, 57113, 57114, 57115, 57116, 57117, 57118 were selected from the 25 ORFs having the nucleotide sequence represented by SEQ ID NO: 4602. The probes having the nucleotide sequence represented by SEQ ID NOS: 57119, 57120, 57121, 57122, 57123, 57124, 952 WO 2006/024951 PCT/IB2005/002908 57125, 57126, 57127, 57128, 57129 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4603. The probes having the nucleotide sequence represented by 5 SEQ ID NOS: 57130, 57131, 57132, 57133, 57134, 57135, 57136, 57137, 57138, 57139, 57140 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4604. The probes having the nucleotide sequence represented by 10 SEQ ID NOS: 57141, 57142, 57143, 57144, 57145, 57146, 57147, 57148, 57149, 57150, 57151 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4605. The probes having the nucleotide sequence represented by 15 SEQ ID NOS: 57152, 57153, 57154, 57155, 57156, 57157, 57158, 57159, 57160, 57161, 57162 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4606. The probes having the nucleotide sequence represented by 20 SEQ ID NOS: 57163, 57164, 57165, 57166, 57167, 57168, 57169, 57170, 57171, 57172, 57173 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4607. The probes having the nucleotide sequence represented by 25 SEQ ID NOS: 57174, 57175, 57176, 57177, 57178, 57179, 57180, 57181, 57182, 57183, 57184 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4608. 953 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 57185, 57186, 57187, 57188, 57189, 57190, 57191, 57192, 57193, 57194, 57195 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4609. The probes having the nucleotide sequence represented by SEQ ID NOS: 57196, 57197, 57198, 57199, 57200, 57201, 57202, 57203, 57204, 57205, 57206 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4610. The probes having the nucleotide sequence represented by SEQ ID NOS: 57207, 57208, 57209, 57210, 57211, 57212, 57213, 57214, 57215, 57216, 57217 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4611. The probes having the nucleotide sequence represented by SEQ ID NOS: 57218, 57219, 57220, 57221, 57222, 57223, 57224, 57225, 57226, 57227, 57228 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4612. The probes having the nucleotide sequence represented by SEQ ID NOS: 57229, 57230, 57231, 57232, 57233, 57234, 57235, 57236, 57237, 57238, 57239 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4613. The probes having the nucleotide sequence represented by SEQ ID NOS: 57240, 57241, 57242, 57243, 57244, 57245, 57246, 57247, 57248, 57249, 57250 were selected from the 954 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4614. The probes having the nucleotide sequence represented by SEQ ID NOS: 57251, 57252, 57253, 57254, 57255, 57256, 5 57257, 57258, 57259, 57260, 57261 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4615. The probes having the nucleotide sequence represented by SEQ ID NOS: 57262, 57263, 57264, 57265, 57266, 57267, 10 57268, 57269, 57270, 57271, 57272 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4616. The probes having the nucleotide sequence represented by SEQ ID NOS: 57273, 57274, 57275, 57276, 57277, 57278, 15 57279, 57280, 57281, 57282, 57283 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4617. The probes having the nucleotide sequence represented by SEQ ID NOS: 57284, 57285, 57286, 57287, 57288, 57289, 20 57290, 57291, 57292, 57293, 57294 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4618. The probes having the nucleotide sequence represented by SEQ ID NOS: 57295, 57296, 57297, 57298, 57299, 57300, 25 57301, 57302, 57303, 57304, 57305 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4619. 955 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 57306, 57307, 57308, 57309, 57310, 57311, 57312, 57313, 57314, 57315, 57316 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4620. The probes having the nucleotide sequence represented by SEQ ID NOS: 57317, 57318, 57319, 57320, 57321, 57322, 57323, 57324, 57325, 57326, 57327 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4621. The probes having the nucleotide sequence represented by SEQ ID NOS: 57328, 57329, 57330, 57331, 57332, 57333, 57334, 57335, 57336, 57337, 57338 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4622. The probes having the nucleotide sequence represented by SEQ ID NOS: 57339, 57340, 57341, 57342, 57343, 57344, 57345, 57346, 57347, 57348, 57349 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4623. The probes having the nucleotide sequence represented by SEQ ID NOS: 57350, 57351, 57352, 57353, 57354, 57355, 57356, 57357, 57358, 57359, 57360 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4624. The probes having the nucleotide sequence represented by SEQ ID NOS: 57361, 57362, 57363, 57364, 57365, 57366, 57367, 57368, 57369, 57370, 57371 were selected from the 956 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4625. The probes having the nucleotide sequence represented by SEQ ID NOS: 57372, 57373, 57374, 57375, 57376, 57377, 5 57378, 57379, 57380, 57381, 57382 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4626. The probes having the nucleotide sequence represented by SEQ ID NOS: 57383, 57384, 57385, 57386, 57387, 57388, 10 57389, 57390, 57391, 57392, 57393 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4627. The probes having the nucleotide sequence represented by SEQ ID NOS: 57394, 57395, 57396, 57397, 57398, 57399, 15 57400, 57401, 57402, 57403, 57404 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4628. The probes having the nucleotide sequence represented by SEQ ID NOS: 57405, 57406, 57407, 57408, 57409, 57410, 20 57411, 57412, 57413, 57414, 57415 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4629. The probes having the nucleotide sequence represented by SEQ ID NOS: 57416, 57417, 57418, 57419, 57420, 57421, 25 57422, 57423, 57424, 57425, 57426 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4630. 957 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 57427, 57428, 57429, 57430, 57431, 57432, 57433, 57434, 57435, 57436, 57437 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4631. The probes having the nucleotide sequence represented by SEQ ID NOS: 57438, 57439, 57440, 57441, 57442, 57443, 57444, 57445, 57446, 57447, 57448 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4632. The probes having the nucleotide sequence represented by SEQ ID NOS: 57449, 57450, 57451, 57452, 57453, 57454, 57455, 57456, 57457, 57458, 57459 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4633. The probes having the nucleotide sequence represented by SEQ ID NOS: 57460, 57461, 57462, 57463, 57464, 57465, 57466, 57467, 57468, 57469, 57470 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4634. The probes having the nucleotide sequence represented by SEQ ID NOS: 57471, 57472, 57473, 57474, 57475, 57476, 57477, 57478, 57479, 57480, 57481 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4635. The probes having the nucleotide sequence represented by SEQ ID NOS: 57482, 57483, 57484, 57485, 57486, 57487, 57488, 57489, 57490, 57491, 57492 were selected from the 958 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID r NO: 4636. The probes having the nucleotide sequence represented by SEQ ID NOS: 57493, 57494, 57495, 57496, 57497, 57498, 5 57499, 57500, 57501, 57502, 57503 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4637. The probes having the nucleotide sequence represented by SEQ ID NOS: 57504, 57505, 57506, 57507, 57508, 57509, 10 57510, 57511, 57512, 57513, 57514 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4638. The probes having the nucleotide sequence represented by SEQ ID NOS: 57515, 57516, 57517, 57518, 57519, 57520, 15 57521, 57522, 57523, 57524, 57525 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4639. The probes having the nucleotide sequence represented by SEQ ID NOS: 57526, 57527, 57528, 57529, 57530, 57531, 20 57532, 57533, 57534, 57535, 57536 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4640. The probes having the nucleotide sequence represented by SEQ ID NOS: 57537, 57538, 57539, 57540, 57541, 57542, 25 57543, 57544, 57545, 57546, 57547 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4641. 959 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 57548, 57549, 57550, 57551, 57552, 57553, 57554, 57555, 57556, 57557, 57558 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4642. The probes having the nucleotide sequence represented by SEQ ID NOS: 57559, 57560, 57561, 57562, 57563, 57564, 57565, 57566, 57567, 57568, 57569 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4643. The probes having the nucleotide sequence represented by SEQ ID NOS: 57570, 57571, 57572, 57573, 57574, 57575, 57576, 57577, 57578, 57579, 57580 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4644. The probes having the nucleotide sequence represented by SEQ ID NOS: 57581, 57582, 57583, 57584, 57585, 57586, 57587, 57588, 57589, 57590, 57591 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4645. The probes having the nucleotide sequence represented by SEQ ID NOS: 57592, 57593, 57594, 57595, 57596, 57597, 57598, 57599, 57600, 57601, 57602 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4646. The probes having the nucleotide sequence represented by SEQ ID NOS: 57603, 57604, 57605, 57606, 57607, 57608, 57609, 57610, 57611, 57612, 57613 were selected from the 960 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4647. The probes having the nucleotide sequence represented by SEQ ID NOS: 57614, 57615, 57616, 57617, 57618, 57619, 5 57620, 57621, 57622, 57623, 57624 were selected from the ORFs having the.nucleotide sequence represented by SEQ ID NO: 4648. The probes having the nucleotide sequence represented by SEQ ID NOS: 57625, 57626, 57627, 57628, 57629, 57630, 10 57631, 57632, 57633, 57634, 57635 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4649. The probes having the nucleotide sequence represented by SEQ ID NOS: 57636, 57637, 57638, 57639, 57640, 57641, 15 57642, 57643, 57644, 57645, 57646 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4650. The probes having the nucleotide sequence represented by SEQ ID NOS: 57647, 57648, 57649, 57650, 57651, 57652, 20 57653, 57654, 57655, 57656, 57657 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4651. The probes having the nucleotide sequence represented by SEQ ID NOS: 57658, 57659, 57660, 57.661, 57662, 57663, 25 57664, 57665, 57666, 57667, 57668 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4652. 961 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 57669, 57670, 57671, 57672, 57673, 57674, 57675, 57676, 57677, 57678, 57679 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4653. The probes having the nucleotide sequence represented by SEQ ID NOS: 57680, 57681, 57682, 57683, 57684, 57685, 57686, 57687, 57688, 57689, 57690 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4654. The probes having the nucleotide sequence represented by SEQ ID NOS: 57691, 57692, 57693, 57694, 57695, 57696, 57697, 57698, 57699, 57700, 57701 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4655. The probes having the nucleotide sequence represented by SEQ ID NOS: 57702, 57703, 57704, 57705, 57706, 57707, 57708, 57709, 57710, 57711, 57712 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4656. The probes having the nucleotide sequence represented by SEQ ID NOS: 57713, 57714, 57715, 57716, 57717, 57718, 57719, 57720, 57721, 57722, 57723 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4657. The probes having the nucleotide sequence represented by SEQ ID NOS: 57724, 57725, 57726, 57727, 57728, 57729, 57730, 57731, 57732, 57733, 57734 were selected from the 962 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4658. The probes having the nucleotide sequence represented by SEQ ID NOS: 57735, 57736, 57737, 57738, 57739, 57740, 5 57741, 57742, 57743, 57744, 57745 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4659. The probes having the nucleotide sequence represented by SEQ ID NOS: 57746, 57747, 57748, 57749, 57750, 57751, 10 57752, 57753, 57754, 57755, 57756 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4660. The probes having the nucleotide sequence represented by SEQ ID NOS: 57757, 57758, 57759, 57760, 57761, 57762, 15 57763, 57764, 57765, 57766, 57767 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4661. The probes having the nucleotide sequence represented by SEQ ID NOS: 57768, 57769, 57770, 57771, 57772, 57773, 20 57774, 57775, 57776, 57777, 57778 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4662. The probes having the nucleotide sequence represented by SEQ ID NOS: 57779, 57780, 57781, 57782, 57783, 57784, 25 57785, 57786, 57787, 57788, 57789 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4663. 963 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 57790, 57791, 57792, 57793, 57794, 57795, 57796, 57797, 57798, 57799, 57800 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4664. The probes having the nucleotide sequence represented by SEQ ID NOS: 57801, 57802, 57803, 57804, 57805, 57806, 57807, 57808, 57809, 57810, 57811 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4665. The probes having the nucleotide sequence represented by SEQ ID NOS: 57812, 57813, 57814, 57815, 57816, 57817, 57818, 57819, 57820, 57821, 57822 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4666. The probes having the nucleotide sequence represented by SEQ ID NOS: 57823, 57824, 57825, 57826, 57827, 57828, 57829, 57830, 57831, 57832, 57833 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4667. The probes having the nucleotide sequence represented by SEQ ID NOS: 57834, 57835, 57836, 57837, 57838, 57839, 57840, 57841, 57842, 57843, 57844 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4668. The probes having the nucleotide sequence represented by SEQ ID NOS: 57845, 57846, 57847, 57848, 57849, 57850, 57851, 57852, 57853, 57854, 57855 were selected from the 964 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4669. The probes having the nucleotide sequence represented by SEQ ID NOS: 57856, 57857, 57858, 57859, 57860, 57861, 5 57862, 57863, 57864, 57865, 57866 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4670. The probes having the nucleotide sequence represented by SEQ ID NOS: 57867, 57868, 57869, 57870, 57871, 57872, 10 57873, 57874, 57875, 57876, 57877 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4671. The probes having the nucleotide sequence represented by SEQ ID NOS: 57878, 57879, 57880, 57881, 57882, 57883, 15 57884, 57885, 57886, 57887, 57888 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4672. The probes having the nucleotide sequence represented by SEQ ID NOS: 57889, 57890, 57891, 57892, 57893, 57894, 20 57895, 57896, 57897, 57898, 57899 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4673. The probes having the nucleotide sequence represented by SEQ ID NOS: 57900, 57901, 57902, 57903, 57904, 57905, 25 57906, 57907, 57908, 57909, 57910 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4674. 965 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 57911, 57912, 57913, 57914, 57915, 57916, 57917, 57918, 57919, 57920, 57921 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4675. The probes having the nucleotide sequence represented by SEQ ID NOS: 57922, 57923, 57924, 57925, 57926, 57927, 57928, 57929, 57930, 57931, 57932 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4676. The probes having the nucleotide sequence represented by SEQ ID NOS: 57933, 57934, 57935, 57936, 57937, 57938, 57939, 57940, 57941, 57942, 57943 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4677. The probes having the nucleotide sequence represented by SEQ ID NOS: 57944, 57945, 57946, 57947, 57948, 57949, 57950, 57951, 57952, 57953, 57954 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4678. The probes having the nucleotide sequence represented by SEQ ID NOS: 57955, 57956, 57957, 57958, 57959, 57960, 57961, 57962, 57963, 57964, 57965 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4679. The probes having the nucleotide sequence represented by SEQ ID NOS: 57966, 57967, 57968, 57969, 57970, 57971, 57972, 57973, 57974, 57975, 57976 were selected from the 966 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4680. The probes having the nucleotide sequence represented by SEQ ID NOS: 57977, 57978, 57979, 57980, 57981, 57982, 5 57983, 57984, 57985, 57986, 57987 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4681. The probes having the nucleotide sequence represented by SEQ ID NOS: 57988, 57989, 57990, 57991, 57992, 57993, 10 57994, 57995, 57996, 57997, 57998 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4682. The probes having the nucleotide sequence represented by SEQ ID NOS: 57999, 58000, 58001, 58002, 58003, 58004, 15 58005, 58006, 58007, 58008, 58009 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4683. The probes having the nucleotide sequence represented by SEQ ID NOS: 58010, 58011, 58012, 58013, 58014, 58015, 20 58016, 58017, 58018, 58019, 58020 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4684. The probes having the nucleotide sequence represented by SEQ ID NOS: 58021, 58022, 58023, 58024, 58025, 58026, 25 58027, 58028, 58029, 58030, 58031 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4685. 967 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 58032, 58033, 58034, 58035, 58036, 58037, 58038, 58039, 58040, 58041, 58042 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4686. The probes having the nucleotide sequence represented by SEQ ID NOS: 58043, 58044, 58045, 58046, 58047, 58048, 58049, 58050, 58051, 58052, 58053 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4687. The probes having the nucleotide sequence represented by SEQ ID NOS: 58054, 58055, 58056, 58057, 58058, 58059, 58060, 58061, 58062, 58063, 58064 were selected from the ORFs having the nucleotide 'sequence represented by SEQ ID 15 NO: 4688. The probes having the nucleotide sequence represented by SEQ ID NOS: 58065, 58066, 58067, 58068, 58069, 58070, 58071, 58072, 58073, 58074, 58075 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4689. The probes having the nucleotide sequence represented by SEQ ID NOS: 58076, 58077, 58078, 58079, 58080, 58081, 58082, 58083, 58084, 58085, 58086 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4690. The probes having the nucleotide sequence represented by SEQ ID NOS: 58087, 58088, 58089, 58090, 58091, 58092, 58093, 58094, 58095, 58096, 58097 were selected from the 968 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4691. The probes having the nucleotide sequence represented by SEQ ID NOS: 58098, 58099, 58100, 58101, 58102, 58103, 5 58104, 58105, 58106, 58107, 58108 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4692. The probes having the nucleotide sequence represented by SEQ ID NOS: 58109, 58110, 58111, 58112, 58113, 58114, 10 58115, 58116, 58117, 58118, 58119 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4693. The probes having the nucleotide sequence represented by SEQ ID NOS: 58120, 58121, 58122, 58123, 58124, 58125, 15 58126, 58127, 58128, 58129, 58130 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4694. The probes having the nucleotide sequence represented by SEQ ID NOS: 58131, 58132, 58133, 58134, 58135, 58136, 20 58137, 58138, 58139, 58140, 58141 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4695. The probes having the nucleotide sequence represented by SEQ ID NOS: 58142, 58143, 58144, 58145, 58146, 58147, . 25 58148, 58149, 58150, 58151, 58152 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4696. 969 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 58153, 58154, 58155, 58156, 58157, 58158, 58159, 58160, 58161, 58162, 58163 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4697. The probes having the nucleotide sequence represented by SEQ ID NOS: 58164, 58165, 58166, 58167, 58168, 58169, 58170, 58171, 58172, 58173, 58174 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4698. The probes having the nucleotide sequence represented by SEQ ID NOS: 58175, 58176, 58177, 58178, 58179, 58180, 58181, 58182, 58183, 58184, 58185 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4699. The probes having the nucleotide sequence represented by SEQ ID NOS: 58186, 58187, 58188, 58189, 58190, 58191, 58192, 58193, 58194, 58195, 58196 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4700. The probes having the nucleotide sequence represented by SEQ ID NOS: 58197, 58198, 58199, 58200, 58201, 58202, 58203, 58204, 58205, 58206, 58207 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4701. The probes having the nucleotide sequence represented by SEQ ID NOS: 58208, 58209, 58210, 58211, 58212, 58213, 58214, 58215, 58216, 58217, 58218 were selected from the 970 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4702. The probes having the nucleotide sequence represented by SEQ ID NOS: 58219, 58220, 58221, 58222, 58223, 58224, 5 58225, 58226, 58227, 58228, 58229 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4703. The probes having the nucleotide sequence represented by SEQ ID NOS: 58230, 58231, 58232, 58233, 58234, 58235, 10 58236, 58237, 58238, 58239, 58240 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4704. The probes having the nucleotide sequence represented by SEQ ID NOS: 58241, 58242, 58243, 58244, 58245, 58246, 15 58247, 58248, 58249, 58250, 58251 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4705. The probes having the nucleotide sequence represented by SEQ ID NOS: 58252, 58253, 58254, 58255, 58256, 58257, 20 58258, 58259, 58260, 58261, 58262 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4706. The probes having the nucleotide sequence represented by SEQ ID NOS: 58263, 58264, 58265, 58266, 58267, 58268, 25 58269, 58270, 58271, 58272, 58273 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4707. 971 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 58274, 58275, 58276, 58277, 58278, 58279, 58280, 58281, 58282, 58283, 58284 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4708. The probes having the nucleotide sequence represented by SEQ ID NOS: 58285, 58286, 58287, 58288, 58289, 58290, 58291, 58292, 58293, 58294, 58295 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4709. The probes having the nucleotide sequence represented by SEQ ID NOS: 58296, 58297, 58298, 58299, 58300, 58301, 58302, 58303, 58304, 58305, 58306 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4710. The probes having the nucleotide sequence represented by SEQ ID NOS: 58307, 58308, 58309, 58310, 58311, 58312, 58313, 58314, 58315, 58316, 58317 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4711. The probes having the nucleotide sequence represented by SEQ ID NOS: 58318, 58319, 58320, 58321, 58322, 58323, 58324, 58325, 58326, 58327, 58328 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4712. The probes having the nucleotide sequence represented by SEQ ID NOS: 58329, 58330, 58331, 58332, 58333, 58334, 58335, 58336, 58337, 58338, 58339 were selected from the 972 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4713. The probes having the nucleotide sequence represented by SEQ ID NOS: 58340, 58341, 58342, 58343, 58344, 58345, 5 58346, 58347, 58348, 58349, 58350 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4714. The probes having the nucleotide sequence represented by SEQ ID NOS: 58351, 58352, 58353, 58354, 58355, 58356, 10 58357, 58358, 58359, 58360, 58361 were selected from the. ORFs having the nucleotide sequence represented by SEQ ID NO: 4715. The probes having the nucleotide sequence represented by SEQ ID NOS: 58362, 58363, 58364, 58365, 58366, 58367, 15 58368, 58369, 58370, 58371, 58372 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4716. The probes having the nucleotide sequence represented by SEQ ID NOS: 58373, 58374, 58375, 58376, 58377, 58378, 20 58379, 58380, 58381, 58382, 58383 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4717. The probes having the nucleotide sequence represented by SEQ ID NOS: 58384, 58385, 58386, 58387, 58388, 58389, 25 58390, 58391, 58392, 58393, 58394 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4718. 973 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 58395, 58396, 58397, 58398, 58399, 58400, 58401, 58402, 58403, 58404, 58405 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4719. The probes having the nucleotide sequence represented by SEQ ID NOS: 58406, 58407, 58408, 58409, 58410, 58411, 58412, 58413, 58414, 58415, 58416 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4720. The probes having the nucleotide sequence represented by SEQ ID NOS: 58417, 58418, 58419, 58420, 58421, 58422, 58423, 58424, 58425, 58426, 58427 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15, NO: 4721. The probes having the nucleotide sequence represented by SEQ ID NOS: 58428, 58429, 58430, 58431, 58432, 58433, 58434, 58435, 58436, 58437, 58438 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4722. The probes having the nucleotide sequence represented by SEQ ID NOS: 58439, 58440, 58441, 58442, 58443, 58444, 58445, 58446, 58447, 58448, 58449 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4723. The probes having the nucleotide sequence represented by SEQ ID NOS: 58450, 58451, 58452, 58453, 58454, 58455, 58456, 58457, 58458, 58459, 58460 were selected from the 974 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4724. The probes having the nucleotide sequence represented by SEQ ID NOS: 58461, 58462, 58463, 58464, 58465, 58466, 5 58467, 58468, 58469, 58470, 58471 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4725. The probes having the nucleotide sequence represented by SEQ ID NOS: 58472, 58473, 58474, 58475, 58476, 58477, 10 58478, 58479, 58480, 58481, 58482 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4726. The probes having the nucleotide sequence represented by SEQ ID NOS: 58483, 58484, 58485, 58486, 58487, 58488, 15 58489, 58490, 58491, 58492, 58493 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4727. The probes having the nucleotide sequence represented by SEQ ID NOS: 58494, 58495, 58496, 58497, 58498, 58499, 20 58500, 58501, 58502, 58503, 58504 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4728. The probes having the nucleotide sequence represented by SEQ ID NOS: 58505, 58506, 58507, 58508, 58509, 58510, 25 58511, 58512, 58513, 58514, 58515 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4729. 975 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 58516, 58517, 58518, 58519, 58520, 58521, 58522, 58523, 58524, 58525, 58526 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4730. The probes having the nucleotide sequence represented by SEQ ID NOS: 58527, 58528, 58529, 58530, 58531, 58532, 58533,, 58534, 58535, 58536, 58537 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4731. The probes having the nucleotide sequence represented by SEQ ID NOS: 58538, 58539, 58540, 58541, 58542, 58543, 58544, 58545, 58546, 58547, 58548 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4732. The probes having the nucleotide sequence represented by SEQ ID NOS: 58549, 58550, 58551, 58552, 58553, 58554, 58555, 58556, 58557, 58558, 58559 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4733. The probes having the nucleotide sequence represented by SEQ ID NOS: 58560, 58561, 58562, 58563, 58564, 58565, 58566, 58567, 58568, 58569, 58570 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4734. The probes having the nucleotide sequence represented by SEQ ID NOS: 58571, 58572, 58573, 58574, 58575, 58576, 58577, 58578, 58579, 58580, 58581 were selected from the 976 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4735. The probes having the nucleotide sequence represented by SEQ ID NOS: 58582, 58583, 58584, 58585, 58586, 58587, 5 58588, 58589, 58590, 58591, 58592 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4736. The probes having the nucleotide sequence represented by SEQ ID NOS: 58593, 58594, 58595, 58596, 58597, 58598, 10 58599, 58600, 58601, 58602, 58603 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4737. The probes having the nucleotide sequence represented by SEQ ID NOS: 58604, 58605, 58606, 58607, 58608, 58609, 15 58610, 58611, 58612, 58613, 58614 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4738. The probes having the nucleotide sequence represented by SEQ ID NOS: 58615, 58616, 58617, 58618, 58619, 58620, 20 58621, 58622, 58623, 58624, 58625 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4739. The probes having the nucleotide sequence represented by SEQ ID NOS: 58626, 58627, 58628, 58629, 58630, 58631, 25 58632, 58633, 58634, 58635, 58636 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4740. 977 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 58637, 58638, 58639, 58640, 58641, 58642, 58643, 58644, 58645, 58646, 58647 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4741. The probes having the nucleotide sequence represented by SEQ ID NOS: 58648, 58649, 58650, 58651, 58652, 58653, 58654, 58655, 58656, 58657, 58658 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4742. The probes having the nucleotide sequence represented by SEQ ID NOS: 58659, 58660, 58661, 58662, 58663, 58664, 58665, 58666, 58667, 58668, 58669 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4743. The probes having the nucleotide sequence represented by SEQ ID NOS: 58670, 58671, 58672, 58673, 58674, 58675, 58676, 58677, 58678, 58679, 58680 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4744. The probes having the nucleotide sequence represented by SEQ ID NOS: 58681, 58682, 58683, 58684, 58685, 58686, 58687, 58688, 58689, 58690, 58691 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4745. The probes having the nucleotide sequence represented by SEQ ID NOS: 58692, 58693, 58694, 58695, 58696, 58697, 58698, 58699, 58700, 58701, 58702 were selected from the 978 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4746. The probes having the nucleotide sequence represented by SEQ ID NOS: 58703, 58704, 58705, 58706, 58707, 58708, 5 58709, 58710, 58711, 58712, 58713 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4747. The probes having the nucleotide sequence represented by SEQ ID NOS: 58714, 58715, 58716, 58717, 58718, 58719, 10 58720, 58721, 58722, 58723, 58724 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4748. The probes having the nucleotide sequence represented by SEQ ID NOS: 58725, 58726, 58727, 58728, 58729, 58730, 15 58731, 58732, 58733, 58734, 58735 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4749. The probes having the nucleotide sequence represented by SEQ ID NOS: 58736, 58737, 58738, 58739, 58740, 58741, 20 58742, 58743, 58744, 58745, 58746 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4750. The probes having the nucleotide sequence represented by SEQ ID NOS: 58747, 58748, 58749, 58750, 58751, 58752, 25 58753, 58754, 58755, 58756, 58757 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4751. 979 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 58758, 58759, 58760, 58761, 58762, 58763, 58764, 58765, 58766, 58767, 58768 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4752. The probes having the nucleotide sequence represented by SEQ ID NOS: 58769, 58770, 58771, 58772, 58773, 58774, 58775, 58776, 58777, 58778, 58779 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4753. The probes having the nucleotide sequence represented by SEQ ID NOS: 58780, 58781, 58782, 58783, 58784, 58785, 58786, 58787, 58788, 58789, 58790 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4754. The probes having the nucleotide sequence represented by SEQ ID NOS: 58791, 58792, 58793, 58794, 58795, 58796, 58797, 58798, 58799, 58800, 58801 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4755. The probes having the nucleotide sequence represented by SEQ ID NOS: 58802, 58803, 58804, 58805, 58806, 58807, 58808, 58809, 58810, 58811, 58812 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4756. The probes having the nucleotide sequence represented by SEQ ID NOS: 58813, 58814, 58815, 58816, 58817, 58818, 58819, 58820, 58821, 58822, 58823 were selected from the 980 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4757. The probes having the nucleotide sequence represented by SEQ ID NOS: 58824, 58825, 58826, 58827, 58828, 58829, 5 58830, 58831, 58832, 58833, 58834 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4758. The probes having the nucleotide sequence represented by SEQ ID NOS: 58835, 58836, 58837, 58838, 58839, 58840, 10 58841, 58842, 58843, 58844, 58845 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4759. The probes having the nucleotide sequence represented by SEQ ID NOS: 58846, 58847, 58848, 58849, 58850, 58851, 15 58852, 58853, 58854, 58855, 58856 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4760. The probes having the nucleotide sequence represented by SEQ ID NOS: 58857, 58858, 58859, 58860, 58861, 58862, 20 58863, 58864, 58865, 58866, 58867 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4761. The probes having the nucleotide sequence represented by SEQ ID NOS: 58868, 58869, 58870, 58871, 58872, 58873, 25 58874, 58875, 58876, 58877, 58878 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4762. 981 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 58879, 58880, 58881, 58882, 58883, 58884, 58885, 58886, 58887, 58888, 58889 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4763. The probes having the nucleotide sequence represented by SEQ ID NOS: 58890, 58891, 58892, 58893, 58894, 58895, 58896, 58897, 58898, 58899, 58900 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4764. The probes having the nucleotide sequence represented by SEQ ID NOS: 58901, 58902, 58903, 58904, 58905, 58906, 58907, 58908, 58909, 58910, 58911 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4765. The probes having the nucleotide sequence represented by SEQ ID NOS: 58912, 58913, 58914, 58915, 58916, 58917, 58918, 58919, 58920, 58921, 58922 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4766. The probes having the nucleotide sequence represented by SEQ ID NOS: 58923, 58924, 58925, 58926, 58927, 58928, 58929, 58930, 58931, 58932, 58933 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4767. The probes having the nucleotide sequence represented by SEQ ID NOS: 58934, 58935, 58936, 58937, 58938, 58939, 58940, 58941, 58942, 58943, 58944 were selected from the 982 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4768. The probes having the nucleotide sequence represented by SEQ ID NOS: 58945, 58946, 58947, 58948, 58949, 58950, 5 58951, 58952, 58953, 58954, 58955 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4769. The probes having the nucleotide sequence represented by SEQ ID NOS: 58956, 58957, 58958, 58959, 58960, 58961, 10 58962, 58963, 58964, 58965, 58966 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4770. The probes having the nucleotide sequence represented by SEQ ID NOS: 58967, 58968, 58969, 58970, 58971, 58972, 15 58973, 58974, 58975, 58976, 58977 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4771. The probes having the nucleotide sequence represented by SEQ ID NOS: 58978, 58979, 58980, 58981, 58982, 58983, 20 58984, 58985, 58986, 58987, 58988 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4772. The probes having the nucleotide sequence represented by SEQ ID NOS: 58989, 58990, 58991, 58992, 58993, 58994, 25 58995, 58996, 58997, 58998, 58999 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4773. 983 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 59000, 59001, 59002, 59003, 59004, 59005, 59006, 59007, 59008, 59009, 59010 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4774. The probes having the nucleotide sequence represented by SEQ ID NOS: 59011, 59012, 59013, 59014, 59015, 59016, 59017, 59018, 59019, 59020, 59021 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4775. The probes having the nucleotide sequence represented by SEQ ID NOS: 59022, 59023, 59024, 59025, 59026, 59027, 59028, 59029, 59030, 59031, 59032 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4776. The probes having the nucleotide sequence represented by SEQ ID NOS: 59033, 59034, 59035, 59036, 59037, 59038, 59039, 59040, 59041, 59042, 59043 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4777. The probes having the nucleotide sequence represented by SEQ IDNOS: 59044, 59045, 59046, 59047, 59048, 59049, 59050, 59051, 59052, 59053, 59054 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4778. The probes having the nucleotide sequence represented by SEQ ID NOS: 59055, 59056, 59057, 59058, 59059, 59060, 59061, 59062, 59063, 59064, 59065 were selected from the 984 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4779. The probes having the nucleotide sequence represented by SEQ ID NOS: 59066, 59067, 59068, 59069, 59070, 59071, 5 59072, 59073, 59074, 59075, 59076 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4780. The probes having the nucleotide sequence represented by SEQ ID NOS: 59077, 59078, 59079, 59080, 59081, 59082, 10 59083, 59084, 59085, 59086, 59087 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4781. The probes having the nucleotide sequence represented by SEQ ID NOS: 59088, 59089, 59090, 59091, 59092, 59093, 15 59094, 59095, 59096, 59097, 59098 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4782. The probes having the nucleotide sequence represented by SEQ ID NOS: 59099, 59100, 59101, 59102, 59103, 59104, 20 59105, 59106, 59107, 59108, 59109 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4783. The probes having the nucleotide sequence represented by SEQ ID NOS: 59110, 59111, 59112, 59113, 59114, 59115, 25 59116, 59117, 59118, 59119, 59120 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4784. 985 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 59121, 59122, 59123, 59124, 59125, 59126, 59127, 59128, 59129, 59130, 59131 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4785. The probes having the nucleotide sequence represented by SEQ ID NOS: 59132, 59133, 59134, 59135, 59136, 59137, 59138, 59139, 59140, 59141, 59142 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4786. The probes having the nucleotide sequence represented by SEQ ID NOS: 59143, 59144, 59145, 59146, 59147, 59148, 59149, 59150, 59151, 59152, 59153 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4787. The probes having the nucleotide sequence represented by SEQ ID NOS: 59154, 59155, 59156, 59157, 59158, 59159, 59160, 59161, 59162, 59163, 59164 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4788. The probes having the nucleotide sequence represented by SEQ ID NOS: 59165, 59166, 59167, 59168, 59169, 59170, 59171, 59172, 59173, 59174, 59175 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4789. The probes having the nucleotide sequence represented by SEQ ID NOS: 59176, 59177, 59178, 59179, 59180, 59181, 59182, 59183, 59184, 59185, 59186 were selected from the 986 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4790. The probes having the nucleotide sequence represented by SEQ ID NOS: 59187, 59188, 59189, 59190, 59191, 59192, 5 59193, 59194, 59195, 59196, 59197 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4791. The probes having the nucleotide sequence represented by SEQ ID NOS: 59198, 59199, 59200, 59201, 59202, 59203, 10 59204, 59205, 59206, 59207, 59208 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4792. The probes having the nucleotide sequence represented by SEQ ID NOS: 59209, 59210, 59211, 59212, 59213, 59214, 15 59215, 59216, 59217, 59218, 59219 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4793. The probes having the nucleotide sequence represented by SEQ ID NOS: 59220, 59221, 59222, 59223, 59224, 59225, 20 59226, 59227, 59228, 59229, 59230 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4794. The probes having the nucleotide sequence represented by SEQ ID NOS: 59231, 59232, 59233, 59234, 59235, 59236, 25 59237, 59238, 59239, 59240, 59241 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4795. 987 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 59242, 59243, 59244, 59245, 59246, 59247, 59248, 59249, 59250, 59251, 59252 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4796. The probes having the nucleotide sequence represented by SEQ ID NOS: 59253, 59254, 59255, 59256, 59257, 59258, 59259, 59260, 59261, 59262, 59263 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4797. The probes having the nucleotide sequence represented by SEQ ID NOS: 59264, 59265, 59266, 59267, 59268, 59269, 59270, 59271, 59272, 59273, 59274 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4798. The probes having the nucleotide sequence represented by SEQ ID NOS: 59275, 59276, 59277, 59278, 59279, 59280, 59281, 59282, 59283, 59284, 59285 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4799. The probes having the nucleotide sequence represented by SEQ ID NOS: 59286, 59287, 59288, 59289, 59290, 59291, 59292, 59293, 59294, 59295, 59296 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4800. The probes having the nucleotide sequence represented by SEQ ID NOS: 59297, 59298, 59299, 59300, 59301, 59302, 59303, 59304, 59305, 59306, 59307 were selected from the 988 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4801. The probes having the nucleotide sequence represented by SEQ ID NOS: 59308, 59309, 59310, 59311, 59312, 59313, 5 59314, 59315, 59316, 59317, 59318 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4802. The probes having the nucleotide sequence represented by SEQ ID NOS: 59319, 59320, 59321, 59322, 59323, 59324, 10 59325, 59326, 59327, 59328, 59329 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4803. The probes having the nucleotide sequence represented by SEQ ID NOS: 59330, 59331, 59332, 59333, 59334, 59335, 15 59336, 59337, 59338, 59339, 59340 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4804. The probes having the nucleotide sequence represented by SEQ ID NOS: 59341, 59342, 59343, 59344, 59345, 59346, 20 59347, 59348, 59349, 59350, 59351 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4805. The probes having the nucleotide sequence represented by SEQ ID NOS: 59352, 59353, 59354, 59355, 59356, 59357, 25 59358, 59359, 59360, 59361, 59362, 59363, 59364, 59365, 59366, 59367, 59368, 59369, 59370, 59371, 59372, 59373 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4806. 989 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 59374, 59375, 59376, 59377, 59378, 59379, 59380, 59381, 59382, 59383, 59384 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4807. The probes having the nucleotide sequence represented by SEQ ID NOS: 59385, 59386, 59387, 59388, 59389, 59390, 59391, 59392, 59393, 59394, 59395 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4808. The probes having the nucleotide sequence represented by SEQ ID NOS: 59396, 59397, 59398, 59399, 59400, 59401, 59402, 59403, 59404, 59405, 59406 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4809. The probes having the nucleotide sequence represented by SEQ ID NOS: 59407, 59408, 59409, 59410, 59411, 59412, 59413, 59414, 59415, 59416, 59417 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4810. The probes having the nucleotide sequence represented by SEQ ID NOS: 59418, 59419, 59420, 59421, 59422, 59423, 59424, 59425, 59426, 59427, 59428 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4811. The probes having the nucleotide sequence represented by SEQ ID NOS: 59429, 59430, 59431, 59432, 59433, 59434, 59435, 59436, 59437, 59438, 59439 were selected from the 990 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4812. The probes having the nucleotide sequence represented by SEQ ID NOS: 59440, 59441, 59442, 59443, 59444, 59445, 5 59446, 59447, 59448, 59449, 59450 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4813. The probes having the nucleotide sequence represented by SEQ ID NOS: 59451, 59452, 59453, 59454, 59455, 59456, 10 59457, 59458, 59459, 59460, 59461 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4814. The probes having the nucleotide sequence represented by SEQ ID NOS: 59462, 59463, 59464, 59465, 59466, 59467, 15 59468, 59469, 59470, 59471, 59472 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4815. The probes having the nucleotide sequence represented by SEQ ID NOS: 59473, 59474, 59475, 59476, 59477, 59478, 20 59479, 59480, 59481, 59482, 59483 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4816. The probes having the nucleotide sequence represented by SEQ ID NOS: 59484, 59485, 59486, 59487, 59488, 59489, 25 59490, 59491, 59492, 59493, 59494 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4817. 991 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 59495, 59496, 59497, 59498, 59499, 59500, 59501, 59502, 59503, 59504, 59505 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4818. The probes having the nucleotide sequence represented by SEQ ID NOS: 59506, 59507, 59508, 59509, 59510, 59511, 59512, 59513, 59514, 59515, 59516 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4819. The probes having the nucleotide sequence represented by SEQ ID NOS: 59517, 59518, 59519, 59520, 59521, 59522, 59523, 59524, 59525, 59526, 59527 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4820. The probes having the nucleotide sequence represented by SEQ ID NOS: 59528, 59529, 59530, 59531, 59532, 59533, 59534, 59535, 59536, 59537, 59538 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4821. The probes having the nucleotide sequence represented by SEQ ID NOS: 59539, 59540, 59541, 59542, 59543, 59544, 59545, 59546, 59547, 59548, 59549 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4822. The probes having the nucleotide sequence represented by SEQ ID NOS: 59550, 59551, 59552, 59553, 59554, 59555, 59556, 59557, 59558, 59559, 59560 were selected from the 992 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4823. The probes having the nucleotide sequence represented by SEQ ID NOS: 59561, 59562, 59563, 59564, 59565, 59566, 5 59567, 59568, 59569, 59570, 59571 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4824. The probes having the nucleotide sequence represented by SEQ ID NOS: 59572, 59573, 59574, 59575, 59576, 59577, 10 59578, 59579, 59580, 59581, 59582 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4825. The probes having the nucleotide sequence represented by SEQ ID NOS: 59583, 59584, 59585, 59586, 59587, 59588, 15 59589, 59590, 59591, 59592, 59593 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4826. The probes having the nucleotide sequence represented by SEQ ID NOS: 59594, 59595, 59596, 59597, 59598, 59599, 20 59600, 59601, 59602, 59603, 59604 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4827. The probes having the nucleotide sequence represented by SEQ ID NOS: 59605, 59606, 59607, 59608, 59609, 59610, 25 59611, 59612, 59613, 59614, 59615, 59616, 59617, 59618, 59619, 59620, 59621, 59622, 59623, 59624, 59625, 59626 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4828. 993 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 59627, 59628, 59629, 59630, 59631, 59632, 59633, 59634, 59635, 59636, 59637 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4829. The probes having the nucleotide sequence represented by SEQ ID NOS: 59638, 59639, 59640, 59641, 59642, 59643, 59644, 59645, 59646, 59647, 59648 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4830. The probes having the nucleotide sequence represented by SEQ ID NOS: 59649, 59650, 59651, 59652, 59653, 59654, 59655, 59656, 59657, 59658, 59659 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4831. The probes having the nucleotide sequence represented by SEQ ID NOS: 59660, 59661, 59662, 59663, 59664, 59665, 59666, 59667, 59668, 59669, 59670 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4832. The probes having the nucleotide sequence represented by SEQ ID NOS: 59671, 59672, 59673, 59674, 59675, 59676, 59677, 59678, 59679, 59680, 59681 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4833. The probes having the nucleotide sequence represented by SEQ ID NOS: 59682, 59683, 59684, 59685, 59686, 59687, 59688, 59689, 59690, 59691, 59692 were selected from the 994 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4834. The probes having the nucleotide sequence represented by SEQ ID NOS: 59693, 59694, 59695, 59696, 59697, 59698, 5 59699, 59700, 59701, 59702, 59703 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4835. The probes having the nucleotide sequence represented by SEQ ID NOS: 59704, 59705, 59706, 59707, 59708, 59709, 10 59710, 59711, 59712, 59713, 59714 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4836. The probes having the nucleotide sequence represented by SEQ ID NOS: 59715, 59716, 59717, 59718, 59719, 59720, 15 59721, 59722, 59723, 59724, 59725 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4837. The probes having the nucleotide sequence represented by SEQ ID NOS: 59726, 59727, 59728, 59729, 59730, 59731, 20 59732, 59733, 59734, 59735, 59736 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4838. The probes having the nucleotide sequence represented by SEQ ID NOS: 59737, 59738, 59739, 59740, 59741, 59742, 25 59743, 59744, 59745, 59746, 59747 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4839. 995 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 59748, 59749, 59750, 59751, 59752, 59753, 59754, 59755, 59756, 59757, 59758 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4840. The probes having the nucleotide sequence represented by SEQ ID NOS: 59759, 59760, 59761, 59762, 59763, 59764, 59765, 59766, 59767, 59768, 59769 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4841. The probes having the nucleotide sequence represented by SEQ ID NOS: 59770, 59771, 59772, 59773, 59774, 59775, 59776, 59777, 59778, 59779, 59780 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4842. The probes having the nucleotide sequence represented by SEQ ID NOS: 59781, 59782, 59783, 59784, 59785, 59786, 59787, 59788, 59789, 59790, 59791 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4843. The probes having the nucleotide sequence represented by SEQ ID NOS: 59792, 59793, 59794, 59795, 59796, 59797, 59798, 59799, 59800, 59801, 59802 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4844. The probes having the nucleotide sequence represented by SEQ ID NOS: 59803, 59804, 59805, 59806, 59807, 59808, 59809, 59810, 59811, 59812, 59813 were selected from the 996 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4845. The probes having the nucleotide sequence represented by SEQ ID NOS: 59814, 59815, 59816, 59817, 59818, 59819, 5 59820, 59821, 59822, 59823, 59824 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4846. The probes having the nucleotide sequence represented by SEQ ID NOS: 59825, 59826, 59827, 59828, 59829, 59830, 10 59831, 59832, 59833, 59834, 59835 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4847. The probes having the nucleotide sequence represented by SEQ ID NOS: 59836, 59837, 59838, 59839, 59840, 59841, 15 59842, 59843, 59844, 59845, 59846 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4848. The probes having the nucleotide sequence represented by SEQ ID NOS: 59847, 59848, 59849, 59850, 59851, 59852, 20 59853, 59854, 59855, 59856, 59857 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4849. The probes having the nucleotide sequence represented by SEQ ID NOS: 59858, 59859, 59860, 59861, 59862, 59863, 25 59864, 59865, 59866, 59867, 59868 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4850. 997 WO 2006/024951 PCT/IB2005/002908 The probes having the nucleotide sequence represented by SEQ ID NOS: 59869, 59870, 59871, 59872, 59873, 59874, 59875, 59876, 59877, 59878, 59879 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 5 NO: 4851. The probes having the nucleotide sequence represented by SEQ ID NOS: 59880, 59881, 59882, 59883, 59884, 59885, 59886, 59887, 59888, 59889, 59890 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 10 NO: 4852. The probes having the nucleotide sequence represented by SEQ ID NOS: 59891, 59892, 59893, 59894, 59895, 59896, 59897, 59898', 59899, 59900, 59901 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 15 NO: 4853. The probes having the nucleotide sequence represented by SEQ ID NOS: 59902, 59903, 59904, 59905, 59906, 59907, 59908, 59909, 59910, 59911, 59912 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 20 NO: 4854. The probes having the nucleotide sequence represented by SEQ ID NOS: 59913, 59914, 59915, 59916, 59917, 59918, 59919, 59920, 59921, 59922, 59923 were selected from the ORFs having the nucleotide sequence represented by SEQ ID 25 NO: 4855. The probes having the nucleotide sequence represented by SEQ ID NOS: 59924, 59925, 59926, 59927, 59928, 59929, 59930, 59931, 59932, 59933, 59934 were selected from the 998 WO 2006/024951 PCT/IB2005/002908 ORFs having the nucleotide sequence represented by SEQ ID NO: 4856. The probes having the nucleotide sequence represented by SEQ ID NOS: 59935, 59936, 59937, 59938, 59939, 59940, 5 59941, 59942, 59943, 59944, 59945 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4857. The probes having the nucleotide sequence represented by SEQ ID NOS: 59946, 59947, 59948, 59949, 59950, 59951, 10 59952, 59953, 59954, 59955, 59956 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4858. The probes having the nucleotide sequence represented by SEQ ID NOS: 59957, 59958, 59959, 59960, 59961, 59962, 15 59963, 59964, 59965, 59966, 59967 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4859. The probes having the nucleotide sequence represented by SEQ ID NOS: 59968, 59969, 59970, 59971, 59972, 59973, 20 59974, 59975, 59976, 59977, 59978 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4860. The probes having the nucleotide sequence represented by SEQ ID NOS: 59979, 59980, 59981, 59982, 59983, 59984, 25 59985, 59986, 59987, 59988, 59989 were selected from the ORFs having the nucleotide sequence represented by SEQ ID NO: 4861. 999

Claims (44)

1. A method for analyzing gene of an industrial yeast comprising 5 (a) analyzing nucleotide sequence of the genome sequence of the industrial yeast; and (c-1) selecting a gene of the industrial yeast encoding an amino acid sequence having 70 to 97% identity to an amino acid sequence encoded by the gene of Saccharomyces 10 cerevisiae, or (c-2) selecting a gene of the industrial yeast consisting of a nucleotide sequence having 60 to 94% identity to the nucleotide sequence of the gene of Saccharomyces cerevisiae. 15

2. The analyzing method according to Claim 1, comprising, (b) comparing the genome sequence of the industrial yeast with the genome sequence of Saccharomyces cerevisiae 20 after the step (a) and before the step (c-1) or (c-2).

3. The analyzing method according to Claim 1 or 2, comprising (d) carrying out functional analysis of the selected 25 gene after the step (c-1) or (c-2).

4. The analyzing method according to Claim 3, which comprises screening genes involved in increase of 3078 WO 2006/024951 PCT/IB2005/002908 productivity and/or improvement in flavor in the production of an alcohol or an alcoholic beverage by the functional analysis of the step (d).

5 5. The analyzing method according to Claim 3 or 4, wherein the functional analysis is performed by disruption of a gene or overexpression of a gene.

6. The analyzing method according to any of Claims 1 10 5, wherein the industrial yeast is a brewing yeast .

7. The analyzing method according to Claim 6, wherein the brewing yeast is a beer yeast. 15

8. The analyzing method according to Claim 7, wherein the beer yeast is a bottom fermenting yeast.

9. A gene of the industrial yeast encoding an amino acid sequence having 70 to 97% identity to an amino acid 20 sequence encoded by the gene of Saccharomyces cerevisiae, or consisting of a nucleotide sequence having 60 to 94% identity to the nucleotide sequence of the gene of Saccharomyces cerevisiae, which is obtained by the analyzing method according to any one of Claims 1-8. 25

10. A gene library comprising one or more of genes of the industrial yeast each of which encodes an amino acid sequence having 70 to 97% identity to an amino acid 3079 WO 2006/024951 PCT/IB2005/002908 sequence encoded by the gene of Saccharomyces cerevisiae, or consists of a nucleotide sequence having 60 to 94% identity to the nucleotide sequence of the gene of Saccharomyces cerevisiae, which is obtained by the 5 analyzing method according to any one of Claims 1-8.

11. The gene library according to Claim 10, wherein the gene of the industrial yeast is comprised in, consists of or has any nucleotide sequence selected from SEQ ID 10 NOs:33 to 6236, SEQ ID NOs:166154 to 166181, SEQ ID NOs:166490 to 167042 and SEQ ID NOs:173125 to 174603.

12. A DNA array comprising one or more of DNAs, wherein each DNA is selected from at least one group of (1) 15 to (4): (1) DNA consisting of a nucleotide sequence of an open reading frame of the genome sequence of an industrial yeast which encodes an amino acid sequence having 70 to 97% identity to an amino acid sequence encoded by the gene of 20 Saccharomyces cerevisiae, or a nucleotide sequence complementary to the above nucleotide sequence, or a nucleotide sequence of continuous 10 or more nucleotides selected from the above nucleotide sequences; (2) DNA consisting of a nucleotide sequence of the 25 genome sequence of an industrial yeast other than from open reading frames which consists of a nucleotide sequence having 60 to 94% identity to the nucleotide sequence of the gene of Saccharomyces cerevisiae, or a nucleotide sequence 3080 WO 2006/024951 PCT/IB2005/002908 complementary to the above nucleotide sequence, or a nucleotide sequence of continuous 10 or more nucleotides selected from the above nucleotide sequences; (3) DNA having a nucleotide sequence of any of SEQ ID 5 NOs:166490 to 167042, or DNA having a nucleotide sequence of any of SEQ ID NOs:167043 to 173124;and (4) DNA having a nucleotide sequence of any of SEQ ID NOs:173125 to 174603, or DNA having a nucleotide sequence of any of SEQ ID NOs:174604 to 190810. 10

13. The DNA array according to Claim 12 comprising DNAs wherein at least one DNA is selected from every group of (1) to (4). 15

14. The DNA array according to Claim 12 or 13, wherein the DNAs of (1) is comprised in, consists of or has any nucleotide sequence selected from SEQ ID NOs:33 to 6236, SEQ ID NOs:166154 to 166181, SEQ ID NOs:6237 to 75336 and SEQ ID NOs:166182 to 166489. 20

15. The DNA array according to any one of Claims 12 14, which further comprises, in addition to at least one group of DNAs selected from (1) to (4), DNAs of the following (5) and/or (6),: 25 (5) DNA consisting of a nucleotide sequence of an open reading frame of the genome sequence of an industrial yeast which encodes an amino acid sequence having identity of more than 97% to an amino acid sequence encoded by the gene 3081 WO 2006/024951 PCT/IB2005/002908 of Saccharomyces cerevisiae, or a nucleotide sequence complementary to the above nucleotide sequence, or a nucleotide sequence of continuous 10 or more nucleotides selected from the above nucleotide sequences; and 5 (6) DNA consisting of a nucleotide sequence of the genome sequence of an industrial yeast other than from open reading frames which consists of a nucleotide sequence having identity of more than 94% to the nucleotide sequence of the gene of Saccharomyces cerevisiae, or a nucleotide 10 sequence complementary to the above nucleotide sequence, or a nucleotide sequence of continuous 10 or more nucleotides selected from the above nucleotide sequences, and optionally comprises DNAs of the following (5') and/or (6'): 15 (5') DNA consisting of a nucleotide sequence which contains mismatch of 1 or more base(s) to the DNA of (5), or a nucleotide sequence complementary to the above nucleotide sequence; and (6') DNA consisting of a nucleotide sequence which 20 contains mismatch of 1 or more base(s) to the DNA of (6), or a nucleotide sequence complementary to the above nucleotide sequence.

16. The DNA array according to Claim 15, wherein the 25 DNAs of (5) has a nucleotide sequence of any one of SEQ ID NOs:75337 to 82784, or SEQ ID NOs:82785 to 166153. 3082 WO 2006/024951 PCT/IB2005/002908

17. The DNA array according to any one of Claims 12 16, which comprises, in addition to at least one group of DNAs selected from (1) to (4), DNAs selected from at least one of (7) to (10): 5 (7) DNA consisting of a nucleotide sequence which contains mismatch of 1 or more base(s) to the DNA of (1), or a nucleotide sequence complementary to the above nucleotide sequence; (8) DNA consisting of a nucleotide sequence which 10 contains mismatch of 1 or more base(s) to the DNA of (2), or a nucleotide sequence complementary to the above nucleotide sequence; (9) DNA consisting of a nucleotide sequence which contains mismatch of 1 or more base(s) to the DNA of (3), 15 or a nucleotide sequence complementary to the above nucleotide sequence; and (10) DNA consisting of a nucleotide sequence which contains mismatch of 1 or more base(s) to the DNA of (4), or a nucleotide sequence complementary to the above 20 nucleotide sequence.

18. The DNA array according to Claim 17, which comprises, in addition to at least one group of DNAs selected from (1) to (4), DNAs selected from at least one 25 of (7-1) to (10-1): (7-1) DNA consisting of a nucleotide sequence which contains mismatch of 1 base to the DNA of (1), or a 3083 WO 2006/024951 PCT/IB2005/002908 nucleotide sequence complementary to the above nucleotide sequence; (8-1) DNA consisting of a nucleotide sequence which contains mismatch of 1 base to the DNA of (2), or a 5 nucleotide sequence complementary to the above nucleotide sequence; (9-1) DNA consisting of a nucleotide sequence which contains mismatch of 1 base to the DNA of (3), or a nucleotide sequence complementary to the above nucleotide 10 sequence; and (10-1) DNA consisting of a nucleotide sequence which contains mismatch of 1 base to the DNA of (4), or a nucleotide sequence complementary to the above nucleotide sequence. 15

19. The DNA array according to any one of Claims 12 18, which comprises at least one group of DNAs selected from (1) to (4), at least one group of DNAs selected from (7) to (10), DNAs of (5) and/or (6) and DNAs of (5') and/or 20 (6').

20. The DNA array according to any one of Claims 12 19, wherein the DNAs are oligonucleotides consisting of 10 30 nucleotides. 25

21. Use of the DNA array according to any one of Claims 12-20 for an analyzing method of genes of an industrial yeast. 3084 WO 2006/024951 PCT/IB2005/002908

22. A method for classifying an industrial yeast comprising (a) hybridizing genomic DNA prepared from the industrial 5 yeast to the DNA array of any one of Claims 15-20; and (b) calculating hybridization ratio to any of (1) to (4), and hybridization ratio to (5) and/or (6).

23. The method for classification according to Claim 10 22, wherein the DNA array of Claim 19 is used, and percentage of genes which hybridize to DNAs of (1) and/or (2), but not to DNAs of (7) and/or (8) is determined as hybridization ratio to any of (1) to (4), and percentage of genes which hybridize to DNAs of (5) 15 and/or (6), but not to DNAs of (5') and/or (6') is determined as hybridization ratio to any of (5) and/or (6).

24. A method for detecting nucleotide polymorphism in genome of an industrial yeast comprising 20 (a) hybridizing genomic DNA prepared from the industrial yeast to the DNA array of any one of Claims 17-20; and (b) selecting a gene wherein hybridization intensity to the DNAs of any of (7) to (10) is higher than hybridization intensity to the DNAs of any of (1) to (4). 25

25. A method for screening a useful strain of industrial yeast, comprising 3085 WO 2006/024951 PCT/IB2005/002908 (a) hybridizing genomic DNA prepared from the industrial yeast strain to the DNA array of any one of Claims 12-20; and (b) determining the industrial yeast strain as useful 5 when the strain contain 1 or more genes wherein hybridization intensity thereof is 1.5 times higher, or 2/3 or less compared to an average hybridization intensity to the DNAs of any of (1) to (4). 10

26. A method for screening a gene of an industrial yeast, comprising (a) hybridizing genomic DNA prepared from the industrial yeast strain to the DNA array of any one of Claims 12-20; and 15 (b) selecting a gene wherein hybridization intensity thereof is 1.5 times higher, or 2/3 or less compared to an average hybridization intensity to the DNAs of any of (1) to (4). 20

27. A method for screening a gene of an industrial yeast, comprising (a-1) hybridizing genomic DNA, cDNA or cRNA prepared from the industrial yeast to the DNA array of any one of Claims 12-20; 25 (a-2) independently from the step (a-1), hybridizing genomic DNA, cDNA or cRNA prepared from another indystrial yeast to the DNA array of any one of Claims 12-20; and 3086 WO 2006/024951 PCT/IB2005/002908 (b) selecting a gene wherein hybridization intensity thereof to the DNAs of any of (1) to (4) at the step (a-1) is significantly different from hybridization intensity thereof at the step (a-2). 5

28. A method for screening a gene of an industrial yeast, comprising (a-1) hybridizing cDNA or cRNA prepared from the industrial yeast to the DNA array of any one of Claims 12 10 20; (a-2) independently from the step (a-1), hybridizing cDNA or cRNA prepared from the industrial yeast to the DNA array of any one of Claims 12-20, wherein the industrial yeast of (a-2) has been cultured in a different condition from the 15 culture condition for the industrial yeast of (a-1); and (b) selecting a gene wherein hybridization intensity thereof to the DNAs of any of (1) to (4) at the step (a-1) is significantly different from hybridization intensity thereof at the step (a-2). 20

29. A gene obtained by the screening method of any one of Claims 26-28.

30. The gene according to Claim 9 or 29 characterized 25 in that concentration of sulfite in a culture medium of an industrial yeast increases when the gene is expressed in the yeast. 3087 WO 2006/024951 PCT/IB2005/002908

31. A nucleic acid encoding a polypeptide of any one of the following i) and ii): i) a polypeptide having the amino acid sequence represented by SEQ ID NO:3, and 5 ii) a polypeptide having an amino acid sequence wherein one or more amino acid residue(s) is deleted from, substituted for and/or added to the amino acid sequence represented by SEQ ID NO:3, and having an activity to increase concentration of sulfite in a culture medium of an 10 industrial yeast when the gene is expressed in the yeast.

32. The nucleic acid according to Claim 31, which is selected from the following a) and b): (a) a nucleic acid having the nucleotide sequence 15 represented by SEQ ID NO:1; and (b) a nucleic acid having a nucleotide sequence which hybridizes to the nucleotide sequence complementary to the nucleotide sequence represented by SEQ ID NO:1 under a stringent condition, and encodes a polypeptide having an 20 activity to increase concentration of sulfite in a culture medium of an industrial yeast when the gene is expressed in the yeast.

33. A recombinant vector containing the gene of Claim 25 9 or Claims 29-30, or the nucleic acid of Claims 31-32.

34. A transformant comprising the recombinant vector of Claim 33. 3088 WO 2006/024951 PCT/IB2005/002908

35. The transformant according to Claim 34, which is a yeast of genus Saccharomyces. 5

36. A polypeptide of any one of the following i) and ii): i) a polypeptide having the amino acid sequence represented by SEQ ID NO:3; and ii) a polypaptide having an amino acid sequence wherein 10 one or more amino acid residue(s) is deleted from, substituted for and/or added to the amino acid sequence represented by SEQ ID N:3, and having an activity to increase concentration of sulfite in a culture medium of an industrial yeast when the gene is expressed in the yeast. 15

37. The polypeptide according to Claim 36, which is encoded by a nucleic acid selected from the following a) and b): (a) a nucleic acid having the nucleotide sequence 20 represented by SEQ ID NO:1; and (b) a nucleic acid having a nucleotide sequence which hybridizes to the nucleotide sequence complementary to the nucleotide sequence represented by SEQ ID No.1 under a stringent condition, and encodes a polypeptide having an 25 activity to increase concentration of sulfite in a culture medium of an industrial yeast when the gene is expressed in the yeast. 3089 WO 2006/024951 PCT/IB2005/002908

38. A method for producing an alcohol or an alcoholic beverage, using the transformant of Claim 34 or 35.

39. A breeding method of yeast which is suitable for 5 the production of an alcohol or an alcoholic beverage, characterized in that, expression of the gene of Claim 9 or Claims 29-30, or the nucleic acid of Claim 31-32 is controlled. 10

40. The breeding method according to Claim 39, wherein the yeast belongs to the genus Saccharomyces.

41. Yeast obtained by the breeding method of Claim 39 or 40. 15

42. A method for producing an alcohol or an alcoholic beverage using the yeast mentioned in Claim 41.

43. An alcohol or an alcoholic beverage which is 20 produced by the producing method of Claim 42.

44. A method for analyzing gene of an industrial yeast comprising (c-1) selecting a gene of the industrial yeast.encoding 25 an amino acid sequence having 70 to 97% identity to an amino acid sequence encoded by the gene of Saccharomyces cerevisiae, or 3090 WO 2006/024951 PCT/IB2005/002908 (c-2) selecting a gene of the industrial yeast consisting of a nucleotide sequence having 60 to 94% identity to the nucleotide sequence of the gene of Saccharomyces cerevisiae. 5 3091